collection_id,dataset_id,subjectkey,src_subject_id,interview_age,interview_date,gender,visitid,visit,truncvis,phase_ct,visday,medad01,medad03,medad06,medad07,msa04,msa04b,medad08,medad10,medad11,medad13,medad14,capsules,dose1,dose2,dose3,presreg1,presreg2,avgcaps1,avgdose1,moddose1,catcaps1,avgcaps2,avgdose2,moddose2,catcaps2,avgdose3,moddose3,max1,max2,max3,madh12a,madh12b,madh13,treat_1,treat2,treat_3,dur_1,dur_2,dur_3,lowdose,highdose,dose,first_d,last_d,first_c,last_c,first_v,last_v,dse_adj1,dse_adj2,compl_1,compl_1c,compl_2,compl_2c,compl_3,compl_3c,b1_day,b2_day,b3_day,boc_day,e1_day,e2_day,e3_day,eoc_day,es_day,b3_cgic,b3_resp,collection_title
2081,8974,NDAR_INVAA412BBY,2341,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,800,Visit2,2,Phase 2,33,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,1000,Visit3,3,Phase 2,61,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,1200,Visit4,4,Phase 2,89,2,91,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,1600,Visit6,6,Phase 3,147,3,,,,,,1,15,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,1800,Visit7,7,Phase 3,174,3,,,,,,1,15,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,2000,Visit8,8,Phase 3,201,3,,,,,,1,15,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,2200,Visit9,9,Phase 3,225,3,,,,,,3,2,1,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,2400,Visit10,10,Phase 3,256,3,,,,,,1,20,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,2600,Visit11,11,Phase 3,286,3,,,,,,1,20,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,2800,Visit12,12,Phase 3,314,3,,,,,,1,20,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,3000,Visit13,13,Phase 3,344,3,,,,,,1,20,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,3200,Visit14,14,Phase 3,370,3,,,,,,1,20,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,3400,Visit15,15,Phase 3,407,3,,,,,,1,20,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,3600,Visit16,16,Phase 3,431,3,,,,,,1,20,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,3800,Visit17,17,Phase 3,462,3,,,,,,1,20,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,19,1 or 1A,100,3,,1,,,,,,1,3,120,,,2,2,3,120,120,3,3,23,15,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,5800,EndofPhase2,5,Phase 2,117,2,96,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB125GA8,2667,,,M,6000,EndofPhase3,18,Phase 3,489,3,,,,,,1,20,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,97,3,,1,,,,,,1,3,24,,,1,,4,28,28,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,1000,Visit3,3,Phase 1B,69,1B,86,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,1200,Visit4,4,Phase 1B,97,1B,95,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,1400,Visit5,5,Phase 1B,131,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,1600,Visit6,6,Phase 1B,167,1B,99,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,1800,Visit7,7,Phase 1B,194,1B,76,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,2000,Visit8,8,Phase 1B,222,1B,96,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,2200,Visit9,9,Phase 1B,250,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,2400,Visit10,10,Phase 1B,281,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,2600,Visit11,11,Phase 1B,309,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,2800,Visit12,12,Phase 1B,336,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,3000,Visit13,13,Phase 1B,364,1B,82,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,3200,Visit14,14,Phase 1B,393,1B,91,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,3400,Visit15,15,Phase 1B,426,1B,96,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,3600,Visit16,16,Phase 1B,449,1B,88,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,3800,Visit17,17,Phase 1B,477,1B,99,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,42,1 or 1A,98,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB164FVP,2808,,,F,5400,EndofPhase1b,18,Phase 1B,505,1B,82,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,600,Visit1,1,Phase 1/1A,39,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,2,,4,30,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,800,Visit2,2,Phase 1/1A,68,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,1000,Visit3,3,Phase 1/1A,99,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,1200,Visit4,4,Phase 1/1A,128,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,1400,Visit5,5,Phase 1/1A,157,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,1600,Visit6,6,Phase 1/1A,187,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,1800,Visit7,7,Phase 1/1A,221,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,2000,Visit8,8,Phase 1/1A,249,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,2200,Visit9,9,Phase 1/1A,282,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,2400,Visit10,10,Phase 1/1A,311,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,2600,Visit11,11,Phase 1/1A,339,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,2800,Visit12,12,Phase 1/1A,362,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,3000,Visit13,13,Phase 1/1A,389,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,3200,Visit14,14,Phase 1/1A,421,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,3400,Visit15,15,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,3600,Visit16,16,Phase 1/1A,484,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,3800,Visit17,17,Phase 1/1A,512,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB580MK8,2748,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,558,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,91,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,77,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,84,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,2000,Visit8,8,Phase 1/1A,238,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,2200,Visit9,9,Phase 1/1A,265,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,2400,Visit10,10,Phase 1/1A,289,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,2600,Visit11,11,Phase 1/1A,317,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,2800,Visit12,12,Phase 1/1A,345,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,3000,Visit13,13,Phase 1/1A,373,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,3200,Visit14,14,Phase 1/1A,401,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,3600,Visit16,16,Phase 1/1A,461,1 or 1A,94,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,3800,Visit17,17,Phase 1/1A,496,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAB636BG0,1117,,,M,4000,Visit18,18,Phase 1/1A,530,1 or 1A,79,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,600,Visit1,1,Phase 1/1A,37,1 or 1A,,1,,1,,,,,,,1,8,,,2,,3,27,32,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,800,Visit2,2,Phase 1/1A,83,1 or 1A,88,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,1200,Visit4,4,Phase 1/1A,128,1 or 1A,92,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,1400,Visit5,5,Phase 1/1A,156,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,1800,Visit7,7,Phase 1/1A,210,1 or 1A,99,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,2000,Visit8,8,Phase 1/1A,239,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,2200,Visit9,9,Phase 1/1A,275,1 or 1A,84,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,2400,Visit10,10,Phase 1/1A,304,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,2600,Visit11,11,Phase 1/1A,325,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,3000,Visit13,13,Phase 1/1A,360,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,3200,Visit14,14,Phase 1/1A,388,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,3400,Visit15,15,Phase 1/1A,416,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,3600,Visit16,16,Phase 1/1A,444,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC199RGN,2676,,,F,5200,EndofPhase1_1a,17,Phase 1/1A,486,1 or 1A,100,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,94,2,,1,,,,,,1,2,3,,,1,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,73,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,74,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,94,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,82,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,85,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,78,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,93,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,98,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,2800,Visit12,12,Phase 1/1A,331,1 or 1A,95,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,93,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,96,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,86,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,96,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAC503FLF,2343,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,499,1 or 1A,86,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD098BRG,1395,,,F,600,Visit1,1,Phase 1/1A,22,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD098BRG,1395,,,F,800,Visit2,2,Phase 1/1A,50,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD098BRG,1395,,,F,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD098BRG,1395,,,F,1200,Visit4,4,Phase 1/1A,106,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD098BRG,1395,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD098BRG,1395,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD098BRG,1395,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD098BRG,1395,,,F,2000,Visit8,8,Phase 1/1A,232,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD098BRG,1395,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD098BRG,1395,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD098BRG,1395,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD098BRG,1395,,,F,2800,Visit12,12,Phase 1/1A,345,1 or 1A,89,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD098BRG,1395,,,F,5200,EndofPhase1_1a,12,Phase 1/1A,345,1 or 1A,89,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD165ECX,1174,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD165ECX,1174,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD165ECX,1174,,,F,1000,Visit3,3,Phase 1/1A,92,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD286JDE,2342,,,M,800,Visit2,2,Phase 2,33,2,75,2,,1,,,,,,2,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD286JDE,2342,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,16,1 or 1A,81,3,,1,,,,,,1,3,120,,,2,1,3,120,120,3,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD286JDE,2342,,,M,5800,EndofPhase2,3,Phase 2,55,2,53,2,,1,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,2200,Visit9,9,Phase 1/1A,275,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,2600,Visit11,11,Phase 1/1A,331,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,2800,Visit12,12,Phase 1/1A,365,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,3000,Visit13,13,Phase 1/1A,394,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,3200,Visit14,14,Phase 1/1A,421,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,3400,Visit15,15,Phase 1/1A,456,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,3800,Visit17,17,Phase 1/1A,515,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD465YGX,1106,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,543,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,82,2,,,,,,,,1,2,15,,,2,2,2,14,15,2,3,650,800,3,151,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,89,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,83,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,47,2,,,,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,1600,Visit6,6,Phase 2,169,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,1800,Visit7,7,Phase 2,195,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,2000,Visit8,8,Phase 2,225,2,98,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,2400,Visit10,10,Phase 3,267,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,2600,Visit11,11,Phase 3,302,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,2800,Visit12,12,Phase 3,344,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,3600,Visit16,16,Phase 3,451,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,3800,Visit17,17,Phase 3,479,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,139,1 or 1A,75,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,5800,EndofPhase2,9,Phase 2,231,2,88,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD713UKY,1438,,,M,6000,EndofPhase3,18,Phase 3,506,3,,,,,,4,160,,,3,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,800,Visit2,2,Phase 2,50,2,,4,,,,,,,,,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,1000,Visit3,3,Phase 2,85,2,,4,,,,,,,,,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,1200,Visit4,4,Phase 2,113,2,96,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,1400,Visit5,5,Phase 2,137,2,96,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,1600,Visit6,6,Phase 2,169,2,,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,1800,Visit7,7,Phase 2,200,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,2000,Visit8,8,Phase 2,228,2,,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,2200,Visit9,9,Phase 2,256,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,2400,Visit10,10,Phase 2,284,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,2600,Visit11,11,Phase 2,312,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,2800,Visit12,12,Phase 2,340,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,3000,Visit13,13,Phase 2,362,2,97,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,3200,Visit14,14,Phase 2,393,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,3400,Visit15,15,Phase 2,421,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,3600,Visit16,16,Phase 2,449,2,93,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,3800,Visit17,17,Phase 2,477,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,11,1 or 1A,100,2,,,,,,,,1,2,400,,,2,1,2,400,400,2,4,30,30,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAD778FDA,1284,,,M,5800,EndofPhase2,18,Phase 2,509,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAE861TMH,1997,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,1,,,,,,1,4,160,,,2,3,4,160,160,4,6,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAE861TMH,1997,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,81,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAE861TMH,1997,,,M,5800,EndofPhase2,4,Phase 2,109,2,99,6,,1,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF213GPT,1910,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,95,2,,,,,,,,1,2,400,,,2,,3,667,800,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF213GPT,1910,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF213GPT,1910,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF213GPT,1910,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF213GPT,1910,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,97,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF213GPT,1910,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF213GPT,1910,,,M,1800,Visit7,7,Phase 1/1A,216,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF213GPT,1910,,,M,2000,Visit8,8,Phase 1/1A,261,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF213GPT,1910,,,M,2200,Visit9,9,Phase 1/1A,285,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,89,2,,,,,,,,1,2,16,,,2,3,3,24,24,3,,475,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,1200,Visit4,4,Phase 1B,114,1B,97,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,1600,Visit6,6,Phase 1B,170,1B,94,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,1800,Visit7,7,Phase 1B,198,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,2000,Visit8,8,Phase 1B,226,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,2200,Visit9,9,Phase 1B,251,1B,75,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,2600,Visit11,11,Phase 2,310,2,100,,50,,,,,,,1,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,2800,Visit12,12,Phase 2,332,2,100,,350,,,,,,,1,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,3000,Visit13,13,Phase 2,365,2,100,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,3200,Visit14,14,Phase 2,394,2,98,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,3400,Visit15,15,Phase 2,421,2,92,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,3600,Visit16,16,Phase 2,449,2,100,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,3800,Visit17,17,Phase 2,477,2,100,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,100,1 or 1A,85,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,5400,EndofPhase1b,10,Phase 1B,283,1B,94,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF433XKU,1759,,,F,5800,EndofPhase2,18,Phase 2,507,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF531WD0,1495,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF531WD0,1495,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,91,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF531WD0,1495,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF531WD0,1495,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,88,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF531WD0,1495,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF531WD0,1495,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF531WD0,1495,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF531WD0,1495,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF531WD0,1495,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAF531WD0,1495,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,94,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,62,4,,1,,,,,,2,4,800,,,2,3,4,800,800,4,3,,,3,6,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,52,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,1400,Visit5,5,Phase 3,128,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,1600,Visit6,6,Phase 3,162,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,1800,Visit7,7,Phase 3,201,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,2000,Visit8,8,Phase 3,238,3,,,,,,3,6,,,2,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,2200,Visit9,9,Phase 3,259,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,2400,Visit10,10,Phase 3,296,3,,,,,,3,6,,,2,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,2600,Visit11,11,Phase 3,317,3,,,,,,3,6,,,2,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,2800,Visit12,12,Phase 3,341,3,,,,,,3,6,,,3,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,3000,Visit13,13,Phase 3,386,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,3200,Visit14,14,Phase 3,400,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,3600,Visit16,16,Phase 3,447,3,,,,,,3,6,,0,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,3800,Visit17,17,Phase 3,481,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,4000,Visit18,18,Phase 3,502,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG103CW4,1510,,,M,5800,EndofPhase2,4,Phase 2,92,2,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,400,,,2,2,3,564,400,3,3,4,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,33,2,,,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,2400,Visit10,10,Phase 1/1A,287,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,2600,Visit11,11,Phase 2,318,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,2800,Visit12,12,Phase 2,346,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,3000,Visit13,13,Phase 2,379,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,3200,Visit14,14,Phase 2,407,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,3400,Visit15,15,Phase 2,435,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,3600,Visit16,16,Phase 2,463,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,3800,Visit17,17,Phase 2,491,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,4000,Visit18,18,Phase 2,514,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG525AK1,1476,,,M,5200,EndofPhase1_1a,10,Phase 1/1A,287,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG751YU1,2846,,,F,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,,4,750,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG751YU1,2846,,,F,800,Visit2,2,Phase 1/1A,60,1 or 1A,85,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG751YU1,2846,,,F,1000,Visit3,3,Phase 1/1A,88,1 or 1A,78,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG751YU1,2846,,,F,1200,Visit4,4,Phase 1/1A,116,1 or 1A,70,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG751YU1,2846,,,F,1400,Visit5,5,Phase 1/1A,144,1 or 1A,67,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG751YU1,2846,,,F,1600,Visit6,6,Phase 1/1A,172,1 or 1A,45,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG751YU1,2846,,,F,1800,Visit7,7,Phase 1/1A,200,1 or 1A,61,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG751YU1,2846,,,F,2000,Visit8,8,Phase 1/1A,227,1 or 1A,25,4,,1,,,,,,4,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG751YU1,2846,,,F,2200,Visit9,9,Phase 1/1A,255,1 or 1A,42,4,,1,,,,,,3,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG751YU1,2846,,,F,2400,Visit10,10,Phase 1/1A,291,1 or 1A,41,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG751YU1,2846,,,F,5200,EndofPhase1_1a,10,Phase 1/1A,312,1 or 1A,92,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAG751YU1,2846,,,F,5800,EndofPhase2,10,Phase 2,315,1 or 1A,25,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,2,1,4,29,32,4,4,714,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,1600,Visit6,6,Phase 1B,169,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,1800,Visit7,7,Phase 1B,197,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,2000,Visit8,8,Phase 1B,226,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,2200,Visit9,9,Phase 1B,255,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,2400,Visit10,10,Phase 1B,281,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,2800,Visit12,12,Phase 2,337,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,3000,Visit13,13,Phase 2,365,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,3200,Visit14,14,Phase 2,394,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,3400,Visit15,15,Phase 2,417,2,100,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,3600,Visit16,16,Phase 2,445,2,94,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,3800,Visit17,17,Phase 2,477,2,100,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,149,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,5400,EndofPhase1b,11,Phase 1B,309,1B,92,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH218TDV,1170,,,M,5800,EndofPhase2,18,Phase 2,520,2,93,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,2,2,3,23,23,3,4,6,6,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,1200,Visit4,4,Phase 2,111,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,1400,Visit5,5,Phase 2,140,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,1600,Visit6,6,Phase 2,160,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,1800,Visit7,7,Phase 2,189,2,93,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,2000,Visit8,8,Phase 2,215,2,96,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,2200,Visit9,9,Phase 2,251,2,89,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,2400,Visit10,10,Phase 2,280,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,2600,Visit11,11,Phase 2,308,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,2800,Visit12,12,Phase 2,336,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,3000,Visit13,13,Phase 2,364,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,3200,Visit14,14,Phase 2,392,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,3400,Visit15,15,Phase 2,420,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,3600,Visit16,16,Phase 2,439,2,,4,,1,,,,,,,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,3800,Visit17,17,Phase 2,469,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,83,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAH389ZPX,2760,,,M,5800,EndofPhase2,18,Phase 2,490,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,2,11,8,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,1000,Visit3,3,Phase 1/1A,82,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,1400,Visit5,5,Phase 1/1A,145,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,1600,Visit6,6,Phase 1/1A,180,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,1800,Visit7,7,Phase 1/1A,208,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,2000,Visit8,8,Phase 1/1A,236,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,2200,Visit9,9,Phase 1/1A,257,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,2400,Visit10,10,Phase 1/1A,286,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,2600,Visit11,11,Phase 1/1A,313,1 or 1A,96,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,3000,Visit13,13,Phase 1/1A,371,1 or 1A,89,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,3200,Visit14,14,Phase 1/1A,419,1 or 1A,92,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,3400,Visit15,15,Phase 1/1A,455,1 or 1A,83,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,3600,Visit16,16,Phase 1/1A,477,1 or 1A,82,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,3800,Visit17,17,Phase 1/1A,498,1 or 1A,100,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ121PYR,1103,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,100,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ790CT2,2130,,,M,600,Visit1,1,Phase 1/1A,48,1 or 1A,100,2,,,,,,,,1,2,400,,,1,,2,350,200,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ790CT2,2130,,,M,800,Visit2,2,Phase 1/1A,97,1 or 1A,100,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ790CT2,2130,,,M,1000,Visit3,3,Phase 1/1A,125,1 or 1A,100,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAJ790CT2,2130,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,188,1 or 1A,0,3,,,,,,,,4,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK200YD8,1948,,,F,600,Visit1,1,Phase 1/1A,23,1 or 1A,24,2,,,,,,,,4,2,400,,,2,2,2,333,400,2,2,80,80,2,20,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK200YD8,1948,,,F,800,Visit2,2,Phase 1/1A,49,1 or 1A,,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK200YD8,1948,,,F,2400,Visit10,10,Phase 2,281,2,,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK200YD8,1948,,,F,2800,Visit12,12,Phase 3,342,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK200YD8,1948,,,F,3000,Visit13,13,Phase 3,369,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK200YD8,1948,,,F,3200,Visit14,14,Phase 3,391,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK200YD8,1948,,,F,3400,Visit15,15,Phase 3,426,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK200YD8,1948,,,F,3600,Visit16,16,Phase 3,453,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK200YD8,1948,,,F,3800,Visit17,17,Phase 3,481,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK200YD8,1948,,,F,5200,EndofPhase1_1a,9,Phase 1/1A,254,1 or 1A,,1,,1,,,,,,4,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK200YD8,1948,,,F,5800,EndofPhase2,11,Phase 2,314,2,1,2,,1,,,,,,4,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK200YD8,1948,,,F,6000,EndofPhase3,18,Phase 3,510,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK341YL1,2576,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,3,4,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,93,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,99,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,98,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,3400,Visit15,15,Phase 1/1A,429,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK395MXX,1034,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,495,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAK871FL6,1864,,,F,600,Visit1,1,Phase 1/1A,35,1 or 1A,43,2,,,,,,,,3,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,3,,,2,2,3,4,3,3,4,30,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,2200,Visit9,9,Phase 2,261,2,99,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,2400,Visit10,10,Phase 2,295,2,65,4,,,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,2600,Visit11,11,Phase 2,310,2,96,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,2800,Visit12,12,Phase 2,337,2,69,4,,,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,3000,Visit13,13,Phase 2,384,2,92,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,3200,Visit14,14,Phase 2,406,2,54,4,,,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,3400,Visit15,15,Phase 2,439,2,92,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,3600,Visit16,16,Phase 2,457,2,70,4,,1,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL145DJ8,1528,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,212,1 or 1A,98,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL189LXL,1616,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,20,1,,,,,,,,1,1,200,,,2,,1,240,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL189LXL,1616,,,M,800,Visit2,2,Phase 1/1A,51,1 or 1A,25,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL189LXL,1616,,,M,1000,Visit3,3,Phase 1/1A,79,1 or 1A,60,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL189LXL,1616,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,80,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL189LXL,1616,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356EFE,1240,,,M,600,Visit1,1,Phase 1/1A,41,1 or 1A,91,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356EFE,1240,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,50,2,,,,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,87,2,,1,,,,,,1,2,3,,,1,1,2,4,3,2,1,54,40,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,59,2,,0,1,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,1200,Visit4,4,Phase 2,113,2,78,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,1400,Visit5,5,Phase 2,134,2,90,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,1600,Visit6,6,Phase 2,157,2,80,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,1800,Visit7,7,Phase 2,185,2,82,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,2000,Visit8,8,Phase 2,219,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,2200,Visit9,9,Phase 2,254,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,2400,Visit10,10,Phase 2,280,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,2600,Visit11,11,Phase 2,310,2,87,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,2800,Visit12,12,Phase 2,336,2,72,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,3000,Visit13,13,Phase 2,366,2,97,1,,0,1,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,3200,Visit14,14,Phase 2,387,2,86,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,3400,Visit15,15,Phase 2,435,2,100,1,,0,1,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,3600,Visit16,16,Phase 2,452,2,100,1,,0,1,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,3800,Visit17,17,Phase 2,478,2,100,1,,0,1,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,4000,Visit18,18,Phase 2,506,2,75,1,,0,1,,,,,2,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,4200,Visit19,19,Phase 2,534,2,100,1,,0,1,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,73,1 or 1A,48,3,,1,,,,,,3,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAL356RRK,2551,,,F,5800,EndofPhase2,20,Phase 2,554,2,100,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,4,,,,,,,,1,4,30,,,2,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,1000,Visit3,3,Phase 1/1A,77,1 or 1A,96,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,1400,Visit5,5,Phase 1/1A,151,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,1600,Visit6,6,Phase 1/1A,193,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,1800,Visit7,7,Phase 1/1A,216,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,2000,Visit8,8,Phase 1/1A,244,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,2400,Visit10,10,Phase 1/1A,307,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,2600,Visit11,11,Phase 1/1A,337,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,2800,Visit12,12,Phase 1/1A,370,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,3000,Visit13,13,Phase 1/1A,397,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,3200,Visit14,14,Phase 1/1A,426,1 or 1A,97,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,3600,Visit16,16,Phase 1/1A,482,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,3800,Visit17,17,Phase 1/1A,510,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM181DG3,1480,,,M,4000,Visit18,18,Phase 1/1A,545,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,93,2,,0,1,,,,,1,2,15,,,1,,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,96,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,1000,Visit3,3,Phase 1/1A,94,1 or 1A,100,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,1200,Visit4,4,Phase 1/1A,115,1 or 1A,33,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,1400,Visit5,5,Phase 1/1A,148,1 or 1A,52,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,1600,Visit6,6,Phase 1/1A,190,1 or 1A,33,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,1800,Visit7,7,Phase 1/1A,218,1 or 1A,43,2,,0,1,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,2000,Visit8,8,Phase 1/1A,241,1 or 1A,91,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,2200,Visit9,9,Phase 1/1A,267,1 or 1A,100,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,2400,Visit10,10,Phase 1/1A,295,1 or 1A,89,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,2600,Visit11,11,Phase 1/1A,323,1 or 1A,89,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,2800,Visit12,12,Phase 1/1A,351,1 or 1A,82,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,3000,Visit13,13,Phase 1/1A,379,1 or 1A,75,2,,0,1,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,3200,Visit14,14,Phase 1/1A,407,1 or 1A,93,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,3400,Visit15,15,Phase 1/1A,456,1 or 1A,67,2,,0,1,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,3600,Visit16,16,Phase 1/1A,486,1 or 1A,100,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,3800,Visit17,17,Phase 1/1A,519,1 or 1A,73,2,,0,1,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM863KJQ,2869,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,539,1 or 1A,90,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,1000,Visit3,3,Phase 1/1A,79,1 or 1A,96,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,1200,Visit4,4,Phase 1/1A,107,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,1400,Visit5,5,Phase 1/1A,132,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,1600,Visit6,6,Phase 1/1A,157,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,1800,Visit7,7,Phase 1/1A,184,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,2000,Visit8,8,Phase 1/1A,210,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,2200,Visit9,9,Phase 1/1A,241,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,2400,Visit10,10,Phase 1/1A,267,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,2600,Visit11,11,Phase 1/1A,302,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,2800,Visit12,12,Phase 1/1A,346,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,3400,Visit15,15,Phase 1/1A,426,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,4000,Visit18,18,Phase 1/1A,505,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAM943HVB,1289,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN082WVM,2886,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,0,1,,,,,1,2,400,,,1,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN082WVM,2886,,,M,800,Visit2,2,Phase 1/1A,67,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN082WVM,2886,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN082WVM,2886,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,146,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN447DJ2,1782,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,600,Visit1,1,Phase 1/1A,32,1 or 1A,97,1,,1,,,,,,1,1,7.5,,,1,,3,21,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,93,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,2200,Visit9,9,Phase 1/1A,256,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,3000,Visit13,13,Phase 1/1A,367,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN564XRU,2617,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,1,3,19,23,3,2,3,3,2,400,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,1400,Visit5,5,Phase 1/1A,156,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,2000,Visit8,8,Phase 1/1A,230,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,3000,Visit13,13,Phase 2,365,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,3200,Visit14,14,Phase 2,398,2,100,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,3400,Visit15,15,Phase 2,428,2,83,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,3600,Visit16,16,Phase 2,457,2,100,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,338,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,5800,EndofPhase2,17,Phase 2,471,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN586HFB,1755,,,M,6000,EndofPhase3,18,Phase 3,498,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,600,Visit1,1,Phase 1/1A,46,1 or 1A,99,3,,,,,,,,1,3,22.5,,,2,,3,23,23,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,800,Visit2,2,Phase 1/1A,67,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,1000,Visit3,3,Phase 1/1A,95,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,96,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,1600,Visit6,6,Phase 1/1A,193,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,2000,Visit8,8,Phase 1/1A,242,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,2200,Visit9,9,Phase 1/1A,276,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,2600,Visit11,11,Phase 1/1A,304,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,3000,Visit13,13,Phase 1/1A,354,1 or 1A,96,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,3200,Visit14,14,Phase 1/1A,382,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,3400,Visit15,15,Phase 1/1A,410,1 or 1A,98,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,3600,Visit16,16,Phase 1/1A,438,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,3800,Visit17,17,Phase 1/1A,466,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAN945BHU,1093,,,M,4000,Visit18,18,Phase 1/1A,501,1 or 1A,95,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,600,Visit1,1,Phase 1/1A,22,1 or 1A,86,1,,,,,,,,1,1,1.5,,,1,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,800,Visit2,2,Phase 1/1A,46,1 or 1A,90,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,1000,Visit3,3,Phase 1/1A,77,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,1600,Visit6,6,Phase 1/1A,179,1 or 1A,,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,1800,Visit7,7,Phase 1/1A,210,1 or 1A,,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,2000,Visit8,8,Phase 1/1A,237,1 or 1A,,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,2200,Visit9,9,Phase 1/1A,265,1 or 1A,78,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,2400,Visit10,10,Phase 1/1A,293,1 or 1A,90,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,2600,Visit11,11,Phase 1/1A,321,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,2800,Visit12,12,Phase 1/1A,349,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,3000,Visit13,13,Phase 1/1A,384,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,3400,Visit15,15,Phase 1/1A,440,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,3600,Visit16,16,Phase 1/1A,475,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,3800,Visit17,17,Phase 1/1A,510,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP621APQ,1223,,,M,4000,Visit18,18,Phase 1/1A,551,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAP988FM7,1126,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAR165VGY,1915,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAR460KRP,1342,,,F,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,3,4,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAR460KRP,1342,,,F,800,Visit2,2,Phase 1/1A,71,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAR460KRP,1342,,,F,1000,Visit3,3,Phase 1/1A,106,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAR460KRP,1342,,,F,1200,Visit4,4,Phase 1/1A,134,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAR460KRP,1342,,,F,1400,Visit5,5,Phase 1/1A,162,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAR460KRP,1342,,,F,1600,Visit6,6,Phase 1/1A,197,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAR460KRP,1342,,,F,1800,Visit7,7,Phase 1/1A,225,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAR460KRP,1342,,,F,2000,Visit8,8,Phase 1/1A,260,1 or 1A,0,4,,,,,,,,4,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAR460KRP,1342,,,F,2400,Visit10,10,Phase 1/1A,316,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAR460KRP,1342,,,F,2600,Visit11,11,Phase 1/1A,349,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAR460KRP,1342,,,F,2800,Visit12,12,Phase 1/1A,386,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAR599PRH,1398,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT008DV3,2881,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,60,2,,1,,,,,,,2,3,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT008DV3,2881,,,M,800,Visit2,2,Phase 1/1A,51,1 or 1A,75,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT008DV3,2881,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,51,1 or 1A,75,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT148VZ5,1175,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,80,1,,,,,,,,1,1,1.5,,,1,2,2,3,5,2,2,80,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT148VZ5,1175,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT148VZ5,1175,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,86,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT148VZ5,1175,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,81,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT148VZ5,1175,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,94,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT148VZ5,1175,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT148VZ5,1175,,,M,5800,EndofPhase2,7,Phase 2,190,2,58,2,,,,,,,,2,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,800,Visit2,2,Phase 1/1A,54,1 or 1A,89,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,1000,Visit3,3,Phase 1/1A,90,1 or 1A,97,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,1400,Visit5,5,Phase 1/1A,145,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,1600,Visit6,6,Phase 1/1A,180,1 or 1A,96,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,2000,Visit8,8,Phase 1/1A,230,1 or 1A,96,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,2200,Visit9,9,Phase 1/1A,273,1 or 1A,92,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,2400,Visit10,10,Phase 1/1A,302,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,2600,Visit11,11,Phase 1/1A,327,1 or 1A,82,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,2800,Visit12,12,Phase 1/1A,365,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,3000,Visit13,13,Phase 1/1A,394,1 or 1A,74,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,3200,Visit14,14,Phase 1/1A,436,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,3600,Visit16,16,Phase 1/1A,475,1 or 1A,87,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT391PB6,2173,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,548,1 or 1A,93,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,98,4,,1,,,,,,1,4,6,,,2,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,93,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,88,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,98,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,2000,Visit8,8,Phase 1/1A,230,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,2200,Visit9,9,Phase 1/1A,261,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,2400,Visit10,10,Phase 1/1A,289,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,2600,Visit11,11,Phase 1/1A,317,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,2800,Visit12,12,Phase 1/1A,345,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,3600,Visit16,16,Phase 1/1A,450,1 or 1A,98,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,3800,Visit17,17,Phase 1/1A,471,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT849XBP,2594,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,94,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT911GMV,2877,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,86,2,,1,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAT911GMV,2877,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,82,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU202MHY,1698,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,,4,5,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU202MHY,1698,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU202MHY,1698,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU202MHY,1698,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,89,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU202MHY,1698,,,M,1400,Visit5,5,Phase 1/1A,146,1 or 1A,86,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU202MHY,1698,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,94,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU202MHY,1698,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,91,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU202MHY,1698,,,M,2000,Visit8,8,Phase 1/1A,236,1 or 1A,40,4,,1,,,,,,3,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU202MHY,1698,,,M,2200,Visit9,9,Phase 1/1A,261,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU202MHY,1698,,,M,2400,Visit10,10,Phase 1/1A,289,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU202MHY,1698,,,M,2600,Visit11,11,Phase 1/1A,314,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU202MHY,1698,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,370,1 or 1A,50,4,,1,,,,,,3,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU600NPZ,1798,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,2,,3,4,4,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU600NPZ,1798,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,20,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU621JJL,2519,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,,2,,,,,,,,3,2,400,,,2,2,3,500,500,3,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU621JJL,2519,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,111,1 or 1A,,3,,,,,,,,,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU621JJL,2519,,,M,5800,EndofPhase2,7,Phase 2,147,2,0,2,,,,,,,,4,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,98,2,,1,,,,,,1,2,400,,,2,2,3,569,600,3,3,120,120,3,325,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,89,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,95,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,97,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,2200,Visit9,9,Phase 1/1A,263,1 or 1A,96,3,,0,2,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,2400,Visit10,10,Phase 1/1A,287,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,2600,Visit11,11,Phase 1/1A,315,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,79,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,3600,Visit16,16,Phase 3,456,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,3800,Visit17,17,Phase 3,483,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,4000,Visit18,18,Phase 3,512,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,4200,Visit19,19,Phase 3,539,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,4400,Visit20,20,Phase 3,563,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,4600,Visit21,21,Phase 3,592,3,,,,,,6,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,4800,Visit22,22,Phase 3,620,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,5200,EndofPhase1_1a,14,Phase 1/1A,385,1 or 1A,94,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,5800,EndofPhase2,15,Phase 2,421,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAU749CKG,2193,,,M,6000,EndofPhase3,23,Phase 3,645,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,92,2,,,,,,,,1,2,3,,,2,,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,98,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,1600,Visit6,6,Phase 1/1A,185,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,1800,Visit7,7,Phase 1/1A,206,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,2200,Visit9,9,Phase 1/1A,263,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,2400,Visit10,10,Phase 1/1A,291,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,2600,Visit11,11,Phase 1/1A,326,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,2800,Visit12,12,Phase 1/1A,362,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,3000,Visit13,13,Phase 1/1A,393,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,3200,Visit14,14,Phase 1/1A,423,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,3400,Visit15,15,Phase 1/1A,452,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,3600,Visit16,16,Phase 1/1A,480,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,3800,Visit17,17,Phase 1/1A,508,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAV767HKY,1164,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,541,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW503EEC,1258,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,95,2,,,,,,,,1,2,16,,,2,,3,26,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW503EEC,1258,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW503EEC,1258,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,96,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW503EEC,1258,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW503EEC,1258,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,93,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW503EEC,1258,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,165,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,2,2,3,24,30,3,2,4,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,96,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,93,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,2000,Visit8,8,Phase 2,224,2,95,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,2200,Visit9,9,Phase 2,256,2,97,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,2400,Visit10,10,Phase 2,284,2,90,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,2600,Visit11,11,Phase 2,306,2,88,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,2800,Visit12,12,Phase 2,333,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,3000,Visit13,13,Phase 2,364,2,90,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,3200,Visit14,14,Phase 2,393,2,100,2,,0,2,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,3400,Visit15,15,Phase 2,421,2,79,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,3600,Visit16,16,Phase 2,459,2,90,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,3800,Visit17,17,Phase 2,483,2,86,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,193,1 or 1A,87,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW744NMK,1957,,,M,5800,EndofPhase2,18,Phase 2,495,2,,2,,1,,,,,,,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAW872RRD,1497,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,26,1 or 1A,92,3,,1,,,,,,1,3,24,,,1,,3,24,24,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,98,2,,1,,,,,,1,2,80,,,2,,2,83,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,86,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,87,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,65,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,2400,Visit10,10,Phase 1/1A,283,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,2800,Visit12,12,Phase 1/1A,339,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,96,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,96,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,95,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,3800,Visit17,17,Phase 1/1A,485,1 or 1A,99,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX038HMQ,2157,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,508,1 or 1A,94,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX090YW2,1544,,,F,600,Visit1,1,Phase 1/1A,22,1 or 1A,100,2,,,,,,,,1,2,400,,,2,1,3,500,400,3,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX090YW2,1544,,,F,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX090YW2,1544,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX090YW2,1544,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,99,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX090YW2,1544,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX090YW2,1544,,,F,1800,Visit7,7,Phase 2,199,2,86,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX090YW2,1544,,,F,2400,Visit10,10,Phase 3,288,3,,,,,,1,15,7,13,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX090YW2,1544,,,F,2600,Visit11,11,Phase 3,311,3,,,,,,1,15,7,25,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX090YW2,1544,,,F,2800,Visit12,12,Phase 3,336,3,,,,,,1,15,7,25,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX090YW2,1544,,,F,3000,Visit13,13,Phase 3,365,3,,,,,,1,15,7,25,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX090YW2,1544,,,F,3200,Visit14,14,Phase 3,384,3,,,,,,1,15,7,13,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX090YW2,1544,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,177,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX090YW2,1544,,,F,6000,EndofPhase3,15,Phase 3,428,3,,,,,,1,15,7,13,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX120VGC,1394,,,F,800,Visit2,2,Phase 2,57,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX120VGC,1394,,,F,1000,Visit3,3,Phase 2,85,2,98,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX120VGC,1394,,,F,1200,Visit4,4,Phase 2,113,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX120VGC,1394,,,F,1400,Visit5,5,Phase 2,141,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX120VGC,1394,,,F,1800,Visit7,7,Phase 3,197,3,,,,,,4,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX120VGC,1394,,,F,2000,Visit8,8,Phase 3,225,3,,,,,,4,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX120VGC,1394,,,F,2200,Visit9,9,Phase 3,253,3,,,,,,4,20,,0,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX120VGC,1394,,,F,2400,Visit10,10,Phase 3,282,3,,,,,,4,40,,0,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX120VGC,1394,,,F,2600,Visit11,11,Phase 3,310,3,,,,,,4,20,,0,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX120VGC,1394,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,30,1 or 1A,98,2,,,,,,,,1,2,400,,,2,2,2,400,400,2,2,3,3,2,33,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX120VGC,1394,,,F,5800,EndofPhase2,6,Phase 2,169,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX120VGC,1394,,,F,6000,EndofPhase3,12,Phase 3,338,3,,,,,,4,80,,0,1,,,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,600,Visit1,1,Phase 1/1A,33,1 or 1A,,2,,1,,,,,,,2,16,,,2,,3,27,32,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,800,Visit2,2,Phase 1/1A,61,1 or 1A,23,4,,0,2,,,,,4,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,1200,Visit4,4,Phase 1B,116,1B,91,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,1400,Visit5,5,Phase 1B,144,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,1600,Visit6,6,Phase 1B,172,1B,98,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,1800,Visit7,7,Phase 1B,200,1B,96,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,2000,Visit8,8,Phase 1B,221,1B,95,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,2200,Visit9,9,Phase 1B,246,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,2400,Visit10,10,Phase 1B,274,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,2600,Visit11,11,Phase 1B,298,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,2800,Visit12,12,Phase 1B,326,1B,95,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,3000,Visit13,13,Phase 1B,354,1B,96,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,3200,Visit14,14,Phase 1B,382,1B,,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,3400,Visit15,15,Phase 1B,410,1B,97,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,3600,Visit16,16,Phase 1B,449,1B,94,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,3800,Visit17,17,Phase 1B,470,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,85,1 or 1A,91,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAX242UGL,2554,,,F,5400,EndofPhase1b,18,Phase 1B,491,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,86,2,,,,,,,,1,2,80,,,2,,3,111,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,80,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,74,2,,,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,94,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,99,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,2600,Visit11,11,Phase 1/1A,318,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,2800,Visit12,12,Phase 1/1A,346,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,3000,Visit13,13,Phase 1/1A,375,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,3200,Visit14,14,Phase 1/1A,403,1 or 1A,96,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,3400,Visit15,15,Phase 1/1A,431,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,3600,Visit16,16,Phase 1/1A,459,1 or 1A,97,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,3800,Visit17,17,Phase 1/1A,501,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAY258HBN,1709,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,522,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,4,,1,,,,,,1,4,32,,,1,2,3,24,16,3,4,160,160,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,50,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,0,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,86,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,1,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,4,,1,,,,,,3,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,1800,Visit7,7,Phase 1/1A,183,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,2000,Visit8,8,Phase 1B,225,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,2400,Visit10,10,Phase 2,282,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,2600,Visit11,11,Phase 2,310,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,2800,Visit12,12,Phase 2,342,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,3000,Visit13,13,Phase 2,366,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,3200,Visit14,14,Phase 2,394,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,3400,Visit15,15,Phase 2,422,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,3600,Visit16,16,Phase 2,450,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,3800,Visit17,17,Phase 2,478,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,183,1 or 1A,100,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,5400,EndofPhase1b,9,Phase 1B,232,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ173YPF,2713,,,M,5800,EndofPhase2,18,Phase 2,503,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,1,,,,,,1,3,120,,,2,,4,153,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,1000,Visit3,3,Phase 1/1A,82,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,94,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,1400,Visit5,5,Phase 1/1A,137,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,91,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,2400,Visit10,10,Phase 1/1A,278,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,2600,Visit11,11,Phase 1/1A,306,1 or 1A,95,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,2800,Visit12,12,Phase 1/1A,334,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,3000,Visit13,13,Phase 1/1A,362,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,3400,Visit15,15,Phase 1/1A,419,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,3600,Visit16,16,Phase 1/1A,447,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ390BM3,2464,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,497,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,80,,,2,,3,133,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,60,3,,,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,61,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,64,3,,,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,62,3,,,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,77,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,62,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,96,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,3000,Visit13,13,Phase 1/1A,369,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,99,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ664YV0,1726,,,M,4000,Visit18,18,Phase 1/1A,518,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,3,25,30,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,79,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,0,,,,,,,,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,96,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,1600,Visit6,6,Phase 1/1A,162,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,1800,Visit7,7,Phase 1/1A,191,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,2000,Visit8,8,Phase 1/1A,222,1 or 1A,92,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,2200,Visit9,9,Phase 1/1A,247,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,96,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVAZ854VLT,1521,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,499,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA923RJR,2828,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,,2,,1,,,,,,,2,3,,,1,1,2,3,3,2,2,15,15,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,800,Visit2,2,Phase 1/1A,71,1 or 1A,85,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,1000,Visit3,3,Phase 1/1A,99,1 or 1A,64,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,50,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,48,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,2000,Visit8,8,Phase 2,204,2,88,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,2200,Visit9,9,Phase 2,231,2,94,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,2400,Visit10,10,Phase 2,260,2,43,2,,1,,,,,,3,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,2600,Visit11,11,Phase 2,288,2,43,2,,1,,,,,,3,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,2800,Visit12,12,Phase 2,316,2,56,2,,1,,,,,,2,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,3000,Visit13,13,Phase 2,358,2,51,2,,1,,,,,,2,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,3200,Visit14,14,Phase 2,372,2,63,2,,1,,,,,,2,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,3400,Visit15,15,Phase 2,400,2,79,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,3600,Visit16,16,Phase 2,428,2,77,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,3800,Visit17,17,Phase 2,463,2,20,2,,1,,,,,,4,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,190,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBA926NYH,2268,,,M,5800,EndofPhase2,18,Phase 2,484,2,67,2,,1,,,,,,2,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,93,4,,,,,,,,1,4,800,,,2,1,4,733,800,4,4,6,6,4,864,800,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,1400,Visit5,5,Phase 3,151,3,,,,,,2,800,,,,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,1600,Visit6,6,Phase 3,182,3,,,,,,2,800,2,800,1,,,,1600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,1800,Visit7,7,Phase 3,200,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,2000,Visit8,8,Phase 3,226,3,,,,,,2,800,,,,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,2200,Visit9,9,Phase 3,252,3,,,,,,2,800,,,,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,2400,Visit10,10,Phase 3,276,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,2600,Visit11,11,Phase 3,308,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,2800,Visit12,12,Phase 3,338,3,,,,,,2,200,2,800,1,,,,1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,3000,Visit13,13,Phase 3,367,3,,,,,,2,500,2,500,1,,,,1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,3200,Visit14,14,Phase 3,395,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,3400,Visit15,15,Phase 3,424,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,3600,Visit16,16,Phase 3,459,3,,,,,,2,200,2,300,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,3800,Visit17,17,Phase 3,491,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,64,1 or 1A,78,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,5800,EndofPhase2,4,Phase 2,100,2,90,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB928ALU,1509,,,M,6000,EndofPhase3,18,Phase 3,529,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB995NKV,2444,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,89,3,,1,,,,,,1,3,4.5,,,2,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB995NKV,2444,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB995NKV,2444,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,92,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB995NKV,2444,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB995NKV,2444,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,95,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB995NKV,2444,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB995NKV,2444,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,99,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB995NKV,2444,,,F,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB995NKV,2444,,,F,2200,Visit9,9,Phase 1/1A,255,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB995NKV,2444,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB995NKV,2444,,,F,2600,Visit11,11,Phase 1/1A,307,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB995NKV,2444,,,F,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBB995NKV,2444,,,F,5200,EndofPhase1_1a,13,Phase 1/1A,366,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD176VUG,2033,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,21,1 or 1A,,,,,,,,,,4,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,77,1,,,,,,,,1,1,1.5,,,1,,1,2,2,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,800,Visit2,2,Phase 1/1A,66,1 or 1A,79,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,1000,Visit3,3,Phase 1/1A,101,1 or 1A,77,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,1200,Visit4,4,Phase 1/1A,130,1 or 1A,83,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,1400,Visit5,5,Phase 1/1A,158,1 or 1A,51,1,,,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,1600,Visit6,6,Phase 1/1A,192,1 or 1A,68,1,,,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,1800,Visit7,7,Phase 1/1A,221,1 or 1A,60,1,,1,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,2000,Visit8,8,Phase 1/1A,249,1 or 1A,88,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,2200,Visit9,9,Phase 1/1A,274,1 or 1A,85,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,2400,Visit10,10,Phase 1/1A,315,1 or 1A,58,1,,1,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,2600,Visit11,11,Phase 1/1A,343,1 or 1A,72,1,,1,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,2800,Visit12,12,Phase 1/1A,378,1 or 1A,75,1,,1,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,3000,Visit13,13,Phase 1/1A,403,1 or 1A,67,1,,1,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,89,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,3800,Visit17,17,Phase 1/1A,464,1 or 1A,69,1,,1,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD202YDD,1706,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,497,1 or 1A,76,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,800,Visit2,2,Phase 1B,50,1B,85,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,1000,Visit3,3,Phase 1B,82,1B,2,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,1400,Visit5,5,Phase 2,130,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,1600,Visit6,6,Phase 2,165,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,2000,Visit8,8,Phase 3,209,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,2200,Visit9,9,Phase 3,239,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,2400,Visit10,10,Phase 3,251,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,2600,Visit11,11,Phase 3,306,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,2800,Visit12,12,Phase 3,335,3,,,,,,4,160,,0,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,3000,Visit13,13,Phase 3,362,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,3200,Visit14,14,Phase 3,390,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,3400,Visit15,15,Phase 3,413,3,,,,,,4,160,,0,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,3600,Visit16,16,Phase 3,439,3,,,,,,4,160,,0,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,3800,Visit17,17,Phase 3,474,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,4000,Visit18,18,Phase 3,516,3,,,,,,4,160,,0,2,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,18,1 or 1A,75,2,,,,,,,,2,2,16,,,1,2,2,16,16,2,2,400,400,2,160,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,5400,EndofPhase1b,4,Phase 1B,89,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBD974GTH,1347,,,M,5800,EndofPhase2,7,Phase 2,174,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE385MVG,1310,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,95,2,,,,,,,,1,2,16,,,2,,3,24,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE385MVG,1310,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,91,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE385MVG,1310,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,82,1 or 1A,97,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,87,1,,,,,,,,1,1,8,,,1,2,2,16,8,2,3,500,500,3,10,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,89,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,92,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,93,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,89,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,1800,Visit7,7,Phase 1B,197,1B,93,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,2200,Visit9,9,Phase 2,253,2,85,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,2800,Visit12,12,Phase 3,337,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,1,10,,,2,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,3600,Visit16,16,Phase 3,452,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,1,10,,,2,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,4000,Visit18,18,Phase 3,505,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,168,1 or 1A,96,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,5400,EndofPhase1b,8,Phase 1B,220,1B,94,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE408EHN,1314,,,M,5800,EndofPhase2,10,Phase 2,273,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,600,Visit1,1,Phase 1/1A,43,1 or 1A,93,1,,,,,,,,1,1,7.5,,,1,,2,13,8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,89,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,89,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,90,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,89,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,1800,Visit7,7,Phase 1/1A,204,1 or 1A,86,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,90,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,86,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,2400,Visit10,10,Phase 1/1A,282,1 or 1A,88,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,2600,Visit11,11,Phase 1/1A,310,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,2800,Visit12,12,Phase 1/1A,338,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,3000,Visit13,13,Phase 1/1A,366,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,86,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,99,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,3600,Visit16,16,Phase 1/1A,442,1 or 1A,81,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,3800,Visit17,17,Phase 1/1A,478,1 or 1A,92,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE738UC3,1558,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,79,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,97,1,,,,,,,,1,1,8,,,1,2,1,10,8,1,2,2,2,2,26,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,85,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,1400,Visit5,5,Phase 1B,133,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,1600,Visit6,6,Phase 1B,171,2,86,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,1800,Visit7,7,Phase 1B,199,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,2000,Visit8,8,Phase 1B,227,1B,85,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,2400,Visit10,10,Phase 2,279,2,72,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,2600,Visit11,11,Phase 2,308,2,53,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,3000,Visit13,13,Phase 3,366,3,,,,,,4,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,3200,Visit14,14,Phase 3,384,3,,,,,,4,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,3400,Visit15,15,Phase 3,419,3,,,,,,4,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,4,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,3800,Visit17,17,Phase 3,479,3,,,,,,4,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,4000,Visit18,18,Phase 3,512,3,,,,,,4,40,,,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,98,1 or 1A,30,1,,,,,,,,3,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,5400,EndofPhase1b,9,Phase 1B,247,1B,75,1,,,,,,,,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,5800,EndofPhase2,12,Phase 2,336,2,76,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBE946TPN,1408,,,M,6000,EndofPhase3,18,Phase 3,512,3,,,,,,4,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,94,3,,,,,,,,1,3,22.5,,,1,,3,23,23,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,96,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,95,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,98,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,2200,Visit9,9,Phase 1/1A,265,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,2400,Visit10,10,Phase 1/1A,287,1 or 1A,95,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,2600,Visit11,11,Phase 1/1A,312,1 or 1A,93,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,93,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,3200,Visit14,14,Phase 1/1A,398,1 or 1A,92,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,90,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,3600,Visit16,16,Phase 1/1A,455,1 or 1A,94,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,97,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF033CUH,1079,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,503,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,2,3,24,23,3,3,600,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,97,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,2000,Visit8,8,Phase 3,241,3,,,,,,4,160,6,75,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,2200,Visit9,9,Phase 3,276,3,,,,,,4,160,6,150,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,2400,Visit10,10,Phase 3,303,3,,,,,,4,160,6,150,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,2600,Visit11,11,Phase 3,338,3,,,,,,6,150,4,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,2800,Visit12,12,Phase 3,374,3,,,,,,4,160,6,150,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,3000,Visit13,13,Phase 3,395,3,,,,,,4,160,6,150,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,3200,Visit14,14,Phase 3,423,3,,,,,,4,160,6,150,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,3400,Visit15,15,Phase 3,450,3,,,,,,6,150,4,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,3600,Visit16,16,Phase 3,478,3,,,,,,6,150,4,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,3800,Visit17,17,Phase 3,506,3,,,,,,6,150,4,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,147,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,5800,EndofPhase2,6,Phase 2,179,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBF815JL0,2261,,,M,6000,EndofPhase3,18,Phase 3,534,3,,,,,,6,150,4,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,1,,,,,,1,3,24,,,1,,2,17,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,88,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,89,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,2200,Visit9,9,Phase 1/1A,259,1 or 1A,82,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,90,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,93,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,3400,Visit15,15,Phase 1/1A,424,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,93,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,92,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG070VNE,2677,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,84,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,,4,,1,,,,,,1,4,160,,,2,2,4,160,160,4,4,5,6,4,40,40,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,86,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,1200,Visit4,4,Phase 2,120,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,1400,Visit5,5,Phase 2,148,2,95,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,1600,Visit6,6,Phase 2,176,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,1800,Visit7,7,Phase 2,204,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,2200,Visit9,9,Phase 3,232,3,,,,,,1,20,,,,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,2400,Visit10,10,Phase 3,260,3,,,,,,1,20,,,,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,2600,Visit11,11,Phase 3,281,3,,,,,,1,40,,,,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,2800,Visit12,12,Phase 3,309,3,,,,,,1,40,,,,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,3000,Visit13,13,Phase 3,337,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,3200,Visit14,14,Phase 3,365,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,3400,Visit15,15,Phase 3,393,3,,,,,,1,60,,,1,,,,60,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,3600,Visit16,16,Phase 3,428,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,3800,Visit17,17,Phase 3,456,3,,,,,,1,60,,,1,,,,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,82,1 or 1A,,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,5800,EndofPhase2,8,Phase 2,216,2,,4,,,,,,,,,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG113KYW,2103,,,M,6000,EndofPhase3,18,Phase 3,484,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG594NRZ,1934,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG849NYU,1236,,,F,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG849NYU,1236,,,F,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG849NYU,1236,,,F,1000,Visit3,3,Phase 1/1A,106,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG849NYU,1236,,,F,1200,Visit4,4,Phase 1/1A,122,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG849NYU,1236,,,F,1400,Visit5,5,Phase 1/1A,162,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG849NYU,1236,,,F,1600,Visit6,6,Phase 1/1A,189,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG849NYU,1236,,,F,1800,Visit7,7,Phase 1/1A,211,1 or 1A,91,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG849NYU,1236,,,F,2000,Visit8,8,Phase 1/1A,249,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBG849NYU,1236,,,F,5200,EndofPhase1_1a,9,Phase 1/1A,283,1 or 1A,80,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,88,2,,1,,,,,,1,2,400,,,2,,4,756,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,93,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,95,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,1200,Visit4,4,Phase 1/1A,107,1 or 1A,97,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,1400,Visit5,5,Phase 1/1A,135,1 or 1A,87,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,1600,Visit6,6,Phase 1/1A,162,1 or 1A,94,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,1800,Visit7,7,Phase 1/1A,191,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,86,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,2200,Visit9,9,Phase 1/1A,247,1 or 1A,85,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,2400,Visit10,10,Phase 1/1A,274,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,2600,Visit11,11,Phase 1/1A,302,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,2800,Visit12,12,Phase 1/1A,330,1 or 1A,84,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,78,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,86,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,3400,Visit15,15,Phase 1/1A,436,1 or 1A,85,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,3600,Visit16,16,Phase 1/1A,457,1 or 1A,93,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,3800,Visit17,17,Phase 1/1A,485,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH357BP1,2399,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,510,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH433JG4,2345,,,M,600,Visit1,1,Phase 1/1A,19,1 or 1A,,,,,,,,,,2,,,,,1,,2,16,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH433JG4,2345,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH433JG4,2345,,,M,1000,Visit3,3,Phase 1/1A,79,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH433JG4,2345,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH433JG4,2345,,,M,1400,Visit5,5,Phase 1/1A,137,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH433JG4,2345,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,165,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,1,,3,23,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,96,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,96,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,83,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,2200,Visit9,9,Phase 1/1A,257,1 or 1A,89,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,2800,Visit12,12,Phase 1/1A,341,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,3000,Visit13,13,Phase 1/1A,368,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,3200,Visit14,14,Phase 1/1A,404,1 or 1A,74,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,3400,Visit15,15,Phase 1/1A,426,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBH921KAQ,1676,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,501,1 or 1A,99,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ073HKT,1588,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,2,,,,,,,,1,2,400,,,2,,2,440,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ073HKT,1588,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ073HKT,1588,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ073HKT,1588,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ073HKT,1588,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ073HKT,1588,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ073HKT,1588,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,85,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ073HKT,1588,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,90,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ073HKT,1588,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,98,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ073HKT,1588,,,M,5200,EndofPhase1_1a,10,Phase 1/1A,276,1 or 1A,62,1,,,,,,,,2,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,52,4,,,,,,,,2,4,30,,,2,2,2,16,15,2,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,95,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,2200,Visit9,9,Phase 1/1A,245,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,2800,Visit12,12,Phase 2,335,2,83,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,3000,Visit13,13,Phase 2,366,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,3200,Visit14,14,Phase 2,393,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,3400,Visit15,15,Phase 2,427,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,3600,Visit16,16,Phase 2,454,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,3800,Visit17,17,Phase 2,477,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,4000,Visit18,18,Phase 2,513,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ229NV6,1367,,,M,5200,EndofPhase1_1a,11,Phase 1/1A,316,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ258LJ7,2335,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,57,1,,1,,,,,,2,1,1.5,,,2,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ258LJ7,2335,,,F,800,Visit2,2,Phase 1/1A,78,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ258LJ7,2335,,,F,1400,Visit5,5,Phase 1/1A,151,1 or 1A,86,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ258LJ7,2335,,,F,1800,Visit7,7,Phase 1/1A,215,1 or 1A,97,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ258LJ7,2335,,,F,2000,Visit8,8,Phase 1/1A,277,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ258LJ7,2335,,,F,2400,Visit10,10,Phase 1/1A,334,1 or 1A,92,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ258LJ7,2335,,,F,2800,Visit12,12,Phase 1/1A,393,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ258LJ7,2335,,,F,3600,Visit16,16,Phase 1/1A,452,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ258LJ7,2335,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,0,0,,,,,,,,4,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ566NYA,1269,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,2,2,4,26,26,4,3,644,600,3,300,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ566NYA,1269,,,M,1800,Visit7,7,Phase 2,190,2,85,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ566NYA,1269,,,M,2000,Visit8,8,Phase 2,225,2,81,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ566NYA,1269,,,M,2200,Visit9,9,Phase 2,260,2,97,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ566NYA,1269,,,M,2400,Visit10,10,Phase 2,281,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ566NYA,1269,,,M,2600,Visit11,11,Phase 2,309,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ566NYA,1269,,,M,2800,Visit12,12,Phase 2,346,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ566NYA,1269,,,M,3000,Visit13,13,Phase 2,367,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ566NYA,1269,,,M,3200,Visit14,14,Phase 2,395,2,,4,,,,,,,,3,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ566NYA,1269,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,51,1 or 1A,83,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ566NYA,1269,,,M,5800,EndofPhase2,15,Phase 2,416,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ566NYA,1269,,,M,6000,EndofPhase3,16,Phase 3,441,3,,,,,,6,300,,,3,,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBJ775APM,2374,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,3,,1,,,,,,1,3,600,,,2,3,3,667,600,3,3,300,300,3,10,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,1200,Visit4,4,Phase 2,113,2,,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,1400,Visit5,5,Phase 2,141,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,1600,Visit6,6,Phase 2,169,2,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,1800,Visit7,7,Phase 2,196,2,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,2000,Visit8,8,Phase 2,225,2,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,2200,Visit9,9,Phase 2,255,2,94,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,2400,Visit10,10,Phase 2,283,2,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,2600,Visit11,11,Phase 2,310,2,99,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,3000,Visit13,13,Phase 3,367,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,3200,Visit14,14,Phase 3,395,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,3400,Visit15,15,Phase 3,420,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,3600,Visit16,16,Phase 3,441,3,,,,,,8,10,,,,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,3800,Visit17,17,Phase 3,476,3,,,,,,8,10,,,,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,81,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,5800,EndofPhase2,12,Phase 2,345,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK235DJB,1966,,,M,6000,EndofPhase3,18,Phase 3,504,3,,,,,,8,10,,,,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK367VDZ,1778,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,72,2,,,,,,,,2,2,400,,,1,,2,300,300,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK367VDZ,1778,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK367VDZ,1778,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,177,1 or 1A,,,,0,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,95,2,,,,,,,,1,2,15,,,2,1,2,15,15,2,1,291,200,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,800,Visit2,2,Phase 1/1A,54,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,1400,Visit5,5,Phase 1/1A,146,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,1800,Visit7,7,Phase 2,203,2,96,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,2000,Visit8,8,Phase 2,231,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,2200,Visit9,9,Phase 2,259,2,91,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,2400,Visit10,10,Phase 2,286,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,2600,Visit11,11,Phase 2,322,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,2800,Visit12,12,Phase 2,365,2,100,1,,,,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,3000,Visit13,13,Phase 2,399,2,100,1,,1,,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,3200,Visit14,14,Phase 2,426,2,100,1,,0,1,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,3400,Visit15,15,Phase 2,454,2,100,1,,0,1,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,3600,Visit16,16,Phase 2,481,2,96,1,,0,1,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,3800,Visit17,17,Phase 2,525,2,43,1,,0,1,,,,,3,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,175,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBK841LCL,2154,,,F,5800,EndofPhase2,18,Phase 2,527,2,0,,0,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL029PEE,2416,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,4,,1,,,,,,1,4,32,,,1,,4,32,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL029PEE,2416,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL029PEE,2416,,,M,1200,Visit4,4,Phase 1B,99,1B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL029PEE,2416,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,77,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL029PEE,2416,,,M,5400,EndofPhase1b,5,Phase 1B,133,1B,,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL536PAX,1358,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,,,,,,,1,3,600,,,2,,3,667,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL536PAX,1358,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL536PAX,1358,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,77,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL626TPV,2430,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,0,2,,,,,,,,4,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL739EY4,2201,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,46,3,,1,,,,,,3,3,600,,,1,,3,660,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL739EY4,2201,,,F,800,Visit2,2,Phase 1/1A,53,1 or 1A,90,3,,0,1,,,,,3,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL739EY4,2201,,,F,1000,Visit3,3,Phase 1/1A,87,1 or 1A,56,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL739EY4,2201,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL739EY4,2201,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL739EY4,2201,,,F,1600,Visit6,6,Phase 1/1A,171,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL739EY4,2201,,,F,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL739EY4,2201,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL739EY4,2201,,,F,2200,Visit9,9,Phase 1/1A,249,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL739EY4,2201,,,F,5200,EndofPhase1_1a,9,Phase 1/1A,309,1 or 1A,48,4,,1,,,,,,,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,2,4,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,97,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,96,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,44,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,57,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,91,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,79,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,2200,Visit9,9,Phase 1/1A,274,1 or 1A,88,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,2400,Visit10,10,Phase 1/1A,295,1 or 1A,88,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,2600,Visit11,11,Phase 1/1A,323,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,90,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,76,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,85,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,3800,Visit17,17,Phase 1/1A,470,1 or 1A,81,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL772UYA,1287,,,M,4000,Visit18,18,Phase 1/1A,504,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,,,,,,,1,2,16,,,1,,3,22,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,800,Visit2,2,Phase 1/1A,82,1 or 1A,66,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,1000,Visit3,3,Phase 1/1A,104,1 or 1A,57,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,1200,Visit4,4,Phase 1/1A,134,1 or 1A,90,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,1400,Visit5,5,Phase 1/1A,162,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,1600,Visit6,6,Phase 1/1A,209,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,1800,Visit7,7,Phase 1/1A,225,1 or 1A,44,3,,,,,,,,3,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,2000,Visit8,8,Phase 1/1A,260,1 or 1A,72,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,2200,Visit9,9,Phase 1/1A,288,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,2400,Visit10,10,Phase 1/1A,314,1 or 1A,88,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,2600,Visit11,11,Phase 1/1A,335,1 or 1A,87,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,2800,Visit12,12,Phase 1/1A,399,1 or 1A,88,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,3200,Visit14,14,Phase 1/1A,427,1 or 1A,82,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,3400,Visit15,15,Phase 1/1A,459,1 or 1A,66,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,3600,Visit16,16,Phase 1/1A,487,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,3800,Visit17,17,Phase 1/1A,522,1 or 1A,89,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBL806MLE,1086,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,544,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM553XKE,2385,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,3,,,,,,,,1,3,22.5,,,2,1,4,26,23,4,4,800,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM553XKE,2385,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM553XKE,2385,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,3,,0,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM553XKE,2385,,,M,1400,Visit5,5,Phase 1/1A,153,1 or 1A,100,3,,0,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM553XKE,2385,,,M,1600,Visit6,6,Phase 1/1A,181,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM553XKE,2385,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,229,1 or 1A,50,4,,0,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM553XKE,2385,,,M,5800,EndofPhase2,10,Phase 2,280,2,50,4,,0,,,,,,3,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM742EZ2,1850,,,F,600,Visit1,1,Phase 1/1A,36,1 or 1A,44,3,,1,,,,,,3,3,4.5,,,2,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM742EZ2,1850,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,105,1 or 1A,2,3,,1,,,,,,4,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,83,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,95,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,1800,Visit7,7,Phase 1/1A,208,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,96,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,2600,Visit11,11,Phase 1/1A,307,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,2800,Visit12,12,Phase 1/1A,335,1 or 1A,93,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,3000,Visit13,13,Phase 1/1A,363,1 or 1A,0,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,98,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,3800,Visit17,17,Phase 1/1A,470,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM759BC4,2740,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,503,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,2,2,80,80,2,3,19,15,3,533,600,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,1000,Visit3,3,Phase 2,83,2,79,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,1200,Visit4,4,Phase 2,110,2,85,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,1400,Visit5,5,Phase 2,141,2,90,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,1600,Visit6,6,Phase 2,168,2,86,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,1800,Visit7,7,Phase 2,197,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,2000,Visit8,8,Phase 2,224,2,99,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,2200,Visit9,9,Phase 2,253,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,2400,Visit10,10,Phase 2,281,2,92,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,2600,Visit11,11,Phase 2,308,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,3000,Visit13,13,Phase 3,350,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,3200,Visit14,14,Phase 3,385,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,3400,Visit15,15,Phase 3,412,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,3600,Visit16,16,Phase 3,440,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,3800,Visit17,17,Phase 3,475,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,42,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,5800,EndofPhase2,12,Phase 2,313,2,94,3,,0,2,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBM981LV1,2326,,,F,6000,EndofPhase3,18,Phase 3,496,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,120,,,2,,4,158,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,1400,Visit5,5,Phase 1/1A,138,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,1600,Visit6,6,Phase 1/1A,161,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,1800,Visit7,7,Phase 1/1A,190,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,2000,Visit8,8,Phase 1/1A,217,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,2200,Visit9,9,Phase 1/1A,246,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,2400,Visit10,10,Phase 1/1A,274,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,2600,Visit11,11,Phase 1/1A,302,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,2800,Visit12,12,Phase 1/1A,333,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,3000,Visit13,13,Phase 1/1A,361,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,3200,Visit14,14,Phase 1/1A,386,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,3400,Visit15,15,Phase 1/1A,418,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,3600,Visit16,16,Phase 1/1A,442,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,3800,Visit17,17,Phase 1/1A,470,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN024ZXL,1775,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,494,1 or 1A,99,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN414VWW,2671,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,28,1 or 1A,75,2,,1,,,,,,3,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBN631VT5,2062,,,M,600,Visit1,1,Phase 1/1A,21,1 or 1A,,2,,1,,,,,,,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,400,,,2,2,2,467,400,2,3,23,23,3,24,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,2,,,,,,,,4,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,1200,Visit4,4,Phase 2,102,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,1400,Visit5,5,Phase 2,135,2,26,3,,,,,,,,4,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,1600,Visit6,6,Phase 2,162,2,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,1800,Visit7,7,Phase 2,187,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,2000,Visit8,8,Phase 2,219,2,94,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,2200,Visit9,9,Phase 2,250,2,94,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,2400,Visit10,10,Phase 2,278,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,2600,Visit11,11,Phase 2,306,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,2800,Visit12,12,Phase 2,341,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,3200,Visit14,14,Phase 3,397,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,3400,Visit15,15,Phase 3,425,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,3600,Visit16,16,Phase 3,453,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,3800,Visit17,17,Phase 3,481,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,65,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,5800,EndofPhase2,13,Phase 2,373,2,96,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR723EU0,1563,,,M,6000,EndofPhase3,18,Phase 3,509,3,,,,,,1,20,1,20,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,89,2,,,,,,,,1,2,3,,,1,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,1200,Visit4,4,Phase 1/1A,106,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,54,3,,,,,,,,2,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,86,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,2200,Visit9,9,Phase 1/1A,262,1 or 1A,37,3,,,,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,81,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,2800,Visit12,12,Phase 1/1A,354,1 or 1A,53,3,,,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,88,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,3400,Visit15,15,Phase 1/1A,429,1 or 1A,30,3,,1,,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,30,3,,1,,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,3800,Visit17,17,Phase 1/1A,480,1 or 1A,80,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBR926MB7,1543,,,M,4000,Visit18,18,Phase 1/1A,508,1 or 1A,79,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBT484UVR,2703,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,37,2,,0,1,,,,,3,2,400,,,1,,3,500,500,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBT484UVR,2703,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,89,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBT956VMC,1839,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,90,2,,,,,,,,1,2,400,,,1,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBT956VMC,1839,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,1,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBT956VMC,1839,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,18,2,,0,1,,,,,4,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBT956VMC,1839,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBT956VMC,1839,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,67,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,80,2,,1,,,,,,1,2,80,,,1,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,86,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,86,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,79,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,88,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,96,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,98,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,2400,Visit10,10,Phase 1/1A,283,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,96,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,3000,Visit13,13,Phase 1/1A,368,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,3400,Visit15,15,Phase 1/1A,435,1 or 1A,86,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,3800,Visit17,17,Phase 1/1A,471,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU258BZE,2693,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU451RPQ,2025,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,,3,4,4,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBU451RPQ,2025,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,96,2,,1,,,,,,1,2,16,,,2,,4,30,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,1000,Visit3,3,Phase 1/1A,99,1 or 1A,85,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,3200,Visit14,14,Phase 1/1A,398,1 or 1A,97,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,3400,Visit15,15,Phase 1/1A,426,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,3600,Visit16,16,Phase 1/1A,455,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,3800,Visit17,17,Phase 1/1A,483,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV511WN3,2222,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,520,1 or 1A,62,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,800,Visit2,2,Phase 2,57,2,45,2,,0,1,,,,,3,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,1000,Visit3,3,Phase 2,85,2,100,2,,0,1,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,1200,Visit4,4,Phase 2,108,2,100,2,,0,1,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,1400,Visit5,5,Phase 2,129,2,92,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,1600,Visit6,6,Phase 2,164,2,79,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,1800,Visit7,7,Phase 2,192,2,20,4,,0,1,,,,,4,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,2000,Visit8,8,Phase 2,220,2,80,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,2200,Visit9,9,Phase 2,248,2,99,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,2400,Visit10,10,Phase 2,276,2,82,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,2600,Visit11,11,Phase 2,304,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,2800,Visit12,12,Phase 2,332,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,3000,Visit13,13,Phase 2,360,2,96,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,3200,Visit14,14,Phase 2,389,2,90,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,3400,Visit15,15,Phase 2,421,2,85,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,3600,Visit16,16,Phase 2,444,2,70,4,,0,2,,,,,2,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,3800,Visit17,17,Phase 2,479,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,50,2,,0,2,,,,,3,2,400,,,2,1,2,400,400,2,4,141,160,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV732BBY,2738,,,M,5800,EndofPhase2,18,Phase 2,498,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV733GVC,1037,,,M,600,Visit1,1,Phase 2,30,2,80,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV733GVC,1037,,,M,1000,Visit3,3,Phase 3,79,3,,,,,,1,15,,,2,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV733GVC,1037,,,M,5200,EndofPhase1_1a,0,Phase 1/1A,9,1 or 1A,100,2,,,,,,,,1,2,15,,,1,2,2,15,15,2,3,600,600,3,13,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV733GVC,1037,,,M,5800,EndofPhase2,2,Phase 2,37,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBV733GVC,1037,,,M,6000,EndofPhase3,4,Phase 3,112,3,,,,,,1,10,,,2,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW552GFF,1147,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,79,2,,,,,,,,2,2,400,,,2,1,2,400,400,2,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW552GFF,1147,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW552GFF,1147,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW552GFF,1147,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW552GFF,1147,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW552GFF,1147,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW552GFF,1147,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW552GFF,1147,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW552GFF,1147,,,M,3000,Visit13,13,Phase 2,363,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW552GFF,1147,,,M,3200,Visit14,14,Phase 2,393,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW552GFF,1147,,,M,3400,Visit15,15,Phase 2,422,2,93,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW552GFF,1147,,,M,4000,Visit18,18,Phase 2,505,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW552GFF,1147,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,338,1 or 1A,35,2,,,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBW909MRX,1282,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,33,1 or 1A,98,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY054VF6,1015,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,800,Visit2,2,Phase 2,57,2,96,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,1000,Visit3,3,Phase 2,85,2,95,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,1200,Visit4,4,Phase 2,113,2,98,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,1400,Visit5,5,Phase 2,141,2,75,4,,1,,,,,,2,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,1600,Visit6,6,Phase 2,168,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,2000,Visit8,8,Phase 3,204,3,,,,,,7,25,,,1,,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,2200,Visit9,9,Phase 3,234,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,2400,Visit10,10,Phase 3,262,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,2600,Visit11,11,Phase 3,290,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,2800,Visit12,12,Phase 3,318,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,3000,Visit13,13,Phase 3,346,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,3200,Visit14,14,Phase 3,374,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,3400,Visit15,15,Phase 3,402,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,3600,Visit16,16,Phase 3,430,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,3800,Visit17,17,Phase 3,457,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,84,2,,,,,,,,1,2,400,,,2,2,2,400,400,2,3,133,160,3,48,50,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,5800,EndofPhase2,7,Phase 2,179,2,36,4,,1,,,,,,3,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVBY476AE8,2023,,,M,6000,EndofPhase3,18,Phase 3,486,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA163DRV,1049,,,F,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,3,,0,1,,,,,1,3,600,,,1,3,3,600,600,3,,300,300,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA163DRV,1049,,,F,1000,Visit3,3,Phase 2,85,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA163DRV,1049,,,F,1200,Visit4,4,Phase 2,113,2,74,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA163DRV,1049,,,F,1400,Visit5,5,Phase 2,140,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA163DRV,1049,,,F,1600,Visit6,6,Phase 2,168,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA163DRV,1049,,,F,1800,Visit7,7,Phase 2,197,2,45,,300,,,,,,,2,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA163DRV,1049,,,F,2000,Visit8,8,Phase 2,224,2,96,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA163DRV,1049,,,F,2200,Visit9,9,Phase 2,252,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA163DRV,1049,,,F,2400,Visit10,10,Phase 2,280,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA163DRV,1049,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,49,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,3,,,,,,,,1,3,600,,,2,,3,667,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,98,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,93,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,99,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,96,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,99,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,93,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,3000,Visit13,13,Phase 1/1A,369,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,85,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,94,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,85,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,99,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA189MFB,1087,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,506,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,3,27,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,94,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,2200,Visit9,9,Phase 1/1A,266,1 or 1A,100,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,2600,Visit11,11,Phase 1/1A,302,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,2800,Visit12,12,Phase 1/1A,350,1 or 1A,67,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,3000,Visit13,13,Phase 1/1A,378,1 or 1A,74,4,,,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,85,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,93,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA280VLE,1455,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,507,1 or 1A,87,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,400,,,1,,4,756,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,1200,Visit4,4,Phase 1/1A,106,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,1400,Visit5,5,Phase 1/1A,127,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,1800,Visit7,7,Phase 1/1A,188,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,2000,Visit8,8,Phase 1/1A,216,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,2200,Visit9,9,Phase 1/1A,245,1 or 1A,50,4,,0,1,,,,,3,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,2400,Visit10,10,Phase 1/1A,273,1 or 1A,100,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,2800,Visit12,12,Phase 1/1A,350,1 or 1A,100,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,63,4,,0,1,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,93,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,3600,Visit16,16,Phase 1/1A,456,1 or 1A,77,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,3800,Visit17,17,Phase 1/1A,490,1 or 1A,100,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA367ETV,1292,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,533,1 or 1A,100,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA544WCZ,2479,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,99,3,,1,,,,,,1,3,22.5,,,1,,3,24,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA544WCZ,2479,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA544WCZ,2479,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA544WCZ,2479,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA544WCZ,2479,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,94,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA544WCZ,2479,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,92,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA544WCZ,2479,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,67,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA544WCZ,2479,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,257,1 or 1A,,4,,0,,,,,,,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,,3,116,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,59,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,55,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,1200,Visit4,4,Phase 1/1A,106,1 or 1A,96,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,1400,Visit5,5,Phase 1/1A,134,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,1600,Visit6,6,Phase 1/1A,162,1 or 1A,95,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,1800,Visit7,7,Phase 1/1A,191,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,2000,Visit8,8,Phase 1/1A,219,1 or 1A,78,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,2200,Visit9,9,Phase 1/1A,247,1 or 1A,97,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,2400,Visit10,10,Phase 1/1A,278,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,2600,Visit11,11,Phase 1/1A,306,1 or 1A,92,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,2800,Visit12,12,Phase 1/1A,334,1 or 1A,98,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,3000,Visit13,13,Phase 1/1A,361,1 or 1A,85,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,3200,Visit14,14,Phase 1/1A,389,1 or 1A,90,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,3400,Visit15,15,Phase 1/1A,417,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,95,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA799MUJ,2636,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,97,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCA959YGL,2216,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,86,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,2000,Visit8,8,Phase 1/1A,242,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,2200,Visit9,9,Phase 1/1A,277,1 or 1A,99,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,2400,Visit10,10,Phase 1/1A,302,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,2600,Visit11,11,Phase 1/1A,331,1 or 1A,89,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,2800,Visit12,12,Phase 1/1A,359,1 or 1A,95,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,3000,Visit13,13,Phase 1/1A,380,1 or 1A,95,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,3200,Visit14,14,Phase 1/1A,407,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,3400,Visit15,15,Phase 1/1A,435,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,3600,Visit16,16,Phase 1/1A,463,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,3800,Visit17,17,Phase 1/1A,505,1 or 1A,99,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB171GLT,1516,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,522,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,600,Visit1,1,Phase 1/1A,37,1 or 1A,,1,,1,,,,,,1,1,8,,,1,,2,16,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,1400,Visit5,5,Phase 1/1A,154,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,1600,Visit6,6,Phase 1/1A,218,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,2000,Visit8,8,Phase 1/1A,245,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,2200,Visit9,9,Phase 1/1A,278,1 or 1A,97,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,2400,Visit10,10,Phase 1/1A,307,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,2600,Visit11,11,Phase 1/1A,336,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,2800,Visit12,12,Phase 1/1A,366,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,3200,Visit14,14,Phase 1/1A,428,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,3400,Visit15,15,Phase 1/1A,456,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,3600,Visit16,16,Phase 1/1A,490,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,3800,Visit17,17,Phase 1/1A,517,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB189WH9,1467,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,551,1 or 1A,97,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,600,Visit1,1,Phase 1/1A,21,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,2,4,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,800,Visit2,2,Phase 1/1A,49,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,1000,Visit3,3,Phase 1/1A,77,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,1200,Visit4,4,Phase 1/1A,105,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,1400,Visit5,5,Phase 1/1A,133,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,1600,Visit6,6,Phase 1/1A,161,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,1800,Visit7,7,Phase 1/1A,189,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,2000,Visit8,8,Phase 1/1A,217,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,2200,Visit9,9,Phase 1/1A,245,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,2400,Visit10,10,Phase 1/1A,273,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,2600,Visit11,11,Phase 1/1A,301,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,2800,Visit12,12,Phase 1/1A,329,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,3000,Visit13,13,Phase 1/1A,357,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,3200,Visit14,14,Phase 1/1A,386,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,3400,Visit15,15,Phase 1/1A,414,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,3600,Visit16,16,Phase 1/1A,442,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,3800,Visit17,17,Phase 1/1A,470,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB708FN4,1083,,,M,4000,Visit18,18,Phase 1/1A,498,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB944PY4,2075,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,97,2,,1,,,,,,1,2,3,,,1,1,3,5,5,3,3,120,120,3,56,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB944PY4,2075,,,M,800,Visit2,2,Phase 1/1A,72,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB944PY4,2075,,,M,1200,Visit4,4,Phase 2,141,2,96,2,,0,1,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB944PY4,2075,,,M,1400,Visit5,5,Phase 2,162,2,95,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB944PY4,2075,,,M,2000,Visit8,8,Phase 3,240,3,,,,,,5,16,5,16,1,,,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB944PY4,2075,,,M,2200,Visit9,9,Phase 3,269,3,,,,,,5,24,5,24,1,,,,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB944PY4,2075,,,M,2400,Visit10,10,Phase 3,297,3,,,,,,5,24,5,24,1,,,,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB944PY4,2075,,,M,2600,Visit11,11,Phase 3,325,3,,,,,,5,32,5,32,1,,,,64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB944PY4,2075,,,M,2800,Visit12,12,Phase 3,353,3,,,,,,5,32,5,32,1,,,,64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB944PY4,2075,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,101,1 or 1A,100,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB944PY4,2075,,,M,5800,EndofPhase2,6,Phase 2,184,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCB944PY4,2075,,,M,6000,EndofPhase3,13,Phase 3,379,3,,,,,,5,40,5,40,1,,,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC028GXB,2767,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,81,2,,1,,,,,,1,2,80,,,2,2,3,129,160,3,3,4,4,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC028GXB,2767,,,F,800,Visit2,2,Phase 1/1A,68,1 or 1A,97,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC028GXB,2767,,,F,1000,Visit3,3,Phase 1/1A,99,1 or 1A,97,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC028GXB,2767,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,96,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC028GXB,2767,,,F,1400,Visit5,5,Phase 1/1A,149,1 or 1A,72,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC028GXB,2767,,,F,1600,Visit6,6,Phase 1/1A,182,1 or 1A,94,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC028GXB,2767,,,F,1800,Visit7,7,Phase 1/1A,211,1 or 1A,99,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC028GXB,2767,,,F,2000,Visit8,8,Phase 1/1A,233,1 or 1A,97,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC028GXB,2767,,,F,2200,Visit9,9,Phase 1/1A,251,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC028GXB,2767,,,F,3000,Visit13,13,Phase 2,393,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC028GXB,2767,,,F,3200,Visit14,14,Phase 2,428,2,78,3,,1,,,,,,2,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC662ZFE,1241,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC662ZFE,1241,,,M,800,Visit2,2,Phase 1/1A,105,1 or 1A,0,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC662ZFE,1241,,,M,1000,Visit3,3,Phase 1/1A,152,1 or 1A,66,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC662ZFE,1241,,,M,1200,Visit4,4,Phase 1/1A,176,1 or 1A,94,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC662ZFE,1241,,,M,1400,Visit5,5,Phase 1/1A,201,1 or 1A,86,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC662ZFE,1241,,,M,1600,Visit6,6,Phase 1/1A,226,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC662ZFE,1241,,,M,1800,Visit7,7,Phase 1/1A,253,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC662ZFE,1241,,,M,2000,Visit8,8,Phase 1/1A,278,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC662ZFE,1241,,,M,2200,Visit9,9,Phase 1/1A,322,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC662ZFE,1241,,,M,2400,Visit10,10,Phase 1/1A,351,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC662ZFE,1241,,,M,2600,Visit11,11,Phase 1/1A,372,1 or 1A,72,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC662ZFE,1241,,,M,2800,Visit12,12,Phase 1/1A,394,1 or 1A,98,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC662ZFE,1241,,,M,3200,Visit14,14,Phase 1/1A,456,1 or 1A,50,1,,0,1,,,,,3,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,4,,,,,,,,1,4,30,,,1,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,800,Visit2,2,Phase 1/1A,49,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,90,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,2200,Visit9,9,Phase 1/1A,266,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,2400,Visit10,10,Phase 1/1A,296,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,2600,Visit11,11,Phase 1/1A,331,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,2800,Visit12,12,Phase 1/1A,370,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,3000,Visit13,13,Phase 1/1A,401,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,3200,Visit14,14,Phase 1/1A,429,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,3400,Visit15,15,Phase 1/1A,461,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,3600,Visit16,16,Phase 1/1A,490,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCC858LCG,1061,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,525,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD286UDX,2059,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,52,2,,,,,,,,2,2,400,,,2,2,3,567,400,3,3,136,120,3,200,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,99,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,97,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,1800,Visit7,7,Phase 2,197,2,100,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,2000,Visit8,8,Phase 2,225,2,100,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,2200,Visit9,9,Phase 2,252,2,100,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,2400,Visit10,10,Phase 2,281,2,99,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,2800,Visit12,12,Phase 3,361,3,,,,,,6,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,6,200,,,1,,,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,6,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,6,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,6,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,169,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,5800,EndofPhase2,11,Phase 2,309,2,100,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD336JWW,1204,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,6,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,2,,,,,,,,1,2,16,,,2,,3,23,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,84,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,73,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,76,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,85,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,1800,Visit7,7,Phase 1/1A,213,1 or 1A,92,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,2000,Visit8,8,Phase 1/1A,239,1 or 1A,98,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,2200,Visit9,9,Phase 1/1A,267,1 or 1A,98,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,2400,Visit10,10,Phase 1/1A,303,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,2600,Visit11,11,Phase 1/1A,331,1 or 1A,88,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,2800,Visit12,12,Phase 1/1A,365,1 or 1A,93,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,3000,Visit13,13,Phase 1/1A,393,1 or 1A,92,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,3200,Visit14,14,Phase 1/1A,421,1 or 1A,97,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,3400,Visit15,15,Phase 1/1A,449,1 or 1A,97,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,3600,Visit16,16,Phase 1/1A,480,1 or 1A,94,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,3800,Visit17,17,Phase 1/1A,505,1 or 1A,94,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD653CCA,2865,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,535,1 or 1A,97,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,800,Visit2,2,Phase 2,64,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,1000,Visit3,3,Phase 2,92,2,96,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,1200,Visit4,4,Phase 2,120,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,1400,Visit5,5,Phase 2,141,2,97,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,1600,Visit6,6,Phase 2,172,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,1800,Visit7,7,Phase 2,200,2,97,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,2000,Visit8,8,Phase 2,225,2,98,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,2200,Visit9,9,Phase 2,259,2,96,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,2400,Visit10,10,Phase 2,295,2,90,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,2600,Visit11,11,Phase 2,323,2,96,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,2800,Visit12,12,Phase 2,337,2,93,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,3000,Visit13,13,Phase 2,365,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,3200,Visit14,14,Phase 2,393,2,95,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,3400,Visit15,15,Phase 2,423,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,3600,Visit16,16,Phase 2,449,2,98,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,3800,Visit17,17,Phase 2,470,2,95,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,4000,Visit18,18,Phase 2,513,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCD867YBU,1453,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,31,1 or 1A,93,1,,,,,,,,1,1,200,,,2,2,1,200,200,1,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE287HWX,2237,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,38,2,,,,,,,,3,2,15,,,2,,3,20,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,17,2,,1,,,,,,4,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,1800,Visit7,7,Phase 1/1A,201,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,2400,Visit10,10,Phase 1/1A,285,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,2800,Visit12,12,Phase 1/1A,348,1 or 1A,99,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,3000,Visit13,13,Phase 1/1A,378,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,3200,Visit14,14,Phase 1/1A,411,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,3400,Visit15,15,Phase 1/1A,441,1 or 1A,75,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,3600,Visit16,16,Phase 1/1A,476,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,3800,Visit17,17,Phase 1/1A,505,1 or 1A,98,3,,0,2,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE656JB3,1833,,,M,4000,Visit18,18,Phase 1/1A,545,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE728WPZ,1051,,,M,600,Visit1,1,Phase 1/1A,24,1 or 1A,100,2,,,,,,,,3,2,3,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE728WPZ,1051,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,57,1 or 1A,40,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,600,Visit1,1,Phase 1/1A,40,1 or 1A,100,4,,,,,,,,1,4,6,,,2,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,800,Visit2,2,Phase 1/1A,71,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,1000,Visit3,3,Phase 1/1A,96,1 or 1A,98,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,1600,Visit6,6,Phase 1/1A,182,1 or 1A,98,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,2600,Visit11,11,Phase 1/1A,307,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,2800,Visit12,12,Phase 1/1A,351,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,3000,Visit13,13,Phase 1/1A,354,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,3200,Visit14,14,Phase 1/1A,382,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,3400,Visit15,15,Phase 1/1A,410,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,3600,Visit16,16,Phase 1/1A,438,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,3800,Visit17,17,Phase 1/1A,466,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE980MLP,1685,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,524,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,1,2,15,,,1,1,3,19,15,3,3,127,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,92,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,96,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,1400,Visit5,5,Phase 1/1A,151,1 or 1A,87,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,1800,Visit7,7,Phase 2,221,2,90,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,2000,Visit8,8,Phase 2,245,2,100,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,2200,Visit9,9,Phase 2,270,2,88,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,2400,Visit10,10,Phase 2,299,2,86,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,2600,Visit11,11,Phase 2,334,2,100,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,3000,Visit13,13,Phase 3,383,3,,,,,,3,2,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,3200,Visit14,14,Phase 3,413,3,,,,,,3,2,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,3400,Visit15,15,Phase 3,452,3,,,,,,3,3,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,3600,Visit16,16,Phase 3,483,3,,,,,,3,3,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,3800,Visit17,17,Phase 3,511,3,,,,,,3,3,2,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,189,1 or 1A,87,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCE986TWM,1573,,,M,5800,EndofPhase2,12,Phase 2,350,2,83,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF093XM6,1561,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,1,1,,,,,,,,2,1,8,,,2,,2,15,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF093XM6,1561,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF093XM6,1561,,,M,1000,Visit3,3,Phase 1/1A,99,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF093XM6,1561,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,45,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF093XM6,1561,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF093XM6,1561,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,201,1 or 1A,71,2,,,,,,,,,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,87,2,,1,,,,,,1,2,15,,,1,,3,22,15,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,1600,Visit6,6,Phase 1/1A,221,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,1800,Visit7,7,Phase 1/1A,258,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,2000,Visit8,8,Phase 1/1A,288,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,2200,Visit9,9,Phase 1/1A,305,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,2400,Visit10,10,Phase 1/1A,333,1 or 1A,86,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,2600,Visit11,11,Phase 1/1A,361,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,2800,Visit12,12,Phase 1/1A,389,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,3000,Visit13,13,Phase 1/1A,417,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,3200,Visit14,14,Phase 1/1A,452,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,3400,Visit15,15,Phase 1/1A,477,1 or 1A,88,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,3600,Visit16,16,Phase 1/1A,511,1 or 1A,65,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,3800,Visit17,17,Phase 1/1A,530,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF455KKU,2596,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,550,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,1800,Visit7,7,Phase 1/1A,206,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,48,2,,1,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,2400,Visit10,10,Phase 1B,273,1B,61,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,2600,Visit11,11,Phase 1B,315,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,2800,Visit12,12,Phase 1B,343,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,3000,Visit13,13,Phase 1B,371,1B,31,3,,1,,,,,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,3200,Visit14,14,Phase 1B,406,1B,57,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,3400,Visit15,15,Phase 1B,449,1B,96,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,3600,Visit16,16,Phase 1B,484,1B,96,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,3800,Visit17,17,Phase 1B,520,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,255,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCF841RW2,2088,,,M,5400,EndofPhase1b,18,Phase 1B,560,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG148UBX,2715,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,2,,1,,,,,,1,2,16,,,2,,4,29,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG148UBX,2715,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG148UBX,2715,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG148UBX,2715,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG148UBX,2715,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG148UBX,2715,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG148UBX,2715,,,F,1800,Visit7,7,Phase 1/1A,203,1 or 1A,78,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,600,Visit1,1,Phase 1/1A,43,1 or 1A,94,3,,,,,,,,1,3,24,,,2,,3,26,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,1000,Visit3,3,Phase 1/1A,96,1 or 1A,91,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,89,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,2400,Visit10,10,Phase 1/1A,277,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,2600,Visit11,11,Phase 1/1A,305,1 or 1A,85,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,3400,Visit15,15,Phase 1/1A,424,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,3600,Visit16,16,Phase 1/1A,455,1 or 1A,,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,3800,Visit17,17,Phase 1/1A,483,1 or 1A,,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG495CP9,1520,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,15,4,,1,,,,,,4,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,2,,1,,,,,,2,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,800,Visit2,2,Phase 1/1A,68,1 or 1A,100,2,,1,,,,,,4,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,1000,Visit3,3,Phase 1/1A,96,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,1200,Visit4,4,Phase 1/1A,131,1 or 1A,95,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,1400,Visit5,5,Phase 1/1A,161,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,94,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,42,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,2000,Visit8,8,Phase 1/1A,239,1 or 1A,96,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,2200,Visit9,9,Phase 1/1A,267,1 or 1A,91,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,2400,Visit10,10,Phase 1/1A,295,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,2600,Visit11,11,Phase 1/1A,320,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,2800,Visit12,12,Phase 1/1A,348,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,3000,Visit13,13,Phase 1/1A,376,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,3200,Visit14,14,Phase 1/1A,427,1 or 1A,60,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,3400,Visit15,15,Phase 1/1A,455,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,3600,Visit16,16,Phase 1/1A,480,1 or 1A,81,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,3800,Visit17,17,Phase 1/1A,510,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCG709UFX,2547,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,537,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,97,2,,,,,,,,1,2,16,,,1,,4,29,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,1400,Visit5,5,Phase 1/1A,146,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,80,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,97,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,95,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,2400,Visit10,10,Phase 1/1A,273,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,2600,Visit11,11,Phase 1/1A,302,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,3200,Visit14,14,Phase 1/1A,401,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,3400,Visit15,15,Phase 1/1A,432,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,3600,Visit16,16,Phase 1/1A,463,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,3800,Visit17,17,Phase 1/1A,492,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH073PE5,1462,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,537,1 or 1A,,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH728KZY,1693,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,87,1,,,,,,,,1,1,8,,,1,,2,13,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH728KZY,1693,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,44,2,,,,,,,,3,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCH728KZY,1693,,,M,1200,Visit4,4,Phase 1/1A,125,1 or 1A,71,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,800,Visit2,2,Phase 1B,58,1B,93,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,1000,Visit3,3,Phase 1B,93,1B,100,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,1200,Visit4,4,Phase 1B,128,1B,97,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,1400,Visit5,5,Phase 1B,149,1B,100,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,1600,Visit6,6,Phase 1B,177,1B,100,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,1800,Visit7,7,Phase 1B,205,1B,91,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,2000,Visit8,8,Phase 1B,233,1B,95,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,2200,Visit9,9,Phase 1B,264,1B,100,4,,0,2,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,2400,Visit10,10,Phase 1B,289,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,2600,Visit11,11,Phase 1B,317,1B,97,4,,0,2,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,3000,Visit13,13,Phase 2,366,2,81,5,,0,2,,,,,1,5,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,3200,Visit14,14,Phase 2,394,2,98,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,3400,Visit15,15,Phase 2,422,2,98,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,3600,Visit16,16,Phase 2,450,2,99,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,3800,Visit17,17,Phase 2,485,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,27,1 or 1A,54,2,,0,1,,,,,2,2,16,,,1,2,2,16,16,2,3,5,5,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,5400,EndofPhase1b,12,Phase 1B,338,1B,93,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ432ZDG,2139,,,M,5800,EndofPhase2,18,Phase 2,518,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ681GF3,2051,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,91,2,,0,1,,,,,1,2,3,,,1,1,3,5,6,3,2,400,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,99,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,95,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,87,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,95,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,1800,Visit7,7,Phase 1/1A,202,1 or 1A,100,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,83,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,2200,Visit9,9,Phase 1/1A,259,1 or 1A,100,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,2400,Visit10,10,Phase 1/1A,287,1 or 1A,83,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,2600,Visit11,11,Phase 1/1A,315,1 or 1A,100,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,2800,Visit12,12,Phase 1/1A,345,1 or 1A,90,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,3000,Visit13,13,Phase 1/1A,378,1 or 1A,90,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,3200,Visit14,14,Phase 1/1A,413,1 or 1A,88,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,3600,Visit16,16,Phase 2,476,2,86,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,3800,Visit17,17,Phase 2,504,2,75,2,,0,1,,,,,2,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,5200,EndofPhase1_1a,15,Phase 1/1A,448,1 or 1A,90,4,,0,2,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ923TE4,2822,,,M,5800,EndofPhase2,18,Phase 2,539,2,79,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ990GAT,2229,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ990GAT,2229,,,M,800,Visit2,2,Phase 1/1A,49,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCJ990GAT,2229,,,M,1000,Visit3,3,Phase 1/1A,76,1 or 1A,65,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK075WY4,1926,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,,,,,,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,3,23,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,,4,,,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,22,4,,,,,,,,4,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,1600,Visit6,6,Phase 1/1A,184,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,2000,Visit8,8,Phase 1/1A,239,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,2200,Visit9,9,Phase 1/1A,274,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,2400,Visit10,10,Phase 1/1A,301,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,2600,Visit11,11,Phase 1/1A,336,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,2800,Visit12,12,Phase 1/1A,371,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,3000,Visit13,13,Phase 1/1A,399,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,3200,Visit14,14,Phase 1/1A,427,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,3400,Visit15,15,Phase 1/1A,455,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,3600,Visit16,16,Phase 1/1A,482,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,3800,Visit17,17,Phase 1/1A,511,1 or 1A,97,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK339BPM,1262,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,551,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCK744UR3,1716,,,F,600,Visit1,1,Phase 1/1A,43,1 or 1A,,2,,1,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL031JZD,2559,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,4,,1,,,,,,1,4,800,,,2,,4,771,800,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL031JZD,2559,,,F,800,Visit2,2,Phase 1/1A,54,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL031JZD,2559,,,F,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL031JZD,2559,,,F,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL031JZD,2559,,,F,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL031JZD,2559,,,F,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL031JZD,2559,,,F,5200,EndofPhase1_1a,7,Phase 1/1A,197,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL303HEL,1904,,,F,1800,Visit7,7,Phase 2,133,2,100,3,,1,,,,,,2,3,,22.5,,,2,,,,,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL303HEL,1904,,,F,2000,Visit8,8,Phase 2,154,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL303HEL,1904,,,F,2200,Visit9,9,Phase 2,182,2,94,4,,1,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL303HEL,1904,,,F,2400,Visit10,10,Phase 2,207,2,94,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL303HEL,1904,,,F,2600,Visit11,11,Phase 2,236,2,100,4,,1,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL303HEL,1904,,,F,2800,Visit12,12,Phase 2,266,2,100,4,,1,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL303HEL,1904,,,F,3000,Visit13,13,Phase 2,294,2,97,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL303HEL,1904,,,F,3200,Visit14,14,Phase 2,322,2,97,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL303HEL,1904,,,F,3400,Visit15,15,Phase 2,350,2,96,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL303HEL,1904,,,F,3600,Visit16,16,Phase 2,378,2,99,4,,1,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL303HEL,1904,,,F,3800,Visit17,17,Phase 2,407,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL303HEL,1904,,,F,5800,EndofPhase2,18,Phase 2,434,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL362JXY,2290,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL362JXY,2290,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,80,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL362JXY,2290,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL362JXY,2290,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCL362JXY,2290,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,99,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM006VLM,1736,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM006VLM,1736,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM006VLM,1736,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM006VLM,1736,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM006VLM,1736,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM006VLM,1736,,,M,1600,Visit6,6,Phase 1/1A,163,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM080VG4,1244,,,F,600,Visit1,1,Phase 1/1A,42,1 or 1A,,,,,,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,1,2,16,,,1,,3,22,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,97,0,,,,,,,,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,98,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,2400,Visit10,10,Phase 1/1A,283,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,2600,Visit11,11,Phase 1/1A,311,1 or 1A,98,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,3000,Visit13,13,Phase 1/1A,368,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,3200,Visit14,14,Phase 1/1A,396,1 or 1A,84,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,3400,Visit15,15,Phase 1/1A,424,1 or 1A,74,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,96,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,3800,Visit17,17,Phase 1/1A,481,1 or 1A,88,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,4000,Visit18,18,Phase 1/1A,513,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,4200,Visit19,19,Phase 1/1A,541,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,4400,Visit20,20,Phase 1/1A,572,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM487UTQ,1192,,,M,5200,EndofPhase1_1a,20,Phase 1/1A,600,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,4,,,,,,,,1,4,800,,,2,1,4,800,800,4,4,6,6,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,1600,Visit6,6,Phase 2,182,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,1800,Visit7,7,Phase 2,210,2,,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,2000,Visit8,8,Phase 2,238,2,,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,2200,Visit9,9,Phase 2,266,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,2400,Visit10,10,Phase 2,288,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,2600,Visit11,11,Phase 2,316,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,2800,Visit12,12,Phase 2,370,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,3000,Visit13,13,Phase 2,399,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,3200,Visit14,14,Phase 2,428,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,3400,Visit15,15,Phase 2,497,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,3600,Visit16,16,Phase 2,526,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCM947TPH,1191,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,131,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN023RVT,1788,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,97,2,,,,,,,,1,2,15,,,2,,3,22,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN023RVT,1788,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN023RVT,1788,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN023RVT,1788,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN023RVT,1788,,,M,1400,Visit5,5,Phase 1/1A,159,1 or 1A,84,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN023RVT,1788,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN023RVT,1788,,,M,2000,Visit8,8,Phase 1/1A,222,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN023RVT,1788,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,95,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN216XUW,2802,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,4,,1,,,,,,1,4,160,,,2,,4,165,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN216XUW,2802,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,87,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN216XUW,2802,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,90,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN216XUW,2802,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,95,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN216XUW,2802,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,95,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN216XUW,2802,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN216XUW,2802,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN216XUW,2802,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,230,1 or 1A,,5,,1,,,,,,,5,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,600,Visit1,1,Phase 1/1A,32,1 or 1A,95,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,800,Visit2,2,Phase 1/1A,53,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,85,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,2,,1,,,,,,4,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,2800,Visit12,12,Phase 1/1A,336,1 or 1A,93,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,86,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,3200,Visit14,14,Phase 1/1A,385,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,3400,Visit15,15,Phase 1/1A,413,1 or 1A,77,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,3600,Visit16,16,Phase 1/1A,441,1 or 1A,98,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,3800,Visit17,17,Phase 1/1A,469,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN295TZG,1302,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,500,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,800,Visit2,2,Phase 1B,53,1B,95,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,1000,Visit3,3,Phase 1B,84,1B,90,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,1200,Visit4,4,Phase 1B,114,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,1400,Visit5,5,Phase 1B,141,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,1600,Visit6,6,Phase 1B,171,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,1800,Visit7,7,Phase 1B,196,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,2200,Visit9,9,Phase 2,263,2,100,2,,1,,,,,,2,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,2800,Visit12,12,Phase 3,336,3,,,,,,2,300,,0,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,3000,Visit13,13,Phase 3,366,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,3200,Visit14,14,Phase 3,393,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,3400,Visit15,15,Phase 3,417,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,3600,Visit16,16,Phase 3,449,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,3800,Visit17,17,Phase 3,477,3,,,,,,2,500,,,4,,,,500,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,24,1 or 1A,64,3,,1,,,,,,2,3,24,,,2,2,3,24,24,3,2,93,80,2,357,300,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,5400,EndofPhase1b,8,Phase 1B,228,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,5800,EndofPhase2,10,Phase 2,303,2,86,2,,1,,,,,,2,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN401LND,2252,,,F,6000,EndofPhase3,18,Phase 3,500,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN551URH,2584,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,99,1,,1,,,,,,1,1,8,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,1400,Visit5,5,Phase 1/1A,137,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,1600,Visit6,6,Phase 1/1A,165,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,91,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,89,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,97,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN621NUC,2889,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,4,729,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,99,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,99,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,91,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,86,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,1800,Visit7,7,Phase 1/1A,202,1 or 1A,89,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,2200,Visit9,9,Phase 1/1A,273,1 or 1A,44,4,,1,,,,,,3,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,2400,Visit10,10,Phase 1/1A,286,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,2600,Visit11,11,Phase 1/1A,307,1 or 1A,88,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,2800,Visit12,12,Phase 1/1A,335,1 or 1A,92,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,3000,Visit13,13,Phase 1/1A,363,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,3200,Visit14,14,Phase 1/1A,405,1 or 1A,,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,3400,Visit15,15,Phase 1/1A,419,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,3600,Visit16,16,Phase 1/1A,447,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCN852HGZ,1914,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,496,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,96,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,,4,,,,,,,,4,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,52,4,,,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,2400,Visit10,10,Phase 1/1A,277,1 or 1A,86,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,2600,Visit11,11,Phase 1/1A,312,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,3000,Visit13,13,Phase 2,369,2,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,3200,Visit14,14,Phase 2,401,2,89,4,,,,,,,,2,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,3400,Visit15,15,Phase 2,428,2,94,4,,,,,,,,2,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,3600,Visit16,16,Phase 3,474,3,,,,,,3,6,5,16,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,3800,Visit17,17,Phase 3,505,3,,,,,,3,6,5,16,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,4000,Visit18,18,Phase 3,540,3,,,,,,3,6,5,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,340,,,,,,,,,,,,,,,,1,2,4,30,30,4,4,160,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCP239PKC,1249,,,M,5800,EndofPhase2,15,Phase 2,456,1 or 1A,98,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,2,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,98,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,94,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,1400,Visit5,5,Phase 1/1A,146,1 or 1A,86,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,92,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,1800,Visit7,7,Phase 1/1A,202,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,2000,Visit8,8,Phase 1/1A,230,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,2200,Visit9,9,Phase 1/1A,258,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,2400,Visit10,10,Phase 1/1A,286,1 or 1A,95,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,2600,Visit11,11,Phase 1/1A,314,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,2800,Visit12,12,Phase 1/1A,342,1 or 1A,99,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,3000,Visit13,13,Phase 1/1A,370,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,3200,Visit14,14,Phase 1/1A,398,1 or 1A,94,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,3400,Visit15,15,Phase 1/1A,426,1 or 1A,95,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,3600,Visit16,16,Phase 1/1A,454,1 or 1A,89,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,3800,Visit17,17,Phase 1/1A,482,1 or 1A,93,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR239XD0,2819,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,503,1 or 1A,99,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,96,2,,,,,,,,1,2,400,,,2,,2,411,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,1400,Visit5,5,Phase 1/1A,151,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,1600,Visit6,6,Phase 1/1A,192,1 or 1A,97,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,2600,Visit11,11,Phase 1/1A,302,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,3000,Visit13,13,Phase 1/1A,368,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,3400,Visit15,15,Phase 1/1A,431,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,86,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR316AZ4,1598,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,,1,,,,,,,,2,1,1.5,,,1,2,2,3,3,2,3,25,30,3,38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,75,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,1000,Visit3,3,Phase 2,87,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,1200,Visit4,4,Phase 2,115,2,30,2,,,,,,,,4,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,1400,Visit5,5,Phase 2,144,2,97,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,1600,Visit6,6,Phase 2,176,2,33,4,,,,,,,,3,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,1800,Visit7,7,Phase 2,206,2,91,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,2000,Visit8,8,Phase 2,228,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,2200,Visit9,9,Phase 2,249,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,2400,Visit10,10,Phase 2,290,2,50,4,,,,,,,,3,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,2800,Visit12,12,Phase 3,351,3,,,,,,7,25,,,3,,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,3400,Visit15,15,Phase 3,423,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,60,1 or 1A,75,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR681DKJ,1286,,,M,5800,EndofPhase2,11,Phase 2,305,2,9,4,,,,,,,,4,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR886XJL,2459,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,1,,3,19,19,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCR886XJL,2459,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,68,1 or 1A,87,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,3,,,,,,,,1,3,4.5,,,2,3,3,5,5,3,,350,350,,500,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,90,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,2000,Visit8,8,Phase 1/1A,229,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,96,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,90,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,3200,Visit14,14,Phase 2,393,2,99,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,5200,EndofPhase1_1a,13,Phase 1/1A,368,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,5800,EndofPhase2,15,Phase 2,419,2,93,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT059BWV,1280,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT319RXW,1882,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,,1,,1,,,,,,1,1,7.5,,,1,2,1,9,8,1,4,160,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT319RXW,1882,,,F,800,Visit2,2,Phase 1/1A,62,1 or 1A,,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT319RXW,1882,,,F,1000,Visit3,3,Phase 1/1A,91,1 or 1A,,1,,,,,,,,3,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT319RXW,1882,,,F,1400,Visit5,5,Phase 2,152,2,,,400,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT319RXW,1882,,,F,1600,Visit6,6,Phase 2,197,2,50,4,,1,,,,,,3,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT319RXW,1882,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,119,1 or 1A,,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,,,,,,,,,1,,,,,2,3,3,24,23,3,,120,100,,313,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,97,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,1600,Visit6,6,Phase 2,169,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,1800,Visit7,7,Phase 2,190,2,100,,100,,,,,,,1,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,2000,Visit8,8,Phase 2,220,2,100,,100,,,,,,,1,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,2200,Visit9,9,Phase 2,247,2,100,,100,,,,,,,1,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,2600,Visit11,11,Phase 3,315,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,2800,Visit12,12,Phase 3,341,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,3000,Visit13,13,Phase 3,371,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,3200,Visit14,14,Phase 3,394,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,3400,Visit15,15,Phase 3,427,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,3600,Visit16,16,Phase 3,450,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,3800,Visit17,17,Phase 3,474,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,126,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,5800,EndofPhase2,10,Phase 2,261,2,100,,100,,,,,,,1,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT439MJW,1981,,,M,6000,EndofPhase3,18,Phase 3,513,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCT757DCE,2151,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,,,,,,,1,3,600,,,2,3,3,636,600,3,4,367,400,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,98,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,2200,Visit9,9,Phase 1/1A,250,1 or 1A,83,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,,4,,0,2,,,,,,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,2800,Visit12,12,Phase 2,337,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,3000,Visit13,13,Phase 2,359,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,3200,Visit14,14,Phase 2,393,2,96,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,3400,Visit15,15,Phase 2,421,2,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,3600,Visit16,16,Phase 2,449,2,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,3800,Visit17,17,Phase 2,470,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,5200,EndofPhase1_1a,11,Phase 1/1A,288,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU554RPB,1514,,,M,5800,EndofPhase2,18,Phase 2,506,2,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU577NZD,2565,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,2,17,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU577NZD,2565,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU577NZD,2565,,,M,1000,Visit3,3,Phase 1/1A,95,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU577NZD,2565,,,M,1200,Visit4,4,Phase 1/1A,126,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,97,2,,,,,,,,1,2,400,,,2,,4,733,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,82,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,85,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,92,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,2000,Visit8,8,Phase 1/1A,229,1 or 1A,94,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,2200,Visit9,9,Phase 1/1A,263,1 or 1A,95,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,2400,Visit10,10,Phase 1/1A,291,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,81,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,54,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,48,4,,1,,,,,,3,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,3600,Visit16,16,Phase 1/1A,468,1 or 1A,82,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,3800,Visit17,17,Phase 1/1A,489,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU610FYT,1835,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,522,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,3,538,400,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,97,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,1400,Visit5,5,Phase 1/1A,189,1 or 1A,,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,1600,Visit6,6,Phase 1/1A,210,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,1800,Visit7,7,Phase 1/1A,238,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,2000,Visit8,8,Phase 1/1A,267,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,2200,Visit9,9,Phase 1/1A,288,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,2400,Visit10,10,Phase 1/1A,299,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,2600,Visit11,11,Phase 1/1A,322,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,3200,Visit14,14,Phase 1/1A,387,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,3400,Visit15,15,Phase 1/1A,439,1 or 1A,88,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,3600,Visit16,16,Phase 1/1A,462,1 or 1A,87,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,3800,Visit17,17,Phase 1/1A,483,1 or 1A,74,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCU820KFD,1082,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,575,1 or 1A,80,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,85,3,,,,,,,,1,3,120,,,2,2,4,140,140,4,3,650,600,3,4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,1000,Visit3,3,Phase 2,85,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,1200,Visit4,4,Phase 2,113,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,1400,Visit5,5,Phase 2,141,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,1800,Visit7,7,Phase 3,197,3,,,,,,3,1,,,2,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,3,4,,,2,,,,4,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,2200,Visit9,9,Phase 3,253,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,2800,Visit12,12,Phase 3,336,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,3,4,,,4,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,57,1 or 1A,77,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,5800,EndofPhase2,6,Phase 2,169,2,91,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV549UGK,2421,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,98,3,,1,,,,,,1,3,600,,,1,,3,589,600,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,98,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,34,3,,1,,,,,,3,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,37,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,1600,Visit6,6,Phase 1/1A,181,1 or 1A,66,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,78,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,2000,Visit8,8,Phase 1/1A,240,1 or 1A,67,3,,0,1,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,2200,Visit9,9,Phase 1/1A,266,1 or 1A,86,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,2400,Visit10,10,Phase 1/1A,289,1 or 1A,88,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,2600,Visit11,11,Phase 1/1A,314,1 or 1A,83,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,2800,Visit12,12,Phase 1/1A,345,1 or 1A,76,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,3000,Visit13,13,Phase 1/1A,373,1 or 1A,89,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,3200,Visit14,14,Phase 1/1A,401,1 or 1A,63,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,3400,Visit15,15,Phase 1/1A,433,1 or 1A,79,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,3600,Visit16,16,Phase 1/1A,454,1 or 1A,88,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,3800,Visit17,17,Phase 1/1A,489,1 or 1A,75,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCV668ED6,2704,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,507,1 or 1A,91,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,99,3,,1,,,,,,1,3,24,,,2,2,4,29,32,4,4,29,30,4,23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,1200,Visit4,4,Phase 1B,113,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,1600,Visit6,6,Phase 2,169,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,1800,Visit7,7,Phase 2,204,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,2000,Visit8,8,Phase 2,232,2,99,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,2200,Visit9,9,Phase 2,253,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,2400,Visit10,10,Phase 2,280,2,95,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,2600,Visit11,11,Phase 2,308,2,96,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,77,1 or 1A,80,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,5400,EndofPhase1b,5,Phase 1B,127,1B,93,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,5800,EndofPhase2,12,Phase 2,341,2,95,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW710BLV,2845,,,M,6000,EndofPhase3,14,Phase 3,371,3,,,,,,8,30,,,,,,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW724BHY,1644,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,4,26,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW724BHY,1644,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,41,4,,,,,,,,3,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW724BHY,1644,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,69,4,,,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCW724BHY,1644,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,78,1 or 1A,69,4,,,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCX062HDC,1189,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,,2,,,,,,,,1,2,15,,,1,,3,21,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCX062HDC,1189,,,M,800,Visit2,2,Phase 1/1A,66,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCX062HDC,1189,,,M,1200,Visit4,4,Phase 1/1A,122,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCX062HDC,1189,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCX062HDC,1189,,,M,1600,Visit6,6,Phase 1/1A,178,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCX062HDC,1189,,,M,1800,Visit7,7,Phase 1/1A,213,1 or 1A,91,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCX062HDC,1189,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,232,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCX409EG0,2631,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,89,3,,1,,,,,,1,3,22.5,,,2,3,4,29,30,4,4,450,450,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,96,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,1600,Visit6,6,Phase 2,161,2,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,1800,Visit7,7,Phase 2,196,2,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,2000,Visit8,8,Phase 2,224,2,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,2200,Visit9,9,Phase 2,252,2,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,2400,Visit10,10,Phase 2,288,2,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,2600,Visit11,11,Phase 2,308,2,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,2800,Visit12,12,Phase 2,338,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,3000,Visit13,13,Phase 2,364,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,3200,Visit14,14,Phase 2,400,2,96,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,3400,Visit15,15,Phase 2,420,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,3600,Visit16,16,Phase 2,447,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,126,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY218XDY,2141,,,M,5800,EndofPhase2,18,Phase 2,507,2,,,450,,,,,,,3,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,4,,1,,,,,,1,4,32,,,1,,3,27,32,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,1200,Visit4,4,Phase 1/1A,104,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,1400,Visit5,5,Phase 1/1A,130,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,1600,Visit6,6,Phase 1/1A,158,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,1800,Visit7,7,Phase 1/1A,188,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,2000,Visit8,8,Phase 1/1A,218,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,2200,Visit9,9,Phase 1/1A,256,1 or 1A,0,4,,,,,,,,4,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,73,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,2600,Visit11,11,Phase 1/1A,313,1 or 1A,67,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,4,,0,1,,,,,3,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,3000,Visit13,13,Phase 1/1A,370,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,3600,Visit16,16,Phase 1/1A,452,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,3800,Visit17,17,Phase 1/1A,479,1 or 1A,97,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY245RXR,2544,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,533,1 or 1A,14,4,,1,,,,,,4,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY633JDE,1955,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,32,1 or 1A,96,2,,,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,64,2,,1,,,,,,2,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,93,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,89,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,68,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,77,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,2000,Visit8,8,Phase 1/1A,239,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,2200,Visit9,9,Phase 1/1A,267,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,2400,Visit10,10,Phase 1/1A,302,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,2600,Visit11,11,Phase 1/1A,330,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,2800,Visit12,12,Phase 1/1A,358,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,3000,Visit13,13,Phase 1/1A,387,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,3200,Visit14,14,Phase 1/1A,414,1 or 1A,96,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,3400,Visit15,15,Phase 1/1A,442,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,3600,Visit16,16,Phase 1/1A,470,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,3800,Visit17,17,Phase 1/1A,491,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCY760HYF,2348,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,600,Visit1,1,Phase 1/1A,38,1 or 1A,97,2,,1,,,,,,1,2,400,,,2,1,4,733,800,4,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,800,Visit2,2,Phase 1/1A,67,1 or 1A,81,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,1000,Visit3,3,Phase 1/1A,94,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,1800,Visit7,7,Phase 2,203,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,2200,Visit9,9,Phase 2,245,2,76,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,2600,Visit11,11,Phase 2,305,2,93,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,2800,Visit12,12,Phase 2,337,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,3000,Visit13,13,Phase 2,365,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,3200,Visit14,14,Phase 2,393,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,3400,Visit15,15,Phase 2,421,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,3600,Visit16,16,Phase 2,449,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,3800,Visit17,17,Phase 2,479,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,189,1 or 1A,25,4,,1,,,,,,4,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVCZ178YJ9,2731,,,F,5800,EndofPhase2,18,Phase 2,504,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA060BEG,2714,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA060BEG,2714,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA060BEG,2714,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA060BEG,2714,,,F,1200,Visit4,4,Phase 1/1A,127,1 or 1A,79,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA060BEG,2714,,,F,1400,Visit5,5,Phase 1/1A,149,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA299KLD,1469,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,83,2,,1,,,,,,1,2,16,,,1,,3,24,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA299KLD,1469,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,35,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA299KLD,1469,,,M,1000,Visit3,3,Phase 1/1A,96,1 or 1A,64,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA299KLD,1469,,,M,1200,Visit4,4,Phase 1/1A,124,1 or 1A,28,4,,,,,,,,3,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,,1,,,,,,,,,1,8,,,1,,3,20,8,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,1000,Visit3,3,Phase 1/1A,81,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,1200,Visit4,4,Phase 1/1A,109,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,1400,Visit5,5,Phase 1/1A,135,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,1600,Visit6,6,Phase 1/1A,165,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,2600,Visit11,11,Phase 1/1A,303,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,2800,Visit12,12,Phase 1/1A,331,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,3000,Visit13,13,Phase 1/1A,359,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,3200,Visit14,14,Phase 1/1A,386,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,3400,Visit15,15,Phase 1/1A,414,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,3600,Visit16,16,Phase 1/1A,443,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,3800,Visit17,17,Phase 1/1A,471,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA522JTA,1420,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,499,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA570EN8,2769,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDA586VRT,1735,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,2,2,3,5,6,3,3,25,23,3,150,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,800,Visit2,2,Phase 1/1A,49,1 or 1A,92,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,1000,Visit3,3,Phase 1/1A,82,1 or 1A,98,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,1400,Visit5,5,Phase 2,138,2,91,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,1600,Visit6,6,Phase 2,174,2,99,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,1800,Visit7,7,Phase 2,194,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,2000,Visit8,8,Phase 2,217,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,2200,Visit9,9,Phase 2,250,2,99,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,2400,Visit10,10,Phase 2,281,2,94,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,2600,Visit11,11,Phase 2,306,2,92,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,3000,Visit13,13,Phase 3,363,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,3200,Visit14,14,Phase 3,391,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,3400,Visit15,15,Phase 3,419,3,,,,,,4,120,,,2,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,3600,Visit16,16,Phase 3,447,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,3800,Visit17,17,Phase 3,473,3,,,,,,4,160,,,2,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,111,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,5800,EndofPhase2,12,Phase 2,334,2,98,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB022BB1,1096,,,F,6000,EndofPhase3,18,Phase 3,502,3,,,,,,4,180,,,1,,,,180,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,800,Visit2,2,Phase 2,67,2,80,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,1000,Visit3,3,Phase 2,85,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,1400,Visit5,5,Phase 3,141,3,,,,,,2,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,1600,Visit6,6,Phase 3,162,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,1800,Visit7,7,Phase 3,208,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,2000,Visit8,8,Phase 3,229,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,2200,Visit9,9,Phase 3,256,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,2400,Visit10,10,Phase 3,281,3,,,,,,2,700,,,1,,,,700,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,2600,Visit11,11,Phase 3,309,3,,,,,,2,700,,,1,,,,700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,2800,Visit12,12,Phase 3,337,3,,,,,,2,700,,,1,,,,700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,3000,Visit13,13,Phase 3,369,3,,,,,,2,700,,,1,,,,700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,3200,Visit14,14,Phase 3,396,3,,,,,,2,700,,,1,,,,700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,3400,Visit15,15,Phase 3,421,3,,,,,,2,700,,,1,,,,700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,3600,Visit16,16,Phase 3,449,3,,,,,,2,700,,,1,,,,700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,3800,Visit17,17,Phase 3,477,3,,,,,,2,700,,,1,,,,700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,33,1 or 1A,97,2,,1,,,,,,1,2,15,,,1,2,2,15,15,2,3,120,120,3,600,700,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,5800,EndofPhase2,4,Phase 2,103,2,71,4,,1,,,,,,2,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB091WNZ,2297,,,F,6000,EndofPhase3,18,Phase 3,504,3,,,,,,2,700,,,1,,,,700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,600,Visit1,1,Phase 1/1A,42,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,,3,122,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,800,Visit2,2,Phase 1/1A,68,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,1000,Visit3,3,Phase 1/1A,98,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,1200,Visit4,4,Phase 1/1A,128,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,1400,Visit5,5,Phase 1/1A,156,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,2000,Visit8,8,Phase 1/1A,240,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,2200,Visit9,9,Phase 1/1A,278,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,2400,Visit10,10,Phase 1/1A,313,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,2600,Visit11,11,Phase 1/1A,341,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,2800,Visit12,12,Phase 1/1A,377,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,3000,Visit13,13,Phase 1/1A,415,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,3200,Visit14,14,Phase 1/1A,446,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,3400,Visit15,15,Phase 1/1A,478,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,3600,Visit16,16,Phase 1/1A,517,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,3800,Visit17,17,Phase 1/1A,534,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB594BZU,2720,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,562,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,91,2,,,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,90,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,1200,Visit4,4,Phase 1B,109,1B,98,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,1400,Visit5,5,Phase 1B,140,1B,90,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,1600,Visit6,6,Phase 1B,175,1B,91,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,1800,Visit7,7,Phase 1B,192,1B,85,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,2000,Visit8,8,Phase 1B,224,1B,95,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,2200,Visit9,9,Phase 1B,254,1B,92,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,2400,Visit10,10,Phase 1B,282,1B,98,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,2600,Visit11,11,Phase 1B,308,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,2800,Visit12,12,Phase 1B,340,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,3000,Visit13,13,Phase 1B,365,1B,96,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,3200,Visit14,14,Phase 1B,392,1B,90,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,3400,Visit15,15,Phase 1B,422,1B,96,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,3600,Visit16,16,Phase 1B,448,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,3800,Visit17,17,Phase 1B,477,1B,97,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,81,1 or 1A,88,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDB884XGF,1602,,,M,5400,EndofPhase1b,18,Phase 1B,505,1B,93,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,3,556,400,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,93,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,1400,Visit5,5,Phase 1/1A,166,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,1600,Visit6,6,Phase 1/1A,187,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,1800,Visit7,7,Phase 1/1A,216,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,2000,Visit8,8,Phase 1/1A,250,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,2200,Visit9,9,Phase 1/1A,274,1 or 1A,65,3,,,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,2400,Visit10,10,Phase 1/1A,306,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,2600,Visit11,11,Phase 1/1A,334,1 or 1A,73,3,,,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,2800,Visit12,12,Phase 1/1A,362,1 or 1A,98,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,3000,Visit13,13,Phase 1/1A,398,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,3200,Visit14,14,Phase 1/1A,425,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,3400,Visit15,15,Phase 1/1A,453,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,3600,Visit16,16,Phase 1/1A,482,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,3800,Visit17,17,Phase 1/1A,523,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC187XCC,1481,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,548,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC201EP9,1629,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,3,19,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC201EP9,1629,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC201EP9,1629,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC201EP9,1629,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC201EP9,1629,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC201EP9,1629,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,2,,,,,,,,1,2,400,,,2,3,2,433,400,2,,267,225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,91,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,1000,Visit3,3,Phase 1/1A,107,1 or 1A,,2,,,,,,,,,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,1200,Visit4,4,Phase 1/1A,124,1 or 1A,94,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,92,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,1800,Visit7,7,Phase 2,215,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,2000,Visit8,8,Phase 2,242,2,,,425,,,,,,,1,,,425,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,2200,Visit9,9,Phase 2,274,2,,,225,,,,,,,1,,,225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,2400,Visit10,10,Phase 2,302,2,,,225,,,,,,,1,,,225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,2600,Visit11,11,Phase 2,330,2,,,225,,,,,,,1,,,225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,2800,Visit12,12,Phase 2,358,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,3000,Visit13,13,Phase 2,386,2,,,250,,,,,,,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDC925MYP,1154,,,M,5800,EndofPhase2,13,Phase 2,389,2,,,250,,,,,,,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,93,4,,,,,,,,1,4,800,,,2,2,4,800,800,4,4,6,6,4,333,300,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,90,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,71,4,,,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,79,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,80,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,88,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,2200,Visit9,9,Phase 2,258,2,95,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,2400,Visit10,10,Phase 2,286,2,68,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,2600,Visit11,11,Phase 2,315,2,74,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,3000,Visit13,13,Phase 3,369,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,3200,Visit14,14,Phase 3,399,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,226,1 or 1A,86,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,5800,EndofPhase2,12,Phase 2,342,2,91,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD412RU3,1916,,,M,6000,EndofPhase3,14,Phase 3,412,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,3,,,,,,,,1,3,22.5,,,1,,4,30,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,96,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,1600,Visit6,6,Phase 1/1A,162,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,1800,Visit7,7,Phase 1/1A,193,1 or 1A,97,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,3000,Visit13,13,Phase 1/1A,367,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,3200,Visit14,14,Phase 1/1A,395,1 or 1A,93,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDD936FCK,1785,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,498,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,1,,,,,,1,4,30,,,2,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,86,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,1600,Visit6,6,Phase 1/1A,182,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,1800,Visit7,7,Phase 1/1A,207,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,2200,Visit9,9,Phase 1/1A,268,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,2400,Visit10,10,Phase 1/1A,283,1 or 1A,93,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,2600,Visit11,11,Phase 1/1A,322,1 or 1A,62,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,2800,Visit12,12,Phase 1/1A,350,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,3000,Visit13,13,Phase 1/1A,371,1 or 1A,85,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,3200,Visit14,14,Phase 1/1A,399,1 or 1A,93,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,3400,Visit15,15,Phase 1/1A,427,1 or 1A,,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,3600,Visit16,16,Phase 1/1A,455,1 or 1A,95,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,3800,Visit17,17,Phase 1/1A,497,1 or 1A,97,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE112CRX,2117,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,525,1 or 1A,95,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,3,20,15,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,1400,Visit5,5,Phase 1/1A,155,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,43,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,50,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,2800,Visit12,12,Phase 1/1A,345,1 or 1A,72,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,55,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,66,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,78,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,39,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,66,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE443GD1,1276,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,514,1 or 1A,85,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,85,2,,,,,,,,1,2,3,,,2,,2,3,3,2,4,380,400,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,76,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,80,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,1600,Visit6,6,Phase 2,189,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,1800,Visit7,7,Phase 2,218,2,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,2000,Visit8,8,Phase 2,245,2,100,6,,,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,2200,Visit9,9,Phase 2,273,2,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,2400,Visit10,10,Phase 2,301,2,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,2600,Visit11,11,Phase 2,328,2,75,3,,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,2800,Visit12,12,Phase 2,349,2,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,3000,Visit13,13,Phase 2,387,2,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,3200,Visit14,14,Phase 2,413,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,3400,Visit15,15,Phase 2,442,2,100,4,,0,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,3600,Visit16,16,Phase 2,469,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,3800,Visit17,17,Phase 2,495,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,4000,Visit18,18,Phase 2,533,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE669KLZ,1553,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,161,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,88,1,,0,2,,,,,1,1,8,,,2,2,4,30,32,4,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,60,4,,0,2,,,,,2,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,88,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,90,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,92,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,93,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,2800,Visit12,12,Phase 2,309,2,,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,3000,Visit13,13,Phase 2,353,2,90,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,3200,Visit14,14,Phase 2,389,2,83,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,3400,Visit15,15,Phase 2,424,2,62,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,3600,Visit16,16,Phase 2,449,2,92,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,3800,Visit17,17,Phase 2,470,2,95,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,5200,EndofPhase1_1a,10,Phase 1/1A,268,1 or 1A,100,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,5400,EndofPhase1b,11,Phase 1B,275,1B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE780NDL,2857,,,M,5800,EndofPhase2,18,Phase 2,499,2,81,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDE930TAR,1950,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF290JFD,1278,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,4,769,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF290JFD,1278,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,84,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF290JFD,1278,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,89,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF290JFD,1278,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF290JFD,1278,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,48,4,,,,,,,,3,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF290JFD,1278,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF290JFD,1278,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,98,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF290JFD,1278,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,74,4,,,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF290JFD,1278,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF290JFD,1278,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF290JFD,1278,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,81,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF290JFD,1278,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,85,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF290JFD,1278,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,,4,,1,,,,,,,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,0,1,,,,,1,2,3,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,2600,Visit11,11,Phase 1/1A,308,1 or 1A,93,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,2800,Visit12,12,Phase 1/1A,336,1 or 1A,96,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,3200,Visit14,14,Phase 1/1A,401,1 or 1A,89,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,3400,Visit15,15,Phase 1/1A,436,1 or 1A,91,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,3600,Visit16,16,Phase 1/1A,476,1 or 1A,98,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,3800,Visit17,17,Phase 1/1A,492,1 or 1A,94,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDF805DXT,1461,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,100,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,2,2,2,3,3,2,2,15,15,2,300,300,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,1000,Visit3,3,Phase 1/1A,92,1 or 1A,98,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,1200,Visit4,4,Phase 1/1A,134,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,1400,Visit5,5,Phase 1/1A,162,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,1600,Visit6,6,Phase 1/1A,190,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,1800,Visit7,7,Phase 1/1A,221,1 or 1A,99,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,2000,Visit8,8,Phase 1/1A,256,1 or 1A,97,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,2200,Visit9,9,Phase 1/1A,282,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,2400,Visit10,10,Phase 1/1A,306,1 or 1A,94,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,3000,Visit13,13,Phase 3,372,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,3200,Visit14,14,Phase 3,403,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,3400,Visit15,15,Phase 3,429,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,5200,EndofPhase1_1a,11,Phase 1/1A,333,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG306KHE,1429,,,F,5800,EndofPhase2,12,Phase 2,354,2,94,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG315FFH,1895,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,2,,,,,,,,1,2,3,,,2,2,2,3,3,2,2,80,80,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG315FFH,1895,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG315FFH,1895,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,0,0,,,,,,,,4,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG315FFH,1895,,,M,1600,Visit6,6,Phase 1/1A,200,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG315FFH,1895,,,M,1800,Visit7,7,Phase 1/1A,232,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG315FFH,1895,,,M,2200,Visit9,9,Phase 2,323,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG315FFH,1895,,,M,2400,Visit10,10,Phase 2,360,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG315FFH,1895,,,M,2600,Visit11,11,Phase 2,407,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG315FFH,1895,,,M,2800,Visit12,12,Phase 2,449,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG315FFH,1895,,,M,3400,Visit15,15,Phase 2,477,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG315FFH,1895,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,271,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG315FFH,1895,,,M,5800,EndofPhase2,18,Phase 2,536,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG379KA7,2787,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG670LLC,1732,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,1,4,,,,,,,,1,4,30,,,2,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,98,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,98,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,98,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,2400,Visit10,10,Phase 1/1A,282,1 or 1A,98,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,3000,Visit13,13,Phase 1/1A,366,1 or 1A,98,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,3600,Visit16,16,Phase 1/1A,450,1 or 1A,96,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,3800,Visit17,17,Phase 1/1A,478,1 or 1A,98,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG912JG1,1104,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,98,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG960HPT,2784,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,96,2,,1,,,,,,1,2,16,,,1,2,2,16,16,2,1,8,8,1,80,80,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG960HPT,2784,,,F,1000,Visit3,3,Phase 1B,86,1B,99,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG960HPT,2784,,,F,1200,Visit4,4,Phase 1B,113,1B,98,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG960HPT,2784,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,51,1 or 1A,83,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG960HPT,2784,,,F,5400,EndofPhase1b,5,Phase 1B,127,1B,93,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG960HPT,2784,,,F,5800,EndofPhase2,6,Phase 2,155,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDG960HPT,2784,,,F,6000,EndofPhase3,7,Phase 3,178,3,,,,,,4,80,,,3,,,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH022ZTQ,2219,,,M,800,Visit2,2,Phase 1/1A,68,1 or 1A,0,2,,,,,,,,4,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH022ZTQ,2219,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,68,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH063EBQ,2294,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,70,1 or 1A,65,2,,1,,,,,,2,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH192EKB,2564,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,55,1,,1,,,,,,2,1,1.5,,,1,,1,2,2,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH192EKB,2564,,,F,800,Visit2,2,Phase 1/1A,71,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH192EKB,2564,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,36,1,,1,,,,,,3,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH192EKB,2564,,,F,1200,Visit4,4,Phase 1/1A,120,1 or 1A,69,1,,1,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH192EKB,2564,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH192EKB,2564,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH354RMH,1545,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,36,1 or 1A,68,1,,,,,,,,2,1,1.5,,,1,,1,2,2,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH720BEE,2539,,,F,600,Visit1,1,Phase 1/1A,43,1 or 1A,51,2,,1,,,,,,3,2,400,,,2,2,3,550,400,3,2,80,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH720BEE,2539,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH720BEE,2539,,,F,1000,Visit3,3,Phase 1/1A,110,1 or 1A,91,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH720BEE,2539,,,F,5200,EndofPhase1_1a,5,Phase 1/1A,133,1 or 1A,41,4,,1,,,,,,3,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDH720BEE,2539,,,F,5800,EndofPhase2,6,Phase 2,172,2,55,2,,1,,,,,,2,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,99,2,,,,,,,,1,2,3,,,2,,3,5,6,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,98,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,1200,Visit4,4,Phase 1/1A,116,1 or 1A,97,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,1600,Visit6,6,Phase 1/1A,173,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,2000,Visit8,8,Phase 1/1A,236,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,2200,Visit9,9,Phase 1/1A,257,1 or 1A,88,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,2400,Visit10,10,Phase 1/1A,282,1 or 1A,94,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,3000,Visit13,13,Phase 1/1A,372,1 or 1A,86,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,3400,Visit15,15,Phase 1/1A,431,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176LRR,1656,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,502,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,3,20,15,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,1800,Visit7,7,Phase 1/1A,202,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,2000,Visit8,8,Phase 1/1A,231,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,2200,Visit9,9,Phase 1/1A,258,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,2400,Visit10,10,Phase 1/1A,297,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,2600,Visit11,11,Phase 1/1A,323,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,2800,Visit12,12,Phase 1/1A,358,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,3000,Visit13,13,Phase 1/1A,391,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,3200,Visit14,14,Phase 1/1A,418,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,3400,Visit15,15,Phase 1/1A,447,1 or 1A,100,3,,0,2,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,3600,Visit16,16,Phase 1/1A,475,1 or 1A,92,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,3800,Visit17,17,Phase 1/1A,504,1 or 1A,100,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ176RZJ,1094,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,524,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,98,2,,,,,,,,1,2,3,,,2,3,3,5,6,3,,215,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,1000,Visit3,3,Phase 1/1A,81,1 or 1A,92,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,1200,Visit4,4,Phase 1/1A,109,1 or 1A,87,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,99,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,1600,Visit6,6,Phase 1/1A,192,1 or 1A,95,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,2000,Visit8,8,Phase 1/1A,230,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,2200,Visit9,9,Phase 1/1A,258,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,2400,Visit10,10,Phase 1/1A,279,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,2600,Visit11,11,Phase 1/1A,307,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,2800,Visit12,12,Phase 1/1A,346,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,3000,Visit13,13,Phase 2,367,2,100,,75,,,,,,,1,,,75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,3200,Visit14,14,Phase 2,398,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,3400,Visit15,15,Phase 2,426,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,3600,Visit16,16,Phase 2,459,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,346,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,5800,EndofPhase2,17,Phase 2,464,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ369WWU,1729,,,M,6000,EndofPhase3,18,Phase 3,535,3,,,,,,6,300,8,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,600,Visit1,1,Phase 1/1A,15,1 or 1A,100,2,,1,,,,,,4,2,16,,,2,,3,20,16,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,800,Visit2,2,Phase 1/1A,43,1 or 1A,88,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,1000,Visit3,3,Phase 1/1A,74,1 or 1A,67,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,1200,Visit4,4,Phase 1/1A,108,1 or 1A,70,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,1400,Visit5,5,Phase 1/1A,136,1 or 1A,94,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,1800,Visit7,7,Phase 1B,198,1B,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,2000,Visit8,8,Phase 1B,228,1B,93,3,,0,2,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,2200,Visit9,9,Phase 1B,256,1B,92,3,,0,2,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,2400,Visit10,10,Phase 1B,280,1B,98,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,2600,Visit11,11,Phase 1B,309,1B,100,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,2800,Visit12,12,Phase 1B,337,1B,84,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,3000,Visit13,13,Phase 1B,365,1B,92,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,3200,Visit14,14,Phase 1B,393,1B,96,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,3400,Visit15,15,Phase 1B,421,1B,91,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,3600,Visit16,16,Phase 1B,449,1B,90,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,3800,Visit17,17,Phase 1B,477,1B,89,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,4000,Visit18,18,Phase 1B,511,1B,94,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ683HL4,2244,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,151,1 or 1A,,3,,1,,,,,,3,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ740PFV,1348,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,90,1,,,,,,,,1,1,8,,,1,,2,12,12,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ740PFV,1348,,,M,2800,Visit12,12,Phase 1B,236,1B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ740PFV,1348,,,M,3000,Visit13,13,Phase 1B,266,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ740PFV,1348,,,M,3200,Visit14,14,Phase 1B,293,1B,96,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ740PFV,1348,,,M,3400,Visit15,15,Phase 1B,320,1B,96,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ740PFV,1348,,,M,3600,Visit16,16,Phase 1B,349,1B,97,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ740PFV,1348,,,M,3800,Visit17,17,Phase 1B,378,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ740PFV,1348,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ740PFV,1348,,,M,5400,EndofPhase1b,18,Phase 1B,411,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ965ECX,2400,,,F,600,Visit1,1,Phase 1/1A,25,1 or 1A,,,,,,,,,,2,,,,,1,,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ965ECX,2400,,,F,800,Visit2,2,Phase 1/1A,53,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ965ECX,2400,,,F,1000,Visit3,3,Phase 1/1A,103,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ965ECX,2400,,,F,1200,Visit4,4,Phase 1/1A,124,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ965ECX,2400,,,F,1400,Visit5,5,Phase 1/1A,155,1 or 1A,100,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ965ECX,2400,,,F,1600,Visit6,6,Phase 1/1A,194,1 or 1A,,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ965ECX,2400,,,F,1800,Visit7,7,Phase 1/1A,214,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDJ965ECX,2400,,,F,3000,Visit13,13,Phase 1/1A,381,1 or 1A,50,2,,1,,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK494ABT,1869,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,63,1 or 1A,11,2,,,,,,,,4,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK562XZG,1288,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,2,14,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK562XZG,1288,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,89,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK562XZG,1288,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,100,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK562XZG,1288,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK562XZG,1288,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK562XZG,1288,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,172,1 or 1A,96,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK789KGF,2733,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,94,4,,1,,,,,,1,4,6,,,2,1,3,4,6,3,2,480,600,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK789KGF,2733,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK789KGF,2733,,,F,1000,Visit3,3,Phase 1/1A,70,1 or 1A,56,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK789KGF,2733,,,F,1200,Visit4,4,Phase 1/1A,100,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK789KGF,2733,,,F,1400,Visit5,5,Phase 1/1A,126,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK789KGF,2733,,,F,1600,Visit6,6,Phase 1/1A,156,1 or 1A,98,4,,0,2,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK789KGF,2733,,,F,2000,Visit8,8,Phase 2,212,2,100,1,,0,1,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK789KGF,2733,,,F,2200,Visit9,9,Phase 2,240,2,100,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK789KGF,2733,,,F,2400,Visit10,10,Phase 2,282,2,98,3,,0,1,,,,,1,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK789KGF,2733,,,F,2600,Visit11,11,Phase 2,309,2,100,3,,0,1,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK789KGF,2733,,,F,5200,EndofPhase1_1a,7,Phase 1/1A,179,1 or 1A,97,4,,0,2,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK789KGF,2733,,,F,5800,EndofPhase2,12,Phase 2,332,2,100,3,,0,1,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,,,,,,,1,2,400,,,1,,2,360,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,2200,Visit9,9,Phase 1/1A,245,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,2400,Visit10,10,Phase 1/1A,273,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,2600,Visit11,11,Phase 1/1A,302,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,2800,Visit12,12,Phase 1/1A,330,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,3000,Visit13,13,Phase 1/1A,347,1 or 1A,30,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,3200,Visit14,14,Phase 1/1A,392,1 or 1A,30,1,,,,,,,,3,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDK916LZP,2210,,,F,5200,EndofPhase1_1a,15,Phase 1/1A,408,1 or 1A,50,1,,,,,,,,2,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,2,,1,,,,,,1,2,3,,,1,,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,87,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,1600,Visit6,6,Phase 1/1A,184,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,1800,Visit7,7,Phase 1/1A,214,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,2000,Visit8,8,Phase 1/1A,246,1 or 1A,,4,,,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,2200,Visit9,9,Phase 1/1A,263,1 or 1A,,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,2400,Visit10,10,Phase 1/1A,291,1 or 1A,46,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,2600,Visit11,11,Phase 1/1A,326,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,2800,Visit12,12,Phase 1/1A,347,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,3000,Visit13,13,Phase 1/1A,368,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,99,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,3800,Visit17,17,Phase 1/1A,481,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL011DR9,1445,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,95,2,,,,,,,,1,2,400,,,1,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,96,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,1200,Visit4,4,Phase 1/1A,122,1 or 1A,92,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,92,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,95,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,88,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,95,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,2200,Visit9,9,Phase 1/1A,267,1 or 1A,90,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,95,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,75,2,,0,1,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,2800,Visit12,12,Phase 1/1A,351,1 or 1A,89,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,3000,Visit13,13,Phase 1/1A,375,1 or 1A,83,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,3400,Visit15,15,Phase 1/1A,425,1 or 1A,96,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,88,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,93,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL420JN1,2061,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,499,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,93,2,,,,,,,,1,2,16,,,1,,4,30,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,74,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,85,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,77,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,87,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,76,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,2200,Visit9,9,Phase 1/1A,266,1 or 1A,74,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,2400,Visit10,10,Phase 1/1A,294,1 or 1A,61,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,2600,Visit11,11,Phase 1/1A,322,1 or 1A,82,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,2800,Visit12,12,Phase 1/1A,350,1 or 1A,76,4,,,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,3000,Visit13,13,Phase 1B,377,1B,89,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,3200,Visit14,14,Phase 1B,405,1B,91,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,3400,Visit15,15,Phase 1B,433,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,3600,Visit16,16,Phase 1B,461,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,3800,Visit17,17,Phase 1B,489,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,350,1 or 1A,76,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL891WTC,1580,,,M,5400,EndofPhase1b,18,Phase 1B,517,1B,79,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL996CWK,2495,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,,,,1,,,,,,1,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL996CWK,2495,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,60,,,1,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL996CWK,2495,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,60,,,1,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL996CWK,2495,,,M,1200,Visit4,4,Phase 1/1A,131,1 or 1A,,,,1,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDL996CWK,2495,,,M,1400,Visit5,5,Phase 1/1A,152,1 or 1A,60,,,1,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,2,2,16,,,2,,4,29,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,84,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,89,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,50,4,,,,,,,,3,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,3000,Visit13,13,Phase 1/1A,371,1 or 1A,94,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,3200,Visit14,14,Phase 1/1A,387,1 or 1A,94,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,3600,Visit16,16,Phase 1/1A,443,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,3800,Visit17,17,Phase 1/1A,471,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDM438YZQ,1324,,,M,4000,Visit18,18,Phase 1/1A,498,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,2,3,5,5,3,2,400,400,2,15,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,800,Visit2,2,Phase 1/1A,47,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,1000,Visit3,3,Phase 2,82,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,1400,Visit5,5,Phase 3,145,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,1600,Visit6,6,Phase 3,172,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,1800,Visit7,7,Phase 3,201,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,2000,Visit8,8,Phase 3,229,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,2200,Visit9,9,Phase 3,257,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,2400,Visit10,10,Phase 3,285,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,2800,Visit12,12,Phase 3,334,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,3000,Visit13,13,Phase 3,362,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,3800,Visit17,17,Phase 3,478,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,47,1 or 1A,65,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,5800,EndofPhase2,4,Phase 2,106,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN591GNG,2873,,,M,6000,EndofPhase3,17,Phase 3,498,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN815MEM,2123,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,16,,,1,,2,18,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN815MEM,2123,,,M,800,Visit2,2,Phase 1/1A,48,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN815MEM,2123,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,50,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN815MEM,2123,,,M,1200,Visit4,4,Phase 1/1A,132,1 or 1A,91,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN815MEM,2123,,,M,1400,Visit5,5,Phase 1/1A,153,1 or 1A,87,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN815MEM,2123,,,M,1600,Visit6,6,Phase 1/1A,181,1 or 1A,84,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDN815MEM,2123,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,83,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDP204WY0,2310,,,M,800,Visit2,2,Phase 2,66,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDP204WY0,2310,,,M,1000,Visit3,3,Phase 2,94,2,53,4,,0,1,,,,,2,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDP204WY0,2310,,,M,1400,Visit5,5,Phase 3,150,3,,,,,,3,4,,,4,,,,4,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDP204WY0,2310,,,M,1600,Visit6,6,Phase 3,182,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDP204WY0,2310,,,M,1800,Visit7,7,Phase 3,214,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDP204WY0,2310,,,M,2000,Visit8,8,Phase 3,262,3,,,,,,3,2,,,2,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDP204WY0,2310,,,M,2200,Visit9,9,Phase 3,281,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDP204WY0,2310,,,M,2400,Visit10,10,Phase 3,310,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDP204WY0,2310,,,M,2600,Visit11,11,Phase 3,337,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDP204WY0,2310,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,8,1 or 1A,29,1,,1,,,,,,4,1,7.5,,,1,1,1,8,8,1,3,107,80,3,2,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDP204WY0,2310,,,M,5800,EndofPhase2,4,Phase 2,122,2,93,2,,0,1,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDP204WY0,2310,,,M,6000,EndofPhase3,14,Phase 3,415,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR332TH0,1884,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,90,4,,,,,,,,1,4,160,,,2,,4,160,160,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR332TH0,1884,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR332TH0,1884,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR332TH0,1884,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,98,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR332TH0,1884,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR332TH0,1884,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR332TH0,1884,,,F,2000,Visit8,8,Phase 1/1A,224,1 or 1A,75,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR332TH0,1884,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR332TH0,1884,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR332TH0,1884,,,F,5200,EndofPhase1_1a,11,Phase 1/1A,302,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR479NPM,1095,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,1,,,,,,,,1,1,8,,,1,,3,20,20,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR479NPM,1095,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,55,1 or 1A,96,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR479NPM,1095,,,M,5400,EndofPhase1b,3,Phase 1B,65,1B,100,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR898LGE,2159,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,78,2,,1,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR898LGE,2159,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,77,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR898LGE,2159,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR898LGE,2159,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,95,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR898LGE,2159,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR898LGE,2159,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,170,1 or 1A,93,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,89,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,96,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,93,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,66,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,93,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,1800,Visit7,7,Phase 1/1A,201,1 or 1A,94,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,90,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,89,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,84,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,91,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,3400,Visit15,15,Phase 1/1A,430,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,3600,Visit16,16,Phase 1/1A,457,1 or 1A,85,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,3800,Visit17,17,Phase 1/1A,485,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDR954BZF,1366,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,520,1 or 1A,76,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,94,2,,1,,,,,,1,2,3,,,1,,3,4,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,1800,Visit7,7,Phase 1/1A,212,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,2000,Visit8,8,Phase 1/1A,240,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,2200,Visit9,9,Phase 1/1A,282,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,2400,Visit10,10,Phase 1/1A,307,1 or 1A,,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,2600,Visit11,11,Phase 1/1A,337,1 or 1A,93,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,2800,Visit12,12,Phase 1/1A,372,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,3000,Visit13,13,Phase 1/1A,395,1 or 1A,61,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,3200,Visit14,14,Phase 1/1A,428,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,3400,Visit15,15,Phase 1/1A,462,1 or 1A,91,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,3600,Visit16,16,Phase 1/1A,484,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT014YFK,1513,,,M,5200,EndofPhase1_1a,17,Phase 1/1A,500,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,50,2,,,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,0,2,,,,,,,,4,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,1400,Visit5,5,Phase 1/1A,162,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,76,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,1800,Visit7,7,Phase 1/1A,212,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,2000,Visit8,8,Phase 1/1A,240,1 or 1A,91,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,2200,Visit9,9,Phase 1/1A,281,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,2400,Visit10,10,Phase 1/1A,305,1 or 1A,0,2,,,,,,,,4,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,2600,Visit11,11,Phase 1/1A,338,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,2800,Visit12,12,Phase 1/1A,365,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,3000,Visit13,13,Phase 1/1A,404,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,3200,Visit14,14,Phase 1/1A,438,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,3400,Visit15,15,Phase 1/1A,456,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,3600,Visit16,16,Phase 1/1A,484,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,3800,Visit17,17,Phase 1/1A,519,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT112TXG,1218,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,548,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT522YDZ,2020,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,3,5,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDT522YDZ,2020,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,61,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,600,Visit1,1,Phase 1/1A,25,1 or 1A,100,2,,,,,,,,1,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,1600,Visit6,6,Phase 1/1A,172,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,96,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,2000,Visit8,8,Phase 1/1A,226,1 or 1A,89,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,93,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,96,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,96,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,3800,Visit17,17,Phase 1/1A,478,1 or 1A,97,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU138LEC,1296,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,514,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU141EYX,2586,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,70,2,,1,,,,,,2,2,80,,,2,,3,107,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU141EYX,2586,,,F,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU141EYX,2586,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,88,1 or 1A,50,3,,1,,,,,,3,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU581MRW,1621,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,85,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU581MRW,1621,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,24,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU581MRW,1621,,,F,1000,Visit3,3,Phase 1/1A,116,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU581MRW,1621,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,129,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU857YYA,1765,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,38,1 or 1A,32,2,,,,,,,,3,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDU857YYA,1765,,,M,5400,EndofPhase1b,2,Phase 1B,56,1B,11,3,,,,,,,,4,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDV165JNJ,2721,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDV533YD9,2329,,,F,600,Visit1,1,Phase 1/1A,34,1 or 1A,46,1,,1,,,,,,3,1,40,,,2,,1,40,40,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW094NA3,1161,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,3,,,,,,,,1,3,24,,,2,,3,24,24,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW094NA3,1161,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW094NA3,1161,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,3,5,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,,4,,1,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,1600,Visit6,6,Phase 1/1A,212,1 or 1A,60,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,2400,Visit10,10,Phase 1/1A,285,1 or 1A,68,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,2600,Visit11,11,Phase 1/1A,321,1 or 1A,36,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,2800,Visit12,12,Phase 1/1A,341,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,3200,Visit14,14,Phase 1/1A,404,1 or 1A,,2,,1,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,3400,Visit15,15,Phase 1/1A,450,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,3800,Visit17,17,Phase 1/1A,488,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW342JD4,1595,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,506,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW380AUM,2214,,,M,600,Visit1,1,Phase 1/1A,43,1 or 1A,95,3,,1,,,,,,2,3,120,,,2,,3,133,160,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW380AUM,2214,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,95,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW380AUM,2214,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,72,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW380AUM,2214,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,,2,,1,,,,,,,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW380AUM,2214,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,,4,,1,,,,,,,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW380AUM,2214,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,88,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW380AUM,2214,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW380AUM,2214,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW380AUM,2214,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,262,1 or 1A,,4,,1,,,,,,,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW810WBQ,2067,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,1,,,,,,1,3,600,,,2,2,4,733,800,4,3,20,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW810WBQ,2067,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW810WBQ,2067,,,M,1400,Visit5,5,Phase 2,148,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW810WBQ,2067,,,M,1600,Visit6,6,Phase 2,168,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW810WBQ,2067,,,M,1800,Visit7,7,Phase 2,197,2,69,3,,0,2,,,,,2,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW810WBQ,2067,,,M,2000,Visit8,8,Phase 2,224,2,72,3,,0,1,,,,,2,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW810WBQ,2067,,,M,2200,Visit9,9,Phase 2,252,2,74,3,,0,1,,,,,2,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW810WBQ,2067,,,M,2400,Visit10,10,Phase 2,287,2,75,3,,0,1,,,,,2,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW810WBQ,2067,,,M,2600,Visit11,11,Phase 2,322,2,61,3,,0,2,,,,,2,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW810WBQ,2067,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,126,1 or 1A,57,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDW868YVX,2885,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,600,Visit1,1,Phase 1/1A,37,1 or 1A,96,2,,,,,,,,1,2,400,,,2,,4,753,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,800,Visit2,2,Phase 1/1A,65,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,1000,Visit3,3,Phase 1/1A,98,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,1200,Visit4,4,Phase 1/1A,122,1 or 1A,98,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,82,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,1600,Visit6,6,Phase 1/1A,178,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,1800,Visit7,7,Phase 1/1A,196,1 or 1A,82,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,2000,Visit8,8,Phase 1/1A,219,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,2400,Visit10,10,Phase 1/1A,275,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,2600,Visit11,11,Phase 1/1A,310,1 or 1A,90,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,2800,Visit12,12,Phase 1/1A,340,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,3000,Visit13,13,Phase 1/1A,371,1 or 1A,94,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,3200,Visit14,14,Phase 1/1A,400,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,3400,Visit15,15,Phase 1/1A,444,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,3800,Visit17,17,Phase 1/1A,469,1 or 1A,79,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX073LA8,1363,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,508,1 or 1A,99,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,600,Visit1,1,Phase 1/1A,36,1 or 1A,92,2,,1,,,,,,1,2,80,,,2,2,3,123,120,3,2,400,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,800,Visit2,2,Phase 1/1A,62,1 or 1A,93,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,93,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,1200,Visit4,4,Phase 1/1A,115,1 or 1A,94,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,1600,Visit6,6,Phase 1/1A,175,1 or 1A,,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,1800,Visit7,7,Phase 1/1A,205,1 or 1A,87,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,2000,Visit8,8,Phase 1/1A,231,1 or 1A,92,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,2200,Visit9,9,Phase 1/1A,275,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,2400,Visit10,10,Phase 1/1A,283,1 or 1A,88,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,2600,Visit11,11,Phase 1/1A,303,1 or 1A,70,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,2800,Visit12,12,Phase 1/1A,343,1 or 1A,83,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,3000,Visit13,13,Phase 1/1A,363,1 or 1A,75,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,3200,Visit14,14,Phase 1/1A,387,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,3600,Visit16,16,Phase 1/1A,456,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,4200,Visit19,19,Phase 2,535,2,95,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,4400,Visit20,20,Phase 2,563,2,95,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,4600,Visit21,21,Phase 2,588,2,70,2,,1,,,,,,2,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,4800,Visit22,22,Phase 2,617,2,75,2,,1,,,,,,2,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX855LK5,2241,,,F,5200,EndofPhase1_1a,17,Phase 1/1A,510,1 or 1A,46,4,,1,,,,,,3,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,4,,1,,,,,,1,4,32,,,1,,4,32,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,98,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,75,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,1800,Visit7,7,Phase 1B,195,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,2000,Visit8,8,Phase 1B,225,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,2200,Visit9,9,Phase 1B,251,1B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,2400,Visit10,10,Phase 1B,279,1B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,2600,Visit11,11,Phase 1B,307,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,2800,Visit12,12,Phase 1B,342,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,3000,Visit13,13,Phase 1B,364,1B,94,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,3200,Visit14,14,Phase 1B,391,1B,,3,,1,,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,3400,Visit15,15,Phase 1B,412,1B,98,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,3600,Visit16,16,Phase 1B,441,1B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,3800,Visit17,17,Phase 1B,475,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,168,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVDX959PXW,2202,,,M,5400,EndofPhase1b,18,Phase 1B,496,1B,94,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA098LRX,2083,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,84,3,,,,,,,,1,3,120,,,2,,4,140,140,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA098LRX,2083,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA146UV7,1054,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA146UV7,1054,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA146UV7,1054,,,M,1000,Visit3,3,Phase 1/1A,81,1 or 1A,0,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA784ANX,1058,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,75,2,,,,,,,,2,2,400,,,2,,3,500,400,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA784ANX,1058,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA784ANX,1058,,,M,1000,Visit3,3,Phase 1/1A,81,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA784ANX,1058,,,M,1200,Visit4,4,Phase 1/1A,124,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA784ANX,1058,,,M,1400,Visit5,5,Phase 1/1A,152,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA784ANX,1058,,,M,1600,Visit6,6,Phase 1/1A,180,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA919VVK,1364,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA919VVK,1364,,,M,800,Visit2,2,Phase 1/1A,80,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEA919VVK,1364,,,M,1000,Visit3,3,Phase 1/1A,107,1 or 1A,,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,76,2,,,,,,,,1,2,400,,,2,1,1,250,200,1,1,8,8,1,10,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,89,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,96,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,1600,Visit6,6,Phase 3,166,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,1800,Visit7,7,Phase 3,197,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,2200,Visit9,9,Phase 3,253,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,2600,Visit11,11,Phase 3,307,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,2800,Visit12,12,Phase 3,337,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,3000,Visit13,13,Phase 3,377,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,3200,Visit14,14,Phase 3,390,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,3400,Visit15,15,Phase 3,428,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,3800,Visit17,17,Phase 3,476,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,4000,Visit18,18,Phase 3,505,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,113,1 or 1A,99,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEB483YXE,1017,,,M,5800,EndofPhase2,5,Phase 2,132,2,100,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEC049BGK,1668,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,98,2,,,,,,,,1,2,16,,,2,,2,19,24,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEC049BGK,1668,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEC049BGK,1668,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,99,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEC049BGK,1668,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEC049BGK,1668,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEC049BGK,1668,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,153,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEC578GFB,1838,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEC621KTU,1986,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,23,1 or 1A,,3,,1,,,,,,2,3,22.5,,,1,2,3,23,23,3,2,80,80,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEC621KTU,1986,,,M,5800,EndofPhase2,2,Phase 2,35,2,70,2,,1,,,,,,2,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,800,Visit2,2,Phase 1/1A,69,1 or 1A,91,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,1000,Visit3,3,Phase 1/1A,99,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,1200,Visit4,4,Phase 1/1A,124,1 or 1A,98,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,1400,Visit5,5,Phase 1/1A,152,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,99,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,91,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,94,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,2400,Visit10,10,Phase 1/1A,286,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,2800,Visit12,12,Phase 1/1A,348,1 or 1A,97,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,87,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,3400,Visit15,15,Phase 1/1A,435,1 or 1A,85,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,3600,Visit16,16,Phase 1/1A,454,1 or 1A,86,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED286CJX,1059,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,94,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,800,Visit2,2,Phase 2,68,2,7,2,,,,,,,,4,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,1200,Visit4,4,Phase 3,114,3,,,,,,2,400,,,2,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,1400,Visit5,5,Phase 3,152,3,,,,,,2,400,,,3,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,1600,Visit6,6,Phase 3,169,3,,,,,,2,300,,,2,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,1800,Visit7,7,Phase 3,203,3,,,,,,2,300,,,3,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,2000,Visit8,8,Phase 3,225,3,,,,,,2,300,,,2,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,2200,Visit9,9,Phase 3,265,3,,,,,,2,500,,,3,,,,500,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,2400,Visit10,10,Phase 3,281,3,,,,,,2,400,,,2,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,2600,Visit11,11,Phase 3,313,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,2800,Visit12,12,Phase 3,337,3,,,,,,2,400,,,2,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,3000,Visit13,13,Phase 3,365,3,,,,,,2,400,,,2,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,3400,Visit15,15,Phase 3,411,3,,,,,,2,400,,,3,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,3600,Visit16,16,Phase 3,446,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,3800,Visit17,17,Phase 3,474,3,,,,,,2,300,,,2,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,19,1 or 1A,100,2,,,,,,,,2,2,400,,,2,1,2,400,400,2,2,15,15,2,371,300,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,5800,EndofPhase2,3,Phase 2,84,2,52,2,,,,,,,,2,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVED579KEG,1071,,,F,6000,EndofPhase3,18,Phase 3,506,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,1,3,533,400,3,2,3,3,2,137,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,1800,Visit7,7,Phase 3,195,3,,,,,,4,160,,0,1,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,2000,Visit8,8,Phase 3,233,3,,,,,,4,120,,0,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,2200,Visit9,9,Phase 3,252,3,,,,,,4,120,,0,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,2400,Visit10,10,Phase 3,272,3,,,,,,4,60,,0,1,,,,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,2600,Visit11,11,Phase 3,308,3,,,,,,4,60,,60,1,,,,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,2800,Visit12,12,Phase 3,336,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,3000,Visit13,13,Phase 3,366,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,3200,Visit14,14,Phase 3,399,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,3400,Visit15,15,Phase 3,427,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,3600,Visit16,16,Phase 3,456,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,3800,Visit17,17,Phase 3,483,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,161,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,5800,EndofPhase2,6,Phase 2,162,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE008KMX,2064,,,M,6000,EndofPhase3,18,Phase 3,518,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE411HBL,2638,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE769PLH,1294,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,2,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE769PLH,1294,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,128,1 or 1A,39,2,,1,,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE780LER,1040,,,F,1000,Visit3,3,Phase 3,60,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE780LER,1040,,,F,1200,Visit4,4,Phase 3,91,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE780LER,1040,,,F,1400,Visit5,5,Phase 3,134,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE780LER,1040,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,17,1 or 1A,50,2,,,,,,,,1,2,3,,,1,1,2,3,3,2,2,15,15,2,800,800,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEE780LER,1040,,,F,5800,EndofPhase2,2,Phase 2,30,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,1,,,,,,,,1,1,8,,,1,,2,15,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,93,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,73,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,83,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,96,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,90,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,86,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF085TJ9,1215,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,511,1 or 1A,86,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF559ZVH,1321,,,M,600,Visit1,1,Phase 1/1A,43,1 or 1A,98,4,,,,,,,,1,4,6,,,1,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF559ZVH,1321,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF559ZVH,1321,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,97,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF559ZVH,1321,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF559ZVH,1321,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,139,1 or 1A,74,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,1,,,,,,1,1,8,,,2,,1,11,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,1200,Visit4,4,Phase 1B,135,1B,71,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,1400,Visit5,5,Phase 1B,163,1B,94,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,1600,Visit6,6,Phase 1B,189,1B,88,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,1800,Visit7,7,Phase 1B,219,1B,75,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,2000,Visit8,8,Phase 1B,245,1B,69,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,2200,Visit9,9,Phase 1B,273,1B,73,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,2400,Visit10,10,Phase 1B,301,1B,55,2,,0,1,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,2600,Visit11,11,Phase 1B,329,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,2800,Visit12,12,Phase 1B,357,1B,68,2,,0,1,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,3000,Visit13,13,Phase 1B,386,1B,98,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,3200,Visit14,14,Phase 1B,414,1B,98,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,3400,Visit15,15,Phase 1B,445,1B,,2,,1,,,,,,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,3600,Visit16,16,Phase 1B,479,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,3800,Visit17,17,Phase 1B,506,1B,93,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,86,1 or 1A,93,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEF867MKT,1883,,,M,5400,EndofPhase1b,18,Phase 1B,541,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,1,9,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,55,1,,,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,1200,Visit4,4,Phase 1/1A,127,1 or 1A,79,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,64,1,,,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,68,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,61,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,2400,Visit10,10,Phase 1/1A,283,1 or 1A,76,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,2600,Visit11,11,Phase 1/1A,311,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,2800,Visit12,12,Phase 1/1A,332,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,3000,Visit13,13,Phase 1/1A,361,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,3200,Visit14,14,Phase 1/1A,389,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,4000,Visit18,18,Phase 1/1A,512,1 or 1A,97,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG019BKF,1190,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,97,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,1,,4,30,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,1600,Visit6,6,Phase 1/1A,183,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,93,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,96,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,2200,Visit9,9,Phase 1/1A,254,1 or 1A,93,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,2600,Visit11,11,Phase 1/1A,302,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,2800,Visit12,12,Phase 1/1A,339,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,3800,Visit17,17,Phase 1/1A,480,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG124CPA,2717,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG508UXC,2177,,,F,600,Visit1,1,Phase 1/1A,43,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG508UXC,2177,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,600,Visit1,1,Phase 1/1A,37,1 or 1A,84,3,,1,,,,,,1,3,120,,,1,1,4,156,160,4,4,800,800,4,275,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,27,4,,1,,,,,,3,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,1000,Visit3,3,Phase 1/1A,97,1 or 1A,84,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,1200,Visit4,4,Phase 1/1A,126,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,1400,Visit5,5,Phase 1/1A,154,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,1600,Visit6,6,Phase 1/1A,188,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,1800,Visit7,7,Phase 1/1A,218,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,2000,Visit8,8,Phase 1/1A,250,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,2600,Visit11,11,Phase 3,344,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,2800,Visit12,12,Phase 3,371,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,3000,Visit13,13,Phase 3,400,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,3200,Visit14,14,Phase 3,428,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,3400,Visit15,15,Phase 3,456,3,,,,,,6,250,,,1,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,3600,Visit16,16,Phase 3,488,3,,,,,,6,250,,,1,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,3800,Visit17,17,Phase 3,524,3,,,,,,6,250,,,1,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,268,1 or 1A,95,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,5800,EndofPhase2,10,Phase 2,316,2,100,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG533GFY,2872,,,M,6000,EndofPhase3,18,Phase 3,553,3,,,,,,6,250,,,1,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG659ZPZ,1341,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG968FJG,1069,,,M,600,Visit1,1,Phase 1/1A,39,1 or 1A,76,3,,,,,,,,2,3,600,,,2,,3,600,600,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEG968FJG,1069,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,70,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH036KBL,1465,,,M,800,Visit2,2,Phase 2,62,2,98,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH036KBL,1465,,,M,1000,Visit3,3,Phase 2,90,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH036KBL,1465,,,M,1200,Visit4,4,Phase 2,120,2,87,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH036KBL,1465,,,M,1400,Visit5,5,Phase 2,149,2,97,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH036KBL,1465,,,M,1600,Visit6,6,Phase 2,174,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH036KBL,1465,,,M,1800,Visit7,7,Phase 2,204,2,91,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH036KBL,1465,,,M,2000,Visit8,8,Phase 2,232,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH036KBL,1465,,,M,2200,Visit9,9,Phase 2,261,2,90,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH036KBL,1465,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,34,1 or 1A,2,2,,0,1,,,,,4,2,400,,,1,1,2,400,400,2,4,28,30,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,3,,,,,,,,1,3,22.5,,,1,2,4,29,30,4,3,600,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,1400,Visit5,5,Phase 1/1A,134,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,2400,Visit10,10,Phase 2,280,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,2600,Visit11,11,Phase 2,308,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,2800,Visit12,12,Phase 2,336,2,96,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,3000,Visit13,13,Phase 2,364,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,3400,Visit15,15,Phase 3,420,3,,,,,,3,8,2,400,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,3600,Visit16,16,Phase 3,456,3,,,,,,3,8,2,400,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,3800,Visit17,17,Phase 3,476,3,,,,,,3,12,2,600,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,4000,Visit18,18,Phase 3,505,3,,,,,,3,12,2,600,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,4200,Visit19,19,Phase 3,532,3,,,,,,3,18,2,600,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,252,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,5800,EndofPhase2,14,Phase 2,393,2,96,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH390PB5,1439,,,M,6000,EndofPhase3,19,Phase 3,574,3,,,,,,3,12,2,600,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH395APT,2560,,,M,600,Visit1,1,Phase 1/1A,67,1 or 1A,94,2,,1,,,,,,1,2,400,,,2,2,2,400,400,2,2,15,15,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH395APT,2560,,,M,800,Visit2,2,Phase 1/1A,93,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH395APT,2560,,,M,1200,Visit4,4,Phase 2,142,2,,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH395APT,2560,,,M,1400,Visit5,5,Phase 2,173,2,,2,,1,,,,,,2,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH395APT,2560,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,129,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH415HZU,2318,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,50,2,,1,,,,,,3,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,600,Visit1,1,Phase 1/1A,50,1 or 1A,98,2,,,,,,,,1,2,400,,,2,,3,588,400,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,800,Visit2,2,Phase 1/1A,85,1 or 1A,,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,1000,Visit3,3,Phase 1/1A,114,1 or 1A,,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,1200,Visit4,4,Phase 1/1A,139,1 or 1A,,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,1400,Visit5,5,Phase 1/1A,167,1 or 1A,,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,1600,Visit6,6,Phase 1/1A,187,1 or 1A,,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,1800,Visit7,7,Phase 1/1A,208,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,2000,Visit8,8,Phase 1/1A,237,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,2200,Visit9,9,Phase 1/1A,257,1 or 1A,,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,2400,Visit10,10,Phase 1/1A,285,1 or 1A,88,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,84,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,84,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,3200,Visit14,14,Phase 1/1A,397,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,3400,Visit15,15,Phase 1/1A,425,1 or 1A,90,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,73,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEH548CM2,1231,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,520,1 or 1A,,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEJ603JCV,1532,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,13,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK026ELQ,2379,,,F,600,Visit1,1,Phase 1/1A,34,1 or 1A,83,2,,1,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK026ELQ,2379,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK026ELQ,2379,,,F,1000,Visit3,3,Phase 1/1A,89,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK026ELQ,2379,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,90,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK026ELQ,2379,,,F,1400,Visit5,5,Phase 1/1A,138,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK026ELQ,2379,,,F,1600,Visit6,6,Phase 1/1A,184,1 or 1A,66,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK026ELQ,2379,,,F,1800,Visit7,7,Phase 1/1A,202,1 or 1A,79,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK026ELQ,2379,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK026ELQ,2379,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK026ELQ,2379,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,0,1,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK026ELQ,2379,,,F,2600,Visit11,11,Phase 1/1A,310,1 or 1A,90,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK026ELQ,2379,,,F,5200,EndofPhase1_1a,11,Phase 1/1A,365,1 or 1A,,,,1,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,96,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,44,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,86,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,1800,Visit7,7,Phase 1/1A,212,1 or 1A,86,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,2000,Visit8,8,Phase 1/1A,240,1 or 1A,90,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,2200,Visit9,9,Phase 1/1A,268,1 or 1A,75,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,2400,Visit10,10,Phase 1/1A,296,1 or 1A,89,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,2600,Visit11,11,Phase 1/1A,323,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,2800,Visit12,12,Phase 1/1A,351,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,3000,Visit13,13,Phase 1/1A,382,1 or 1A,61,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,3200,Visit14,14,Phase 1/1A,414,1 or 1A,72,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK257YWW,1247,,,M,3400,Visit15,15,Phase 1/1A,457,1 or 1A,,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK396PZZ,1852,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,6,,,1,1,4,6,6,4,4,30,30,4,25,25,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK396PZZ,1852,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK396PZZ,1852,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,95,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK396PZZ,1852,,,M,1200,Visit4,4,Phase 1/1A,108,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK396PZZ,1852,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,94,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK396PZZ,1852,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK396PZZ,1852,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK396PZZ,1852,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK396PZZ,1852,,,M,2400,Visit10,10,Phase 2,283,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK396PZZ,1852,,,M,2600,Visit11,11,Phase 2,309,2,99,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK396PZZ,1852,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,262,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK396PZZ,1852,,,M,5800,EndofPhase2,12,Phase 2,337,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK396PZZ,1852,,,M,6000,EndofPhase3,13,Phase 3,350,3,,,,,,6,25,,,1,,,,25,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,4,,1,,,,,,1,4,6,,,1,2,4,5,5,4,4,160,160,4,175,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,1400,Visit5,5,Phase 2,133,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,1600,Visit6,6,Phase 2,162,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,1800,Visit7,7,Phase 2,189,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,2000,Visit8,8,Phase 2,217,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,2200,Visit9,9,Phase 2,245,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,2400,Visit10,10,Phase 2,273,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,2600,Visit11,11,Phase 2,300,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,2800,Visit12,12,Phase 2,330,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,3000,Visit13,13,Phase 2,357,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,3400,Visit15,15,Phase 3,413,3,,,,,,6,100,6,100,1,,,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,3600,Visit16,16,Phase 3,447,3,,,,,,6,100,6,100,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,3800,Visit17,17,Phase 3,478,3,,,,,,6,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,107,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,5800,EndofPhase2,14,Phase 2,386,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEK675HU4,2569,,,M,6000,EndofPhase3,18,Phase 3,517,3,,,,,,6,200,6,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,98,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,3600,Visit16,16,Phase 1/1A,451,1 or 1A,97,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL195MK3,2408,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,1.5,,,1,,1,2,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,78,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,97,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,2000,Visit8,8,Phase 1/1A,218,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,2200,Visit9,9,Phase 1/1A,246,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,2400,Visit10,10,Phase 1/1A,267,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,92,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL339YN3,1865,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,504,1 or 1A,90,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL454JAE,1878,,,F,600,Visit1,1,Phase 1/1A,34,1 or 1A,96,3,,,,,,,,1,3,120,,,2,,3,113,120,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL454JAE,1878,,,F,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL454JAE,1878,,,F,1000,Visit3,3,Phase 1/1A,87,1 or 1A,95,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL454JAE,1878,,,F,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL454JAE,1878,,,F,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL454JAE,1878,,,F,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL646EVW,2228,,,F,600,Visit1,1,Phase 1/1A,37,1 or 1A,49,3,,1,,,,,,3,3,22.5,,,2,,3,23,23,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL756JUP,2299,,,F,1000,Visit3,3,Phase 3,90,3,,,,,,6,400,,,3,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL756JUP,2299,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,94,3,,1,,,,,,1,3,4.5,,,1,2,3,5,5,3,3,600,600,3,450,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL756JUP,2299,,,F,5800,EndofPhase2,2,Phase 2,57,2,74,3,,1,,,,,,2,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEL756JUP,2299,,,F,6000,EndofPhase3,4,Phase 3,100,3,,,,,,6,500,,,3,,,,500,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,32,,,2,,4,32,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,1600,Visit6,6,Phase 1/1A,221,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,2000,Visit8,8,Phase 1B,235,1B,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,2200,Visit9,9,Phase 1B,276,1B,,4,,,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,2400,Visit10,10,Phase 1B,303,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,2600,Visit11,11,Phase 1B,331,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,2800,Visit12,12,Phase 1B,363,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,3000,Visit13,13,Phase 1B,387,1B,,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,3200,Visit14,14,Phase 1B,415,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,3400,Visit15,15,Phase 1B,442,1B,,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,3600,Visit16,16,Phase 1B,464,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,3800,Visit17,17,Phase 1B,492,1B,94,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM147JJW,1113,,,F,5400,EndofPhase1b,18,Phase 1B,513,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM262ZMQ,2302,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM262ZMQ,2302,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM262ZMQ,2302,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM262ZMQ,2302,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM262ZMQ,2302,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,121,1 or 1A,,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM266FVL,2572,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,33,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,2,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM351NJK,2366,,,M,600,Visit1,1,Phase 1/1A,45,1 or 1A,,2,,1,,,,,,4,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM351NJK,2366,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM468NHZ,2027,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,160,,,2,,4,160,160,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM468NHZ,2027,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,88,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM468NHZ,2027,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,79,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM498VU0,2497,,,F,600,Visit1,1,Phase 1/1A,37,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,2,2,18,15,2,2,400,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM498VU0,2497,,,F,800,Visit2,2,Phase 1/1A,61,1 or 1A,88,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM498VU0,2497,,,F,1200,Visit4,4,Phase 2,114,2,84,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM498VU0,2497,,,F,1400,Visit5,5,Phase 2,134,2,78,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM498VU0,2497,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,76,1 or 1A,77,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM498VU0,2497,,,F,5800,EndofPhase2,6,Phase 2,160,2,74,2,,1,,,,,,2,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM498VU0,2497,,,F,6000,EndofPhase3,7,Phase 3,163,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM556WEZ,1207,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,94,2,,,,,,,,1,2,15,,,2,2,2,14,15,2,2,360,400,2,2,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM556WEZ,1207,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM556WEZ,1207,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM556WEZ,1207,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM556WEZ,1207,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM556WEZ,1207,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,86,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM556WEZ,1207,,,M,2000,Visit8,8,Phase 2,221,2,91,1,,,,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM556WEZ,1207,,,M,2200,Visit9,9,Phase 2,256,2,89,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM556WEZ,1207,,,M,2400,Visit10,10,Phase 2,279,2,91,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM556WEZ,1207,,,M,2600,Visit11,11,Phase 2,307,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM556WEZ,1207,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,195,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM556WEZ,1207,,,M,5800,EndofPhase2,12,Phase 2,334,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM556WEZ,1207,,,M,6000,EndofPhase3,13,Phase 3,354,3,,,,,,3,2,,,4,,,,2,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,1400,Visit5,5,Phase 1/1A,146,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,1800,Visit7,7,Phase 1/1A,202,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,2200,Visit9,9,Phase 1/1A,268,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,2400,Visit10,10,Phase 1/1A,296,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,2600,Visit11,11,Phase 1/1A,324,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,2800,Visit12,12,Phase 1/1A,352,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,3000,Visit13,13,Phase 1/1A,392,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,3200,Visit14,14,Phase 1/1A,420,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM709PTV,1256,,,M,3400,Visit15,15,Phase 1/1A,449,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,1,2,4,5,6,4,4,160,160,4,75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,800,Visit2,2,Phase 1/1A,51,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,68,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,1600,Visit6,6,Phase 1/1A,165,1 or 1A,91,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,84,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,,4,,1,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,2200,Visit9,9,Phase 1/1A,250,1 or 1A,83,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,36,3,,1,,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,,3,,1,,,,,,,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,91,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,3400,Visit15,15,Phase 2,421,2,63,4,,1,,,,,,2,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,3800,Visit17,17,Phase 3,485,3,,,,,,7,50,7,50,1,,,,100,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,5200,EndofPhase1_1a,14,Phase 1/1A,390,1 or 1A,91,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,5800,EndofPhase2,16,Phase 2,439,2,,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM710PGL,1877,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,800,Visit2,2,Phase 2,58,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,1000,Visit3,3,Phase 2,93,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,1200,Visit4,4,Phase 2,121,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,1400,Visit5,5,Phase 2,150,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,1600,Visit6,6,Phase 2,179,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,1800,Visit7,7,Phase 2,204,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,2000,Visit8,8,Phase 2,233,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,2200,Visit9,9,Phase 2,268,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,2400,Visit10,10,Phase 2,296,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,2600,Visit11,11,Phase 2,324,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,2800,Visit12,12,Phase 2,351,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,3000,Visit13,13,Phase 2,382,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,3200,Visit14,14,Phase 2,416,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,3400,Visit15,15,Phase 2,444,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,3600,Visit16,16,Phase 2,480,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,3800,Visit17,17,Phase 2,512,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,30,1 or 1A,100,4,,1,,,,,,1,4,30,,,1,2,4,30,30,4,3,5,5,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM743VP3,2635,,,M,5800,EndofPhase2,18,Phase 2,551,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,600,Visit1,1,Phase 1/1A,38,1 or 1A,86,2,,1,,,,,,1,2,15,,,1,1,2,14,15,2,1,53,40,1,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,800,Visit2,2,Phase 1/1A,72,1 or 1A,51,2,,0,1,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,1000,Visit3,3,Phase 1/1A,106,1 or 1A,38,2,,0,1,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,1200,Visit4,4,Phase 1/1A,134,1 or 1A,50,2,,0,1,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,1400,Visit5,5,Phase 1/1A,168,1 or 1A,43,2,,0,1,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,1600,Visit6,6,Phase 1/1A,191,1 or 1A,54,2,,0,1,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,1800,Visit7,7,Phase 1/1A,219,1 or 1A,80,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,2000,Visit8,8,Phase 1/1A,248,1 or 1A,47,3,,0,1,,,,,3,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,2200,Visit9,9,Phase 1/1A,276,1 or 1A,100,1,,1,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,2600,Visit11,11,Phase 2,330,2,43,2,,0,1,,,,,3,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,2800,Visit12,12,Phase 2,372,2,52,1,,1,,,,,,2,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,3200,Visit14,14,Phase 3,409,3,,,,,,3,2,3,2,4,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,3400,Visit15,15,Phase 3,436,3,,,,,,3,4,3,4,1,,,,8,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,3600,Visit16,16,Phase 3,463,3,,,,,,3,4,3,4,2,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,3800,Visit17,17,Phase 3,492,3,,,,,,3,1,3,3,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,5200,EndofPhase1_1a,10,Phase 1/1A,309,1 or 1A,100,1,,1,,,,,,3,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,5800,EndofPhase2,13,Phase 2,380,2,100,1,,1,,,,,,3,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM909BCN,2568,,,M,6000,EndofPhase3,18,Phase 3,520,3,,,,,,3,3,3,1,3,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM912FU1,2205,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,44,2,,1,,,,,,3,2,400,,,1,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM912FU1,2205,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,30,2,,0,1,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM912FU1,2205,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,46,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM912FU1,2205,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,84,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEM912FU1,2205,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,144,1 or 1A,48,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEN612TX2,1661,,,M,600,Visit1,1,Phase 1/1A,46,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEN612TX2,1661,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,58,,,,,,,,,,,,,,,,2,,2,400,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,3,,,,,,,,1,3,22.5,,,2,2,4,28,30,4,4,153,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,1600,Visit6,6,Phase 1/1A,185,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,1800,Visit7,7,Phase 1/1A,220,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,2000,Visit8,8,Phase 1/1A,248,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,2200,Visit9,9,Phase 1/1A,269,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,2400,Visit10,10,Phase 1/1A,304,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,2600,Visit11,11,Phase 1/1A,332,1 or 1A,16,4,,1,,,,,,4,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,2800,Visit12,12,Phase 1/1A,360,1 or 1A,86,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,3000,Visit13,13,Phase 1/1A,395,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,3400,Visit15,15,Phase 2,452,2,92,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,3600,Visit16,16,Phase 2,472,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,3800,Visit17,17,Phase 2,499,2,95,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,4000,Visit18,18,Phase 2,521,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,4200,Visit19,19,Phase 2,556,2,75,4,,1,,,,,,2,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,5200,EndofPhase1_1a,14,Phase 1/1A,416,1 or 1A,90,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEP854MB5,1952,,,M,5800,EndofPhase2,20,Phase 2,591,2,62,3,,1,,,,,,2,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,1,,,,,,1,2,3,,,1,,2,4,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,89,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,96,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,1400,Visit5,5,Phase 1/1A,137,1 or 1A,76,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,85,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,93,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,89,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,2400,Visit10,10,Phase 1/1A,279,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,86,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,70,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,3000,Visit13,13,Phase 1/1A,370,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,3200,Visit14,14,Phase 1/1A,390,1 or 1A,95,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,3400,Visit15,15,Phase 1/1A,419,1 or 1A,82,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,90,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER218LNE,2575,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,64,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,3,,,1,2,3,5,3,3,4,800,800,4,40,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,1200,Visit4,4,Phase 1/1A,101,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,1400,Visit5,5,Phase 1/1A,120,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,1600,Visit6,6,Phase 1/1A,140,1 or 1A,95,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,1800,Visit7,7,Phase 1/1A,175,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,2400,Visit10,10,Phase 3,272,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,2600,Visit11,11,Phase 3,324,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,2800,Visit12,12,Phase 3,346,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,3000,Visit13,13,Phase 3,377,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,3200,Visit14,14,Phase 3,407,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,3400,Visit15,15,Phase 3,440,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,3600,Visit16,16,Phase 3,468,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,3800,Visit17,17,Phase 3,497,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,5200,EndofPhase1_1a,8,Phase 1/1A,205,1 or 1A,70,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,5800,EndofPhase2,9,Phase 2,217,2,4,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER280TET,2065,,,F,6000,EndofPhase3,18,Phase 3,553,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER371JMR,1077,,,F,600,Visit1,1,Phase 1/1A,21,1 or 1A,79,2,,,,,,,,1,2,400,,,2,1,2,400,400,2,2,3,3,2,13,13,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER371JMR,1077,,,F,1000,Visit3,3,Phase 2,77,2,0,2,,,,,,,,4,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER371JMR,1077,,,F,1400,Visit5,5,Phase 3,133,3,,,,,,7,13,,,1,,,,12.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER371JMR,1077,,,F,1600,Visit6,6,Phase 3,154,3,,,,,,7,13,,,3,,,,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER371JMR,1077,,,F,2000,Visit8,8,Phase 3,224,3,,,,,,7,13,,,3,,,,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER371JMR,1077,,,F,2200,Visit9,9,Phase 3,266,3,,,,,,7,13,,,1,,,,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER371JMR,1077,,,F,2400,Visit10,10,Phase 3,315,3,,,,,,7,13,,,2,,,,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER371JMR,1077,,,F,2600,Visit11,11,Phase 3,329,3,,,,,,7,13,,,1,,,,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER371JMR,1077,,,F,2800,Visit12,12,Phase 3,351,3,,,,,,7,13,,,3,,,,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER371JMR,1077,,,F,3400,Visit15,15,Phase 3,393,3,,,,,,7,13,,,4,,,,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER371JMR,1077,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,49,1 or 1A,0,2,,,,,,,,4,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER371JMR,1077,,,F,5800,EndofPhase2,4,Phase 2,105,2,0,2,,,,,,,,4,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,,4,,1,,,,,,1,4,6,,,1,1,4,6,6,4,4,30,30,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,1000,Visit3,3,Phase 2,88,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,1200,Visit4,4,Phase 2,109,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,1400,Visit5,5,Phase 2,137,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,1600,Visit6,6,Phase 2,165,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,1800,Visit7,7,Phase 2,193,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,2000,Visit8,8,Phase 2,225,2,97,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,2200,Visit9,9,Phase 2,248,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,2400,Visit10,10,Phase 2,282,2,91,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,2600,Visit11,11,Phase 2,309,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,3,6,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,3200,Visit14,14,Phase 3,394,3,,,,,,3,6,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,3400,Visit15,15,Phase 3,422,3,,,,,,3,6,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,3600,Visit16,16,Phase 3,445,3,,,,,,3,6,2,400,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,3,6,2,600,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,53,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,5800,EndofPhase2,12,Phase 2,330,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER411YRZ,2663,,,M,6000,EndofPhase3,18,Phase 3,508,3,,,,,,3,6,2,600,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER469ZUU,1308,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,3,4,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER469ZUU,1308,,,M,800,Visit2,2,Phase 1/1A,51,1 or 1A,98,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER469ZUU,1308,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER469ZUU,1308,,,M,1200,Visit4,4,Phase 1/1A,122,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER469ZUU,1308,,,M,1400,Visit5,5,Phase 1/1A,157,1 or 1A,,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER469ZUU,1308,,,M,1600,Visit6,6,Phase 1/1A,187,1 or 1A,,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER469ZUU,1308,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,221,1 or 1A,,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER731LMC,1172,,,F,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER731LMC,1172,,,F,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER749TJ0,2651,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,75,2,,1,,,,,,2,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER749TJ0,2651,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,77,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER749TJ0,2651,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,56,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER766RTL,2368,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,75,3,,1,,,,,,2,3,22.5,,,2,,3,23,23,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER766RTL,2368,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,56,1 or 1A,60,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVER803ZG6,2136,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET024AVQ,2894,,,F,600,Visit1,1,Phase 1/1A,25,1 or 1A,100,4,,,,,,,,1,4,6,,,1,1,4,6,6,4,4,800,800,4,120,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET024AVQ,2894,,,F,800,Visit2,2,Phase 1/1A,52,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET024AVQ,2894,,,F,1200,Visit4,4,Phase 2,108,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET024AVQ,2894,,,F,1400,Visit5,5,Phase 2,141,2,82,4,,0,1,,,,,3,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET024AVQ,2894,,,F,1600,Visit6,6,Phase 2,164,2,11,4,,0,1,,,,,4,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET024AVQ,2894,,,F,1800,Visit7,7,Phase 2,191,2,82,4,,0,1,,,,,,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET024AVQ,2894,,,F,2000,Visit8,8,Phase 2,214,2,93,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET024AVQ,2894,,,F,2400,Visit10,10,Phase 3,274,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET024AVQ,2894,,,F,2600,Visit11,11,Phase 3,297,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET024AVQ,2894,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,79,1 or 1A,71,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET024AVQ,2894,,,F,5800,EndofPhase2,9,Phase 2,243,2,94,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET024AVQ,2894,,,F,6000,EndofPhase3,12,Phase 3,326,3,,,,,,4,160,,,2,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,2,2,436,400,2,2,80,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,84,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,25,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,,2,,1,,,,,,4,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,2000,Visit8,8,Phase 1/1A,215,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,2200,Visit9,9,Phase 1/1A,250,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,2400,Visit10,10,Phase 1/1A,278,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,2600,Visit11,11,Phase 1/1A,324,1 or 1A,,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,3000,Visit13,13,Phase 2,370,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,3200,Visit14,14,Phase 2,398,2,85,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,3400,Visit15,15,Phase 2,421,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,3600,Visit16,16,Phase 2,449,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,3800,Visit17,17,Phase 2,477,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,337,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET037ZA7,2766,,,M,5800,EndofPhase2,18,Phase 2,505,2,91,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,96,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,87,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,78,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,81,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,81,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,78,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,80,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,2600,Visit11,11,Phase 1/1A,304,1 or 1A,67,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,2800,Visit12,12,Phase 1/1A,332,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,3000,Visit13,13,Phase 1/1A,359,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,85,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,79,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,3800,Visit17,17,Phase 1/1A,479,1 or 1A,72,2,,0,1,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET431XM0,1146,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,507,1 or 1A,86,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,90,1,,,,,,,,1,1,7.5,,,1,,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,1000,Visit3,3,Phase 1/1A,92,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,59,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,1400,Visit5,5,Phase 1/1A,134,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,2200,Visit9,9,Phase 1/1A,260,1 or 1A,92,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,96,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,83,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,3000,Visit13,13,Phase 1/1A,367,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVET886NU4,1443,,,F,4000,Visit18,18,Phase 1/1A,512,1 or 1A,71,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,92,2,,,,,,,,1,2,15,,,1,,1,9,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,86,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,1400,Visit5,5,Phase 1/1A,156,1 or 1A,83,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,1600,Visit6,6,Phase 1/1A,184,1 or 1A,90,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,1800,Visit7,7,Phase 1/1A,212,1 or 1A,86,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,2000,Visit8,8,Phase 1/1A,249,1 or 1A,89,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,2200,Visit9,9,Phase 1/1A,277,1 or 1A,100,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,2400,Visit10,10,Phase 1/1A,305,1 or 1A,100,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,2600,Visit11,11,Phase 1/1A,331,1 or 1A,98,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,2800,Visit12,12,Phase 1/1A,357,1 or 1A,,1,,0,1,,,,,,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,3000,Visit13,13,Phase 1/1A,378,1 or 1A,91,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,3200,Visit14,14,Phase 1/1A,408,1 or 1A,96,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,3400,Visit15,15,Phase 1/1A,436,1 or 1A,93,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,3600,Visit16,16,Phase 1/1A,464,1 or 1A,100,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,3800,Visit17,17,Phase 1/1A,492,1 or 1A,100,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEU255FHP,1903,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,513,1 or 1A,100,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV176YT5,2832,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,400,,,1,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV176YT5,2832,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,48,2,,0,1,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV176YT5,2832,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,100,4,,1,,,,,,1,4,800,,,2,2,4,800,800,4,4,160,160,4,7,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,86,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,1400,Visit5,5,Phase 2,138,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,1800,Visit7,7,Phase 3,187,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,2000,Visit8,8,Phase 3,223,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,2200,Visit9,9,Phase 3,252,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,2400,Visit10,10,Phase 3,278,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,2600,Visit11,11,Phase 3,320,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,2800,Visit12,12,Phase 3,328,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,3000,Visit13,13,Phase 3,369,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,3200,Visit14,14,Phase 3,396,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,3400,Visit15,15,Phase 3,425,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,3,9,,,2,,,,9,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,3,9,,,2,,,,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,116,1 or 1A,88,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,5800,EndofPhase2,6,Phase 2,165,2,82,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV392KH4,2323,,,M,6000,EndofPhase3,18,Phase 3,508,3,,,,,,3,9,,,2,,,,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,4,744,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,86,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,1400,Visit5,5,Phase 1/1A,146,1 or 1A,84,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,1800,Visit7,7,Phase 1/1A,202,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,2400,Visit10,10,Phase 1/1A,286,1 or 1A,94,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,2600,Visit11,11,Phase 1/1A,314,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,2800,Visit12,12,Phase 1/1A,342,1 or 1A,93,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,3000,Visit13,13,Phase 1/1A,363,1 or 1A,95,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,3400,Visit15,15,Phase 1/1A,419,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,3600,Visit16,16,Phase 1/1A,454,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,80,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV446AAR,1493,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,496,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV490HBK,1743,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV490HBK,1743,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,92,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV490HBK,1743,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV490HBK,1743,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV490HBK,1743,,,M,1400,Visit5,5,Phase 1/1A,133,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV490HBK,1743,,,M,1600,Visit6,6,Phase 1/1A,161,1 or 1A,18,1,,,,,,,,4,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV490HBK,1743,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,66,1,,,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV490HBK,1743,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV490HBK,1743,,,M,2200,Visit9,9,Phase 1/1A,247,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV490HBK,1743,,,M,2400,Visit10,10,Phase 1/1A,275,1 or 1A,90,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV490HBK,1743,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,91,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV490HBK,1743,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,85,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV490HBK,1743,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,85,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,600,Visit1,1,Phase 1/1A,46,1 or 1A,93,2,,0,1,,,,,1,2,80,,,1,2,3,120,120,3,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,1000,Visit3,3,Phase 2,105,2,90,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,1200,Visit4,4,Phase 2,130,2,98,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,1400,Visit5,5,Phase 2,159,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,1600,Visit6,6,Phase 2,193,2,93,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,1800,Visit7,7,Phase 2,214,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,2000,Visit8,8,Phase 2,244,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,2200,Visit9,9,Phase 2,281,2,86,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,2400,Visit10,10,Phase 2,316,2,91,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,2600,Visit11,11,Phase 2,336,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,2800,Visit12,12,Phase 2,364,2,75,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,3000,Visit13,13,Phase 2,397,2,85,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,3400,Visit15,15,Phase 2,440,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,3600,Visit16,16,Phase 2,452,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,3800,Visit17,17,Phase 2,476,2,88,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,78,1 or 1A,95,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEV605NTH,2542,,,F,5800,EndofPhase2,18,Phase 2,518,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW075KYL,1468,,,M,800,Visit2,2,Phase 2,60,2,86,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW075KYL,1468,,,M,1000,Visit3,3,Phase 2,86,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW075KYL,1468,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,30,1 or 1A,76,2,,,,,,,,1,2,3,,,2,1,2,3,3,2,1,8,8,1,40,40,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW075KYL,1468,,,M,5800,EndofPhase2,4,Phase 2,114,2,100,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW075KYL,1468,,,M,6000,EndofPhase3,5,Phase 3,127,3,,,,,,4,40,,,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,,4,,,,,,,,1,4,32,,,1,1,4,32,32,4,4,160,160,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,800,Visit2,2,Phase 1/1A,70,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,1200,Visit4,4,Phase 1B,114,1B,99,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,1400,Visit5,5,Phase 1B,149,1B,97,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,1600,Visit6,6,Phase 1B,189,1B,,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,1800,Visit7,7,Phase 1B,218,1B,95,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,2200,Visit9,9,Phase 1B,266,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,2400,Visit10,10,Phase 1B,302,1B,86,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,2600,Visit11,11,Phase 1B,331,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,2800,Visit12,12,Phase 1B,350,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,3000,Visit13,13,Phase 1B,377,1B,,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,3200,Visit14,14,Phase 1B,401,1B,96,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,3400,Visit15,15,Phase 1B,429,1B,96,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,3600,Visit16,16,Phase 1B,454,1B,100,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,3800,Visit17,17,Phase 1B,483,1B,100,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,4200,Visit19,19,Phase 2,542,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,4400,Visit20,20,Phase 2,570,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,4600,Visit21,21,Phase 2,601,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,4800,Visit22,22,Phase 2,630,2,94,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,78,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,5400,EndofPhase1b,18,Phase 1B,511,1B,100,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW387JPR,1139,,,M,5800,EndofPhase2,23,Phase 2,659,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,800,Visit2,2,Phase 2,50,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,1000,Visit3,3,Phase 2,84,2,99,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,1200,Visit4,4,Phase 2,113,2,97,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,1400,Visit5,5,Phase 2,142,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,1600,Visit6,6,Phase 2,172,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,1800,Visit7,7,Phase 2,200,2,98,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,2000,Visit8,8,Phase 2,228,2,98,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,2200,Visit9,9,Phase 2,259,2,99,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,2400,Visit10,10,Phase 2,287,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,2600,Visit11,11,Phase 2,315,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,2800,Visit12,12,Phase 2,339,1 or 1A,100,4,,1,,,,,,1,4,160,,,2,1,4,147,160,4,3,5,5,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,3000,Visit13,13,Phase 2,367,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,3200,Visit14,14,Phase 2,395,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,3400,Visit15,15,Phase 2,423,2,96,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,3600,Visit16,16,Phase 2,451,2,93,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,3800,Visit17,17,Phase 2,479,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,32,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW452HZB,1752,,,M,5800,EndofPhase2,18,Phase 2,507,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,1,,,,,,,,1,1,200,,,2,1,1,220,200,1,1,40,40,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,2200,Visit9,9,Phase 1/1A,252,1 or 1A,92,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,2600,Visit11,11,Phase 2,309,2,100,1,,,,,,,,1,1,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,2800,Visit12,12,Phase 2,337,2,100,1,,,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,3000,Visit13,13,Phase 2,365,2,100,1,,,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,3200,Visit14,14,Phase 2,393,2,100,1,,,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,3400,Visit15,15,Phase 2,422,2,100,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,3600,Visit16,16,Phase 2,449,2,100,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,3800,Visit17,17,Phase 2,477,2,100,1,,0,1,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,5200,EndofPhase1_1a,10,Phase 1/1A,275,1 or 1A,91,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEW970LLD,1618,,,F,5800,EndofPhase2,18,Phase 2,527,2,100,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX008ZA4,2702,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,91,1,,0,1,,,,,1,1,8,,,1,,2,15,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX008ZA4,2702,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX008ZA4,2702,,,M,1000,Visit3,3,Phase 1/1A,101,1 or 1A,,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX008ZA4,2702,,,M,1200,Visit4,4,Phase 1/1A,144,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX008ZA4,2702,,,M,1800,Visit7,7,Phase 1/1A,219,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX008ZA4,2702,,,M,2400,Visit10,10,Phase 1/1A,292,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX008ZA4,2702,,,M,3000,Visit13,13,Phase 1/1A,353,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX008ZA4,2702,,,M,3200,Visit14,14,Phase 1/1A,423,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX008ZA4,2702,,,M,3800,Visit17,17,Phase 1/1A,500,1 or 1A,81,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX008ZA4,2702,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,521,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,3,21,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,94,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,98,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,75,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,3400,Visit15,15,Phase 1/1A,430,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,4000,Visit18,18,Phase 1/1A,492,1 or 1A,99,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX068AV0,1123,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,492,1 or 1A,99,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX218GCQ,2673,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,52,4,,1,,,,,,2,4,6,,,1,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX218GCQ,2673,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,95,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX218GCQ,2673,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEX218GCQ,2673,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,4,,,,,,,,1,4,6,,,1,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,1600,Visit6,6,Phase 1/1A,165,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,2400,Visit10,10,Phase 1/1A,285,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,2600,Visit11,11,Phase 1/1A,306,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,3000,Visit13,13,Phase 1/1A,361,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,4000,Visit18,18,Phase 1/1A,491,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY283XXR,1245,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,491,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVEY411VH4,1734,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,36,1 or 1A,1,1,,,,,,,,4,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,99,4,,1,,,,,,1,4,32,,,1,,2,17,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,93,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,82,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,98,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,90,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,2400,Visit10,10,Phase 1/1A,293,1 or 1A,84,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,2800,Visit12,12,Phase 1/1A,359,1 or 1A,94,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,3000,Visit13,13,Phase 1/1A,387,1 or 1A,96,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,3200,Visit14,14,Phase 1/1A,415,1 or 1A,89,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,3600,Visit16,16,Phase 1/1A,482,1 or 1A,80,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA114VBR,1038,,,M,3800,Visit17,17,Phase 1/1A,511,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,600,Visit1,1,Phase 1/1A,33,1 or 1A,95,2,,1,,,,,,1,2,400,,,2,,3,647,800,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,1400,Visit5,5,Phase 1/1A,145,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,1800,Visit7,7,Phase 1/1A,203,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,2000,Visit8,8,Phase 1/1A,231,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,2200,Visit9,9,Phase 1/1A,257,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,2400,Visit10,10,Phase 1/1A,289,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,2600,Visit11,11,Phase 1/1A,316,1 or 1A,93,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,2800,Visit12,12,Phase 1/1A,348,1 or 1A,95,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,3000,Visit13,13,Phase 1/1A,369,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,3400,Visit15,15,Phase 1/1A,432,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,3600,Visit16,16,Phase 1/1A,453,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,3800,Visit17,17,Phase 1/1A,476,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA190VV8,2433,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,498,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,1,2,3,3,2,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,1600,Visit6,6,Phase 2,170,2,93,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,1800,Visit7,7,Phase 2,196,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,2000,Visit8,8,Phase 2,224,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,2200,Visit9,9,Phase 2,253,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,2400,Visit10,10,Phase 2,281,2,91,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,2600,Visit11,11,Phase 2,309,2,82,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,2800,Visit12,12,Phase 2,337,2,88,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,3000,Visit13,13,Phase 2,365,2,93,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,3200,Visit14,14,Phase 2,393,2,98,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,3400,Visit15,15,Phase 2,421,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,3600,Visit16,16,Phase 2,449,2,100,2,,0,1,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,3800,Visit17,17,Phase 2,477,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,140,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFA700LY3,2640,,,M,5800,EndofPhase2,18,Phase 2,505,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,69,2,,0,1,,,,,2,2,400,,,1,,3,667,800,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,800,Visit2,2,Phase 1/1A,72,1 or 1A,59,2,,0,1,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,1000,Visit3,3,Phase 1/1A,104,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,1200,Visit4,4,Phase 1/1A,133,1 or 1A,74,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,1400,Visit5,5,Phase 1/1A,157,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,1600,Visit6,6,Phase 1/1A,185,1 or 1A,99,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,1800,Visit7,7,Phase 1/1A,220,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,2000,Visit8,8,Phase 1/1A,248,1 or 1A,96,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,2200,Visit9,9,Phase 1/1A,276,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,2400,Visit10,10,Phase 1/1A,311,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,2600,Visit11,11,Phase 1/1A,339,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,2800,Visit12,12,Phase 1/1A,367,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,3000,Visit13,13,Phase 1/1A,399,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,3200,Visit14,14,Phase 1/1A,430,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,3400,Visit15,15,Phase 1/1A,464,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,3600,Visit16,16,Phase 1/1A,493,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,3800,Visit17,17,Phase 1/1A,520,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB106JZK,2771,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,548,1 or 1A,95,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,3,22,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,1600,Visit6,6,Phase 1/1A,198,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFB525EHZ,1546,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,2,2,3,24,23,3,2,3,3,2,210,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,1600,Visit6,6,Phase 2,168,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,1800,Visit7,7,Phase 2,196,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,2000,Visit8,8,Phase 2,224,2,94,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,2200,Visit9,9,Phase 2,252,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,2400,Visit10,10,Phase 2,281,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,2600,Visit11,11,Phase 2,309,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,2800,Visit12,12,Phase 2,336,2,96,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,3000,Visit13,13,Phase 2,365,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,3400,Visit15,15,Phase 3,391,3,,,,,,4,80,4,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,3600,Visit16,16,Phase 3,421,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,3800,Visit17,17,Phase 3,449,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,4000,Visit18,18,Phase 3,468,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,5200,EndofPhase1_1a,5,Phase 1/1A,140,1 or 1A,88,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC014VBM,1577,,,F,5800,EndofPhase2,14,Phase 2,371,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,800,Visit2,2,Phase 2,69,2,0,0,0,,,,,,,4,0,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,1000,Visit3,3,Phase 2,93,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,1200,Visit4,4,Phase 2,118,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,1400,Visit5,5,Phase 2,146,2,91,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,1600,Visit6,6,Phase 2,168,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,1800,Visit7,7,Phase 2,195,2,97,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,2000,Visit8,8,Phase 2,226,2,100,6,,,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,2200,Visit9,9,Phase 2,252,2,100,,550,,,,,,,1,,,550,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,2400,Visit10,10,Phase 2,287,2,95,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,2600,Visit11,11,Phase 2,308,2,65,,600,,,,,,,2,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,2800,Visit12,12,Phase 2,336,2,100,,25,,,,,,,1,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,3000,Visit13,13,Phase 2,364,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,3200,Visit14,14,Phase 2,392,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,3400,Visit15,15,Phase 2,434,2,100,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,3600,Visit16,16,Phase 2,455,2,95,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,3800,Visit17,17,Phase 2,476,2,100,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,27,1 or 1A,100,3,,,,,,,,1,3,22.5,,,1,3,3,23,23,3,3,448,600,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC408CBV,1517,,,M,5800,EndofPhase2,18,Phase 2,505,2,100,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC775WR9,2735,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,96,2,,1,,,,,,1,2,3,,,2,,3,5,6,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC775WR9,2735,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFC775WR9,2735,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,75,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,0,2,,,,,1,2,16,,,2,,1,9,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,0,2,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,1000,Visit3,3,Phase 1/1A,89,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,1400,Visit5,5,Phase 1/1A,145,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,2000,Visit8,8,Phase 1/1A,218,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,2400,Visit10,10,Phase 1/1A,300,1 or 1A,96,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,2800,Visit12,12,Phase 1/1A,335,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,3200,Visit14,14,Phase 1/1A,390,1 or 1A,88,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,92,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD288JZ1,2679,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,520,1 or 1A,98,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD366KRE,2212,,,F,1600,Visit6,6,Phase 2,129,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,2,1,1,8,8,1,2,60,60,2,0,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD366KRE,2212,,,F,1800,Visit7,7,Phase 2,159,2,100,1,,0,1,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD366KRE,2212,,,F,5800,EndofPhase2,8,Phase 2,173,2,91,2,,0,1,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFD366KRE,2212,,,F,6000,EndofPhase3,9,Phase 3,201,3,,,,,,3,0,,,2,,,,0.3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFE685JVP,2449,,,F,600,Visit1,1,Phase 1/1A,26,1 or 1A,96,2,,1,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFE685JVP,2449,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,102,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFE862RVR,2668,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,4,,0,,,,,,1,4,800,,,1,1,4,800,800,4,4,152,160,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFE862RVR,2668,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFE862RVR,2668,,,M,1200,Visit4,4,Phase 2,95,2,100,3,,0,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFE862RVR,2668,,,M,1600,Visit6,6,Phase 2,193,2,76,4,,0,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFE862RVR,2668,,,M,1800,Visit7,7,Phase 2,221,2,100,4,,0,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFE862RVR,2668,,,M,2000,Visit8,8,Phase 2,246,2,100,4,,0,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFE862RVR,2668,,,M,2200,Visit9,9,Phase 2,308,2,100,4,,0,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFE862RVR,2668,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,75,1 or 1A,100,4,,0,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF105HRL,1902,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,97,2,,,,,,,,1,2,16,,,1,2,2,16,16,2,3,120,120,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF105HRL,1902,,,M,1000,Visit3,3,Phase 1B,56,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF105HRL,1902,,,M,1200,Visit4,4,Phase 1B,106,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF105HRL,1902,,,M,1400,Visit5,5,Phase 1B,141,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF105HRL,1902,,,M,1600,Visit6,6,Phase 1B,168,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF105HRL,1902,,,M,1800,Visit7,7,Phase 1B,196,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF105HRL,1902,,,M,2000,Visit8,8,Phase 1B,218,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF105HRL,1902,,,M,2400,Visit10,10,Phase 2,273,2,98,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF105HRL,1902,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,43,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF105HRL,1902,,,M,5400,EndofPhase1b,9,Phase 1B,253,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF105HRL,1902,,,M,5800,EndofPhase2,11,Phase 2,300,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF185LGD,2213,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,91,2,,0,1,,,,,1,2,3,,,1,1,2,3,3,2,2,450,400,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF185LGD,2213,,,M,800,Visit2,2,Phase 1/1A,68,1 or 1A,0,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF185LGD,2213,,,M,1200,Visit4,4,Phase 2,120,2,27,2,,0,1,,,,,3,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF185LGD,2213,,,M,1400,Visit5,5,Phase 2,141,2,90,3,,0,1,,,,,1,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF185LGD,2213,,,M,1600,Visit6,6,Phase 2,169,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF185LGD,2213,,,M,5800,EndofPhase2,6,Phase 2,201,2,0,2,,,,,,,,4,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF260EBV,2349,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF572DXB,1055,,,M,800,Visit2,2,Phase 2,53,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF572DXB,1055,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,12,1 or 1A,100,1,,,,,,,,1,1,200,,,2,1,1,200,200,1,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF641KMM,2223,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,24,,,1,,4,31,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF641KMM,2223,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF641KMM,2223,,,M,1000,Visit3,3,Phase 1/1A,79,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF641KMM,2223,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,91,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF641KMM,2223,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF641KMM,2223,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF641KMM,2223,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF641KMM,2223,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF641KMM,2223,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF641KMM,2223,,,M,5200,EndofPhase1_1a,10,Phase 1/1A,269,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,2,2,4,5,6,4,4,800,800,4,380,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,97,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,,4,,,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,2400,Visit10,10,Phase 2,273,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,2600,Visit11,11,Phase 2,289,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,2800,Visit12,12,Phase 2,322,2,,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,3200,Visit14,14,Phase 3,377,3,,,,,,6,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,3400,Visit15,15,Phase 3,407,3,,,,,,6,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,3600,Visit16,16,Phase 3,433,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,3800,Visit17,17,Phase 3,462,3,,,,,,6,600,,,1,,,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,244,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,5800,EndofPhase2,13,Phase 2,336,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFF888HC8,2000,,,M,6000,EndofPhase3,18,Phase 3,495,3,,,,,,6,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG064XXW,1026,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,3,,,,,,,,4,3,600,,,2,,3,600,600,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG064XXW,1026,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,75,1 or 1A,,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,88,2,,0,2,,,,,1,2,16,,,2,,4,30,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,99,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,99,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,98,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,88,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,91,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,1800,Visit7,7,Phase 1/1A,201,1 or 1A,97,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,2000,Visit8,8,Phase 1/1A,229,1 or 1A,97,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,2200,Visit9,9,Phase 1/1A,257,1 or 1A,90,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,2400,Visit10,10,Phase 1/1A,286,1 or 1A,99,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,2600,Visit11,11,Phase 1/1A,306,1 or 1A,71,4,,0,2,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,90,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,90,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,90,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,3600,Visit16,16,Phase 1/1A,459,1 or 1A,100,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,3800,Visit17,17,Phase 1/1A,504,1 or 1A,70,4,,0,2,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG252HVR,2142,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,91,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG255EWG,2153,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,92,2,,,,,,,,1,2,16,,,1,,1,11,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG255EWG,2153,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,87,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG255EWG,2153,,,F,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG255EWG,2153,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,88,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG255EWG,2153,,,F,1400,Visit5,5,Phase 1/1A,142,1 or 1A,79,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG255EWG,2153,,,F,1600,Visit6,6,Phase 1/1A,182,1 or 1A,92,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG255EWG,2153,,,F,5200,EndofPhase1_1a,7,Phase 1/1A,197,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,,2,,,,,,,,1,2,15,,,1,,2,18,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,1800,Visit7,7,Phase 1/1A,224,1 or 1A,0,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,2000,Visit8,8,Phase 1/1A,259,1 or 1A,,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,2200,Visit9,9,Phase 1/1A,284,1 or 1A,,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,2400,Visit10,10,Phase 1/1A,336,1 or 1A,,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,2600,Visit11,11,Phase 1/1A,364,1 or 1A,,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,2800,Visit12,12,Phase 1/1A,392,1 or 1A,,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,3000,Visit13,13,Phase 1/1A,427,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,3200,Visit14,14,Phase 1/1A,448,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,3400,Visit15,15,Phase 1/1A,469,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG705FDW,1007,,,M,3800,Visit17,17,Phase 1/1A,511,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,1,,,,,,,,1,1,8,,,2,,2,15,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,1600,Visit6,6,Phase 1/1A,179,1 or 1A,63,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,1800,Visit7,7,Phase 1/1A,207,1 or 1A,71,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,2000,Visit8,8,Phase 1/1A,240,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,2200,Visit9,9,Phase 1/1A,269,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,2400,Visit10,10,Phase 1/1A,297,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,2600,Visit11,11,Phase 1/1A,324,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,2800,Visit12,12,Phase 1/1A,353,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,3000,Visit13,13,Phase 1/1A,380,1 or 1A,94,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,3200,Visit14,14,Phase 1/1A,409,1 or 1A,89,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,3400,Visit15,15,Phase 1/1A,430,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG756JHZ,1265,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,492,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG996LA6,2809,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,1,,,,,,3,2,16,,,2,,4,30,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG996LA6,2809,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,91,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG996LA6,2809,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,68,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG996LA6,2809,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,64,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG996LA6,2809,,,M,1400,Visit5,5,Phase 1/1A,153,1 or 1A,65,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG996LA6,2809,,,M,1600,Visit6,6,Phase 1/1A,181,1 or 1A,46,4,,0,2,,,,,3,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG996LA6,2809,,,M,1800,Visit7,7,Phase 1/1A,210,1 or 1A,46,4,,1,,,,,,3,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG996LA6,2809,,,M,2000,Visit8,8,Phase 1/1A,245,1 or 1A,80,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG996LA6,2809,,,M,2400,Visit10,10,Phase 1B,310,1B,83,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG996LA6,2809,,,M,2600,Visit11,11,Phase 1B,335,1B,57,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFG996LA6,2809,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,280,1 or 1A,62,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFH529HX9,1874,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,53,2,,,,,,,,3,2,3,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,3600,Visit16,16,Phase 1/1A,456,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ190ZUF,1584,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ285HT0,1537,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,1,1,2,16,16,2,2,80,80,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ285HT0,1537,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,72,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ285HT0,1537,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,52,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ285HT0,1537,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ285HT0,1537,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,0,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ285HT0,1537,,,M,1800,Visit7,7,Phase 1B,176,1B,85,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ285HT0,1537,,,M,4200,Visit19,19,Phase 2,411,2,73,2,,0,1,,,,,2,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ285HT0,1537,,,M,4400,Visit20,20,Phase 2,432,2,77,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ285HT0,1537,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,156,1 or 1A,0,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,99,1,,,,,,,,1,1,7.5,,,1,2,4,26,30,4,4,160,160,4,338,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,1200,Visit4,4,Phase 1/1A,106,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,1400,Visit5,5,Phase 1/1A,134,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,1800,Visit7,7,Phase 2,197,2,100,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,2000,Visit8,8,Phase 2,225,2,100,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,2200,Visit9,9,Phase 2,252,2,94,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,2600,Visit11,11,Phase 3,308,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,2800,Visit12,12,Phase 3,336,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,3000,Visit13,13,Phase 3,364,3,,,,,,6,350,,,1,,,,350,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,3200,Visit14,14,Phase 3,392,3,,,,,,6,350,,,1,,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,3400,Visit15,15,Phase 3,420,3,,,,,,6,350,,,1,,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,3600,Visit16,16,Phase 3,448,3,,,,,,6,350,,,1,,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,3800,Visit17,17,Phase 3,476,3,,,,,,6,350,,,1,,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,169,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,5800,EndofPhase2,10,Phase 2,283,2,95,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ435WLH,1047,,,M,6000,EndofPhase3,18,Phase 3,504,3,,,,,,6,350,,,1,,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,32,3,,,,,,,,3,3,600,,,2,,4,771,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,93,3,,,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,81,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,2200,Visit9,9,Phase 1/1A,250,1 or 1A,100,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,2400,Visit10,10,Phase 1/1A,278,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,3000,Visit13,13,Phase 1/1A,344,1 or 1A,100,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,3200,Visit14,14,Phase 1/1A,375,1 or 1A,100,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,3400,Visit15,15,Phase 1/1A,436,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,3600,Visit16,16,Phase 1/1A,467,1 or 1A,100,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,3800,Visit17,17,Phase 1/1A,498,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFJ584WFN,1673,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,526,1 or 1A,,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,800,Visit2,2,Phase 2,57,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,1000,Visit3,3,Phase 2,78,2,95,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,1200,Visit4,4,Phase 2,113,2,98,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,1400,Visit5,5,Phase 2,141,2,97,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,1600,Visit6,6,Phase 2,169,2,81,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,1800,Visit7,7,Phase 2,197,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,2000,Visit8,8,Phase 2,232,2,75,3,,1,,,,,,2,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,2200,Visit9,9,Phase 2,260,2,92,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,2400,Visit10,10,Phase 2,288,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,2600,Visit11,11,Phase 2,323,2,,3,,1,,,,,,,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,2800,Visit12,12,Phase 2,351,2,63,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,3000,Visit13,13,Phase 2,379,2,60,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,3200,Visit14,14,Phase 2,424,2,47,4,,1,,,,,,3,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,3400,Visit15,15,Phase 2,445,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,3600,Visit16,16,Phase 2,473,2,77,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,3800,Visit17,17,Phase 2,501,2,87,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,85,3,,1,,,,,,1,3,120,,,2,2,3,120,120,3,4,5,6,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK153TFZ,1940,,,M,5800,EndofPhase2,18,Phase 2,522,2,88,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,3,21,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,89,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,90,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,92,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,94,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,90,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,87,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,90,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,2200,Visit9,9,Phase 1/1A,259,1 or 1A,84,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,2400,Visit10,10,Phase 1/1A,287,1 or 1A,83,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,2600,Visit11,11,Phase 1/1A,315,1 or 1A,82,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,2800,Visit12,12,Phase 1/1A,350,1 or 1A,84,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,3000,Visit13,13,Phase 1/1A,371,1 or 1A,87,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,3200,Visit14,14,Phase 1/1A,406,1 or 1A,81,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,3400,Visit15,15,Phase 1/1A,433,1 or 1A,77,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,3600,Visit16,16,Phase 1/1A,462,1 or 1A,86,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,3800,Visit17,17,Phase 1/1A,490,1 or 1A,80,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK259LWB,1435,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,516,1 or 1A,80,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,800,Visit2,2,Phase 2,64,2,71,5,,,,,,,,2,5,,37.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,1000,Visit3,3,Phase 2,92,2,88,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,1200,Visit4,4,Phase 2,112,2,89,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,1400,Visit5,5,Phase 2,146,2,74,4,,,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,1600,Visit6,6,Phase 2,170,2,44,4,,,,,,,,3,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,1800,Visit7,7,Phase 2,196,2,90,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,2200,Visit9,9,Phase 3,253,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,2800,Visit12,12,Phase 3,337,3,,,,,,1,60,,,1,,,,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,1,60,,,1,,,,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,1,70,,,1,,,,70,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,3400,Visit15,15,Phase 3,420,3,,,,,,1,70,,,1,,,,70,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,1,80,,,1,,,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,1,80,,,2,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,4000,Visit18,18,Phase 3,505,3,,,,,,1,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,35,1 or 1A,91,4,,,,,,,,2,4,6,,,2,2,4,6,6,4,4,31,30,4,63,80,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFK650RWP,1433,,,M,5800,EndofPhase2,8,Phase 2,217,2,79,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL285LWJ,1441,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,2,,,,,,,,2,2,400,,,2,3,2,400,400,2,0,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL285LWJ,1441,,,M,1000,Visit3,3,Phase 2,91,2,0,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL285LWJ,1441,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,63,1 or 1A,88,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL285LWJ,1441,,,M,5800,EndofPhase2,4,Phase 2,117,2,0,0,,,,,,,,3,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL458KWF,2096,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,95,4,,,,,,,,1,4,800,,,2,1,4,800,800,4,4,29,30,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,1000,Visit3,3,Phase 2,93,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,1200,Visit4,4,Phase 2,122,2,97,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,1400,Visit5,5,Phase 2,150,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,1600,Visit6,6,Phase 2,183,2,96,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,1800,Visit7,7,Phase 2,206,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,2000,Visit8,8,Phase 2,225,2,89,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,2200,Visit9,9,Phase 2,254,2,93,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,2400,Visit10,10,Phase 2,283,2,93,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,2600,Visit11,11,Phase 2,310,2,96,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,2800,Visit12,12,Phase 2,340,2,90,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,3000,Visit13,13,Phase 2,368,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,3200,Visit14,14,Phase 2,394,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,3400,Visit15,15,Phase 2,428,2,93,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,3600,Visit16,16,Phase 2,451,2,97,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,3800,Visit17,17,Phase 2,478,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,52,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL479VZ4,2101,,,M,5800,EndofPhase2,18,Phase 2,514,2,83,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFL961FTN,2874,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM359CA1,1298,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM392EL1,2090,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,3,,1,,,,,,1,3,600,,,2,,3,675,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM392EL1,2090,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,96,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM392EL1,2090,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,99,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM392EL1,2090,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,97,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM392EL1,2090,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,98,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM392EL1,2090,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM392EL1,2090,,,M,1800,Visit7,7,Phase 1/1A,207,1 or 1A,71,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM392EL1,2090,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,240,1 or 1A,,4,,,,,,,,,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,800,Visit2,2,Phase 2,51,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,1000,Visit3,3,Phase 2,79,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,1200,Visit4,4,Phase 2,107,2,98,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,1400,Visit5,5,Phase 2,135,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,1600,Visit6,6,Phase 2,163,2,96,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,1800,Visit7,7,Phase 2,191,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,2000,Visit8,8,Phase 2,219,2,,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,2600,Visit11,11,Phase 3,296,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,2800,Visit12,12,Phase 3,323,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,3000,Visit13,13,Phase 3,352,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,3200,Visit14,14,Phase 3,381,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,3400,Visit15,15,Phase 3,410,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,3600,Visit16,16,Phase 3,441,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,3800,Visit17,17,Phase 3,470,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,22,1 or 1A,,4,,1,,,,,,1,4,800,,,2,2,4,800,800,4,4,6,6,4,40,40,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,5800,EndofPhase2,9,Phase 2,253,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM522XE7,2600,,,M,6000,EndofPhase3,18,Phase 3,500,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,1,4,720,800,4,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,1000,Visit3,3,Phase 1/1A,81,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,1600,Visit6,6,Phase 2,175,2,91,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,1800,Visit7,7,Phase 2,199,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,2000,Visit8,8,Phase 2,228,2,93,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,2200,Visit9,9,Phase 2,253,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,2400,Visit10,10,Phase 2,281,2,96,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,2600,Visit11,11,Phase 2,309,2,79,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,2800,Visit12,12,Phase 2,337,2,93,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,3000,Visit13,13,Phase 2,365,2,89,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,3200,Visit14,14,Phase 2,392,2,85,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,3400,Visit15,15,Phase 2,421,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,3600,Visit16,16,Phase 2,448,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,3800,Visit17,17,Phase 2,476,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,5200,EndofPhase1_1a,5,Phase 1/1A,141,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM531ULK,2298,,,F,5800,EndofPhase2,18,Phase 2,507,2,94,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,1,,,,,,1,4,160,,,1,,4,160,160,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,96,4,,1,,,,,,,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,89,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,86,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,58,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,1600,Visit6,6,Phase 1/1A,186,1 or 1A,82,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,1800,Visit7,7,Phase 1/1A,212,1 or 1A,83,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,48,4,,1,,,,,,3,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,2600,Visit11,11,Phase 1/1A,312,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,97,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,3200,Visit14,14,Phase 1/1A,396,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,3400,Visit15,15,Phase 1/1A,424,1 or 1A,93,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,3600,Visit16,16,Phase 1/1A,459,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,3800,Visit17,17,Phase 1/1A,487,1 or 1A,99,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM934MZ4,2493,,,M,4000,Visit18,18,Phase 1/1A,527,1 or 1A,79,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,800,Visit2,2,Phase 2,40,2,44,2,,1,,,,,,3,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,1000,Visit3,3,Phase 2,60,2,88,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,1200,Visit4,4,Phase 2,95,2,50,2,,1,,,,,,3,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,1400,Visit5,5,Phase 2,134,2,,2,,1,,,,,,4,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,1800,Visit7,7,Phase 3,172,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,2000,Visit8,8,Phase 3,207,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,2200,Visit9,9,Phase 3,242,3,,,,,,8,10,,,2,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,2400,Visit10,10,Phase 3,257,3,,,,,,8,10,,,3,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,2600,Visit11,11,Phase 3,284,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,2800,Visit12,12,Phase 3,312,3,,,,,,8,15,,,2,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,3000,Visit13,13,Phase 3,354,3,,,,,,8,15,,,2,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,3200,Visit14,14,Phase 3,368,3,,,,,,8,15,,,,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,3400,Visit15,15,Phase 3,396,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,3600,Visit16,16,Phase 3,424,3,,,,,,8,15,,,,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,3800,Visit17,17,Phase 3,459,3,,,,,,8,15,,,,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,19,1 or 1A,97,2,,1,,,,,,1,2,80,,,2,2,2,80,80,2,2,3,3,2,13,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,5800,EndofPhase2,6,Phase 2,143,2,54,2,,1,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFM962PD0,2701,,,F,6000,EndofPhase3,18,Phase 3,494,3,,,,,,8,15,,,,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,98,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,98,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,2400,Visit10,10,Phase 1/1A,283,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,2600,Visit11,11,Phase 1/1A,311,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,2800,Visit12,12,Phase 1/1A,341,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,3000,Visit13,13,Phase 1/1A,367,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,3400,Visit15,15,Phase 1/1A,424,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,3600,Visit16,16,Phase 1/1A,457,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,3800,Visit17,17,Phase 1/1A,480,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,4000,Visit18,18,Phase 1/1A,508,1 or 1A,99,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN167BKZ,2486,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,508,1 or 1A,99,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN226EVK,2337,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,78,2,,0,1,,,,,1,2,80,,,1,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN226EVK,2337,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,61,2,,0,1,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,80,,,1,,3,118,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,1200,Visit4,4,Phase 1/1A,125,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,1400,Visit5,5,Phase 1/1A,155,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,1800,Visit7,7,Phase 1/1A,213,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,2000,Visit8,8,Phase 1/1A,239,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,2200,Visit9,9,Phase 1/1A,268,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,2400,Visit10,10,Phase 1/1A,297,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,2600,Visit11,11,Phase 1/1A,332,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,2800,Visit12,12,Phase 1/1A,379,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,3200,Visit14,14,Phase 1/1A,408,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,3400,Visit15,15,Phase 1/1A,443,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN882TCD,2502,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFN914PW3,2855,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,1,1,,0,1,,,,,4,1,40,,,1,,1,40,40,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,3,21,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,94,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,97,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,2600,Visit11,11,Phase 1/1A,323,1 or 1A,70,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,95,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,3400,Visit15,15,Phase 1/1A,423,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,99,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR442UTU,2360,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,504,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFR884UTW,2346,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,,3,21,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,99,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,89,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,1,,,,,,4,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,100,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,3200,Visit14,14,Phase 1/1A,403,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,3600,Visit16,16,Phase 1/1A,454,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT510FGU,2264,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT523DFX,1446,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT695GH1,1832,,,M,800,Visit2,2,Phase 2,60,2,,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT695GH1,1832,,,M,1000,Visit3,3,Phase 2,94,2,55,2,,,,,,,,2,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT695GH1,1832,,,M,1200,Visit4,4,Phase 2,122,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT695GH1,1832,,,M,1800,Visit7,7,Phase 3,206,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT695GH1,1832,,,M,2000,Visit8,8,Phase 3,221,3,,,,,,1,5,1,10,3,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT695GH1,1832,,,M,2200,Visit9,9,Phase 3,284,3,,,,,,1,5,1,10,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT695GH1,1832,,,M,2400,Visit10,10,Phase 3,305,3,,,,,,1,10,1,5,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT695GH1,1832,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,31,1 or 1A,10,2,,1,,,,,,4,2,3,,,2,2,2,3,3,2,2,400,400,2,14,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFT695GH1,1832,,,M,5800,EndofPhase2,6,Phase 2,169,2,95,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU277HDV,1841,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,5,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,600,Visit1,1,Phase 1/1A,66,1 or 1A,100,4,,1,,,,,,1,4,30,,,1,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,800,Visit2,2,Phase 1/1A,94,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,1000,Visit3,3,Phase 1/1A,121,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,1200,Visit4,4,Phase 1/1A,149,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,1400,Visit5,5,Phase 1/1A,176,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,1600,Visit6,6,Phase 1/1A,198,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,1800,Visit7,7,Phase 1/1A,224,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,2000,Visit8,8,Phase 1/1A,252,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,2200,Visit9,9,Phase 1/1A,280,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,2400,Visit10,10,Phase 1/1A,309,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,2600,Visit11,11,Phase 1/1A,337,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,2800,Visit12,12,Phase 1/1A,365,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,3000,Visit13,13,Phase 1/1A,393,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,3200,Visit14,14,Phase 1/1A,421,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,3400,Visit15,15,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,3600,Visit16,16,Phase 1/1A,477,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,3800,Visit17,17,Phase 1/1A,505,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU434HRE,1988,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,540,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU536JPY,2347,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,93,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,93,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,95,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,96,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,97,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,3800,Visit17,17,Phase 1/1A,481,1 or 1A,93,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFU741DDC,1526,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,498,1 or 1A,88,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV244VJY,2646,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,88,1,,1,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV244VJY,2646,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,40,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,,3,,1,,,,,,,3,22.5,,,2,,2,18,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,,3,,1,,,,,,,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,1000,Visit3,3,Phase 1/1A,87,1 or 1A,,2,,,,,,,,,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,1200,Visit4,4,Phase 1/1A,115,1 or 1A,,2,,1,,,,,,,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,1400,Visit5,5,Phase 1/1A,143,1 or 1A,,2,,1,,,,,,,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,1600,Visit6,6,Phase 1/1A,171,1 or 1A,,2,,,,,,,,,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,1800,Visit7,7,Phase 1/1A,199,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,2000,Visit8,8,Phase 1/1A,227,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,2200,Visit9,9,Phase 1/1A,255,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,2400,Visit10,10,Phase 1/1A,282,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,2600,Visit11,11,Phase 1/1A,311,1 or 1A,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,2800,Visit12,12,Phase 1/1A,339,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,3000,Visit13,13,Phase 1/1A,367,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,3200,Visit14,14,Phase 1/1A,395,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,3400,Visit15,15,Phase 1/1A,423,1 or 1A,89,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,3600,Visit16,16,Phase 1/1A,451,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,3800,Visit17,17,Phase 1/1A,481,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV469UJQ,2498,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,508,1 or 1A,,3,,,,,,,,,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,76,2,,1,,,,,,2,2,80,,,2,2,3,120,120,3,4,800,800,4,7,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,1000,Visit3,3,Phase 2,87,2,94,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,1200,Visit4,4,Phase 2,115,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,1400,Visit5,5,Phase 2,143,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,1600,Visit6,6,Phase 2,175,2,84,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,1800,Visit7,7,Phase 2,206,2,90,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,2200,Visit9,9,Phase 3,268,3,,,,,,3,6,,,2,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,2400,Visit10,10,Phase 3,296,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,2600,Visit11,11,Phase 3,328,3,,,,,,3,6,,,2,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,2800,Visit12,12,Phase 3,357,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,3000,Visit13,13,Phase 3,388,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,3200,Visit14,14,Phase 3,419,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,3600,Visit16,16,Phase 3,478,3,,,,,,3,6,3,6,2,,,,12,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,3800,Visit17,17,Phase 3,507,3,,,,,,3,9,,,1,,,,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,4000,Visit18,18,Phase 3,539,3,,,,,,3,9,,,1,,,,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,59,1 or 1A,99,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFV746EA1,1875,,,M,5800,EndofPhase2,8,Phase 2,233,2,96,4,,1,,,,,,2,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,16,,,2,2,2,16,16,2,1,40,40,1,163,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,80,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,84,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,1400,Visit5,5,Phase 1B,148,1B,84,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,1800,Visit7,7,Phase 2,197,2,,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,2000,Visit8,8,Phase 2,225,2,,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,2200,Visit9,9,Phase 2,253,2,,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,2400,Visit10,10,Phase 2,281,2,,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,2600,Visit11,11,Phase 2,309,2,,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,2800,Visit12,12,Phase 2,337,2,,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,3400,Visit15,15,Phase 3,435,3,,,,,,2,200,,,,,,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,3600,Visit16,16,Phase 3,442,3,,,,,,2,50,,,,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,2,200,,,,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,113,1 or 1A,76,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,5400,EndofPhase1b,6,Phase 1B,162,1B,87,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,5800,EndofPhase2,13,Phase 2,365,2,71,1,,1,,,,,,2,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW120DLR,2645,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,2,200,,,3,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,84,2,,1,,,,,,1,2,15,,,1,1,3,19,19,3,1,40,40,1,19,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,1200,Visit4,4,Phase 3,103,3,,,,,,1,20,1,0,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,1400,Visit5,5,Phase 3,131,3,,,,,,1,20,1,5,1,,,,25,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,1600,Visit6,6,Phase 3,159,3,,,,,,1,25,,,2,,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,1800,Visit7,7,Phase 3,187,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,2000,Visit8,8,Phase 3,222,3,,,,,,1,25,,,1,,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,2200,Visit9,9,Phase 3,280,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,2400,Visit10,10,Phase 3,308,3,,,,,,1,15,,,2,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,2600,Visit11,11,Phase 3,341,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,3000,Visit13,13,Phase 3,372,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,47,1 or 1A,44,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,5800,EndofPhase2,3,Phase 2,58,2,25,1,,0,1,,,,,4,1,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW298YL1,2256,,,M,6000,EndofPhase3,15,Phase 3,408,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW318LE5,2697,,,M,800,Visit2,2,Phase 2,56,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW318LE5,2697,,,M,1000,Visit3,3,Phase 2,85,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW318LE5,2697,,,M,1200,Visit4,4,Phase 2,112,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW318LE5,2697,,,M,1400,Visit5,5,Phase 2,141,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFW318LE5,2697,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,20,1 or 1A,22,2,,1,,,,,,4,2,80,,,2,1,2,80,80,2,2,15,15,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX031DT7,1487,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,98,2,,,,,,,,1,2,3,,,2,2,2,3,3,2,2,11,11,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX031DT7,1487,,,M,1000,Visit3,3,Phase 2,101,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX031DT7,1487,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,75,1 or 1A,45,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX031DT7,1487,,,M,5800,EndofPhase2,4,Phase 2,141,2,19,1,,,,,,,,4,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,,,,,,,1,3,22.5,,,2,,3,22,23,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,1600,Visit6,6,Phase 1/1A,179,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,1800,Visit7,7,Phase 1/1A,212,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,2000,Visit8,8,Phase 1/1A,240,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,2200,Visit9,9,Phase 1/1A,268,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,2400,Visit10,10,Phase 1/1A,295,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,2600,Visit11,11,Phase 1/1A,324,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,2800,Visit12,12,Phase 1/1A,352,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,3000,Visit13,13,Phase 1/1A,379,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,3200,Visit14,14,Phase 1/1A,408,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,3400,Visit15,15,Phase 1/1A,435,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,3600,Visit16,16,Phase 1/1A,464,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,3800,Visit17,17,Phase 1/1A,485,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX309XU6,1488,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,507,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,24,,,2,,2,20,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,99,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,91,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,90,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,2000,Visit8,8,Phase 1/1A,230,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,2200,Visit9,9,Phase 1/1A,272,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,2600,Visit11,11,Phase 1/1A,307,1 or 1A,98,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,2800,Visit12,12,Phase 1/1A,342,1 or 1A,94,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,3000,Visit13,13,Phase 1/1A,370,1 or 1A,90,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,3200,Visit14,14,Phase 1/1A,399,1 or 1A,82,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,3400,Visit15,15,Phase 1/1A,439,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,3800,Visit17,17,Phase 1/1A,468,1 or 1A,79,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX734PNM,2203,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,495,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,4,778,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,93,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,91,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,95,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,93,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,95,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,2200,Visit9,9,Phase 1/1A,259,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,97,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,93,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,95,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,95,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,89,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,3800,Visit17,17,Phase 1/1A,480,1 or 1A,84,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFX938WMQ,1440,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,501,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY588YCY,1426,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,98,4,,,,,,,,1,4,6,,,2,1,3,4,3,3,3,633,800,3,80,80,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY588YCY,1426,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY588YCY,1426,,,F,1000,Visit3,3,Phase 1/1A,80,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY588YCY,1426,,,F,1200,Visit4,4,Phase 1/1A,109,1 or 1A,84,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY588YCY,1426,,,F,1600,Visit6,6,Phase 2,155,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY588YCY,1426,,,F,1800,Visit7,7,Phase 2,184,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY588YCY,1426,,,F,2000,Visit8,8,Phase 2,211,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY588YCY,1426,,,F,2200,Visit9,9,Phase 2,247,2,96,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY588YCY,1426,,,F,2400,Visit10,10,Phase 2,291,2,96,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY588YCY,1426,,,F,5200,EndofPhase1_1a,5,Phase 1/1A,122,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY588YCY,1426,,,F,5800,EndofPhase2,11,Phase 2,318,2,94,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY588YCY,1426,,,F,6000,EndofPhase3,12,Phase 3,361,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY880WZZ,1996,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,97,3,,,,,,,,1,3,22.5,,,1,2,3,23,23,3,4,800,800,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFY880WZZ,1996,,,M,5800,EndofPhase2,2,Phase 2,55,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ214BJY,2231,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,30,2,,1,,,,,,3,2,400,,,2,2,2,400,400,2,2,80,80,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ214BJY,2231,,,M,5800,EndofPhase2,1,Phase 2,31,2,8,2,,1,,,,,,4,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ430VY8,1332,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,30,,,1,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ430VY8,1332,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ430VY8,1332,,,M,1000,Visit3,3,Phase 1/1A,82,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ430VY8,1332,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ430VY8,1332,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,800,Visit2,2,Phase 2,51,2,85,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,1000,Visit3,3,Phase 2,85,2,96,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,1200,Visit4,4,Phase 2,114,2,95,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,1400,Visit5,5,Phase 2,141,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,1600,Visit6,6,Phase 2,170,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,1800,Visit7,7,Phase 2,205,2,90,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,2000,Visit8,8,Phase 2,226,2,95,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,2200,Visit9,9,Phase 2,253,2,74,2,,1,,,,,,2,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,2400,Visit10,10,Phase 2,281,2,77,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,2600,Visit11,11,Phase 2,316,2,90,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,2800,Visit12,12,Phase 2,343,2,76,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,3000,Visit13,13,Phase 2,371,2,89,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,3200,Visit14,14,Phase 2,392,2,79,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,28,1 or 1A,75,2,,,,,,,,2,2,3,,,2,2,2,3,3,2,2,83,80,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ895JUJ,1956,,,M,5800,EndofPhase2,15,Phase 2,425,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ972MUM,2534,,,M,600,Visit1,1,Phase 1/1A,33,,,,,,,,,,,1,,,,,2,2,4,6,6,4,4,160,160,4,16,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ972MUM,2534,,,M,1000,Visit3,3,Phase 3,78,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ972MUM,2534,,,M,1200,Visit4,4,Phase 3,113,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ972MUM,2534,,,M,1400,Visit5,5,Phase 3,137,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ972MUM,2534,,,M,1600,Visit6,6,Phase 3,169,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ972MUM,2534,,,M,1800,Visit7,7,Phase 3,197,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ972MUM,2534,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ972MUM,2534,,,M,2200,Visit9,9,Phase 3,253,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ972MUM,2534,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,33,1 or 1A,92,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ972MUM,2534,,,M,5800,EndofPhase2,2,Phase 2,46,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVFZ972MUM,2534,,,M,6000,EndofPhase3,10,Phase 3,269,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA266WDV,2324,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,8,1 or 1A,57,2,,1,,,,,,2,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,600,Visit1,1,Phase 1/1A,17,1 or 1A,84,2,,1,,,,,,1,2,400,,,2,2,4,760,800,4,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,800,Visit2,2,Phase 1/1A,45,1 or 1A,68,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,1000,Visit3,3,Phase 1/1A,75,1 or 1A,,,,1,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,1200,Visit4,4,Phase 1/1A,107,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,1400,Visit5,5,Phase 1/1A,136,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,1600,Visit6,6,Phase 1/1A,164,1 or 1A,,4,,1,,,,,,,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,1800,Visit7,7,Phase 1/1A,193,1 or 1A,100,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,2000,Visit8,8,Phase 1/1A,221,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,2200,Visit9,9,Phase 1/1A,249,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,2400,Visit10,10,Phase 1/1A,277,1 or 1A,98,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,2600,Visit11,11,Phase 2,318,2,88,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,2800,Visit12,12,Phase 2,338,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,3000,Visit13,13,Phase 2,366,2,96,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,3200,Visit14,14,Phase 2,394,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,3400,Visit15,15,Phase 2,425,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,3600,Visit16,16,Phase 2,452,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,3800,Visit17,17,Phase 2,480,2,100,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,4000,Visit18,18,Phase 2,509,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA436AXV,2487,,,F,5200,EndofPhase1_1a,10,Phase 1/1A,288,1 or 1A,100,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA561LML,2367,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,15,1 or 1A,97,3,,1,,,,,,1,3,600,,,2,,3,600,600,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA783TCP,2239,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,1,,,,,,1,4,32,,,2,3,2,19,16,2,3,100,100,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA783TCP,2239,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA783TCP,2239,,,F,1200,Visit4,4,Phase 1B,112,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA783TCP,2239,,,F,1400,Visit5,5,Phase 1B,142,1B,82,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA783TCP,2239,,,F,1600,Visit6,6,Phase 1B,170,1B,93,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA783TCP,2239,,,F,1800,Visit7,7,Phase 1B,204,1B,84,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA783TCP,2239,,,F,2000,Visit8,8,Phase 1B,233,1B,94,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA783TCP,2239,,,F,2400,Visit10,10,Phase 2,266,2,95,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA783TCP,2239,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,80,1 or 1A,96,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA783TCP,2239,,,F,5400,EndofPhase1b,9,Phase 1B,240,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGA783TCP,2239,,,F,5800,EndofPhase2,11,Phase 2,296,2,89,,100,,,,,,,1,,,100,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB277FD7,2573,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,1,,,,,,1,4,6,,,2,2,4,6,6,4,4,800,800,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB277FD7,2573,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,98,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB277FD7,2573,,,F,1200,Visit4,4,Phase 2,113,2,88,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB277FD7,2573,,,F,1400,Visit5,5,Phase 2,141,2,82,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB277FD7,2573,,,F,1600,Visit6,6,Phase 2,169,2,86,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB277FD7,2573,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,85,1 or 1A,77,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB507BG6,1304,,,M,600,Visit1,1,Phase 1/1A,41,1 or 1A,,2,,1,,,,,,1,2,16,,,2,,1,11,16,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB507BG6,1304,,,M,800,Visit2,2,Phase 1/1A,78,1 or 1A,,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB507BG6,1304,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,106,1 or 1A,,0,,1,,,,,,4,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,4,,,,,,,,1,4,800,,,2,2,4,800,800,4,4,30,30,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,800,Visit2,2,Phase 1/1A,54,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,1200,Visit4,4,Phase 2,109,2,100,,0,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,1400,Visit5,5,Phase 2,137,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,1600,Visit6,6,Phase 2,168,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,1800,Visit7,7,Phase 2,193,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,2000,Visit8,8,Phase 2,221,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,2200,Visit9,9,Phase 2,249,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,2400,Visit10,10,Phase 2,277,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,2600,Visit11,11,Phase 2,305,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,2800,Visit12,12,Phase 2,332,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,3000,Visit13,13,Phase 2,361,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,3200,Visit14,14,Phase 2,389,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,3400,Visit15,15,Phase 2,417,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,3600,Visit16,16,Phase 2,445,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,3800,Visit17,17,Phase 2,474,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,82,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB626CFZ,2044,,,F,5800,EndofPhase2,18,Phase 2,495,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,4,756,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,98,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,1000,Visit3,3,Phase 1/1A,80,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,1200,Visit4,4,Phase 1/1A,106,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,1400,Visit5,5,Phase 1/1A,134,1 or 1A,98,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,1600,Visit6,6,Phase 1/1A,162,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,1800,Visit7,7,Phase 1/1A,192,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,2400,Visit10,10,Phase 1/1A,279,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,2800,Visit12,12,Phase 1/1A,335,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,3000,Visit13,13,Phase 1/1A,360,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,3200,Visit14,14,Phase 1/1A,384,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,3400,Visit15,15,Phase 1/1A,412,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,3600,Visit16,16,Phase 1/1A,440,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,3800,Visit17,17,Phase 1/1A,468,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGB837GF0,1684,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,483,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGC368ZBX,2056,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGC370XVE,2746,,,M,600,Visit1,1,Phase 1/1A,23,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD188VYU,1473,,,M,5200,EndofPhase1_1a,0,Phase 1/1A,1,1 or 1A,0,2,,,,,,,,4,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,85,2,,1,,,,,,1,2,3,,,1,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,95,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,99,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,2600,Visit11,11,Phase 1/1A,315,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,2800,Visit12,12,Phase 1/1A,351,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,3200,Visit14,14,Phase 1/1A,401,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,3400,Visit15,15,Phase 1/1A,429,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,3600,Visit16,16,Phase 1/1A,456,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,3800,Visit17,17,Phase 1/1A,489,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD295DGB,2121,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,524,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD673HLR,2780,,,F,5200,EndofPhase1_1a,0,Phase 1/1A,1,1 or 1A,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,81,2,,1,,,,,,2,2,80,,,2,,4,153,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,90,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,99,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,99,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,1600,Visit6,6,Phase 1/1A,179,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,1800,Visit7,7,Phase 1/1A,209,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,95,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD726PWP,2403,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,504,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGD984LDX,2627,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,88,3,,1,,,,,,1,3,4.5,,,2,,4,5,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,99,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,99,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,2400,Visit10,10,Phase 1/1A,279,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,99,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,3000,Visit13,13,Phase 1/1A,358,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,3200,Visit14,14,Phase 1/1A,386,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGE627LK8,2022,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF264JYH,2550,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,0,1,,,,,1,2,80,,,1,,4,150,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF264JYH,2550,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF264JYH,2550,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF264JYH,2550,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF264JYH,2550,,,F,1400,Visit5,5,Phase 1/1A,150,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF264JYH,2550,,,F,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF264JYH,2550,,,F,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF264JYH,2550,,,F,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF264JYH,2550,,,F,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF264JYH,2550,,,F,2400,Visit10,10,Phase 1/1A,289,1 or 1A,100,3,,0,1,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF264JYH,2550,,,F,2600,Visit11,11,Phase 1/1A,317,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF264JYH,2550,,,F,5200,EndofPhase1_1a,12,Phase 1/1A,352,1 or 1A,89,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF423NNG,2429,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,90,4,,1,,,,,,1,4,6,,,2,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF423NNG,2429,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF423NNG,2429,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,70,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,2,2,,,,,,,,1,2,3,,,1,1,3,4,4,3,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,1000,Visit3,3,Phase 2,74,2,100,2,,,,,,,,2,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,1200,Visit4,4,Phase 2,102,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,1400,Visit5,5,Phase 2,129,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,1600,Visit6,6,Phase 2,157,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,1800,Visit7,7,Phase 2,185,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,2000,Visit8,8,Phase 2,221,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,2200,Visit9,9,Phase 2,256,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,2400,Visit10,10,Phase 2,281,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,2600,Visit11,11,Phase 2,309,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,2800,Visit12,12,Phase 2,338,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,3000,Visit13,13,Phase 2,361,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,3200,Visit14,14,Phase 2,393,2,97,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,3400,Visit15,15,Phase 2,421,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,3600,Visit16,16,Phase 2,451,2,93,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,3800,Visit17,17,Phase 2,477,2,92,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,50,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF724XM4,1267,,,M,5800,EndofPhase2,18,Phase 2,505,2,100,2,,0,1,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF972PJA,1719,,,M,600,Visit1,1,Phase 1/1A,44,1 or 1A,100,4,,,,,,,,1,4,6,,,1,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF972PJA,1719,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF972PJA,1719,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF972PJA,1719,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF972PJA,1719,,,M,1400,Visit5,5,Phase 1/1A,168,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF972PJA,1719,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF972PJA,1719,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF972PJA,1719,,,M,2000,Visit8,8,Phase 1/1A,235,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGF972PJA,1719,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,267,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,30,,,2,3,4,30,30,4,,198,200,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,1000,Visit3,3,Phase 2,86,2,100,,25,,,,,,,1,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,1200,Visit4,4,Phase 2,113,2,100,,225,,,,,,,1,,,225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,1400,Visit5,5,Phase 2,143,2,91,,225,,,,,,,1,,,225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,1600,Visit6,6,Phase 2,171,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,1800,Visit7,7,Phase 2,199,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,2000,Visit8,8,Phase 2,225,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,2200,Visit9,9,Phase 2,261,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,2400,Visit10,10,Phase 2,282,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,2600,Visit11,11,Phase 2,310,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,2800,Visit12,12,Phase 2,338,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,3000,Visit13,13,Phase 2,367,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,3200,Visit14,14,Phase 2,395,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,3400,Visit15,15,Phase 2,416,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,3600,Visit16,16,Phase 2,444,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,3800,Visit17,17,Phase 2,472,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,33,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG222FPL,1812,,,M,5800,EndofPhase2,18,Phase 2,507,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG654MFF,1281,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,84,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG654MFF,1281,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,92,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG654MFF,1281,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,7,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG654MFF,1281,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,169,1 or 1A,41,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,1,,,,,,,,1,1,1.5,,,1,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,2200,Visit9,9,Phase 1/1A,257,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,2600,Visit11,11,Phase 1/1A,312,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,2800,Visit12,12,Phase 1/1A,345,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,3000,Visit13,13,Phase 1/1A,373,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,3200,Visit14,14,Phase 1/1A,401,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,3400,Visit15,15,Phase 1/1A,443,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,3600,Visit16,16,Phase 1/1A,466,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,3800,Visit17,17,Phase 1/1A,494,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGG739HTG,1133,,,M,4000,Visit18,18,Phase 1/1A,522,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,800,,,2,,4,800,800,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,95,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,97,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,3600,Visit16,16,Phase 1/1A,455,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH230GEQ,1620,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,490,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,90,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,90,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,94,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,1600,Visit6,6,Phase 1/1A,171,1 or 1A,80,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,75,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,82,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,2200,Visit9,9,Phase 1/1A,248,1 or 1A,83,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,85,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,93,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,91,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,93,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,86,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH248AVE,2424,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,498,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,86,3,,1,,,,,,1,3,120,,,2,,4,146,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,60,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,97,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,91,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,97,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,2800,Visit12,12,Phase 1/1A,339,1 or 1A,99,0,,1,,,,,,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,91,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,95,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,88,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH606WVP,2357,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,506,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,2,3,26,30,3,3,5,5,3,600,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,800,Visit2,2,Phase 1/1A,66,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,1000,Visit3,3,Phase 1/1A,98,1 or 1A,,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,2000,Visit8,8,Phase 1/1A,245,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,2600,Visit11,11,Phase 3,330,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,2800,Visit12,12,Phase 3,367,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,3000,Visit13,13,Phase 3,395,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,3200,Visit14,14,Phase 3,427,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,3400,Visit15,15,Phase 3,462,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,3600,Visit16,16,Phase 3,489,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,3800,Visit17,17,Phase 3,520,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,4000,Visit18,18,Phase 3,549,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,279,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGH764EWK,1596,,,M,5800,EndofPhase2,10,Phase 2,295,2,,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ199ACH,1160,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ199ACH,1160,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,89,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ199ACH,1160,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,79,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ199ACH,1160,,,M,1200,Visit4,4,Phase 1/1A,126,1 or 1A,95,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ199ACH,1160,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,80,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ199ACH,1160,,,M,1800,Visit7,7,Phase 1/1A,202,1 or 1A,81,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,84,3,,1,,,,,,1,3,4.5,,,1,,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,64,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,1000,Visit3,3,Phase 1/1A,87,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,1200,Visit4,4,Phase 1/1A,115,1 or 1A,82,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,1400,Visit5,5,Phase 1/1A,143,1 or 1A,93,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,1600,Visit6,6,Phase 1/1A,171,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,92,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,2000,Visit8,8,Phase 1/1A,227,1 or 1A,97,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,2200,Visit9,9,Phase 1/1A,254,1 or 1A,,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,2400,Visit10,10,Phase 1/1A,282,1 or 1A,90,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,93,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,2800,Visit12,12,Phase 1/1A,341,1 or 1A,97,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,3000,Visit13,13,Phase 1/1A,366,1 or 1A,84,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,3400,Visit15,15,Phase 1/1A,418,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,87,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ423FAB,2879,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,501,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,70,1,,,,,,,,2,1,1.5,,,2,1,2,3,3,2,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,71,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,1000,Visit3,3,Phase 1/1A,106,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,1200,Visit4,4,Phase 1/1A,127,1 or 1A,57,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,64,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,37,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,68,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,82,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,2800,Visit12,12,Phase 2,337,2,75,2,,,,,,,,2,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,3000,Visit13,13,Phase 2,358,2,95,2,,0,1,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,3200,Visit14,14,Phase 2,393,2,83,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,3400,Visit15,15,Phase 2,428,2,,2,,0,1,,,,,,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,3600,Visit16,16,Phase 2,449,2,14,2,,1,,,,,,4,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,3800,Visit17,17,Phase 2,477,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,5200,EndofPhase1_1a,11,Phase 1/1A,309,1 or 1A,63,3,,,,,,,,3,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ830PFP,1519,,,M,5800,EndofPhase2,18,Phase 2,505,2,43,2,,1,,,,,,3,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,600,Visit1,1,Phase 1/1A,45,1 or 1A,89,2,,1,,,,,,1,2,400,,,2,1,3,533,400,3,3,5,6,3,361,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,84,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,1400,Visit5,5,Phase 2,141,2,92,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,1600,Visit6,6,Phase 2,171,2,86,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,1800,Visit7,7,Phase 2,197,2,99,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,2000,Visit8,8,Phase 3,222,3,,,,,,6,175,,,2,,,,175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,2200,Visit9,9,Phase 3,249,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,2400,Visit10,10,Phase 3,276,3,,,,,,6,300,,,2,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,2600,Visit11,11,Phase 3,303,3,,,,,,6,400,,,2,,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,2800,Visit12,12,Phase 3,340,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,3000,Visit13,13,Phase 3,368,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,3200,Visit14,14,Phase 3,397,3,,,,,,6,400,,,2,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,3400,Visit15,15,Phase 3,428,3,,,,,,6,400,,,2,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,3600,Visit16,16,Phase 3,445,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,3800,Visit17,17,Phase 3,472,3,,,,,,6,400,,,2,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,117,1 or 1A,88,4,,1,,,,,,3,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,5800,EndofPhase2,7,Phase 2,197,2,99,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGJ862KM9,2742,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,6,400,,,2,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,800,Visit2,2,Phase 2,58,2,85,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,1000,Visit3,3,Phase 2,104,2,98,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,1200,Visit4,4,Phase 2,126,2,88,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,1400,Visit5,5,Phase 2,154,2,88,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,1800,Visit7,7,Phase 3,196,3,,,,,,8,15,8,15,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,2000,Visit8,8,Phase 3,217,3,,,,,,8,15,8,15,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,2200,Visit9,9,Phase 3,246,3,,,,,,8,15,8,15,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,2400,Visit10,10,Phase 3,282,3,,,,,,8,15,8,15,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,2600,Visit11,11,Phase 3,310,3,,,,,,8,15,8,15,4,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,2800,Visit12,12,Phase 3,338,3,,,,,,8,15,8,15,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,8,20,8,20,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,8,20,8,20,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,3400,Visit15,15,Phase 3,419,3,,,,,,8,20,8,20,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,8,20,8,20,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,3800,Visit17,17,Phase 3,478,3,,,,,,8,20,8,20,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,95,2,,1,,,,,,2,2,3,,,2,2,2,3,3,2,3,600,600,3,35,30,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,5800,EndofPhase2,6,Phase 2,163,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL183LE3,2272,,,M,6000,EndofPhase3,18,Phase 3,509,3,,,,,,8,20,8,20,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL443VDT,2532,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,95,2,,,,,,,,1,2,3,,,2,1,2,3,3,2,1,200,200,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,51,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,85,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,52,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,78,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,2200,Visit9,9,Phase 1/1A,265,1 or 1A,80,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,2600,Visit11,11,Phase 2,335,2,100,1,,0,1,,,,,1,1,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,2800,Visit12,12,Phase 2,356,2,85,1,,0,1,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,3000,Visit13,13,Phase 2,401,2,100,1,,0,1,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,3200,Visit14,14,Phase 2,433,2,100,1,,0,1,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,3400,Visit15,15,Phase 2,463,2,100,1,,0,1,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,3600,Visit16,16,Phase 2,497,2,100,1,,0,1,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,3800,Visit17,17,Phase 2,532,2,100,1,,0,1,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,5200,EndofPhase1_1a,10,Phase 1/1A,296,1 or 1A,50,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL533HMF,2092,,,M,5800,EndofPhase2,18,Phase 2,567,2,100,1,,1,,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,64,2,,,,,,,,2,2,15,,,1,2,2,17,15,2,4,140,120,4,478,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,800,Visit2,2,Phase 1/1A,68,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,70,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,1400,Visit5,5,Phase 2,142,2,85,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,1600,Visit6,6,Phase 2,176,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,1800,Visit7,7,Phase 2,218,2,96,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,2400,Visit10,10,Phase 3,295,3,,,,,,6,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,2600,Visit11,11,Phase 3,323,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,2800,Visit12,12,Phase 3,344,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,3200,Visit14,14,Phase 3,400,3,,,,,,6,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,6,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,114,1 or 1A,97,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,5800,EndofPhase2,9,Phase 2,268,2,97,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL786TZP,1822,,,M,6000,EndofPhase3,18,Phase 3,501,3,,,,,,6,700,,,1,,,,700,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL828YXN,1603,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,,,,,,,1,3,24,,,1,,3,24,24,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL828YXN,1603,,,M,1000,Visit3,3,Phase 1B,85,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL828YXN,1603,,,M,1200,Visit4,4,Phase 1B,113,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL828YXN,1603,,,M,1400,Visit5,5,Phase 1B,142,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL828YXN,1603,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,61,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGL828YXN,1603,,,M,5400,EndofPhase1b,6,Phase 1B,156,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,91,3,,,,,,,,1,3,22.5,,,2,2,3,25,23,3,4,6,6,4,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,89,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,98,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,95,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,95,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,93,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,96,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,97,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,97,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,89,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,4000,Visit18,18,Phase 2,504,2,93,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,4200,Visit19,19,Phase 2,532,2,92,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,4400,Visit20,20,Phase 2,560,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,4800,Visit22,22,Phase 3,616,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,5200,EndofPhase1_1a,17,Phase 1/1A,476,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,5800,EndofPhase2,21,Phase 2,589,2,75,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM160JV7,1639,,,M,6000,EndofPhase3,23,Phase 3,637,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,3,560,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,86,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,75,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,60,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,1400,Visit5,5,Phase 1/1A,151,1 or 1A,92,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,1600,Visit6,6,Phase 1/1A,180,1 or 1A,84,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,1800,Visit7,7,Phase 1/1A,214,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,2000,Visit8,8,Phase 1/1A,243,1 or 1A,93,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,2200,Visit9,9,Phase 1/1A,267,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,2400,Visit10,10,Phase 1/1A,299,1 or 1A,86,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,2600,Visit11,11,Phase 1/1A,327,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,2800,Visit12,12,Phase 1/1A,365,1 or 1A,95,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,3000,Visit13,13,Phase 1/1A,382,1 or 1A,98,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,3200,Visit14,14,Phase 1/1A,396,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM256NLJ,1275,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,530,1 or 1A,0,3,,,,,,,,4,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,3,,,,,,,,1,3,22.5,,,1,1,3,23,23,3,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,1000,Visit3,3,Phase 1/1A,97,1 or 1A,98,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,1800,Visit7,7,Phase 1/1A,208,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,2000,Visit8,8,Phase 1/1A,251,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,2200,Visit9,9,Phase 1/1A,321,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,2400,Visit10,10,Phase 1/1A,354,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,2600,Visit11,11,Phase 1/1A,386,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,2800,Visit12,12,Phase 1/1A,425,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,3000,Visit13,13,Phase 2,460,2,50,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,3200,Visit14,14,Phase 2,494,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,3400,Visit15,15,Phase 2,526,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,3600,Visit16,16,Phase 2,545,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,3800,Visit17,17,Phase 2,588,2,99,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM281VGA,1221,,,M,5800,EndofPhase2,18,Phase 2,623,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM690DLQ,1027,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,4,,,,,,,,1,4,30,,,2,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM690DLQ,1027,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,86,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM690DLQ,1027,,,M,1000,Visit3,3,Phase 1/1A,95,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM690DLQ,1027,,,M,1200,Visit4,4,Phase 1/1A,122,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM690DLQ,1027,,,M,1600,Visit6,6,Phase 1/1A,179,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM690DLQ,1027,,,M,1800,Visit7,7,Phase 1/1A,207,1 or 1A,99,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM690DLQ,1027,,,M,2000,Visit8,8,Phase 1/1A,234,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM690DLQ,1027,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM690DLQ,1027,,,M,2400,Visit10,10,Phase 1/1A,291,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM690DLQ,1027,,,M,2600,Visit11,11,Phase 1/1A,319,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM690DLQ,1027,,,M,2800,Visit12,12,Phase 1/1A,361,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM690DLQ,1027,,,M,3000,Visit13,13,Phase 1/1A,386,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGM690DLQ,1027,,,M,5200,EndofPhase1_1a,14,Phase 1/1A,393,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,76,3,,1,,,,,,1,3,4.5,,,1,2,3,4,5,3,4,26,26,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,93,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,1000,Visit3,3,Phase 1/1A,91,1 or 1A,85,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,1400,Visit5,5,Phase 1/1A,161,1 or 1A,79,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,1600,Visit6,6,Phase 1/1A,189,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,1800,Visit7,7,Phase 1/1A,215,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,2000,Visit8,8,Phase 1/1A,242,1 or 1A,99,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,2200,Visit9,9,Phase 1/1A,270,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,2400,Visit10,10,Phase 1/1A,298,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,2600,Visit11,11,Phase 1/1A,330,1 or 1A,97,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,2800,Visit12,12,Phase 1/1A,363,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,3000,Visit13,13,Phase 1/1A,383,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,3200,Visit14,14,Phase 1/1A,403,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,3400,Visit15,15,Phase 1/1A,424,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,3800,Visit17,17,Phase 2,475,2,55,3,,1,,,,,,2,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,5200,EndofPhase1_1a,16,Phase 1/1A,445,1 or 1A,91,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN326JHD,2397,,,F,5800,EndofPhase2,18,Phase 2,503,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN431PHR,1301,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,76,2,,,,,,,,2,2,3,,,2,2,2,3,3,2,2,400,400,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN431PHR,1301,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,50,1 or 1A,78,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGN431PHR,1301,,,M,5800,EndofPhase2,3,Phase 2,85,2,30,2,,,,,,,,3,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP049NL4,2221,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,21,2,,1,,,,,,4,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP268FVT,2829,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,600,Visit1,1,Phase 1/1A,25,1 or 1A,61,2,,,,,,,,2,2,16,,,1,,3,27,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,800,Visit2,2,Phase 1/1A,44,1 or 1A,74,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,1000,Visit3,3,Phase 1/1A,72,1 or 1A,96,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,1200,Visit4,4,Phase 1/1A,99,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,1400,Visit5,5,Phase 1/1A,127,1 or 1A,98,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,1600,Visit6,6,Phase 1/1A,175,1 or 1A,97,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,1800,Visit7,7,Phase 1/1A,207,1 or 1A,88,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,2000,Visit8,8,Phase 1/1A,235,1 or 1A,79,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,2200,Visit9,9,Phase 1/1A,268,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,2400,Visit10,10,Phase 1/1A,298,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,2600,Visit11,11,Phase 1/1A,322,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,2800,Visit12,12,Phase 1/1A,350,1 or 1A,98,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,3200,Visit14,14,Phase 1/1A,424,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,3400,Visit15,15,Phase 1/1A,452,1 or 1A,71,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,3600,Visit16,16,Phase 1/1A,486,1 or 1A,82,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,3800,Visit17,17,Phase 1/1A,515,1 or 1A,91,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP298BP2,1277,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,543,1 or 1A,98,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,2,2,400,,,1,,4,778,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,95,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,85,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,88,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,15,4,,0,1,,,,,4,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,1600,Visit6,6,Phase 1/1A,179,1 or 1A,66,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,1800,Visit7,7,Phase 1/1A,208,1 or 1A,64,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,2000,Visit8,8,Phase 1/1A,236,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,94,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,80,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,2600,Visit11,11,Phase 1/1A,330,1 or 1A,73,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,2800,Visit12,12,Phase 1/1A,355,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,3000,Visit13,13,Phase 1/1A,379,1 or 1A,81,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,75,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,3400,Visit15,15,Phase 1/1A,424,1 or 1A,81,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGP692MCH,1820,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,509,1 or 1A,92,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,8,,,2,,4,30,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,95,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,90,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,3200,Visit14,14,Phase 1/1A,397,1 or 1A,97,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,87,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR781MY3,1873,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,504,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,800,Visit2,2,Phase 1B,65,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,1000,Visit3,3,Phase 1B,101,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,1200,Visit4,4,Phase 1B,122,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,1400,Visit5,5,Phase 1B,154,1B,92,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,1600,Visit6,6,Phase 1B,190,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,1800,Visit7,7,Phase 1B,219,1B,97,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,2000,Visit8,8,Phase 1B,245,1B,92,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,2200,Visit9,9,Phase 1B,283,1B,97,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,2400,Visit10,10,Phase 1B,309,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,2600,Visit11,11,Phase 1B,346,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,2800,Visit12,12,Phase 1B,372,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,3000,Visit13,13,Phase 1B,402,1B,92,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,3200,Visit14,14,Phase 1B,435,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,3400,Visit15,15,Phase 1B,465,1B,93,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,3600,Visit16,16,Phase 1B,494,1B,97,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,3800,Visit17,17,Phase 1B,532,1B,95,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,14,1 or 1A,75,1,,1,,,,,,1,1,8,,,2,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGR926JV1,2641,,,M,5400,EndofPhase1b,18,Phase 1B,557,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,94,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,1200,Visit4,4,Phase 1/1A,128,1 or 1A,95,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,1400,Visit5,5,Phase 1/1A,154,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,2000,Visit8,8,Phase 1/1A,238,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,2200,Visit9,9,Phase 1/1A,267,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,2400,Visit10,10,Phase 1/1A,294,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,2600,Visit11,11,Phase 1/1A,323,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,2800,Visit12,12,Phase 1/1A,351,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,3000,Visit13,13,Phase 1/1A,374,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,3200,Visit14,14,Phase 1/1A,396,1 or 1A,66,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,3600,Visit16,16,Phase 1/1A,442,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,3800,Visit17,17,Phase 1/1A,470,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT086YUT,1712,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,485,1 or 1A,88,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,3,506,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,1600,Visit6,6,Phase 1/1A,178,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,2000,Visit8,8,Phase 1/1A,238,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,2200,Visit9,9,Phase 1/1A,265,1 or 1A,97,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,2400,Visit10,10,Phase 1/1A,308,1 or 1A,71,3,,,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,2600,Visit11,11,Phase 1/1A,342,1 or 1A,80,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,2800,Visit12,12,Phase 1/1A,372,1 or 1A,77,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,3000,Visit13,13,Phase 1/1A,400,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,3200,Visit14,14,Phase 1/1A,428,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,3600,Visit16,16,Phase 1/1A,483,1 or 1A,75,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,3800,Visit17,17,Phase 1/1A,512,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT145TPG,1085,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,540,1 or 1A,92,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,4,,,,,,,,1,4,6,,,2,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,98,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,1400,Visit5,5,Phase 1/1A,146,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,1800,Visit7,7,Phase 1/1A,194,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,91,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,2200,Visit9,9,Phase 1/1A,257,1 or 1A,39,4,,,,,,,,3,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,2400,Visit10,10,Phase 1/1A,285,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,2600,Visit11,11,Phase 1/1A,313,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,2800,Visit12,12,Phase 1/1A,341,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,3000,Visit13,13,Phase 1/1A,369,1 or 1A,96,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,3200,Visit14,14,Phase 1/1A,397,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,3800,Visit17,17,Phase 1/1A,481,1 or 1A,99,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,4000,Visit18,18,Phase 1/1A,509,1 or 1A,98,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT423PZ6,1185,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,509,1 or 1A,98,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,,,,,,,,,,,,,,2,,3,100,80,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,800,Visit2,2,Phase 1/1A,51,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,1400,Visit5,5,Phase 1/1A,134,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,1600,Visit6,6,Phase 1/1A,162,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,2400,Visit10,10,Phase 1/1A,273,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,2600,Visit11,11,Phase 1/1A,293,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,2800,Visit12,12,Phase 1/1A,328,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,3000,Visit13,13,Phase 1/1A,355,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,3200,Visit14,14,Phase 1/1A,383,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,3400,Visit15,15,Phase 1/1A,411,1 or 1A,,3,,,,,,,,,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,3600,Visit16,16,Phase 1/1A,446,1 or 1A,97,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT559ECP,2401,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,498,1 or 1A,99,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT705GCV,2577,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,7,1 or 1A,80,2,,1,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,600,Visit1,1,Phase 1/1A,22,1 or 1A,80,4,,1,,,,,,1,4,30,,,2,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,800,Visit2,2,Phase 1/1A,50,1 or 1A,86,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,1000,Visit3,3,Phase 1/1A,81,1 or 1A,,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,1200,Visit4,4,Phase 1/1A,109,1 or 1A,,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,1400,Visit5,5,Phase 1/1A,137,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,1600,Visit6,6,Phase 1/1A,167,1 or 1A,92,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,1800,Visit7,7,Phase 1/1A,190,1 or 1A,75,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,2000,Visit8,8,Phase 1/1A,228,1 or 1A,78,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,2200,Visit9,9,Phase 1/1A,263,1 or 1A,54,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,2400,Visit10,10,Phase 1/1A,291,1 or 1A,58,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,2600,Visit11,11,Phase 1/1A,319,1 or 1A,52,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,2800,Visit12,12,Phase 1/1A,351,1 or 1A,51,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,3000,Visit13,13,Phase 1/1A,386,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,3200,Visit14,14,Phase 1/1A,412,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,3400,Visit15,15,Phase 1/1A,440,1 or 1A,75,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,3600,Visit16,16,Phase 1/1A,469,1 or 1A,94,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,3800,Visit17,17,Phase 1/1A,497,1 or 1A,84,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGT982LLZ,2389,,,F,4000,Visit18,18,Phase 1/1A,526,1 or 1A,100,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,,,,,,,1,3,24,,,2,3,3,26,24,3,4,364,400,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,92,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,1600,Visit6,6,Phase 2,168,2,88,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,1800,Visit7,7,Phase 2,197,2,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,2000,Visit8,8,Phase 2,225,2,96,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,2200,Visit9,9,Phase 2,252,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,2400,Visit10,10,Phase 2,280,2,98,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,2600,Visit11,11,Phase 2,308,2,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,2800,Visit12,12,Phase 2,340,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,3000,Visit13,13,Phase 2,368,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,3200,Visit14,14,Phase 2,396,2,80,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,3400,Visit15,15,Phase 2,424,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,3600,Visit16,16,Phase 2,445,2,100,,300,,,,,,,2,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,3800,Visit17,17,Phase 2,473,2,61,,250,,,,,,,2,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,112,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,5400,EndofPhase1b,5,Phase 1B,139,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU369CLX,1918,,,M,5800,EndofPhase2,18,Phase 2,502,2,100,,250,,,,,,,2,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,,,,,,,1,2,3,,,1,3,3,5,3,3,,277,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,800,Visit2,2,Phase 1/1A,66,1 or 1A,99,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,1600,Visit6,6,Phase 2,176,2,100,,25,,,,,,,1,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,1800,Visit7,7,Phase 2,198,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,2000,Visit8,8,Phase 2,225,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,2200,Visit9,9,Phase 2,261,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,2400,Visit10,10,Phase 2,282,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,2600,Visit11,11,Phase 2,310,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,2800,Visit12,12,Phase 2,344,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,3000,Visit13,13,Phase 2,365,2,100,,300,,,,,,,3,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,3200,Visit14,14,Phase 2,393,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,3600,Visit16,16,Phase 2,451,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,3800,Visit17,17,Phase 2,479,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,4000,Visit18,18,Phase 2,506,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU563FT1,1466,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,136,1 or 1A,88,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,1,,4,29,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,78,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,92,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,,4,,1,,,,,,,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,69,4,,,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,76,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,66,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,66,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,82,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,82,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,81,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,79,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,3000,Visit13,13,Phase 1/1A,366,1 or 1A,69,4,,,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,79,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,3400,Visit15,15,Phase 1/1A,422,1 or 1A,84,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,3600,Visit16,16,Phase 1/1A,450,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,3800,Visit17,17,Phase 1/1A,485,1 or 1A,,4,,,,,,,,,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,4000,Visit18,18,Phase 1/1A,512,1 or 1A,81,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGU638ZYA,1654,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,81,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,89,2,,1,,,,,,1,2,16,,,2,3,4,29,32,4,6,400,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,98,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,1600,Visit6,6,Phase 1B,161,1B,98,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,1800,Visit7,7,Phase 1B,187,1B,50,4,,1,,,,,,3,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,2200,Visit9,9,Phase 2,259,2,85,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,2400,Visit10,10,Phase 2,280,2,95,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,2600,Visit11,11,Phase 2,309,2,98,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,2800,Visit12,12,Phase 2,336,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,3000,Visit13,13,Phase 2,372,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,3200,Visit14,14,Phase 2,396,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,3400,Visit15,15,Phase 2,424,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,3600,Visit16,16,Phase 2,446,2,63,,700,,,,,,,2,,,700,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,3800,Visit17,17,Phase 2,481,2,,7,,1,,,,,,1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,127,1 or 1A,98,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,5400,EndofPhase1b,8,Phase 1B,228,1B,,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV401TKA,1929,,,M,5800,EndofPhase2,18,Phase 2,505,2,,9,,1,,,,,,1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV707XGF,1842,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,1,,,,,,,,1,1,200,,,2,,2,322,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,93,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,1200,Visit4,4,Phase 1/1A,136,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,93,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,1800,Visit7,7,Phase 1/1A,190,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,2000,Visit8,8,Phase 1/1A,220,1 or 1A,88,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,2200,Visit9,9,Phase 1/1A,248,1 or 1A,96,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,2400,Visit10,10,Phase 1/1A,276,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,2600,Visit11,11,Phase 1/1A,304,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,2800,Visit12,12,Phase 1/1A,331,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,3000,Visit13,13,Phase 1/1A,357,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,3200,Visit14,14,Phase 1/1A,386,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,3400,Visit15,15,Phase 1/1A,417,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,3600,Visit16,16,Phase 1/1A,444,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,3800,Visit17,17,Phase 1/1A,472,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGV773PAA,1484,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,537,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW298LF4,2750,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,92,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,88,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,90,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,77,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,96,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,95,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,96,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,88,2,,0,2,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,2400,Visit10,10,Phase 1/1A,286,1 or 1A,78,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,92,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,96,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,75,2,,0,1,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,79,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,3600,Visit16,16,Phase 1/1A,471,1 or 1A,72,2,,0,1,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW831EA4,2055,,,M,5200,EndofPhase1_1a,17,Phase 1/1A,485,1 or 1A,,2,,0,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,1200,Visit4,4,Phase 1/1A,104,1 or 1A,63,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,1600,Visit6,6,Phase 1/1A,188,1 or 1A,59,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,86,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,94,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,2600,Visit11,11,Phase 1/1A,312,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,2800,Visit12,12,Phase 1/1A,342,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,3000,Visit13,13,Phase 1/1A,371,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,3200,Visit14,14,Phase 1/1A,396,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,3400,Visit15,15,Phase 1/1A,433,1 or 1A,65,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,3600,Visit16,16,Phase 1/1A,447,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGW951LP7,2045,,,M,4000,Visit18,18,Phase 1/1A,509,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,98,3,,1,,,,,,1,3,120,,,2,2,4,147,160,4,3,600,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,97,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,1200,Visit4,4,Phase 2,113,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,1400,Visit5,5,Phase 2,148,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,1600,Visit6,6,Phase 2,171,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,1800,Visit7,7,Phase 2,197,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,2000,Visit8,8,Phase 2,225,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,2200,Visit9,9,Phase 2,265,2,99,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,2400,Visit10,10,Phase 2,283,2,96,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,2600,Visit11,11,Phase 2,309,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,2800,Visit12,12,Phase 2,342,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,3000,Visit13,13,Phase 2,357,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,3200,Visit14,14,Phase 2,398,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,3400,Visit15,15,Phase 2,421,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,3600,Visit16,16,Phase 2,450,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,3800,Visit17,17,Phase 2,476,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,86,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX058DL5,2328,,,F,5800,EndofPhase2,18,Phase 2,512,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,89,2,,1,,,,,,1,2,400,,,2,,3,556,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,1000,Visit3,3,Phase 1/1A,80,1 or 1A,59,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,2,,1,,,,,,4,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,1400,Visit5,5,Phase 1/1A,137,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,80,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,1800,Visit7,7,Phase 1/1A,206,1 or 1A,91,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,2000,Visit8,8,Phase 1/1A,234,1 or 1A,83,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,2200,Visit9,9,Phase 1/1A,267,1 or 1A,73,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,2400,Visit10,10,Phase 1/1A,302,1 or 1A,76,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,2600,Visit11,11,Phase 1/1A,326,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,2800,Visit12,12,Phase 1/1A,359,1 or 1A,76,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,3000,Visit13,13,Phase 1/1A,387,1 or 1A,80,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,3200,Visit14,14,Phase 1/1A,416,1 or 1A,96,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,3400,Visit15,15,Phase 1/1A,443,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,3600,Visit16,16,Phase 1/1A,471,1 or 1A,100,3,,0,2,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,3800,Visit17,17,Phase 1/1A,501,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX096VM4,2585,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,536,1 or 1A,99,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX776WRX,2292,,,M,600,Visit1,1,Phase 1/1A,43,1 or 1A,67,3,,1,,,,,,2,3,24,,,2,,4,29,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX776WRX,2292,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,,4,,1,,,,,,,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX776WRX,2292,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,76,1 or 1A,75,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,77,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,1200,Visit4,4,Phase 1/1A,124,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,1400,Visit5,5,Phase 1/1A,152,1 or 1A,97,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,1600,Visit6,6,Phase 1/1A,182,1 or 1A,93,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,86,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,2000,Visit8,8,Phase 1/1A,239,1 or 1A,82,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,2200,Visit9,9,Phase 1/1A,268,1 or 1A,89,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,2400,Visit10,10,Phase 1/1A,296,1 or 1A,82,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,2600,Visit11,11,Phase 1/1A,327,1 or 1A,100,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,2800,Visit12,12,Phase 1/1A,352,1 or 1A,92,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,3000,Visit13,13,Phase 1/1A,380,1 or 1A,93,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,3200,Visit14,14,Phase 1/1A,412,1 or 1A,84,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,3400,Visit15,15,Phase 1/1A,436,1 or 1A,98,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,3600,Visit16,16,Phase 1/1A,464,1 or 1A,86,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,3800,Visit17,17,Phase 1/1A,492,1 or 1A,,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGX806TUQ,1646,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,527,1 or 1A,94,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY745AMC,2277,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,1,,,,,,1,4,160,,,2,2,4,160,160,4,4,6,6,4,700,800,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,1200,Visit4,4,Phase 2,114,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,1600,Visit6,6,Phase 3,170,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,1800,Visit7,7,Phase 3,197,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,2000,Visit8,8,Phase 3,226,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,2200,Visit9,9,Phase 3,253,3,,,,,,2,900,,,1,,,,900,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,2400,Visit10,10,Phase 3,281,3,,,,,,2,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,2600,Visit11,11,Phase 3,309,3,,,,,,2,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,2800,Visit12,12,Phase 3,344,3,,,,,,2,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,3000,Visit13,13,Phase 3,366,3,,,,,,2,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,3200,Visit14,14,Phase 3,397,3,,,,,,2,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,3400,Visit15,15,Phase 3,425,3,,,,,,2,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,3600,Visit16,16,Phase 3,449,3,,,,,,2,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,3800,Visit17,17,Phase 3,477,3,,,,,,2,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,88,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,5800,EndofPhase2,5,Phase 2,131,2,60,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGY982YB5,2892,,,F,6000,EndofPhase3,18,Phase 3,495,3,,,,,,2,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,600,Visit1,1,Phase 1/1A,23,1 or 1A,77,2,,1,,,,,,1,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,800,Visit2,2,Phase 1/1A,53,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,1000,Visit3,3,Phase 1/1A,82,1 or 1A,65,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,1200,Visit4,4,Phase 1/1A,110,1 or 1A,50,2,,1,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,1400,Visit5,5,Phase 1/1A,137,1 or 1A,42,2,,1,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,1600,Visit6,6,Phase 1/1A,171,1 or 1A,77,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,1800,Visit7,7,Phase 1B,211,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,2000,Visit8,8,Phase 1B,241,1B,83,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,2200,Visit9,9,Phase 1B,268,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,2400,Visit10,10,Phase 1B,296,1B,96,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,2600,Visit11,11,Phase 1B,320,1B,97,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,2800,Visit12,12,Phase 1B,348,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,3000,Visit13,13,Phase 1B,376,1B,98,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,3200,Visit14,14,Phase 1B,401,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,3400,Visit15,15,Phase 1B,432,1B,92,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,3600,Visit16,16,Phase 1B,460,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,3800,Visit17,17,Phase 1B,492,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,180,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ074ENQ,2687,,,F,5400,EndofPhase1b,18,Phase 1B,508,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,86,2,,1,,,,,,1,2,15,,,1,,3,22,15,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,1400,Visit5,5,Phase 1/1A,152,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,2200,Visit9,9,Phase 1/1A,267,1 or 1A,97,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,2400,Visit10,10,Phase 1/1A,292,1 or 1A,94,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,2600,Visit11,11,Phase 1/1A,320,1 or 1A,95,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,2800,Visit12,12,Phase 1/1A,348,1 or 1A,95,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,3000,Visit13,13,Phase 1/1A,376,1 or 1A,89,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,3200,Visit14,14,Phase 1/1A,404,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,3400,Visit15,15,Phase 1/1A,432,1 or 1A,99,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,3600,Visit16,16,Phase 1/1A,460,1 or 1A,93,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,3800,Visit17,17,Phase 1/1A,488,1 or 1A,96,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ423YMJ,2471,,,M,4000,Visit18,18,Phase 1/1A,516,1 or 1A,95,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,800,Visit2,2,Phase 2,51,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,1000,Visit3,3,Phase 2,79,2,75,4,,,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,1200,Visit4,4,Phase 2,107,2,85,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,1600,Visit6,6,Phase 3,166,3,,,,,,3,1,3,3,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,1800,Visit7,7,Phase 3,199,3,,,,,,3,8,,,1,,,,8,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,2000,Visit8,8,Phase 3,232,3,,,,,,3,8,,,1,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,2200,Visit9,9,Phase 3,254,3,,,,,,3,1,3,3,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,2400,Visit10,10,Phase 3,283,3,,,,,,3,1,3,3,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,2600,Visit11,11,Phase 3,311,3,,,,,,3,2,3,6,1,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,2800,Visit12,12,Phase 3,344,3,,,,,,3,2,3,6,1,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,3000,Visit13,13,Phase 3,376,3,,,,,,3,2,3,6,1,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,3200,Visit14,14,Phase 3,400,3,,,,,,3,6,3,2,1,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,3400,Visit15,15,Phase 3,429,3,,,,,,3,1,3,6,1,,,,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,3600,Visit16,16,Phase 3,457,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,3800,Visit17,17,Phase 3,485,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,23,1 or 1A,74,2,,,,,,,,2,2,15,,,1,2,2,15,15,2,4,6,6,4,7,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,5800,EndofPhase2,5,Phase 2,122,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ545GWT,1635,,,M,6000,EndofPhase3,18,Phase 3,526,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ856UJ3,1803,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,95,4,,,,,,,,1,4,160,,,2,2,4,160,160,4,4,733,800,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ856UJ3,1803,,,M,1000,Visit3,3,Phase 2,91,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ856UJ3,1803,,,M,1200,Visit4,4,Phase 2,114,2,97,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ856UJ3,1803,,,M,1400,Visit5,5,Phase 2,142,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ856UJ3,1803,,,M,1600,Visit6,6,Phase 2,171,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ856UJ3,1803,,,M,1800,Visit7,7,Phase 2,199,2,98,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ856UJ3,1803,,,M,2000,Visit8,8,Phase 2,228,2,91,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ856UJ3,1803,,,M,2200,Visit9,9,Phase 2,268,2,93,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ856UJ3,1803,,,M,2400,Visit10,10,Phase 2,288,2,92,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ856UJ3,1803,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,66,1 or 1A,94,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVGZ856UJ3,1803,,,M,5800,EndofPhase2,11,Phase 2,295,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,1,,,,,,1,1,8,,,1,,1,11,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,1200,Visit4,4,Phase 1B,99,1B,93,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,1400,Visit5,5,Phase 1B,139,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,1600,Visit6,6,Phase 1B,167,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,1800,Visit7,7,Phase 1B,199,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,2000,Visit8,8,Phase 1B,227,1B,94,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,2200,Visit9,9,Phase 1B,255,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,2400,Visit10,10,Phase 1B,283,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,2600,Visit11,11,Phase 1B,311,1B,87,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,2800,Visit12,12,Phase 1B,349,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,3000,Visit13,13,Phase 1B,367,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,3200,Visit14,14,Phase 1B,391,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,3400,Visit15,15,Phase 1B,419,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,3600,Visit16,16,Phase 1B,449,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,3800,Visit17,17,Phase 1B,477,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,72,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA082YTY,2243,,,M,5400,EndofPhase1b,18,Phase 1B,489,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA106GA4,2593,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA222JBF,1675,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,75,3,,,,,,,,2,3,24,,,1,,3,24,24,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA222JBF,1675,,,M,800,Visit2,2,Phase 1/1A,52,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA222JBF,1675,,,M,1200,Visit4,4,Phase 1B,113,1B,98,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA222JBF,1675,,,M,1400,Visit5,5,Phase 1B,141,1B,,4,,1,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA222JBF,1675,,,M,1600,Visit6,6,Phase 1B,183,1B,,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA222JBF,1675,,,M,1800,Visit7,7,Phase 1B,200,1B,,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA222JBF,1675,,,M,2000,Visit8,8,Phase 1B,225,1B,,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA222JBF,1675,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,70,1 or 1A,100,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA222JBF,1675,,,M,5400,EndofPhase1b,9,Phase 1B,262,1B,,4,,1,,,,,,3,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA344XGZ,2373,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,80,,,1,1,2,80,80,2,2,400,400,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA344XGZ,2373,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA344XGZ,2373,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA344XGZ,2373,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,115,1 or 1A,89,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHA344XGZ,2373,,,M,5800,EndofPhase2,5,Phase 2,145,2,93,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHB318THQ,2523,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC057YL8,2852,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,58,2,,1,,,,,,2,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC382LJ8,2665,,,M,600,Visit1,1,Phase 1/1A,38,1 or 1A,,3,,1,,,,,,1,3,4.5,,,2,,3,4,4,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC382LJ8,2665,,,M,800,Visit2,2,Phase 1/1A,67,1 or 1A,88,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC382LJ8,2665,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC399WHA,1430,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,,,,,,,,,,1,,,,,1,,4,31,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,93,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,1000,Visit3,3,Phase 1/1A,73,1 or 1A,83,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,92,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,1400,Visit5,5,Phase 1/1A,137,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,1600,Visit6,6,Phase 1/1A,165,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,2000,Visit8,8,Phase 1B,213,1B,96,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,2200,Visit9,9,Phase 1B,247,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,2400,Visit10,10,Phase 1B,275,1B,96,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,2600,Visit11,11,Phase 1B,303,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,2800,Visit12,12,Phase 1B,331,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,3000,Visit13,13,Phase 1B,361,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,3200,Visit14,14,Phase 1B,388,1B,,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,3400,Visit15,15,Phase 1B,416,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,3600,Visit16,16,Phase 1B,444,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,3800,Visit17,17,Phase 1B,472,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,176,1 or 1A,83,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC436ZKD,1259,,,M,5400,EndofPhase1b,18,Phase 1B,502,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,32,,,2,2,4,32,32,4,4,30,30,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,1000,Visit3,3,Phase 1B,86,1B,77,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,1200,Visit4,4,Phase 1B,114,1B,93,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,1400,Visit5,5,Phase 1B,141,1B,95,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,1800,Visit7,7,Phase 2,197,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,2000,Visit8,8,Phase 2,222,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,2200,Visit9,9,Phase 2,253,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,2400,Visit10,10,Phase 2,281,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,2600,Visit11,11,Phase 2,309,2,,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,2800,Visit12,12,Phase 2,344,2,9,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,3,6,5,16,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,3400,Visit15,15,Phase 3,438,3,,,,,,3,6,5,16,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,3600,Visit16,16,Phase 3,453,3,,,,,,3,6,5,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,3800,Visit17,17,Phase 3,481,3,,,,,,3,6,5,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,4000,Visit18,18,Phase 3,523,3,,,,,,3,16,5,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,59,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,5400,EndofPhase1b,6,Phase 1B,165,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHC837FTW,1499,,,M,6000,EndofPhase3,18,Phase 3,523,3,,,,,,3,16,5,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHD868NZ7,1005,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,93,3,,,,,,,,1,3,600,,,2,2,4,733,800,4,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHD868NZ7,1005,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,93,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHD868NZ7,1005,,,M,1200,Visit4,4,Phase 2,120,2,72,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHD868NZ7,1005,,,M,1400,Visit5,5,Phase 2,141,2,95,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHD868NZ7,1005,,,M,1600,Visit6,6,Phase 2,169,2,89,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHD868NZ7,1005,,,M,1800,Visit7,7,Phase 2,204,2,82,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHD868NZ7,1005,,,M,2000,Visit8,8,Phase 2,223,2,82,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHD868NZ7,1005,,,M,2200,Visit9,9,Phase 2,252,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHD868NZ7,1005,,,M,2400,Visit10,10,Phase 2,283,2,90,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHD868NZ7,1005,,,M,2600,Visit11,11,Phase 2,309,2,79,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHD868NZ7,1005,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,91,1 or 1A,0,4,,,,,,,,4,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,2,3,680,800,3,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,94,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,1600,Visit6,6,Phase 2,169,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,1800,Visit7,7,Phase 2,204,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,2000,Visit8,8,Phase 2,225,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,2200,Visit9,9,Phase 2,260,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,2400,Visit10,10,Phase 2,281,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,2600,Visit11,11,Phase 2,309,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,2800,Visit12,12,Phase 2,337,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,3000,Visit13,13,Phase 2,365,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,3200,Visit14,14,Phase 2,393,2,100,3,,0,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,3400,Visit15,15,Phase 2,421,2,100,3,,0,1,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,3600,Visit16,16,Phase 2,449,2,100,3,,0,2,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,3800,Visit17,17,Phase 2,477,2,100,3,,0,2,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,145,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHE449RWH,2653,,,M,5800,EndofPhase2,18,Phase 2,497,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,2,3,107,80,3,3,600,600,3,31,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,70,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,1400,Visit5,5,Phase 3,127,3,,,,,,1,10,1,10,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,1600,Visit6,6,Phase 3,155,3,,,,,,1,10,1,20,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,1800,Visit7,7,Phase 3,184,3,,,,,,1,30,1,30,1,,,,60,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,2000,Visit8,8,Phase 3,211,3,,,,,,1,30,1,30,1,,,,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,2200,Visit9,9,Phase 3,240,3,,,,,,1,30,1,30,1,,,,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,2400,Visit10,10,Phase 3,268,3,,,,,,1,10,1,10,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,2600,Visit11,11,Phase 3,295,3,,,,,,1,10,1,10,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,2800,Visit12,12,Phase 3,323,3,,,,,,1,10,1,10,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,3000,Visit13,13,Phase 3,360,3,,,,,,1,10,1,10,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,3200,Visit14,14,Phase 3,388,3,,,,,,1,10,1,10,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,81,1 or 1A,75,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,5800,EndofPhase2,4,Phase 2,99,2,100,3,,1,,,,,,2,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF055PUY,2758,,,M,6000,EndofPhase3,15,Phase 3,421,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,400,,,2,1,2,450,400,2,3,23,23,3,120,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,83,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,96,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,84,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,1800,Visit7,7,Phase 1/1A,206,1 or 1A,81,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,2200,Visit9,9,Phase 2,241,2,97,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,2400,Visit10,10,Phase 2,269,2,89,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,2600,Visit11,11,Phase 2,297,2,87,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,2800,Visit12,12,Phase 2,339,2,87,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,3200,Visit14,14,Phase 3,374,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,212,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF073KBJ,1305,,,M,5800,EndofPhase2,13,Phase 2,353,2,24,3,,0,1,,,,,4,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,800,Visit2,2,Phase 1B,63,1B,94,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,1000,Visit3,3,Phase 1B,87,1B,99,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,1200,Visit4,4,Phase 1B,111,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,1400,Visit5,5,Phase 1B,140,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,1600,Visit6,6,Phase 1B,168,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,1800,Visit7,7,Phase 1B,196,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,2000,Visit8,8,Phase 1B,223,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,2200,Visit9,9,Phase 1B,251,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,2400,Visit10,10,Phase 1B,279,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,2600,Visit11,11,Phase 1B,308,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,2800,Visit12,12,Phase 1B,330,1B,,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,3000,Visit13,13,Phase 1B,360,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,3200,Visit14,14,Phase 1B,391,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,3400,Visit15,15,Phase 1B,428,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,3800,Visit17,17,Phase 1B,465,1B,,3,,1,,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,48,1 or 1A,30,2,,1,,,,,,3,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF829WHN,2719,,,M,5400,EndofPhase1b,18,Phase 1B,493,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF978HK7,1763,,,M,800,Visit2,2,Phase 2,57,2,100,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF978HK7,1763,,,M,1000,Visit3,3,Phase 2,82,2,100,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF978HK7,1763,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,31,1 or 1A,50,2,,,,,,,,3,2,15,,,2,2,2,15,15,2,2,80,80,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHF978HK7,1763,,,M,5800,EndofPhase2,4,Phase 2,116,2,44,2,,,,,,,,3,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,16,,,1,,2,16,8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,40,2,,1,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,1400,Visit5,5,Phase 1/1A,138,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,1800,Visit7,7,Phase 1B,209,1B,86,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,2000,Visit8,8,Phase 1B,239,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,2200,Visit9,9,Phase 1B,267,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,2400,Visit10,10,Phase 1B,295,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,2600,Visit11,11,Phase 1B,323,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,2800,Visit12,12,Phase 1B,352,1B,98,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,3000,Visit13,13,Phase 1B,380,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,3200,Visit14,14,Phase 1B,413,1B,97,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,3400,Visit15,15,Phase 1B,446,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,3600,Visit16,16,Phase 1B,471,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH011APP,2778,,,F,5400,EndofPhase1b,18,Phase 1B,503,1B,98,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,1,2,3,,,2,2,2,3,3,2,4,800,800,4,300,300,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,1600,Visit6,6,Phase 3,164,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,1800,Visit7,7,Phase 3,197,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,2000,Visit8,8,Phase 3,218,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,2200,Visit9,9,Phase 3,246,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,2400,Visit10,10,Phase 3,274,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,2600,Visit11,11,Phase 3,302,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,2800,Visit12,12,Phase 3,330,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,3000,Visit13,13,Phase 3,358,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,3200,Visit14,14,Phase 3,386,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,3400,Visit15,15,Phase 3,414,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,3600,Visit16,16,Phase 3,442,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,3800,Visit17,17,Phase 3,470,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,88,1 or 1A,,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,5800,EndofPhase2,5,Phase 2,131,2,97,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHH401NKC,1483,,,M,6000,EndofPhase3,18,Phase 3,498,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ306LDB,2191,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,82,1,,1,,,,,,1,1,8,,,1,1,1,10,8,1,1,40,40,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ306LDB,2191,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,68,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ306LDB,2191,,,M,1000,Visit3,3,Phase 1/1A,99,1 or 1A,85,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ306LDB,2191,,,M,1600,Visit6,6,Phase 2,232,2,97,1,,0,1,,,,,1,1,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ306LDB,2191,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,142,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ306LDB,2191,,,M,5400,EndofPhase1b,5,Phase 1B,190,1B,76,1,,0,1,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,2,,1,,,,,,1,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,2200,Visit9,9,Phase 1/1A,254,1 or 1A,98,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,2400,Visit10,10,Phase 1/1A,289,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,96,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,3400,Visit15,15,Phase 1/1A,423,1 or 1A,93,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHJ472JCP,2545,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,514,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,600,Visit1,1,Phase 1/1A,14,1 or 1A,69,1,,,,,,,,2,1,1.5,,,1,2,3,4,5,3,4,160,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,800,Visit2,2,Phase 1/1A,40,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,1200,Visit4,4,Phase 2,82,2,86,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,1400,Visit5,5,Phase 2,109,2,100,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,2000,Visit8,8,Phase 3,180,3,,,,,,1,0,5,16,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,2200,Visit9,9,Phase 3,207,3,,,,,,1,5,5,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,2400,Visit10,10,Phase 3,238,3,,,,,,1,20,5,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,3000,Visit13,13,Phase 3,266,3,,,,,,1,20,5,32,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,3200,Visit14,14,Phase 3,299,3,,,,,,1,20,5,32,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,3400,Visit15,15,Phase 3,326,3,,,,,,5,16,1,20,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,3600,Visit16,16,Phase 3,356,3,,,,,,5,16,1,20,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,3800,Visit17,17,Phase 3,390,3,,,,,,1,20,5,8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,4000,Visit18,18,Phase 3,418,3,,,,,,1,20,5,8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,54,1 or 1A,46,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,5800,EndofPhase2,6,Phase 2,131,2,,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK159WKT,1971,,,M,6000,EndofPhase3,18,Phase 3,418,3,,,,,,1,5,5,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,,1,,1,,,,,,1,1,7.5,,,1,,1,9,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,800,Visit2,2,Phase 1/1A,55,1 or 1A,96,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,1400,Visit5,5,Phase 1/1A,131,1 or 1A,89,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,1800,Visit7,7,Phase 1/1A,204,1 or 1A,96,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,2000,Visit8,8,Phase 1/1A,238,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,96,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,97,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,3200,Visit14,14,Phase 1/1A,391,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,3600,Visit16,16,Phase 1/1A,450,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,3800,Visit17,17,Phase 1/1A,484,1 or 1A,90,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK282TD5,2135,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,504,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,4,,,,,,,,2,4,6,,,2,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,94,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,1000,Visit3,3,Phase 1/1A,82,1 or 1A,98,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,1400,Visit5,5,Phase 1/1A,138,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,1600,Visit6,6,Phase 1/1A,166,1 or 1A,98,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,1800,Visit7,7,Phase 1/1A,194,1 or 1A,99,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,2200,Visit9,9,Phase 1/1A,250,1 or 1A,95,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,2400,Visit10,10,Phase 1/1A,278,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,2600,Visit11,11,Phase 1/1A,305,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,2800,Visit12,12,Phase 1/1A,334,1 or 1A,98,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,3000,Visit13,13,Phase 1/1A,362,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,3200,Visit14,14,Phase 1/1A,390,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,3400,Visit15,15,Phase 1/1A,418,1 or 1A,100,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,3600,Visit16,16,Phase 1/1A,446,1 or 1A,99,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,3800,Visit17,17,Phase 1/1A,474,1 or 1A,100,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHK948JU3,1723,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,496,1 or 1A,100,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL002PZ0,1612,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,15,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL047ML7,1721,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,3,22,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL047ML7,1721,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL047ML7,1721,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL047ML7,1721,,,M,1400,Visit5,5,Phase 1/1A,154,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL047ML7,1721,,,M,1600,Visit6,6,Phase 1/1A,192,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL047ML7,1721,,,M,1800,Visit7,7,Phase 1/1A,219,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL047ML7,1721,,,M,2000,Visit8,8,Phase 1/1A,248,1 or 1A,100,3,,0,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL047ML7,1721,,,M,2200,Visit9,9,Phase 1/1A,276,1 or 1A,100,3,,0,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL047ML7,1721,,,M,2400,Visit10,10,Phase 1/1A,311,1 or 1A,100,3,,0,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL047ML7,1721,,,M,2600,Visit11,11,Phase 1/1A,343,1 or 1A,100,3,,0,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL047ML7,1721,,,M,2800,Visit12,12,Phase 1/1A,385,1 or 1A,100,3,,0,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,600,Visit1,1,Phase 1/1A,37,1 or 1A,97,2,,,,,,,,1,2,16,,,1,,3,27,32,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,67,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,98,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,1800,Visit7,7,Phase 1B,199,1B,100,2,,0,1,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,2000,Visit8,8,Phase 1B,239,1B,100,2,,0,1,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,2200,Visit9,9,Phase 1B,254,1B,100,2,,0,1,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,2400,Visit10,10,Phase 1B,281,1B,100,3,,0,1,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,2600,Visit11,11,Phase 1B,310,1B,100,3,,0,1,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,2800,Visit12,12,Phase 1B,337,1B,100,3,,0,1,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,3000,Visit13,13,Phase 1B,366,1B,93,3,,0,1,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,3200,Visit14,14,Phase 1B,394,1B,100,3,,0,1,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,3400,Visit15,15,Phase 1B,445,1B,81,3,,0,1,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,3800,Visit17,17,Phase 1B,505,1B,69,3,,0,1,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,165,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL424YTX,1942,,,M,5400,EndofPhase1b,18,Phase 1B,554,1B,44,3,,0,1,,,,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL795HZ4,1410,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,,,,,,,1,3,4.5,,,2,1,3,5,5,3,1,8,8,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL795HZ4,1410,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,51,1 or 1A,94,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHL795HZ4,1410,,,F,5800,EndofPhase2,3,Phase 2,56,2,100,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,95,3,,,,,,,,1,3,22.5,,,2,,3,23,23,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,95,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,1600,Visit6,6,Phase 1/1A,166,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,92,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,2600,Visit11,11,Phase 1/1A,307,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHM953EC0,1687,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,516,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,0,1,,,,,1,2,80,,,1,1,3,100,100,3,4,27,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,1000,Visit3,3,Phase 2,91,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,1200,Visit4,4,Phase 2,121,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,1400,Visit5,5,Phase 2,147,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,1600,Visit6,6,Phase 2,176,2,100,4,,0,1,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,1800,Visit7,7,Phase 2,203,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,2000,Visit8,8,Phase 2,233,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,2200,Visit9,9,Phase 2,259,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,2400,Visit10,10,Phase 2,287,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,2600,Visit11,11,Phase 2,315,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,2800,Visit12,12,Phase 2,343,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,3000,Visit13,13,Phase 2,372,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,3200,Visit14,14,Phase 2,402,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,3400,Visit15,15,Phase 2,435,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,3600,Visit16,16,Phase 2,463,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,3800,Visit17,17,Phase 2,491,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,63,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN275BW5,2500,,,F,5800,EndofPhase2,18,Phase 2,569,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,81,2,,0,1,,,,,1,2,80,,,1,,4,151,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,3,,0,1,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,1000,Visit3,3,Phase 1/1A,98,1 or 1A,100,3,,0,1,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,1200,Visit4,4,Phase 1/1A,161,1 or 1A,63,4,,0,1,,,,,2,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,1400,Visit5,5,Phase 1/1A,188,1 or 1A,94,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,1600,Visit6,6,Phase 1/1A,209,1 or 1A,82,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,1800,Visit7,7,Phase 1/1A,246,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,2000,Visit8,8,Phase 1/1A,273,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,2200,Visit9,9,Phase 1/1A,302,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,2400,Visit10,10,Phase 1/1A,337,1 or 1A,80,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,2600,Visit11,11,Phase 1/1A,358,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,2800,Visit12,12,Phase 1/1A,386,1 or 1A,97,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,3000,Visit13,13,Phase 1/1A,414,1 or 1A,94,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,3200,Visit14,14,Phase 1/1A,440,1 or 1A,88,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,3400,Visit15,15,Phase 1/1A,468,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,3600,Visit16,16,Phase 1/1A,509,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,3800,Visit17,17,Phase 1/1A,524,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN380TAC,2131,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,561,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,99,2,,1,,,,,,1,2,80,,,2,,2,84,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,1200,Visit4,4,Phase 1/1A,122,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,1800,Visit7,7,Phase 1/1A,219,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,2000,Visit8,8,Phase 1/1A,249,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,2200,Visit9,9,Phase 1/1A,283,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,2400,Visit10,10,Phase 1/1A,311,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,2600,Visit11,11,Phase 1/1A,339,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,2800,Visit12,12,Phase 1/1A,375,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,3000,Visit13,13,Phase 1/1A,408,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,3200,Visit14,14,Phase 1/1A,436,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,3400,Visit15,15,Phase 1/1A,466,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,3600,Visit16,16,Phase 1/1A,492,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,3800,Visit17,17,Phase 1/1A,531,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHN723KX3,2632,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,571,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR247BZT,2170,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,82,2,,1,,,,,,1,2,400,,,2,,3,580,800,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR247BZT,2170,,,M,1000,Visit3,3,Phase 1/1A,119,1 or 1A,46,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR247BZT,2170,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR247BZT,2170,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR247BZT,2170,,,M,1800,Visit7,7,Phase 1/1A,190,1 or 1A,73,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR247BZT,2170,,,M,2000,Visit8,8,Phase 1/1A,234,1 or 1A,70,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR247BZT,2170,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,12,4,,1,,,,,,4,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR247BZT,2170,,,M,3400,Visit15,15,Phase 1/1A,423,1 or 1A,0,0,,,,,,,,4,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR247BZT,2170,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,88,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR247BZT,2170,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,87,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR247BZT,2170,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,91,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,600,Visit1,1,Phase 1/1A,37,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,800,Visit2,2,Phase 1/1A,51,1 or 1A,82,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,89,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,52,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,11,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,1600,Visit6,6,Phase 1/1A,163,1 or 1A,16,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,0,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,0,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,71,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,2400,Visit10,10,Phase 1/1A,289,1 or 1A,49,2,,0,1,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,2600,Visit11,11,Phase 1/1A,317,1 or 1A,89,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,84,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,86,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,68,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,75,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,69,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,86,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR457JBL,1014,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,569,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHR724VGN,2634,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,,,,,,,,,,,,,,,1,,2,400,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,,,,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,1400,Visit5,5,Phase 1/1A,134,1 or 1A,90,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,1600,Visit6,6,Phase 1/1A,156,1 or 1A,0,2,,,,,,,,4,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,1800,Visit7,7,Phase 1/1A,192,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,2000,Visit8,8,Phase 1/1A,220,1 or 1A,78,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,2200,Visit9,9,Phase 1/1A,248,1 or 1A,67,2,,0,1,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,2400,Visit10,10,Phase 1/1A,275,1 or 1A,57,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,94,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,3000,Visit13,13,Phase 1/1A,360,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,2,,0,1,,,,,,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,3400,Visit15,15,Phase 1/1A,423,1 or 1A,42,2,,0,1,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,3600,Visit16,16,Phase 1/1A,451,1 or 1A,98,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,3800,Visit17,17,Phase 1/1A,482,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT173RPK,2319,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,514,1 or 1A,98,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT588LEK,2492,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,,3,110,80,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT588LEK,2492,,,F,800,Visit2,2,Phase 1/1A,60,1 or 1A,86,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT588LEK,2492,,,F,1000,Visit3,3,Phase 1/1A,89,1 or 1A,75,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHT588LEK,2492,,,F,5200,EndofPhase1_1a,5,Phase 1/1A,179,1 or 1A,50,4,,1,,,,,,3,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU225AKV,2851,,,M,800,Visit2,2,Phase 2,53,2,32,4,,1,,,,,,3,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU225AKV,2851,,,M,1000,Visit3,3,Phase 2,82,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU225AKV,2851,,,M,1400,Visit5,5,Phase 3,127,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU225AKV,2851,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,22,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,1,2,3,5,5,3,4,800,800,4,15,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU225AKV,2851,,,M,5800,EndofPhase2,4,Phase 2,98,2,3,4,,1,,,,,,4,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU225AKV,2851,,,M,6000,EndofPhase3,6,Phase 3,165,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU736MPK,1628,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,1,,1,,,,,,1,1,200,,,2,3,3,650,800,3,,338,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,86,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,1400,Visit5,5,Phase 2,140,2,100,,25,,,,,,,1,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,1600,Visit6,6,Phase 2,174,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,1800,Visit7,7,Phase 2,195,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,2000,Visit8,8,Phase 2,223,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,2200,Visit9,9,Phase 2,258,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,2400,Visit10,10,Phase 2,279,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,2600,Visit11,11,Phase 2,300,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,2800,Visit12,12,Phase 2,342,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,3000,Visit13,13,Phase 2,356,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,3200,Visit14,14,Phase 2,384,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,3400,Visit15,15,Phase 2,440,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,3600,Visit16,16,Phase 2,454,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,3800,Visit17,17,Phase 2,468,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,114,1 or 1A,86,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU912VJ0,2398,,,M,5800,EndofPhase2,18,Phase 2,520,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,2,,,,,,,,1,2,15,,,2,,3,22,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,1200,Visit4,4,Phase 1/1A,120,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,1400,Visit5,5,Phase 1/1A,147,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,2200,Visit9,9,Phase 1/1A,261,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,2400,Visit10,10,Phase 1/1A,287,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,2600,Visit11,11,Phase 1/1A,314,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,2800,Visit12,12,Phase 1/1A,343,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,3000,Visit13,13,Phase 1/1A,373,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,3200,Visit14,14,Phase 1/1A,407,1 or 1A,94,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,3400,Visit15,15,Phase 1/1A,440,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,3600,Visit16,16,Phase 1/1A,470,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,3800,Visit17,17,Phase 1/1A,498,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHU948UG2,2084,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,538,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,0,1,,,,,1,2,400,,,1,1,3,600,600,3,4,6,6,4,340,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,1200,Visit4,4,Phase 2,112,2,93,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,1400,Visit5,5,Phase 2,140,2,96,4,,0,1,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,1600,Visit6,6,Phase 2,168,2,100,4,,0,1,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,1800,Visit7,7,Phase 2,198,2,97,4,,0,1,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,2000,Visit8,8,Phase 2,225,2,100,4,,0,1,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,2200,Visit9,9,Phase 2,252,2,93,4,,0,1,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,2600,Visit11,11,Phase 3,316,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,2800,Visit12,12,Phase 3,345,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,3000,Visit13,13,Phase 3,373,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,3200,Visit14,14,Phase 3,398,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,3400,Visit15,15,Phase 3,428,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,3600,Visit16,16,Phase 3,457,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,3800,Visit17,17,Phase 3,485,3,,,,,,4,200,4,200,1,,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,85,1 or 1A,97,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,5800,EndofPhase2,10,Phase 2,288,2,92,4,,0,1,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV131NAU,1730,,,M,6000,EndofPhase3,18,Phase 3,513,3,,,,,,4,200,4,200,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV683RTH,1501,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,90,1,,,,,,,,1,1,8,,,1,3,2,12,12,2,2,150,150,2,6,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV683RTH,1501,,,M,800,Visit2,2,Phase 1/1A,69,1 or 1A,99,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV683RTH,1501,,,M,1200,Visit4,4,Phase 1B,132,1B,17,1,,,,,,,,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV683RTH,1501,,,M,1600,Visit6,6,Phase 2,204,2,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV683RTH,1501,,,M,2000,Visit8,8,Phase 2,233,2,100,,150,,,,,,,1,,,150,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV683RTH,1501,,,M,2200,Visit9,9,Phase 2,265,2,50,2,,,,,,,,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV683RTH,1501,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,104,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV683RTH,1501,,,M,5400,EndofPhase1b,5,Phase 1B,149,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV683RTH,1501,,,M,5800,EndofPhase2,10,Phase 2,283,2,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV683RTH,1501,,,M,6000,EndofPhase3,11,Phase 3,317,3,,,,,,3,6,,,,,,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHV997EHA,2048,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,27,1 or 1A,100,4,,,,,,,,1,4,30,,,2,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHW644GNP,2465,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,800,Visit2,2,Phase 2,55,2,72,2,,1,,,,,,2,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,1200,Visit4,4,Phase 3,112,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,1400,Visit5,5,Phase 3,140,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,1600,Visit6,6,Phase 3,169,3,,,,,,1,5,1,5,1,,,,10,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,1800,Visit7,7,Phase 3,195,3,,,,,,1,5,1,5,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,2000,Visit8,8,Phase 3,247,3,,,,,,1,5,1,5,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,2200,Visit9,9,Phase 3,266,3,,,,,,1,5,1,5,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,2400,Visit10,10,Phase 3,294,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,2600,Visit11,11,Phase 3,322,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,2800,Visit12,12,Phase 3,351,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,3000,Visit13,13,Phase 3,377,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,3200,Visit14,14,Phase 3,410,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,3400,Visit15,15,Phase 3,438,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,3600,Visit16,16,Phase 3,466,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,3800,Visit17,17,Phase 3,494,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,4000,Visit18,18,Phase 3,525,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,27,1 or 1A,,,,,,,,,,1,,,,,2,2,,,,,2,3,3,2,6,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX172BW6,1867,,,M,5800,EndofPhase2,3,Phase 2,84,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,87,3,,,,,,,,1,3,600,,,2,2,3,600,600,3,4,6,6,4,6,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,21,3,,,,,,,,4,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,1400,Visit5,5,Phase 3,140,3,,,,,,3,4,,,3,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,1600,Visit6,6,Phase 3,169,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,1800,Visit7,7,Phase 3,194,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,2000,Visit8,8,Phase 3,222,3,,,,,,3,6,,,3,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,2200,Visit9,9,Phase 3,250,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,2400,Visit10,10,Phase 3,287,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,2600,Visit11,11,Phase 3,301,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,2800,Visit12,12,Phase 3,336,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,3000,Visit13,13,Phase 3,364,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,3200,Visit14,14,Phase 3,392,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,3400,Visit15,15,Phase 3,428,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,3600,Visit16,16,Phase 3,446,3,,,,,,3,6,,,2,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,63,1 or 1A,,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,5800,EndofPhase2,4,Phase 2,105,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX267UED,1512,,,M,6000,EndofPhase3,18,Phase 3,504,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX284TCW,2189,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,1,,,,,,1,1,8,,,2,,2,12,8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX284TCW,2189,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX284TCW,2189,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX284TCW,2189,,,F,1600,Visit6,6,Phase 1B,204,1B,,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX284TCW,2189,,,F,1800,Visit7,7,Phase 1B,225,1B,,1,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX284TCW,2189,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,162,1 or 1A,,1,,0,,,,,,,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX589YY2,1194,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,,,,,,,1,3,600,,,2,2,3,600,600,3,2,80,80,2,63,63,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX589YY2,1194,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX589YY2,1194,,,M,1000,Visit3,3,Phase 1/1A,66,1 or 1A,64,3,,,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX589YY2,1194,,,M,1400,Visit5,5,Phase 3,134,3,,,,,,7,63,,,1,,,,62.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX589YY2,1194,,,M,1600,Visit6,6,Phase 3,169,3,,,,,,7,63,,,1,,,,62.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX589YY2,1194,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,66,1 or 1A,67,3,,,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX589YY2,1194,,,M,5800,EndofPhase2,4,Phase 2,78,2,100,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX589YY2,1194,,,M,6000,EndofPhase3,7,Phase 3,176,3,,,,,,7,63,,,1,,,,62.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX897ZZ5,1270,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,3,,,,,,,,1,3,600,,,2,,4,778,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX897ZZ5,1270,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,69,4,,,,,,,,2,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX897ZZ5,1270,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,95,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX897ZZ5,1270,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,69,4,,,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX897ZZ5,1270,,,M,1400,Visit5,5,Phase 1/1A,151,1 or 1A,64,4,,,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX897ZZ5,1270,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,77,4,,,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX897ZZ5,1270,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,79,4,,,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX897ZZ5,1270,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,79,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHX897ZZ5,1270,,,M,2200,Visit9,9,Phase 1/1A,249,1 or 1A,,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVHZ501AVT,2209,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA101FXG,1695,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,84,2,,,,,,,,1,2,3,,,2,2,3,4,5,3,1,8,8,1,20,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA101FXG,1695,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,83,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA101FXG,1695,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,96,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA101FXG,1695,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,75,3,,,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA101FXG,1695,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,93,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA101FXG,1695,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA101FXG,1695,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,94,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA101FXG,1695,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA101FXG,1695,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA101FXG,1695,,,M,2800,Visit12,12,Phase 3,337,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA101FXG,1695,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,225,1 or 1A,91,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA101FXG,1695,,,M,5800,EndofPhase2,9,Phase 2,239,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA101FXG,1695,,,M,6000,EndofPhase3,13,Phase 3,365,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA299TCN,2072,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,,,,,,,1,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA426HJF,1198,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA426HJF,1198,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA426HJF,1198,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA426HJF,1198,,,F,1200,Visit4,4,Phase 1/1A,110,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA426HJF,1198,,,F,1400,Visit5,5,Phase 1/1A,145,1 or 1A,94,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA426HJF,1198,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA426HJF,1198,,,F,1800,Visit7,7,Phase 1/1A,211,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA426HJF,1198,,,F,2000,Visit8,8,Phase 1/1A,232,1 or 1A,,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA426HJF,1198,,,F,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA426HJF,1198,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,,2,,,,,,,,,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,4,,,,,,,,1,4,30,,,1,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,62,4,,,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,99,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,99,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,96,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,96,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,3400,Visit15,15,Phase 1/1A,424,1 or 1A,97,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,3800,Visit17,17,Phase 1/1A,482,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJA941MJQ,1472,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,1000,Visit3,3,Phase 3,85,3,,,,,,2,200,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,1200,Visit4,4,Phase 3,113,3,,,,,,7,13,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,1400,Visit5,5,Phase 3,138,3,,,,,,2,200,7,13,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,1600,Visit6,6,Phase 3,169,3,,,,,,2,400,7,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,1800,Visit7,7,Phase 3,194,3,,,,,,2,400,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,2000,Visit8,8,Phase 3,222,3,,,,,,2,200,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,2200,Visit9,9,Phase 3,250,3,,,,,,2,200,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,2400,Visit10,10,Phase 3,278,3,,,,,,7,13,2,400,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,2600,Visit11,11,Phase 3,306,3,,,,,,2,600,7,13,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,2800,Visit12,12,Phase 3,334,3,,,,,,2,600,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,3000,Visit13,13,Phase 3,362,3,,,,,,2,600,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,3200,Visit14,14,Phase 3,390,3,,,,,,2,600,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,3400,Visit15,15,Phase 3,418,3,,,,,,2,600,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,3600,Visit16,16,Phase 3,445,3,,,,,,2,600,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,22,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,2,1,8,8,1,4,800,800,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,5800,EndofPhase2,2,Phase 2,47,2,98,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB090LCJ,1381,,,M,6000,EndofPhase3,18,Phase 3,501,3,,,,,,2,600,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,97,2,,,,,,,,1,2,400,,,2,,4,756,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,2400,Visit10,10,Phase 1/1A,287,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,93,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,3200,Visit14,14,Phase 1/1A,395,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,99,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB091EC5,2060,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,511,1 or 1A,88,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,1,2,4,5,5,4,,,,,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,1600,Visit6,6,Phase 3,170,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,1800,Visit7,7,Phase 3,191,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,2000,Visit8,8,Phase 3,226,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,2200,Visit9,9,Phase 3,264,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,2400,Visit10,10,Phase 3,289,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,2600,Visit11,11,Phase 3,314,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,2800,Visit12,12,Phase 3,341,3,,,,,,3,6,3,6,1,,,,12,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,3000,Visit13,13,Phase 3,365,3,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,3200,Visit14,14,Phase 3,393,3,,,,,,3,3,3,1,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,3400,Visit15,15,Phase 3,422,3,,,,,,3,1,3,3,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,3600,Visit16,16,Phase 3,450,3,,,,,,3,4,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,82,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,5800,EndofPhase2,4,Phase 2,141,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB260JWP,1452,,,F,6000,EndofPhase3,18,Phase 3,516,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,96,2,,1,,,,,,1,2,15,,,1,,2,18,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,1400,Visit5,5,Phase 1/1A,149,1 or 1A,88,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,1600,Visit6,6,Phase 1/1A,175,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,1800,Visit7,7,Phase 1/1A,204,1 or 1A,97,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,2200,Visit9,9,Phase 1/1A,255,1 or 1A,97,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,2400,Visit10,10,Phase 1/1A,290,1 or 1A,88,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,2600,Visit11,11,Phase 1/1A,316,1 or 1A,84,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,2800,Visit12,12,Phase 1/1A,344,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,3000,Visit13,13,Phase 1/1A,372,1 or 1A,90,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,3200,Visit14,14,Phase 1/1A,408,1 or 1A,92,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,3400,Visit15,15,Phase 1/1A,434,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,3600,Visit16,16,Phase 1/1A,465,1 or 1A,94,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,3800,Visit17,17,Phase 1/1A,490,1 or 1A,88,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB370PHG,2355,,,F,4000,Visit18,18,Phase 1/1A,518,1 or 1A,67,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB592TG4,2835,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJB975MNW,2688,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,9,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD063WJ9,1090,,,M,5200,EndofPhase1_1a,0,Phase 1/1A,68,1 or 1A,,,,,,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,84,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,2000,Visit8,8,Phase 1/1A,229,1 or 1A,98,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,80,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,2600,Visit11,11,Phase 1/1A,313,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,2800,Visit12,12,Phase 1/1A,345,1 or 1A,92,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,80,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,3800,Visit17,17,Phase 1/1A,482,1 or 1A,88,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD356ZXP,2255,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,79,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,2,2,3,5,5,3,4,800,800,4,36,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,1400,Visit5,5,Phase 2,140,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,1600,Visit6,6,Phase 2,175,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,2000,Visit8,8,Phase 3,238,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,2200,Visit9,9,Phase 3,271,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,2800,Visit12,12,Phase 3,371,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,3200,Visit14,14,Phase 3,435,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,3400,Visit15,15,Phase 3,474,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,3600,Visit16,16,Phase 3,496,3,,,,,,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,3800,Visit17,17,Phase 3,526,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,97,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,5800,EndofPhase2,7,Phase 2,204,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJD657UJ7,1633,,,M,6000,EndofPhase3,18,Phase 3,554,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,80,,,1,2,3,107,80,3,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,0,1,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,1800,Visit7,7,Phase 2,197,2,88,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,2000,Visit8,8,Phase 2,232,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,2200,Visit9,9,Phase 2,253,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,2400,Visit10,10,Phase 2,281,2,87,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,2600,Visit11,11,Phase 2,309,2,98,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,2800,Visit12,12,Phase 2,337,2,93,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,3000,Visit13,13,Phase 2,365,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,3200,Visit14,14,Phase 2,393,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,3400,Visit15,15,Phase 2,421,2,96,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,3600,Visit16,16,Phase 2,449,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,3800,Visit17,17,Phase 2,477,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,161,1 or 1A,,4,,1,,,,,,,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJE356JMY,2824,,,M,5800,EndofPhase2,18,Phase 2,512,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,3,25,30,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,95,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,1400,Visit5,5,Phase 1/1A,131,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,84,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,92,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,2000,Visit8,8,Phase 1/1A,222,1 or 1A,96,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,78,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,93,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,3000,Visit13,13,Phase 1/1A,368,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJF857RY6,1114,,,M,5200,EndofPhase1_1a,14,Phase 1/1A,393,1 or 1A,98,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,600,Visit1,1,Phase 1/1A,49,1 or 1A,45,1,,,,,,,,3,1,1.5,,,1,1,1,2,2,1,4,151,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,800,Visit2,2,Phase 1/1A,83,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,1000,Visit3,3,Phase 1/1A,122,1 or 1A,51,1,,,,,,,,3,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,1200,Visit4,4,Phase 1/1A,150,1 or 1A,97,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,1400,Visit5,5,Phase 1/1A,181,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,1600,Visit6,6,Phase 1/1A,216,1 or 1A,94,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,1800,Visit7,7,Phase 1/1A,247,1 or 1A,91,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,2000,Visit8,8,Phase 1/1A,272,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,2400,Visit10,10,Phase 2,337,2,60,2,,0,1,,,,,2,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,2600,Visit11,11,Phase 2,372,2,100,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,2800,Visit12,12,Phase 2,399,2,100,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,3000,Visit13,13,Phase 2,429,2,94,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,3200,Visit14,14,Phase 2,458,2,96,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,3400,Visit15,15,Phase 2,483,2,96,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,3600,Visit16,16,Phase 2,506,2,91,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,3800,Visit17,17,Phase 2,527,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,4000,Visit18,18,Phase 2,553,2,93,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG168UD9,1599,,,F,5200,EndofPhase1_1a,9,Phase 1/1A,314,1 or 1A,93,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,600,Visit1,1,Phase 1/1A,35,1 or 1A,32,2,,,,,,,,3,2,400,,,1,,2,322,200,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,800,Visit2,2,Phase 1/1A,73,1 or 1A,,1,,,,,,,,,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,1000,Visit3,3,Phase 1/1A,101,1 or 1A,,1,,,,,,,,,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,1200,Visit4,4,Phase 1/1A,136,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,1400,Visit5,5,Phase 1/1A,164,1 or 1A,87,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,1600,Visit6,6,Phase 1/1A,197,1 or 1A,97,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,1800,Visit7,7,Phase 1/1A,232,1 or 1A,97,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,2000,Visit8,8,Phase 1/1A,255,1 or 1A,75,1,,0,1,,,,,2,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,2200,Visit9,9,Phase 1/1A,288,1 or 1A,,1,,0,1,,,,,,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,2400,Visit10,10,Phase 1/1A,317,1 or 1A,,1,,0,1,,,,,,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,2600,Visit11,11,Phase 1/1A,344,1 or 1A,100,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,2800,Visit12,12,Phase 1/1A,373,1 or 1A,83,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,3000,Visit13,13,Phase 1/1A,401,1 or 1A,50,3,,1,,,,,,3,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,3200,Visit14,14,Phase 1/1A,437,1 or 1A,87,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,3400,Visit15,15,Phase 1/1A,465,1 or 1A,,3,,1,,,,,,,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,3600,Visit16,16,Phase 1/1A,496,1 or 1A,,3,,1,,,,,,,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,3800,Visit17,17,Phase 1/1A,524,1 or 1A,,2,,1,,,,,,,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG234YM4,1810,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,553,1 or 1A,,2,,1,,,,,,,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,86,2,,1,,,,,,1,2,80,,,2,1,2,80,80,2,2,15,15,2,2,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,96,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,91,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,93,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,2000,Visit8,8,Phase 2,216,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,2600,Visit11,11,Phase 3,307,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,2800,Visit12,12,Phase 3,335,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,3000,Visit13,13,Phase 3,363,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,3200,Visit14,14,Phase 3,398,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,3400,Visit15,15,Phase 3,426,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,3600,Visit16,16,Phase 3,447,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,3800,Visit17,17,Phase 3,475,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,195,1 or 1A,77,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,5800,EndofPhase2,9,Phase 2,251,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG428NKA,2611,,,M,6000,EndofPhase3,18,Phase 3,489,3,,,,,,3,1,3,1,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,1,,,,,,1,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,800,Visit2,2,Phase 1/1A,63,1 or 1A,99,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,1000,Visit3,3,Phase 1/1A,94,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,1200,Visit4,4,Phase 1/1A,128,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,1400,Visit5,5,Phase 1/1A,163,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,1800,Visit7,7,Phase 1B,232,1B,98,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,2000,Visit8,8,Phase 1B,266,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,2200,Visit9,9,Phase 1B,311,1B,83,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,2400,Visit10,10,Phase 1B,337,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,2600,Visit11,11,Phase 1B,367,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,2800,Visit12,12,Phase 1B,388,1B,98,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,3000,Visit13,13,Phase 1B,416,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,3200,Visit14,14,Phase 1B,444,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,3400,Visit15,15,Phase 1B,472,1B,95,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,3600,Visit16,16,Phase 1B,500,1B,50,2,,0,2,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,3800,Visit17,17,Phase 1B,526,1B,100,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,196,1 or 1A,96,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG621KB1,2737,,,F,5400,EndofPhase1b,18,Phase 1B,561,1B,94,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,,,,,,,1,3,4.5,,,1,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,3400,Visit15,15,Phase 1/1A,417,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,3600,Visit16,16,Phase 1/1A,446,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJG908GB7,1155,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,60,2,,,,,,,,2,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,79,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,2200,Visit9,9,Phase 1/1A,247,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,2800,Visit12,12,Phase 1/1A,341,1 or 1A,81,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,3000,Visit13,13,Phase 1/1A,373,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH420AHL,1922,,,M,5200,EndofPhase1_1a,15,Phase 1/1A,421,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,94,2,,1,,,,,,1,2,16,,,2,2,3,24,24,3,3,113,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,92,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,1200,Visit4,4,Phase 1B,111,1B,41,3,,1,,,,,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,1400,Visit5,5,Phase 1B,151,1B,95,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,1600,Visit6,6,Phase 1B,169,1B,72,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,1800,Visit7,7,Phase 1B,200,1B,94,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,2000,Visit8,8,Phase 1B,230,1B,94,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,2200,Visit9,9,Phase 1B,250,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,2400,Visit10,10,Phase 1B,284,1B,79,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,2600,Visit11,11,Phase 1B,315,1B,98,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,3000,Visit13,13,Phase 2,364,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,3200,Visit14,14,Phase 2,400,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,3400,Visit15,15,Phase 2,425,2,97,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,3600,Visit16,16,Phase 2,461,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,3800,Visit17,17,Phase 2,483,2,98,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,90,1 or 1A,92,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,5400,EndofPhase1b,12,Phase 1B,334,1B,90,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJH922YHA,2739,,,M,5800,EndofPhase2,18,Phase 2,512,2,91,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,1,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,1000,Visit3,3,Phase 1/1A,98,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,1400,Visit5,5,Phase 1/1A,140,1 or 1A,93,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,2200,Visit9,9,Phase 1/1A,258,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,93,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJK329CNL,2253,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJL870DZR,1109,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,22,1 or 1A,0,2,,,,,,,,4,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM274VYR,1534,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,2,,,,,,,,1,2,3,,,2,3,4,5,6,4,1,,,1,480,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM274VYR,1534,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,98,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM274VYR,1534,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,96,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM274VYR,1534,,,M,1600,Visit6,6,Phase 3,169,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM274VYR,1534,,,M,1800,Visit7,7,Phase 3,197,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM274VYR,1534,,,M,2000,Visit8,8,Phase 3,221,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM274VYR,1534,,,M,2200,Visit9,9,Phase 3,253,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM274VYR,1534,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,99,1 or 1A,93,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM274VYR,1534,,,M,5800,EndofPhase2,5,Phase 2,121,2,,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM274VYR,1534,,,M,6000,EndofPhase3,10,Phase 3,261,3,,,,,,2,600,,,3,,,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,85,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,1600,Visit6,6,Phase 1/1A,180,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,1800,Visit7,7,Phase 1/1A,208,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,2000,Visit8,8,Phase 1/1A,243,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,2200,Visit9,9,Phase 1/1A,278,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,2400,Visit10,10,Phase 1/1A,306,1 or 1A,96,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,2600,Visit11,11,Phase 1/1A,334,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,2800,Visit12,12,Phase 1/1A,375,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,3000,Visit13,13,Phase 1/1A,393,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,3200,Visit14,14,Phase 1/1A,425,1 or 1A,97,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,3400,Visit15,15,Phase 1/1A,457,1 or 1A,100,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,3600,Visit16,16,Phase 1/1A,479,1 or 1A,92,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,3800,Visit17,17,Phase 1/1A,500,1 or 1A,95,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM518XET,1322,,,M,4000,Visit18,18,Phase 1/1A,528,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM531LCL,1592,,,M,1200,Visit4,4,Phase 3,131,3,,,,,,6,100,,,4,,,,100,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM531LCL,1592,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,38,1 or 1A,68,2,,1,,,,,,2,2,400,,,2,1,2,400,400,2,3,23,23,3,100,100,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM531LCL,1592,,,M,5800,EndofPhase2,2,Phase 2,58,2,,3,,,,,,,,4,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM531LCL,1592,,,M,6000,EndofPhase3,5,Phase 3,145,3,,,,,,6,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,100,3,,,,,,,,1,3,24,,,2,2,4,31,32,4,4,30,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,,4,,,,,,,,,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,93,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,1800,Visit7,7,Phase 1B,197,1B,100,4,,0,2,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,2000,Visit8,8,Phase 1B,225,1B,98,4,,0,2,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,2200,Visit9,9,Phase 1B,253,1B,100,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,2600,Visit11,11,Phase 2,296,2,99,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,2800,Visit12,12,Phase 2,327,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,3000,Visit13,13,Phase 2,352,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,3200,Visit14,14,Phase 2,380,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,3400,Visit15,15,Phase 2,409,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,3600,Visit16,16,Phase 2,437,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,3800,Visit17,17,Phase 2,464,2,100,4,,0,1,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,171,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,5400,EndofPhase1b,10,Phase 1B,267,1B,100,4,,0,2,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM981PYD,1912,,,M,5800,EndofPhase2,18,Phase 2,495,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,95,2,,0,1,,,,,1,2,15,,,1,,4,28,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,78,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,93,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,1600,Visit6,6,Phase 1/1A,182,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,93,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,2000,Visit8,8,Phase 1/1A,239,1 or 1A,96,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,2200,Visit9,9,Phase 1/1A,266,1 or 1A,90,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,2400,Visit10,10,Phase 1/1A,295,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,2600,Visit11,11,Phase 1/1A,323,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,2800,Visit12,12,Phase 1/1A,365,1 or 1A,93,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,3000,Visit13,13,Phase 1/1A,396,1 or 1A,97,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,3200,Visit14,14,Phase 1/1A,427,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,3400,Visit15,15,Phase 1/1A,454,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,3600,Visit16,16,Phase 1/1A,483,1 or 1A,96,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,3800,Visit17,17,Phase 1/1A,512,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJM997GKH,2706,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,561,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJN081PA5,1972,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,68,1,,,,,,,,2,1,1.5,,,1,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJN081PA5,1972,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,52,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJN081PA5,1972,,,M,1000,Visit3,3,Phase 1/1A,82,1 or 1A,44,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJN081PA5,1972,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,71,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJN081PA5,1972,,,M,1400,Visit5,5,Phase 1/1A,138,1 or 1A,34,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJN081PA5,1972,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,166,1 or 1A,13,2,,1,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJP154RFB,1432,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJP159MZ9,2350,,,M,600,Visit1,1,Phase 1/1A,37,1 or 1A,99,2,,1,,,,,,1,2,3,,,1,2,3,5,5,3,4,160,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJP159MZ9,2350,,,M,1200,Visit4,4,Phase 2,114,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJP159MZ9,2350,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,79,1 or 1A,98,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJP159MZ9,2350,,,M,5800,EndofPhase2,5,Phase 2,136,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,1,,3,25,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,93,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,98,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,90,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,3200,Visit14,14,Phase 1/1A,395,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,3600,Visit16,16,Phase 1B,448,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,3800,Visit17,17,Phase 1B,477,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,4000,Visit18,18,Phase 1B,506,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,4200,Visit19,19,Phase 1B,533,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,4400,Visit20,20,Phase 1B,562,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,5200,EndofPhase1_1a,15,Phase 1/1A,421,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR064RZC,1132,,,M,5400,EndofPhase1b,21,Phase 1B,589,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,2,,,,,,,,1,2,3,,,1,2,2,3,3,2,2,400,400,2,7,5,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,800,Visit2,2,Phase 1/1A,40,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,1000,Visit3,3,Phase 2,79,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,1200,Visit4,4,Phase 2,104,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,1400,Visit5,5,Phase 2,135,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,1800,Visit7,7,Phase 3,176,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,2000,Visit8,8,Phase 3,211,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,2200,Visit9,9,Phase 3,245,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,2400,Visit10,10,Phase 3,273,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,2600,Visit11,11,Phase 3,306,3,,,,,,1,5,1,5,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,2800,Visit12,12,Phase 3,331,3,,,,,,1,5,1,0,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,3000,Visit13,13,Phase 3,366,3,,,,,,1,5,1,0,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,3200,Visit14,14,Phase 3,401,3,,,,,,1,0,1,0,1,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,3400,Visit15,15,Phase 3,440,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,3600,Visit16,16,Phase 3,468,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,3800,Visit17,17,Phase 3,496,3,,,,,,1,5,1,10,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,40,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,5800,EndofPhase2,6,Phase 2,162,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR389GUV,1527,,,F,6000,EndofPhase3,18,Phase 3,524,3,,,,,,1,10,1,10,1,,,,20,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,98,2,,,,,,,,1,2,3,,,1,3,3,4,4,3,,800,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,1000,Visit3,3,Phase 2,85,2,100,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,1200,Visit4,4,Phase 2,113,2,100,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,1400,Visit5,5,Phase 2,141,2,96,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,1600,Visit6,6,Phase 2,175,2,99,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,1800,Visit7,7,Phase 2,204,2,100,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,2000,Visit8,8,Phase 2,229,2,100,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,2200,Visit9,9,Phase 2,259,2,99,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,2400,Visit10,10,Phase 2,286,2,100,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,2600,Visit11,11,Phase 2,314,2,100,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,2800,Visit12,12,Phase 2,351,2,98,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,3000,Visit13,13,Phase 2,366,2,100,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,3200,Visit14,14,Phase 2,386,2,95,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,3400,Visit15,15,Phase 2,427,2,100,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,3600,Visit16,16,Phase 2,446,2,100,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,3800,Visit17,17,Phase 2,478,2,100,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,43,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR448AWR,1889,,,M,5800,EndofPhase2,18,Phase 2,512,2,100,,800,,,,,,,1,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,600,Visit1,1,Phase 1/1A,17,1 or 1A,98,4,,,,,,,,1,4,800,,,2,3,4,800,800,4,5,494,500,5,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,800,Visit2,2,Phase 2,73,2,100,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,1000,Visit3,3,Phase 2,113,2,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,1400,Visit5,5,Phase 2,141,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,1600,Visit6,6,Phase 2,177,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,1800,Visit7,7,Phase 2,204,2,100,5,,,,,,,,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,2000,Visit8,8,Phase 2,225,2,100,5,,,,,,,,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,2200,Visit9,9,Phase 2,254,2,100,5,,,,,,,,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,2400,Visit10,10,Phase 2,282,2,100,5,,,,,,,,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,2600,Visit11,11,Phase 2,310,2,100,5,,1,,,,,,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,2800,Visit12,12,Phase 2,339,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,3000,Visit13,13,Phase 2,366,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,3200,Visit14,14,Phase 2,392,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,3400,Visit15,15,Phase 2,423,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,3600,Visit16,16,Phase 2,450,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,3800,Visit17,17,Phase 2,478,2,98,5,,,,,,,,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,17,1 or 1A,98,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR663ATG,1019,,,M,5800,EndofPhase2,18,Phase 2,515,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR912BGW,1579,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,75,2,,1,,,,,,2,2,3,,,2,2,3,5,6,3,3,26,30,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,91,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,95,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,1600,Visit6,6,Phase 2,162,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,1800,Visit7,7,Phase 2,190,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,2000,Visit8,8,Phase 2,218,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,2200,Visit9,9,Phase 2,246,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,2400,Visit10,10,Phase 2,277,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,2600,Visit11,11,Phase 2,306,2,98,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,2800,Visit12,12,Phase 2,332,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,3000,Visit13,13,Phase 2,360,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,3200,Visit14,14,Phase 2,388,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,3400,Visit15,15,Phase 2,423,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,3600,Visit16,16,Phase 2,444,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,3800,Visit17,17,Phase 2,472,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,5200,EndofPhase1_1a,5,Phase 1/1A,135,1 or 1A,97,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJR928MXM,2143,,,F,5800,EndofPhase2,18,Phase 2,514,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT481LN0,1362,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,800,,,2,,4,800,800,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT481LN0,1362,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT481LN0,1362,,,F,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT481LN0,1362,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,120,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT616KT0,2800,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,2,,,,,,,,1,2,80,,,1,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,60,2,,0,1,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,77,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,91,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,2400,Visit10,10,Phase 1/1A,283,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,2600,Visit11,11,Phase 1/1A,311,1 or 1A,76,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,2800,Visit12,12,Phase 1/1A,339,1 or 1A,64,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,3000,Visit13,13,Phase 1/1A,359,1 or 1A,63,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,3200,Visit14,14,Phase 1/1A,408,1 or 1A,95,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,3400,Visit15,15,Phase 1/1A,436,1 or 1A,75,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,3600,Visit16,16,Phase 1/1A,469,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,3800,Visit17,17,Phase 1/1A,499,1 or 1A,81,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJT774WLE,1847,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,527,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU227NL8,1978,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,96,2,,,,,,,,1,2,400,,,2,,4,720,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU227NL8,1978,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,99,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU227NL8,1978,,,F,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU227NL8,1978,,,F,1200,Visit4,4,Phase 1/1A,116,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU227NL8,1978,,,F,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU644BL9,1464,,,F,800,Visit2,2,Phase 2,69,2,94,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU644BL9,1464,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,26,1 or 1A,75,2,,,,,,,,2,2,400,,,2,1,2,400,400,2,3,19,19,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU644BL9,1464,,,F,5800,EndofPhase2,3,Phase 2,117,2,74,3,,,,,,,,3,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,2,,,,,,,,1,2,400,,,1,1,3,600,400,3,3,23,23,3,328,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,800,Visit2,2,Phase 1/1A,71,1 or 1A,89,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,1000,Visit3,3,Phase 1/1A,105,1 or 1A,100,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,1200,Visit4,4,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,1600,Visit6,6,Phase 2,190,2,91,2,,0,1,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,1800,Visit7,7,Phase 2,218,2,100,3,,0,1,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,2200,Visit9,9,Phase 3,274,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,2400,Visit10,10,Phase 3,302,3,,,,,,4,160,4,160,2,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,2600,Visit11,11,Phase 3,330,3,,,,,,4,200,4,200,2,,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,2800,Visit12,12,Phase 3,356,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,3000,Visit13,13,Phase 3,384,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,3200,Visit14,14,Phase 3,415,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,3400,Visit15,15,Phase 3,442,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,3600,Visit16,16,Phase 3,470,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,3800,Visit17,17,Phase 3,498,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,162,1 or 1A,95,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,5800,EndofPhase2,8,Phase 2,244,2,92,4,,0,1,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU652FDQ,2093,,,M,6000,EndofPhase3,18,Phase 3,524,3,,,,,,4,160,4,160,1,,,,320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU694ATC,1928,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,4,,,,,,,,1,4,30,,,1,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU694ATC,1928,,,M,800,Visit2,2,Phase 1/1A,75,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU694ATC,1928,,,M,1400,Visit5,5,Phase 1/1A,162,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU694ATC,1928,,,M,1600,Visit6,6,Phase 1/1A,210,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU694ATC,1928,,,M,2000,Visit8,8,Phase 1/1A,245,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU694ATC,1928,,,M,2200,Visit9,9,Phase 1/1A,271,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU694ATC,1928,,,M,2400,Visit10,10,Phase 1/1A,306,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU694ATC,1928,,,M,2600,Visit11,11,Phase 1/1A,334,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU694ATC,1928,,,M,2800,Visit12,12,Phase 1/1A,366,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU694ATC,1928,,,M,3200,Visit14,14,Phase 1/1A,420,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU694ATC,1928,,,M,3400,Visit15,15,Phase 1/1A,454,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU694ATC,1928,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,516,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,3,,,1,2,3,4,5,3,4,727,800,4,60,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,800,Visit2,2,Phase 1/1A,66,1 or 1A,96,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,1000,Visit3,3,Phase 1/1A,98,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,97,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,1800,Visit7,7,Phase 2,197,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,2000,Visit8,8,Phase 2,219,2,93,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,2200,Visit9,9,Phase 2,253,2,98,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,2400,Visit10,10,Phase 2,281,2,98,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,2600,Visit11,11,Phase 2,310,2,91,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,2800,Visit12,12,Phase 2,337,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,3000,Visit13,13,Phase 2,366,2,90,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,3200,Visit14,14,Phase 2,393,2,99,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,3400,Visit15,15,Phase 2,423,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,3600,Visit16,16,Phase 2,449,2,94,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,169,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,5800,EndofPhase2,17,Phase 2,477,2,93,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU768RVU,1405,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,4,60,,,1,,,,60,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU962AD5,2730,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,,3,500,500,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJU962AD5,2730,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,1200,Visit4,4,Phase 3,110,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,1400,Visit5,5,Phase 3,136,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,1600,Visit6,6,Phase 3,172,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,1800,Visit7,7,Phase 3,197,3,,,,,,2,400,,,2,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,2,100,2,200,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,2200,Visit9,9,Phase 3,257,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,2400,Visit10,10,Phase 3,284,3,,,,,,2,500,2,500,1,,,,1000,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,2600,Visit11,11,Phase 3,312,3,,,,,,2,100,2,200,4,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,2800,Visit12,12,Phase 3,345,3,,,,,,2,400,,,2,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,3000,Visit13,13,Phase 3,373,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,3200,Visit14,14,Phase 3,400,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,3400,Visit15,15,Phase 3,428,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,3600,Visit16,16,Phase 3,457,3,,,,,,2,400,2,400,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,3800,Visit17,17,Phase 3,485,3,,,,,,2,400,2,400,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,96,2,,1,,,,,,1,2,16,,,1,1,2,16,16,2,3,23,23,3,520,400,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,5400,EndofPhase1b,2,Phase 1B,61,1B,80,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,5800,EndofPhase2,3,Phase 2,86,2,80,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV239ZFU,1076,,,M,6000,EndofPhase3,18,Phase 3,514,3,,,,,,2,400,2,400,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV255EVD,2847,,,M,600,Visit1,1,Phase 1/1A,99,1 or 1A,100,1,,1,,,,,,1,1,200,,,2,1,3,500,500,3,3,120,160,3,10,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV255EVD,2847,,,M,1400,Visit5,5,Phase 2,160,2,100,1,,0,1,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV255EVD,2847,,,M,1800,Visit7,7,Phase 2,197,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV255EVD,2847,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,127,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV255EVD,2847,,,M,5800,EndofPhase2,8,Phase 2,214,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV255EVD,2847,,,M,6000,EndofPhase3,9,Phase 3,217,3,,,,,,8,10,,,4,,,,10,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV571NV3,1827,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,,2,,1,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,800,Visit2,2,Phase 2,66,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,1000,Visit3,3,Phase 2,86,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,1200,Visit4,4,Phase 2,114,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,1400,Visit5,5,Phase 2,142,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,1600,Visit6,6,Phase 2,170,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,1800,Visit7,7,Phase 2,198,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,2000,Visit8,8,Phase 2,226,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,2200,Visit9,9,Phase 2,254,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,2400,Visit10,10,Phase 2,281,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,2600,Visit11,11,Phase 2,303,2,100,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,2800,Visit12,12,Phase 2,331,2,100,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,3000,Visit13,13,Phase 2,358,2,100,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,3200,Visit14,14,Phase 2,385,2,100,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,3400,Visit15,15,Phase 2,415,2,100,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,3600,Visit16,16,Phase 2,443,2,100,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,3800,Visit17,17,Phase 2,464,2,100,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,4000,Visit18,18,Phase 2,485,2,84,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,30,1 or 1A,100,4,,,,,,,,1,4,30,,,1,1,4,30,30,4,4,800,800,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV726LZH,1756,,,F,5800,EndofPhase2,18,Phase 2,485,2,100,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,4,722,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,99,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,95,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,2000,Visit8,8,Phase 1/1A,218,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,2200,Visit9,9,Phase 1/1A,248,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,2400,Visit10,10,Phase 1/1A,273,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,2600,Visit11,11,Phase 1/1A,301,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,2800,Visit12,12,Phase 1/1A,329,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,3000,Visit13,13,Phase 1/1A,357,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,3200,Visit14,14,Phase 1/1A,385,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,3400,Visit15,15,Phase 1/1A,413,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,3600,Visit16,16,Phase 1/1A,434,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,3800,Visit17,17,Phase 1/1A,462,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJV977BFE,1913,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,483,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,600,Visit1,1,Phase 1/1A,24,1 or 1A,100,2,,,,,,,,1,2,15,,,2,1,2,18,15,2,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,1200,Visit4,4,Phase 1/1A,122,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,1600,Visit6,6,Phase 1/1A,182,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,1800,Visit7,7,Phase 1/1A,210,1 or 1A,94,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,2000,Visit8,8,Phase 1/1A,240,1 or 1A,98,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,2400,Visit10,10,Phase 2,296,2,82,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,2600,Visit11,11,Phase 2,325,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,2800,Visit12,12,Phase 2,353,2,93,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,3000,Visit13,13,Phase 2,381,2,96,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,3200,Visit14,14,Phase 2,416,2,88,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,3400,Visit15,15,Phase 2,442,2,96,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,3600,Visit16,16,Phase 2,469,2,63,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,268,1 or 1A,97,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW411UUK,1448,,,M,5800,EndofPhase2,17,Phase 2,518,2,89,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,96,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,85,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,3000,Visit13,13,Phase 1/1A,367,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,3800,Visit17,17,Phase 1/1A,491,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW716RBX,1412,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,600,Visit1,1,Phase 1/1A,25,1 or 1A,100,3,,,,,,,,1,3,600,,,2,2,3,600,600,3,3,4,3,3,26,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,1200,Visit4,4,Phase 2,135,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,1400,Visit5,5,Phase 2,152,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,1600,Visit6,6,Phase 2,173,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,2000,Visit8,8,Phase 3,219,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,2200,Visit9,9,Phase 3,249,3,,,,,,1,20,1,0,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,2400,Visit10,10,Phase 3,285,3,,,,,,1,20,1,0,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,2600,Visit11,11,Phase 3,327,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,3000,Visit13,13,Phase 3,395,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,3200,Visit14,14,Phase 3,415,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,3400,Visit15,15,Phase 3,444,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,3600,Visit16,16,Phase 3,479,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,3800,Visit17,17,Phase 3,507,3,,,,,,1,20,1,20,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,86,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,5800,EndofPhase2,7,Phase 2,198,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJW840YA6,1128,,,F,6000,EndofPhase3,18,Phase 3,542,3,,,,,,1,20,1,20,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX042TML,2467,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,92,2,,1,,,,,,1,2,400,,,2,2,2,400,400,2,2,80,80,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,1400,Visit5,5,Phase 2,137,2,96,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,1600,Visit6,6,Phase 2,169,2,98,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,1800,Visit7,7,Phase 2,197,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,2000,Visit8,8,Phase 2,225,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,2200,Visit9,9,Phase 2,253,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,2400,Visit10,10,Phase 2,281,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,2600,Visit11,11,Phase 2,305,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,2800,Visit12,12,Phase 2,337,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,3000,Visit13,13,Phase 2,366,2,94,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,3200,Visit14,14,Phase 2,396,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,3400,Visit15,15,Phase 2,421,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,3600,Visit16,16,Phase 2,452,2,95,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,3800,Visit17,17,Phase 2,477,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,116,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX753JPC,2279,,,F,5800,EndofPhase2,18,Phase 2,507,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX900VAM,1145,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,34,2,,,,,,,,3,2,3,,,2,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX900VAM,1145,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,2,3,,,,,,,,4,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX900VAM,1145,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,45,3,,,,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX900VAM,1145,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,68,3,,,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJX900VAM,1145,,,M,1800,Visit7,7,Phase 1/1A,207,1 or 1A,89,3,,,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,98,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,1400,Visit5,5,Phase 1/1A,140,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,2600,Visit11,11,Phase 1/1A,308,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,3000,Visit13,13,Phase 1/1A,364,1 or 1A,98,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJY447NMK,2184,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,2400,Visit10,10,Phase 1/1A,277,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,2600,Visit11,11,Phase 1/1A,304,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVJZ140NX8,1379,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,1,1,1,8,8,1,1,2,2,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,1200,Visit4,4,Phase 2,113,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,1400,Visit5,5,Phase 2,148,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,1600,Visit6,6,Phase 2,174,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,1800,Visit7,7,Phase 2,204,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,2200,Visit9,9,Phase 2,246,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,2400,Visit10,10,Phase 2,274,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,2600,Visit11,11,Phase 2,309,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,2800,Visit12,12,Phase 2,344,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,3000,Visit13,13,Phase 2,372,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,3200,Visit14,14,Phase 2,400,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,3400,Visit15,15,Phase 2,434,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,88,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKA464PP4,2698,,,M,5800,EndofPhase2,16,Phase 2,439,2,,2,,1,,,,,,,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC015LFK,2435,,,F,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,1,,3,26,23,3,,,,,112,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC015LFK,2435,,,F,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC015LFK,2435,,,F,1000,Visit3,3,Phase 1/1A,97,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC015LFK,2435,,,F,1200,Visit4,4,Phase 1/1A,125,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC015LFK,2435,,,F,1400,Visit5,5,Phase 3,153,3,,,,,,4,80,4,80,1,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC015LFK,2435,,,F,1600,Visit6,6,Phase 3,183,3,,,,,,4,80,4,80,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC015LFK,2435,,,F,1800,Visit7,7,Phase 3,214,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC015LFK,2435,,,F,2000,Visit8,8,Phase 3,239,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC015LFK,2435,,,F,2200,Visit9,9,Phase 3,270,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC015LFK,2435,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,125,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC020KTM,1022,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC086XZB,2765,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,33,1 or 1A,100,4,,1,,,,,,1,4,800,,,2,,4,800,800,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC462WF8,2893,,,F,800,Visit2,2,Phase 1/1A,30,1 or 1A,100,4,,1,,,,,,1,4,800,,,2,,4,800,800,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC462WF8,2893,,,F,1000,Visit3,3,Phase 1/1A,60,1 or 1A,93,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC462WF8,2893,,,F,1200,Visit4,4,Phase 1/1A,88,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC462WF8,2893,,,F,1400,Visit5,5,Phase 1/1A,116,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC462WF8,2893,,,F,1600,Visit6,6,Phase 1/1A,143,1 or 1A,,4,,,,,,,,,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC462WF8,2893,,,F,5200,EndofPhase1_1a,7,Phase 1/1A,197,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC617GT6,2531,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,800,Visit2,2,Phase 2,52,2,90,6,,1,,,,,,1,6,,1200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,1000,Visit3,3,Phase 2,80,2,73,4,,1,,,,,,2,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,1400,Visit5,5,Phase 3,134,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,1600,Visit6,6,Phase 3,175,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,1800,Visit7,7,Phase 3,203,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,2000,Visit8,8,Phase 3,231,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,2200,Visit9,9,Phase 3,252,3,,,,,,3,3,3,1,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,2400,Visit10,10,Phase 3,280,3,,,,,,3,3,3,1,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,2600,Visit11,11,Phase 3,308,3,,,,,,3,1,3,3,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,2800,Visit12,12,Phase 3,337,3,,,,,,3,3,3,1,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,3000,Visit13,13,Phase 3,364,3,,,,,,3,8,,,1,,,,8,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,3200,Visit14,14,Phase 3,388,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,3400,Visit15,15,Phase 3,421,3,,,,,,3,4,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,3600,Visit16,16,Phase 3,456,3,,,,,,3,8,,,1,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,3800,Visit17,17,Phase 3,471,3,,,,,,3,8,,,1,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,17,1 or 1A,100,4,,1,,,,,,1,4,30,,,1,2,4,30,30,4,5,933,800,5,5,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,5800,EndofPhase2,4,Phase 2,99,2,89,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKC621FX1,2781,,,F,6000,EndofPhase3,18,Phase 3,513,3,,,,,,3,8,,,2,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,,,,,,,1,3,22.5,,,2,2,4,27,30,4,3,5,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,78,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,72,4,,,,,,,,2,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,1600,Visit6,6,Phase 2,167,2,89,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,1800,Visit7,7,Phase 2,195,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,2000,Visit8,8,Phase 2,222,2,82,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,2200,Visit9,9,Phase 2,253,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,2400,Visit10,10,Phase 2,280,2,84,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,2600,Visit11,11,Phase 2,310,2,93,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,2800,Visit12,12,Phase 2,337,2,91,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,3000,Visit13,13,Phase 2,377,2,76,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,3200,Visit14,14,Phase 2,390,2,95,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,3400,Visit15,15,Phase 2,414,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,3600,Visit16,16,Phase 2,442,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,3800,Visit17,17,Phase 2,469,2,81,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,128,1 or 1A,97,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD155AP4,1056,,,M,5800,EndofPhase2,18,Phase 2,499,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD981KMB,1169,,,M,600,Visit1,1,Phase 1/1A,22,1 or 1A,100,1,,,,,,,,1,1,1.5,,,1,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD981KMB,1169,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,54,1,,,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD981KMB,1169,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,56,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD981KMB,1169,,,M,1200,Visit4,4,Phase 1/1A,124,1 or 1A,33,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD981KMB,1169,,,M,1400,Visit5,5,Phase 1/1A,162,1 or 1A,29,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD981KMB,1169,,,M,1600,Visit6,6,Phase 1/1A,190,1 or 1A,76,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD981KMB,1169,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD981KMB,1169,,,M,2000,Visit8,8,Phase 1/1A,238,1 or 1A,16,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD981KMB,1169,,,M,2200,Visit9,9,Phase 1/1A,267,1 or 1A,98,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKD981KMB,1169,,,M,2400,Visit10,10,Phase 1/1A,293,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,70,4,,,,,,,,2,4,800,,,2,,4,789,800,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,99,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,92,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,98,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,97,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,1600,Visit6,6,Phase 1/1A,166,1 or 1A,97,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,2000,Visit8,8,Phase 1/1A,221,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,2600,Visit11,11,Phase 1/1A,312,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,3000,Visit13,13,Phase 1/1A,371,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,3200,Visit14,14,Phase 1/1A,399,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,3600,Visit16,16,Phase 1/1A,456,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE116DA7,1391,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,99,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE220URD,2853,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,24,2,,1,,,,,,4,2,400,,,2,2,4,720,800,4,2,80,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE220URD,2853,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE220URD,2853,,,M,1200,Visit4,4,Phase 1/1A,101,1 or 1A,74,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE220URD,2853,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,80,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE220URD,2853,,,M,1800,Visit7,7,Phase 2,199,2,100,2,,1,,,,,,4,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE220URD,2853,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,176,1 or 1A,85,4,,1,,,,,,3,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE220URD,2853,,,M,5800,EndofPhase2,7,Phase 2,205,2,88,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE360AEG,1807,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,69,4,,1,,,,,,1,4,6,,,1,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE360AEG,1807,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,98,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE360AEG,1807,,,M,1000,Visit3,3,Phase 1/1A,98,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE360AEG,1807,,,M,1200,Visit4,4,Phase 1/1A,134,1 or 1A,81,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE360AEG,1807,,,M,1400,Visit5,5,Phase 1/1A,155,1 or 1A,86,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE360AEG,1807,,,M,1600,Visit6,6,Phase 1/1A,192,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE360AEG,1807,,,M,1800,Visit7,7,Phase 1/1A,218,1 or 1A,91,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE360AEG,1807,,,M,2000,Visit8,8,Phase 1/1A,248,1 or 1A,67,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE360AEG,1807,,,M,2200,Visit9,9,Phase 1/1A,276,1 or 1A,75,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE360AEG,1807,,,M,2400,Visit10,10,Phase 1/1A,309,1 or 1A,86,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE360AEG,1807,,,M,2600,Visit11,11,Phase 1/1A,350,1 or 1A,34,4,,1,,,,,,3,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE360AEG,1807,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,394,1 or 1A,42,4,,1,,,,,,3,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE460WG2,2126,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,73,2,,1,,,,,,2,2,400,,,2,,3,511,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,99,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,99,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,99,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE613TKP,2524,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,499,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE735LYG,2620,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE738GKM,1012,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,96,2,,,,,,,,1,2,400,,,2,,2,417,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE738GKM,1012,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,84,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE738GKM,1012,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,95,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE738GKM,1012,,,F,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE738GKM,1012,,,F,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE738GKM,1012,,,F,1600,Visit6,6,Phase 1/1A,175,1 or 1A,92,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE738GKM,1012,,,F,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE738GKM,1012,,,F,2000,Visit8,8,Phase 1/1A,232,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE738GKM,1012,,,F,2200,Visit9,9,Phase 1/1A,267,1 or 1A,92,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE738GKM,1012,,,F,2400,Visit10,10,Phase 1/1A,288,1 or 1A,86,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE738GKM,1012,,,F,2600,Visit11,11,Phase 1/1A,316,1 or 1A,80,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE738GKM,1012,,,F,2800,Visit12,12,Phase 1/1A,342,1 or 1A,50,3,,1,,,,,,3,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,3,,,,,,,,1,3,24,,,2,,3,24,24,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,86,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,98,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,93,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,1400,Visit5,5,Phase 1/1A,146,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,1800,Visit7,7,Phase 1/1A,202,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,2000,Visit8,8,Phase 1/1A,230,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,2200,Visit9,9,Phase 1/1A,249,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,2400,Visit10,10,Phase 1/1A,286,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,2600,Visit11,11,Phase 1/1A,314,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,3000,Visit13,13,Phase 1/1A,370,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,86,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKE958KXT,1449,,,M,3600,Visit16,16,Phase 1/1A,455,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,600,Visit1,1,Phase 1/1A,41,1 or 1A,85,2,,,,,,,,1,2,16,,,2,,4,30,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,1000,Visit3,3,Phase 1/1A,98,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,1200,Visit4,4,Phase 1/1A,125,1 or 1A,80,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,1400,Visit5,5,Phase 1/1A,153,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,1600,Visit6,6,Phase 1/1A,181,1 or 1A,,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,1800,Visit7,7,Phase 1/1A,208,1 or 1A,,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,2000,Visit8,8,Phase 1/1A,230,1 or 1A,,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,2200,Visit9,9,Phase 1/1A,258,1 or 1A,,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,2400,Visit10,10,Phase 1/1A,279,1 or 1A,,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,2600,Visit11,11,Phase 1/1A,301,1 or 1A,,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,2800,Visit12,12,Phase 1/1A,328,1 or 1A,,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,3000,Visit13,13,Phase 1/1A,356,1 or 1A,,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,3400,Visit15,15,Phase 1/1A,391,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF668XU5,1825,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,515,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF908NM7,2538,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,,4,711,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF908NM7,2538,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,92,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF908NM7,2538,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF908NM7,2538,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF908NM7,2538,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,97,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF908NM7,2538,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF908NM7,2538,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,94,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF908NM7,2538,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF908NM7,2538,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,239,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,98,2,,,,,,,,1,2,15,,,1,2,3,20,23,3,2,400,400,2,104,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,1400,Visit5,5,Phase 1/1A,152,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,2200,Visit9,9,Phase 3,253,3,,,,,,4,60,,,1,,,,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,2400,Visit10,10,Phase 3,280,3,,,,,,4,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,2800,Visit12,12,Phase 3,336,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,3000,Visit13,13,Phase 3,364,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,3200,Visit14,14,Phase 3,392,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,3400,Visit15,15,Phase 3,420,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,3600,Visit16,16,Phase 3,448,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,3800,Visit17,17,Phase 3,475,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,204,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,5800,EndofPhase2,8,Phase 2,235,2,92,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF983CB0,2111,,,M,6000,EndofPhase3,18,Phase 3,497,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKF991AAQ,2364,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,1200,Visit4,4,Phase 1/1A,122,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,1400,Visit5,5,Phase 1/1A,157,1 or 1A,75,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,1600,Visit6,6,Phase 1/1A,190,1 or 1A,75,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,1800,Visit7,7,Phase 1/1A,220,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,2000,Visit8,8,Phase 1/1A,248,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,2200,Visit9,9,Phase 1/1A,282,1 or 1A,75,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,2400,Visit10,10,Phase 1/1A,325,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,2600,Visit11,11,Phase 1/1A,360,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,2800,Visit12,12,Phase 1/1A,413,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,3000,Visit13,13,Phase 1/1A,444,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,3200,Visit14,14,Phase 1/1A,472,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,3400,Visit15,15,Phase 1/1A,499,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG034VZ1,1591,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,549,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,1,,3,21,15,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,82,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,91,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,95,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,90,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,95,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,2200,Visit9,9,Phase 1/1A,257,1 or 1A,68,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,79,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,84,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,90,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,81,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,88,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,80,4,,1,,,,,,4,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,3800,Visit17,17,Phase 1/1A,482,1 or 1A,94,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG133MC0,2674,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,510,1 or 1A,71,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,600,Visit1,1,Phase 1/1A,42,1 or 1A,97,3,,,,,,,,1,3,22.5,,,1,,3,20,23,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,800,Visit2,2,Phase 1/1A,70,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,1000,Visit3,3,Phase 1/1A,105,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,1200,Visit4,4,Phase 1/1A,133,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,1400,Visit5,5,Phase 1/1A,161,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,1600,Visit6,6,Phase 1/1A,203,1 or 1A,94,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,1800,Visit7,7,Phase 1/1A,231,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,2000,Visit8,8,Phase 1/1A,259,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,2200,Visit9,9,Phase 1/1A,294,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,2400,Visit10,10,Phase 1/1A,322,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,2600,Visit11,11,Phase 1/1A,357,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,2800,Visit12,12,Phase 1/1A,385,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,3000,Visit13,13,Phase 1/1A,413,1 or 1A,52,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,3200,Visit14,14,Phase 1/1A,448,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,3400,Visit15,15,Phase 1/1A,476,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,3600,Visit16,16,Phase 1/1A,504,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,3800,Visit17,17,Phase 1/1A,539,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,4000,Visit18,18,Phase 1/1A,574,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG251TP1,1523,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,574,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,1,2,2,3,3,2,2,80,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,1200,Visit4,4,Phase 2,128,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,1400,Visit5,5,Phase 2,170,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,1600,Visit6,6,Phase 2,198,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,1800,Visit7,7,Phase 2,231,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,2000,Visit8,8,Phase 2,256,2,100,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,2200,Visit9,9,Phase 2,289,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,2400,Visit10,10,Phase 2,319,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,2600,Visit11,11,Phase 2,352,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,2800,Visit12,12,Phase 2,380,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,3000,Visit13,13,Phase 2,408,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,3200,Visit14,14,Phase 2,436,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,3400,Visit15,15,Phase 2,464,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,3600,Visit16,16,Phase 2,499,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,3800,Visit17,17,Phase 2,534,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,4000,Visit18,18,Phase 2,555,2,98,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG543MEA,2630,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,98,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG589DUB,2530,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,8,1 or 1A,100,2,,,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,1,2,1,2,2,1,3,600,400,3,15,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,1800,Visit7,7,Phase 2,200,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,2000,Visit8,8,Phase 2,233,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,2200,Visit9,9,Phase 2,263,2,96,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,2400,Visit10,10,Phase 2,291,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,2800,Visit12,12,Phase 3,339,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,3000,Visit13,13,Phase 3,368,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,3200,Visit14,14,Phase 3,396,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,3400,Visit15,15,Phase 3,424,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,3600,Visit16,16,Phase 3,452,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,3800,Visit17,17,Phase 3,480,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,184,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,5800,EndofPhase2,11,Phase 2,295,2,75,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG832ZDP,2883,,,M,6000,EndofPhase3,18,Phase 3,512,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,800,Visit2,2,Phase 2,60,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,1000,Visit3,3,Phase 2,88,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,1200,Visit4,4,Phase 2,116,2,98,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,1600,Visit6,6,Phase 2,172,2,,,,0,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,1800,Visit7,7,Phase 2,200,2,98,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,2000,Visit8,8,Phase 2,231,2,98,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,2200,Visit9,9,Phase 2,252,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,2400,Visit10,10,Phase 2,290,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,2600,Visit11,11,Phase 2,309,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,2800,Visit12,12,Phase 2,339,2,97,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,3000,Visit13,13,Phase 2,371,2,97,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,3200,Visit14,14,Phase 2,400,2,97,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,3400,Visit15,15,Phase 2,422,2,,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,3600,Visit16,16,Phase 2,452,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,3800,Visit17,17,Phase 3,473,3,,,,,,2,600,8,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,28,1 or 1A,100,4,,1,,,,,,1,4,160,,,2,2,4,160,160,4,4,30,30,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,5800,EndofPhase2,16,Phase 2,459,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG874DX2,2897,,,F,6000,EndofPhase3,18,Phase 3,501,3,,,,,,2,400,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,1,3,533,600,3,4,140,160,4,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,1200,Visit4,4,Phase 2,100,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,1400,Visit5,5,Phase 2,127,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,1600,Visit6,6,Phase 2,156,2,97,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,1800,Visit7,7,Phase 2,184,2,96,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,2000,Visit8,8,Phase 2,218,2,98,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,2200,Visit9,9,Phase 2,246,2,98,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,2400,Visit10,10,Phase 2,274,2,91,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,2600,Visit11,11,Phase 2,303,2,89,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,2800,Visit12,12,Phase 2,337,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,3000,Visit13,13,Phase 2,373,2,100,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,3200,Visit14,14,Phase 2,394,2,90,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,3600,Visit16,16,Phase 3,435,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,3800,Visit17,17,Phase 3,478,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,74,1 or 1A,94,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,5800,EndofPhase2,15,Phase 2,410,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKG986HC7,2263,,,M,6000,EndofPhase3,18,Phase 3,506,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,4,,,,,,,,1,4,6,,,1,2,4,6,6,4,4,800,800,4,160,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,1400,Visit5,5,Phase 2,129,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,1600,Visit6,6,Phase 2,161,2,94,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,2000,Visit8,8,Phase 3,226,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,2200,Visit9,9,Phase 3,254,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,2400,Visit10,10,Phase 3,282,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,2600,Visit11,11,Phase 3,308,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,2800,Visit12,12,Phase 3,337,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,3000,Visit13,13,Phase 3,365,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,3200,Visit14,14,Phase 3,393,3,,,,,,4,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,3400,Visit15,15,Phase 3,421,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,3600,Visit16,16,Phase 3,448,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,3800,Visit17,17,Phase 3,473,3,,,,,,4,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,102,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,5800,EndofPhase2,7,Phase 2,183,2,99,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKH175HP3,1360,,,F,6000,EndofPhase3,18,Phase 3,504,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ548HBB,2887,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,3,1 or 1A,50,1,,1,,,,,,3,1,200,,,2,,1,200,200,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,2,3,3,5,5,3,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,90,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,1200,Visit4,4,Phase 2,113,2,47,4,,,,,,,,3,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,1400,Visit5,5,Phase 2,141,2,84,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,1600,Visit6,6,Phase 2,173,2,100,5,,,,,,,,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,1800,Visit7,7,Phase 2,204,2,100,6,,,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,2000,Visit8,8,Phase 2,225,2,85,6,,,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,2200,Visit9,9,Phase 2,253,2,100,6,,,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,2400,Visit10,10,Phase 2,279,2,100,6,,,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,2600,Visit11,11,Phase 2,309,2,90,6,,,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,2800,Visit12,12,Phase 2,335,2,100,6,,,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,3200,Visit14,14,Phase 2,393,2,78,6,,1,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,3400,Visit15,15,Phase 2,424,2,100,6,,1,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,3600,Visit16,16,Phase 2,455,2,89,6,,1,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,3800,Visit17,17,Phase 2,470,2,99,6,,1,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKJ827ZBA,1638,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,76,1 or 1A,84,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,600,Visit1,1,Phase 1/1A,18,1 or 1A,100,1,,,,,,,,1,1,1.5,,,1,,1,2,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,800,Visit2,2,Phase 1/1A,46,1 or 1A,96,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,1000,Visit3,3,Phase 1/1A,81,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,1200,Visit4,4,Phase 1/1A,109,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,1400,Visit5,5,Phase 1/1A,137,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,1600,Visit6,6,Phase 1/1A,165,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,1800,Visit7,7,Phase 1/1A,207,1 or 1A,93,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,2000,Visit8,8,Phase 1/1A,222,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,2200,Visit9,9,Phase 1/1A,242,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,2400,Visit10,10,Phase 1/1A,277,1 or 1A,89,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,2600,Visit11,11,Phase 1/1A,312,1 or 1A,97,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,2800,Visit12,12,Phase 1/1A,341,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,3000,Visit13,13,Phase 1/1A,373,1 or 1A,90,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,81,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,3400,Visit15,15,Phase 1/1A,425,1 or 1A,97,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,3600,Visit16,16,Phase 1/1A,445,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,3800,Visit17,17,Phase 1/1A,473,1 or 1A,97,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKK036DX9,1556,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,502,1 or 1A,93,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL043UXP,1919,,,F,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,2,,,,,,,,1,2,3,,,1,2,3,5,3,3,4,160,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL043UXP,1919,,,F,800,Visit2,2,Phase 1/1A,62,1 or 1A,97,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL043UXP,1919,,,F,1000,Visit3,3,Phase 1/1A,89,1 or 1A,95,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL043UXP,1919,,,F,1200,Visit4,4,Phase 1/1A,124,1 or 1A,40,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL043UXP,1919,,,F,1400,Visit5,5,Phase 1/1A,140,1 or 1A,83,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL043UXP,1919,,,F,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL043UXP,1919,,,F,1800,Visit7,7,Phase 1/1A,194,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL043UXP,1919,,,F,2000,Visit8,8,Phase 1/1A,222,1 or 1A,58,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL043UXP,1919,,,F,2200,Visit9,9,Phase 1/1A,244,1 or 1A,100,4,,0,2,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL043UXP,1919,,,F,2400,Visit10,10,Phase 2,285,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL043UXP,1919,,,F,2600,Visit11,11,Phase 2,306,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL043UXP,1919,,,F,5200,EndofPhase1_1a,9,Phase 1/1A,244,1 or 1A,87,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL043UXP,1919,,,F,5800,EndofPhase2,12,Phase 2,327,2,75,4,,1,,,,,,2,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL337YGU,2041,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,98,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL337YGU,2041,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,88,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,95,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,2800,Visit12,12,Phase 1/1A,335,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL650REQ,2082,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,,,,,,,1,3,120,,,2,3,4,147,160,4,,462,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,95,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,1200,Visit4,4,Phase 2,118,2,100,,125,,,,,,,1,,,125,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,1400,Visit5,5,Phase 2,160,2,77,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,1600,Visit6,6,Phase 2,183,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,1800,Visit7,7,Phase 2,211,2,64,,400,,,,,,,2,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,2000,Visit8,8,Phase 2,246,2,100,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,2200,Visit9,9,Phase 2,274,2,100,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,2400,Visit10,10,Phase 2,306,2,100,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,2600,Visit11,11,Phase 2,331,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,2800,Visit12,12,Phase 2,372,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,3000,Visit13,13,Phase 2,399,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,3200,Visit14,14,Phase 2,434,2,74,,500,,,,,,,2,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,3400,Visit15,15,Phase 2,460,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,3600,Visit16,16,Phase 2,490,2,76,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,3800,Visit17,17,Phase 2,516,2,,,500,,,,,,,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,90,1 or 1A,70,4,,,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKL952FVJ,1866,,,M,5800,EndofPhase2,18,Phase 2,541,2,,,400,,,,,,,4,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003VDY,2315,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,95,4,,1,,,,,,1,4,800,,,2,,4,800,800,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003VDY,2315,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003VDY,2315,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,98,3,,,,,,,,1,3,4.5,,,1,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,94,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,88,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,82,3,,,,,,,,4,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,87,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,2400,Visit10,10,Phase 1/1A,279,1 or 1A,93,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,2600,Visit11,11,Phase 1/1A,307,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,2800,Visit12,12,Phase 1/1A,332,1 or 1A,82,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,3000,Visit13,13,Phase 1/1A,363,1 or 1A,82,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,,3,,,,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,3400,Visit15,15,Phase 1/1A,419,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,3600,Visit16,16,Phase 1/1A,447,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,100,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM003XT8,1099,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,503,1 or 1A,,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,86,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,1600,Visit6,6,Phase 1/1A,181,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,2400,Visit10,10,Phase 1/1A,286,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,2600,Visit11,11,Phase 1/1A,314,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,88,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,3400,Visit15,15,Phase 1/1A,419,1 or 1A,85,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,3600,Visit16,16,Phase 1/1A,447,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,3800,Visit17,17,Phase 1/1A,469,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM486MPF,1507,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,510,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,600,Visit1,1,Phase 1/1A,49,1 or 1A,100,1,,,,,,,,1,1,1.5,,,2,,2,3,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,800,Visit2,2,Phase 1/1A,81,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,1000,Visit3,3,Phase 1/1A,109,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,1200,Visit4,4,Phase 1/1A,137,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,1400,Visit5,5,Phase 1/1A,165,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,1600,Visit6,6,Phase 1/1A,193,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,1800,Visit7,7,Phase 1/1A,221,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,2000,Visit8,8,Phase 1/1A,249,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,2200,Visit9,9,Phase 1/1A,277,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,2400,Visit10,10,Phase 1/1A,305,1 or 1A,99,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,2600,Visit11,11,Phase 1/1A,336,1 or 1A,97,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,2800,Visit12,12,Phase 1/1A,364,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,3000,Visit13,13,Phase 1/1A,396,1 or 1A,100,2,,0,2,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,3200,Visit14,14,Phase 1/1A,421,1 or 1A,100,2,,0,2,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,3400,Visit15,15,Phase 1/1A,452,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,3600,Visit16,16,Phase 1/1A,480,1 or 1A,98,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,3800,Visit17,17,Phase 1/1A,505,1 or 1A,100,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM632LXZ,1549,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,533,1 or 1A,97,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,600,Visit1,1,Phase 1/1A,24,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,800,Visit2,2,Phase 1/1A,51,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,1400,Visit5,5,Phase 1/1A,142,1 or 1A,71,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,1600,Visit6,6,Phase 1/1A,170,1 or 1A,95,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,1800,Visit7,7,Phase 1/1A,199,1 or 1A,97,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,2000,Visit8,8,Phase 1/1A,226,1 or 1A,93,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,2200,Visit9,9,Phase 1/1A,254,1 or 1A,98,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,2600,Visit11,11,Phase 1/1A,310,1 or 1A,97,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,2800,Visit12,12,Phase 1/1A,339,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,3200,Visit14,14,Phase 1/1A,402,1 or 1A,93,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,3400,Visit15,15,Phase 1/1A,449,1 or 1A,95,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM736RNK,1072,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,523,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM926NJU,1066,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,89,2,,,,,,,,2,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM926NJU,1066,,,M,800,Visit2,2,Phase 1/1A,42,1 or 1A,82,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKM926NJU,1066,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,42,1 or 1A,82,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,600,Visit1,1,Phase 1/1A,23,1 or 1A,95,2,,,,,,,,1,2,15,,,2,,3,22,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,800,Visit2,2,Phase 1/1A,39,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,1000,Visit3,3,Phase 1/1A,67,1 or 1A,67,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,1200,Visit4,4,Phase 1/1A,102,1 or 1A,75,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,1400,Visit5,5,Phase 1/1A,129,1 or 1A,71,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,1600,Visit6,6,Phase 1/1A,164,1 or 1A,77,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,1800,Visit7,7,Phase 1/1A,186,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,2000,Visit8,8,Phase 1/1A,220,1 or 1A,61,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,81,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,78,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,71,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,2800,Visit12,12,Phase 1/1A,346,1 or 1A,64,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,3000,Visit13,13,Phase 1/1A,367,1 or 1A,87,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,3200,Visit14,14,Phase 1/1A,395,1 or 1A,96,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,3400,Visit15,15,Phase 1/1A,423,1 or 1A,90,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,94,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,3800,Visit17,17,Phase 1/1A,487,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKN096DXL,1179,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,513,1 or 1A,59,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKP474ELA,1232,,,M,600,Visit1,1,Phase 1/1A,45,1 or 1A,,2,,,,,,,,4,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKP474ELA,1232,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,,,,,,,1,2,16,,,2,2,2,16,16,2,2,15,15,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,99,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,88,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,90,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,1600,Visit6,6,Phase 1B,174,1B,98,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,1800,Visit7,7,Phase 1B,197,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,2000,Visit8,8,Phase 1B,225,1B,89,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,2200,Visit9,9,Phase 1B,252,1B,98,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,2400,Visit10,10,Phase 1B,282,1B,95,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,2600,Visit11,11,Phase 1B,310,1B,91,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,2800,Visit12,12,Phase 1B,343,1B,94,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,3000,Visit13,13,Phase 1B,364,1B,98,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,3200,Visit14,14,Phase 1B,393,1B,99,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,3400,Visit15,15,Phase 1B,422,1B,96,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,3800,Visit17,17,Phase 2,474,2,98,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,146,1 or 1A,98,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,5400,EndofPhase1b,16,Phase 1B,439,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR261AJG,1511,,,M,5800,EndofPhase2,18,Phase 2,504,2,95,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR320TJX,2405,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,1,,,,,,1,2,80,,,1,,3,120,80,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR320TJX,2405,,,M,800,Visit2,2,Phase 1/1A,84,1 or 1A,,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR320TJX,2405,,,M,1000,Visit3,3,Phase 1/1A,106,1 or 1A,,4,,,,,,,,,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR320TJX,2405,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,129,1 or 1A,,4,,0,1,,,,,4,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,2,,,,,,,,1,2,16,,,1,2,2,16,16,2,3,500,500,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,1400,Visit5,5,Phase 2,139,2,93,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,1800,Visit7,7,Phase 3,199,3,,,,,,6,,4,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,2000,Visit8,8,Phase 3,227,3,,,,,,6,0,4,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,2200,Visit9,9,Phase 3,260,3,,,,,,6,25,4,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,2400,Visit10,10,Phase 3,279,3,,,,,,6,125,4,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,2600,Visit11,11,Phase 3,308,3,,,,,,6,150,4,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,2800,Visit12,12,Phase 3,339,3,,,,,,6,250,4,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,3000,Visit13,13,Phase 3,367,3,,,,,,6,350,4,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,6,350,4,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,78,1 or 1A,95,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,5400,EndofPhase1b,4,Phase 1B,125,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,5800,EndofPhase2,6,Phase 2,170,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR375VWT,1817,,,M,6000,EndofPhase3,17,Phase 3,489,3,,,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,99,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,1200,Visit4,4,Phase 1/1A,127,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,2000,Visit8,8,Phase 1/1A,230,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,2600,Visit11,11,Phase 1/1A,323,1 or 1A,2,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,2800,Visit12,12,Phase 1/1A,365,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,3000,Visit13,13,Phase 1/1A,398,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,3200,Visit14,14,Phase 1/1A,433,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,3400,Visit15,15,Phase 1/1A,463,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,3600,Visit16,16,Phase 1/1A,496,1 or 1A,85,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,3800,Visit17,17,Phase 1/1A,525,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR422MM7,2308,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,611,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR857UYD,1634,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,,2,,,,,,,,1,2,400,,,2,1,3,600,600,3,3,23,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR857UYD,1634,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR857UYD,1634,,,M,1200,Visit4,4,Phase 2,140,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR857UYD,1634,,,M,1400,Visit5,5,Phase 2,169,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKR857UYD,1634,,,M,5800,EndofPhase2,6,Phase 2,177,2,91,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT226ZH3,1078,,,M,600,Visit1,1,Phase 1/1A,37,1 or 1A,91,1,,,,,,,,1,1,200,,,2,2,3,600,800,3,3,5,6,3,350,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT226ZH3,1078,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,99,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT226ZH3,1078,,,M,1200,Visit4,4,Phase 2,99,2,93,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT226ZH3,1078,,,M,1400,Visit5,5,Phase 2,130,2,97,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT226ZH3,1078,,,M,1800,Visit7,7,Phase 3,204,3,,,,,,6,350,,,3,,,,350,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT226ZH3,1078,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,74,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT226ZH3,1078,,,M,5800,EndofPhase2,6,Phase 2,169,2,96,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT303FNU,2447,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,,,,,,,,,,,,,,2,,3,24,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT303FNU,2447,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT303FNU,2447,,,M,1000,Visit3,3,Phase 1/1A,82,1 or 1A,15,3,,1,,,,,,4,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT303FNU,2447,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,64,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT303FNU,2447,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,78,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT303FNU,2447,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,170,1 or 1A,78,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,1,,,,,,,,1,1,200,,,2,2,1,200,200,1,1,8,8,1,37,40,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,800,Visit2,2,Phase 1/1A,66,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,1000,Visit3,3,Phase 1/1A,101,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,1200,Visit4,4,Phase 1/1A,134,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,1400,Visit5,5,Phase 1/1A,164,1 or 1A,97,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,1800,Visit7,7,Phase 2,213,2,100,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,2000,Visit8,8,Phase 2,241,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,2200,Visit9,9,Phase 2,262,2,100,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,2400,Visit10,10,Phase 2,283,2,100,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,2800,Visit12,12,Phase 3,344,3,,,,,,4,40,,,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,3000,Visit13,13,Phase 3,367,3,,,,,,4,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,3200,Visit14,14,Phase 3,393,3,,,,,,4,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,3400,Visit15,15,Phase 3,423,3,,,,,,4,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,3600,Visit16,16,Phase 3,451,3,,,,,,4,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,3800,Visit17,17,Phase 3,477,3,,,,,,4,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,192,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,5800,EndofPhase2,11,Phase 2,318,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKT596WVU,1046,,,F,6000,EndofPhase3,18,Phase 3,507,3,,,,,,4,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU250FT8,2282,,,M,800,Visit2,2,Phase 2,67,2,0,2,,,,,,,,4,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU250FT8,2282,,,M,1000,Visit3,3,Phase 2,102,2,0,2,,,,,,,,4,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU250FT8,2282,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,10,2,,0,1,,,,,4,2,15,,,1,2,2,15,15,2,2,80,80,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,8,,,1,,3,25,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,96,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,1600,Visit6,6,Phase 1/1A,171,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,2200,Visit9,9,Phase 1/1A,255,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,2800,Visit12,12,Phase 1/1A,339,1 or 1A,93,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,3400,Visit15,15,Phase 1/1A,423,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,3600,Visit16,16,Phase 1/1A,446,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU841WRT,1863,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,506,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,3,,0,1,,,,,1,3,600,,,1,2,3,675,600,3,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,93,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,1200,Visit4,4,Phase 1/1A,133,1 or 1A,96,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,83,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,85,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,2200,Visit9,9,Phase 2,262,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,2400,Visit10,10,Phase 2,288,2,98,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,2600,Visit11,11,Phase 2,316,2,91,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,2800,Visit12,12,Phase 2,353,2,91,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,3000,Visit13,13,Phase 2,379,2,73,4,,1,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,3200,Visit14,14,Phase 2,407,2,88,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,3400,Visit15,15,Phase 2,435,2,95,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,3600,Visit16,16,Phase 2,456,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,3800,Visit17,17,Phase 2,484,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,241,1 or 1A,,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKU947CLP,2011,,,M,5800,EndofPhase2,18,Phase 2,512,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,600,Visit1,1,Phase 1/1A,5,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,2,2,15,15,2,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,800,Visit2,2,Phase 3,41,3,,,,,,2,800,5,32,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,1000,Visit3,3,Phase 3,70,3,,,,,,5,16,2,300,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,1200,Visit4,4,Phase 3,99,3,,,,,,5,32,2,400,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,1400,Visit5,5,Phase 3,127,3,,,,,,2,400,5,32,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,1600,Visit6,6,Phase 3,161,3,,,,,,2,600,5,32,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,1800,Visit7,7,Phase 3,191,3,,,,,,5,32,2,600,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,2000,Visit8,8,Phase 3,219,3,,,,,,5,32,2,600,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,2200,Visit9,9,Phase 3,247,3,,,,,,2,800,5,32,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,2400,Visit10,10,Phase 3,275,3,,,,,,2,800,5,48,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,2600,Visit11,11,Phase 3,303,3,,,,,,2,800,5,48,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,2800,Visit12,12,Phase 3,335,3,,,,,,5,48,2,800,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,3000,Visit13,13,Phase 3,363,3,,,,,,5,48,2,800,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,3200,Visit14,14,Phase 3,391,3,,,,,,5,48,2,800,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,3400,Visit15,15,Phase 3,422,3,,,,,,2,800,5,48,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,3600,Visit16,16,Phase 3,450,3,,,,,,5,48,2,800,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,3800,Visit17,17,Phase 3,474,3,,,,,,2,800,5,48,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,5,1 or 1A,87,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,5800,EndofPhase2,1,Phase 2,12,2,50,2,,1,,,,,,3,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKV233CBM,2724,,,F,6000,EndofPhase3,18,Phase 3,502,3,,,,,,2,800,5,48,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,88,2,,1,,,,,,1,2,15,,,1,2,2,15,15,2,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,800,Visit2,2,Phase 1/1A,55,1 or 1A,89,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,1200,Visit4,4,Phase 1/1A,111,1 or 1A,93,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,1600,Visit6,6,Phase 1/1A,167,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,1800,Visit7,7,Phase 1/1A,195,1 or 1A,80,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,2000,Visit8,8,Phase 1/1A,223,1 or 1A,95,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,85,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,2400,Visit10,10,Phase 1/1A,278,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,2600,Visit11,11,Phase 1/1A,307,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,2800,Visit12,12,Phase 1/1A,331,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,3000,Visit13,13,Phase 1/1A,363,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,3200,Visit14,14,Phase 1/1A,391,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,3600,Visit16,16,Phase 2,447,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,3800,Visit17,17,Phase 2,478,2,73,1,,1,,,,,,2,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,4000,Visit18,18,Phase 2,503,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,4200,Visit19,19,Phase 2,531,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,4400,Visit20,20,Phase 2,559,2,96,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,4600,Visit21,21,Phase 2,587,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,4800,Visit22,22,Phase 2,615,2,95,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,5200,EndofPhase1_1a,15,Phase 1/1A,411,1 or 1A,95,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW099DZA,2186,,,F,5800,EndofPhase2,23,Phase 2,636,2,91,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW756PRT,1428,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,,,,,,,1,3,600,,,2,3,4,700,700,4,,400,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW756PRT,1428,,,M,1000,Visit3,3,Phase 2,91,2,94,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKW756PRT,1428,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,48,1 or 1A,97,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,600,Visit1,1,Phase 1/1A,37,1 or 1A,60,3,,,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,800,Visit2,2,Phase 1/1A,58,,,,,,,,,,,,,,,,2,,3,5,6,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,0,3,,,,,,,,4,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,30,3,,,,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,1600,Visit6,6,Phase 1/1A,184,1 or 1A,32,4,,,,,,,,3,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,1800,Visit7,7,Phase 1/1A,212,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,2000,Visit8,8,Phase 1/1A,240,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,2200,Visit9,9,Phase 1/1A,268,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,2400,Visit10,10,Phase 1/1A,310,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,2600,Visit11,11,Phase 1/1A,338,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,2800,Visit12,12,Phase 1/1A,380,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,3000,Visit13,13,Phase 1/1A,394,1 or 1A,42,4,,1,,,,,,3,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX100LBG,1784,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,74,4,,,,,,,,2,4,30,,,1,,2,18,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,93,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,71,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,95,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,93,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,84,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,2200,Visit9,9,Phase 1/1A,259,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,2400,Visit10,10,Phase 1/1A,289,1 or 1A,68,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,2600,Visit11,11,Phase 1/1A,317,1 or 1A,,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,2800,Visit12,12,Phase 1/1A,345,1 or 1A,98,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX282CC6,1237,,,M,3200,Visit14,14,Phase 1/1A,399,1 or 1A,,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX897UXC,1227,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,88,2,,,,,,,,2,2,400,,,2,,2,420,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX897UXC,1227,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,80,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX897UXC,1227,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,58,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX897UXC,1227,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX897UXC,1227,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX897UXC,1227,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX897UXC,1227,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,96,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX897UXC,1227,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,93,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX897UXC,1227,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,91,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKX897UXC,1227,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY125NUT,2066,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,91,2,,0,1,,,,,1,2,80,,,1,3,3,120,120,3,3,100,100,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY125NUT,2066,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,93,3,,0,1,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY125NUT,2066,,,M,1200,Visit4,4,Phase 2,90,2,73,,100,,,,,,,2,,,100,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY125NUT,2066,,,M,1600,Visit6,6,Phase 2,184,2,41,2,,1,,,,,,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY125NUT,2066,,,M,1800,Visit7,7,Phase 2,215,2,29,7,,1,,,,,,3,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY125NUT,2066,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,72,1 or 1A,72,4,,0,1,,,,,2,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY125NUT,2066,,,M,5800,EndofPhase2,8,Phase 2,280,2,0,1,,,,,,,,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,4,,1,,,,,,1,4,6,,,2,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,1600,Visit6,6,Phase 1/1A,184,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,2000,Visit8,8,Phase 1/1A,239,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,2200,Visit9,9,Phase 1/1A,268,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,2400,Visit10,10,Phase 1/1A,295,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,2600,Visit11,11,Phase 1/1A,323,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,2800,Visit12,12,Phase 1/1A,357,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,3000,Visit13,13,Phase 1/1A,382,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,3200,Visit14,14,Phase 1/1A,411,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,3400,Visit15,15,Phase 1/1A,448,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,3600,Visit16,16,Phase 1/1A,480,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,3800,Visit17,17,Phase 1/1A,512,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKY460GX8,2728,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,545,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,1.5,,,1,,1,2,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,1000,Visit3,3,Phase 1/1A,80,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,1200,Visit4,4,Phase 1/1A,106,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,1600,Visit6,6,Phase 1/1A,177,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,1800,Visit7,7,Phase 1/1A,199,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,2200,Visit9,9,Phase 1/1A,259,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,2400,Visit10,10,Phase 1/1A,283,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,2600,Visit11,11,Phase 1/1A,316,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,2800,Visit12,12,Phase 1/1A,346,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,3000,Visit13,13,Phase 1/1A,380,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,3400,Visit15,15,Phase 1/1A,415,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,3800,Visit17,17,Phase 1/1A,475,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ112BLF,2365,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,78,2,,,,,,,,2,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,800,Visit2,2,Phase 1B,60,1B,50,2,,,,,,,,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,1000,Visit3,3,Phase 1B,91,1B,100,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,1200,Visit4,4,Phase 1B,120,1B,93,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,1400,Visit5,5,Phase 1B,148,1B,100,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,1600,Visit6,6,Phase 1B,184,1B,,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,1800,Visit7,7,Phase 1B,212,1B,100,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,2000,Visit8,8,Phase 1B,240,1B,93,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,2200,Visit9,9,Phase 1B,269,1B,100,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,2400,Visit10,10,Phase 1B,297,1B,100,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,2600,Visit11,11,Phase 1B,325,1B,89,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,2800,Visit12,12,Phase 1B,358,1B,97,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,3000,Visit13,13,Phase 1B,386,1B,,2,,,,,,,,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,3200,Visit14,14,Phase 1B,421,1B,50,2,,0,1,,,,,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,3400,Visit15,15,Phase 1B,449,1B,100,2,,0,1,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,3600,Visit16,16,Phase 1B,470,1B,100,2,,0,1,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,3800,Visit17,17,Phase 1B,490,1B,100,2,,0,1,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,42,1 or 1A,78,2,,,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ215BBD,1001,,,F,5400,EndofPhase1b,18,Phase 1B,511,1B,95,2,,0,1,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ365ZLA,1418,,,M,600,Visit1,1,Phase 1/1A,65,1 or 1A,9,1,,,,,,,,4,1,200,,,2,,1,200,200,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,94,1,,,,,,,,1,1,7.5,,,1,1,2,16,15,2,2,4,5,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,96,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,1400,Visit5,5,Phase 1/1A,135,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,1600,Visit6,6,Phase 1/1A,160,1 or 1A,83,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,2000,Visit8,8,Phase 2,223,2,93,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,2200,Visit9,9,Phase 2,252,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,2400,Visit10,10,Phase 2,279,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,2600,Visit11,11,Phase 2,310,2,76,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,2800,Visit12,12,Phase 2,339,2,90,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,3000,Visit13,13,Phase 2,364,2,92,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,3200,Visit14,14,Phase 2,394,2,87,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,3400,Visit15,15,Phase 2,423,2,48,3,,,,,,,,3,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,3600,Visit16,16,Phase 2,457,2,88,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,3800,Visit17,17,Phase 2,478,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,4,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ377XMU,1533,,,M,5800,EndofPhase2,18,Phase 2,506,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ575RWH,2599,,,M,1000,Visit3,3,Phase 3,78,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ575RWH,2599,,,M,1200,Visit4,4,Phase 3,108,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ575RWH,2599,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,83,2,,1,,,,,,1,2,400,,,2,2,2,400,400,2,2,80,80,2,10,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ575RWH,2599,,,M,5800,EndofPhase2,2,Phase 2,38,2,81,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,16,,,2,,4,31,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,800,Visit2,2,Phase 1/1A,66,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,88,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,96,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,95,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,1800,Visit7,7,Phase 1B,198,1B,73,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,2000,Visit8,8,Phase 1B,223,1B,94,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,2200,Visit9,9,Phase 1B,252,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,2400,Visit10,10,Phase 1B,281,1B,91,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,2600,Visit11,11,Phase 1B,318,1B,97,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,2800,Visit12,12,Phase 1B,338,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,3000,Visit13,13,Phase 1B,365,1B,,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,3200,Visit14,14,Phase 1B,399,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,3400,Visit15,15,Phase 1B,420,1B,79,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,3600,Visit16,16,Phase 1B,456,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,3800,Visit17,17,Phase 1B,484,1B,89,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,175,1 or 1A,83,5,,1,,,,,,2,5,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ749DHX,2623,,,M,5400,EndofPhase1b,18,Phase 1B,521,1B,98,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,91,1,,,,,,,,1,1,8,,,1,1,2,16,16,2,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,800,Visit2,2,Phase 1B,71,1B,100,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,1000,Visit3,3,Phase 1B,108,1B,66,3,,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,1200,Visit4,4,Phase 1B,129,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,1400,Visit5,5,Phase 1B,166,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,1800,Visit7,7,Phase 2,225,2,82,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,2000,Visit8,8,Phase 2,247,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,2200,Visit9,9,Phase 2,278,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,2400,Visit10,10,Phase 2,309,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,2600,Visit11,11,Phase 2,337,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,2800,Visit12,12,Phase 2,365,2,96,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,3000,Visit13,13,Phase 2,395,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,3200,Visit14,14,Phase 2,430,2,94,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,3400,Visit15,15,Phase 2,463,2,64,3,,,,,,,,2,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,3600,Visit16,16,Phase 2,499,2,99,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,3800,Visit17,17,Phase 2,520,2,88,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,4000,Visit18,18,Phase 2,565,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,54,1 or 1A,85,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVKZ899BRA,1124,,,M,5400,EndofPhase1b,6,Phase 1B,200,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,600,Visit1,1,Phase 1/1A,38,1 or 1A,70,3,,1,,,,,,2,3,24,,,1,,3,27,32,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,86,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,84,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,71,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,59,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,27,4,,0,1,,,,,3,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,72,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,2400,Visit10,10,Phase 1/1A,282,1B,99,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,2800,Visit12,12,Phase 1B,317,1B,83,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,3000,Visit13,13,Phase 1B,345,1B,88,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,3200,Visit14,14,Phase 1B,373,1B,83,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,5200,EndofPhase1_1a,11,Phase 1/1A,289,1 or 1A,91,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLA282ARY,2624,,,M,5400,EndofPhase1b,15,Phase 1B,409,1B,42,4,,1,,,,,,3,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,1,,3,25,32,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,99,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,2000,Visit8,8,Phase 1/1A,222,1 or 1A,96,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,2200,Visit9,9,Phase 1/1A,250,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,96,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,3600,Visit16,16,Phase 1/1A,464,1 or 1A,77,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,3800,Visit17,17,Phase 1/1A,492,1 or 1A,96,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB128HEX,1127,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,506,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB355YV8,1033,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,74,2,,,,,,,,2,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB355YV8,1033,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,42,1 or 1A,68,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB538EZT,2443,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,94,1,,1,,,,,,1,1,1.5,,,1,3,3,5,6,3,,256,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB538EZT,2443,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB538EZT,2443,,,M,1200,Visit4,4,Phase 2,132,2,100,,25,,,,,,,1,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB538EZT,2443,,,M,1400,Visit5,5,Phase 2,160,2,89,,175,,,,,,,1,,,175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB538EZT,2443,,,M,1600,Visit6,6,Phase 2,209,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB538EZT,2443,,,M,1800,Visit7,7,Phase 2,230,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB538EZT,2443,,,M,2000,Visit8,8,Phase 2,258,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB538EZT,2443,,,M,2200,Visit9,9,Phase 2,286,2,96,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB538EZT,2443,,,M,2400,Visit10,10,Phase 2,314,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB538EZT,2443,,,M,2600,Visit11,11,Phase 2,342,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB538EZT,2443,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,100,1 or 1A,76,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB538EZT,2443,,,M,5800,EndofPhase2,12,Phase 2,370,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB982ZWN,2281,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,1,,,,,,1,2,3,,,1,2,3,5,3,3,4,140,140,4,21,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB982ZWN,2281,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB982ZWN,2281,,,M,1000,Visit3,3,Phase 1/1A,81,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB982ZWN,2281,,,M,1200,Visit4,4,Phase 1/1A,109,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB982ZWN,2281,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB982ZWN,2281,,,M,1800,Visit7,7,Phase 2,189,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB982ZWN,2281,,,M,2200,Visit9,9,Phase 3,249,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB982ZWN,2281,,,M,2400,Visit10,10,Phase 3,284,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB982ZWN,2281,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB982ZWN,2281,,,M,2800,Visit12,12,Phase 3,337,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB982ZWN,2281,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,151,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB982ZWN,2281,,,M,5800,EndofPhase2,8,Phase 2,218,2,83,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLB982ZWN,2281,,,M,6000,EndofPhase3,12,Phase 3,354,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC113LWB,2696,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,3,25,30,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC113LWB,2696,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,88,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC113LWB,2696,,,M,1000,Visit3,3,Phase 1/1A,79,1 or 1A,92,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC113LWB,2696,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC113LWB,2696,,,M,1400,Visit5,5,Phase 1/1A,134,1 or 1A,74,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC113LWB,2696,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,58,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC164MAC,1208,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,90,2,,,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC164MAC,1208,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,81,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC164MAC,1208,,,M,1000,Visit3,3,Phase 1/1A,102,1 or 1A,76,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC164MAC,1208,,,M,1200,Visit4,4,Phase 1/1A,122,1 or 1A,65,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC164MAC,1208,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,136,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC500ER7,1871,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,3,,,1,1,2,3,3,2,3,138,120,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC500ER7,1871,,,M,800,Visit2,2,Phase 1/1A,66,1 or 1A,70,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC500ER7,1871,,,M,1200,Visit4,4,Phase 2,128,2,89,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC500ER7,1871,,,M,1400,Visit5,5,Phase 2,156,2,80,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC500ER7,1871,,,M,1600,Visit6,6,Phase 2,185,2,16,3,,,,,,,,4,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC500ER7,1871,,,M,1800,Visit7,7,Phase 2,212,2,89,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC500ER7,1871,,,M,2000,Visit8,8,Phase 2,238,2,93,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC500ER7,1871,,,M,2200,Visit9,9,Phase 2,267,2,99,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC500ER7,1871,,,M,2400,Visit10,10,Phase 2,294,2,67,3,,0,1,,,,,4,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC500ER7,1871,,,M,2600,Visit11,11,Phase 2,322,2,95,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC500ER7,1871,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,106,1 or 1A,92,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC500ER7,1871,,,M,5800,EndofPhase2,11,Phase 2,338,2,,4,,,,,,,,,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,1,,,,,,1,4,30,,,2,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,78,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,71,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,41,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,91,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,1800,Visit7,7,Phase 1/1A,206,1 or 1A,87,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,2000,Visit8,8,Phase 1/1A,238,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,2200,Visit9,9,Phase 1/1A,266,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,2400,Visit10,10,Phase 1/1A,287,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,2600,Visit11,11,Phase 1/1A,322,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,3000,Visit13,13,Phase 1/1A,371,1 or 1A,91,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,3200,Visit14,14,Phase 1/1A,414,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,3400,Visit15,15,Phase 1/1A,427,1 or 1A,,4,,1,,,,,,,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,3600,Visit16,16,Phase 1/1A,471,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,3800,Visit17,17,Phase 1/1A,497,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738JBL,2248,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,525,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,,,,,,,1,3,22.5,,,1,,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLC738TNV,2013,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,503,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLD134LEG,1575,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,37,1 or 1A,82,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLD572XB3,2783,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,100,2,,0,2,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLD572XB3,2783,,,M,800,Visit2,2,Phase 1/1A,51,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLD572XB3,2783,,,M,1000,Visit3,3,Phase 1/1A,101,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,800,Visit2,2,Phase 2,36,2,96,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,1000,Visit3,3,Phase 2,63,2,100,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,1200,Visit4,4,Phase 2,98,2,100,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,1400,Visit5,5,Phase 2,133,2,100,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,1600,Visit6,6,Phase 2,167,2,97,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,1800,Visit7,7,Phase 2,194,2,100,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,2000,Visit8,8,Phase 2,219,2,99,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,2200,Visit9,9,Phase 2,247,2,100,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,2400,Visit10,10,Phase 2,274,2,100,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,2600,Visit11,11,Phase 2,309,2,100,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,2800,Visit12,12,Phase 2,336,2,99,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,3000,Visit13,13,Phase 2,365,2,100,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,9,1 or 1A,22,2,,0,1,,,,,4,2,80,,,1,1,2,80,80,2,2,400,400,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLE131NYP,2759,,,F,5800,EndofPhase2,14,Phase 2,393,2,100,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLF125KA8,1349,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,2,,,,,,,,4,2,15,,,2,,3,19,19,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLF125KA8,1349,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,,3,,,,,,,,,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,79,4,,,,,,,,1,4,800,,,2,1,4,800,800,4,4,6,6,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,99,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,97,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,99,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,83,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,2000,Visit8,8,Phase 2,229,2,85,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,2200,Visit9,9,Phase 2,269,2,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,2400,Visit10,10,Phase 2,299,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,2600,Visit11,11,Phase 2,330,2,99,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,2800,Visit12,12,Phase 2,359,2,100,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,3000,Visit13,13,Phase 2,389,2,100,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,3200,Visit14,14,Phase 2,421,2,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,3400,Visit15,15,Phase 2,451,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,3600,Visit16,16,Phase 2,480,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,3800,Visit17,17,Phase 2,512,2,,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,184,1 or 1A,,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG113LD8,1769,,,M,5800,EndofPhase2,18,Phase 2,541,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,600,Visit1,1,Phase 1/1A,36,1 or 1A,88,2,,,,,,,,1,2,16,,,1,,3,20,16,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,800,Visit2,2,Phase 1/1A,67,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,1400,Visit5,5,Phase 1/1A,148,1 or 1A,91,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,1600,Visit6,6,Phase 1/1A,186,1 or 1A,99,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,1800,Visit7,7,Phase 1/1A,212,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,2000,Visit8,8,Phase 1/1A,235,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,2200,Visit9,9,Phase 1/1A,263,1 or 1A,96,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,88,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,94,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,2800,Visit12,12,Phase 1/1A,358,1 or 1A,83,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,3000,Visit13,13,Phase 1/1A,379,1 or 1A,92,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,3200,Visit14,14,Phase 1/1A,414,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,3400,Visit15,15,Phase 1/1A,436,1 or 1A,82,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,3600,Visit16,16,Phase 1/1A,473,1 or 1A,86,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,3800,Visit17,17,Phase 1/1A,494,1 or 1A,83,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG609WBM,1605,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,526,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG948HKH,2888,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,2,3,107,120,3,2,400,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG948HKH,2888,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG948HKH,2888,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG948HKH,2888,,,M,1400,Visit5,5,Phase 1/1A,136,1 or 1A,69,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG948HKH,2888,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG948HKH,2888,,,M,2600,Visit11,11,Phase 2,304,2,74,2,,1,,,,,,2,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG948HKH,2888,,,M,2800,Visit12,12,Phase 2,339,2,80,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLG948HKH,2888,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,260,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH277HFT,2474,,,M,600,Visit1,1,Phase 1/1A,43,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH277HFT,2474,,,M,800,Visit2,2,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH277HFT,2474,,,M,1000,Visit3,3,Phase 1/1A,115,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH277HFT,2474,,,M,1200,Visit4,4,Phase 1/1A,136,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH277HFT,2474,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,176,1 or 1A,0,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,98,2,,,,,,,,1,2,15,,,2,2,2,15,15,2,2,2,2,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,1600,Visit6,6,Phase 2,170,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,1800,Visit7,7,Phase 2,197,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,2000,Visit8,8,Phase 2,227,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,2200,Visit9,9,Phase 2,254,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,2400,Visit10,10,Phase 2,284,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,2600,Visit11,11,Phase 2,309,2,72,1,,,,,,,,2,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,2800,Visit12,12,Phase 2,332,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,3000,Visit13,13,Phase 2,361,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,3200,Visit14,14,Phase 2,396,2,97,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,3400,Visit15,15,Phase 2,427,2,88,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,3600,Visit16,16,Phase 2,451,2,100,,0,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,3800,Visit17,17,Phase 2,479,2,95,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,4000,Visit18,18,Phase 2,518,2,100,3,,0,2,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH348NRN,1649,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,135,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH411AZH,1571,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,86,2,,,,,,,,1,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH411AZH,1571,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH411AZH,1571,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,109,1 or 1A,,2,,,,,,,,,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH471MZY,1246,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,80,2,,,,,,,,1,2,3,,,2,,2,2,2,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLH471MZY,1246,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ244MAY,2727,,,M,600,Visit1,1,Phase 1/1A,21,1 or 1A,100,3,,1,,,,,,1,3,120,,,1,,4,150,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ244MAY,2727,,,M,800,Visit2,2,Phase 1/1A,49,1 or 1A,70,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ244MAY,2727,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,75,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ244MAY,2727,,,M,1400,Visit5,5,Phase 1/1A,138,1 or 1A,38,4,,0,1,,,,,3,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,800,Visit2,2,Phase 2,71,2,92,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,1000,Visit3,3,Phase 2,85,2,94,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,1200,Visit4,4,Phase 2,116,2,89,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,1400,Visit5,5,Phase 2,148,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,1600,Visit6,6,Phase 2,176,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,1800,Visit7,7,Phase 2,198,2,87,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,2000,Visit8,8,Phase 2,225,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,2200,Visit9,9,Phase 2,249,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,2400,Visit10,10,Phase 2,281,2,95,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,2600,Visit11,11,Phase 2,310,2,93,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,2800,Visit12,12,Phase 2,345,2,89,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,3000,Visit13,13,Phase 2,366,2,95,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,3200,Visit14,14,Phase 2,394,2,91,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,3400,Visit15,15,Phase 2,421,2,96,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,3600,Visit16,16,Phase 2,449,2,98,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,3800,Visit17,17,Phase 2,477,2,93,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,92,2,,1,,,,,,1,2,80,,,2,2,2,80,80,2,4,6,6,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ704BGG,2232,,,F,5800,EndofPhase2,18,Phase 2,507,2,92,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,84,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,96,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,86,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,2400,Visit10,10,Phase 1/1A,278,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,2600,Visit11,11,Phase 1/1A,307,1 or 1A,90,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,2800,Visit12,12,Phase 1/1A,335,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,3000,Visit13,13,Phase 1/1A,362,1 or 1A,82,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,3400,Visit15,15,Phase 1/1A,419,1 or 1A,97,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,3600,Visit16,16,Phase 1/1A,447,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,91,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLJ804HFZ,1823,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,497,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,1,2,,,,,,,,1,2,3,,,2,1,3,5,5,3,1,10,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,1000,Visit3,3,Phase 2,93,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,1200,Visit4,4,Phase 2,121,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,1400,Visit5,5,Phase 2,148,2,100,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,1600,Visit6,6,Phase 2,177,2,100,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,1800,Visit7,7,Phase 2,205,2,100,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,2000,Visit8,8,Phase 2,232,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,2200,Visit9,9,Phase 2,261,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,2400,Visit10,10,Phase 2,287,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,2600,Visit11,11,Phase 2,317,2,100,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,2800,Visit12,12,Phase 2,345,2,100,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,3000,Visit13,13,Phase 2,373,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,3200,Visit14,14,Phase 2,401,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,3400,Visit15,15,Phase 2,429,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,3600,Visit16,16,Phase 2,457,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,3800,Visit17,17,Phase 2,485,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,4000,Visit18,18,Phase 2,512,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK310ZV1,2171,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,63,1 or 1A,95,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK368KRY,2708,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,2,,1,,,,,,,2,3,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK368KRY,2708,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,,,,1,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK409XVG,2862,,,M,600,Visit1,1,Phase 1/1A,43,1 or 1A,100,2,,1,,,,,,1,2,16,,,2,,2,19,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK409XVG,2862,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,50,2,,1,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK409XVG,2862,,,M,1200,Visit4,4,Phase 1B,125,1B,,1,,,,,,,,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK409XVG,2862,,,M,1400,Visit5,5,Phase 1B,152,1B,,2,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK409XVG,2862,,,M,1600,Visit6,6,Phase 1B,200,1B,,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK409XVG,2862,,,M,1800,Visit7,7,Phase 1B,236,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK409XVG,2862,,,M,2000,Visit8,8,Phase 1B,264,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK409XVG,2862,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,92,1 or 1A,,3,,,,,,,,,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK409XVG,2862,,,M,5400,EndofPhase1b,8,Phase 1B,271,1B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,600,Visit1,1,Phase 1/1A,27,,,,,,,,,,,,,,,,2,2,3,5,5,3,,,,,29,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,1200,Visit4,4,Phase 3,117,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,1400,Visit5,5,Phase 3,153,3,,,,,,1,20,1,0,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,1600,Visit6,6,Phase 3,186,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,1800,Visit7,7,Phase 3,218,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,2000,Visit8,8,Phase 3,253,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,2200,Visit9,9,Phase 3,288,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,2400,Visit10,10,Phase 3,321,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,2600,Visit11,11,Phase 3,397,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,2800,Visit12,12,Phase 3,425,3,,,,,,1,20,1,20,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,3000,Visit13,13,Phase 3,468,3,,,,,,1,20,1,20,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,3200,Visit14,14,Phase 3,501,3,,,,,,1,20,1,20,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,3400,Visit15,15,Phase 3,529,3,,,,,,1,20,1,20,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,3600,Visit16,16,Phase 3,551,3,,,,,,1,20,1,20,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,27,1 or 1A,100,3,,,,,,,,4,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,5800,EndofPhase2,2,Phase 2,56,2,,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK667RA5,1016,,,M,6000,EndofPhase3,16,Phase 3,564,3,,,,,,1,20,1,20,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,15,,,2,3,3,23,23,3,,517,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,94,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,1200,Visit4,4,Phase 2,100,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,1400,Visit5,5,Phase 2,130,2,91,,350,,,,,,,1,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,1600,Visit6,6,Phase 2,164,2,97,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,1800,Visit7,7,Phase 2,197,2,87,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,2000,Visit8,8,Phase 2,225,2,93,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,2200,Visit9,9,Phase 2,253,2,92,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,2400,Visit10,10,Phase 2,281,2,99,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,2600,Visit11,11,Phase 2,309,2,92,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,2800,Visit12,12,Phase 2,333,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,3000,Visit13,13,Phase 2,365,2,92,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,3200,Visit14,14,Phase 2,393,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,3400,Visit15,15,Phase 2,421,2,100,,600,,,,,,,1,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,3600,Visit16,16,Phase 2,443,2,99,,700,,,,,,,1,,,700,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,3800,Visit17,17,Phase 2,477,2,100,,700,,,,,,,1,,,700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,65,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLK707KDG,2105,,,F,5800,EndofPhase2,18,Phase 2,505,2,94,,700,,,,,,,1,,,700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,63,4,,1,,,,,,2,4,800,,,2,2,4,800,800,4,4,6,6,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,1000,Visit3,3,Phase 2,85,2,76,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,1200,Visit4,4,Phase 2,113,2,54,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,1400,Visit5,5,Phase 2,141,2,95,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,1600,Visit6,6,Phase 2,167,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,1800,Visit7,7,Phase 2,197,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,2000,Visit8,8,Phase 2,225,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,2200,Visit9,9,Phase 2,253,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,2400,Visit10,10,Phase 2,286,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,2600,Visit11,11,Phase 2,309,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,2800,Visit12,12,Phase 2,341,2,98,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,3200,Visit14,14,Phase 2,389,2,5,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,3600,Visit16,16,Phase 2,447,2,45,4,,1,,,,,,3,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,3800,Visit17,17,Phase 2,480,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,53,1 or 1A,79,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL215JLR,2732,,,M,5800,EndofPhase2,18,Phase 2,509,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,88,2,,,,,,,,1,2,16,,,2,,2,19,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,96,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,1400,Visit5,5,Phase 1B,140,1B,97,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,1600,Visit6,6,Phase 1B,175,1B,93,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,1800,Visit7,7,Phase 1B,196,1B,95,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,2000,Visit8,8,Phase 1B,223,1B,91,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,2200,Visit9,9,Phase 1B,253,1B,91,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,2400,Visit10,10,Phase 1B,286,1B,47,2,,1,,,,,,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,2600,Visit11,11,Phase 1B,307,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,2800,Visit12,12,Phase 1B,335,1B,74,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,3000,Visit13,13,Phase 1B,363,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,3200,Visit14,14,Phase 1B,392,1B,84,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,3400,Visit15,15,Phase 1B,424,1B,81,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,3600,Visit16,16,Phase 1B,448,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,3800,Visit17,17,Phase 1B,476,1B,60,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,102,1 or 1A,,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL288KNC,2042,,,M,5400,EndofPhase1b,18,Phase 1B,503,1B,94,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL614WJ7,1500,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,4,2,16,,,2,,4,29,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL614WJ7,1500,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL614WJ7,1500,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL614WJ7,1500,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL614WJ7,1500,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,95,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,600,Visit1,1,Phase 2,36,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,800,Visit2,2,Phase 2,64,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,1000,Visit3,3,Phase 2,83,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,1200,Visit4,4,Phase 2,111,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,1400,Visit5,5,Phase 2,141,2,55,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,1600,Visit6,6,Phase 2,170,2,67,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,1800,Visit7,7,Phase 2,197,2,91,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,2000,Visit8,8,Phase 2,223,2,96,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,2200,Visit9,9,Phase 2,251,2,94,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,2400,Visit10,10,Phase 2,279,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,2600,Visit11,11,Phase 2,303,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,2800,Visit12,12,Phase 2,330,2,83,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,3000,Visit13,13,Phase 2,358,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,3200,Visit14,14,Phase 2,394,2,83,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,3400,Visit15,15,Phase 2,427,2,78,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,3600,Visit16,16,Phase 2,440,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,3800,Visit17,17,Phase 2,468,2,82,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,4000,Visit18,18,Phase 2,497,2,74,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL765HV9,1505,,,M,5200,EndofPhase1_1a,0,Phase 1/1A,8,1 or 1A,100,2,,,,,,,,1,2,400,,,2,1,2,400,400,2,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,120,,,2,,3,127,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,1400,Visit5,5,Phase 1/1A,146,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,1600,Visit6,6,Phase 1/1A,192,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,1800,Visit7,7,Phase 1/1A,209,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,2000,Visit8,8,Phase 1/1A,241,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,2200,Visit9,9,Phase 1/1A,272,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,2400,Visit10,10,Phase 1/1A,303,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,2600,Visit11,11,Phase 1/1A,343,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,2800,Visit12,12,Phase 1/1A,373,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,3000,Visit13,13,Phase 1/1A,405,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,3200,Visit14,14,Phase 1/1A,433,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,3400,Visit15,15,Phase 1/1A,461,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,3600,Visit16,16,Phase 1/1A,496,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,3800,Visit17,17,Phase 1/1A,527,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL816KXF,2026,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,555,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,3,,,,,,,,1,3,22.5,,,1,,3,22,23,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,81,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,76,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,80,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,93,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,80,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,57,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,3400,Visit15,15,Phase 1/1A,449,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLL921FKT,1064,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,44,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,99,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,2200,Visit9,9,Phase 1/1A,266,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,2400,Visit10,10,Phase 1/1A,295,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,2600,Visit11,11,Phase 1/1A,329,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,2800,Visit12,12,Phase 1/1A,367,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,3000,Visit13,13,Phase 1/1A,396,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,3200,Visit14,14,Phase 1/1A,424,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,3400,Visit15,15,Phase 1/1A,449,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,3600,Visit16,16,Phase 1/1A,477,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,3800,Visit17,17,Phase 1/1A,505,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM190MXJ,1762,,,M,4000,Visit18,18,Phase 1/1A,540,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLM361KWN,1494,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,94,4,,1,,,,,,1,4,32,,,1,,4,32,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN140DEQ,2407,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,600,Visit1,1,Phase 1/1A,24,1 or 1A,100,2,,,,,,,,1,2,16,,,1,,3,27,32,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,800,Visit2,2,Phase 1/1A,51,1 or 1A,86,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,1400,Visit5,5,Phase 1B,120,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,1600,Visit6,6,Phase 1B,134,1B,96,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,1800,Visit7,7,Phase 1B,173,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,2000,Visit8,8,Phase 1B,197,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,2200,Visit9,9,Phase 1B,225,1B,37,4,,1,,,,,,3,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,2400,Visit10,10,Phase 1B,250,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,2600,Visit11,11,Phase 1B,274,1B,88,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,2800,Visit12,12,Phase 1B,299,1B,91,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,3000,Visit13,13,Phase 1B,330,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,3200,Visit14,14,Phase 1B,365,1B,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,3400,Visit15,15,Phase 1B,386,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,3600,Visit16,16,Phase 1B,415,1B,93,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,3800,Visit17,17,Phase 1B,442,1B,94,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,93,1 or 1A,,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN538UKX,1389,,,M,5400,EndofPhase1b,18,Phase 1B,477,1B,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,2,,1,,,,,,1,2,16,,,1,,3,23,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,1000,Visit3,3,Phase 1/1A,82,1 or 1A,95,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,98,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,94,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,96,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,3,,0,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,89,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,2800,Visit12,12,Phase 1/1A,330,1 or 1A,99,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,3400,Visit15,15,Phase 1/1A,424,1 or 1A,93,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,99,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,3800,Visit17,17,Phase 1/1A,480,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLN961YU6,2147,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,511,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLP321TBN,1485,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,2,2,2,15,15,2,3,667,800,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLP321TBN,1485,,,M,800,Visit2,2,Phase 1/1A,71,1 or 1A,99,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLP321TBN,1485,,,M,1000,Visit3,3,Phase 1/1A,101,1 or 1A,71,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLP321TBN,1485,,,M,1200,Visit4,4,Phase 1/1A,136,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLP321TBN,1485,,,M,1400,Visit5,5,Phase 1/1A,176,1 or 1A,94,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLP321TBN,1485,,,M,1600,Visit6,6,Phase 1/1A,214,1 or 1A,92,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLP321TBN,1485,,,M,1800,Visit7,7,Phase 1/1A,238,1 or 1A,83,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLP321TBN,1485,,,M,2200,Visit9,9,Phase 1/1A,282,1 or 1A,95,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLP321TBN,1485,,,M,2600,Visit11,11,Phase 1/1A,315,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLP321TBN,1485,,,M,4000,Visit18,18,Phase 2,477,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLP321TBN,1485,,,M,4600,Visit21,21,Phase 2,554,2,84,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLP321TBN,1485,,,M,4800,Visit22,22,Phase 2,582,2,94,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLP321TBN,1485,,,M,5800,EndofPhase2,23,Phase 2,620,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR186ZGE,1819,,,M,600,Visit1,1,Phase 2,29,2,76,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR186ZGE,1819,,,M,800,Visit2,2,Phase 2,57,2,97,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR186ZGE,1819,,,M,1000,Visit3,3,Phase 2,86,2,88,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR186ZGE,1819,,,M,1200,Visit4,4,Phase 2,113,2,90,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR186ZGE,1819,,,M,1400,Visit5,5,Phase 2,141,2,,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR186ZGE,1819,,,M,5200,EndofPhase1_1a,0,Phase 1/1A,7,1 or 1A,86,1,,,,,,,,1,1,1.5,,,1,2,1,2,2,1,2,400,400,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR186ZGE,1819,,,M,5800,EndofPhase2,6,Phase 2,168,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,13,2,,,,,,,,4,2,15,,,1,1,2,15,15,2,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,71,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,1200,Visit4,4,Phase 2,114,2,69,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,1400,Visit5,5,Phase 2,144,2,73,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,1600,Visit6,6,Phase 2,169,2,56,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,1800,Visit7,7,Phase 2,197,2,75,2,,1,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,2000,Visit8,8,Phase 2,227,2,73,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,2200,Visit9,9,Phase 2,254,2,79,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,2400,Visit10,10,Phase 2,281,2,83,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,2600,Visit11,11,Phase 2,308,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,2800,Visit12,12,Phase 2,337,2,71,2,,1,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,3000,Visit13,13,Phase 2,372,2,63,2,,1,,,,,,3,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,3200,Visit14,14,Phase 2,394,2,75,2,,1,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,3400,Visit15,15,Phase 2,436,2,63,3,,1,,,,,,2,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,3600,Visit16,16,Phase 2,458,2,97,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,92,1 or 1A,40,2,,,,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR341AGJ,1153,,,M,5800,EndofPhase2,17,Phase 2,477,2,100,3,,1,,,,,,3,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,98,3,,0,1,,,,,1,3,600,,,1,2,3,575,600,3,2,15,15,2,13,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,2400,Visit10,10,Phase 3,224,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,2600,Visit11,11,Phase 3,259,3,,,,,,8,10,,,,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,2800,Visit12,12,Phase 3,288,3,,,,,,8,10,,,,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,3000,Visit13,13,Phase 3,315,3,,,,,,8,15,,,,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,3200,Visit14,14,Phase 3,347,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,3400,Visit15,15,Phase 3,378,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,3600,Visit16,16,Phase 3,399,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,3800,Visit17,17,Phase 3,423,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,204,1 or 1A,87,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,5800,EndofPhase2,9,Phase 2,212,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR359HJE,2621,,,M,6000,EndofPhase3,18,Phase 3,441,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,73,1,,,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,1200,Visit4,4,Phase 1/1A,125,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,97,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,96,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,97,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,2800,Visit12,12,Phase 1/1A,350,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,3000,Visit13,13,Phase 1/1A,370,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,3200,Visit14,14,Phase 1/1A,401,1 or 1A,93,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,3400,Visit15,15,Phase 1/1A,433,1 or 1A,,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLR806ZAL,1630,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,504,1 or 1A,96,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,82,4,,,,,,,,1,4,6,,,1,,3,5,6,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,800,Visit2,2,Phase 1/1A,63,1 or 1A,95,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,1000,Visit3,3,Phase 1/1A,88,1 or 1A,96,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,1200,Visit4,4,Phase 1/1A,115,1 or 1A,94,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,1600,Visit6,6,Phase 1/1A,175,1 or 1A,97,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,1800,Visit7,7,Phase 1/1A,206,1 or 1A,99,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,2000,Visit8,8,Phase 1/1A,245,1 or 1A,97,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,2200,Visit9,9,Phase 1/1A,269,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,2400,Visit10,10,Phase 1/1A,297,1 or 1A,96,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,2600,Visit11,11,Phase 1/1A,325,1 or 1A,94,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,2800,Visit12,12,Phase 1/1A,350,1 or 1A,84,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,3000,Visit13,13,Phase 1/1A,378,1 or 1A,100,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,3200,Visit14,14,Phase 1/1A,416,1 or 1A,100,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,3400,Visit15,15,Phase 1/1A,444,1 or 1A,83,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,3600,Visit16,16,Phase 1/1A,472,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,3800,Visit17,17,Phase 1/1A,511,1 or 1A,95,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLT848KRW,1714,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,540,1 or 1A,91,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,90,1,,,,,,,,1,1,40,,,1,,1,40,40,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,1,,1,,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,97,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,2400,Visit10,10,Phase 1/1A,279,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,2600,Visit11,11,Phase 1/1A,307,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,2800,Visit12,12,Phase 1/1A,335,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,3000,Visit13,13,Phase 1/1A,363,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,89,1,,1,,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU090ZX3,2161,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,96,2,,,,,,,,1,2,400,,,2,3,3,600,600,3,3,379,450,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,87,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,1200,Visit4,4,Phase 2,113,2,82,,100,,,,,,,1,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,1400,Visit5,5,Phase 2,141,2,79,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,1600,Visit6,6,Phase 2,168,2,89,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,1800,Visit7,7,Phase 2,197,2,92,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,2000,Visit8,8,Phase 2,218,2,98,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,2200,Visit9,9,Phase 2,258,2,96,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,2400,Visit10,10,Phase 2,282,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,2600,Visit11,11,Phase 2,309,2,98,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,2800,Visit12,12,Phase 2,334,2,77,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,3000,Visit13,13,Phase 2,366,2,93,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,3200,Visit14,14,Phase 2,398,2,98,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,3400,Visit15,15,Phase 2,426,2,98,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,3600,Visit16,16,Phase 2,448,2,89,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,3800,Visit17,17,Phase 2,477,2,90,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,89,1 or 1A,84,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU137ERT,1328,,,M,5800,EndofPhase2,18,Phase 2,504,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU425AN3,2876,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,4,,0,,,,,,1,4,160,,,1,1,4,140,120,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU425AN3,2876,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,3,,0,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU425AN3,2876,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU425AN3,2876,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU425AN3,2876,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU425AN3,2876,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU425AN3,2876,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,226,1 or 1A,,,,,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU425AN3,2876,,,M,5800,EndofPhase2,8,Phase 2,267,2,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,,,,1,,,,,,,,,,,1,,1,8,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,93,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,96,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,2800,Visit12,12,Phase 1/1A,330,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,3000,Visit13,13,Phase 1/1A,372,1 or 1A,90,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU534TP0,2553,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,,1,,1,,,,,,,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU800FDD,2664,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,37,1 or 1A,78,1,,1,,,,,,1,1,40,,,2,,1,40,40,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU883HM0,2414,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,4,,1,,,,,,1,4,160,,,2,2,3,133,120,3,3,4,4,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU883HM0,2414,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU883HM0,2414,,,M,1200,Visit4,4,Phase 2,120,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU883HM0,2414,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,81,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU883HM0,2414,,,M,5800,EndofPhase2,5,Phase 2,143,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,600,Visit1,1,Phase 1/1A,37,1 or 1A,100,2,,1,,,,,,1,2,80,,,1,,1,53,40,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,800,Visit2,2,Phase 1/1A,72,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,1000,Visit3,3,Phase 1/1A,98,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,1200,Visit4,4,Phase 1/1A,128,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,1400,Visit5,5,Phase 1/1A,168,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,1600,Visit6,6,Phase 1/1A,196,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,1800,Visit7,7,Phase 1/1A,233,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,2200,Visit9,9,Phase 1/1A,294,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,2400,Visit10,10,Phase 1/1A,331,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,2600,Visit11,11,Phase 1/1A,359,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,2800,Visit12,12,Phase 1/1A,387,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,3000,Visit13,13,Phase 1/1A,415,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,3200,Visit14,14,Phase 1/1A,443,1 or 1A,78,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,3400,Visit15,15,Phase 1/1A,478,1 or 1A,89,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,3600,Visit16,16,Phase 1/1A,527,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLU985JW3,2602,,,F,4000,Visit18,18,Phase 1/1A,560,1 or 1A,100,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,1,,2,15,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,1000,Visit3,3,Phase 1/1A,99,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,1600,Visit6,6,Phase 1/1A,183,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,1800,Visit7,7,Phase 1/1A,204,1 or 1A,95,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,2000,Visit8,8,Phase 1/1A,232,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,2200,Visit9,9,Phase 1/1A,273,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,2400,Visit10,10,Phase 1/1A,303,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,2600,Visit11,11,Phase 1/1A,330,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,2800,Visit12,12,Phase 1/1A,359,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,3000,Visit13,13,Phase 1/1A,394,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLV570TXE,1193,,,F,3200,Visit14,14,Phase 1/1A,429,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW132VAR,2035,,,F,600,Visit1,1,Phase 1/1A,23,1 or 1A,100,2,,1,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW132VAR,2035,,,F,800,Visit2,2,Phase 1/1A,51,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW132VAR,2035,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW132VAR,2035,,,F,1200,Visit4,4,Phase 1/1A,116,1 or 1A,97,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW132VAR,2035,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW132VAR,2035,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,77,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW132VAR,2035,,,F,2200,Visit9,9,Phase 1/1A,261,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,600,,,2,1,3,600,600,3,3,23,23,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,41,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,73,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,1200,Visit4,4,Phase 1/1A,129,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,1600,Visit6,6,Phase 2,200,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,2000,Visit8,8,Phase 2,228,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,2200,Visit9,9,Phase 2,253,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,2400,Visit10,10,Phase 2,284,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,2600,Visit11,11,Phase 2,310,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,2800,Visit12,12,Phase 2,339,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,3000,Visit13,13,Phase 2,366,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,3200,Visit14,14,Phase 2,394,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,3400,Visit15,15,Phase 2,422,2,,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,3600,Visit16,16,Phase 2,450,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,3800,Visit17,17,Phase 2,477,2,,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,136,1 or 1A,50,3,,1,,,,,,3,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW210WH8,2404,,,M,5800,EndofPhase2,18,Phase 2,507,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,4,733,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,1600,Visit6,6,Phase 1/1A,163,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW305RHQ,1219,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,503,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW894CPZ,1754,,,M,600,Visit1,1,Phase 1/1A,57,1 or 1A,22,3,,,,,,,,4,3,24,,,1,,2,19,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW894CPZ,1754,,,M,800,Visit2,2,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLW894CPZ,1754,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,114,1 or 1A,,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX086NPR,1906,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,,2,,,,,,,,1,2,15,,,2,,4,28,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,86,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,94,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,85,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,90,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,87,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,91,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,96,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,98,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,98,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,3400,Visit15,15,Phase 1/1A,419,1 or 1A,98,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,93,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,88,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX373BC8,1388,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,497,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX459CXH,2227,,,M,1400,Visit5,5,Phase 1B,133,1B,,3,,1,,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX459CXH,2227,,,M,1600,Visit6,6,Phase 1B,161,1B,96,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX459CXH,2227,,,M,1800,Visit7,7,Phase 1B,201,1B,57,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX459CXH,2227,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,105,1 or 1A,59,2,,1,,,,,,2,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX459CXH,2227,,,M,5400,EndofPhase1b,7,Phase 1B,245,1B,53,2,,1,,,,,,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,800,Visit2,2,Phase 1B,76,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,1000,Visit3,3,Phase 1B,104,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,1400,Visit5,5,Phase 1B,139,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,1600,Visit6,6,Phase 1B,175,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,1800,Visit7,7,Phase 1B,196,1B,41,3,,1,,,,,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,2000,Visit8,8,Phase 1B,224,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,2200,Visit9,9,Phase 1B,253,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,2400,Visit10,10,Phase 1B,281,1B,67,4,,,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,2600,Visit11,11,Phase 1B,309,1B,90,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,2800,Visit12,12,Phase 1B,356,1B,87,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,3000,Visit13,13,Phase 1B,391,1 or 1A,100,4,,1,,,,,,1,4,32,,,2,,3,24,24,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,3200,Visit14,14,Phase 1B,426,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,3400,Visit15,15,Phase 1B,456,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,3600,Visit16,16,Phase 1B,484,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,3800,Visit17,17,Phase 1B,512,1B,0,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,33,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLX620WTX,1538,,,M,5400,EndofPhase1b,18,Phase 1B,544,1B,0,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY453LT5,2755,,,M,800,Visit2,2,Phase 2,68,2,82,2,,0,2,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY453LT5,2755,,,M,1000,Visit3,3,Phase 2,96,2,100,2,,0,2,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY453LT5,2755,,,M,1200,Visit4,4,Phase 2,123,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY453LT5,2755,,,M,1400,Visit5,5,Phase 2,148,2,,2,,0,2,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY453LT5,2755,,,M,1600,Visit6,6,Phase 2,194,2,,2,,0,2,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY453LT5,2755,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,32,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,2,2,3,3,2,2,15,15,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY733BF3,2744,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,93,2,,1,,,,,,1,2,80,,,2,,4,142,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY733BF3,2744,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,92,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY733BF3,2744,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY733BF3,2744,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,74,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY733BF3,2744,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY733BF3,2744,,,M,1600,Visit6,6,Phase 1/1A,178,1 or 1A,89,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY733BF3,2744,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY733BF3,2744,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY733BF3,2744,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY733BF3,2744,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,85,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY733BF3,2744,,,M,5200,EndofPhase1_1a,11,Phase 1/1A,318,1 or 1A,90,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,4,,1,,,,,,1,4,32,,,2,,4,32,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,800,Visit2,2,Phase 1/1A,52,1 or 1A,99,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,1400,Visit5,5,Phase 1/1A,152,1 or 1A,90,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,1600,Visit6,6,Phase 1/1A,173,1 or 1A,89,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,2600,Visit11,11,Phase 1/1A,311,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,3400,Visit15,15,Phase 1/1A,417,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,3600,Visit16,16,Phase 1/1A,450,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,99,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVLY933FNK,2240,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,506,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,99,2,,,,,,,,1,2,400,,,2,,4,767,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,80,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,1400,Visit5,5,Phase 1/1A,140,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,1600,Visit6,6,Phase 1/1A,172,1 or 1A,98,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,1800,Visit7,7,Phase 1/1A,193,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,2200,Visit9,9,Phase 1/1A,255,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,2400,Visit10,10,Phase 1/1A,280,1 or 1A,92,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,2800,Visit12,12,Phase 1/1A,333,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,3000,Visit13,13,Phase 1/1A,368,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,3200,Visit14,14,Phase 1/1A,389,1 or 1A,98,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,3400,Visit15,15,Phase 1/1A,416,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,3600,Visit16,16,Phase 1/1A,444,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA045MTH,1239,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,497,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,88,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,1600,Visit6,6,Phase 1/1A,184,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,1800,Visit7,7,Phase 1/1A,206,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,2000,Visit8,8,Phase 1/1A,243,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,2200,Visit9,9,Phase 1/1A,269,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,2400,Visit10,10,Phase 1/1A,292,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,2600,Visit11,11,Phase 1/1A,332,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,2800,Visit12,12,Phase 1/1A,359,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,3000,Visit13,13,Phase 1/1A,381,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,3200,Visit14,14,Phase 1/1A,418,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,3400,Visit15,15,Phase 1/1A,442,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA894CMY,1535,,,M,5200,EndofPhase1_1a,16,Phase 1/1A,456,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA927FD1,2792,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,15,1 or 1A,18,2,,1,,,,,,4,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,71,2,,1,,,,,,1,2,3,,,1,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,63,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,94,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,1200,Visit4,4,Phase 1/1A,122,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,1400,Visit5,5,Phase 1/1A,155,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,1600,Visit6,6,Phase 1/1A,179,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,85,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,95,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,84,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,66,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,79,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,86,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,3000,Visit13,13,Phase 1/1A,368,1 or 1A,80,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,3200,Visit14,14,Phase 1/1A,396,1 or 1A,75,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,3400,Visit15,15,Phase 1/1A,430,1 or 1A,58,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,3600,Visit16,16,Phase 1/1A,459,1 or 1A,59,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,97,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMA954KEF,2579,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,523,1 or 1A,95,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,60,1,,,,,,,,2,1,8,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,23,1,,,,,,,,4,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,75,1,,,,,,,,2,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,1200,Visit4,4,Phase 1/1A,105,1 or 1A,63,1,,,,,,,,2,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,1400,Visit5,5,Phase 1/1A,130,1 or 1A,52,1,,,,,,,,2,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,1600,Visit6,6,Phase 1/1A,156,1 or 1A,65,1,,,,,,,,2,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,1800,Visit7,7,Phase 1/1A,184,1 or 1A,61,1,,,,,,,,2,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,2000,Visit8,8,Phase 1/1A,214,1 or 1A,80,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,2200,Visit9,9,Phase 1/1A,245,1 or 1A,58,1,,,,,,,,2,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,2400,Visit10,10,Phase 1/1A,268,1 or 1A,48,1,,1,,,,,,3,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,2600,Visit11,11,Phase 1/1A,303,1 or 1A,37,1,,1,,,,,,4,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,2800,Visit12,12,Phase 1/1A,331,1 or 1A,32,1,,1,,,,,,3,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,3000,Visit13,13,Phase 1/1A,360,1 or 1A,20,1,,1,,,,,,4,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB096BEU,1351,,,F,5200,EndofPhase1_1a,15,Phase 1/1A,423,1 or 1A,20,1,,1,,,,,,4,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,2,,,,,,,,1,2,400,,,2,2,2,467,400,2,3,127,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,96,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,1800,Visit7,7,Phase 2,192,2,100,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,2000,Visit8,8,Phase 2,232,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,2200,Visit9,9,Phase 2,253,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,2400,Visit10,10,Phase 2,281,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,2600,Visit11,11,Phase 2,309,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,2800,Visit12,12,Phase 2,333,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,3000,Visit13,13,Phase 2,366,2,87,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,3200,Visit14,14,Phase 2,395,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,3400,Visit15,15,Phase 2,424,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,3600,Visit16,16,Phase 2,451,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,3800,Visit17,17,Phase 2,479,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,158,1 or 1A,98,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMB605HZ1,1011,,,M,5800,EndofPhase2,18,Phase 2,505,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMC042WD0,1522,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMC042WD0,1522,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMC042WD0,1522,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMC295GDH,2353,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,28,1 or 1A,100,4,,1,,,,,,1,4,6,,,1,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD025EN0,2382,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,19,1 or 1A,64,2,,0,1,,,,,2,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,30,,,2,1,4,30,30,4,4,157,160,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,95,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,1400,Visit5,5,Phase 2,141,2,96,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,1600,Visit6,6,Phase 2,175,2,100,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,1800,Visit7,7,Phase 2,204,2,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,2000,Visit8,8,Phase 2,239,2,86,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,2200,Visit9,9,Phase 2,260,2,86,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,2400,Visit10,10,Phase 2,297,2,,4,,0,1,,,,,3,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,2800,Visit12,12,Phase 2,350,2,59,4,,0,1,,,,,2,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,3000,Visit13,13,Phase 2,378,2,85,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,3200,Visit14,14,Phase 2,409,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,3400,Visit15,15,Phase 2,449,2,59,4,,0,1,,,,,2,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,3800,Visit17,17,Phase 2,477,2,,4,,0,1,,,,,2,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,4000,Visit18,18,Phase 2,505,2,,4,,0,1,,,,,3,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,107,1 or 1A,33,4,,,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD062XMR,1793,,,F,5800,EndofPhase2,18,Phase 2,505,2,,4,,0,1,,,,,3,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,,2,,1,,,,,,2,2,3,,,1,,4,5,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,800,Visit2,2,Phase 1/1A,68,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,1000,Visit3,3,Phase 1/1A,96,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,1200,Visit4,4,Phase 1/1A,121,1 or 1A,,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,1400,Visit5,5,Phase 1/1A,142,1 or 1A,,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,1600,Visit6,6,Phase 1/1A,170,1 or 1A,,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,1800,Visit7,7,Phase 1/1A,191,1 or 1A,,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,2000,Visit8,8,Phase 1/1A,219,1 or 1A,100,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,2200,Visit9,9,Phase 1/1A,259,1 or 1A,99,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,2400,Visit10,10,Phase 1/1A,287,1 or 1A,,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,2600,Visit11,11,Phase 1/1A,315,1 or 1A,,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,2800,Visit12,12,Phase 1/1A,345,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,3000,Visit13,13,Phase 1/1A,373,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,3200,Visit14,14,Phase 1/1A,401,1 or 1A,92,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,3400,Visit15,15,Phase 1/1A,436,1 or 1A,85,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,3600,Visit16,16,Phase 1/1A,464,1 or 1A,89,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,3800,Visit17,17,Phase 1/1A,492,1 or 1A,92,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD277JEA,2503,,,F,4000,Visit18,18,Phase 1/1A,524,1 or 1A,86,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,1,,,,,,1,3,600,,,2,,3,689,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,99,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,99,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,98,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,95,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,,4,,,,,,,,,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,2600,Visit11,11,Phase 1/1A,303,1 or 1A,93,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,2800,Visit12,12,Phase 1/1A,352,1 or 1A,77,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,3200,Visit14,14,Phase 1/1A,387,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,3400,Visit15,15,Phase 1/1A,414,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,77,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,95,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD336MA2,2388,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,498,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD516KE3,1970,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,88,4,,,,,,,,1,4,32,,,1,,3,21,16,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD516KE3,1970,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,90,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD516KE3,1970,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,0,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD516KE3,1970,,,M,1200,Visit4,4,Phase 1/1A,106,1 or 1A,36,2,,0,1,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD516KE3,1970,,,M,1400,Visit5,5,Phase 1/1A,128,1 or 1A,0,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD516KE3,1970,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,0,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD543CVT,1689,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD704EJQ,2820,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,1,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD704EJQ,2820,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,70,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD704EJQ,2820,,,M,1000,Visit3,3,Phase 1/1A,82,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD704EJQ,2820,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD704EJQ,2820,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD704EJQ,2820,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD704EJQ,2820,,,M,1800,Visit7,7,Phase 1/1A,202,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMD704EJQ,2820,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,98,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME016TKT,2074,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,30,,,2,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,95,2,,1,,,,,,1,2,16,,,2,,2,17,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,2000,Visit8,8,Phase 1/1A,233,1 or 1A,10,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,2400,Visit10,10,Phase 1/1A,283,1 or 1A,95,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,3000,Visit13,13,Phase 1/1A,358,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,3200,Visit14,14,Phase 1/1A,387,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,3400,Visit15,15,Phase 1/1A,429,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,3600,Visit16,16,Phase 1/1A,442,1 or 1A,93,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,3800,Visit17,17,Phase 1/1A,471,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME483GC4,2344,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,506,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME607JXP,2751,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,20,1 or 1A,20,1,,1,,,,,,4,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME957NEB,2122,,,F,600,Visit1,1,Phase 1/1A,22,1 or 1A,100,4,,1,,,,,,1,4,800,,,2,,4,800,800,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVME957NEB,2122,,,F,5800,EndofPhase2,2,Phase 2,54,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF053DR2,2420,,,F,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,1,2,4,29,30,4,3,100,100,3,600,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF053DR2,2420,,,F,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF053DR2,2420,,,F,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF053DR2,2420,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,95,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF053DR2,2420,,,F,1600,Visit6,6,Phase 2,176,2,94,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF053DR2,2420,,,F,2000,Visit8,8,Phase 3,225,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF053DR2,2420,,,F,2200,Visit9,9,Phase 3,260,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF053DR2,2420,,,F,5200,EndofPhase1_1a,5,Phase 1/1A,152,1 or 1A,75,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF053DR2,2420,,,F,5800,EndofPhase2,7,Phase 2,197,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,30,4,,,,,,,,3,4,160,,,2,1,4,160,160,4,2,16,15,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,1000,Visit3,3,Phase 2,80,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,1200,Visit4,4,Phase 2,106,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,1400,Visit5,5,Phase 2,136,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,1600,Visit6,6,Phase 2,162,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,1800,Visit7,7,Phase 2,193,2,80,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,2000,Visit8,8,Phase 2,220,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,2200,Visit9,9,Phase 2,249,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,2400,Visit10,10,Phase 2,274,2,92,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,2600,Visit11,11,Phase 2,305,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,2800,Visit12,12,Phase 2,330,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,3000,Visit13,13,Phase 2,358,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,3200,Visit14,14,Phase 2,393,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,3400,Visit15,15,Phase 2,416,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,3600,Visit16,16,Phase 2,441,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,3800,Visit17,17,Phase 2,470,2,97,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,52,1 or 1A,61,4,,,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMF919JJ4,1870,,,M,5800,EndofPhase2,18,Phase 2,508,2,,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG586PFK,1963,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,400,,,2,2,2,483,400,2,2,80,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG586PFK,1963,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG586PFK,1963,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,75,3,,,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG586PFK,1963,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,,3,,,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG586PFK,1963,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG586PFK,1963,,,M,1600,Visit6,6,Phase 1/1A,182,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG586PFK,1963,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG586PFK,1963,,,M,2000,Visit8,8,Phase 1/1A,234,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG586PFK,1963,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG586PFK,1963,,,M,2400,Visit10,10,Phase 1/1A,297,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG586PFK,1963,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG586PFK,1963,,,M,3000,Visit13,13,Phase 2,359,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG586PFK,1963,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,331,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG756CWR,1459,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,,,,,,,,,,,,,,,2,,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG756CWR,1459,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG756CWR,1459,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG756CWR,1459,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG756CWR,1459,,,M,1400,Visit5,5,Phase 1/1A,154,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG756CWR,1459,,,M,1600,Visit6,6,Phase 1/1A,204,1 or 1A,,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG756CWR,1459,,,M,1800,Visit7,7,Phase 1/1A,231,1 or 1A,,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG756CWR,1459,,,M,2000,Visit8,8,Phase 1/1A,252,1 or 1A,,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG756CWR,1459,,,M,2200,Visit9,9,Phase 1/1A,279,1 or 1A,,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG756CWR,1459,,,M,2400,Visit10,10,Phase 1/1A,301,1 or 1A,,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG756CWR,1459,,,M,2600,Visit11,11,Phase 1/1A,329,1 or 1A,,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMG756CWR,1459,,,M,2800,Visit12,12,Phase 1/1A,351,1 or 1A,,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH212WWB,2489,,,F,600,Visit1,1,Phase 1/1A,22,1 or 1A,73,2,,1,,,,,,2,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH212WWB,2489,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,44,1 or 1A,34,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,600,Visit1,1,Phase 1/1A,22,1 or 1A,,4,,,,,,,,,4,6,,,2,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,,4,,,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,1000,Visit3,3,Phase 1/1A,71,1 or 1A,,4,,,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,1200,Visit4,4,Phase 1/1A,92,1 or 1A,,4,,1,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,1400,Visit5,5,Phase 1/1A,119,1 or 1A,,4,,1,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,1600,Visit6,6,Phase 1/1A,161,1 or 1A,83,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,,4,,1,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,2000,Visit8,8,Phase 1/1A,217,1 or 1A,,4,,1,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,2200,Visit9,9,Phase 1/1A,245,1 or 1A,0,4,,,,,,,,4,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,,4,,1,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,2600,Visit11,11,Phase 1/1A,301,1 or 1A,0,4,,,,,,,,4,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,2800,Visit12,12,Phase 1/1A,329,1 or 1A,51,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,3000,Visit13,13,Phase 1/1A,357,1 or 1A,1,4,,1,,,,,,4,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,3200,Visit14,14,Phase 1/1A,386,1 or 1A,66,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,3400,Visit15,15,Phase 1/1A,413,1 or 1A,37,4,,1,,,,,,3,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,3600,Visit16,16,Phase 1/1A,441,1 or 1A,67,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,3800,Visit17,17,Phase 1/1A,468,1 or 1A,20,4,,1,,,,,,4,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH533VPM,2133,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,483,1 or 1A,72,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,89,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,2200,Visit9,9,Phase 1/1A,276,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,2400,Visit10,10,Phase 1/1A,303,1 or 1A,69,1,,1,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,2600,Visit11,11,Phase 1/1A,328,1 or 1A,88,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,2800,Visit12,12,Phase 1/1A,352,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,3000,Visit13,13,Phase 1/1A,384,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,3200,Visit14,14,Phase 1/1A,429,1 or 1A,84,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,3400,Visit15,15,Phase 1/1A,462,1 or 1A,90,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,3600,Visit16,16,Phase 1/1A,517,1 or 1A,94,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,3800,Visit17,17,Phase 1/1A,561,1 or 1A,90,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMH706BG3,1879,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,601,1 or 1A,75,1,,1,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ584WWU,1238,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,800,,,2,2,3,600,600,3,2,3,3,2,20,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ584WWU,1238,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,57,1 or 1A,94,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ584WWU,1238,,,M,5800,EndofPhase2,3,Phase 2,90,2,10,2,,,,,,,,4,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ584WWU,1238,,,M,6000,EndofPhase3,6,Phase 3,175,3,,,,,,1,20,,,4,,,,20,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,93,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,1800,Visit7,7,Phase 1/1A,191,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,2000,Visit8,8,Phase 1/1A,216,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,2200,Visit9,9,Phase 1/1A,246,1 or 1A,58,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,2800,Visit12,12,Phase 1/1A,335,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,3600,Visit16,16,Phase 1/1A,456,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,3800,Visit17,17,Phase 1/1A,491,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMJ694HNA,2057,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,6,,,2,2,4,6,6,4,4,760,800,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,1000,Visit3,3,Phase 2,90,2,98,1,,,,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,1200,Visit4,4,Phase 2,126,2,96,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,1400,Visit5,5,Phase 2,143,2,95,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,1600,Visit6,6,Phase 2,184,2,98,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,1800,Visit7,7,Phase 2,211,2,94,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,2000,Visit8,8,Phase 2,226,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,2200,Visit9,9,Phase 2,260,2,98,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,2400,Visit10,10,Phase 2,283,2,98,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,2600,Visit11,11,Phase 2,311,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,2800,Visit12,12,Phase 2,338,2,98,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,3000,Visit13,13,Phase 2,366,2,98,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,3200,Visit14,14,Phase 2,398,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,3600,Visit16,16,Phase 2,465,2,93,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,3800,Visit17,17,Phase 2,493,2,98,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,59,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK102EKH,1862,,,M,5800,EndofPhase2,18,Phase 2,505,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK446URG,2798,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,,3,,1,,,,,,,3,22.5,,,1,,4,28,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK446URG,2798,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK446URG,2798,,,F,1000,Visit3,3,Phase 1/1A,102,1 or 1A,,4,,1,,,,,,,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK446URG,2798,,,F,1200,Visit4,4,Phase 1/1A,116,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK750CV9,1749,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,18,2,,,,,,,,4,2,400,,,2,1,4,720,800,4,4,30,30,4,6,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK750CV9,1749,,,F,800,Visit2,2,Phase 1/1A,63,1 or 1A,98,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK750CV9,1749,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,99,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK750CV9,1749,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,79,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK750CV9,1749,,,F,1400,Visit5,5,Phase 2,128,2,0,4,,,,,,,,4,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK750CV9,1749,,,F,1600,Visit6,6,Phase 3,169,3,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK750CV9,1749,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,114,1 or 1A,79,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK750CV9,1749,,,F,5800,EndofPhase2,5,Phase 2,128,2,0,4,,,,,,,,4,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMK750CV9,1749,,,F,6000,EndofPhase3,7,Phase 3,233,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML149YRX,2269,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML199FN8,1717,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,52,2,,,,,,,,2,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML199FN8,1717,,,M,800,Visit2,2,Phase 1/1A,96,1 or 1A,39,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML199FN8,1717,,,M,1000,Visit3,3,Phase 1/1A,103,1 or 1A,40,2,,0,1,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML199FN8,1717,,,M,1200,Visit4,4,Phase 1/1A,145,1 or 1A,4,2,,1,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML199FN8,1717,,,M,1400,Visit5,5,Phase 1/1A,175,1 or 1A,31,2,,1,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML199FN8,1717,,,M,1600,Visit6,6,Phase 1/1A,202,1 or 1A,0,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML199FN8,1717,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,222,1 or 1A,16,2,,1,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,91,2,,,,,,,,1,2,400,,,2,2,4,764,800,4,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,90,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,89,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,2400,Visit10,10,Phase 1/1A,283,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,2800,Visit12,12,Phase 2,325,2,98,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,3000,Visit13,13,Phase 2,364,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,3200,Visit14,14,Phase 2,399,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,3400,Visit15,15,Phase 2,423,2,94,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,3600,Visit16,16,Phase 2,449,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,3800,Visit17,17,Phase 2,472,2,98,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,5200,EndofPhase1_1a,11,Phase 1/1A,290,1 or 1A,86,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML843GMU,1887,,,M,5800,EndofPhase2,18,Phase 2,501,2,,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,800,Visit2,2,Phase 2,63,2,62,2,,,,,,,,2,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,1000,Visit3,3,Phase 2,91,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,1200,Visit4,4,Phase 2,119,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,1400,Visit5,5,Phase 2,147,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,1600,Visit6,6,Phase 2,175,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,1800,Visit7,7,Phase 2,203,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,2000,Visit8,8,Phase 2,233,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,2200,Visit9,9,Phase 2,268,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,2400,Visit10,10,Phase 2,296,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,2600,Visit11,11,Phase 2,324,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,2800,Visit12,12,Phase 2,352,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,3000,Visit13,13,Phase 2,380,1 or 1A,96,2,,1,,,,,,1,2,15,,,2,2,2,15,15,2,2,400,400,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,3200,Visit14,14,Phase 2,408,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,3400,Visit15,15,Phase 2,436,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,3600,Visit16,16,Phase 2,464,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,3800,Visit17,17,Phase 2,492,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,1,2,,,,,,,,4,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVML850AYA,1800,,,M,5800,EndofPhase2,18,Phase 2,520,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,100,4,,,,,,,,1,4,160,,,2,,4,160,160,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,1800,Visit7,7,Phase 1/1A,190,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,2000,Visit8,8,Phase 1/1A,222,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,2200,Visit9,9,Phase 1/1A,249,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,2400,Visit10,10,Phase 1/1A,274,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,2600,Visit11,11,Phase 1/1A,299,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,2800,Visit12,12,Phase 1/1A,335,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,3000,Visit13,13,Phase 1/1A,362,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,3200,Visit14,14,Phase 1/1A,384,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,3400,Visit15,15,Phase 1/1A,411,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,3600,Visit16,16,Phase 1/1A,440,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,3800,Visit17,17,Phase 1/1A,467,1 or 1A,100,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM478ERT,2039,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,495,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,800,Visit2,2,Phase 2,52,2,92,2,,1,,,,,,2,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,1000,Visit3,3,Phase 2,71,2,86,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,1200,Visit4,4,Phase 2,106,2,96,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,1400,Visit5,5,Phase 2,127,2,90,1,,1,,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,1600,Visit6,6,Phase 2,162,2,100,1,,,,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,1800,Visit7,7,Phase 2,190,2,100,1,,,,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,2200,Visit9,9,Phase 3,239,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,2400,Visit10,10,Phase 3,267,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,2600,Visit11,11,Phase 3,295,3,,,,,,3,5,,,1,,,,5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,2800,Visit12,12,Phase 3,330,3,,,,,,3,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,3000,Visit13,13,Phase 3,358,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,22,1 or 1A,97,1,,,,,,,,1,1,40,,,2,2,1,40,40,1,1,286,200,1,4,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,5800,EndofPhase2,8,Phase 2,204,2,100,1,,1,,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM496CMP,2270,,,M,6000,EndofPhase3,14,Phase 3,489,3,,,,,,3,4,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM730HYM,1643,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,35,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM849FA7,1745,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,94,4,,,,,,,,1,4,32,,,2,,4,32,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM849FA7,1745,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,38,4,,,,,,,,3,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM849FA7,1745,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,69,4,,,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM849FA7,1745,,,M,1400,Visit5,5,Phase 1B,139,1B,71,4,,,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM849FA7,1745,,,M,1600,Visit6,6,Phase 1B,169,1B,80,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM849FA7,1745,,,M,1800,Visit7,7,Phase 1B,195,1B,87,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM849FA7,1745,,,M,2000,Visit8,8,Phase 1B,224,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM849FA7,1745,,,M,2200,Visit9,9,Phase 1B,251,1B,93,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM849FA7,1745,,,M,2400,Visit10,10,Phase 1B,280,1B,77,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM849FA7,1745,,,M,2600,Visit11,11,Phase 1B,307,1B,94,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM849FA7,1745,,,M,2800,Visit12,12,Phase 1B,335,1B,66,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM849FA7,1745,,,M,3000,Visit13,13,Phase 1B,363,1B,88,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM849FA7,1745,,,M,5400,EndofPhase1b,18,Phase 1B,482,1B,100,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMM981NC6,1036,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN366CGG,1899,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,92,1,,1,,,,,,1,1,7.5,,,2,1,2,18,23,2,3,5,6,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN366CGG,1899,,,M,800,Visit2,2,Phase 1/1A,71,1 or 1A,85,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN366CGG,1899,,,M,1200,Visit4,4,Phase 2,124,2,75,2,,1,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN366CGG,1899,,,M,1400,Visit5,5,Phase 2,141,2,68,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN366CGG,1899,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,91,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN366CGG,1899,,,M,5800,EndofPhase2,6,Phase 2,194,2,75,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,600,Visit1,1,Phase 1/1A,24,1 or 1A,88,2,,,,,,,,1,2,3,,,2,2,2,3,3,2,2,80,80,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,800,Visit2,2,Phase 1/1A,52,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,1000,Visit3,3,Phase 1/1A,80,1 or 1A,97,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,1800,Visit7,7,Phase 2,206,2,93,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,2000,Visit8,8,Phase 2,227,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,2200,Visit9,9,Phase 2,260,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,2400,Visit10,10,Phase 2,288,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,2600,Visit11,11,Phase 2,316,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,2800,Visit12,12,Phase 2,339,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,3000,Visit13,13,Phase 2,374,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,3400,Visit15,15,Phase 2,416,2,99,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,3600,Visit16,16,Phase 2,465,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,178,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN574PY7,1855,,,F,5800,EndofPhase2,18,Phase 2,505,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,96,3,,,,,,,,1,3,24,,,2,,4,31,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,1000,Visit3,3,Phase 1/1A,74,1 or 1A,97,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,98,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,1600,Visit6,6,Phase 1/1A,192,1 or 1A,99,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,2000,Visit8,8,Phase 1/1A,228,1 or 1A,97,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,2400,Visit10,10,Phase 1/1A,285,1 or 1A,95,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,2600,Visit11,11,Phase 1/1A,312,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,3600,Visit16,16,Phase 1/1A,451,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN585DN6,1378,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,498,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMN616AN6,2018,,,M,600,Visit1,1,Phase 1/1A,10,1 or 1A,,2,,,,,,,,4,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP244UNM,1806,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,1,,,,,,,,1,1,200,,,2,,2,386,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,84,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,93,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,1600,Visit6,6,Phase 1/1A,175,1 or 1A,74,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,2000,Visit8,8,Phase 1/1A,237,1 or 1A,65,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,2600,Visit11,11,Phase 1/1A,313,1 or 1A,72,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,2800,Visit12,12,Phase 1/1A,334,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,84,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,3200,Visit14,14,Phase 1/1A,401,1 or 1A,76,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,3400,Visit15,15,Phase 1/1A,440,1 or 1A,69,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP324WRF,1908,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,510,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP410HW5,1496,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,3,4,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP410HW5,1496,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP410HW5,1496,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,98,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP410HW5,1496,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,106,1 or 1A,100,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP715ZYC,1371,,,F,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,4,,,,,,,,1,4,6,,,2,2,4,6,6,4,4,800,800,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP715ZYC,1371,,,F,800,Visit2,2,Phase 1/1A,69,1 or 1A,88,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP715ZYC,1371,,,F,1000,Visit3,3,Phase 1/1A,126,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP715ZYC,1371,,,F,1400,Visit5,5,Phase 2,141,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP715ZYC,1371,,,F,1600,Visit6,6,Phase 2,168,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP715ZYC,1371,,,F,1800,Visit7,7,Phase 2,203,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP715ZYC,1371,,,F,2000,Visit8,8,Phase 2,222,2,89,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP715ZYC,1371,,,F,2200,Visit9,9,Phase 2,253,2,79,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP715ZYC,1371,,,F,2600,Visit11,11,Phase 3,308,3,,,,,,2,800,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP715ZYC,1371,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,131,1 or 1A,95,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP715ZYC,1371,,,F,5800,EndofPhase2,10,Phase 2,273,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP715ZYC,1371,,,F,6000,EndofPhase3,12,Phase 3,335,3,,,,,,2,800,7,25,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,600,Visit1,1,Phase 1/1A,24,1 or 1A,93,2,,1,,,,,,1,2,400,,,2,,3,678,800,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,800,Visit2,2,Phase 1/1A,52,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,1000,Visit3,3,Phase 1/1A,80,1 or 1A,93,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,1200,Visit4,4,Phase 1/1A,108,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,1400,Visit5,5,Phase 1/1A,136,1 or 1A,93,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,95,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,93,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,81,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,2800,Visit12,12,Phase 1/1A,339,1 or 1A,97,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,3000,Visit13,13,Phase 1/1A,367,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,3200,Visit14,14,Phase 1/1A,395,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,3400,Visit15,15,Phase 1/1A,423,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,3600,Visit16,16,Phase 1/1A,451,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,3800,Visit17,17,Phase 1/1A,479,1 or 1A,93,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMP988HLB,2736,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,79,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,600,Visit1,1,Phase 1/1A,44,1 or 1A,98,2,,1,,,,,,1,2,80,,,1,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,96,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,1400,Visit5,5,Phase 1/1A,146,1 or 1A,84,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,79,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,2000,Visit8,8,Phase 1/1A,220,1 or 1A,89,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,2800,Visit12,12,Phase 1/1A,329,1 or 1A,100,2,,0,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,3000,Visit13,13,Phase 1/1A,357,1 or 1A,100,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,3200,Visit14,14,Phase 1/1A,401,1 or 1A,100,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,3400,Visit15,15,Phase 1/1A,434,1 or 1A,100,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,3600,Visit16,16,Phase 1/1A,461,1 or 1A,100,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,3800,Visit17,17,Phase 1/1A,479,1 or 1A,100,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR416APU,2864,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,514,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,13,2,,,,,,,,4,2,400,,,2,2,3,583,600,3,2,80,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,51,3,,,,,,,,2,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,17,3,,,,,,,,4,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,2200,Visit9,9,Phase 1/1A,246,1 or 1A,58,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,2600,Visit11,11,Phase 1/1A,305,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,3000,Visit13,13,Phase 1/1A,367,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,4000,Visit18,18,Phase 1/1A,513,1 or 1A,21,3,,1,,,,,,4,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,4200,Visit19,19,Phase 2,533,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMR670JTD,1744,,,M,4400,Visit20,20,Phase 2,563,2,100,2,,1,,,,,,3,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,2,2,3,,,1,1,3,4,5,3,2,80,40,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,1200,Visit4,4,Phase 2,123,2,77,2,,,,,,,,3,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,1400,Visit5,5,Phase 2,149,2,,1,,1,,,,,,,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,1600,Visit6,6,Phase 2,171,2,100,1,,1,,,,,,4,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,1800,Visit7,7,Phase 2,197,2,100,1,,0,1,,,,,2,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,2000,Visit8,8,Phase 2,227,2,100,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,2200,Visit9,9,Phase 2,261,2,100,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,2400,Visit10,10,Phase 2,288,2,100,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,2600,Visit11,11,Phase 2,315,2,74,2,,1,,,,,,2,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,2800,Visit12,12,Phase 2,352,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,3000,Visit13,13,Phase 2,365,2,100,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,3200,Visit14,14,Phase 2,393,2,75,3,,0,1,,,,,2,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,3400,Visit15,15,Phase 2,416,2,100,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,3600,Visit16,16,Phase 2,449,2,96,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,3800,Visit17,17,Phase 2,485,2,100,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,94,1 or 1A,95,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT158VH7,1936,,,F,5800,EndofPhase2,18,Phase 2,498,2,51,3,,0,1,,,,,2,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,,4,26,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,80,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,1000,Visit3,3,Phase 1/1A,99,1 or 1A,83,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,1200,Visit4,4,Phase 1/1A,108,1 or 1A,50,4,,0,1,,,,,3,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,94,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,94,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,68,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,59,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,2200,Visit9,9,Phase 1/1A,260,1 or 1A,65,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,67,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,2800,Visit12,12,Phase 1/1A,330,1 or 1A,41,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,3000,Visit13,13,Phase 1/1A,368,1 or 1A,76,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,3400,Visit15,15,Phase 1/1A,423,1 or 1A,69,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,3600,Visit16,16,Phase 1/1A,450,1 or 1A,60,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,52,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT304FZL,2460,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,498,1 or 1A,75,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,0,1,,,,,2,3,4.5,,,1,,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,93,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,98,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,90,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,88,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,81,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,2200,Visit9,9,Phase 1/1A,244,1 or 1A,100,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,2400,Visit10,10,Phase 1/1A,273,1 or 1A,87,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,90,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,2800,Visit12,12,Phase 1/1A,335,1 or 1A,86,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,3000,Visit13,13,Phase 1/1A,363,1 or 1A,83,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,90,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,3400,Visit15,15,Phase 1/1A,419,1 or 1A,88,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,3600,Visit16,16,Phase 1/1A,447,1 or 1A,94,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,100,4,,0,2,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT617RXB,1724,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,503,1 or 1A,96,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT746DTV,1111,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,800,,,2,1,4,800,800,4,4,30,30,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT746DTV,1111,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT746DTV,1111,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,4,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT746DTV,1111,,,M,1400,Visit5,5,Phase 2,139,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT746DTV,1111,,,M,1600,Visit6,6,Phase 2,185,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT746DTV,1111,,,M,2000,Visit8,8,Phase 2,218,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMT746DTV,1111,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,104,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU034UAX,2321,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,1,,1,,,,,,1,1,8,,,1,,2,15,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU034UAX,2321,,,F,800,Visit2,2,Phase 1/1A,69,1 or 1A,86,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU034UAX,2321,,,F,1000,Visit3,3,Phase 1/1A,99,1 or 1A,53,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU034UAX,2321,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU034UAX,2321,,,F,1400,Visit5,5,Phase 1/1A,145,1 or 1A,91,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU034UAX,2321,,,F,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU034UAX,2321,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,87,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU034UAX,2321,,,F,2000,Visit8,8,Phase 1/1A,230,1 or 1A,,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU034UAX,2321,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU034UAX,2321,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU034UAX,2321,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU034UAX,2321,,,F,2800,Visit12,12,Phase 1/1A,336,1 or 1A,,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU034UAX,2321,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,75,2,,1,,,,,,2,2,16,,,1,,3,20,20,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,1000,Visit3,3,Phase 1B,85,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,1200,Visit4,4,Phase 1B,116,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,1400,Visit5,5,Phase 1B,145,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,1600,Visit6,6,Phase 1B,172,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,1800,Visit7,7,Phase 1B,197,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,2000,Visit8,8,Phase 1B,225,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,2200,Visit9,9,Phase 1B,256,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,2400,Visit10,10,Phase 1B,281,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,2600,Visit11,11,Phase 1B,309,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,2800,Visit12,12,Phase 1B,340,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,3000,Visit13,13,Phase 1B,369,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,3200,Visit14,14,Phase 1B,396,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,3400,Visit15,15,Phase 1B,421,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,3600,Visit16,16,Phase 1B,449,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,3800,Visit17,17,Phase 1B,477,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,47,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMU755UN3,2426,,,M,5400,EndofPhase1b,18,Phase 1B,505,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW132XC8,2304,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,16,,,2,,2,18,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW132XC8,2304,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,,2,,1,,,,,,,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW132XC8,2304,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,84,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW132XC8,2304,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,53,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW132XC8,2304,,,M,1400,Visit5,5,Phase 1/1A,146,1 or 1A,62,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,6,,,1,1,3,4,3,3,2,15,15,2,175,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,2000,Visit8,8,Phase 2,253,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,2400,Visit10,10,Phase 2,308,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,2600,Visit11,11,Phase 2,330,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,3000,Visit13,13,Phase 3,393,3,,,,,,2,200,,,2,,,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,3200,Visit14,14,Phase 3,421,3,,,,,,2,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,3400,Visit15,15,Phase 3,449,3,,,,,,2,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,195,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,5800,EndofPhase2,12,Phase 2,351,2,83,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW376RY0,1365,,,M,6000,EndofPhase3,16,Phase 3,491,3,,,,,,2,200,,,2,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,98,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,2400,Visit10,10,Phase 1/1A,279,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,2600,Visit11,11,Phase 1/1A,312,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,89,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,88,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,98,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW502BHK,1797,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,496,1 or 1A,73,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW940NN6,1283,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,93,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW940NN6,1283,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,86,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW940NN6,1283,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMW940NN6,1283,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,95,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,87,1,,,,,,,,1,1,200,,,2,2,3,500,500,3,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,1000,Visit3,3,Phase 2,85,2,89,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,1200,Visit4,4,Phase 2,113,2,,4,,1,,,,,,,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,1400,Visit5,5,Phase 2,144,2,68,4,,,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,1600,Visit6,6,Phase 2,178,2,72,4,,,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,1800,Visit7,7,Phase 2,212,2,75,4,,,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,2000,Visit8,8,Phase 2,226,2,71,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,2200,Visit9,9,Phase 2,254,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,2400,Visit10,10,Phase 2,289,2,76,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,2600,Visit11,11,Phase 2,317,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,2800,Visit12,12,Phase 2,358,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,3000,Visit13,13,Phase 2,365,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,3200,Visit14,14,Phase 2,396,2,55,2,,1,,,,,,2,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,3400,Visit15,15,Phase 2,424,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,3600,Visit16,16,Phase 2,452,2,89,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,3800,Visit17,17,Phase 2,480,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,37,1 or 1A,88,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX035XL5,1168,,,M,5800,EndofPhase2,18,Phase 2,530,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX250HHH,2017,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,94,2,,1,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX250HHH,2017,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX250HHH,2017,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,90,1 or 1A,100,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX356EZX,2747,,,M,800,Visit2,2,Phase 1B,57,1B,100,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX356EZX,2747,,,M,1000,Visit3,3,Phase 1B,85,1B,100,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX356EZX,2747,,,M,1200,Visit4,4,Phase 1B,113,1B,69,1,,1,,,,,,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX356EZX,2747,,,M,1400,Visit5,5,Phase 1B,141,1B,83,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX356EZX,2747,,,M,1600,Visit6,6,Phase 1B,168,1B,96,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX356EZX,2747,,,M,1800,Visit7,7,Phase 1B,197,1B,89,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX356EZX,2747,,,M,2000,Visit8,8,Phase 1B,228,1B,100,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX356EZX,2747,,,M,2200,Visit9,9,Phase 1B,258,1B,77,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX356EZX,2747,,,M,2400,Visit10,10,Phase 1B,287,1B,100,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX356EZX,2747,,,M,2600,Visit11,11,Phase 1B,315,1B,100,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX356EZX,2747,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,90,1,,1,,,,,,1,1,8,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX575ZTU,1450,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMX734LGR,1479,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,2,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,89,3,,,,,,,,1,3,600,,,2,2,4,775,800,4,4,160,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,97,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,97,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,2400,Visit10,10,Phase 3,263,3,,,,,,3,,5,16,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,2600,Visit11,11,Phase 3,294,3,,,,,,3,4,5,16,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,2800,Visit12,12,Phase 3,353,3,,,,,,3,,5,16,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,3000,Visit13,13,Phase 3,382,3,,,,,,3,,5,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,3200,Visit14,14,Phase 3,413,3,,,,,,3,4,5,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,3400,Visit15,15,Phase 3,444,3,,,,,,5,40,3,6,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,3600,Visit16,16,Phase 3,473,3,,,,,,3,,5,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,3800,Visit17,17,Phase 3,515,3,,,,,,5,40,3,6,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,221,1 or 1A,98,4,,,,,,,,3,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,5800,EndofPhase2,9,Phase 2,234,2,58,4,,,,,,,,2,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY137MTN,1002,,,M,6000,EndofPhase3,18,Phase 3,546,3,,,,,,5,40,3,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY530MF1,1142,,,M,600,Visit1,1,Phase 1/1A,55,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY530MF1,1142,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,91,1 or 1A,21,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,16,,,1,,3,20,20,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,1000,Visit3,3,Phase 1B,78,1B,53,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,1200,Visit4,4,Phase 1B,113,1B,97,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,1400,Visit5,5,Phase 1B,141,1B,97,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,1600,Visit6,6,Phase 1B,171,1B,75,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,1800,Visit7,7,Phase 1B,197,1B,100,2,,0,1,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,2000,Visit8,8,Phase 1B,225,1B,79,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,2200,Visit9,9,Phase 1B,260,1B,57,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,2400,Visit10,10,Phase 1B,285,1B,88,2,,0,1,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,2600,Visit11,11,Phase 1B,313,1B,89,2,,0,1,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,2800,Visit12,12,Phase 1B,346,1B,94,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,3000,Visit13,13,Phase 1B,368,1B,82,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,3200,Visit14,14,Phase 1B,396,1B,93,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,3400,Visit15,15,Phase 1B,424,1B,100,3,,0,1,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMY622GTW,2496,,,F,5400,EndofPhase1b,16,Phase 1B,456,1B,6,3,,0,1,,,,,4,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,90,2,,,,,,,,1,2,15,,,1,,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,1000,Visit3,3,Phase 1/1A,89,1 or 1A,93,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,1600,Visit6,6,Phase 1/1A,173,1 or 1A,96,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,1800,Visit7,7,Phase 1/1A,200,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,2000,Visit8,8,Phase 1/1A,234,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,2200,Visit9,9,Phase 1/1A,274,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,2400,Visit10,10,Phase 1/1A,305,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,2600,Visit11,11,Phase 1/1A,331,1 or 1A,97,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,2800,Visit12,12,Phase 1/1A,366,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,3000,Visit13,13,Phase 1/1A,389,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,3200,Visit14,14,Phase 1/1A,416,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,3400,Visit15,15,Phase 1/1A,444,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,3600,Visit16,16,Phase 1/1A,474,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,3800,Visit17,17,Phase 1/1A,501,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ005TXY,1576,,,F,4000,Visit18,18,Phase 1/1A,543,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,,,,,,,1,3,600,,,1,,2,411,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,97,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,2800,Visit12,12,Phase 1/1A,339,1 or 1A,93,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,93,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,96,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ197RTC,1023,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,506,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ915JRK,1581,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,19,1 or 1A,83,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,3,,,1,2,4,6,6,4,4,160,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,2800,Visit12,12,Phase 1/1A,341,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,3000,Visit13,13,Phase 1/1A,370,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,3200,Visit14,14,Phase 2,398,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,3400,Visit15,15,Phase 2,427,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,3600,Visit16,16,Phase 2,455,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,3800,Visit17,17,Phase 2,483,2,98,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,5200,EndofPhase1_1a,13,Phase 1/1A,372,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVMZ935JR6,2375,,,F,5800,EndofPhase2,18,Phase 2,513,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,600,Visit1,1,Phase 1/1A,18,1 or 1A,28,2,,1,,,,,,4,2,15,,,1,,4,27,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,800,Visit2,2,Phase 1/1A,48,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,83,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,72,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,1800,Visit7,7,Phase 1/1A,209,1 or 1A,89,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,2000,Visit8,8,Phase 1/1A,235,1 or 1A,74,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,2200,Visit9,9,Phase 1/1A,265,1 or 1A,,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,2400,Visit10,10,Phase 1/1A,291,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,2600,Visit11,11,Phase 1/1A,319,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,2800,Visit12,12,Phase 1/1A,350,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,3000,Visit13,13,Phase 1/1A,379,1 or 1A,96,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,3200,Visit14,14,Phase 1/1A,407,1 or 1A,89,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,3400,Visit15,15,Phase 1/1A,435,1 or 1A,96,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,3600,Visit16,16,Phase 1/1A,463,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,3800,Visit17,17,Phase 1/1A,489,1 or 1A,87,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNA619PWB,2254,,,M,4000,Visit18,18,Phase 1/1A,518,1 or 1A,92,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,3,23,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,94,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,89,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,89,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,94,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,96,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,76,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,2800,Visit12,12,Phase 1/1A,352,1 or 1A,87,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,3000,Visit13,13,Phase 1/1A,373,1 or 1A,98,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,3200,Visit14,14,Phase 1/1A,404,1 or 1A,96,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,3400,Visit15,15,Phase 1/1A,431,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,3600,Visit16,16,Phase 1/1A,458,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,3800,Visit17,17,Phase 1/1A,487,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,4000,Visit18,18,Phase 1/1A,513,1 or 1A,92,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,4200,Visit19,19,Phase 1/1A,544,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB024ART,1138,,,M,5200,EndofPhase1_1a,19,Phase 1/1A,572,1 or 1A,99,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,1000,Visit3,3,Phase 3,91,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,1200,Visit4,4,Phase 3,112,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,1400,Visit5,5,Phase 3,141,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,1600,Visit6,6,Phase 3,169,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,1800,Visit7,7,Phase 3,197,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,2200,Visit9,9,Phase 3,253,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,2600,Visit11,11,Phase 3,316,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,2800,Visit12,12,Phase 3,343,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,3000,Visit13,13,Phase 3,371,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,3200,Visit14,14,Phase 3,398,3,,,,,,1,50,1,50,1,,,,100,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,3400,Visit15,15,Phase 3,428,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,3600,Visit16,16,Phase 3,454,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,3800,Visit17,17,Phase 3,482,3,,,,,,1,40,1,40,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,42,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,5800,EndofPhase2,2,Phase 2,70,2,,,,,,,,,,1,,,,,,2,,,,,,,,,55,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB856FVM,1606,,,M,6000,EndofPhase3,18,Phase 3,511,3,,,,,,1,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNB954NDU,1211,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,6,1 or 1A,100,1,,,,,,,,1,1,200,,,2,,1,200,200,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC577CL7,1740,,,M,600,Visit1,1,Phase 1/1A,42,1 or 1A,75,2,,,,,,,,2,2,15,,,1,,2,16,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC577CL7,1740,,,M,800,Visit2,2,Phase 1/1A,76,1 or 1A,,2,,,,,,,,,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC577CL7,1740,,,M,1000,Visit3,3,Phase 1/1A,107,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC577CL7,1740,,,M,1200,Visit4,4,Phase 1/1A,148,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC577CL7,1740,,,M,1400,Visit5,5,Phase 1/1A,176,1 or 1A,81,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC577CL7,1740,,,M,1600,Visit6,6,Phase 1/1A,220,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC577CL7,1740,,,M,2000,Visit8,8,Phase 1/1A,280,1 or 1A,69,2,,,,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC577CL7,1740,,,M,2200,Visit9,9,Phase 1/1A,308,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC577CL7,1740,,,M,2400,Visit10,10,Phase 1/1A,344,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC577CL7,1740,,,M,2600,Visit11,11,Phase 1/1A,372,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,1,,,,,,,,1,1,200,,,2,,3,689,800,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,80,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,1000,Visit3,3,Phase 1/1A,88,1 or 1A,84,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,1200,Visit4,4,Phase 1/1A,124,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,1600,Visit6,6,Phase 1/1A,182,1 or 1A,77,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,1800,Visit7,7,Phase 1/1A,211,1 or 1A,87,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,2000,Visit8,8,Phase 1/1A,239,1 or 1A,89,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,2200,Visit9,9,Phase 1/1A,266,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,2400,Visit10,10,Phase 1/1A,301,1 or 1A,44,4,,,,,,,,3,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,2600,Visit11,11,Phase 1/1A,322,1 or 1A,70,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,2800,Visit12,12,Phase 1/1A,356,1 or 1A,35,4,,1,,,,,,3,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,3000,Visit13,13,Phase 1/1A,376,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,3200,Visit14,14,Phase 1/1A,403,1 or 1A,52,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,3400,Visit15,15,Phase 1/1A,433,1 or 1A,73,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,3600,Visit16,16,Phase 1/1A,461,1 or 1A,95,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,3800,Visit17,17,Phase 1/1A,484,1 or 1A,79,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC943RHV,1226,,,F,4000,Visit18,18,Phase 1/1A,517,1 or 1A,77,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC994CGK,1125,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,90,1,,,,,,,,1,1,8,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNC994CGK,1125,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,90,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,24,,,2,,3,23,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,95,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,1400,Visit5,5,Phase 1/1A,138,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,1600,Visit6,6,Phase 1/1A,166,1 or 1A,93,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,1800,Visit7,7,Phase 1/1A,191,1 or 1A,96,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,2000,Visit8,8,Phase 1/1A,211,1 or 1A,93,4,,0,2,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,2200,Visit9,9,Phase 1/1A,239,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,2400,Visit10,10,Phase 1/1A,277,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,2600,Visit11,11,Phase 1/1A,302,1 or 1A,92,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,3000,Visit13,13,Phase 1B,359,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,3200,Visit14,14,Phase 1B,389,1B,90,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,3400,Visit15,15,Phase 1B,417,1B,58,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,3600,Visit16,16,Phase 1B,450,1B,67,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,3800,Visit17,17,Phase 1B,485,1B,63,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,330,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND139LTG,2514,,,M,5400,EndofPhase1b,18,Phase 1B,515,1B,96,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND168CHY,2782,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,1,,1,,,,,,1,1,8,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND401LPF,1119,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,77,1,,,,,,,,1,1,1.5,,,1,,1,2,2,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,96,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,2200,Visit9,9,Phase 1/1A,259,1 or 1A,92,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,2400,Visit10,10,Phase 1/1A,287,1 or 1A,96,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,2600,Visit11,11,Phase 1/1A,315,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,3000,Visit13,13,Phase 1/1A,371,1 or 1A,28,1,,,,,,,,3,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,3200,Visit14,14,Phase 1/1A,395,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,3400,Visit15,15,Phase 1/1A,423,1 or 1A,89,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,3600,Visit16,16,Phase 1/1A,455,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND812FZH,1590,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,514,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,99,1,,,,,,,,1,1,200,,,2,2,2,300,200,2,3,22,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,1000,Visit3,3,Phase 1/1A,90,1 or 1A,,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,1400,Visit5,5,Phase 1/1A,153,1 or 1A,60,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,1800,Visit7,7,Phase 2,209,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,2000,Visit8,8,Phase 2,237,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,2200,Visit9,9,Phase 2,265,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,2400,Visit10,10,Phase 2,293,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,2600,Visit11,11,Phase 2,321,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,2800,Visit12,12,Phase 2,349,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,3000,Visit13,13,Phase 2,384,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,3200,Visit14,14,Phase 2,407,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,3400,Visit15,15,Phase 2,433,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,3600,Visit16,16,Phase 2,461,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,3800,Visit17,17,Phase 2,489,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,4000,Visit18,18,Phase 2,524,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVND882AAF,1419,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,174,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,1,,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,800,Visit2,2,Phase 1/1A,66,1 or 1A,23,2,,1,,,,,,4,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,,2,,1,,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,98,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,77,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,94,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,91,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,,2,,1,,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,3000,Visit13,13,Phase 1/1A,367,1 or 1A,93,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,3400,Visit15,15,Phase 1/1A,430,1 or 1A,83,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,3600,Visit16,16,Phase 1/1A,455,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,3800,Visit17,17,Phase 1/1A,486,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE716GN4,2695,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,507,1 or 1A,90,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,3,,,,,,,,1,3,22.5,,,2,3,4,30,30,4,,275,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,99,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,95,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,93,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,2000,Visit8,8,Phase 1/1A,222,1 or 1A,88,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,2200,Visit9,9,Phase 1/1A,249,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,2600,Visit11,11,Phase 1/1A,311,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,3600,Visit16,16,Phase 2,450,2,100,,100,,,,,,,1,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,3800,Visit17,17,Phase 2,480,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,4000,Visit18,18,Phase 2,506,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,4200,Visit19,19,Phase 2,533,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,4400,Visit20,20,Phase 2,562,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,5200,EndofPhase1_1a,15,Phase 1/1A,429,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNE811NJ2,1844,,,M,5800,EndofPhase2,21,Phase 2,620,2,100,,350,,,,,,,1,,,350,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,800,Visit2,2,Phase 2,46,2,100,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,1200,Visit4,4,Phase 3,96,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,1400,Visit5,5,Phase 3,124,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,1600,Visit6,6,Phase 3,152,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,1800,Visit7,7,Phase 3,176,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,2000,Visit8,8,Phase 3,200,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,2200,Visit9,9,Phase 3,228,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,2400,Visit10,10,Phase 3,256,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,2600,Visit11,11,Phase 3,284,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,2800,Visit12,12,Phase 3,312,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,3000,Visit13,13,Phase 3,340,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,3200,Visit14,14,Phase 3,368,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,3400,Visit15,15,Phase 3,397,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,3600,Visit16,16,Phase 3,425,3,,,,,,1,5,,0,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,3800,Visit17,17,Phase 3,453,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,12,1 or 1A,100,4,,,,,,,,1,4,6,,,2,2,4,6,6,4,4,160,160,4,6,5,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,5800,EndofPhase2,3,Phase 2,64,2,100,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNF019HLW,2038,,,F,6000,EndofPhase3,18,Phase 3,470,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,71,1,,1,,,,,,2,1,1.5,,,1,1,1,2,2,1,3,102,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,800,Visit2,2,Phase 1/1A,63,1 or 1A,,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,,1,,1,,,,,,4,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,1400,Visit5,5,Phase 1/1A,142,1 or 1A,,1,,1,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,1800,Visit7,7,Phase 2,202,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,2000,Visit8,8,Phase 2,230,2,79,2,,1,,,,,,2,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,2200,Visit9,9,Phase 2,254,2,96,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,2400,Visit10,10,Phase 2,283,2,,2,,1,,,,,,3,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,2600,Visit11,11,Phase 2,318,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,2800,Visit12,12,Phase 2,338,2,100,2,,1,,,,,,2,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,3000,Visit13,13,Phase 2,372,2,,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,3200,Visit14,14,Phase 2,394,2,100,3,,1,,,,,,3,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,3400,Visit15,15,Phase 2,427,2,,3,,0,,,,,,4,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,3600,Visit16,16,Phase 2,451,2,,3,,1,,,,,,2,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,3800,Visit17,17,Phase 2,478,2,100,3,,1,,,,,,2,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,175,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG526BWY,2678,,,F,5800,EndofPhase2,18,Phase 2,510,2,,3,,1,,,,,,,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG882ZDF,2361,,,F,800,Visit2,2,Phase 1/1A,63,1 or 1A,98,1,,1,,,,,,1,1,8,,,2,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNG882ZDF,2361,,,F,5400,EndofPhase1b,4,Phase 1B,113,1B,,2,,1,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH072URL,1559,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH466HXW,1263,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,1,,,,,,,,2,1,1.5,,,1,2,1,2,2,1,3,600,600,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH466HXW,1263,,,M,800,Visit2,2,Phase 2,70,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH466HXW,1263,,,M,1000,Visit3,3,Phase 2,98,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH466HXW,1263,,,M,1200,Visit4,4,Phase 2,126,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH466HXW,1263,,,M,1400,Visit5,5,Phase 2,154,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH466HXW,1263,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,42,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH466HXW,1263,,,M,5800,EndofPhase2,6,Phase 2,166,2,94,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,400,,,2,1,4,700,800,4,4,26,26,4,371,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,88,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,88,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,1400,Visit5,5,Phase 2,128,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,1800,Visit7,7,Phase 3,190,3,,,,,,6,150,,,1,,,,150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,2000,Visit8,8,Phase 3,224,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,2200,Visit9,9,Phase 3,254,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,2400,Visit10,10,Phase 3,282,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,2600,Visit11,11,Phase 3,310,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,2800,Visit12,12,Phase 3,345,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,3000,Visit13,13,Phase 3,366,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,3200,Visit14,14,Phase 3,401,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,3400,Visit15,15,Phase 3,429,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,3600,Visit16,16,Phase 3,457,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,3800,Visit17,17,Phase 3,483,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,100,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,5800,EndofPhase2,6,Phase 2,168,2,82,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH506JW4,1272,,,M,6000,EndofPhase3,18,Phase 3,525,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH580AGC,2393,,,M,800,Visit2,2,Phase 1B,59,1B,88,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH580AGC,2393,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,33,1 or 1A,88,1,,0,2,,,,,1,1,8,,,2,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH580AGC,2393,,,M,5400,EndofPhase1b,2,Phase 1B,86,1B,50,1,,1,,,,,,3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNH676VKJ,1031,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,50,1 or 1A,,,,,,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ023ZUZ,1692,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,120,,,2,,3,120,120,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,0,1,,,,,1,2,15,,,1,,3,23,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,93,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,95,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,97,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,1400,Visit5,5,Phase 1/1A,154,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,96,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,97,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,96,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,2400,Visit10,10,Phase 1/1A,286,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,2600,Visit11,11,Phase 1/1A,314,1 or 1A,89,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,2800,Visit12,12,Phase 1/1A,342,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,3000,Visit13,13,Phase 1/1A,370,1 or 1A,100,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,3200,Visit14,14,Phase 1/1A,405,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,3400,Visit15,15,Phase 1/1A,426,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,3600,Visit16,16,Phase 1/1A,461,1 or 1A,97,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,3800,Visit17,17,Phase 1/1A,489,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNJ356WBD,2099,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,524,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,1,2,3,,,1,2,3,4,3,3,3,23,23,3,160,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,1400,Visit5,5,Phase 2,144,2,87,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,1600,Visit6,6,Phase 2,172,2,98,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,1800,Visit7,7,Phase 2,204,2,98,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,2000,Visit8,8,Phase 2,228,2,96,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,2400,Visit10,10,Phase 3,288,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,2600,Visit11,11,Phase 3,316,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,2800,Visit12,12,Phase 3,344,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,3000,Visit13,13,Phase 3,372,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,3200,Visit14,14,Phase 3,399,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,3400,Visit15,15,Phase 3,427,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,3600,Visit16,16,Phase 3,455,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,3800,Visit17,17,Phase 3,484,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,116,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,5800,EndofPhase2,9,Phase 2,260,2,97,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL402JND,1271,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNL917LKX,1490,,,F,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,60,2,,1,,,,,,1,2,80,,,2,,4,149,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,70,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,38,4,,1,,,,,,3,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,17,4,,1,,,,,,4,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,33,4,,1,,,,,,3,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,60,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,75,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,71,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,81,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,95,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,,3,,1,,,,,,3,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,2800,Visit12,12,Phase 1/1A,342,1 or 1A,60,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,63,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,89,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM416KDL,2358,,,M,3400,Visit15,15,Phase 1/1A,424,1 or 1A,71,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,2,2,15,15,2,2,400,400,2,15,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,1000,Visit3,3,Phase 2,90,2,95,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,1200,Visit4,4,Phase 2,115,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,1400,Visit5,5,Phase 2,143,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,1800,Visit7,7,Phase 3,204,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,2000,Visit8,8,Phase 3,231,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,2200,Visit9,9,Phase 3,260,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,2400,Visit10,10,Phase 3,288,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,2600,Visit11,11,Phase 3,314,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,2800,Visit12,12,Phase 3,344,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,3000,Visit13,13,Phase 3,372,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,3200,Visit14,14,Phase 3,405,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,3400,Visit15,15,Phase 3,428,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,3800,Visit17,17,Phase 3,479,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,63,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,5800,EndofPhase2,6,Phase 2,181,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM694RM7,2813,,,M,6000,EndofPhase3,18,Phase 3,503,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,600,Visit1,1,Phase 1/1A,35,1 or 1A,54,2,,,,,,,,2,2,16,,,2,,3,22,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,90,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,1200,Visit4,4,Phase 1/1A,111,1 or 1A,88,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,99,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,99,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,2000,Visit8,8,Phase 1/1A,230,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,93,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,95,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,90,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,2800,Visit12,12,Phase 1/1A,334,1 or 1A,97,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,3000,Visit13,13,Phase 1/1A,372,1 or 1A,96,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,3200,Visit14,14,Phase 1/1A,399,1 or 1A,78,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,3400,Visit15,15,Phase 1/1A,426,1 or 1A,95,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,94,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,3800,Visit17,17,Phase 1/1A,485,1 or 1A,74,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNM903PYC,1188,,,F,4000,Visit18,18,Phase 1/1A,502,1 or 1A,94,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,91,4,,,,,,,,1,4,30,,,1,,3,25,23,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,71,4,,,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,1000,Visit3,3,Phase 1/1A,87,1 or 1A,50,4,,,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,1200,Visit4,4,Phase 1/1A,115,1 or 1A,50,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,1600,Visit6,6,Phase 1/1A,178,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,1800,Visit7,7,Phase 1/1A,206,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,2000,Visit8,8,Phase 1/1A,241,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,2200,Visit9,9,Phase 1/1A,262,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,2400,Visit10,10,Phase 1/1A,290,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,2600,Visit11,11,Phase 1/1A,318,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,2800,Visit12,12,Phase 1/1A,346,1 or 1A,100,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,3000,Visit13,13,Phase 1/1A,374,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,3200,Visit14,14,Phase 1/1A,402,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN264HR6,1212,,,F,5200,EndofPhase1_1a,15,Phase 1/1A,430,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN289GHU,1830,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN289GHU,1830,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN289GHU,1830,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN289GHU,1830,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNN289GHU,1830,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,400,,,1,,2,456,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,98,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,1000,Visit3,3,Phase 1/1A,93,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,1200,Visit4,4,Phase 1/1A,116,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,93,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,1800,Visit7,7,Phase 1/1A,201,1 or 1A,88,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,2000,Visit8,8,Phase 1/1A,229,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,2200,Visit9,9,Phase 1/1A,267,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,2400,Visit10,10,Phase 1/1A,288,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,2600,Visit11,11,Phase 1/1A,313,1 or 1A,68,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,2800,Visit12,12,Phase 1/1A,348,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,3000,Visit13,13,Phase 1/1A,379,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,3200,Visit14,14,Phase 1/1A,418,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,3400,Visit15,15,Phase 1/1A,429,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,3600,Visit16,16,Phase 1/1A,450,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP114APU,2537,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,509,1 or 1A,,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP663AY9,2562,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,0,1,,,,,1,2,3,,,1,2,2,3,3,2,2,80,80,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP663AY9,2562,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP663AY9,2562,,,M,1600,Visit6,6,Phase 2,170,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNP663AY9,2562,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,154,1 or 1A,,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,96,3,,,,,,,,1,3,22.5,,,1,2,3,23,23,3,3,585,600,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,1200,Visit4,4,Phase 2,113,2,100,1,,,,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,1400,Visit5,5,Phase 2,138,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,1600,Visit6,6,Phase 2,174,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,1800,Visit7,7,Phase 2,197,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,2000,Visit8,8,Phase 2,225,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,2200,Visit9,9,Phase 2,251,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,2600,Visit11,11,Phase 2,302,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,2800,Visit12,12,Phase 2,341,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,3000,Visit13,13,Phase 2,365,2,75,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,3200,Visit14,14,Phase 2,393,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,3400,Visit15,15,Phase 2,421,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,3600,Visit16,16,Phase 2,449,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,96,1 or 1A,88,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR566KRC,1790,,,M,5800,EndofPhase2,17,Phase 2,469,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,800,Visit2,2,Phase 2,60,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,1000,Visit3,3,Phase 2,87,2,94,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,1200,Visit4,4,Phase 2,113,2,96,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,1400,Visit5,5,Phase 2,138,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,1600,Visit6,6,Phase 2,177,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,1800,Visit7,7,Phase 2,201,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,2000,Visit8,8,Phase 2,225,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,2200,Visit9,9,Phase 2,253,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,2400,Visit10,10,Phase 2,281,2,,4,,1,,,,,,3,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,2600,Visit11,11,Phase 2,304,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,2800,Visit12,12,Phase 2,326,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,3200,Visit14,14,Phase 3,390,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,3400,Visit15,15,Phase 3,418,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,3600,Visit16,16,Phase 3,449,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,3800,Visit17,17,Phase 3,477,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,4000,Visit18,18,Phase 3,501,3,,,,,,2,500,,,2,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,37,1 or 1A,75,2,,,,,,,,2,2,3,,,1,2,2,3,3,2,4,150,160,4,500,500,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNR964HE4,2107,,,F,5800,EndofPhase2,13,Phase 2,367,2,86,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT123TT7,1821,,,M,600,Visit1,1,Phase 1/1A,38,1 or 1A,76,1,,,,,,,,1,1,7.5,,,2,,2,16,23,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT123TT7,1821,,,M,800,Visit2,2,Phase 1/1A,67,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT123TT7,1821,,,M,1000,Visit3,3,Phase 1/1A,95,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT123TT7,1821,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,75,1,,,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT123TT7,1821,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT123TT7,1821,,,M,1600,Visit6,6,Phase 1/1A,190,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT123TT7,1821,,,M,1800,Visit7,7,Phase 1/1A,218,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT123TT7,1821,,,M,2000,Visit8,8,Phase 1/1A,246,1 or 1A,90,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT123TT7,1821,,,M,2200,Visit9,9,Phase 1/1A,277,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT123TT7,1821,,,M,2400,Visit10,10,Phase 1/1A,309,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT123TT7,1821,,,M,2600,Visit11,11,Phase 1/1A,339,1 or 1A,90,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT123TT7,1821,,,M,2800,Visit12,12,Phase 1/1A,373,1 or 1A,89,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT123TT7,1821,,,M,5200,EndofPhase1_1a,13,Phase 1/1A,408,1 or 1A,100,3,,0,2,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,93,4,,1,,,,,,1,4,30,,,2,3,4,30,30,4,,154,175,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,97,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,1200,Visit4,4,Phase 1/1A,107,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,1400,Visit5,5,Phase 1/1A,135,1 or 1A,96,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,94,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,1800,Visit7,7,Phase 1/1A,194,1 or 1A,80,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,88,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,2600,Visit11,11,Phase 1/1A,302,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,93,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,3600,Visit16,16,Phase 2,446,2,100,,50,,,,,,,1,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,4000,Visit18,18,Phase 2,505,2,100,,175,,,,,,,1,,,175,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,4200,Visit19,19,Phase 2,533,2,66,,175,,,,,,,2,,,175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,4400,Visit20,20,Phase 2,562,2,100,,175,,,,,,,1,,,175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,4600,Visit21,21,Phase 2,590,2,100,,175,,,,,,,3,,,175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,5200,EndofPhase1_1a,15,Phase 1/1A,432,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNT464YZK,2169,,,M,5800,EndofPhase2,22,Phase 2,624,2,100,,175,,,,,,,1,,,175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,90,2,,,,,,,,1,2,400,,,2,2,3,571,600,3,2,16,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,800,Visit2,2,Phase 1/1A,52,1 or 1A,92,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,1000,Visit3,3,Phase 1/1A,82,1 or 1A,90,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,1200,Visit4,4,Phase 1/1A,115,1 or 1A,86,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,1400,Visit5,5,Phase 1/1A,149,1 or 1A,85,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,1600,Visit6,6,Phase 1/1A,179,1 or 1A,81,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,2000,Visit8,8,Phase 2,234,2,80,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,2200,Visit9,9,Phase 2,261,2,83,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,2400,Visit10,10,Phase 2,290,2,82,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,2600,Visit11,11,Phase 2,318,2,76,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,2800,Visit12,12,Phase 2,339,2,86,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,3000,Visit13,13,Phase 2,369,2,97,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,3200,Visit14,14,Phase 2,400,2,85,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,3400,Visit15,15,Phase 2,423,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,3600,Visit16,16,Phase 2,452,2,96,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,3800,Visit17,17,Phase 2,481,2,90,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,4000,Visit18,18,Phase 2,508,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,4200,Visit19,19,Phase 2,541,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,5200,EndofPhase1_1a,7,Phase 1/1A,206,1 or 1A,33,3,,,,,,,,3,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU008CCX,1013,,,F,5800,EndofPhase2,20,Phase 2,570,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU946AFG,2555,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,1,3,500,500,3,3,23,23,3,450,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,1000,Visit3,3,Phase 2,87,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,1400,Visit5,5,Phase 3,154,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,1600,Visit6,6,Phase 3,196,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,2000,Visit8,8,Phase 3,226,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,2200,Visit9,9,Phase 3,255,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,2600,Visit11,11,Phase 3,308,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,2800,Visit12,12,Phase 3,336,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,3000,Visit13,13,Phase 3,359,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,3200,Visit14,14,Phase 3,387,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,5800,EndofPhase2,4,Phase 2,99,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNU972TNA,1608,,,M,6000,EndofPhase3,18,Phase 3,504,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,81,2,,,,,,,,1,2,15,,,2,2,3,25,30,3,4,800,800,4,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,99,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,1200,Visit4,4,Phase 2,131,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,1400,Visit5,5,Phase 2,166,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,1600,Visit6,6,Phase 2,194,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,2000,Visit8,8,Phase 3,278,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,2200,Visit9,9,Phase 3,302,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,2400,Visit10,10,Phase 3,344,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,2600,Visit11,11,Phase 3,392,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,2800,Visit12,12,Phase 3,420,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,3000,Visit13,13,Phase 3,449,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,3200,Visit14,14,Phase 3,477,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,3400,Visit15,15,Phase 3,504,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,3600,Visit16,16,Phase 3,546,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,3800,Visit17,17,Phase 3,568,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,89,1 or 1A,99,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,5800,EndofPhase2,7,Phase 2,225,2,100,4,,0,2,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV699KD6,2148,,,M,6000,EndofPhase3,18,Phase 3,603,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV838LPV,1896,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,47,1 or 1A,28,2,,,,,,,,4,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV847MZ6,1107,,,F,800,Visit2,2,Phase 1B,60,1B,83,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV847MZ6,1107,,,F,1000,Visit3,3,Phase 1B,86,1B,90,2,,,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV847MZ6,1107,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,38,1 or 1A,36,2,,,,,,,,4,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNV847MZ6,1107,,,F,5400,EndofPhase1b,4,Phase 1B,116,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,1,,2,13,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,97,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,1600,Visit6,6,Phase 1/1A,156,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,50,2,,0,1,,,,,3,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,2000,Visit8,8,Phase 1/1A,216,1 or 1A,95,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,2400,Visit10,10,Phase 1/1A,279,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,3600,Visit16,16,Phase 1/1A,451,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW240YGQ,2352,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,513,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW268FA1,1214,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,,4,778,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,93,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,93,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,93,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,3200,Visit14,14,Phase 1/1A,385,1 or 1A,95,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,94,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,95,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW747THY,2472,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,93,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW814NK7,2166,,,M,600,Visit1,1,Phase 1/1A,48,1 or 1A,62,2,,1,,,,,,2,2,400,,,2,2,2,300,300,2,2,80,80,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW814NK7,2166,,,M,1600,Visit6,6,Phase 2,175,2,,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW814NK7,2166,,,M,1800,Visit7,7,Phase 2,201,2,84,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW814NK7,2166,,,M,2000,Visit8,8,Phase 2,228,2,,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW814NK7,2166,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,152,1 or 1A,43,1,,1,,,,,,3,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNW862WRN,2262,,,M,600,Visit1,1,Phase 1/1A,15,1 or 1A,69,2,,1,,,,,,2,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,80,,,2,2,3,116,120,3,3,514,600,3,15,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,96,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,96,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,1400,Visit5,5,Phase 1/1A,156,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,82,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,92,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,97,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,2400,Visit10,10,Phase 2,255,2,92,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,2600,Visit11,11,Phase 2,288,2,88,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,2800,Visit12,12,Phase 2,340,2,91,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,3000,Visit13,13,Phase 2,367,2,92,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,3200,Visit14,14,Phase 2,394,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,3400,Visit15,15,Phase 2,422,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,239,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,5800,EndofPhase2,16,Phase 2,452,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX003UKH,1737,,,M,6000,EndofPhase3,17,Phase 3,465,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX257JV8,2490,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX320YH1,2140,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX684YL2,1089,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX684YL2,1089,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX684YL2,1089,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,61,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX755ZTW,2427,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,,3,107,80,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX755ZTW,2427,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX755ZTW,2427,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX755ZTW,2427,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,,3,,1,,,,,,,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX755ZTW,2427,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNX755ZTW,2427,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,188,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY212JAC,1424,,,M,600,Visit1,1,Phase 1/1A,38,1 or 1A,66,2,,,,,,,,2,2,15,,,2,,3,21,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY212JAC,1424,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,3,,,,,,,,,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY212JAC,1424,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,90,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY212JAC,1424,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY212JAC,1424,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY212JAC,1424,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,600,Visit1,1,Phase 1/1A,40,1 or 1A,97,2,,,,,,,,1,2,80,,,2,2,3,133,160,3,3,24,30,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,1400,Visit5,5,Phase 1/1A,133,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,1800,Visit7,7,Phase 2,200,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,2000,Visit8,8,Phase 2,222,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,2200,Visit9,9,Phase 2,253,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,2400,Visit10,10,Phase 2,284,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,2600,Visit11,11,Phase 2,308,2,94,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,2800,Visit12,12,Phase 2,337,2,99,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,3000,Visit13,13,Phase 2,364,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,3200,Visit14,14,Phase 2,390,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,3400,Visit15,15,Phase 2,419,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,3600,Visit16,16,Phase 2,445,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,3800,Visit17,17,Phase 2,476,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,172,1 or 1A,94,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY605WYR,1710,,,M,5800,EndofPhase2,18,Phase 2,515,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,,,,,,,1,3,4.5,,,1,2,4,5,5,4,4,800,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,1000,Visit3,3,Phase 2,85,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,1400,Visit5,5,Phase 2,141,2,99,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,1600,Visit6,6,Phase 2,176,2,93,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,1800,Visit7,7,Phase 2,204,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,2000,Visit8,8,Phase 2,225,2,96,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,1,10,5,16,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,2800,Visit12,12,Phase 3,337,3,,,,,,1,10,5,16,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,3000,Visit13,13,Phase 3,386,3,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,3200,Visit14,14,Phase 3,414,3,,,,,,5,32,1,20,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,3400,Visit15,15,Phase 3,442,3,,,,,,5,32,1,20,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,3800,Visit17,17,Phase 3,484,3,,,,,,5,32,1,20,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,5800,EndofPhase2,9,Phase 2,246,2,73,,100,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY606BKA,1648,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,5,,1,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY959THN,1766,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,3,,,,,,,,1,3,600,,,2,2,4,733,800,4,4,30,30,4,400,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY959THN,1766,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY959THN,1766,,,M,1200,Visit4,4,Phase 2,109,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY959THN,1766,,,M,1400,Visit5,5,Phase 2,134,2,94,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY959THN,1766,,,M,1800,Visit7,7,Phase 3,193,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY959THN,1766,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,88,1 or 1A,93,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY959THN,1766,,,M,5800,EndofPhase2,6,Phase 2,158,2,85,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVNY959THN,1766,,,M,6000,EndofPhase3,8,Phase 3,213,3,,,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA179JJH,2563,,,M,1000,Visit3,3,Phase 3,54,3,,,,,,2,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA179JJH,2563,,,M,1200,Visit4,4,Phase 3,96,3,,,,,,2,200,,,1,,,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA179JJH,2563,,,M,1400,Visit5,5,Phase 3,124,3,,,,,,2,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA179JJH,2563,,,M,1600,Visit6,6,Phase 3,150,3,,,,,,2,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA179JJH,2563,,,M,1800,Visit7,7,Phase 3,192,3,,,,,,2,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA179JJH,2563,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,2,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA179JJH,2563,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,19,1 or 1A,60,1,,0,1,,,,,2,1,40,,,1,1,1,40,40,1,1,2,2,1,183,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA179JJH,2563,,,M,5800,EndofPhase2,2,Phase 2,33,2,100,1,,0,1,,,,,1,1,,1.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,800,Visit2,2,Phase 2,62,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,1200,Visit4,4,Phase 3,115,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,1400,Visit5,5,Phase 3,143,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,1600,Visit6,6,Phase 3,165,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,1800,Visit7,7,Phase 3,193,3,,,,,,8,15,,,2,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,2000,Visit8,8,Phase 3,221,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,2200,Visit9,9,Phase 3,249,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,2400,Visit10,10,Phase 3,277,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,2600,Visit11,11,Phase 3,305,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,2800,Visit12,12,Phase 3,333,3,,,,,,8,15,,,,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,3000,Visit13,13,Phase 3,361,3,,,,,,8,15,,,,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,3200,Visit14,14,Phase 3,390,3,,,,,,8,15,,,,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,3400,Visit15,15,Phase 3,417,3,,,,,,8,15,,,,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,3600,Visit16,16,Phase 3,445,3,,,,,,8,15,,,3,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,3800,Visit17,17,Phase 3,478,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,39,1 or 1A,0,2,,,,,,,,4,2,400,,,2,2,2,400,400,2,3,120,120,3,14,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,5800,EndofPhase2,3,Phase 2,85,2,96,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA225WJC,2796,,,M,6000,EndofPhase3,18,Phase 3,502,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA430NJX,2325,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,600,Visit1,1,Phase 1/1A,23,1 or 1A,100,1,,0,1,,,,,1,1,200,,,1,2,1,200,200,1,2,80,80,2,5,5,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,800,Visit2,2,Phase 1/1A,52,1 or 1A,100,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,1400,Visit5,5,Phase 3,143,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,1600,Visit6,6,Phase 3,177,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,1800,Visit7,7,Phase 3,197,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,2200,Visit9,9,Phase 3,248,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,2600,Visit11,11,Phase 3,310,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,2800,Visit12,12,Phase 3,337,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,3000,Visit13,13,Phase 3,367,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,3200,Visit14,14,Phase 3,394,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,3400,Visit15,15,Phase 3,430,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,92,1 or 1A,100,1,,1,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,5800,EndofPhase2,4,Phase 2,113,2,44,2,,1,,,,,,3,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPA507AW3,2475,,,M,6000,EndofPhase3,18,Phase 3,507,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,1000,Visit3,3,Phase 3,77,3,,,,,,3,2,,,1,,,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,1200,Visit4,4,Phase 3,106,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,1400,Visit5,5,Phase 3,136,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,1600,Visit6,6,Phase 3,164,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,1800,Visit7,7,Phase 3,192,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,2000,Visit8,8,Phase 3,220,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,2200,Visit9,9,Phase 3,248,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,2600,Visit11,11,Phase 3,304,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,2800,Visit12,12,Phase 3,332,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,3000,Visit13,13,Phase 3,360,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,3200,Visit14,14,Phase 3,388,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,3400,Visit15,15,Phase 3,416,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,3600,Visit16,16,Phase 3,444,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,3800,Visit17,17,Phase 3,472,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,10,1 or 1A,20,2,,,,,,,,4,2,400,,,2,1,2,400,400,2,1,2,2,1,2,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,5800,EndofPhase2,2,Phase 2,44,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB385LEZ,1140,,,M,6000,EndofPhase3,18,Phase 3,500,3,,,,,,3,2,3,2,1,,,,4,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB479HY6,1329,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,8,1 or 1A,100,1,,,,,,,,1,1,1.5,,,1,1,1,2,2,1,1,8,8,1,200,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB479HY6,1329,,,M,5800,EndofPhase2,2,Phase 2,27,2,,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPB479HY6,1329,,,M,6000,EndofPhase3,3,Phase 3,60,3,,,,,,2,200,,,1,,,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,3,22,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,86,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,2600,Visit11,11,Phase 1/1A,322,1 or 1A,83,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC098RAV,1951,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,513,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC246WXU,2439,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,126,1 or 1A,,1,,1,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,800,Visit2,2,Phase 2,60,2,,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,1000,Visit3,3,Phase 2,85,2,84,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,1400,Visit5,5,Phase 3,141,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,1600,Visit6,6,Phase 3,169,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,1800,Visit7,7,Phase 3,197,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,2200,Visit9,9,Phase 3,260,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,2600,Visit11,11,Phase 3,316,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,2800,Visit12,12,Phase 3,346,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,3000,Visit13,13,Phase 3,372,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,3200,Visit14,14,Phase 3,400,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,3400,Visit15,15,Phase 3,424,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,30,1 or 1A,,,,1,,,,,,1,,,,,2,2,,,,,3,600,600,3,15,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,5800,EndofPhase2,4,Phase 2,113,2,88,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC258DP7,2626,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,,2,,,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,,1,,,,,,,,,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,1200,Visit4,4,Phase 1/1A,105,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,97,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,60,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,2200,Visit9,9,Phase 1/1A,246,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,2800,Visit12,12,Phase 1/1A,330,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,3200,Visit14,14,Phase 1/1A,388,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,94,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC499XAF,1504,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,507,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC979YRX,2390,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,600,,,1,,3,640,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC979YRX,2390,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,74,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC979YRX,2390,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,,3,,1,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC979YRX,2390,,,F,1200,Visit4,4,Phase 1/1A,115,1 or 1A,,3,,1,,,,,,3,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPC979YRX,2390,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,142,1 or 1A,100,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,52,2,,1,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,50,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,96,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,96,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,68,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,2000,Visit8,8,Phase 1/1A,237,1 or 1A,52,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,2200,Visit9,9,Phase 1/1A,259,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,2400,Visit10,10,Phase 1/1A,287,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,2600,Visit11,11,Phase 1/1A,315,1 or 1A,92,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,3000,Visit13,13,Phase 1/1A,371,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,3200,Visit14,14,Phase 1/1A,399,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,96,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD031PDP,1315,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,1,,,,,,1,4,30,,,1,2,4,30,30,4,4,160,160,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,96,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,85,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,99,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,94,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,2600,Visit11,11,Phase 2,302,2,81,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,2800,Visit12,12,Phase 2,330,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,3000,Visit13,13,Phase 2,358,2,32,4,,1,,,,,,3,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,3200,Visit14,14,Phase 2,386,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,3400,Visit15,15,Phase 2,414,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,3600,Visit16,16,Phase 2,440,2,99,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,3800,Visit17,17,Phase 2,470,2,97,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,5200,EndofPhase1_1a,10,Phase 1/1A,259,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD304CM4,2525,,,M,5800,EndofPhase2,18,Phase 2,498,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,2,,,,,,,,1,2,15,,,2,,4,28,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,99,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,1200,Visit4,4,Phase 1/1A,110,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,1800,Visit7,7,Phase 1/1A,194,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,99,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,3600,Visit16,16,Phase 1/1A,452,1 or 1A,95,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD448NJC,1152,,,F,4000,Visit18,18,Phase 1/1A,512,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,600,Visit1,1,Phase 1/1A,22,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,3,25,30,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,1200,Visit4,4,Phase 1/1A,106,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,1400,Visit5,5,Phase 1/1A,134,1 or 1A,80,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,96,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,88,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,96,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPD821GTR,1261,,,M,4000,Visit18,18,Phase 1/1A,513,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,4,,,,,,,,1,4,6,,,2,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,96,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,86,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,1600,Visit6,6,Phase 1/1A,180,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,1800,Visit7,7,Phase 1/1A,214,1 or 1A,95,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,2000,Visit8,8,Phase 1/1A,236,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,97,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,2600,Visit11,11,Phase 1/1A,312,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,3200,Visit14,14,Phase 1/1A,395,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,3400,Visit15,15,Phase 1/1A,423,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,3600,Visit16,16,Phase 1/1A,451,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,3800,Visit17,17,Phase 1/1A,479,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE952HKV,1949,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,507,1 or 1A,97,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,80,2,,1,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,97,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,93,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,90,2,,0,2,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,1400,Visit5,5,Phase 1/1A,152,1 or 1A,81,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,79,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,1800,Visit7,7,Phase 1/1A,209,1 or 1A,88,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,2000,Visit8,8,Phase 1/1A,245,1 or 1A,85,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,2200,Visit9,9,Phase 1/1A,281,1 or 1A,94,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,2400,Visit10,10,Phase 1/1A,313,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,2600,Visit11,11,Phase 1/1A,341,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,2800,Visit12,12,Phase 1/1A,370,1 or 1A,97,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,3000,Visit13,13,Phase 1/1A,396,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,3200,Visit14,14,Phase 1/1A,425,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,3400,Visit15,15,Phase 1/1A,452,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,3600,Visit16,16,Phase 1/1A,477,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,3800,Visit17,17,Phase 1/1A,505,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPE961ZJ2,2448,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,537,1 or 1A,81,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF339DKJ,2233,,,F,600,Visit1,1,Phase 1/1A,36,1 or 1A,,2,,0,1,,,,,2,2,80,,,1,,1,50,40,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF339DKJ,2233,,,F,1400,Visit5,5,Phase 1/1A,144,1 or 1A,,1,,0,1,,,,,,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF339DKJ,2233,,,F,1600,Visit6,6,Phase 1/1A,200,1 or 1A,,1,,1,,,,,,,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF339DKJ,2233,,,F,5200,EndofPhase1_1a,7,Phase 1/1A,238,1 or 1A,0,1,,,,,,,,4,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF539UGK,1672,,,M,800,Visit2,2,Phase 2,60,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF539UGK,1672,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,31,1 or 1A,,2,,,,,,,,,2,400,,,2,2,2,400,400,2,3,5,5,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF539UGK,1672,,,M,5800,EndofPhase2,3,Phase 2,82,2,97,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF672TKA,1667,,,F,600,Visit1,1,Phase 1/1A,37,1 or 1A,100,2,,,,,,,,1,2,15,,,1,2,4,27,30,4,4,160,160,4,733,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF672TKA,1667,,,F,1000,Visit3,3,Phase 1/1A,90,1 or 1A,95,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF672TKA,1667,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,97,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF672TKA,1667,,,F,1400,Visit5,5,Phase 1/1A,145,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF672TKA,1667,,,F,2000,Visit8,8,Phase 3,240,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF672TKA,1667,,,F,2200,Visit9,9,Phase 3,268,3,,,,,,2,800,,,,,,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF672TKA,1667,,,F,2400,Visit10,10,Phase 3,286,3,,,,,,2,800,,,,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF672TKA,1667,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,174,1 or 1A,46,4,,,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF672TKA,1667,,,F,5800,EndofPhase2,7,Phase 2,208,2,79,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,1.5,,,1,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,54,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,75,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,1600,Visit6,6,Phase 1/1A,190,1 or 1A,56,1,,,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,2000,Visit8,8,Phase 1/1A,227,1 or 1A,,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,83,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,2400,Visit10,10,Phase 1/1A,288,1 or 1A,81,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,2600,Visit11,11,Phase 1/1A,308,1 or 1A,52,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,2800,Visit12,12,Phase 1/1A,344,1 or 1A,80,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,95,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,79,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,3800,Visit17,17,Phase 1/1A,484,1 or 1A,94,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPF944NW4,1098,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,95,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,,4,,,,,,,,1,4,32,,,1,,4,32,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,800,Visit2,2,Phase 1/1A,53,1 or 1A,83,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,79,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,1400,Visit5,5,Phase 1/1A,137,1 or 1A,82,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,1600,Visit6,6,Phase 1/1A,165,1 or 1A,84,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,94,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,76,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,86,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,89,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,2800,Visit12,12,Phase 1/1A,338,1 or 1A,90,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,3000,Visit13,13,Phase 1/1A,366,1 or 1A,96,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,93,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,96,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,3800,Visit17,17,Phase 1/1A,484,1 or 1A,89,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,4000,Visit18,18,Phase 1/1A,506,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG391RB6,2681,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,506,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG997KG7,1985,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,2,4,700,800,4,4,160,160,4,200,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG997KG7,1985,,,F,800,Visit2,2,Phase 1/1A,66,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG997KG7,1985,,,F,1000,Visit3,3,Phase 1/1A,98,1 or 1A,89,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG997KG7,1985,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,109,1 or 1A,86,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG997KG7,1985,,,F,5800,EndofPhase2,5,Phase 2,151,2,87,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPG997KG7,1985,,,F,6000,EndofPhase3,6,Phase 3,186,3,,,,,,2,200,,,2,,,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH326TWU,1531,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,,1,,,,,,,,,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH813KHF,2513,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,81,1,,1,,,,,,1,1,200,,,2,,3,600,800,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH813KHF,2513,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH813KHF,2513,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH868ELE,1041,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH868ELE,1041,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH868ELE,1041,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,600,Visit1,1,Phase 1/1A,23,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,1,2,3,24,23,3,2,80,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,800,Visit2,2,Phase 1/1A,51,1 or 1A,75,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,86,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,1600,Visit6,6,Phase 3,141,3,,,,,,,10,3,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,1800,Visit7,7,Phase 3,161,3,,,,,,,10,3,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,2000,Visit8,8,Phase 3,189,3,,,,,,,10,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,2200,Visit9,9,Phase 3,217,3,,,,,,,15,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,2400,Visit10,10,Phase 3,259,3,,,,,,,30,3,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,2600,Visit11,11,Phase 3,301,3,,,,,,,10,3,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,2800,Visit12,12,Phase 3,343,3,,,,,,,10,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,3000,Visit13,13,Phase 3,378,3,,,,,,,10,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,3200,Visit14,14,Phase 3,392,3,,,,,,,10,3,3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,,10,3,3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,90,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPH877JXE,2817,,,M,5800,EndofPhase2,5,Phase 2,113,2,65,2,,1,,,,,,3,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ126DL1,1333,,,M,800,Visit2,2,Phase 2,77,2,89,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ126DL1,1333,,,M,1000,Visit3,3,Phase 2,110,2,62,3,,0,1,,,,,2,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ126DL1,1333,,,M,1200,Visit4,4,Phase 2,135,2,90,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ126DL1,1333,,,M,1400,Visit5,5,Phase 2,162,2,100,1,,,,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ126DL1,1333,,,M,1600,Visit6,6,Phase 2,196,2,72,1,,,,,,,,2,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ126DL1,1333,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,42,1 or 1A,48,2,,,,,,,,4,2,15,,,1,1,2,15,15,2,2,333,200,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ126DL1,1333,,,M,5800,EndofPhase2,7,Phase 2,222,2,67,1,,,,,,,,2,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,97,2,,1,,,,,,1,2,16,,,2,,4,30,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,99,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,99,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,2000,Visit8,8,Phase 1/1A,234,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,2200,Visit9,9,Phase 1/1A,262,1 or 1A,95,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,2400,Visit10,10,Phase 1/1A,297,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,2600,Visit11,11,Phase 1/1A,325,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,2800,Visit12,12,Phase 1/1A,353,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,3000,Visit13,13,Phase 1/1A,386,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,3200,Visit14,14,Phase 1/1A,416,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,3400,Visit15,15,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,3600,Visit16,16,Phase 1/1A,477,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,3800,Visit17,17,Phase 1/1A,507,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ185HDR,2866,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,540,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,48,2,,1,,,,,,3,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,58,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,66,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,61,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,59,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,66,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,64,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,77,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,68,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,73,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,80,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,2800,Visit12,12,Phase 1/1A,335,1 or 1A,69,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,73,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,63,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,3400,Visit15,15,Phase 1/1A,441,1 or 1A,65,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,3600,Visit16,16,Phase 1/1A,467,1 or 1A,63,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,3800,Visit17,17,Phase 1/1A,489,1 or 1A,75,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ342TDK,2775,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,510,1 or 1A,76,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ466WRF,2582,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,3,,0,,,,,,1,3,600,,,1,,4,785,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ466WRF,2582,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,4,,0,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ466WRF,2582,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,0,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ466WRF,2582,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,4,,0,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ466WRF,2582,,,M,1600,Visit6,6,Phase 1/1A,190,1 or 1A,100,4,,0,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ466WRF,2582,,,M,2000,Visit8,8,Phase 1/1A,219,1 or 1A,100,4,,0,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ466WRF,2582,,,M,2200,Visit9,9,Phase 1/1A,247,1 or 1A,100,4,,0,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ466WRF,2582,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,4,,0,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ466WRF,2582,,,M,2800,Visit12,12,Phase 1/1A,368,1 or 1A,100,4,,0,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ466WRF,2582,,,M,3000,Visit13,13,Phase 1/1A,396,1 or 1A,100,4,,0,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ466WRF,2582,,,M,3200,Visit14,14,Phase 1/1A,430,1 or 1A,100,4,,0,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ466WRF,2582,,,M,3400,Visit15,15,Phase 1/1A,491,1 or 1A,100,4,,0,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ466WRF,2582,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,530,1 or 1A,100,4,,0,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ476PFK,2410,,,F,600,Visit1,1,Phase 1/1A,21,1 or 1A,,,,,,,,,,,,,,,2,2,3,667,800,3,3,127,160,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ476PFK,2410,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ476PFK,2410,,,F,1000,Visit3,3,Phase 1/1A,93,1 or 1A,,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ476PFK,2410,,,F,1400,Visit5,5,Phase 1/1A,128,1 or 1A,,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ476PFK,2410,,,F,1600,Visit6,6,Phase 1/1A,148,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ476PFK,2410,,,F,1800,Visit7,7,Phase 1/1A,177,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ476PFK,2410,,,F,3000,Visit13,13,Phase 2,352,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ476PFK,2410,,,F,3200,Visit14,14,Phase 2,379,2,25,1,,1,,,,,,4,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ476PFK,2410,,,F,3400,Visit15,15,Phase 2,406,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ476PFK,2410,,,F,3600,Visit16,16,Phase 2,440,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ476PFK,2410,,,F,3800,Visit17,17,Phase 2,475,2,,4,,1,,,,,,,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ476PFK,2410,,,F,5800,EndofPhase2,18,Phase 2,523,2,,4,,1,,,,,,,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ561VBB,1122,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,84,3,,,,,,,,1,3,4.5,,,2,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ561VBB,1122,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,48,1 or 1A,,3,,,,,,,,,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ650TTA,1311,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,600,Visit1,1,Phase 1/1A,43,1 or 1A,57,2,,,,,,,,2,2,16,,,1,,3,22,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,800,Visit2,2,Phase 1/1A,71,1 or 1A,75,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,1000,Visit3,3,Phase 1/1A,106,1 or 1A,98,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,1200,Visit4,4,Phase 1/1A,134,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,1400,Visit5,5,Phase 1/1A,169,1 or 1A,90,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,1600,Visit6,6,Phase 1/1A,190,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,74,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,2000,Visit8,8,Phase 1/1A,239,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,2200,Visit9,9,Phase 1/1A,267,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,2400,Visit10,10,Phase 1/1A,295,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,2600,Visit11,11,Phase 1/1A,323,1 or 1A,96,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,2800,Visit12,12,Phase 1/1A,351,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,3000,Visit13,13,Phase 1/1A,379,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,3200,Visit14,14,Phase 1/1A,407,1 or 1A,93,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,3400,Visit15,15,Phase 1/1A,435,1 or 1A,,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,3600,Visit16,16,Phase 1/1A,463,1 or 1A,93,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,3800,Visit17,17,Phase 1/1A,498,1 or 1A,91,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPJ746TN7,1861,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,94,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK027RUY,2546,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,1,,3,25,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK027RUY,2546,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK027RUY,2546,,,F,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,93,4,,1,,,,,,1,4,30,,,2,2,4,30,30,4,3,120,120,3,360,225,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,1200,Visit4,4,Phase 3,117,3,,,,,,6,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,1400,Visit5,5,Phase 3,141,3,,,,,,6,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,1600,Visit6,6,Phase 3,170,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,1800,Visit7,7,Phase 3,197,3,,,,,,6,225,,,1,,,,225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,6,225,,,1,,,,225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,2200,Visit9,9,Phase 3,253,3,,,,,,6,250,,,1,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,2400,Visit10,10,Phase 3,280,3,,,,,,6,250,,,1,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,2800,Visit12,12,Phase 3,337,3,,,,,,6,350,,,1,,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,6,550,,,1,,,,550,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,3600,Visit16,16,Phase 3,456,3,,,,,,6,550,,,1,,,,550,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,6,600,,,1,,,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,64,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,5800,EndofPhase2,3,Phase 2,93,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK140BW5,2218,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,6,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK185YLP,1402,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,2,3,19,19,3,3,5,5,3,800,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK185YLP,1402,,,M,1000,Visit3,3,Phase 2,97,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK185YLP,1402,,,M,1200,Visit4,4,Phase 2,113,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK185YLP,1402,,,M,1600,Visit6,6,Phase 3,167,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK185YLP,1402,,,M,1800,Visit7,7,Phase 3,195,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK185YLP,1402,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,50,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK185YLP,1402,,,M,5800,EndofPhase2,5,Phase 2,141,2,87,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK185YLP,1402,,,M,6000,EndofPhase3,8,Phase 3,223,3,,,,,,2,800,,,4,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,4,,1,,,,,,1,4,30,,,2,1,3,25,23,3,3,5,5,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,76,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,24,3,,1,,,,,,4,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,89,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,1800,Visit7,7,Phase 2,197,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,2000,Visit8,8,Phase 2,228,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,2200,Visit9,9,Phase 2,259,2,71,3,,1,,,,,,2,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,2400,Visit10,10,Phase 2,284,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,2600,Visit11,11,Phase 2,305,2,100,3,,1,,,,,,2,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,2800,Visit12,12,Phase 2,333,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,3000,Visit13,13,Phase 2,357,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,3200,Visit14,14,Phase 2,385,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,3400,Visit15,15,Phase 2,413,2,96,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,3600,Visit16,16,Phase 2,448,2,97,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,3800,Visit17,17,Phase 2,480,2,94,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,175,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK187JR6,2351,,,M,5800,EndofPhase2,18,Phase 2,522,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK392ZU3,2076,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,2,,,,,,,,1,2,15,,,1,1,3,25,30,3,3,130,160,3,100,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK392ZU3,2076,,,M,800,Visit2,2,Phase 1/1A,71,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK392ZU3,2076,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,95,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK392ZU3,2076,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,50,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK392ZU3,2076,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,80,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK392ZU3,2076,,,M,1800,Visit7,7,Phase 2,198,2,93,2,,0,1,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK392ZU3,2076,,,M,2000,Visit8,8,Phase 2,226,2,65,3,,0,1,,,,,2,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK392ZU3,2076,,,M,2200,Visit9,9,Phase 2,252,2,62,4,,1,,,,,,2,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK392ZU3,2076,,,M,2800,Visit12,12,Phase 3,371,3,,,,,,6,50,6,50,4,,,,100,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK392ZU3,2076,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,168,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK392ZU3,2076,,,M,5800,EndofPhase2,10,Phase 2,315,2,,4,,0,1,,,,,,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPK392ZU3,2076,,,M,6000,EndofPhase3,13,Phase 3,393,3,,,,,,6,50,6,50,4,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,,2,,,,,,,,,2,15,,,2,,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,92,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,1600,Visit6,6,Phase 1/1A,186,1 or 1A,78,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,1800,Visit7,7,Phase 1/1A,214,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,2000,Visit8,8,Phase 1/1A,247,1 or 1A,89,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,2200,Visit9,9,Phase 1/1A,268,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,2400,Visit10,10,Phase 1/1A,289,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,81,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,80,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,89,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,81,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,3800,Visit17,17,Phase 1/1A,480,1 or 1A,93,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPL724GG5,1097,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,72,2,,1,,,,,,2,2,400,,,2,,1,215,200,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,83,1,,1,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,1000,Visit3,3,Phase 1/1A,95,1 or 1A,86,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,1400,Visit5,5,Phase 1/1A,137,1 or 1A,,,,1,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,1600,Visit6,6,Phase 1/1A,165,1 or 1A,93,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,1800,Visit7,7,Phase 1/1A,194,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,2000,Visit8,8,Phase 1/1A,222,1 or 1A,68,1,,,,,,,,2,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,88,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,2600,Visit11,11,Phase 1/1A,305,1 or 1A,49,1,,,,,,,,3,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,71,1,,,,,,,,2,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,3000,Visit13,13,Phase 1/1A,361,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,3200,Visit14,14,Phase 1/1A,389,1 or 1A,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,100,1,,1,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,3800,Visit17,17,Phase 1/1A,480,1 or 1A,100,1,,1,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM144DLP,1652,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,523,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,77,2,,1,,,,,,1,2,3,,,2,,3,5,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,2000,Visit8,8,Phase 1/1A,217,1 or 1A,92,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,2200,Visit9,9,Phase 1/1A,244,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,2600,Visit11,11,Phase 1/1A,301,1 or 1A,94,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,2800,Visit12,12,Phase 1/1A,328,1 or 1A,98,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,3000,Visit13,13,Phase 1/1A,360,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,3200,Visit14,14,Phase 1/1A,384,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,3400,Visit15,15,Phase 1/1A,415,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,3600,Visit16,16,Phase 1/1A,446,1 or 1A,97,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,3800,Visit17,17,Phase 1/1A,468,1 or 1A,97,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM276XAV,2332,,,M,4000,Visit18,18,Phase 1/1A,489,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,89,2,,1,,,,,,1,2,3,,,1,2,2,3,3,2,2,80,80,2,10,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,32,2,,0,1,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,82,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,50,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,1400,Visit5,5,Phase 1/1A,154,1 or 1A,85,2,,0,1,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,1800,Visit7,7,Phase 1/1A,218,1 or 1A,62,2,,0,1,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,2000,Visit8,8,Phase 1/1A,239,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,2400,Visit10,10,Phase 1/1A,302,1 or 1A,0,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,2600,Visit11,11,Phase 1/1A,351,1 or 1A,52,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,3200,Visit14,14,Phase 2,442,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,3400,Visit15,15,Phase 2,470,2,72,2,,1,,,,,,2,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,3600,Visit16,16,Phase 2,498,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,3800,Visit17,17,Phase 2,519,2,76,2,,1,,,,,,2,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,4000,Visit18,18,Phase 2,561,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,4200,Visit19,19,Phase 2,603,2,100,2,,1,,,,,,2,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,4400,Visit20,20,Phase 3,638,3,,,,,,1,10,,0,3,,,,10,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,5200,EndofPhase1_1a,13,Phase 1/1A,414,1 or 1A,100,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPM595JJ5,2234,,,M,5800,EndofPhase2,19,Phase 2,603,2,100,2,,1,,,,,,2,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN069RVU,2463,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN560VKP,1542,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,200,,,2,,2,333,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN560VKP,1542,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN560VKP,1542,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,72,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN750HUN,1826,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,400,,,2,2,2,467,400,2,3,107,80,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN750HUN,1826,,,F,800,Visit2,2,Phase 1/1A,66,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN750HUN,1826,,,F,1000,Visit3,3,Phase 1/1A,94,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN750HUN,1826,,,F,1200,Visit4,4,Phase 1/1A,128,1 or 1A,80,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN750HUN,1826,,,F,2200,Visit9,9,Phase 1/1A,247,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN750HUN,1826,,,F,2400,Visit10,10,Phase 1/1A,282,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN750HUN,1826,,,F,2600,Visit11,11,Phase 1/1A,311,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN750HUN,1826,,,F,2800,Visit12,12,Phase 1/1A,352,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN750HUN,1826,,,F,3000,Visit13,13,Phase 1/1A,377,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN750HUN,1826,,,F,3600,Visit16,16,Phase 2,436,2,92,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN750HUN,1826,,,F,3800,Visit17,17,Phase 2,471,2,,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN750HUN,1826,,,F,5200,EndofPhase1_1a,15,Phase 1/1A,415,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPN750HUN,1826,,,F,5800,EndofPhase2,18,Phase 2,513,2,98,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP627DZR,1777,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP627DZR,1777,,,M,1000,Visit3,3,Phase 1B,78,,,,,,,,,,,,,,,,1,,3,20,20,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP627DZR,1777,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,50,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP627DZR,1777,,,M,5400,EndofPhase1b,3,Phase 1B,78,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,71,2,,,,,,,,2,2,15,,,1,2,2,14,15,2,3,108,120,3,15,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,78,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,95,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,1800,Visit7,7,Phase 2,197,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,2000,Visit8,8,Phase 2,226,2,78,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,2200,Visit9,9,Phase 2,252,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,2400,Visit10,10,Phase 2,283,2,59,3,,1,,,,,,2,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,2600,Visit11,11,Phase 2,308,2,75,3,,1,,,,,,2,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,2800,Visit12,12,Phase 2,343,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,3000,Visit13,13,Phase 2,365,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,3200,Visit14,14,Phase 2,387,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,3400,Visit15,15,Phase 2,427,2,91,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,3800,Visit17,17,Phase 3,482,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,169,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,5800,EndofPhase2,16,Phase 2,451,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPP829MJ2,1960,,,M,6000,EndofPhase3,18,Phase 3,507,3,,,,,,8,15,,0,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,800,Visit2,2,Phase 2,51,2,80,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,1000,Visit3,3,Phase 2,79,2,86,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,1200,Visit4,4,Phase 2,116,2,100,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,1600,Visit6,6,Phase 2,191,2,91,1,,0,1,,,,,1,1,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,1800,Visit7,7,Phase 2,220,2,54,2,,1,,,,,,2,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,2000,Visit8,8,Phase 2,257,2,77,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,2200,Visit9,9,Phase 2,309,2,65,4,,1,,,,,,2,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,2600,Visit11,11,Phase 3,347,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,2800,Visit12,12,Phase 3,368,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,3000,Visit13,13,Phase 3,396,3,,,,,,1,25,,,1,,,,25,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,3200,Visit14,14,Phase 3,424,3,,,,,,1,25,,,1,,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,3400,Visit15,15,Phase 3,464,3,,,,,,1,25,,,1,,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,3600,Visit16,16,Phase 3,492,3,,,,,,1,25,,,1,,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,15,1 or 1A,1,3,,,,,,,,4,3,600,,,2,1,3,600,600,3,3,105,80,3,23,25,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR029WPX,1984,,,M,5800,EndofPhase2,10,Phase 2,326,2,95,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,97,3,,,,,,,,1,3,120,,,1,,3,118,120,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,,3,,1,,,,,,,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,87,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,,3,,1,,,,,,,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,2000,Visit8,8,Phase 1/1A,218,1 or 1A,67,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,,3,,1,,,,,,,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,,3,,1,,,,,,,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,2600,Visit11,11,Phase 1/1A,302,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,2800,Visit12,12,Phase 1/1A,330,1 or 1A,86,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,3000,Visit13,13,Phase 1/1A,358,1 or 1A,33,3,,1,,,,,,3,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,3200,Visit14,14,Phase 1/1A,386,1 or 1A,68,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,3400,Visit15,15,Phase 1/1A,442,1 or 1A,63,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,3800,Visit17,17,Phase 1/1A,470,1 or 1A,73,2,,0,1,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPR066AUZ,1905,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,94,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPT420FZX,2716,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,16,,,1,,3,24,24,3,,,,,983,1200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,1200,Visit4,4,Phase 1B,113,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,1400,Visit5,5,Phase 1B,141,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,1600,Visit6,6,Phase 1B,169,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,1800,Visit7,7,Phase 1B,197,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,2000,Visit8,8,Phase 1B,227,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,2400,Visit10,10,Phase 3,289,3,,,,,,6,200,6,200,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,2600,Visit11,11,Phase 3,330,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,2800,Visit12,12,Phase 3,359,3,,,,,,6,500,6,500,1,,,,1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,3000,Visit13,13,Phase 3,372,3,,,,,,6,500,6,500,1,,,,1000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,3200,Visit14,14,Phase 3,400,3,,,,,,6,600,6,600,1,,,,1200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,3400,Visit15,15,Phase 3,429,3,,,,,,6,600,6,600,1,,,,1200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,3600,Visit16,16,Phase 3,456,3,,,,,,6,600,6,600,1,,,,1200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,3800,Visit17,17,Phase 3,484,3,,,,,,6,600,6,600,1,,,,1200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,86,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,5400,EndofPhase1b,9,Phase 1B,254,1B,100,4,,0,1,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU108GD2,1771,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,6,600,6,600,1,,,,1200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU149HBG,2552,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,,2,,1,,,,,,1,2,3,,,2,,3,5,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPU149HBG,2552,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,50,1 or 1A,98,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPV052MMJ,1650,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,,,,,,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPV053EPK,2266,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,76,1,,,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPV625NAY,1569,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPV867DYH,1498,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,2,,,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPV867DYH,1498,,,M,800,Visit2,2,Phase 1/1A,68,1 or 1A,96,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPW301XMW,1057,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX136VZJ,1070,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,4,,,,,,,,1,4,800,,,2,,4,800,800,4,,,,,800,800,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX136VZJ,1070,,,M,800,Visit2,2,Phase 1/1A,51,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX136VZJ,1070,,,M,1400,Visit5,5,Phase 3,79,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX136VZJ,1070,,,M,1600,Visit6,6,Phase 3,119,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX136VZJ,1070,,,M,1800,Visit7,7,Phase 3,141,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX136VZJ,1070,,,M,2000,Visit8,8,Phase 3,169,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX136VZJ,1070,,,M,2200,Visit9,9,Phase 3,197,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX136VZJ,1070,,,M,2400,Visit10,10,Phase 3,218,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX136VZJ,1070,,,M,2600,Visit11,11,Phase 3,260,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX136VZJ,1070,,,M,2800,Visit12,12,Phase 3,288,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX136VZJ,1070,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,66,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX161BHY,2040,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX675GWU,2363,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,1,2,4,26,30,4,4,160,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX675GWU,2363,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX675GWU,2363,,,M,1000,Visit3,3,Phase 1/1A,82,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX675GWU,2363,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX675GWU,2363,,,M,1800,Visit7,7,Phase 1/1A,206,1 or 1A,94,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX675GWU,2363,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,291,1 or 1A,30,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX675GWU,2363,,,M,5800,EndofPhase2,12,Phase 2,361,2,,4,,1,,,,,,4,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX748YLP,2091,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,60,1 or 1A,9,4,,1,,,,,,4,4,32,,,1,,4,32,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX769HMJ,1562,,,M,600,Visit1,1,Phase 1/1A,39,1 or 1A,100,4,,1,,,,,,1,4,30,,,2,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX769HMJ,1562,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX769HMJ,1562,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX769HMJ,1562,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX769HMJ,1562,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX769HMJ,1562,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX769HMJ,1562,,,M,1800,Visit7,7,Phase 1/1A,193,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX877FZ2,1623,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,85,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX877FZ2,1623,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,83,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX877FZ2,1623,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,79,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX877FZ2,1623,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,89,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX877FZ2,1623,,,M,1400,Visit5,5,Phase 1/1A,155,1 or 1A,90,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX877FZ2,1623,,,M,1600,Visit6,6,Phase 1/1A,191,1 or 1A,90,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX877FZ2,1623,,,M,1800,Visit7,7,Phase 1/1A,212,1 or 1A,76,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX877FZ2,1623,,,M,2000,Visit8,8,Phase 1/1A,239,1 or 1A,82,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX877FZ2,1623,,,M,3000,Visit13,13,Phase 1/1A,373,1 or 1A,83,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX877FZ2,1623,,,M,3200,Visit14,14,Phase 1/1A,408,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX877FZ2,1623,,,M,3600,Visit16,16,Phase 1/1A,463,1 or 1A,88,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX877FZ2,1623,,,M,3800,Visit17,17,Phase 1/1A,491,1 or 1A,98,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX877FZ2,1623,,,M,4000,Visit18,18,Phase 1/1A,538,1 or 1A,83,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX890WTY,1460,,,M,600,Visit1,1,Phase 1/1A,23,1 or 1A,100,1,,,,,,,,1,1,1.5,,,2,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPX890WTY,1460,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,28,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPY547PGZ,1658,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,1,,,,,,,,1,1,8,,,1,,2,16,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPY547PGZ,1658,,,M,1800,Visit7,7,Phase 1B,205,1B,96,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPY547PGZ,1658,,,M,2000,Visit8,8,Phase 1B,237,1B,67,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPY547PGZ,1658,,,M,2200,Visit9,9,Phase 1B,260,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPY547PGZ,1658,,,M,2400,Visit10,10,Phase 1B,287,1B,70,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPY547PGZ,1658,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,177,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,3,25,30,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,2400,Visit10,10,Phase 1/1A,293,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,2600,Visit11,11,Phase 1/1A,321,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,2800,Visit12,12,Phase 1/1A,349,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,3000,Visit13,13,Phase 1/1A,377,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,3200,Visit14,14,Phase 1/1A,405,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,3400,Visit15,15,Phase 1/1A,433,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,3600,Visit16,16,Phase 1/1A,461,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,3800,Visit17,17,Phase 1/1A,489,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ071XF1,1417,,,M,4000,Visit18,18,Phase 1/1A,540,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,30,,,1,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,4000,Visit18,18,Phase 1/1A,504,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ329HCK,1470,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,504,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ348JR1,2504,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,1,3,26,30,3,3,127,160,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ348JR1,2504,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,62,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ348JR1,2504,,,M,1000,Visit3,3,Phase 1/1A,114,1 or 1A,50,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ348JR1,2504,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ348JR1,2504,,,M,1800,Visit7,7,Phase 2,212,2,47,4,,,,,,,,3,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ348JR1,2504,,,M,2000,Visit8,8,Phase 2,234,2,100,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ348JR1,2504,,,M,2200,Visit9,9,Phase 2,262,2,21,4,,0,1,,,,,4,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ348JR1,2504,,,M,2400,Visit10,10,Phase 2,289,2,34,4,,0,1,,,,,3,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ348JR1,2504,,,M,2600,Visit11,11,Phase 2,319,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ348JR1,2504,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,185,1 or 1A,66,4,,0,1,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ348JR1,2504,,,M,5800,EndofPhase2,12,Phase 2,346,2,100,2,,0,1,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,600,Visit1,1,Phase 1/1A,22,1 or 1A,76,2,,,,,,,,1,2,15,,,2,2,3,19,15,3,4,700,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,6,2,,,,,,,,4,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,1000,Visit3,3,Phase 1/1A,81,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,,4,,,,,,,,,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,1600,Visit6,6,Phase 1/1A,199,1 or 1A,,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,1800,Visit7,7,Phase 1/1A,238,1 or 1A,,4,,,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,2200,Visit9,9,Phase 2,284,2,86,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,2400,Visit10,10,Phase 2,311,2,,4,,1,,,,,,2,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,2600,Visit11,11,Phase 2,360,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,2800,Visit12,12,Phase 2,409,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,3000,Visit13,13,Phase 2,431,2,,,,,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,3200,Visit14,14,Phase 2,452,2,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,256,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVPZ384MUC,1268,,,M,5800,EndofPhase2,16,Phase 2,514,2,,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA369MTG,2712,,,F,600,Visit1,1,Phase 1/1A,26,1 or 1A,97,1,,1,,,,,,1,1,1.5,,,1,,3,4,4,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA369MTG,2712,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,57,1 or 1A,23,4,,1,,,,,,4,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,800,Visit2,2,Phase 1/1A,54,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,1400,Visit5,5,Phase 1/1A,138,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,1800,Visit7,7,Phase 1/1A,194,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,2000,Visit8,8,Phase 1/1A,222,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,2200,Visit9,9,Phase 1/1A,250,1 or 1A,,2,,1,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,2400,Visit10,10,Phase 1/1A,286,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,2600,Visit11,11,Phase 1/1A,306,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,2800,Visit12,12,Phase 1/1A,334,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,3000,Visit13,13,Phase 1/1A,362,1 or 1A,95,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,3200,Visit14,14,Phase 1/1A,390,1 or 1A,97,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,3400,Visit15,15,Phase 1/1A,411,1 or 1A,,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,3600,Visit16,16,Phase 1/1A,456,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA703VPM,1702,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,511,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA742CA4,1252,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,,,,,,,1,3,4.5,,,1,,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,2800,Visit12,12,Phase 1/1A,330,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,3000,Visit13,13,Phase 1/1A,357,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,3200,Visit14,14,Phase 1/1A,389,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA784VZA,1671,,,M,4000,Visit18,18,Phase 1/1A,494,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA991HCL,1158,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,97,3,,,,,,,,1,3,24,,,2,,4,31,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA991HCL,1158,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA991HCL,1158,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA991HCL,1158,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA991HCL,1158,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA991HCL,1158,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRA991HCL,1158,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,182,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,3,24,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,1000,Visit3,3,Phase 1B,108,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,1200,Visit4,4,Phase 1B,141,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,1400,Visit5,5,Phase 1B,169,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,1600,Visit6,6,Phase 1B,197,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,1800,Visit7,7,Phase 1B,227,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,2000,Visit8,8,Phase 1B,255,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,2200,Visit9,9,Phase 1B,283,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,2400,Visit10,10,Phase 1B,311,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,2600,Visit11,11,Phase 1B,339,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,2800,Visit12,12,Phase 1B,367,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,3000,Visit13,13,Phase 1B,395,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,3200,Visit14,14,Phase 1B,423,1B,98,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,3400,Visit15,15,Phase 1B,451,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,3600,Visit16,16,Phase 1B,479,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,3800,Visit17,17,Phase 1B,507,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,4000,Visit18,18,Phase 1B,542,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB027RJ8,2114,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,71,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,97,2,,,,,,,,1,2,400,,,1,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,1000,Visit3,3,Phase 1/1A,98,1 or 1A,,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,95,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,1400,Visit5,5,Phase 1/1A,151,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,1600,Visit6,6,Phase 1/1A,179,1 or 1A,95,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,96,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,2000,Visit8,8,Phase 1/1A,234,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,2200,Visit9,9,Phase 1/1A,269,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,2400,Visit10,10,Phase 1/1A,297,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,2600,Visit11,11,Phase 1/1A,330,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,2800,Visit12,12,Phase 1/1A,371,1 or 1A,96,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,3000,Visit13,13,Phase 1/1A,399,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,3200,Visit14,14,Phase 1/1A,423,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,3400,Visit15,15,Phase 1/1A,436,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,3800,Visit17,17,Phase 1/1A,480,1 or 1A,94,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB221EYA,1028,,,M,4000,Visit18,18,Phase 1/1A,512,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,3,21,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,84,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,99,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,99,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,97,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,2000,Visit8,8,Phase 1/1A,239,1 or 1A,87,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,2200,Visit9,9,Phase 1/1A,267,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,99,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,2800,Visit12,12,Phase 1/1A,355,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,3000,Visit13,13,Phase 1/1A,371,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB231DC2,1574,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,511,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB602HCL,2163,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,86,1,,0,1,,,,,1,1,200,,,1,,1,200,200,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB602HCL,2163,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,78,1,,0,1,,,,,2,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB602HCL,2163,,,M,1600,Visit6,6,Phase 1/1A,148,1 or 1A,100,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB602HCL,2163,,,M,1800,Visit7,7,Phase 1/1A,173,1 or 1A,100,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB602HCL,2163,,,M,2000,Visit8,8,Phase 1/1A,201,1 or 1A,100,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB602HCL,2163,,,M,2200,Visit9,9,Phase 1/1A,229,1 or 1A,100,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB602HCL,2163,,,M,2400,Visit10,10,Phase 1/1A,252,1 or 1A,100,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB602HCL,2163,,,M,2600,Visit11,11,Phase 1/1A,273,1 or 1A,68,1,,0,1,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB602HCL,2163,,,M,2800,Visit12,12,Phase 1/1A,309,1 or 1A,80,1,,1,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB602HCL,2163,,,M,3000,Visit13,13,Phase 1/1A,328,1 or 1A,100,1,,1,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB602HCL,2163,,,M,3400,Visit15,15,Phase 1/1A,391,1 or 1A,94,1,,1,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB602HCL,2163,,,M,3600,Visit16,16,Phase 1/1A,412,1 or 1A,100,1,,1,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB602HCL,2163,,,M,4000,Visit18,18,Phase 1/1A,463,1 or 1A,16,1,,0,1,,,,,4,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,80,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,80,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,99,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,86,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,86,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,1600,Visit6,6,Phase 1/1A,179,1 or 1A,75,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,79,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,2000,Visit8,8,Phase 1/1A,229,1 or 1A,90,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,92,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,2800,Visit12,12,Phase 1/1A,334,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,3000,Visit13,13,Phase 1/1A,373,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,3200,Visit14,14,Phase 1/1A,396,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,4000,Visit18,18,Phase 1/1A,516,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRB990VNF,1068,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,516,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,88,2,,,,,,,,2,2,3,,,1,2,2,3,3,2,2,400,400,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,800,Visit2,2,Phase 1/1A,68,1 or 1A,100,1,,,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,1000,Visit3,3,Phase 2,92,2,97,2,,,,,,,,2,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,1200,Visit4,4,Phase 2,123,2,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,1400,Visit5,5,Phase 2,159,2,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,1600,Visit6,6,Phase 2,181,2,89,2,,,,,,,,4,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,2000,Visit8,8,Phase 2,229,2,36,2,,,,,,,,4,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,2200,Visit9,9,Phase 2,251,2,89,2,,,,,,,,4,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,2400,Visit10,10,Phase 2,281,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,2600,Visit11,11,Phase 2,309,2,100,2,,,,,,,,3,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,2800,Visit12,12,Phase 2,335,2,100,2,,,,,,,,3,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,3000,Visit13,13,Phase 2,361,2,83,2,,,,,,,,3,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,3200,Visit14,14,Phase 2,383,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,82,1 or 1A,97,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC235DXR,1642,,,M,5800,EndofPhase2,15,Phase 2,418,2,97,2,,,,,,,,3,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,800,Visit2,2,Phase 2,61,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,1000,Visit3,3,Phase 2,99,2,88,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,1200,Visit4,4,Phase 2,113,2,98,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,1400,Visit5,5,Phase 2,141,2,97,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,1600,Visit6,6,Phase 2,176,2,88,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,1800,Visit7,7,Phase 2,197,2,91,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,2000,Visit8,8,Phase 2,225,2,95,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,2200,Visit9,9,Phase 2,254,2,97,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,2400,Visit10,10,Phase 2,281,2,98,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,2800,Visit12,12,Phase 3,344,3,,,,,,8,15,6,25,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,3000,Visit13,13,Phase 3,367,3,,,,,,8,15,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,3200,Visit14,14,Phase 3,397,3,,,,,,8,15,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,3400,Visit15,15,Phase 3,428,3,,,,,,8,20,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,8,20,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,3800,Visit17,17,Phase 3,470,3,,,,,,8,20,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,18,1 or 1A,53,1,,1,,,,,,2,1,200,,,2,2,1,200,200,1,4,140,160,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,5800,EndofPhase2,11,Phase 2,310,2,96,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC494GT7,2601,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,8,20,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,96,4,,,,,,,,1,4,30,,,1,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,87,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,88,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,89,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,3200,Visit14,14,Phase 1/1A,397,1 or 1A,63,4,,,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,3400,Visit15,15,Phase 1/1A,426,1 or 1A,54,4,,,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,56,4,,,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRC968YZA,1195,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,86,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,69,3,,,,,,,,2,3,22.5,,,2,,3,23,23,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,99,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,93,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,2400,Visit10,10,Phase 1/1A,277,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,2600,Visit11,11,Phase 1/1A,305,1 or 1A,96,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,2800,Visit12,12,Phase 1/1A,333,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,3000,Visit13,13,Phase 1/1A,361,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,3200,Visit14,14,Phase 1/1A,389,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,3400,Visit15,15,Phase 1/1A,417,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,3600,Visit16,16,Phase 1/1A,445,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,3800,Visit17,17,Phase 1/1A,473,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD299KAL,1601,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,504,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD358PKH,1354,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,95,2,,,,,,,,1,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD358PKH,1354,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD358PKH,1354,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD358PKH,1354,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD358PKH,1354,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,92,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD358PKH,1354,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,71,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD358PKH,1354,,,M,1800,Visit7,7,Phase 1/1A,210,1 or 1A,51,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD358PKH,1354,,,M,2000,Visit8,8,Phase 1/1A,238,1 or 1A,81,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD358PKH,1354,,,M,2200,Visit9,9,Phase 1/1A,268,1 or 1A,88,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD358PKH,1354,,,M,2400,Visit10,10,Phase 1/1A,296,1 or 1A,,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD358PKH,1354,,,M,2600,Visit11,11,Phase 1/1A,338,1 or 1A,68,2,,1,,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD358PKH,1354,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,422,1 or 1A,,2,,1,,,,,,,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD425RRA,1390,,,M,600,Visit1,1,Phase 1/1A,23,1 or 1A,85,2,,,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD425RRA,1390,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,57,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD425RRA,1390,,,M,1200,Visit4,4,Phase 1/1A,122,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD440WC0,2016,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,,2,,1,,,,,,,2,16,,,2,,3,20,20,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD440WC0,2016,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,64,1 or 1A,63,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD551ED7,1063,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,3,,,1,1,3,5,5,3,3,107,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD551ED7,1063,,,F,800,Visit2,2,Phase 1/1A,68,1 or 1A,20,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD551ED7,1063,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD551ED7,1063,,,F,1200,Visit4,4,Phase 1/1A,109,1 or 1A,0,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD551ED7,1063,,,F,1400,Visit5,5,Phase 1/1A,134,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD551ED7,1063,,,F,1800,Visit7,7,Phase 2,193,2,100,2,,0,1,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD551ED7,1063,,,F,2000,Visit8,8,Phase 2,218,2,88,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD551ED7,1063,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,169,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD551ED7,1063,,,F,5800,EndofPhase2,9,Phase 2,233,2,67,3,,0,1,,,,,2,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,600,Visit1,1,Phase 1/1A,39,1 or 1A,,1,,,,,,,,,1,7.5,,,2,2,3,19,15,3,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,1200,Visit4,4,Phase 1/1A,116,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,1400,Visit5,5,Phase 1/1A,144,1 or 1A,51,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,1600,Visit6,6,Phase 1/1A,172,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,1800,Visit7,7,Phase 1/1A,194,1 or 1A,100,2,,0,2,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,2000,Visit8,8,Phase 1/1A,214,1 or 1A,100,3,,0,2,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,2200,Visit9,9,Phase 1/1A,248,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,2400,Visit10,10,Phase 1/1A,276,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,2600,Visit11,11,Phase 1/1A,311,1 or 1A,80,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,2800,Visit12,12,Phase 1/1A,332,1 or 1A,95,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,5200,EndofPhase1_1a,13,Phase 1/1A,344,2,,4,,1,,,,,,,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD714ZWG,1845,,,F,5800,EndofPhase2,14,Phase 2,366,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,2,,,,,,,,1,2,16,,,1,,2,20,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,800,Visit2,2,Phase 1/1A,52,1 or 1A,91,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,80,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,1400,Visit5,5,Phase 1/1A,142,1 or 1A,90,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,93,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,70,4,,,,,,,,2,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,98,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,3000,Visit13,13,Phase 1/1A,372,1 or 1A,90,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,90,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,96,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,3800,Visit17,17,Phase 1/1A,484,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD780DMD,1403,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,514,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,37,2,,,,,,,,3,2,15,,,2,,4,28,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,72,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,57,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,50,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,44,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,45,4,,0,2,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,44,4,,0,2,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,2000,Visit8,8,Phase 1/1A,234,1 or 1A,49,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,2200,Visit9,9,Phase 1/1A,261,1 or 1A,64,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,2400,Visit10,10,Phase 1/1A,294,1 or 1A,74,4,,0,2,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,2600,Visit11,11,Phase 1/1A,325,1 or 1A,67,4,,0,2,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,2800,Visit12,12,Phase 1/1A,360,1 or 1A,60,4,,0,2,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,3000,Visit13,13,Phase 1/1A,388,1 or 1A,51,4,,0,2,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,3200,Visit14,14,Phase 1/1A,420,1 or 1A,81,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,3400,Visit15,15,Phase 1/1A,456,1 or 1A,80,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,3600,Visit16,16,Phase 1/1A,484,1 or 1A,61,4,,0,2,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,3800,Visit17,17,Phase 1/1A,518,1 or 1A,86,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRD974LTH,2019,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,539,1 or 1A,74,4,,0,2,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRE239FFW,2112,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRE326MLP,2285,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,2,2,,1,,,,,,4,2,3,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRE326MLP,2285,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,0,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRE326MLP,2285,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,57,1 or 1A,0,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRF963KRF,2830,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG415MDR,1163,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,70,1,,,,,,,,2,1,1.5,,,1,,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,88,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,47,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,1200,Visit4,4,Phase 1/1A,132,1 or 1A,50,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,90,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,1800,Visit7,7,Phase 1/1A,201,1 or 1A,82,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,2000,Visit8,8,Phase 1/1A,229,1 or 1A,97,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,2200,Visit9,9,Phase 1/1A,264,1 or 1A,91,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,94,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,2600,Visit11,11,Phase 1/1A,307,1 or 1A,62,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,93,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,79,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,89,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,84,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,87,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG500UP9,1374,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,504,1 or 1A,81,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,3,19,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,99,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,81,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,1400,Visit5,5,Phase 1/1A,140,1 or 1A,70,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,1600,Visit6,6,Phase 1/1A,168,1 or 1A,52,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,52,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,82,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,2200,Visit9,9,Phase 1/1A,256,1 or 1A,64,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,2400,Visit10,10,Phase 1/1A,284,1 or 1A,63,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,2600,Visit11,11,Phase 1/1A,312,1 or 1A,82,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,2800,Visit12,12,Phase 1/1A,348,1 or 1A,66,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,3000,Visit13,13,Phase 1/1A,377,1 or 1A,59,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,3200,Visit14,14,Phase 1/1A,407,1 or 1A,78,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,3400,Visit15,15,Phase 1/1A,448,1 or 1A,68,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,3600,Visit16,16,Phase 1/1A,475,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRG612HJ9,1456,,,F,3800,Visit17,17,Phase 1/1A,503,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH091VC4,1187,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,2,,,,,,,,1,2,16,,,2,,3,24,24,3,,,,,660,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH091VC4,1187,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH091VC4,1187,,,M,1200,Visit4,4,Phase 1B,107,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH091VC4,1187,,,M,1400,Visit5,5,Phase 1B,135,1B,100,3,,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH091VC4,1187,,,M,1600,Visit6,6,Phase 1B,163,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH091VC4,1187,,,M,2000,Visit8,8,Phase 3,233,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH091VC4,1187,,,M,2200,Visit9,9,Phase 3,248,3,,,,,,2,600,,0,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH091VC4,1187,,,M,2400,Visit10,10,Phase 3,275,3,,,,,,2,800,,0,1,,,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH091VC4,1187,,,M,2600,Visit11,11,Phase 3,300,3,,,,,,2,800,,0,4,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH091VC4,1187,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH091VC4,1187,,,M,5400,EndofPhase1b,7,Phase 1B,191,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH091VC4,1187,,,M,6000,EndofPhase3,12,Phase 3,359,3,,,,,,2,800,,,4,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,75,2,,,,,,,,2,2,400,,,2,2,4,756,800,4,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,99,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,2000,Visit8,8,Phase 1/1A,218,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,2400,Visit10,10,Phase 2,267,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,2600,Visit11,11,Phase 2,295,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,2800,Visit12,12,Phase 2,323,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,3000,Visit13,13,Phase 2,352,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,3200,Visit14,14,Phase 2,387,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,3400,Visit15,15,Phase 2,422,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,3600,Visit16,16,Phase 2,456,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,3800,Visit17,17,Phase 2,478,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,232,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH974JMB,2030,,,M,5800,EndofPhase2,18,Phase 2,499,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,3,22,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,1200,Visit4,4,Phase 1/1A,100,1 or 1A,98,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,1400,Visit5,5,Phase 1/1A,134,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,99,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,87,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,2200,Visit9,9,Phase 1/1A,244,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,2400,Visit10,10,Phase 1/1A,273,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,92,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,3000,Visit13,13,Phase 1/1A,363,1 or 1A,92,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,3200,Visit14,14,Phase 1/1A,385,1 or 1A,97,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,3400,Visit15,15,Phase 1/1A,413,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,3600,Visit16,16,Phase 1/1A,441,1 or 1A,97,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,3800,Visit17,17,Phase 1/1A,469,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRH976HXT,1183,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,498,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRJ980WLC,2481,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK125MRZ,1336,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,16,1 or 1A,25,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK380CZB,1181,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,96,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK380CZB,1181,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,95,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK380CZB,1181,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,95,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK380CZB,1181,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK380CZB,1181,,,F,1400,Visit5,5,Phase 1/1A,144,1 or 1A,94,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK380CZB,1181,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,94,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK380CZB,1181,,,F,1800,Visit7,7,Phase 1/1A,214,1 or 1A,82,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK380CZB,1181,,,F,2000,Visit8,8,Phase 1/1A,247,1 or 1A,79,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK380CZB,1181,,,F,5200,EndofPhase1_1a,12,Phase 1/1A,347,1 or 1A,44,2,,,,,,,,4,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,600,Visit1,1,Phase 1/1A,25,1 or 1A,100,1,,,,,,,,1,1,8,,,1,,3,25,32,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,800,Visit2,2,Phase 1/1A,53,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,1400,Visit5,5,Phase 1/1A,155,1 or 1A,78,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,2000,Visit8,8,Phase 1/1A,231,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,2200,Visit9,9,Phase 1/1A,261,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,2400,Visit10,10,Phase 1/1A,287,1 or 1A,98,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,2600,Visit11,11,Phase 1/1A,318,1 or 1A,98,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,3000,Visit13,13,Phase 1/1A,359,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,3600,Visit16,16,Phase 1/1A,448,1 or 1A,98,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,3800,Visit17,17,Phase 1/1A,473,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRK842RN5,1780,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,499,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,600,Visit1,1,Phase 1/1A,22,1 or 1A,100,2,,,,,,,,1,2,80,,,2,2,2,80,80,2,2,15,15,2,15,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,97,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,1600,Visit6,6,Phase 1/1A,165,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,2400,Visit10,10,Phase 1/1A,298,1 or 1A,99,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,3600,Visit16,16,Phase 3,444,3,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,3800,Visit17,17,Phase 3,484,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,338,1 or 1A,,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,5800,EndofPhase2,13,Phase 2,361,2,,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRL545XJY,1761,,,M,6000,EndofPhase3,18,Phase 3,502,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM037MVX,2770,,,F,800,Visit2,2,Phase 2,57,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM037MVX,2770,,,F,1000,Visit3,3,Phase 2,87,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM037MVX,2770,,,F,1400,Visit5,5,Phase 3,122,3,,,,,,3,1,,,1,,,,1,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM037MVX,2770,,,F,1600,Visit6,6,Phase 3,156,3,,,,,,3,1,,,3,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM037MVX,2770,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,30,1 or 1A,79,1,,1,,,,,,1,1,200,,,2,1,1,200,200,1,1,8,8,1,1,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM037MVX,2770,,,F,5800,EndofPhase2,4,Phase 2,94,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM051ZTR,2195,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,25,1 or 1A,14,3,,1,,,,,,4,3,120,,,2,,3,120,120,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,3,5,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,1800,Visit7,7,Phase 1/1A,210,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,96,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,92,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,3600,Visit16,16,Phase 1/1A,450,1 or 1A,98,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,3800,Visit17,17,Phase 1/1A,482,1 or 1A,91,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM395MTG,1029,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,93,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,1000,Visit3,3,Phase 3,81,3,,,,,,6,25,1,30,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,1200,Visit4,4,Phase 3,116,3,,,,,,6,400,1,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,1400,Visit5,5,Phase 3,137,3,,,,,,6,400,1,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,1600,Visit6,6,Phase 3,176,3,,,,,,6,500,1,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,1800,Visit7,7,Phase 3,200,3,,,,,,6,600,1,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,2000,Visit8,8,Phase 3,221,3,,,,,,6,600,1,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,2200,Visit9,9,Phase 3,260,3,,,,,,1,0,6,600,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,2400,Visit10,10,Phase 3,284,3,,,,,,6,600,1,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,2600,Visit11,11,Phase 3,312,3,,,,,,6,600,1,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,2800,Visit12,12,Phase 3,340,3,,,,,,6,600,1,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,3000,Visit13,13,Phase 3,368,3,,,,,,6,600,1,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,3200,Visit14,14,Phase 3,396,3,,,,,,6,600,1,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,3400,Visit15,15,Phase 3,424,3,,,,,,6,600,1,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,3600,Visit16,16,Phase 3,452,3,,,,,,6,700,1,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,3800,Visit17,17,Phase 3,480,3,,,,,,1,0,6,700,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,26,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,1,1,1,2,2,1,1,8,8,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,5800,EndofPhase2,2,Phase 2,53,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM608VCY,2182,,,M,6000,EndofPhase3,18,Phase 3,508,3,,,,,,1,0,6,700,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,3,,,,,,,,1,3,22.5,,,2,,4,27,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,1200,Visit4,4,Phase 1/1A,127,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,1600,Visit6,6,Phase 1/1A,161,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,1800,Visit7,7,Phase 1/1A,190,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,2200,Visit9,9,Phase 1/1A,275,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,2400,Visit10,10,Phase 1/1A,316,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,2600,Visit11,11,Phase 1/1A,358,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,2800,Visit12,12,Phase 1/1A,386,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,3000,Visit13,13,Phase 1/1A,414,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,3200,Visit14,14,Phase 1/1A,442,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,3400,Visit15,15,Phase 1/1A,470,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,3600,Visit16,16,Phase 1/1A,512,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,3800,Visit17,17,Phase 1/1A,542,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM666PPN,1285,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,582,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM730UMJ,2637,,,M,600,Visit1,1,Phase 1/1A,39,1 or 1A,100,3,,1,,,,,,1,3,600,,,2,,3,600,600,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM730UMJ,2637,,,M,800,Visit2,2,Phase 1/1A,66,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM730UMJ,2637,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRM730UMJ,2637,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,99,1 or 1A,0,3,,,,,,,,4,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN277AA6,1156,,,F,600,Visit1,1,Phase 1/1A,39,1 or 1A,100,1,,,,,,,,1,1,7.5,,,2,,2,17,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN277AA6,1156,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN277AA6,1156,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN277AA6,1156,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,108,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN291KNC,2517,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,98,4,,1,,,,,,1,4,160,,,2,2,4,160,160,4,4,6,6,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN291KNC,2517,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,97,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN291KNC,2517,,,M,1000,Visit3,3,Phase 2,91,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN291KNC,2517,,,M,1200,Visit4,4,Phase 2,119,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN291KNC,2517,,,M,1400,Visit5,5,Phase 2,147,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN291KNC,2517,,,M,1600,Visit6,6,Phase 2,176,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN291KNC,2517,,,M,1800,Visit7,7,Phase 2,203,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN291KNC,2517,,,M,2000,Visit8,8,Phase 2,231,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN291KNC,2517,,,M,2200,Visit9,9,Phase 2,259,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN291KNC,2517,,,M,2400,Visit10,10,Phase 2,286,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN291KNC,2517,,,M,2600,Visit11,11,Phase 2,312,2,83,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN291KNC,2517,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,62,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN291KNC,2517,,,M,5800,EndofPhase2,12,Phase 2,342,2,93,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,1000,Visit3,3,Phase 3,58,3,,,,,,2,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,1200,Visit4,4,Phase 3,94,3,,,,,,2,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,1400,Visit5,5,Phase 3,115,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,1600,Visit6,6,Phase 3,143,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,1800,Visit7,7,Phase 3,170,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,2000,Visit8,8,Phase 3,198,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,2200,Visit9,9,Phase 3,234,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,2400,Visit10,10,Phase 3,262,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,2600,Visit11,11,Phase 3,290,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,2800,Visit12,12,Phase 3,325,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,3000,Visit13,13,Phase 3,360,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,3200,Visit14,14,Phase 3,388,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,3400,Visit15,15,Phase 3,412,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,3600,Visit16,16,Phase 3,442,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,3800,Visit17,17,Phase 3,470,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,20,1 or 1A,63,1,,,,,,,,2,1,7.5,,,2,1,1,8,8,1,1,2,2,1,288,300,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,5800,EndofPhase2,2,Phase 2,37,2,94,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN352YFF,1045,,,M,6000,EndofPhase3,18,Phase 3,513,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN403NDD,2052,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,1,,,,,,1,1,8,,,1,,2,15,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN403NDD,2052,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,61,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN403NDD,2052,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN403NDD,2052,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN403NDD,2052,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,50,2,,1,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN403NDD,2052,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN403NDD,2052,,,M,1800,Visit7,7,Phase 1/1A,213,1 or 1A,77,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN403NDD,2052,,,M,2000,Visit8,8,Phase 1/1A,248,1 or 1A,83,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN459NF2,2875,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,0,2,,,,,,,,4,2,80,,,2,,3,133,160,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN459NF2,2875,,,F,800,Visit2,2,Phase 1/1A,55,1 or 1A,82,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN459NF2,2875,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,99,1 or 1A,24,4,,,,,,,,4,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN513EXN,2338,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,4,,,,,,,,1,4,6,,,1,1,4,6,6,4,4,30,30,4,775,800,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,1800,Visit7,7,Phase 3,198,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,2000,Visit8,8,Phase 3,226,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,2200,Visit9,9,Phase 3,254,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,2400,Visit10,10,Phase 3,277,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,2600,Visit11,11,Phase 3,304,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,2800,Visit12,12,Phase 3,337,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,3000,Visit13,13,Phase 3,360,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,3200,Visit14,14,Phase 3,388,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,3400,Visit15,15,Phase 3,416,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,3600,Visit16,16,Phase 3,442,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,3800,Visit17,17,Phase 3,470,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,151,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,5800,EndofPhase2,6,Phase 2,170,2,100,4,,,,,,,,2,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN808RGP,2685,,,M,6000,EndofPhase3,18,Phase 3,498,3,,,,,,2,900,,,1,,,,900,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN931LV6,1677,,,F,800,Visit2,2,Phase 1/1A,53,1 or 1A,27,1,,,,,,,,4,1,1.5,,,1,,2,2,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN931LV6,1677,,,F,1000,Visit3,3,Phase 1/1A,83,1 or 1A,27,1,,,,,,,,3,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN931LV6,1677,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,24,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN931LV6,1677,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,41,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN931LV6,1677,,,F,1600,Visit6,6,Phase 1/1A,172,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN931LV6,1677,,,F,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN931LV6,1677,,,F,2000,Visit8,8,Phase 1/1A,239,1 or 1A,71,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN931LV6,1677,,,F,2200,Visit9,9,Phase 1/1A,257,1 or 1A,83,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRN931LV6,1677,,,F,2400,Visit10,10,Phase 1/1A,280,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP318LJG,1201,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,16,1 or 1A,72,1,,,,,,,,2,1,7.5,,,1,2,1,8,8,1,1,200,200,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP318LJG,1201,,,M,5800,EndofPhase2,2,Phase 2,31,2,88,1,,,,,,,,1,1,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP485GWJ,2451,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,8,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,97,3,,,,,,,,1,3,600,,,2,2,4,760,800,4,4,30,30,4,7,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,800,Visit2,2,Phase 1/1A,67,1 or 1A,61,4,,,,,,,,2,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,81,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,51,4,,,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,1600,Visit6,6,Phase 2,179,2,95,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,1800,Visit7,7,Phase 2,214,2,85,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,2000,Visit8,8,Phase 2,238,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,2200,Visit9,9,Phase 2,274,2,90,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,2400,Visit10,10,Phase 2,308,2,90,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,2600,Visit11,11,Phase 2,330,2,76,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,2800,Visit12,12,Phase 2,358,2,88,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,3000,Visit13,13,Phase 2,385,2,73,4,,,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,3200,Visit14,14,Phase 2,421,2,76,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,3600,Visit16,16,Phase 3,482,3,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,3800,Visit17,17,Phase 3,497,3,,,,,,3,7,,,1,,,,7,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,146,1 or 1A,62,4,,,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,5800,EndofPhase2,15,Phase 2,441,2,88,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP589CD1,1297,,,M,6000,EndofPhase3,18,Phase 3,525,3,,,,,,3,7,,,1,,,,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,,2,,,,,,,,1,2,16,,,2,,3,21,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,90,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,82,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,80,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,1400,Visit5,5,Phase 1/1A,155,1 or 1A,96,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,1800,Visit7,7,Phase 1/1A,212,1 or 1A,41,2,,1,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,2000,Visit8,8,Phase 1/1A,233,1 or 1A,63,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,2200,Visit9,9,Phase 1/1A,248,1 or 1A,67,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,2400,Visit10,10,Phase 1/1A,282,1 or 1A,69,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,2600,Visit11,11,Phase 1/1A,310,1 or 1A,,3,,,,,,,,,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,2800,Visit12,12,Phase 1/1A,345,1 or 1A,74,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,3000,Visit13,13,Phase 1/1A,372,1 or 1A,64,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,3200,Visit14,14,Phase 1/1A,400,1 or 1A,87,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,3600,Visit16,16,Phase 1/1A,442,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,3800,Visit17,17,Phase 1/1A,484,1 or 1A,71,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP764XAF,1478,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,492,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,600,Visit1,1,Phase 1/1A,25,1 or 1A,83,2,,1,,,,,,1,2,80,,,2,,3,113,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,1000,Visit3,3,Phase 1/1A,82,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,89,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,1400,Visit5,5,Phase 1/1A,146,1 or 1A,98,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,1800,Visit7,7,Phase 1/1A,194,1 or 1A,88,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,2000,Visit8,8,Phase 1/1A,222,1 or 1A,95,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,88,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,2400,Visit10,10,Phase 1/1A,277,1 or 1A,91,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,2600,Visit11,11,Phase 1/1A,312,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,2800,Visit12,12,Phase 1/1A,343,1 or 1A,97,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,3000,Visit13,13,Phase 1/1A,368,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,3200,Visit14,14,Phase 1/1A,396,1 or 1A,98,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,3600,Visit16,16,Phase 1/1A,445,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,3800,Visit17,17,Phase 1/1A,474,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP824KUD,2807,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,600,Visit1,1,Phase 1/1A,45,1 or 1A,100,3,,,,,,,,1,3,4.5,,,2,1,4,6,6,4,3,23,23,3,380,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,98,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,78,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,2800,Visit12,12,Phase 2,337,2,100,2,,0,1,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,2,300,,,2,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,5200,EndofPhase1_1a,11,Phase 1/1A,309,1 or 1A,79,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,5800,EndofPhase2,13,Phase 2,365,2,98,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRP989LBV,1134,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR007EHH,2805,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,2,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR007EHH,2805,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR007EHH,2805,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,110,1 or 1A,40,3,,1,,,,,,4,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,2,4,767,800,4,4,160,160,4,275,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,1600,Visit6,6,Phase 1/1A,157,1 or 1A,,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,1800,Visit7,7,Phase 1/1A,185,1 or 1A,99,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,2000,Visit8,8,Phase 1/1A,212,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,2200,Visit9,9,Phase 1/1A,233,1 or 1A,,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,2400,Visit10,10,Phase 1/1A,262,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,2800,Visit12,12,Phase 1/1A,339,1 or 1A,100,4,,0,2,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,3200,Visit14,14,Phase 1/1A,374,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,3800,Visit17,17,Phase 3,458,3,,,,,,6,250,,,1,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,5200,EndofPhase1_1a,15,Phase 1/1A,415,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,5800,EndofPhase2,16,Phase 2,430,2,10,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR350XWG,2029,,,M,6000,EndofPhase3,18,Phase 3,486,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR355DDG,1699,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,95,1,,,,,,,,1,1,1.5,,,1,,2,2,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRR355DDG,1699,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,66,1 or 1A,70,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,92,2,,,,,,,,1,2,400,,,2,,2,433,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,2200,Visit9,9,Phase 1/1A,259,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,2600,Visit11,11,Phase 1/1A,315,1 or 1A,90,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,2800,Visit12,12,Phase 1/1A,352,1 or 1A,96,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,95,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,96,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT708URG,1713,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,96,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT825DG0,2119,,,F,600,Visit1,1,Phase 1/1A,46,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,1,3,23,23,3,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT825DG0,2119,,,F,1000,Visit3,3,Phase 3,99,3,,,,,,2,100,3,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT825DG0,2119,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,66,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT825DG0,2119,,,F,5800,EndofPhase2,2,Phase 2,81,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT964RXC,1399,,,F,600,Visit1,1,Phase 1/1A,116,1 or 1A,,2,,,,,,,,,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRT964RXC,1399,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,116,1 or 1A,,2,,,,,,,,,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,88,2,,1,,,,,,1,2,15,,,1,,1,9,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,1000,Visit3,3,Phase 1/1A,92,1 or 1A,97,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,95,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,1400,Visit5,5,Phase 1/1A,139,1 or 1A,50,2,,1,,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,2000,Visit8,8,Phase 1/1A,222,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,2400,Visit10,10,Phase 1/1A,286,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,2800,Visit12,12,Phase 1/1A,335,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,3000,Visit13,13,Phase 1/1A,363,1 or 1A,50,2,,1,,,,,,3,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,3400,Visit15,15,Phase 1/1A,419,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,3600,Visit16,16,Phase 1/1A,447,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,3800,Visit17,17,Phase 1/1A,475,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRU923XE7,2603,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,600,Visit1,1,Phase 1/1A,37,1 or 1A,,,,,,,,,,,,,,,1,,3,571,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,,2,,,,,,,,,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,60,2,,0,1,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,5,2,,0,1,,,,,4,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,83,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,72,3,,0,1,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,60,3,,0,1,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,2000,Visit8,8,Phase 1/1A,233,1 or 1A,70,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,2200,Visit9,9,Phase 1/1A,261,1 or 1A,59,3,,0,1,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,2400,Visit10,10,Phase 1/1A,289,1 or 1A,79,3,,0,1,,,,,3,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,2600,Visit11,11,Phase 1/1A,317,1 or 1A,56,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,3000,Visit13,13,Phase 1/1A,376,1 or 1A,88,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,3200,Visit14,14,Phase 1/1A,404,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRV108KBU,2556,,,M,3400,Visit15,15,Phase 1/1A,434,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,1000,Visit3,3,Phase 3,83,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,1200,Visit4,4,Phase 3,107,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,1400,Visit5,5,Phase 3,134,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,1600,Visit6,6,Phase 3,155,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,1800,Visit7,7,Phase 3,195,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,2000,Visit8,8,Phase 3,223,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,2200,Visit9,9,Phase 3,258,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,2400,Visit10,10,Phase 3,286,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,2600,Visit11,11,Phase 3,307,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,2800,Visit12,12,Phase 3,335,3,,,,,,4,200,,,1,,,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,3000,Visit13,13,Phase 3,363,3,,,,,,4,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,3200,Visit14,14,Phase 3,386,3,,,,,,4,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,41,1 or 1A,99,3,,,,,,,,1,3,600,,,2,2,3,600,600,3,2,3,3,2,160,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,5800,EndofPhase2,2,Phase 2,48,2,100,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW270ZCY,2004,,,F,6000,EndofPhase3,15,Phase 3,428,3,,,,,,4,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW381BEH,2106,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,4,,1,,,,,,1,4,6,,,1,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW381BEH,2106,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW381BEH,2106,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,95,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW381BEH,2106,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,92,1 or 1A,100,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,62,3,,1,,,,,,2,3,24,,,1,,4,30,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,77,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,77,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,59,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,82,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,94,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,1800,Visit7,7,Phase 1/1A,204,1 or 1A,79,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,2000,Visit8,8,Phase 1/1A,232,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,2200,Visit9,9,Phase 1/1A,260,1 or 1A,94,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,2400,Visit10,10,Phase 1/1A,294,1 or 1A,94,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,2600,Visit11,11,Phase 1/1A,315,1 or 1A,88,4,,0,1,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,2800,Visit12,12,Phase 1/1A,343,1 or 1A,98,4,,0,1,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,3000,Visit13,13,Phase 1/1A,371,1 or 1A,100,4,,0,1,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,3200,Visit14,14,Phase 1/1A,399,1 or 1A,97,4,,0,1,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW400JTH,1783,,,F,5200,EndofPhase1_1a,15,Phase 1/1A,413,1 or 1A,,4,,0,1,,,,,,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW540GAG,1789,,,M,800,Visit2,2,Phase 2,57,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW540GAG,1789,,,M,1000,Visit3,3,Phase 2,85,2,71,2,,,,,,,,2,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW540GAG,1789,,,M,1200,Visit4,4,Phase 2,128,2,100,2,,,,,,,,3,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW540GAG,1789,,,M,1400,Visit5,5,Phase 2,156,2,93,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW540GAG,1789,,,M,1600,Visit6,6,Phase 2,170,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW540GAG,1789,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,21,1 or 1A,98,1,,,,,,,,1,1,40,,,2,2,1,40,40,1,2,400,400,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW540GAG,1789,,,M,5800,EndofPhase2,6,Phase 2,170,2,96,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW963CR1,1525,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,98,3,,,,,,,,1,3,4.5,,,1,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW963CR1,1525,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,81,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRW963CR1,1525,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRX445HZ4,2581,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,1,,1,,,,,,1,1,40,,,2,1,2,67,80,2,1,2,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRX445HZ4,2581,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,97,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRX445HZ4,2581,,,F,1200,Visit4,4,Phase 2,109,2,94,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRX445HZ4,2581,,,F,1400,Visit5,5,Phase 2,138,2,93,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRX445HZ4,2581,,,F,1600,Visit6,6,Phase 2,145,2,71,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRX445HZ4,2581,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,75,1 or 1A,87,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRX445HZ4,2581,,,F,5800,EndofPhase2,6,Phase 2,145,2,71,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY026GJK,2768,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,3,,0,,,,,,1,3,120,,,1,,2,90,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY026GJK,2768,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY026GJK,2768,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,50,2,,1,,,,,,3,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY026GJK,2768,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,150,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,3,24,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,93,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,89,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,94,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,96,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,98,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,93,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,2200,Visit9,9,Phase 1/1A,266,1 or 1A,97,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,2400,Visit10,10,Phase 1/1A,294,1 or 1A,93,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,2600,Visit11,11,Phase 1/1A,322,1 or 1A,93,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,2800,Visit12,12,Phase 1/1A,357,1 or 1A,94,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,3000,Visit13,13,Phase 1/1A,385,1 or 1A,94,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,3200,Visit14,14,Phase 1/1A,427,1 or 1A,97,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,3400,Visit15,15,Phase 1/1A,448,1 or 1A,97,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,3600,Visit16,16,Phase 1/1A,476,1 or 1A,96,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,3800,Visit17,17,Phase 1/1A,504,1 or 1A,98,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY242VU4,1741,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,527,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY395DYP,1597,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY395DYP,1597,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY395DYP,1597,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY395DYP,1597,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY395DYP,1597,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY395DYP,1597,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY395DYP,1597,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,212,1 or 1A,24,2,,,,,,,,4,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,4,,1,,,,,,1,4,30,,,2,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,1000,Visit3,3,Phase 1/1A,79,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,1200,Visit4,4,Phase 1/1A,107,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,1400,Visit5,5,Phase 1/1A,135,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,1600,Visit6,6,Phase 1/1A,163,1 or 1A,90,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,1800,Visit7,7,Phase 1/1A,191,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,2000,Visit8,8,Phase 1/1A,219,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,2200,Visit9,9,Phase 1/1A,247,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,2400,Visit10,10,Phase 1/1A,268,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,2600,Visit11,11,Phase 1/1A,296,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,2800,Visit12,12,Phase 1/1A,324,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,3000,Visit13,13,Phase 1/1A,352,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,3200,Visit14,14,Phase 1/1A,380,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY503YTT,2588,,,M,5200,EndofPhase1_1a,15,Phase 1/1A,408,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY623JA7,1808,,,F,800,Visit2,2,Phase 2,54,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY623JA7,1808,,,F,1000,Visit3,3,Phase 2,89,2,97,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY623JA7,1808,,,F,1400,Visit5,5,Phase 3,145,3,,,,,,6,125,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY623JA7,1808,,,F,1600,Visit6,6,Phase 3,169,3,,,,,,6,200,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY623JA7,1808,,,F,1800,Visit7,7,Phase 3,201,3,,,,,,6,300,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY623JA7,1808,,,F,2000,Visit8,8,Phase 3,222,3,,,,,,6,350,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY623JA7,1808,,,F,2200,Visit9,9,Phase 3,257,3,,,,,,6,350,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY623JA7,1808,,,F,2400,Visit10,10,Phase 3,278,3,,,,,,6,400,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY623JA7,1808,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,33,1 or 1A,100,3,,,,,,,,1,3,22.5,,,2,1,3,23,23,3,2,4,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY623JA7,1808,,,F,5800,EndofPhase2,4,Phase 2,112,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY623JA7,1808,,,F,6000,EndofPhase3,11,Phase 3,299,3,,,,,,6,400,7,19,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,,,,,,,1,3,22.5,,,2,,3,23,23,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,41,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,1600,Visit6,6,Phase 1/1A,149,1 or 1A,44,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,1800,Visit7,7,Phase 1/1A,188,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,2000,Visit8,8,Phase 1/1A,215,1 or 1A,79,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,2200,Visit9,9,Phase 1/1A,243,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,2400,Visit10,10,Phase 1/1A,285,1 or 1A,74,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,2600,Visit11,11,Phase 1/1A,313,1 or 1A,90,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,81,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,77,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,3200,Visit14,14,Phase 1/1A,398,1 or 1A,66,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,3400,Visit15,15,Phase 1/1A,435,1 or 1A,69,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,3600,Visit16,16,Phase 1/1A,456,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,3800,Visit17,17,Phase 1/1A,489,1 or 1A,41,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRY734LZ3,1731,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,,3,,,,,,,,,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,478,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,70,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,87,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,90,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,1600,Visit6,6,Phase 1/1A,178,1 or 1A,90,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,1800,Visit7,7,Phase 1/1A,206,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,2200,Visit9,9,Phase 1/1A,261,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,2400,Visit10,10,Phase 1/1A,294,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,2600,Visit11,11,Phase 1/1A,317,1 or 1A,96,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,2800,Visit12,12,Phase 1/1A,351,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,3000,Visit13,13,Phase 1/1A,379,1 or 1A,88,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,3200,Visit14,14,Phase 1/1A,407,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,3400,Visit15,15,Phase 1/1A,434,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,99,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ581ADK,1393,,,M,4000,Visit18,18,Phase 1/1A,511,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ825LE0,2406,,,M,600,Visit1,1,Phase 1/1A,22,1 or 1A,52,2,,1,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,86,1,,1,,,,,,1,1,40,,,2,1,2,67,80,2,2,17,15,2,367,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,97,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,1200,Visit4,4,Phase 2,99,2,100,2,,0,1,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,1400,Visit5,5,Phase 2,126,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,1600,Visit6,6,Phase 2,154,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,1800,Visit7,7,Phase 2,182,2,100,2,,0,1,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,2000,Visit8,8,Phase 2,212,2,100,2,,0,1,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,2200,Visit9,9,Phase 2,239,2,100,3,,0,1,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,2400,Visit10,10,Phase 2,267,2,100,2,,0,1,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,2600,Visit11,11,Phase 2,301,2,100,2,,0,1,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,3000,Visit13,13,Phase 3,365,3,,,,,,2,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,3200,Visit14,14,Phase 3,393,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,3400,Visit15,15,Phase 3,428,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,3600,Visit16,16,Phase 3,449,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,3800,Visit17,17,Phase 3,476,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,70,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,5800,EndofPhase2,12,Phase 2,323,2,100,3,,0,1,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVRZ970GTH,2598,,,F,6000,EndofPhase3,18,Phase 3,505,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,1,,3,21,30,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,93,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,98,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,97,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,3400,Visit15,15,Phase 1/1A,418,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,3600,Visit16,16,Phase 1/1A,447,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTA976EWX,2615,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB464CY0,1073,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,23,1 or 1A,50,2,,1,,,,,,3,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB501WZJ,2235,,,M,600,Visit1,1,Phase 1/1A,62,1 or 1A,,2,,1,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,800,Visit2,2,Phase 1B,51,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,1400,Visit5,5,Phase 2,125,2,83,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,1600,Visit6,6,Phase 2,153,2,88,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,1800,Visit7,7,Phase 2,181,2,73,4,,1,,,,,,2,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,2000,Visit8,8,Phase 2,209,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,2200,Visit9,9,Phase 2,237,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,2400,Visit10,10,Phase 2,265,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,2600,Visit11,11,Phase 2,296,2,85,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,2800,Visit12,12,Phase 2,324,2,72,4,,1,,,,,,2,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,3000,Visit13,13,Phase 2,349,2,81,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,3200,Visit14,14,Phase 2,380,2,75,3,,1,,,,,,2,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,3400,Visit15,15,Phase 2,408,2,98,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,3600,Visit16,16,Phase 2,436,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,3800,Visit17,17,Phase 2,471,2,95,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,23,1 or 1A,100,2,,1,,,,,,1,2,16,,,2,2,2,16,16,2,4,146,160,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,5400,EndofPhase1b,3,Phase 1B,76,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTB954BPP,2549,,,M,5800,EndofPhase2,18,Phase 2,503,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTC102HJM,1697,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,4,,,,,,,,1,4,32,,,2,,4,31,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTC102HJM,1697,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,97,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTC102HJM,1697,,,F,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTC102HJM,1697,,,F,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTC102HJM,1697,,,F,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTC102HJM,1697,,,F,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTC102HJM,1697,,,F,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTC102HJM,1697,,,F,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTC102HJM,1697,,,F,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTC102HJM,1697,,,F,2400,Visit10,10,Phase 1/1A,282,1 or 1A,93,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTC102HJM,1697,,,F,5200,EndofPhase1_1a,11,Phase 1/1A,294,1 or 1A,,4,,,,,,,,,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,49,3,,1,,,,,,3,3,24,,,1,,4,30,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,89,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,79,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,97,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,97,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,97,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,96,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,89,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,3000,Visit13,13,Phase 1/1A,377,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,3400,Visit15,15,Phase 1/1A,427,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,3600,Visit16,16,Phase 1/1A,455,1 or 1A,85,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,89,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD401LZX,2028,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,530,1 or 1A,98,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD430AFA,2001,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,93,2,,0,1,,,,,1,2,400,,,1,1,2,400,400,2,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD430AFA,2001,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD430AFA,2001,,,F,1000,Visit3,3,Phase 1/1A,91,1 or 1A,88,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD430AFA,2001,,,F,2800,Visit12,12,Phase 2,344,2,11,2,,1,,,,,,4,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD430AFA,2001,,,F,3000,Visit13,13,Phase 2,366,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD430AFA,2001,,,F,3200,Visit14,14,Phase 2,394,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD430AFA,2001,,,F,3400,Visit15,15,Phase 2,421,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD430AFA,2001,,,F,3600,Visit16,16,Phase 2,450,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD430AFA,2001,,,F,3800,Visit17,17,Phase 2,479,2,98,2,,1,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD430AFA,2001,,,F,4000,Visit18,18,Phase 2,507,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,1800,Visit7,7,Phase 1/1A,196,1 or 1A,93,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,2000,Visit8,8,Phase 1/1A,224,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,2200,Visit9,9,Phase 1/1A,252,1 or 1A,75,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,2400,Visit10,10,Phase 1/1A,280,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,2800,Visit12,12,Phase 1/1A,338,1 or 1A,93,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,3000,Visit13,13,Phase 1/1A,366,1 or 1A,95,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,3200,Visit14,14,Phase 1/1A,390,1 or 1A,96,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,3400,Visit15,15,Phase 1/1A,420,1 or 1A,97,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,3600,Visit16,16,Phase 1/1A,448,1 or 1A,90,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,3800,Visit17,17,Phase 1/1A,478,1 or 1A,95,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTD510EY1,2535,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,506,1 or 1A,93,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE625VPB,1770,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,79,3,,,,,,,,1,3,4.5,,,2,,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,93,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,97,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,93,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,90,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,82,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,2600,Visit11,11,Phase 1/1A,318,1 or 1A,93,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,2800,Visit12,12,Phase 1/1A,347,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,3000,Visit13,13,Phase 1/1A,375,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,3200,Visit14,14,Phase 1/1A,403,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,3400,Visit15,15,Phase 1/1A,437,1 or 1A,91,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,3600,Visit16,16,Phase 1/1A,465,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,3800,Visit17,17,Phase 1/1A,493,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE784XUQ,2276,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,84,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,2,,1,,,,,,1,2,16,,,2,,4,29,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,83,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,91,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,93,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,1600,Visit6,6,Phase 1B,174,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,1800,Visit7,7,Phase 1B,202,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,2200,Visit9,9,Phase 1B,259,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,2400,Visit10,10,Phase 1B,287,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,2600,Visit11,11,Phase 1B,314,1B,98,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,2800,Visit12,12,Phase 1B,342,1B,98,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,3000,Visit13,13,Phase 1B,376,1B,98,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,3200,Visit14,14,Phase 1B,400,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,3400,Visit15,15,Phase 1B,434,1B,99,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,3600,Visit16,16,Phase 1B,463,1B,90,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,3800,Visit17,17,Phase 1B,492,1B,88,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,146,1 or 1A,89,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTE920FV2,2265,,,M,5400,EndofPhase1b,18,Phase 1B,517,1B,100,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,97,1,,1,,,,,,1,1,40,,,2,,4,141,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,85,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,1000,Visit3,3,Phase 1/1A,97,1 or 1A,89,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,1200,Visit4,4,Phase 1/1A,141,1 or 1A,75,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,1600,Visit6,6,Phase 1/1A,178,1 or 1A,77,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,1800,Visit7,7,Phase 1/1A,199,1 or 1A,77,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,2000,Visit8,8,Phase 1/1A,234,1 or 1A,89,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,2200,Visit9,9,Phase 1/1A,265,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,2400,Visit10,10,Phase 1/1A,300,1 or 1A,89,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,2600,Visit11,11,Phase 1/1A,328,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,2800,Visit12,12,Phase 1/1A,400,1 or 1A,86,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,3200,Visit14,14,Phase 1/1A,422,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,3600,Visit16,16,Phase 1/1A,464,1 or 1A,72,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,3800,Visit17,17,Phase 1/1A,496,1 or 1A,97,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF185EEF,2145,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,524,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF243FFY,2777,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF243FFY,2777,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTF243FFY,2777,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,112,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,3,,,,,,,,1,3,4.5,,,1,,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,1400,Visit5,5,Phase 1/1A,146,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,1800,Visit7,7,Phase 1/1A,202,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,2000,Visit8,8,Phase 1/1A,230,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,96,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,2600,Visit11,11,Phase 1/1A,307,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,3000,Visit13,13,Phase 1/1A,363,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,3200,Visit14,14,Phase 1/1A,387,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,3400,Visit15,15,Phase 1/1A,409,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,3600,Visit16,16,Phase 1/1A,437,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,3800,Visit17,17,Phase 1/1A,465,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG142GEA,1437,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,496,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG213HAZ,2236,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,86,2,,1,,,,,,1,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,3,,,,,,,,1,3,4.5,,,2,1,4,6,6,4,4,28,30,4,160,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,98,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,88,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,1400,Visit5,5,Phase 2,149,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,1600,Visit6,6,Phase 2,177,2,79,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,1800,Visit7,7,Phase 2,211,2,65,4,,,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,2000,Visit8,8,Phase 2,232,2,74,4,,,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,2200,Visit9,9,Phase 2,253,2,88,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,2400,Visit10,10,Phase 2,281,2,95,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,2600,Visit11,11,Phase 2,308,2,84,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,2800,Visit12,12,Phase 2,352,2,61,3,,1,,,,,,2,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,3000,Visit13,13,Phase 2,366,2,71,4,,1,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,3200,Visit14,14,Phase 2,393,2,74,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,3400,Visit15,15,Phase 2,421,2,41,4,,1,,,,,,3,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,3600,Visit16,16,Phase 2,448,2,38,4,,1,,,,,,3,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,121,1 or 1A,98,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,5800,EndofPhase2,17,Phase 2,483,2,62,4,,1,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTG828ZF9,1801,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,4,160,,,3,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH044CDG,2548,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,3,,1,,,,,,1,3,24,,,2,,3,26,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH044CDG,2548,,,M,800,Visit2,2,Phase 1/1A,79,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH044CDG,2548,,,M,1000,Visit3,3,Phase 1/1A,119,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH044CDG,2548,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,600,Visit1,1,Phase 1/1A,35,1 or 1A,52,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,86,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,1000,Visit3,3,Phase 1/1A,88,1 or 1A,90,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,64,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,2000,Visit8,8,Phase 2,223,2,94,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,2200,Visit9,9,Phase 2,244,2,60,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,2400,Visit10,10,Phase 2,287,2,56,3,,,,,,,,2,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,2600,Visit11,11,Phase 2,309,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,2800,Visit12,12,Phase 2,336,2,80,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,3200,Visit14,14,Phase 3,392,3,,,,,,4,120,,,3,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,3400,Visit15,15,Phase 3,420,3,,,,,,4,80,,,4,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,3600,Visit16,16,Phase 3,447,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,3800,Visit17,17,Phase 3,475,3,,,,,,4,80,4,80,1,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,4000,Visit18,18,Phase 3,502,3,,,,,,4,80,4,80,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,5200,EndofPhase1_1a,7,Phase 1/1A,208,1 or 1A,82,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,5800,EndofPhase2,13,Phase 2,364,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH171FTE,1454,,,F,6000,EndofPhase3,18,Phase 3,502,,,,,,,,,,,,,,,,1,2,2,15,15,2,3,4,5,3,120,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH370TJA,2200,,,M,1000,Visit3,3,Phase 3,83,3,,,,,,5,32,,,1,,,,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH370TJA,2200,,,M,1200,Visit4,4,Phase 3,120,3,,,,,,5,32,5,0,1,,,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH370TJA,2200,,,M,1400,Visit5,5,Phase 3,141,3,,,,,,5,32,,,1,,,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH370TJA,2200,,,M,1600,Visit6,6,Phase 3,211,3,,,,,,5,32,,,1,,,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH370TJA,2200,,,M,2200,Visit9,9,Phase 3,265,3,,,,,,5,32,,,1,,,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH370TJA,2200,,,M,2800,Visit12,12,Phase 3,363,3,,,,,,5,32,,,1,,,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH370TJA,2200,,,M,3200,Visit14,14,Phase 3,396,3,,,,,,5,32,,,1,,,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH370TJA,2200,,,M,3600,Visit16,16,Phase 3,453,3,,,,,,5,32,,,1,,,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH370TJA,2200,,,M,3800,Visit17,17,Phase 3,480,3,,,,,,5,32,,,1,,,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH370TJA,2200,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,8,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,1,1,1,2,2,1,1,8,8,1,32,32,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH370TJA,2200,,,M,5800,EndofPhase2,2,Phase 2,19,2,67,1,,1,,,,,,2,1,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH370TJA,2200,,,M,6000,EndofPhase3,18,Phase 3,517,3,,,,,,5,32,,,1,,,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,,,,,,,,,,1,,,,,2,,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,87,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,96,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,98,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,1600,Visit6,6,Phase 1/1A,174,1 or 1A,95,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,2000,Visit8,8,Phase 1/1A,226,1 or 1A,,2,,,,,,,,,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,2200,Visit9,9,Phase 1/1A,254,1 or 1A,66,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,2600,Visit11,11,Phase 1/1A,310,1 or 1A,89,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,2800,Visit12,12,Phase 1/1A,351,1 or 1A,,2,,1,,,,,,,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,3000,Visit13,13,Phase 1/1A,372,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,19,1,,1,,,,,,4,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,64,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,3800,Visit17,17,Phase 1/1A,472,1 or 1A,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH715NPJ,1669,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,510,1 or 1A,71,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,600,Visit1,1,Phase 1/1A,19,1 or 1A,,,,,,,,,,,,,,,2,1,2,400,400,2,2,16,15,2,133,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,800,Visit2,2,Phase 2,54,2,98,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,1000,Visit3,3,Phase 2,82,2,96,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,1200,Visit4,4,Phase 2,117,2,97,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,1400,Visit5,5,Phase 2,137,2,95,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,1600,Visit6,6,Phase 2,172,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,1800,Visit7,7,Phase 2,197,2,96,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,2000,Visit8,8,Phase 2,230,2,89,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,2200,Visit9,9,Phase 2,251,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,2400,Visit10,10,Phase 2,284,2,94,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,2600,Visit11,11,Phase 2,307,2,95,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,3000,Visit13,13,Phase 3,368,3,,,,,,4,160,,0,1,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,3200,Visit14,14,Phase 3,390,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,19,1 or 1A,97,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,5800,EndofPhase2,12,Phase 2,326,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH861CHX,1540,,,F,6000,EndofPhase3,15,Phase 3,417,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,600,Visit1,1,Phase 1/1A,35,1 or 1A,97,3,,1,,,,,,1,3,22.5,,,1,2,3,23,23,3,3,600,600,3,133,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,90,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,82,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,1400,Visit5,5,Phase 1/1A,143,1 or 1A,38,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,1600,Visit6,6,Phase 1/1A,170,1 or 1A,31,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,41,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,2000,Visit8,8,Phase 1/1A,224,1 or 1A,37,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,2200,Visit9,9,Phase 2,252,2,83,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,2400,Visit10,10,Phase 2,280,2,96,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,2600,Visit11,11,Phase 2,316,2,67,3,,1,,,,,,2,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,2800,Visit12,12,Phase 2,344,2,75,3,,1,,,,,,2,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,3000,Visit13,13,Phase 3,364,3,,,,,,4,160,,0,2,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,3200,Visit14,14,Phase 3,491,3,,,,,,4,160,,0,3,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,5200,EndofPhase1_1a,8,Phase 1/1A,224,1 or 1A,37,3,,1,,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,5800,EndofPhase2,12,Phase 2,344,2,75,3,,1,,,,,,2,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH945VDB,2648,,,F,6000,EndofPhase3,14,Phase 3,491,3,,,,,,4,80,,0,3,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,81,2,,0,1,,,,,1,2,15,,,1,,3,20,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,87,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,71,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,88,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,2200,Visit9,9,Phase 1/1A,259,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,2400,Visit10,10,Phase 1/1A,283,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,2600,Visit11,11,Phase 1/1A,312,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTH949LW5,2175,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,501,1 or 1A,91,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ006LZN,2619,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,100,3,,1,,,,,,1,3,24,,,2,2,4,30,32,4,3,600,600,3,107,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,800,Visit2,2,Phase 1/1A,52,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,84,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,93,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,83,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,80,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,68,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,2200,Visit9,9,Phase 1B,253,1B,35,3,,1,,,,,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,2400,Visit10,10,Phase 1B,283,1B,45,3,,0,1,,,,,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,2600,Visit11,11,Phase 1B,309,1B,86,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,3000,Visit13,13,Phase 2,382,2,81,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,3200,Visit14,14,Phase 2,396,2,90,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,3400,Visit15,15,Phase 3,417,3,,,,,,4,80,,,2,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,3600,Visit16,16,Phase 3,458,3,,,,,,4,120,,0,2,,,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,3800,Visit17,17,Phase 3,478,3,,,,,,4,120,,0,3,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,225,1 or 1A,83,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,5400,EndofPhase1b,12,Phase 1B,340,1B,67,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ188JGA,2834,,,M,5800,EndofPhase2,14,Phase 2,396,2,90,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ200BRH,2217,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ913FZB,2152,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ913FZB,2152,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTJ913FZB,2152,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,84,2,,,,,,,,1,2,3,,,1,2,2,4,3,2,3,120,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,91,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,69,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,46,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,1800,Visit7,7,Phase 1/1A,193,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,2400,Visit10,10,Phase 2,281,2,91,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,2600,Visit11,11,Phase 2,312,2,89,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,2800,Visit12,12,Phase 2,337,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,3000,Visit13,13,Phase 2,365,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,3200,Visit14,14,Phase 2,393,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,3400,Visit15,15,Phase 2,421,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,3600,Visit16,16,Phase 2,449,2,98,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,3800,Visit17,17,Phase 2,477,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,254,1 or 1A,100,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK224VJP,1694,,,M,5800,EndofPhase2,18,Phase 2,505,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,3,,,,,,,,1,3,4.5,,,2,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,800,Visit2,2,Phase 1/1A,68,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,1600,Visit6,6,Phase 1/1A,166,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,93,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,2200,Visit9,9,Phase 1/1A,257,1 or 1A,97,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,2400,Visit10,10,Phase 1/1A,285,1 or 1A,94,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,2600,Visit11,11,Phase 1/1A,313,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,2800,Visit12,12,Phase 1/1A,341,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,3000,Visit13,13,Phase 1/1A,369,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,3200,Visit14,14,Phase 1/1A,397,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,3800,Visit17,17,Phase 1/1A,481,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTK504DTZ,1392,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,800,Visit2,2,Phase 2,57,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,1000,Visit3,3,Phase 2,85,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,1200,Visit4,4,Phase 2,113,2,97,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,1400,Visit5,5,Phase 2,141,2,96,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,1600,Visit6,6,Phase 2,169,2,99,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,1800,Visit7,7,Phase 2,196,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,2000,Visit8,8,Phase 2,222,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,2200,Visit9,9,Phase 2,250,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,2400,Visit10,10,Phase 2,278,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,2600,Visit11,11,Phase 2,307,2,98,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,2800,Visit12,12,Phase 2,337,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,3000,Visit13,13,Phase 2,365,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,3200,Visit14,14,Phase 2,393,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,3400,Visit15,15,Phase 2,420,2,99,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,3600,Visit16,16,Phase 2,448,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,3800,Visit17,17,Phase 2,476,2,98,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,1,2,2,3,3,2,4,29,30,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL188VAX,2078,,,F,5800,EndofPhase2,18,Phase 2,512,2,98,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL217WDX,1186,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,38,2,,,,,,,,3,2,3,,,2,,2,3,3,2,,,,,4,3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL217WDX,1186,,,M,1000,Visit3,3,Phase 3,69,3,,,,,,3,3,,,3,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL217WDX,1186,,,M,1200,Visit4,4,Phase 3,98,3,,,,,,3,6,,,,,,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL217WDX,1186,,,M,1400,Visit5,5,Phase 3,125,3,,,,,,3,6,,,3,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL217WDX,1186,,,M,1600,Visit6,6,Phase 3,160,3,,,,,,3,3,,,4,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL217WDX,1186,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,48,1 or 1A,21,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL217WDX,1186,,,M,6000,EndofPhase3,7,Phase 3,202,3,,,,,,3,3,,,4,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,1,,,,,,,,1,1,8,,,2,,2,19,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,50,1,,,,,,,,3,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,95,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,51,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,70,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,48,2,,,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,2200,Visit9,9,Phase 1/1A,248,1 or 1A,90,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,2400,Visit10,10,Phase 1/1A,283,1 or 1A,50,2,,,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,2600,Visit11,11,Phase 1/1A,311,1 or 1A,95,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,2800,Visit12,12,Phase 1/1A,387,1 or 1A,59,4,,,,,,,,2,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,71,4,,,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,64,4,,,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,3600,Visit16,16,Phase 1/1A,457,1 or 1A,31,4,,,,,,,,3,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,70,4,,,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL259EMD,1317,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,506,1 or 1A,41,4,,0,2,,,,,3,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,3,26,30,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,1200,Visit4,4,Phase 1/1A,125,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,1400,Visit5,5,Phase 1/1A,153,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,1600,Visit6,6,Phase 1/1A,181,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,1800,Visit7,7,Phase 1/1A,216,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,2000,Visit8,8,Phase 1/1A,238,1 or 1A,50,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,2200,Visit9,9,Phase 1/1A,265,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,2400,Visit10,10,Phase 1/1A,293,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,2600,Visit11,11,Phase 1/1A,321,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,2800,Visit12,12,Phase 1/1A,342,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,3200,Visit14,14,Phase 1/1A,391,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,3400,Visit15,15,Phase 1/1A,426,1 or 1A,89,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTL952YZZ,1703,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,499,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,1,3,550,600,3,3,5,5,3,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,88,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,1000,Visit3,3,Phase 1/1A,90,1 or 1A,,3,,,,,,,,2,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,1600,Visit6,6,Phase 3,176,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,1800,Visit7,7,Phase 3,211,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,2000,Visit8,8,Phase 3,234,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,2200,Visit9,9,Phase 3,268,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,2400,Visit10,10,Phase 3,296,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,2600,Visit11,11,Phase 3,324,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,2800,Visit12,12,Phase 3,345,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,3000,Visit13,13,Phase 3,366,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,3200,Visit14,14,Phase 3,400,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,3400,Visit15,15,Phase 3,421,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,3600,Visit16,16,Phase 3,449,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,3800,Visit17,17,Phase 3,491,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,98,1 or 1A,99,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,5800,EndofPhase2,5,Phase 2,127,2,84,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM586DVN,1397,,,F,6000,EndofPhase3,18,Phase 3,512,3,,,,,,3,3,,,2,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,1,,1,,,,,,1,1,7.5,,,1,2,3,19,23,3,4,153,160,4,17,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,1400,Visit5,5,Phase 2,140,2,95,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,1600,Visit6,6,Phase 2,169,2,96,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,1800,Visit7,7,Phase 2,197,2,95,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,2000,Visit8,8,Phase 2,225,2,95,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,2200,Visit9,9,Phase 2,253,2,78,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,2800,Visit12,12,Phase 3,338,3,,,,,,8,30,,,2,,,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,3000,Visit13,13,Phase 3,374,3,,,,,,8,15,,,2,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,3600,Visit16,16,Phase 3,448,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,3800,Visit17,17,Phase 3,476,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,4000,Visit18,18,Phase 3,515,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,99,1 or 1A,,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,5800,EndofPhase2,10,Phase 2,269,2,84,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTM724FW4,2178,,,M,6000,EndofPhase3,18,Phase 3,515,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,3,544,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,100,2,,,,,,,,4,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,91,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,98,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,2600,Visit11,11,Phase 1/1A,312,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,3000,Visit13,13,Phase 1/1A,369,1 or 1A,96,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,3200,Visit14,14,Phase 1/1A,396,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,3400,Visit15,15,Phase 1/1A,424,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,96,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN147RB8,1279,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,509,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,2,3,20,23,3,2,400,400,2,15,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,1200,Visit4,4,Phase 2,118,2,90,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,1400,Visit5,5,Phase 2,143,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,1600,Visit6,6,Phase 2,175,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,1800,Visit7,7,Phase 2,195,2,91,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,2200,Visit9,9,Phase 3,260,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,2400,Visit10,10,Phase 3,286,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,2600,Visit11,11,Phase 3,314,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,2800,Visit12,12,Phase 3,338,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,3000,Visit13,13,Phase 3,367,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,3200,Visit14,14,Phase 3,394,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,3400,Visit15,15,Phase 3,426,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,3600,Visit16,16,Phase 3,454,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,3800,Visit17,17,Phase 3,476,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,94,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,5800,EndofPhase2,8,Phase 2,224,2,96,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN318ZVD,2682,,,F,6000,EndofPhase3,18,Phase 3,505,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,98,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,82,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,1800,Visit7,7,Phase 1/1A,195,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,98,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,3800,Visit17,17,Phase 1/1A,479,1 or 1A,93,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN355DAZ,2208,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,503,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN556PKJ,2692,,,M,5200,EndofPhase1_1a,0,Phase 1/1A,23,1 or 1A,94,3,,1,,,,,,1,3,24,,,2,,3,24,24,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,1000,Visit3,3,Phase 1/1A,102,1 or 1A,94,3,,,,,,,,4,3,600,,,2,1,4,782,800,4,3,120,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,1200,Visit4,4,Phase 1/1A,126,1 or 1A,38,4,,,,,,,,4,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,1600,Visit6,6,Phase 1/1A,201,1 or 1A,88,4,,,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,84,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,58,4,,,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,2400,Visit10,10,Phase 1/1A,285,1 or 1A,46,4,,,,,,,,3,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,2600,Visit11,11,Phase 1/1A,306,1 or 1A,48,4,,,,,,,,3,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,2800,Visit12,12,Phase 1/1A,335,1 or 1A,1,4,,,,,,,,4,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,12,4,,,,,,,,4,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,3400,Visit15,15,Phase 2,426,2,50,3,,0,1,,,,,3,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,3600,Visit16,16,Phase 2,449,2,87,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,5200,EndofPhase1_1a,14,Phase 1/1A,405,1 or 1A,0,4,,,,,,,,4,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN649KVP,1486,,,M,5800,EndofPhase2,17,Phase 2,460,2,80,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN831JWE,1091,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,1,1,2,3,3,2,3,23,23,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN831JWE,1091,,,F,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN831JWE,1091,,,F,1000,Visit3,3,Phase 2,94,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN831JWE,1091,,,F,1200,Visit4,4,Phase 2,126,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN831JWE,1091,,,F,1400,Visit5,5,Phase 2,154,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN831JWE,1091,,,F,1600,Visit6,6,Phase 2,184,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN831JWE,1091,,,F,1800,Visit7,7,Phase 2,218,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN831JWE,1091,,,F,2000,Visit8,8,Phase 2,246,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN831JWE,1091,,,F,2200,Visit9,9,Phase 2,277,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN831JWE,1091,,,F,2400,Visit10,10,Phase 2,305,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN831JWE,1091,,,F,2600,Visit11,11,Phase 2,340,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN831JWE,1091,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,63,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTN831JWE,1091,,,F,5800,EndofPhase2,11,Phase 2,340,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP339NHK,2699,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,92,2,,1,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP339NHK,2699,,,F,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP339NHK,2699,,,F,1000,Visit3,3,Phase 1/1A,92,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP339NHK,2699,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP339NHK,2699,,,F,1400,Visit5,5,Phase 1/1A,139,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP339NHK,2699,,,F,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,81,2,,1,,,,,,1,2,3,,,2,2,2,3,3,2,2,400,400,2,10,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,800,Visit2,2,Phase 1/1A,52,1 or 1A,89,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,98,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,90,2,,0,2,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,79,2,,0,2,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,84,2,,0,2,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,64,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,2000,Visit8,8,Phase 3,259,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,2200,Visit9,9,Phase 3,290,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,2400,Visit10,10,Phase 3,357,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,2600,Visit11,11,Phase 3,318,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,2800,Visit12,12,Phase 3,389,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,3000,Visit13,13,Phase 3,416,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,3200,Visit14,14,Phase 3,442,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,3400,Visit15,15,Phase 3,477,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,3600,Visit16,16,Phase 3,505,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,3800,Visit17,17,Phase 3,548,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,211,1 or 1A,64,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,5800,EndofPhase2,7,Phase 2,227,2,63,2,,1,,,,,,2,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTP957PKK,2291,,,M,6000,EndofPhase3,18,Phase 3,577,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR115VUV,1372,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,12,1 or 1A,8,2,,,,,,,,4,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,1,10,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,1600,Visit6,6,Phase 1/1A,195,1 or 1A,100,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,1800,Visit7,7,Phase 1/1A,219,1 or 1A,96,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,2200,Visit9,9,Phase 1/1A,254,1 or 1A,96,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,2400,Visit10,10,Phase 1/1A,275,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,2600,Visit11,11,Phase 1/1A,303,1 or 1A,100,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,89,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,3400,Visit15,15,Phase 1/1A,422,1 or 1A,86,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,3600,Visit16,16,Phase 1/1A,450,1 or 1A,68,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,3800,Visit17,17,Phase 1/1A,470,1 or 1A,100,2,,0,1,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR690DVD,2012,,,F,4000,Visit18,18,Phase 1/1A,499,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,2,18,23,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,89,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,89,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,2400,Visit10,10,Phase 1/1A,283,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,2600,Visit11,11,Phase 1/1A,311,1 or 1A,89,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,90,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,86,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTR972AEA,1319,,,M,4000,Visit18,18,Phase 1/1A,514,1 or 1A,97,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT302PMN,2197,,,M,800,Visit2,2,Phase 1B,59,1B,100,1,,0,1,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT302PMN,2197,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,37,1 or 1A,90,2,,1,,,,,,4,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,100,1,,1,,,,,,1,1,8,,,1,1,2,16,16,2,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,1200,Visit4,4,Phase 1B,117,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,1400,Visit5,5,Phase 1B,139,1B,82,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,1600,Visit6,6,Phase 1B,166,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,1800,Visit7,7,Phase 1B,195,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,2000,Visit8,8,Phase 1B,222,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,2200,Visit9,9,Phase 1B,250,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,2400,Visit10,10,Phase 1B,285,1B,,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,2600,Visit11,11,Phase 1B,306,1B,90,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,3000,Visit13,13,Phase 2,387,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,3200,Visit14,14,Phase 2,411,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,3400,Visit15,15,Phase 2,439,2,,4,,0,1,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,3600,Visit16,16,Phase 2,463,2,98,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,3800,Visit17,17,Phase 2,488,2,94,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,79,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,5400,EndofPhase1b,12,Phase 1B,348,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT495DDA,2454,,,M,5800,EndofPhase2,18,Phase 2,516,2,89,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,600,Visit1,1,Phase 1/1A,39,1 or 1A,93,2,,0,2,,,,,1,2,16,,,2,,3,24,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,99,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,98,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,2200,Visit9,9,Phase 1/1A,251,1 or 1A,100,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,3000,Visit13,13,Phase 1/1A,363,1 or 1A,100,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,3200,Visit14,14,Phase 1/1A,389,1 or 1A,100,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,3400,Visit15,15,Phase 1/1A,425,1 or 1A,96,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,3800,Visit17,17,Phase 1/1A,475,1 or 1A,100,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT567HV6,1230,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,3,,0,2,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,2,3,3,23,23,3,,200,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,1,,0,2,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,95,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,1800,Visit7,7,Phase 1/1A,195,1 or 1A,100,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,2600,Visit11,11,Phase 2,308,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,2800,Visit12,12,Phase 2,336,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,3000,Visit13,13,Phase 2,365,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,3200,Visit14,14,Phase 2,387,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,3400,Visit15,15,Phase 2,420,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,3600,Visit16,16,Phase 2,450,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,3800,Visit17,17,Phase 2,477,2,98,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,5200,EndofPhase1_1a,10,Phase 1/1A,278,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT723NPW,2110,,,F,5800,EndofPhase2,18,Phase 2,504,2,100,,200,,,,,,,1,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT995AZV,2425,,,M,800,Visit2,2,Phase 1B,53,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT995AZV,2425,,,M,1000,Visit3,3,Phase 1B,79,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT995AZV,2425,,,M,1200,Visit4,4,Phase 1B,108,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT995AZV,2425,,,M,1400,Visit5,5,Phase 1B,136,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT995AZV,2425,,,M,1600,Visit6,6,Phase 1B,164,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT995AZV,2425,,,M,1800,Visit7,7,Phase 2,213,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT995AZV,2425,,,M,2000,Visit8,8,Phase 2,241,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT995AZV,2425,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,22,1 or 1A,100,3,,1,,,,,,1,3,24,,,2,2,3,24,24,3,3,600,600,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT995AZV,2425,,,M,5400,EndofPhase1b,6,Phase 1B,172,1B,100,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTT995AZV,2425,,,M,5800,EndofPhase2,9,Phase 2,262,2,,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,1400,Visit5,5,Phase 3,142,3,,,,,,6,25,4,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,1600,Visit6,6,Phase 3,186,3,,,,,,6,300,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,1800,Visit7,7,Phase 3,191,3,,,,,,6,300,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,2000,Visit8,8,Phase 3,233,3,,,,,,6,350,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,2200,Visit9,9,Phase 3,256,3,,,,,,6,350,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,6,400,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,6,400,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,2800,Visit12,12,Phase 3,343,3,,,,,,6,450,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,3000,Visit13,13,Phase 3,371,3,,,,,,6,450,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,3200,Visit14,14,Phase 3,396,3,,,,,,6,450,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,3400,Visit15,15,Phase 3,424,3,,,,,,6,450,4,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,6,500,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,6,500,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,98,2,,,,,,,,1,2,400,,,2,1,2,400,400,2,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,5800,EndofPhase2,4,Phase 2,120,2,97,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTU970LL0,1999,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,6,500,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTV288JZP,2246,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,53,2,,1,,,,,,3,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTV288JZP,2246,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,98,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTV288JZP,2246,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,75,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTV288JZP,2246,,,M,1200,Visit4,4,Phase 1/1A,105,1 or 1A,69,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTV288JZP,2246,,,M,1400,Visit5,5,Phase 1/1A,133,1 or 1A,,2,,1,,,,,,,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTV346DJY,2204,,,M,600,Visit1,1,Phase 1/1A,23,1 or 1A,72,3,,1,,,,,,2,3,120,,,2,,4,150,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTV346DJY,2204,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,99,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTV346DJY,2204,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,66,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTV346DJY,2204,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,104,1 or 1A,,4,,1,,,,,,,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW092YYY,2371,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,120,,,2,,4,157,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW092YYY,2371,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW092YYY,2371,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,97,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW092YYY,2371,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW092YYY,2371,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW092YYY,2371,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW092YYY,2371,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,76,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW092YYY,2371,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,79,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW092YYY,2371,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,88,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW092YYY,2371,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,77,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW092YYY,2371,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW092YYY,2371,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,54,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW092YYY,2371,,,M,5200,EndofPhase1_1a,13,Phase 1/1A,373,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW121PX2,1893,,,F,800,Visit2,2,Phase 2,56,2,98,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW121PX2,1893,,,F,1200,Visit4,4,Phase 3,113,3,,,,,,6,150,,0,1,,,,150,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW121PX2,1893,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,21,1 or 1A,83,2,,,,,,,,1,2,3,,,2,2,2,3,3,2,3,100,100,3,150,150,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW121PX2,1893,,,F,5800,EndofPhase2,3,Phase 2,72,2,100,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW558ZHT,2372,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,69,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW558ZHT,2372,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW558ZHT,2372,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW558ZHT,2372,,,M,1200,Visit4,4,Phase 1/1A,115,,,,,,,,,,,,,,,,1,2,4,6,6,4,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW558ZHT,2372,,,M,1600,Visit6,6,Phase 2,169,2,54,2,,1,,,,,,2,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTW558ZHT,2372,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,115,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTX844XU6,2694,,,M,800,Visit2,2,Phase 2,43,2,94,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTX844XU6,2694,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,12,1 or 1A,48,2,,1,,,,,,3,2,80,,,2,1,2,80,80,2,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,2,3,100,100,3,2,400,400,2,9,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,1200,Visit4,4,Phase 3,72,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,1400,Visit5,5,Phase 3,100,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,1600,Visit6,6,Phase 3,131,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,1800,Visit7,7,Phase 3,156,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,2000,Visit8,8,Phase 3,187,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,2200,Visit9,9,Phase 3,216,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,2600,Visit11,11,Phase 3,275,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,2800,Visit12,12,Phase 3,306,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,3000,Visit13,13,Phase 3,334,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,3200,Visit14,14,Phase 3,364,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,3400,Visit15,15,Phase 3,392,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,3600,Visit16,16,Phase 3,420,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,3800,Visit17,17,Phase 3,448,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,37,1 or 1A,58,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,5800,EndofPhase2,3,Phase 2,42,2,0,2,,,,,,,,4,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY425KG4,2438,,,F,6000,EndofPhase3,18,Phase 3,485,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,91,1,,1,,,,,,1,1,40,,,2,1,3,120,120,3,3,5,5,3,15,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,97,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,1000,Visit3,3,Phase 1/1A,76,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,1200,Visit4,4,Phase 1/1A,97,1 or 1A,81,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,1600,Visit6,6,Phase 1/1A,203,1 or 1A,85,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,1800,Visit7,7,Phase 1/1A,226,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,2000,Visit8,8,Phase 1/1A,250,1 or 1A,83,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,2400,Visit10,10,Phase 2,292,1 or 1A,,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,2800,Visit12,12,Phase 3,341,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,3000,Visit13,13,Phase 3,369,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,3200,Visit14,14,Phase 3,397,3,,,,,,8,15,,,2,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,3400,Visit15,15,Phase 3,419,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,3600,Visit16,16,Phase 3,443,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,3800,Visit17,17,Phase 3,474,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,5200,EndofPhase1_1a,9,Phase 1/1A,275,1 or 1A,,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,5800,EndofPhase2,11,Phase 2,317,2,,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY650WF3,2286,,,F,6000,EndofPhase3,18,Phase 3,509,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,80,,,2,1,3,123,120,3,2,13,15,2,15,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,92,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,97,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,93,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,89,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,87,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,92,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,95,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,3000,Visit13,13,Phase 2,372,2,98,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,3200,Visit14,14,Phase 2,400,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,3600,Visit16,16,Phase 3,456,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,3800,Visit17,17,Phase 3,484,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,344,1 or 1A,95,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,5800,EndofPhase2,15,Phase 2,428,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTY982LJM,1859,,,M,6000,EndofPhase3,18,Phase 3,512,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,600,Visit1,1,Phase 1/1A,72,1 or 1A,100,1,,,,,,,,1,1,40,,,2,,3,136,160,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,800,Visit2,2,Phase 1/1A,128,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,1000,Visit3,3,Phase 1/1A,177,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,1200,Visit4,4,Phase 1/1A,207,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,1400,Visit5,5,Phase 1/1A,235,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,1600,Visit6,6,Phase 1/1A,263,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,2000,Visit8,8,Phase 1/1A,338,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,2200,Visit9,9,Phase 1/1A,375,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,2400,Visit10,10,Phase 1/1A,403,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,2600,Visit11,11,Phase 1/1A,431,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,2800,Visit12,12,Phase 1/1A,459,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,3000,Visit13,13,Phase 1/1A,494,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,3200,Visit14,14,Phase 1/1A,520,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,3400,Visit15,15,Phase 1/1A,548,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,3600,Visit16,16,Phase 1/1A,576,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,3800,Visit17,17,Phase 1/1A,604,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ070VDK,1987,,,M,4000,Visit18,18,Phase 1/1A,646,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ560RN5,1613,,,F,1000,Visit3,3,Phase 2,71,2,50,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ560RN5,1613,,,F,1200,Visit4,4,Phase 3,99,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ560RN5,1613,,,F,1400,Visit5,5,Phase 3,127,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ560RN5,1613,,,F,1600,Visit6,6,Phase 3,190,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ560RN5,1613,,,F,1800,Visit7,7,Phase 3,218,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ560RN5,1613,,,F,2000,Visit8,8,Phase 3,221,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ560RN5,1613,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,14,1 or 1A,10,4,,,,,,,,1,4,32,,,2,1,4,32,32,4,2,3,3,2,40,40,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ560RN5,1613,,,F,5400,EndofPhase1b,2,Phase 1B,43,1B,75,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVTZ560RN5,1613,,,F,5800,EndofPhase2,3,Phase 2,71,2,85,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,,2,,1,,,,,,1,2,80,,,2,1,2,80,80,2,1,8,8,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,80,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,97,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,96,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,2000,Visit8,8,Phase 1/1A,219,1 or 1A,,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,3200,Visit14,14,Phase 1/1A,402,1 or 1A,,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,4000,Visit18,18,Phase 1/1A,513,1 or 1A,,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,4200,Visit19,19,Phase 2,549,2,,1,,1,,,,,,2,1,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA055LUX,2709,,,M,4400,Visit20,20,Phase 2,584,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA710TN3,1343,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,1,2,3,19,19,3,3,600,600,3,442,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,1000,Visit3,3,Phase 2,89,2,99,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,1200,Visit4,4,Phase 2,109,2,99,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,1600,Visit6,6,Phase 3,169,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,1800,Visit7,7,Phase 3,197,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,2200,Visit9,9,Phase 3,253,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,2800,Visit12,12,Phase 3,344,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,4000,Visit18,18,Phase 3,505,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,47,1 or 1A,89,3,,,,,,,,3,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUA871GZA,1400,,,M,5800,EndofPhase2,5,Phase 2,128,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,1000,Visit3,3,Phase 2,85,2,100,3,,,,,,,,2,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,1600,Visit6,6,Phase 3,170,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,1800,Visit7,7,Phase 3,198,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,2000,Visit8,8,Phase 3,226,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,2200,Visit9,9,Phase 3,253,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,2400,Visit10,10,Phase 3,284,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,2600,Visit11,11,Phase 3,310,3,,,,,,2,500,,,2,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,2800,Visit12,12,Phase 3,360,3,,,,,,2,500,,,2,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,3200,Visit14,14,Phase 3,408,3,,,,,,2,500,,,2,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,3400,Visit15,15,Phase 3,421,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,3600,Visit16,16,Phase 3,449,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,3800,Visit17,17,Phase 3,477,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,37,1 or 1A,100,3,,,,,,,,2,3,22.5,,,2,1,3,23,23,3,3,4,4,3,458,500,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,5800,EndofPhase2,4,Phase 2,134,2,68,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB021BHY,1416,,,F,6000,EndofPhase3,18,Phase 3,501,3,,,,,,2,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,600,Visit1,1,Phase 1/1A,18,1 or 1A,99,1,,,,,,,,1,1,1.5,,,1,,4,5,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,1200,Visit4,4,Phase 1/1A,-276,1 or 1A,24,1,,,,,,,,4,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,1400,Visit5,5,Phase 1/1A,117,1 or 1A,89,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,1600,Visit6,6,Phase 1/1A,144,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,1800,Visit7,7,Phase 1/1A,173,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,2000,Visit8,8,Phase 1/1A,203,1 or 1A,97,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,2200,Visit9,9,Phase 1/1A,231,1 or 1A,93,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,2400,Visit10,10,Phase 1/1A,266,1 or 1A,97,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,2600,Visit11,11,Phase 1/1A,295,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,2800,Visit12,12,Phase 1/1A,326,1 or 1A,93,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,3000,Visit13,13,Phase 1/1A,355,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,3200,Visit14,14,Phase 1/1A,382,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,3400,Visit15,15,Phase 1/1A,404,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,3600,Visit16,16,Phase 1/1A,441,1 or 1A,99,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,3800,Visit17,17,Phase 1/1A,460,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB027UJG,1228,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,484,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,2,3,533,400,3,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,1200,Visit4,4,Phase 2,113,2,79,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,1400,Visit5,5,Phase 2,149,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,1800,Visit7,7,Phase 2,204,2,94,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,2000,Visit8,8,Phase 2,231,2,96,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,2200,Visit9,9,Phase 2,260,2,98,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,2400,Visit10,10,Phase 2,289,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,2600,Visit11,11,Phase 2,317,2,98,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,2800,Visit12,12,Phase 2,344,2,98,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,3000,Visit13,13,Phase 2,372,2,98,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,3200,Visit14,14,Phase 2,400,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,3400,Visit15,15,Phase 2,424,2,88,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,3800,Visit17,17,Phase 2,484,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,85,1 or 1A,99,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB219AKB,2009,,,M,5800,EndofPhase2,18,Phase 2,508,2,86,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,99,3,,,,,,,,1,3,24,,,2,,4,32,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,2200,Visit9,9,Phase 1/1A,246,1 or 1A,97,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,2400,Visit10,10,Phase 1/1A,276,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,2600,Visit11,11,Phase 1/1A,303,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,3000,Visit13,13,Phase 1/1A,363,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,99,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,3800,Visit17,17,Phase 1B,483,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,4000,Visit18,18,Phase 1B,505,1B,99,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,4200,Visit19,19,Phase 1B,537,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,4400,Visit20,20,Phase 1B,562,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,4600,Visit21,21,Phase 1B,593,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,5200,EndofPhase1_1a,16,Phase 1/1A,454,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB310RU6,1935,,,M,5400,EndofPhase1b,22,Phase 1B,616,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,15,,,2,2,3,20,23,3,2,400,400,2,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,75,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,1200,Visit4,4,Phase 2,120,2,35,2,,,,,,,,3,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,1400,Visit5,5,Phase 2,148,2,80,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,1800,Visit7,7,Phase 3,253,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,2800,Visit12,12,Phase 3,324,3,,,,,,3,3,,,3,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,3000,Visit13,13,Phase 3,351,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,3200,Visit14,14,Phase 3,391,3,,,,,,3,3,,,3,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,3400,Visit15,15,Phase 3,405,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,3600,Visit16,16,Phase 3,453,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,3,4,,,2,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,89,1 or 1A,65,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,5800,EndofPhase2,6,Phase 2,215,2,50,2,,1,,,,,,3,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB416EL5,1327,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,,4,,,,,,,,1,4,6,,,2,2,4,6,6,4,3,120,120,3,58,50,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,0,4,,,,,,,,4,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,0,4,,,,,,,,4,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,0,4,,,,,,,,4,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,2800,Visit12,12,Phase 1/1A,333,1 or 1A,71,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,3000,Visit13,13,Phase 3,366,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,3200,Visit14,14,Phase 3,394,3,,,,,,7,75,,,1,,,,75,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,3400,Visit15,15,Phase 3,422,3,,,,,,7,75,,,1,,,,75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,3600,Visit16,16,Phase 3,450,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,3800,Visit17,17,Phase 3,473,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,344,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,5800,EndofPhase2,12,Phase 2,353,2,85,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB526MFT,1998,,,M,6000,EndofPhase3,18,Phase 3,494,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,90,3,,,,,,,,1,3,120,,,2,,4,158,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,97,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,97,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,99,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,2000,Visit8,8,Phase 1/1A,236,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,2200,Visit9,9,Phase 1/1A,261,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,2400,Visit10,10,Phase 1/1A,289,1 or 1A,94,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,2800,Visit12,12,Phase 1/1A,345,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,3000,Visit13,13,Phase 1/1A,380,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,3400,Visit15,15,Phase 1/1A,415,1 or 1A,92,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,3600,Visit16,16,Phase 1/1A,454,1 or 1A,95,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,3800,Visit17,17,Phase 1/1A,481,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB941WTK,1894,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,499,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB974LTM,2155,,,M,600,Visit1,1,Phase 1/1A,24,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,2,2,3,5,5,3,3,120,120,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB974LTM,2155,,,M,1200,Visit4,4,Phase 3,63,3,,,,,,1,20,3,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB974LTM,2155,,,M,5800,EndofPhase2,3,Phase 2,38,2,80,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB986DER,2333,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,1,,,,,,1,4,800,,,2,,3,600,600,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB986DER,2333,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB986DER,2333,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB986DER,2333,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUB986DER,2333,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,140,1 or 1A,96,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,1,,,,,,,,1,1,8,,,1,2,2,13,16,2,4,6,6,4,15,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,1200,Visit4,4,Phase 1B,117,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,1400,Visit5,5,Phase 1B,145,1B,73,2,,,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,1600,Visit6,6,Phase 1B,173,1B,69,2,,,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,2200,Visit9,9,Phase 3,241,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,2400,Visit10,10,Phase 3,276,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,2600,Visit11,11,Phase 3,304,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,2800,Visit12,12,Phase 3,338,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,3000,Visit13,13,Phase 3,359,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,3200,Visit14,14,Phase 3,388,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,3400,Visit15,15,Phase 3,417,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,3600,Visit16,16,Phase 3,444,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,3800,Visit17,17,Phase 3,472,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,81,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,5400,EndofPhase1b,7,Phase 1B,199,1B,91,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,5800,EndofPhase2,8,Phase 2,205,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUC008PTG,1293,,,F,6000,EndofPhase3,18,Phase 3,499,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD454MFH,2843,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD478NWA,1560,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,800,,,2,,3,514,400,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD478NWA,1560,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD478NWA,1560,,,M,1000,Visit3,3,Phase 1/1A,77,1 or 1A,,2,,,,,,,,,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD478NWA,1560,,,M,1200,Visit4,4,Phase 1/1A,105,1 or 1A,72,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD478NWA,1560,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD478NWA,1560,,,M,1600,Visit6,6,Phase 1/1A,162,1 or 1A,,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD478NWA,1560,,,M,1800,Visit7,7,Phase 1/1A,194,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,800,Visit2,2,Phase 1B,56,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,1000,Visit3,3,Phase 1B,85,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,1200,Visit4,4,Phase 1B,105,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,1400,Visit5,5,Phase 1B,138,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,1600,Visit6,6,Phase 1B,169,1B,99,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,1800,Visit7,7,Phase 1B,196,1B,99,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,2000,Visit8,8,Phase 1B,223,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,2200,Visit9,9,Phase 1B,253,1B,97,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,2400,Visit10,10,Phase 1B,280,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,2600,Visit11,11,Phase 1B,301,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,2800,Visit12,12,Phase 1B,337,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,3000,Visit13,13,Phase 1B,365,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,3200,Visit14,14,Phase 1B,396,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,3400,Visit15,15,Phase 1B,419,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,3600,Visit16,16,Phase 1B,447,1B,93,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,3800,Visit17,17,Phase 1B,466,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,19,1 or 1A,,2,,1,,,,,,,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUD692PHD,2831,,,M,5400,EndofPhase1b,18,Phase 1B,510,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,600,,,2,,4,767,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,65,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,87,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,78,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,95,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,88,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,75,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,3600,Visit16,16,Phase 1/1A,458,1 or 1A,60,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,3800,Visit17,17,Phase 1/1A,483,1 or 1A,79,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUE115PGE,2149,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,513,1 or 1A,66,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,90,3,,1,,,,,,1,3,4.5,,,2,,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,1000,Visit3,3,Phase 1/1A,95,1 or 1A,73,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,,3,,,,,,,,,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,,3,,,,,,,,,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,,4,,,,,,,,,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,1800,Visit7,7,Phase 1/1A,201,1 or 1A,88,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,2000,Visit8,8,Phase 1/1A,229,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,2200,Visit9,9,Phase 1/1A,257,1 or 1A,91,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,2400,Visit10,10,Phase 1/1A,285,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,2600,Visit11,11,Phase 1/1A,312,1 or 1A,,4,,,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,2800,Visit12,12,Phase 1/1A,342,1 or 1A,,4,,,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,4,,0,2,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,3800,Visit17,17,Phase 1/1A,482,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUF960VT8,1888,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,516,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG103THW,2786,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,7,1 or 1A,9,2,,0,1,,,,,4,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG201FYP,2162,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,400,,,1,,3,567,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG201FYP,2162,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,3,,0,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG201FYP,2162,,,M,1200,Visit4,4,Phase 1/1A,108,1 or 1A,100,3,,0,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG201FYP,2162,,,M,1400,Visit5,5,Phase 1/1A,135,1 or 1A,100,3,,0,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG201FYP,2162,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,3,,0,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG201FYP,2162,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,3,,0,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,85,2,,,,,,,,1,2,3,,,2,3,3,5,6,3,,181,188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,94,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,86,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,97,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,1600,Visit6,6,Phase 2,171,2,99,,50,,,,,,,1,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,1800,Visit7,7,Phase 2,197,2,100,,225,,,,,,,1,,,225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,2000,Visit8,8,Phase 2,234,2,,,,1,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,2200,Visit9,9,Phase 2,260,2,100,,150,,,,,,,3,,,150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,2600,Visit11,11,Phase 3,316,3,,,,,,5,16,7,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,2800,Visit12,12,Phase 3,337,3,,,,,,7,50,5,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,7,13,5,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,164,1 or 1A,88,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,5800,EndofPhase2,10,Phase 2,297,2,77,,300,,,,,,,3,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG573DWR,1331,,,M,6000,EndofPhase3,14,Phase 3,393,3,,,,,,7,13,5,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,8,,,1,,3,27,32,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,1400,Visit5,5,Phase 1/1A,146,1 or 1A,,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,96,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,1800,Visit7,7,Phase 1/1A,201,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,2000,Visit8,8,Phase 1/1A,229,1 or 1A,99,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,2200,Visit9,9,Phase 1/1A,257,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,2400,Visit10,10,Phase 1/1A,285,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,2600,Visit11,11,Phase 1/1A,313,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,2800,Visit12,12,Phase 1/1A,341,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,3000,Visit13,13,Phase 1/1A,369,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,3200,Visit14,14,Phase 1/1A,397,1 or 1A,97,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,3800,Visit17,17,Phase 1/1A,474,1 or 1A,89,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUG930AA9,1518,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,99,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH274GFE,2741,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,,4,,1,,,,,,2,4,160,,,2,,2,95,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH274GFE,2741,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,64,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH274GFE,2741,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,0,4,,,,,,,,4,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH274GFE,2741,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,,2,,1,,,,,,,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH274GFE,2741,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,0,2,,,,,,,,4,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH274GFE,2741,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,39,3,,1,,,,,,3,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH274GFE,2741,,,M,2000,Visit8,8,Phase 1/1A,215,1 or 1A,,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH274GFE,2741,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,,2,,1,,,,,,4,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH274GFE,2741,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH274GFE,2741,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,93,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH274GFE,2741,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,,2,,1,,,,,,3,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH274GFE,2741,,,M,3000,Visit13,13,Phase 1/1A,383,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH274GFE,2741,,,M,3200,Visit14,14,Phase 1/1A,401,1 or 1A,0,2,,,,,,,,4,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,90,1,,0,1,,,,,1,1,40,,,1,2,1,56,40,1,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,1000,Visit3,3,Phase 1/1A,94,1 or 1A,80,1,,0,1,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,52,2,,0,1,,,,,2,2,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,1400,Visit5,5,Phase 1/1A,152,1 or 1A,8,2,,0,1,,,,,4,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,1600,Visit6,6,Phase 1/1A,166,1 or 1A,25,2,,0,1,,,,,4,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,1800,Visit7,7,Phase 1/1A,201,1 or 1A,50,1,,0,1,,,,,3,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,25,2,,0,1,,,,,4,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,2400,Visit10,10,Phase 1/1A,285,1 or 1A,67,1,,0,2,,,,,2,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,2600,Visit11,11,Phase 1/1A,317,1 or 1A,50,1,,0,1,,,,,3,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,3000,Visit13,13,Phase 2,369,2,55,2,,1,,,,,,2,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,3400,Visit15,15,Phase 2,411,2,50,2,,1,,,,,,3,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,3600,Visit16,16,Phase 2,446,2,21,2,,1,,,,,,4,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,3800,Visit17,17,Phase 2,473,2,25,2,,1,,,,,,4,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,334,1 or 1A,41,1,,1,,,,,,3,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH466KFZ,2381,,,M,5800,EndofPhase2,18,Phase 2,516,2,50,2,,1,,,,,,3,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUH736LXX,2339,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,22,1 or 1A,100,4,,1,,,,,,1,4,160,,,2,,4,160,160,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ276BZJ,2436,,,F,600,Visit1,1,Phase 1/1A,15,1 or 1A,,,,1,,,,,,,,,,,2,,3,120,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ276BZJ,2436,,,F,800,Visit2,2,Phase 1/1A,39,1 or 1A,42,3,,1,,,,,,4,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ276BZJ,2436,,,F,1000,Visit3,3,Phase 1/1A,113,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ276BZJ,2436,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,113,1 or 1A,,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,16,,,1,2,3,20,16,3,3,128,120,3,20,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,1200,Visit4,4,Phase 1B,113,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,1400,Visit5,5,Phase 1B,136,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,1600,Visit6,6,Phase 1B,168,1B,94,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,1800,Visit7,7,Phase 1B,198,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,2000,Visit8,8,Phase 1B,225,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,2200,Visit9,9,Phase 1B,249,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,2400,Visit10,10,Phase 1B,277,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,2600,Visit11,11,Phase 2,311,2,98,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,2800,Visit12,12,Phase 2,337,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,3000,Visit13,13,Phase 2,367,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,3200,Visit14,14,Phase 2,394,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,5400,EndofPhase1b,10,Phase 1B,284,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,5800,EndofPhase2,15,Phase 2,416,2,98,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ397VYA,2392,,,F,6000,EndofPhase3,16,Phase 3,449,3,,,,,,8,20,,,2,,,,20,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,3,,,,,,,,1,3,4.5,,,2,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,97,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,94,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,99,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,95,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,96,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUJ589MX0,1708,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,497,1 or 1A,100,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,8,,,1,2,2,16,16,2,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,1000,Visit3,3,Phase 1B,85,1B,100,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,1200,Visit4,4,Phase 1B,114,1B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,1400,Visit5,5,Phase 1B,141,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,1800,Visit7,7,Phase 2,195,2,97,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,2000,Visit8,8,Phase 2,218,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,2200,Visit9,9,Phase 2,267,2,93,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,2400,Visit10,10,Phase 2,285,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,2600,Visit11,11,Phase 2,313,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,2800,Visit12,12,Phase 2,357,2,77,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,3200,Visit14,14,Phase 2,394,2,,4,,1,,,,,,,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,3400,Visit15,15,Phase 2,422,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,2,800,8,5,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,35,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,5400,EndofPhase1b,6,Phase 1B,155,1B,87,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,5800,EndofPhase2,16,Phase 2,442,2,74,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK248FD1,1931,,,M,6000,EndofPhase3,18,Phase 3,506,3,,,,,,2,800,8,5,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,600,Visit1,1,Phase 1/1A,44,1 or 1A,,2,,1,,,,,,1,2,3,,,1,,3,4,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,,2,,1,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,1200,Visit4,4,Phase 1/1A,120,1 or 1A,89,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,1400,Visit5,5,Phase 1/1A,160,1 or 1A,83,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,78,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,1800,Visit7,7,Phase 1/1A,204,1 or 1A,,2,,1,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,2000,Visit8,8,Phase 1/1A,232,1 or 1A,82,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,2200,Visit9,9,Phase 1/1A,260,1 or 1A,54,2,,0,1,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,2400,Visit10,10,Phase 1/1A,296,1 or 1A,44,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,2600,Visit11,11,Phase 1/1A,323,1 or 1A,79,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,2800,Visit12,12,Phase 1/1A,344,1 or 1A,81,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,3000,Visit13,13,Phase 1/1A,386,1 or 1A,98,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,3200,Visit14,14,Phase 1/1A,400,1 or 1A,43,4,,1,,,,,,3,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,3400,Visit15,15,Phase 1/1A,428,1 or 1A,,4,,1,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,3600,Visit16,16,Phase 1/1A,456,1 or 1A,77,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,3800,Visit17,17,Phase 1/1A,484,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK356VZW,2167,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,,4,,1,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK526BWA,2499,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,4,27,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK526BWA,2499,,,M,800,Visit2,2,Phase 1/1A,68,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK526BWA,2499,,,M,1000,Visit3,3,Phase 1/1A,98,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK526BWA,2499,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK526BWA,2499,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,97,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK526BWA,2499,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,80,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK526BWA,2499,,,M,1800,Visit7,7,Phase 1/1A,201,1 or 1A,72,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK526BWA,2499,,,M,2000,Visit8,8,Phase 1/1A,229,1 or 1A,69,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK526BWA,2499,,,M,2200,Visit9,9,Phase 1/1A,250,1 or 1A,36,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK526BWA,2499,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,327,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,2,4,27,30,4,4,160,160,4,4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,78,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,1000,Visit3,3,Phase 1/1A,99,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,1200,Visit4,4,Phase 1/1A,127,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,1400,Visit5,5,Phase 1/1A,148,1 or 1A,83,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,2000,Visit8,8,Phase 2,232,2,1,4,,1,,,,,,4,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,2400,Visit10,10,Phase 3,260,3,,,,,,3,4,,,,,,,4,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,2600,Visit11,11,Phase 3,281,3,,,,,,3,4,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,2800,Visit12,12,Phase 3,316,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,3000,Visit13,13,Phase 3,331,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,3200,Visit14,14,Phase 3,372,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,3400,Visit15,15,Phase 3,394,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,3600,Visit16,16,Phase 3,421,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,3800,Visit17,17,Phase 3,442,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,5200,EndofPhase1_1a,7,Phase 1/1A,197,1 or 1A,43,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,5800,EndofPhase2,9,Phase 2,245,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUK788TFH,2108,,,F,6000,EndofPhase3,18,Phase 3,477,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUL035KZQ,1705,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,2,,,,,,,,,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUL035KZQ,1705,,,M,800,Visit2,2,Phase 1/1A,70,1 or 1A,,2,,,,,,,,,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUL035KZQ,1705,,,M,4000,Visit18,18,Phase 1/1A,131,1 or 1A,,2,,,,,,,,,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUL650JV6,2007,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUM121BFD,1235,,,F,600,Visit1,1,Phase 1/1A,38,1 or 1A,75,1,,,,,,,,3,1,8,,,1,,1,9,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUM121BFD,1235,,,F,800,Visit2,2,Phase 1/1A,66,1 or 1A,100,1,,,,,,,,2,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUM121BFD,1235,,,F,1000,Visit3,3,Phase 1/1A,104,1 or 1A,72,1,,,,,,,,3,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUM121BFD,1235,,,F,1200,Visit4,4,Phase 1/1A,133,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUM121BFD,1235,,,F,1400,Visit5,5,Phase 1/1A,160,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUM121BFD,1235,,,F,1600,Visit6,6,Phase 1/1A,197,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUM121BFD,1235,,,F,1800,Visit7,7,Phase 1/1A,210,1 or 1A,95,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUM121BFD,1235,,,F,2000,Visit8,8,Phase 1/1A,245,1 or 1A,82,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUM121BFD,1235,,,F,2200,Visit9,9,Phase 1/1A,273,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUM121BFD,1235,,,F,2400,Visit10,10,Phase 1/1A,296,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUM121BFD,1235,,,F,2600,Visit11,11,Phase 1/1A,317,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUM121BFD,1235,,,F,5200,EndofPhase1_1a,12,Phase 1/1A,365,1 or 1A,46,1,,,,,,,,3,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUM967YBV,1657,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,47,2,,,,,,,,3,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,96,1,,1,,,,,,1,1,200,,,2,,4,767,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,1200,Visit4,4,Phase 1/1A,106,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,1400,Visit5,5,Phase 1/1A,137,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,94,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,2000,Visit8,8,Phase 1/1A,230,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,2200,Visit9,9,Phase 1/1A,259,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,2400,Visit10,10,Phase 1/1A,292,1 or 1A,97,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,2600,Visit11,11,Phase 1/1A,326,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,2800,Visit12,12,Phase 1/1A,354,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,3000,Visit13,13,Phase 1/1A,386,1 or 1A,97,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,3200,Visit14,14,Phase 1/1A,412,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,3400,Visit15,15,Phase 1/1A,433,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,3800,Visit17,17,Phase 1/1A,480,1 or 1A,86,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN188JYV,2491,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,508,1 or 1A,65,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,800,Visit2,2,Phase 2,57,2,100,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,1000,Visit3,3,Phase 2,90,2,100,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,1200,Visit4,4,Phase 2,113,2,100,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,1400,Visit5,5,Phase 2,141,2,100,3,,,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,1600,Visit6,6,Phase 2,169,2,64,3,,1,,,,,,2,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,2000,Visit8,8,Phase 3,211,3,,,,,,4,160,2,100,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,2200,Visit9,9,Phase 3,244,3,,,,,,4,160,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,2400,Visit10,10,Phase 3,267,3,,,,,,2,200,4,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,2600,Visit11,11,Phase 3,302,3,,,,,,2,200,4,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,2800,Visit12,12,Phase 3,336,3,,,,,,4,160,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,3000,Visit13,13,Phase 3,365,3,,,,,,4,180,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,3200,Visit14,14,Phase 3,393,3,,,,,,4,160,2,175,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,3400,Visit15,15,Phase 3,419,3,,,,,,2,175,4,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,3600,Visit16,16,Phase 3,449,3,,,,,,2,150,4,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,3800,Visit17,17,Phase 3,477,3,,,,,,2,100,4,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,30,1 or 1A,96,2,,,,,,,,1,2,15,,,1,2,2,15,15,2,3,100,80,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,5800,EndofPhase2,7,Phase 2,183,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUN857PW0,1921,,,F,6000,EndofPhase3,18,Phase 3,499,3,,,,,,2,100,4,160,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,75,3,,1,,,,,,2,3,22.5,,,1,2,3,24,23,3,4,157,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,70,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,1400,Visit5,5,Phase 2,152,2,78,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,1600,Visit6,6,Phase 2,180,2,98,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,1800,Visit7,7,Phase 2,210,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,2000,Visit8,8,Phase 2,239,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,2200,Visit9,9,Phase 2,279,2,90,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,2400,Visit10,10,Phase 2,309,2,88,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,2600,Visit11,11,Phase 2,330,2,92,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,2800,Visit12,12,Phase 2,354,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,3000,Visit13,13,Phase 2,375,2,96,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,3200,Visit14,14,Phase 2,396,2,90,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,3400,Visit15,15,Phase 2,424,2,96,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,3600,Visit16,16,Phase 2,452,2,97,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,3800,Visit17,17,Phase 2,480,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,124,1 or 1A,85,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUP593HYD,2578,,,M,5800,EndofPhase2,18,Phase 2,509,2,100,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,47,2,,1,,,,,,3,2,3,,,1,,3,4,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,88,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,83,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,90,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,1400,Visit5,5,Phase 1/1A,138,1 or 1A,62,2,,0,1,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,2,,0,1,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,96,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,77,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,2200,Visit9,9,Phase 1/1A,258,1 or 1A,100,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,90,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,92,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,93,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,3000,Visit13,13,Phase 1/1A,369,1 or 1A,88,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,92,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,3400,Visit15,15,Phase 1/1A,419,1 or 1A,92,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,93,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,3800,Visit17,17,Phase 1/1A,481,1 or 1A,100,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR760AYF,2878,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,498,1 or 1A,100,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,600,Visit1,1,Phase 1/1A,37,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,3,26,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,50,4,,,,,,,,3,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,1200,Visit4,4,Phase 1/1A,109,1 or 1A,68,4,,,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,1800,Visit7,7,Phase 1/1A,193,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,2000,Visit8,8,Phase 1/1A,221,1 or 1A,84,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,94,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,2600,Visit11,11,Phase 1/1A,319,1 or 1A,94,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,2800,Visit12,12,Phase 1/1A,347,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,3200,Visit14,14,Phase 1/1A,396,1 or 1A,,3,,1,,,,,,,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,3400,Visit15,15,Phase 1/1A,427,1 or 1A,92,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,3600,Visit16,16,Phase 1/1A,459,1 or 1A,94,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUR840DMM,1444,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,511,1 or 1A,79,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,600,Visit1,1,Phase 1/1A,25,1 or 1A,88,3,,1,,,,,,1,3,22.5,,,2,,3,23,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,800,Visit2,2,Phase 1/1A,55,1 or 1A,90,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,1800,Visit7,7,Phase 1/1A,195,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,2400,Visit10,10,Phase 1/1A,279,1 or 1A,97,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,2600,Visit11,11,Phase 1/1A,312,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,3000,Visit13,13,Phase 1/1A,369,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,3200,Visit14,14,Phase 1/1A,392,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,3600,Visit16,16,Phase 1/1A,442,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,3800,Visit17,17,Phase 1/1A,470,1 or 1A,100,4,,0,2,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT333DJ2,2655,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,497,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,600,Visit1,1,Phase 1/1A,44,,,,,,,,,,,,,,,,1,1,1,2,2,1,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,800,Visit2,2,Phase 2,79,2,94,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,1000,Visit3,3,Phase 2,107,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,1200,Visit4,4,Phase 2,139,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,1400,Visit5,5,Phase 2,160,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,1600,Visit6,6,Phase 2,182,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,1800,Visit7,7,Phase 2,236,2,77,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,2000,Visit8,8,Phase 2,257,2,85,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,2200,Visit9,9,Phase 2,278,2,95,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,2400,Visit10,10,Phase 2,299,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,2600,Visit11,11,Phase 2,320,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,2800,Visit12,12,Phase 2,351,2,93,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,3000,Visit13,13,Phase 2,379,2,96,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,3200,Visit14,14,Phase 2,407,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,3400,Visit15,15,Phase 2,428,2,81,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,3600,Visit16,16,Phase 2,456,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,3800,Visit17,17,Phase 2,484,2,82,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,4000,Visit18,18,Phase 2,519,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,44,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUT835XPV,1008,,,M,5800,EndofPhase2,18,Phase 2,519,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,3,,,,,,,,1,3,600,,,2,2,4,711,800,4,3,102,80,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,98,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,1800,Visit7,7,Phase 1/1A,202,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,2400,Visit10,10,Phase 2,281,2,93,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,2600,Visit11,11,Phase 2,308,2,94,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,2800,Visit12,12,Phase 2,337,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,3000,Visit13,13,Phase 2,365,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,3200,Visit14,14,Phase 2,392,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,3400,Visit15,15,Phase 2,421,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,3600,Visit16,16,Phase 2,449,2,98,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,3800,Visit17,17,Phase 2,476,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,253,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU592YVL,2015,,,M,5800,EndofPhase2,18,Phase 2,506,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,2,,,,,,,,1,2,3,,,1,2,3,4,4,3,4,800,800,4,353,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,1000,Visit3,3,Phase 2,104,2,92,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,1200,Visit4,4,Phase 3,131,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,1400,Visit5,5,Phase 3,141,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,1600,Visit6,6,Phase 3,176,3,,,,,,6,450,,,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,1800,Visit7,7,Phase 3,194,3,,,,,,6,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,2000,Visit8,8,Phase 3,225,3,,,,,,6,250,,,1,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,2200,Visit9,9,Phase 3,250,3,,,,,,6,250,,,1,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,2400,Visit10,10,Phase 3,281,3,,,,,,6,250,,,1,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,2600,Visit11,11,Phase 3,314,3,,,,,,6,250,,,1,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,2800,Visit12,12,Phase 3,335,3,,,,,,6,250,,,1,,,,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,3000,Visit13,13,Phase 3,366,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,3200,Visit14,14,Phase 3,391,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,3400,Visit15,15,Phase 3,419,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,3600,Visit16,16,Phase 3,447,3,,,,,,6,500,,,,,,,500,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,3800,Visit17,17,Phase 3,475,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,58,1 or 1A,94,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,5800,EndofPhase2,3,Phase 2,104,2,92,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU693RD0,1173,,,F,6000,EndofPhase3,18,Phase 3,509,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,4,,,,,,,,1,4,30,,,1,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,800,Visit2,2,Phase 1/1A,53,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,1000,Visit3,3,Phase 1/1A,82,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,1600,Visit6,6,Phase 1/1A,166,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,1800,Visit7,7,Phase 1/1A,195,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,2000,Visit8,8,Phase 1/1A,223,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,2200,Visit9,9,Phase 1/1A,250,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,2400,Visit10,10,Phase 1/1A,279,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,2600,Visit11,11,Phase 1/1A,305,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,2800,Visit12,12,Phase 1/1A,342,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,3000,Visit13,13,Phase 1/1A,369,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,3200,Visit14,14,Phase 1/1A,391,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,3400,Visit15,15,Phase 1/1A,419,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,3600,Visit16,16,Phase 1/1A,446,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,3800,Visit17,17,Phase 1/1A,475,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUU926DVN,1184,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,487,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,1,,,,,,,,1,1,7.5,,,2,,1,11,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,1600,Visit6,6,Phase 1/1A,199,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,2200,Visit9,9,Phase 1/1A,261,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,2400,Visit10,10,Phase 1/1A,297,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,2600,Visit11,11,Phase 1/1A,339,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,2800,Visit12,12,Phase 1/1A,373,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,3000,Visit13,13,Phase 1/1A,400,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,3200,Visit14,14,Phase 1/1A,422,1 or 1A,50,3,,0,,,,,,3,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,3400,Visit15,15,Phase 1/1A,465,1 or 1A,100,3,,0,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUV426DUR,1159,,,M,3800,Visit17,17,Phase 1/1A,494,1 or 1A,100,3,,0,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,73,2,,1,,,,,,2,2,80,,,2,,4,156,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,2000,Visit8,8,Phase 1/1A,217,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,2200,Visit9,9,Phase 1/1A,244,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,2600,Visit11,11,Phase 1/1A,301,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,2800,Visit12,12,Phase 1/1A,328,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,3000,Visit13,13,Phase 1/1A,360,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,3200,Visit14,14,Phase 1/1A,384,1 or 1A,99,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,3400,Visit15,15,Phase 1/1A,415,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,3600,Visit16,16,Phase 1/1A,446,1 or 1A,99,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,3800,Visit17,17,Phase 1/1A,468,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW044NT0,2354,,,M,4000,Visit18,18,Phase 1/1A,489,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUW838LVT,1980,,,F,5200,EndofPhase1_1a,0,Phase 1/1A,7,1 or 1A,17,1,,1,,,,,,4,1,8,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX108UFL,1075,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,1,,,,,,,,1,1,8,,,1,,1,10,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX108UFL,1075,,,M,800,Visit2,2,Phase 1/1A,51,1 or 1A,88,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX108UFL,1075,,,M,1000,Visit3,3,Phase 1/1A,79,1 or 1A,86,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX108UFL,1075,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,58,1,,,,,,,,2,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX108UFL,1075,,,M,1400,Visit5,5,Phase 1/1A,137,1 or 1A,100,1,,,,,,,,4,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX108UFL,1075,,,M,1600,Visit6,6,Phase 1/1A,166,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX108UFL,1075,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,0,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX108UFL,1075,,,M,2000,Visit8,8,Phase 1/1A,219,1 or 1A,0,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX203MV4,1088,,,F,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,2,,,,,,,,1,2,16,,,1,,2,18,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX203MV4,1088,,,F,800,Visit2,2,Phase 1/1A,77,1 or 1A,57,3,,,,,,,,2,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX203MV4,1088,,,F,1000,Visit3,3,Phase 1/1A,105,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX203MV4,1088,,,F,1200,Visit4,4,Phase 1/1A,137,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX225WRB,1052,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,26,1 or 1A,95,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUX562PYR,1570,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,38,1 or 1A,0,2,,,,,,,,4,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,1,2,3,5,6,3,4,714,800,4,21,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,1200,Visit4,4,Phase 2,114,2,100,1,,1,,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,1400,Visit5,5,Phase 2,142,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,1600,Visit6,6,Phase 2,164,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,1800,Visit7,7,Phase 2,199,2,89,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,2000,Visit8,8,Phase 2,226,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,2200,Visit9,9,Phase 2,254,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,2600,Visit11,11,Phase 3,289,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,2800,Visit12,12,Phase 3,321,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,3000,Visit13,13,Phase 3,351,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,3200,Visit14,14,Phase 3,378,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,3400,Visit15,15,Phase 3,426,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,3800,Visit17,17,Phase 3,484,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,94,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,5800,EndofPhase2,10,Phase 2,265,2,37,4,,1,,,,,,3,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY313LVY,2516,,,M,6000,EndofPhase3,18,Phase 3,500,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,600,Visit1,1,Phase 1/1A,22,1 or 1A,100,2,,,,,,,,3,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,59,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,1000,Visit3,3,Phase 1/1A,88,,,,,,,,,,,,,,,,2,1,2,13,15,2,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,1200,Visit4,4,Phase 2,116,2,89,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,1400,Visit5,5,Phase 2,140,2,83,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,1600,Visit6,6,Phase 2,169,2,91,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,1800,Visit7,7,Phase 2,200,2,71,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,2000,Visit8,8,Phase 2,243,2,96,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,2200,Visit9,9,Phase 2,252,2,60,2,,,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,2400,Visit10,10,Phase 2,280,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,2600,Visit11,11,Phase 2,308,2,96,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,2800,Visit12,12,Phase 2,342,2,96,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,3000,Visit13,13,Phase 2,364,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,3200,Visit14,14,Phase 2,390,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,3800,Visit17,17,Phase 2,476,2,86,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,88,1 or 1A,83,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY327NL4,1234,,,M,5800,EndofPhase2,18,Phase 2,497,2,59,3,,0,1,,,,,2,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,,2,,,,,,,,1,2,400,,,2,,2,424,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,1400,Visit5,5,Phase 1/1A,138,1 or 1A,,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,1800,Visit7,7,Phase 1/1A,184,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,2000,Visit8,8,Phase 1/1A,211,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,2200,Visit9,9,Phase 1/1A,240,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,2400,Visit10,10,Phase 1/1A,271,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,2600,Visit11,11,Phase 1/1A,305,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,3000,Visit13,13,Phase 1/1A,369,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,3200,Visit14,14,Phase 1/1A,397,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,3600,Visit16,16,Phase 1/1A,446,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,3800,Visit17,17,Phase 1/1A,479,1 or 1A,87,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUY836FAR,1253,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,520,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,71,2,,1,,,,,,2,2,400,,,2,1,2,400,400,2,3,25,23,3,6,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,800,Visit2,2,Phase 2,69,2,65,4,,1,,,,,,2,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,1000,Visit3,3,Phase 2,90,2,,4,,1,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,1200,Visit4,4,Phase 2,118,2,96,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,1400,Visit5,5,Phase 2,148,2,97,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,1600,Visit6,6,Phase 2,181,2,65,3,,1,,,,,,2,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,1800,Visit7,7,Phase 2,211,2,65,3,,1,,,,,,2,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,2200,Visit9,9,Phase 3,258,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,2400,Visit10,10,Phase 3,292,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,2600,Visit11,11,Phase 3,321,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,2800,Visit12,12,Phase 3,349,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,3000,Visit13,13,Phase 3,377,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,3200,Visit14,14,Phase 3,405,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,3400,Visit15,15,Phase 3,434,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,3800,Visit17,17,Phase 3,468,3,,,,,,3,6,,,4,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,4000,Visit18,18,Phase 3,502,3,,,,,,3,6,,,4,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,34,2,,,,0,1,,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,5800,EndofPhase2,8,Phase 2,224,2,56,3,,1,,,,,,2,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ032ZR1,2423,,,M,6000,EndofPhase3,18,Phase 3,502,3,,,,,,3,6,,,4,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ101HJH,2118,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,96,3,,1,,,,,,1,3,120,,,2,,4,140,140,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ101HJH,2118,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ199FKW,2215,,,F,800,Visit2,2,Phase 2,52,2,77,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ199FKW,2215,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,28,1 or 1A,96,2,,1,,,,,,1,2,15,,,2,2,2,15,15,2,2,400,400,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVUZ199FKW,2215,,,F,5800,EndofPhase2,3,Phase 2,64,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,2,,1,,,,,,1,2,80,,,1,3,3,133,160,3,,358,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,800,Visit2,2,Phase 1/1A,69,1 or 1A,,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,1200,Visit4,4,Phase 2,125,2,,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,1400,Visit5,5,Phase 2,149,2,,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,1600,Visit6,6,Phase 2,190,2,,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,1800,Visit7,7,Phase 2,217,2,,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,2000,Visit8,8,Phase 2,261,2,,,350,,,,,,,1,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,2200,Visit9,9,Phase 2,301,2,,,350,,,,,,,1,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,2600,Visit11,11,Phase 2,338,2,,,350,,,,,,,1,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,2800,Visit12,12,Phase 2,365,2,,,350,,,,,,,1,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,3200,Visit14,14,Phase 2,428,2,,,350,,,,,,,1,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,3400,Visit15,15,Phase 2,468,2,,,350,,,,,,,3,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,3600,Visit16,16,Phase 2,496,2,,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,3800,Visit17,17,Phase 2,526,2,,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA110JVY,1968,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,79,1 or 1A,,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,3,567,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,85,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,99,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,98,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,82,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,99,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,97,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,95,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,89,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA529WUA,1116,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,497,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,600,Visit1,1,Phase 1/1A,40,1 or 1A,100,4,,1,,,,,,1,4,6,,,1,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,90,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,1200,Visit4,4,Phase 1/1A,108,1 or 1A,,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,83,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,2400,Visit10,10,Phase 1/1A,289,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,68,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,3200,Visit14,14,Phase 1/1A,396,1 or 1A,85,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,3400,Visit15,15,Phase 1/1A,423,1 or 1A,53,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,3600,Visit16,16,Phase 1/1A,458,1 or 1A,45,3,,1,,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,3800,Visit17,17,Phase 1/1A,479,1 or 1A,59,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA539WZ0,2377,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,520,1 or 1A,33,3,,1,,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVA655XDP,2605,,,F,600,Visit1,1,Phase 1/1A,26,1 or 1A,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB140MCL,2138,,,F,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB140MCL,2138,,,F,800,Visit2,2,Phase 1/1A,68,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB140MCL,2138,,,F,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB140MCL,2138,,,F,1200,Visit4,4,Phase 1/1A,121,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB140MCL,2138,,,F,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB364LJN,2763,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,99,3,,1,,,,,,1,3,600,,,2,1,4,700,700,4,4,30,30,4,40,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB364LJN,2763,,,F,1000,Visit3,3,Phase 2,82,2,99,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB364LJN,2763,,,F,1400,Visit5,5,Phase 3,132,3,,,,,,4,40,,,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB364LJN,2763,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,54,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB364LJN,2763,,,F,5800,EndofPhase2,4,Phase 2,104,2,95,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,800,Visit2,2,Phase 1/1A,68,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,1000,Visit3,3,Phase 1/1A,95,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,1200,Visit4,4,Phase 1/1A,123,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,1600,Visit6,6,Phase 1/1A,179,1 or 1A,97,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,1800,Visit7,7,Phase 1/1A,214,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,2000,Visit8,8,Phase 1/1A,249,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,2200,Visit9,9,Phase 1/1A,274,1 or 1A,92,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,2400,Visit10,10,Phase 1/1A,302,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,2600,Visit11,11,Phase 1/1A,326,1 or 1A,79,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,86,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,80,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,3200,Visit14,14,Phase 1/1A,407,1 or 1A,93,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,3400,Visit15,15,Phase 1/1A,431,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,3600,Visit16,16,Phase 1/1A,463,1 or 1A,88,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,3800,Visit17,17,Phase 1/1A,487,1 or 1A,92,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB610CEC,1229,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,515,1 or 1A,93,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,91,2,,,,,,,,1,2,400,,,2,2,4,720,800,4,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,94,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,1200,Visit4,4,Phase 1/1A,106,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,1400,Visit5,5,Phase 2,141,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,1600,Visit6,6,Phase 2,169,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,1800,Visit7,7,Phase 2,197,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,2000,Visit8,8,Phase 2,232,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,2200,Visit9,9,Phase 2,260,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,2400,Visit10,10,Phase 2,281,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,2600,Visit11,11,Phase 2,309,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,2800,Visit12,12,Phase 2,337,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,3000,Visit13,13,Phase 2,372,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,3200,Visit14,14,Phase 2,398,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,3400,Visit15,15,Phase 2,421,2,99,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,3600,Visit16,16,Phase 2,442,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,3800,Visit17,17,Phase 2,474,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,106,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVB880NL1,1053,,,M,5800,EndofPhase2,18,Phase 2,505,2,98,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD104GP4,2811,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,90,1,,1,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,800,Visit2,2,Phase 2,55,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,1000,Visit3,3,Phase 2,84,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,1200,Visit4,4,Phase 2,112,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,1600,Visit6,6,Phase 3,167,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,1800,Visit7,7,Phase 3,195,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,2000,Visit8,8,Phase 3,223,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,2200,Visit9,9,Phase 3,253,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,2400,Visit10,10,Phase 3,278,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,2800,Visit12,12,Phase 3,336,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,3000,Visit13,13,Phase 3,364,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,3200,Visit14,14,Phase 3,392,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,3400,Visit15,15,Phase 3,413,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,3600,Visit16,16,Phase 3,442,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,3800,Visit17,17,Phase 3,469,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,35,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,2,2,15,15,2,3,600,600,3,6,6,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,5800,EndofPhase2,5,Phase 2,133,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD142RTF,2473,,,M,6000,EndofPhase3,18,Phase 3,496,3,,,,,,3,6,,,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD436LLK,1564,,,F,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,3,600,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD436LLK,1564,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,62,1 or 1A,99,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,2,2,457,400,2,3,23,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,95,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,93,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,1200,Visit4,4,Phase 1/1A,107,1 or 1A,75,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,1400,Visit5,5,Phase 1/1A,134,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,1600,Visit6,6,Phase 1/1A,163,1 or 1A,55,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,2000,Visit8,8,Phase 2,218,2,85,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,2200,Visit9,9,Phase 2,245,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,2400,Visit10,10,Phase 2,281,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,2600,Visit11,11,Phase 2,310,2,95,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,2800,Visit12,12,Phase 2,337,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,3000,Visit13,13,Phase 2,365,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,3200,Visit14,14,Phase 2,393,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,3400,Visit15,15,Phase 2,422,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,3600,Visit16,16,Phase 2,449,2,99,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,3800,Visit17,17,Phase 2,478,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,184,1 or 1A,6,2,,,,,,,,4,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVD715VTJ,1747,,,M,5800,EndofPhase2,18,Phase 2,504,2,91,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVE801YDM,2812,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,2,4,720,800,4,3,23,23,3,32,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVE801YDM,2812,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVE801YDM,2812,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVE801YDM,2812,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,73,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVE801YDM,2812,,,M,1600,Visit6,6,Phase 2,177,2,90,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVE801YDM,2812,,,M,2000,Visit8,8,Phase 3,227,3,,,,,,5,32,,,1,,,,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVE801YDM,2812,,,M,2200,Visit9,9,Phase 3,254,3,,,,,,5,32,,,1,,,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVE801YDM,2812,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,5,32,,,2,,,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVE801YDM,2812,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,145,1 or 1A,26,4,,1,,,,,,4,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVE801YDM,2812,,,M,5800,EndofPhase2,7,Phase 2,199,2,92,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVE801YDM,2812,,,M,6000,EndofPhase3,11,Phase 3,298,3,,,,,,5,32,,,2,,,,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,77,2,,,,,,,,1,2,400,,,2,,2,444,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,89,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,2000,Visit8,8,Phase 1/1A,218,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,3200,Visit14,14,Phase 1/1A,390,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,3600,Visit16,16,Phase 1/1A,445,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,3800,Visit17,17,Phase 1/1A,472,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF107RA8,1733,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF208VR0,1753,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,1,,,,,,,,1,1,200,,,2,1,2,400,400,2,2,3,3,2,150,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF208VR0,1753,,,F,1200,Visit4,4,Phase 3,106,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF208VR0,1753,,,F,1400,Visit5,5,Phase 3,142,3,,,,,,6,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF208VR0,1753,,,F,1600,Visit6,6,Phase 3,171,3,,,,,,6,100,,0,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF208VR0,1753,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,45,1 or 1A,74,3,,,,,,,,2,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF208VR0,1753,,,F,5800,EndofPhase2,3,Phase 2,71,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF208VR0,1753,,,F,6000,EndofPhase3,7,Phase 3,183,3,,,,,,6,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,90,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,1200,Visit4,4,Phase 1/1A,124,1 or 1A,100,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,75,4,,,,,,,,2,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,1600,Visit6,6,Phase 1/1A,178,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,1800,Visit7,7,Phase 1/1A,213,1 or 1A,99,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,2000,Visit8,8,Phase 1/1A,241,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,2200,Visit9,9,Phase 1/1A,268,1 or 1A,,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,2400,Visit10,10,Phase 1/1A,296,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,2600,Visit11,11,Phase 1/1A,332,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,2800,Visit12,12,Phase 1/1A,373,1 or 1A,91,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,3000,Visit13,13,Phase 1/1A,400,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,3200,Visit14,14,Phase 1/1A,425,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,3400,Visit15,15,Phase 1/1A,457,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,3600,Visit16,16,Phase 1/1A,499,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,3800,Visit17,17,Phase 1/1A,530,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF407WXG,1224,,,M,4000,Visit18,18,Phase 1/1A,562,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF508CU8,1306,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,84,4,,,,,,,,1,4,6,,,2,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF508CU8,1306,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF508CU8,1306,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,62,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF508CU8,1306,,,M,1200,Visit4,4,Phase 1/1A,126,1 or 1A,80,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF554CZ1,1199,,,M,1600,Visit6,6,Phase 1/1A,189,1 or 1A,92,1,,,,,,,,1,1,8,,,1,,2,13,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF554CZ1,1199,,,M,2200,Visit9,9,Phase 1/1A,280,1 or 1A,83,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF554CZ1,1199,,,M,2600,Visit11,11,Phase 1/1A,343,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF571NX5,2312,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,9,1 or 1A,1,2,,1,,,,,,4,2,80,,,2,1,2,80,80,2,1,8,8,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF571NX5,2312,,,M,5800,EndofPhase2,2,Phase 2,19,2,20,1,,1,,,,,,4,1,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF703LVQ,2612,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,36,4,,1,,,,,,3,4,160,,,2,2,4,160,160,4,4,6,6,4,23,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF703LVQ,2612,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,62,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF703LVQ,2612,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF703LVQ,2612,,,M,1400,Visit5,5,Phase 2,159,2,66,3,,1,,,,,,2,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF703LVQ,2612,,,M,1600,Visit6,6,Phase 2,186,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF703LVQ,2612,,,M,1800,Visit7,7,Phase 2,218,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF703LVQ,2612,,,M,2000,Visit8,8,Phase 2,249,2,97,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF703LVQ,2612,,,M,2400,Visit10,10,Phase 3,309,3,,,,,,8,20,,,2,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF703LVQ,2612,,,M,2600,Visit11,11,Phase 3,330,3,,,,,,8,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF703LVQ,2612,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,124,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF703LVQ,2612,,,M,5800,EndofPhase2,9,Phase 2,278,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVF703LVQ,2612,,,M,6000,EndofPhase3,12,Phase 3,361,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG401NFK,2583,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,1,,,,,,1,3,24,,,1,,4,28,28,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG401NFK,2583,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,53,1 or 1A,75,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,1,,3,23,23,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,1800,Visit7,7,Phase 1/1A,199,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,91,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,80,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,3400,Visit15,15,Phase 1/1A,430,1 or 1A,86,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,3600,Visit16,16,Phase 1/1A,458,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,,3,,1,,,,,,,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG481HB4,1609,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG792GC3,1200,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,1,,,,,,,,1,1,200,,,2,,1,200,200,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG792GC3,1200,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG792GC3,1200,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG792GC3,1200,,,M,1200,Visit4,4,Phase 1/1A,107,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG792GC3,1200,,,M,1400,Visit5,5,Phase 1/1A,135,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG792GC3,1200,,,M,1600,Visit6,6,Phase 1/1A,163,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG792GC3,1200,,,M,1800,Visit7,7,Phase 1/1A,191,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG792GC3,1200,,,M,2000,Visit8,8,Phase 1/1A,219,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVG792GC3,1200,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,253,1 or 1A,90,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,600,Visit1,1,Phase 1/1A,47,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,,3,622,800,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,800,Visit2,2,Phase 1/1A,75,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,1000,Visit3,3,Phase 1/1A,103,1 or 1A,96,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,1200,Visit4,4,Phase 1/1A,141,1 or 1A,97,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,1400,Visit5,5,Phase 1/1A,162,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,1600,Visit6,6,Phase 1/1A,182,1 or 1A,95,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,1800,Visit7,7,Phase 1/1A,208,1 or 1A,90,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,2200,Visit9,9,Phase 1/1A,263,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,96,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,3200,Visit14,14,Phase 1/1A,391,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,3800,Visit17,17,Phase 1/1A,481,1 or 1A,89,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH072TUT,2102,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,84,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH361WEZ,2558,,,F,5200,EndofPhase1_1a,0,Phase 1/1A,28,1 or 1A,15,2,,0,2,,,,,4,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,1,,1,,,,,,1,1,1.5,,,2,,2,3,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,89,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,1400,Visit5,5,Phase 1/1A,135,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,99,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,2000,Visit8,8,Phase 1/1A,216,1 or 1A,90,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,2200,Visit9,9,Phase 1/1A,247,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,2400,Visit10,10,Phase 1/1A,275,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,2600,Visit11,11,Phase 1/1A,311,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,2800,Visit12,12,Phase 1/1A,345,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,3200,Visit14,14,Phase 1/1A,408,1 or 1A,66,3,,0,2,,,,,2,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,3600,Visit16,16,Phase 1/1A,447,1 or 1A,100,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,99,3,,0,2,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH568CGZ,2320,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,506,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,1000,Visit3,3,Phase 3,85,3,,,,,,5,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,1200,Visit4,4,Phase 3,113,3,,,,,,5,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,1400,Visit5,5,Phase 3,138,3,,,,,,5,4,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,1600,Visit6,6,Phase 3,174,3,,,,,,5,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,1800,Visit7,7,Phase 3,202,3,,,,,,5,16,,,2,,,,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,2000,Visit8,8,Phase 3,252,3,,,,,,5,8,,,1,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,2200,Visit9,9,Phase 3,290,3,,,,,,5,8,,,1,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,2400,Visit10,10,Phase 3,321,3,,,,,,5,8,,,3,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,2800,Visit12,12,Phase 3,338,3,,,,,,5,8,,,1,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,3000,Visit13,13,Phase 3,363,3,,,,,,5,16,,,2,,,,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,3200,Visit14,14,Phase 3,391,3,,,,,,5,16,,,2,,,,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,5,8,5,8,1,,,,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,3600,Visit16,16,Phase 3,452,3,,,,,,5,8,,,1,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,3800,Visit17,17,Phase 3,486,3,,,,,,5,8,,,1,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,4000,Visit18,18,Phase 3,506,3,,,,,,5,8,,,1,,,,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,31,1 or 1A,5,2,,,,,,,,4,2,3,,,2,2,2,3,3,2,2,400,400,2,9,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVH747VD2,1632,,,M,5800,EndofPhase2,2,Phase 2,44,2,46,2,,,,,,,,3,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ275WD8,1660,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,,,,,,,,,1,,,,,1,,3,21,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ275WD8,1660,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ275WD8,1660,,,F,1200,Visit4,4,Phase 1/1A,137,1 or 1A,43,3,,,,,,,,3,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ275WD8,1660,,,F,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,92,4,,1,,,,,,1,4,32,,,1,,4,29,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,98,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,89,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,96,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,89,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,68,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,4,,0,1,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,2800,Visit12,12,Phase 1/1A,333,1 or 1A,100,4,,0,1,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,3000,Visit13,13,Phase 1/1A,354,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,3200,Visit14,14,Phase 1/1A,382,1 or 1A,89,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,3400,Visit15,15,Phase 1/1A,410,1 or 1A,79,4,,0,1,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,3600,Visit16,16,Phase 1/1A,438,1 or 1A,96,4,,0,1,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,3800,Visit17,17,Phase 1/1A,473,1 or 1A,78,4,,0,1,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ500HJN,2387,,,M,4000,Visit18,18,Phase 1/1A,508,1 or 1A,87,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ896WAY,1436,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,90,1,,,,,,,,1,1,1.5,,,1,,1,2,2,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVJ896WAY,1436,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,1000,Visit3,3,Phase 1/1A,75,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,1200,Visit4,4,Phase 1/1A,107,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,1400,Visit5,5,Phase 1/1A,135,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,1800,Visit7,7,Phase 1/1A,191,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,2400,Visit10,10,Phase 1/1A,283,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,3000,Visit13,13,Phase 1/1A,359,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,98,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,98,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK617FB3,1274,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,519,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,,,,,,,,,,,,,,,2,,4,29,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,74,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,80,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,1400,Visit5,5,Phase 1/1A,162,1 or 1A,75,3,,1,,,,,,2,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,1600,Visit6,6,Phase 1/1A,190,1 or 1A,91,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,1800,Visit7,7,Phase 1/1A,222,1 or 1A,81,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,2000,Visit8,8,Phase 1/1A,253,1 or 1A,92,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,2200,Visit9,9,Phase 1/1A,278,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,2400,Visit10,10,Phase 1/1A,321,1 or 1A,88,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,2600,Visit11,11,Phase 1/1A,350,1 or 1A,97,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,2800,Visit12,12,Phase 1/1A,384,1 or 1A,87,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,3000,Visit13,13,Phase 1/1A,419,1 or 1A,87,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,3200,Visit14,14,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,3400,Visit15,15,Phase 1/1A,491,1 or 1A,68,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,3600,Visit16,16,Phase 1/1A,519,1 or 1A,98,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,3800,Visit17,17,Phase 1/1A,554,1 or 1A,82,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVK650PGC,2303,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,589,1 or 1A,91,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM176XUZ,1130,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,88,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM176XUZ,1130,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM176XUZ,1130,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM176XUZ,1130,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM176XUZ,1130,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,75,2,,1,,,,,,1,2,3,,,1,1,4,5,6,4,3,25,30,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,98,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,1600,Visit6,6,Phase 1/1A,166,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,2200,Visit9,9,Phase 1/1A,250,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,2600,Visit11,11,Phase 2,312,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,2800,Visit12,12,Phase 2,339,2,78,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,3000,Visit13,13,Phase 2,366,2,96,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,3200,Visit14,14,Phase 2,394,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,3400,Visit15,15,Phase 2,422,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,3600,Visit16,16,Phase 2,450,2,93,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,3800,Visit17,17,Phase 2,481,2,94,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,5200,EndofPhase1_1a,10,Phase 1/1A,290,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVM607JZM,2187,,,M,5800,EndofPhase2,18,Phase 2,501,2,93,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN663FU9,1060,,,F,600,Visit1,1,Phase 1/1A,33,1 or 1A,71,1,,1,,,,,,2,1,1.5,,,1,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN663FU9,1060,,,F,800,Visit2,2,Phase 1/1A,105,1 or 1A,,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN663FU9,1060,,,F,1000,Visit3,3,Phase 1/1A,126,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN663FU9,1060,,,F,1200,Visit4,4,Phase 1/1A,152,1 or 1A,,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,97,2,,,,,,,,1,2,400,,,2,,4,733,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,99,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,2200,Visit9,9,Phase 1/1A,274,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,2400,Visit10,10,Phase 1/1A,287,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,2600,Visit11,11,Phase 1/1A,315,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,2800,Visit12,12,Phase 1/1A,354,1 or 1A,100,4,,0,2,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,3000,Visit13,13,Phase 1/1A,379,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,3200,Visit14,14,Phase 1/1A,408,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,3600,Visit16,16,Phase 1/1A,459,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,3800,Visit17,17,Phase 1/1A,487,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN763VKE,1118,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,507,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVN784HEY,1992,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVP107DUU,2827,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,10,3,,1,,,,,,4,3,600,,,2,,3,600,600,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVP372CTZ,2014,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,160,,,2,2,4,140,140,4,4,800,800,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVP372CTZ,2014,,,M,1000,Visit3,3,Phase 2,68,2,99,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVP372CTZ,2014,,,M,1200,Visit4,4,Phase 2,102,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVP372CTZ,2014,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,34,1 or 1A,95,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR205GBF,1503,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,20,1 or 1A,18,2,,,,,,,,4,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,88,2,,1,,,,,,1,2,80,,,2,,2,84,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,84,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,100,2,,1,,,,,,3,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,93,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,3200,Visit14,14,Phase 1/1A,407,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,3400,Visit15,15,Phase 1/1A,435,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,3600,Visit16,16,Phase 1/1A,463,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,3800,Visit17,17,Phase 1/1A,498,1 or 1A,86,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVR460GLQ,2156,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,537,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT288FAM,2206,,,M,800,Visit2,2,Phase 2,57,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT288FAM,2206,,,M,1000,Visit3,3,Phase 2,86,2,96,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT288FAM,2206,,,M,1200,Visit4,4,Phase 2,113,2,92,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT288FAM,2206,,,M,1400,Visit5,5,Phase 2,140,2,88,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT288FAM,2206,,,M,1600,Visit6,6,Phase 2,166,2,92,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT288FAM,2206,,,M,1800,Visit7,7,Phase 2,197,2,87,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT288FAM,2206,,,M,2000,Visit8,8,Phase 2,225,2,94,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT288FAM,2206,,,M,2200,Visit9,9,Phase 2,250,2,98,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT288FAM,2206,,,M,2400,Visit10,10,Phase 2,279,2,91,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT288FAM,2206,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,97,4,,1,,,,,,1,4,160,,,2,2,4,160,160,4,4,30,30,4,200,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT288FAM,2206,,,M,5800,EndofPhase2,10,Phase 2,287,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT288FAM,2206,,,M,6000,EndofPhase3,11,Phase 3,310,3,,,,,,6,200,,,1,,,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT668DYK,1853,,,M,800,Visit2,2,Phase 2,62,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT668DYK,1853,,,M,1000,Visit3,3,Phase 2,90,2,93,,0,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT668DYK,1853,,,M,1200,Visit4,4,Phase 2,118,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT668DYK,1853,,,M,1600,Visit6,6,Phase 3,189,3,,,,,,6,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT668DYK,1853,,,M,1800,Visit7,7,Phase 3,219,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT668DYK,1853,,,M,2000,Visit8,8,Phase 3,248,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT668DYK,1853,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,86,4,,,,,,,,1,4,30,,,2,2,4,30,30,4,4,733,800,4,375,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT668DYK,1853,,,M,5800,EndofPhase2,5,Phase 2,161,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVT668DYK,1853,,,M,6000,EndofPhase3,9,Phase 3,275,3,,,,,,6,600,,,1,,,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,600,Visit1,1,Phase 1/1A,22,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,2,2,80,80,2,2,15,15,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,1000,Visit3,3,Phase 2,76,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,1200,Visit4,4,Phase 2,105,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,1400,Visit5,5,Phase 2,133,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,1600,Visit6,6,Phase 2,169,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,1800,Visit7,7,Phase 2,198,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,2000,Visit8,8,Phase 2,230,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,2200,Visit9,9,Phase 2,251,2,98,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,2400,Visit10,10,Phase 2,273,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,2600,Visit11,11,Phase 2,308,2,,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,2800,Visit12,12,Phase 2,337,2,93,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,3000,Visit13,13,Phase 2,373,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,3200,Visit14,14,Phase 2,394,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,3400,Visit15,15,Phase 2,428,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,3600,Visit16,16,Phase 2,450,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,3800,Visit17,17,Phase 2,477,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,50,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVU532MM4,2797,,,M,5800,EndofPhase2,18,Phase 2,504,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV432PZQ,1967,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV432PZQ,1967,,,M,800,Visit2,2,Phase 1/1A,71,1 or 1A,38,2,,,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV432PZQ,1967,,,M,1200,Visit4,4,Phase 1/1A,155,1 or 1A,31,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,600,Visit1,1,Phase 1/1A,22,1 or 1A,100,4,,1,,,,,,1,4,160,,,2,,4,160,160,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,70,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,82,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,1800,Visit7,7,Phase 1/1A,193,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,89,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,90,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,95,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,96,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,93,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,77,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV623ZFA,2250,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,492,1 or 1A,88,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,89,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,1600,Visit6,6,Phase 1/1A,179,1 or 1A,93,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,98,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,2800,Visit12,12,Phase 1/1A,332,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,3200,Visit14,14,Phase 1/1A,395,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,3400,Visit15,15,Phase 1/1A,437,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,3600,Visit16,16,Phase 1/1A,451,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,3800,Visit17,17,Phase 1/1A,486,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVV805DAH,1067,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,514,1 or 1A,79,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,,,,,,,1,3,4.5,,,1,,3,5,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,94,3,,0,1,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,93,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,94,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW240HY0,1209,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,504,1 or 1A,91,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW428CKB,2856,,,M,600,Visit1,1,Phase 1/1A,23,1 or 1A,,2,,1,,,,,,,2,400,,,2,,2,467,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW428CKB,2856,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,,2,,1,,,,,,,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW428CKB,2856,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,103,1 or 1A,,3,,,,,,,,4,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,1,3,130,160,3,4,5,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,95,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,87,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,1400,Visit5,5,Phase 2,149,2,94,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,1600,Visit6,6,Phase 2,178,2,80,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,1800,Visit7,7,Phase 2,206,2,96,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,2000,Visit8,8,Phase 2,234,2,99,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,2200,Visit9,9,Phase 2,275,2,91,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,2400,Visit10,10,Phase 2,311,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,2600,Visit11,11,Phase 2,332,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,2800,Visit12,12,Phase 2,346,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,3000,Visit13,13,Phase 2,367,2,76,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,3200,Visit14,14,Phase 2,393,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,3400,Visit15,15,Phase 2,421,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,3600,Visit16,16,Phase 2,449,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,3800,Visit17,17,Phase 2,477,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,119,1 or 1A,96,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW567UKB,1917,,,M,5800,EndofPhase2,18,Phase 2,501,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,600,Visit1,1,Phase 1/1A,32,1 or 1A,,,,,,,,,,2,,,,,2,2,4,6,6,4,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,800,Visit2,2,Phase 1/1A,60,1 or 1A,90,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,1000,Visit3,3,Phase 1/1A,88,1 or 1A,92,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,1200,Visit4,4,Phase 1/1A,116,1 or 1A,92,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,1600,Visit6,6,Phase 2,173,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,1800,Visit7,7,Phase 2,201,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,2000,Visit8,8,Phase 2,232,2,99,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,2200,Visit9,9,Phase 2,260,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,2400,Visit10,10,Phase 2,292,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,2600,Visit11,11,Phase 2,321,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,2800,Visit12,12,Phase 2,334,2,96,4,,1,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,3000,Visit13,13,Phase 2,372,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,3200,Visit14,14,Phase 2,406,2,91,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,3400,Visit15,15,Phase 2,431,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,3600,Visit16,16,Phase 2,462,2,88,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,3800,Visit17,17,Phase 2,490,2,80,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,4000,Visit18,18,Phase 2,518,2,91,4,,1,,,,,,2,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW581CZH,2485,,,F,5200,EndofPhase1_1a,5,Phase 1/1A,148,1 or 1A,78,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW592FA3,2690,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,4,,1,,,,,,1,4,32,,,1,,4,32,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW592FA3,2690,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,64,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW592FA3,2690,,,M,5400,EndofPhase1b,18,Phase 1B,77,1B,64,2,,0,1,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW632GC2,2700,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,89,2,,1,,,,,,1,2,400,,,1,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW632GC2,2700,,,F,800,Visit2,2,Phase 1/1A,50,1 or 1A,72,2,,0,1,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW632GC2,2700,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,71,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW632GC2,2700,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,75,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW632GC2,2700,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,77,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW632GC2,2700,,,F,1600,Visit6,6,Phase 1/1A,183,1 or 1A,68,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW632GC2,2700,,,F,1800,Visit7,7,Phase 1/1A,204,1 or 1A,50,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW632GC2,2700,,,F,2000,Visit8,8,Phase 1/1A,223,1 or 1A,71,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW632GC2,2700,,,F,2200,Visit9,9,Phase 1/1A,273,1 or 1A,51,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW632GC2,2700,,,F,2600,Visit11,11,Phase 1/1A,313,1 or 1A,50,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW632GC2,2700,,,F,2800,Visit12,12,Phase 1/1A,348,1 or 1A,57,2,,1,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW632GC2,2700,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,97,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW632GC2,2700,,,F,3200,Visit14,14,Phase 1/1A,386,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,1,12,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,2200,Visit9,9,Phase 1/1A,242,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,3200,Visit14,14,Phase 1/1A,386,1 or 1A,61,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,3400,Visit15,15,Phase 1/1A,428,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,3600,Visit16,16,Phase 1/1A,442,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,2,,0,2,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW653NEP,1030,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,600,Visit1,1,Phase 1/1A,24,1 or 1A,95,2,,1,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,1000,Visit3,3,Phase 1/1A,80,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,1200,Visit4,4,Phase 1/1A,109,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,1400,Visit5,5,Phase 1/1A,137,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,97,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,93,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,3200,Visit14,14,Phase 1/1A,399,1 or 1A,98,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,3600,Visit16,16,Phase 1/1A,443,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,3800,Visit17,17,Phase 1/1A,473,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVW686WX6,2844,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,97,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX155EC5,1678,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,,2,,1,,,,,,1,2,15,,,1,,3,25,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,1000,Visit3,3,Phase 1/1A,93,1 or 1A,66,3,,0,1,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,1400,Visit5,5,Phase 1/1A,142,1 or 1A,82,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,1600,Visit6,6,Phase 1/1A,174,1 or 1A,97,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,1800,Visit7,7,Phase 1/1A,205,1 or 1A,95,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,2000,Visit8,8,Phase 1/1A,234,1 or 1A,83,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,2200,Visit9,9,Phase 1/1A,268,1 or 1A,85,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,2400,Visit10,10,Phase 1/1A,295,1 or 1A,89,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,2600,Visit11,11,Phase 1/1A,323,1 or 1A,89,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,2800,Visit12,12,Phase 1/1A,349,1 or 1A,95,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,3000,Visit13,13,Phase 1/1A,380,1 or 1A,82,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,3200,Visit14,14,Phase 1/1A,408,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,3400,Visit15,15,Phase 1/1A,435,1 or 1A,91,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,3600,Visit16,16,Phase 1/1A,464,1 or 1A,87,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,3800,Visit17,17,Phase 1/1A,486,1 or 1A,95,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX245FM3,2440,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,535,1 or 1A,95,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX356ZJX,2267,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,,2,4,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX356ZJX,2267,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX356ZJX,2267,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX356ZJX,2267,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,80,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX356ZJX,2267,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,74,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX356ZJX,2267,,,M,1600,Visit6,6,Phase 1/1A,171,1 or 1A,86,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX658RT4,2526,,,F,1000,Visit3,3,Phase 3,86,3,,,,,,4,80,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX658RT4,2526,,,F,1200,Visit4,4,Phase 3,118,3,,,,,,2,200,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX658RT4,2526,,,F,1400,Visit5,5,Phase 3,136,3,,,,,,2,100,4,80,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX658RT4,2526,,,F,1600,Visit6,6,Phase 3,176,3,,,,,,2,100,4,80,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX658RT4,2526,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,15,1 or 1A,100,2,,1,,,,,,2,2,15,,,1,2,2,15,15,2,2,80,80,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX658RT4,2526,,,F,5800,EndofPhase2,2,Phase 2,44,2,82,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX658RT4,2526,,,F,6000,EndofPhase3,7,Phase 3,198,3,,,,,,2,100,4,80,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,0,2,,,,,,,,,2,80,,,2,,2,86,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,1,2,,,,,,,,4,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,1000,Visit3,3,Phase 1/1A,106,1 or 1A,1,2,,1,,,,,,4,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,1200,Visit4,4,Phase 1/1A,134,1 or 1A,50,2,,1,,,,,,3,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,1400,Visit5,5,Phase 1/1A,163,1 or 1A,76,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,1600,Visit6,6,Phase 1/1A,197,1 or 1A,,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,1800,Visit7,7,Phase 1/1A,232,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,2000,Visit8,8,Phase 1/1A,253,1 or 1A,,2,,,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,2200,Visit9,9,Phase 1/1A,275,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,2600,Visit11,11,Phase 1/1A,317,1 or 1A,,,,,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,2800,Visit12,12,Phase 1/1A,349,1 or 1A,100,1,,,,,,,,2,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,3000,Visit13,13,Phase 1/1A,372,1 or 1A,,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,3400,Visit15,15,Phase 1/1A,475,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,3600,Visit16,16,Phase 1/1A,502,1 or 1A,90,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,3800,Visit17,17,Phase 1/1A,530,1 or 1A,82,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX715XJ0,1824,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,562,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,90,2,,,,,,,,1,2,400,,,2,2,3,600,600,3,4,28,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,1000,Visit3,3,Phase 2,85,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,1200,Visit4,4,Phase 2,113,2,100,0,,,,,,,,1,0,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,1400,Visit5,5,Phase 2,144,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,1600,Visit6,6,Phase 2,177,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,1800,Visit7,7,Phase 2,206,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,2000,Visit8,8,Phase 2,227,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,2200,Visit9,9,Phase 2,255,2,96,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,2400,Visit10,10,Phase 2,277,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,2600,Visit11,11,Phase 2,302,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,2800,Visit12,12,Phase 2,325,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,3000,Visit13,13,Phase 2,354,2,99,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,3200,Visit14,14,Phase 2,382,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,3400,Visit15,15,Phase 2,410,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,3600,Visit16,16,Phase 2,445,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,3800,Visit17,17,Phase 2,473,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,4000,Visit18,18,Phase 2,511,2,92,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,60,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVX955KYT,1334,,,M,5800,EndofPhase2,18,Phase 2,511,2,92,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY174NF5,1554,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY594WPX,2080,,,M,600,Visit1,1,Phase 1/1A,21,1 or 1A,80,1,,,,,,,,1,1,1.5,,,1,3,2,3,3,2,,250,250,,147,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY594WPX,2080,,,M,800,Visit2,2,Phase 1/1A,49,1 or 1A,83,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY594WPX,2080,,,M,1000,Visit3,3,Phase 1/1A,77,1 or 1A,96,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY594WPX,2080,,,M,1400,Visit5,5,Phase 2,132,2,90,,250,,,,,,,1,,,250,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY594WPX,2080,,,M,1600,Visit6,6,Phase 3,160,3,,,,,,4,120,,,4,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY594WPX,2080,,,M,1800,Visit7,7,Phase 3,188,3,,,,,,4,160,,,,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY594WPX,2080,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,105,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY594WPX,2080,,,M,6000,EndofPhase3,8,Phase 3,218,3,,,,,,4,160,,,4,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,2,3,23,15,3,3,120,120,3,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,2000,Visit8,8,Phase 1/1A,232,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,2200,Visit9,9,Phase 1/1A,261,1 or 1A,87,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,2400,Visit10,10,Phase 1/1A,287,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,2600,Visit11,11,Phase 1/1A,315,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,3200,Visit14,14,Phase 3,391,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,3600,Visit16,16,Phase 3,450,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,343,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,5800,EndofPhase2,13,Phase 2,363,2,,3,,,,,,,,,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVY623WFW,2669,,,M,6000,EndofPhase3,17,Phase 3,467,3,,,,,,3,1,,,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVZ416YDT,2370,,,M,600,Visit1,1,Phase 1/1A,21,1 or 1A,100,2,,1,,,,,,1,2,400,,,1,1,2,400,400,2,2,15,15,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVZ416YDT,2370,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVZ416YDT,2370,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,99,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVZ416YDT,2370,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVZ416YDT,2370,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVZ416YDT,2370,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVZ416YDT,2370,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVZ416YDT,2370,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,88,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVZ416YDT,2370,,,M,2400,Visit10,10,Phase 2,279,2,98,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVZ416YDT,2370,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,253,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVZ418LZN,1129,,,M,800,Visit2,2,Phase 1B,57,1B,83,4,,,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVZ418LZN,1129,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVVZ562UC6,1475,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,3,21,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,71,4,,,,,,,,2,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,82,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,86,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,99,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,89,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,96,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,3400,Visit15,15,Phase 1/1A,431,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,61,2,,0,1,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA295TC2,1120,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA551WF8,2077,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA662ZFP,2734,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,25,2,,0,1,,,,,4,2,3,,,1,,3,4,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA662ZFP,2734,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,26,2,,0,1,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA662ZFP,2734,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,,3,,,,,,,,,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA662ZFP,2734,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA662ZFP,2734,,,M,1400,Visit5,5,Phase 1/1A,153,1 or 1A,28,2,,0,1,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA662ZFP,2734,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,,2,,,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA662ZFP,2734,,,M,1800,Visit7,7,Phase 1/1A,211,1 or 1A,79,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA662ZFP,2734,,,M,2000,Visit8,8,Phase 1/1A,237,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA662ZFP,2734,,,M,2200,Visit9,9,Phase 1/1A,265,1 or 1A,,4,,,,,,,,,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA662ZFP,2734,,,M,2400,Visit10,10,Phase 1/1A,292,1 or 1A,90,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWA662ZFP,2734,,,M,2600,Visit11,11,Phase 1/1A,320,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB158FFZ,1813,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,3,,1,,,,,,1,3,24,,,1,1,4,28,24,4,4,5,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,,3,,,,,,,,,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,98,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,1200,Visit4,4,Phase 1/1A,110,1 or 1A,96,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,1400,Visit5,5,Phase 1/1A,131,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,1600,Visit6,6,Phase 1/1A,152,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,1800,Visit7,7,Phase 1/1A,180,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,2000,Visit8,8,Phase 1/1A,208,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,2200,Visit9,9,Phase 1/1A,236,1 or 1A,96,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,2600,Visit11,11,Phase 1B,264,1B,86,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,2800,Visit12,12,Phase 1B,299,1B,96,3,,0,2,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,3000,Visit13,13,Phase 1B,320,1B,85,4,,0,2,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,3200,Visit14,14,Phase 1B,355,1B,95,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,3400,Visit15,15,Phase 1B,387,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,3800,Visit17,17,Phase 2,432,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,4000,Visit18,18,Phase 2,460,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,4200,Visit19,19,Phase 2,488,2,96,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,4400,Visit20,20,Phase 2,516,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,4600,Visit21,21,Phase 2,544,2,98,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,4800,Visit22,22,Phase 2,572,2,,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,5200,EndofPhase1_1a,10,Phase 1/1A,243,1 or 1A,100,4,,0,1,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,5400,EndofPhase1b,16,Phase 1B,404,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB262MKH,2445,,,F,5800,EndofPhase2,23,Phase 2,601,2,73,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,600,Visit1,1,Phase 1/1A,24,1 or 1A,100,2,,,,,,,,1,2,400,,,2,1,2,400,400,2,2,3,3,2,76,80,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,42,2,,,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,1200,Visit4,4,Phase 2,112,2,94,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,1400,Visit5,5,Phase 2,140,2,91,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,1600,Visit6,6,Phase 2,169,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,1800,Visit7,7,Phase 2,200,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,2000,Visit8,8,Phase 2,226,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,2400,Visit10,10,Phase 3,283,3,,,,,,4,80,,,2,,,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,2600,Visit11,11,Phase 3,310,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,2800,Visit12,12,Phase 3,337,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,3000,Visit13,13,Phase 3,364,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,3200,Visit14,14,Phase 3,392,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,3400,Visit15,15,Phase 3,428,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,3600,Visit16,16,Phase 3,457,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,3800,Visit17,17,Phase 3,485,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,4000,Visit18,18,Phase 3,512,3,,,,,,4,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,78,1 or 1A,73,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB586DLN,1203,,,M,5800,EndofPhase2,9,Phase 2,261,2,100,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,73,1,,1,,,,,,2,1,1.5,,,1,,3,5,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,93,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,81,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,89,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,90,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,69,3,,,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,59,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,2000,Visit8,8,Phase 1/1A,222,1 or 1A,87,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,2200,Visit9,9,Phase 1/1A,250,1 or 1A,94,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,2400,Visit10,10,Phase 1/1A,278,1 or 1A,98,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,2600,Visit11,11,Phase 1/1A,306,1 or 1A,89,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,94,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,3000,Visit13,13,Phase 1/1A,362,1 or 1A,74,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,3200,Visit14,14,Phase 1/1A,390,1 or 1A,64,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,3400,Visit15,15,Phase 1/1A,425,1 or 1A,87,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,84,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,85,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB748NJW,1291,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,498,1 or 1A,90,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,84,2,,1,,,,,,1,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,78,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,86,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,84,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,79,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,86,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,68,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,88,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,79,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,66,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,2600,Visit11,11,Phase 1/1A,314,1 or 1A,74,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,72,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,80,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,3200,Visit14,14,Phase 1/1A,405,1 or 1A,73,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,3400,Visit15,15,Phase 1/1A,428,1 or 1A,74,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,64,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,3800,Visit17,17,Phase 1/1A,479,1 or 1A,67,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWB974EBQ,2795,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,503,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,800,Visit2,2,Phase 2,57,2,69,2,,,,,,,,2,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,1200,Visit4,4,Phase 3,117,3,,,,,,1,5,,,3,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,1400,Visit5,5,Phase 3,141,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,1600,Visit6,6,Phase 3,169,3,,,,,,1,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,1800,Visit7,7,Phase 3,197,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,1,10,,,2,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,2200,Visit9,9,Phase 3,253,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,2400,Visit10,10,Phase 3,280,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,2800,Visit12,12,Phase 3,337,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,1,25,,,1,,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,1,25,,,1,,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,3400,Visit15,15,Phase 3,419,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,3600,Visit16,16,Phase 3,446,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,3800,Visit17,17,Phase 3,476,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,27,1 or 1A,0,2,,,,,,,,4,2,3,,,2,2,2,3,3,2,2,400,400,2,18,5,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,5800,EndofPhase2,3,Phase 2,85,2,0,2,,,,,,,,4,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWC888DBE,1149,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWD860CRF,2199,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,,2,90,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWD860CRF,2199,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,98,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWD860CRF,2199,,,M,1000,Visit3,3,Phase 1/1A,105,1 or 1A,74,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWD860CRF,2199,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,165,1 or 1A,77,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,0,1,,,,,1,2,3,,,1,1,4,6,6,4,3,120,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,98,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,98,4,,0,2,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,98,4,,0,2,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,2200,Visit9,9,Phase 1/1A,261,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,97,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,2600,Visit11,11,Phase 1/1A,319,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,2800,Visit12,12,Phase 1/1A,347,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,3000,Visit13,13,Phase 1/1A,382,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,3400,Visit15,15,Phase 2,436,2,93,2,,0,1,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,3600,Visit16,16,Phase 2,473,2,93,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,3800,Visit17,17,Phase 2,499,2,58,3,,0,1,,,,,2,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,5200,EndofPhase1_1a,14,Phase 1/1A,408,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE201KX2,2743,,,M,5800,EndofPhase2,18,Phase 2,527,2,48,4,,0,1,,,,,3,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,20,2,,1,,,,,,4,2,3,,,1,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,70,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,68,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,24,3,,1,,,,,,4,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,71,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,76,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,1800,Visit7,7,Phase 1/1A,206,1 or 1A,85,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,2000,Visit8,8,Phase 1/1A,234,1 or 1A,75,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,2200,Visit9,9,Phase 1/1A,262,1 or 1A,68,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,2400,Visit10,10,Phase 1/1A,290,1 or 1A,63,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,2600,Visit11,11,Phase 1/1A,318,1 or 1A,62,3,,0,1,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,2800,Visit12,12,Phase 1/1A,346,1 or 1A,79,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,3000,Visit13,13,Phase 1/1A,381,1 or 1A,72,3,,0,1,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,3200,Visit14,14,Phase 1/1A,409,1 or 1A,40,3,,1,,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,3400,Visit15,15,Phase 1/1A,442,1 or 1A,48,3,,0,1,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,3600,Visit16,16,Phase 1/1A,470,1 or 1A,63,3,,0,1,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,3800,Visit17,17,Phase 1/1A,495,1 or 1A,75,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE336ZRH,2644,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,526,1 or 1A,33,3,,1,,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE337XNR,2656,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,37,2,,1,,,,,,3,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE337XNR,2656,,,M,800,Visit2,2,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE337XNR,2656,,,M,1000,Visit3,3,Phase 1/1A,98,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE337XNR,2656,,,M,1200,Visit4,4,Phase 1/1A,126,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE337XNR,2656,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE337XNR,2656,,,M,1600,Visit6,6,Phase 1/1A,189,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE337XNR,2656,,,M,1800,Visit7,7,Phase 1/1A,213,1 or 1A,28,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE337XNR,2656,,,M,2000,Visit8,8,Phase 1/1A,252,1 or 1A,95,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE337XNR,2656,,,M,2200,Visit9,9,Phase 1/1A,280,1 or 1A,50,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE337XNR,2656,,,M,2400,Visit10,10,Phase 1/1A,315,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE337XNR,2656,,,M,2600,Visit11,11,Phase 1/1A,343,1 or 1A,95,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE337XNR,2656,,,M,2800,Visit12,12,Phase 1/1A,371,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE337XNR,2656,,,M,3000,Visit13,13,Phase 1/1A,400,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,25,2,,,,,,,,3,2,400,,,2,1,3,600,600,3,4,30,30,4,47,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,1600,Visit6,6,Phase 3,169,3,,,,,,7,25,,,1,,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,1800,Visit7,7,Phase 3,198,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,2200,Visit9,9,Phase 3,245,3,,,,,,7,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,2400,Visit10,10,Phase 3,274,3,,,,,,7,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,2800,Visit12,12,Phase 3,336,3,,,,,,7,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,3000,Visit13,13,Phase 3,364,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,3200,Visit14,14,Phase 3,399,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,3400,Visit15,15,Phase 3,427,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,3600,Visit16,16,Phase 3,455,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,3800,Visit17,17,Phase 3,483,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,112,1 or 1A,10,4,,,,,,,,4,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,5800,EndofPhase2,5,Phase 2,127,2,50,4,,,,,,,,2,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE449JD2,1552,,,M,6000,EndofPhase3,18,Phase 3,510,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWE493FHM,2274,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,33,1 or 1A,8,1,,0,1,,,,,4,1,8,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF045RC4,2073,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,92,4,,,,,,,,1,4,32,,,2,,4,32,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF045RC4,2073,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,86,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF045RC4,2073,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF045RC4,2073,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,93,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF045RC4,2073,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,92,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF045RC4,2073,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,178,1 or 1A,91,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF045RC4,2073,,,M,5400,EndofPhase1b,7,Phase 1B,191,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,76,2,,1,,,,,,1,2,80,,,2,2,3,120,120,3,4,800,800,4,32,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,800,Visit2,2,Phase 1/1A,74,1 or 1A,88,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,1200,Visit4,4,Phase 2,109,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,1400,Visit5,5,Phase 2,127,2,94,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,1600,Visit6,6,Phase 3,164,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,1800,Visit7,7,Phase 3,193,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,2000,Visit8,8,Phase 3,225,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,2200,Visit9,9,Phase 3,255,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,2400,Visit10,10,Phase 3,288,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,2600,Visit11,11,Phase 3,317,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,2800,Visit12,12,Phase 3,351,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,3000,Visit13,13,Phase 3,394,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,3200,Visit14,14,Phase 3,417,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,3400,Visit15,15,Phase 3,443,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,3600,Visit16,16,Phase 3,471,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,3800,Visit17,17,Phase 3,502,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,88,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,5800,EndofPhase2,5,Phase 2,142,2,92,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF505PV5,2528,,,F,6000,EndofPhase3,18,Phase 3,530,3,,,,,,8,30,8,30,2,,,,60,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF823YW7,1583,,,M,800,Visit2,2,Phase 2,57,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF823YW7,1583,,,M,1000,Visit3,3,Phase 2,85,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF823YW7,1583,,,M,1200,Visit4,4,Phase 2,112,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF823YW7,1583,,,M,1400,Visit5,5,Phase 2,140,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF823YW7,1583,,,M,1600,Visit6,6,Phase 2,168,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF823YW7,1583,,,M,1800,Visit7,7,Phase 2,203,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF823YW7,1583,,,M,2000,Visit8,8,Phase 2,231,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF823YW7,1583,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,30,1 or 1A,94,3,,,,,,,,1,3,4.5,,,2,2,3,5,5,3,3,21,23,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF823YW7,1583,,,M,5800,EndofPhase2,10,Phase 2,292,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,97,1,,1,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,56,1,,1,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,54,1,,1,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,1200,Visit4,4,Phase 1/1A,107,1 or 1A,63,1,,1,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,1400,Visit5,5,Phase 1/1A,134,1 or 1A,54,1,,1,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,67,1,,1,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,43,1,,1,,,,,,3,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,2000,Visit8,8,Phase 1/1A,229,1 or 1A,71,1,,1,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,79,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,52,1,,1,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,64,1,,1,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,2800,Visit12,12,Phase 1/1A,331,1 or 1A,67,1,,1,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,3000,Visit13,13,Phase 1/1A,369,1 or 1A,50,1,,1,,,,,,3,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,3200,Visit14,14,Phase 1/1A,399,1 or 1A,43,1,,1,,,,,,3,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,79,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,76,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWF871JW9,2705,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,499,1 or 1A,67,1,,1,,,,,,2,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,,,,,,,1,3,22.5,,,2,,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,96,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,1600,Visit6,6,Phase 1/1A,161,1 or 1A,95,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,1800,Visit7,7,Phase 1/1A,191,1 or 1A,92,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,2400,Visit10,10,Phase 1/1A,279,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,2600,Visit11,11,Phase 1/1A,307,1 or 1A,96,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,96,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,96,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,3600,Visit16,16,Phase 1/1A,441,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,3800,Visit17,17,Phase 1/1A,469,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG522NPA,1477,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,497,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG774AVD,2100,,,M,600,Visit1,1,Phase 1/1A,36,,,,,,,,,,,,,,,,2,2,3,23,23,3,3,100,100,3,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG774AVD,2100,,,M,800,Visit2,2,Phase 2,65,2,66,3,,,,,,,,2,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG774AVD,2100,,,M,1000,Visit3,3,Phase 2,79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG774AVD,2100,,,M,1200,Visit4,4,Phase 3,114,3,,,,,,3,2,,,1,,,,2,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG774AVD,2100,,,M,1400,Visit5,5,Phase 3,142,3,,,,,,3,2,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG774AVD,2100,,,M,1600,Visit6,6,Phase 3,170,3,,,,,,3,2,,,2,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG774AVD,2100,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,36,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG774AVD,2100,,,M,5800,EndofPhase2,3,Phase 2,79,2,34,2,,1,,,,,,3,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG774AVD,2100,,,M,6000,EndofPhase3,8,Phase 3,219,3,,,,,,3,2,,,3,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,800,Visit2,2,Phase 2,63,2,80,4,,,,,,,,2,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,1200,Visit4,4,Phase 3,113,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,1400,Visit5,5,Phase 3,135,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,1600,Visit6,6,Phase 3,167,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,1800,Visit7,7,Phase 3,196,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,2000,Visit8,8,Phase 3,225,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,2200,Visit9,9,Phase 3,252,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,2400,Visit10,10,Phase 3,280,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,2600,Visit11,11,Phase 3,308,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,2800,Visit12,12,Phase 3,337,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,3000,Visit13,13,Phase 3,364,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,3200,Visit14,14,Phase 3,392,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,3400,Visit15,15,Phase 3,422,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,3600,Visit16,16,Phase 3,443,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,3800,Visit17,17,Phase 3,471,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,42,1 or 1A,84,2,,,,,,,,1,2,15,,,2,2,2,15,15,2,4,160,160,4,4,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,5800,EndofPhase2,3,Phase 2,83,2,61,4,,,,,,,,2,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWG956VA4,1663,,,F,6000,EndofPhase3,18,Phase 3,499,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH509PJR,1856,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,6,1 or 1A,55,2,,,,,,,,1,2,3,,,2,1,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH509PJR,1856,,,F,5800,EndofPhase2,2,Phase 2,28,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,1000,Visit3,3,Phase 2,92,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,1200,Visit4,4,Phase 2,113,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,1400,Visit5,5,Phase 2,140,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,1600,Visit6,6,Phase 2,168,2,45,3,,1,,,,,,3,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,1800,Visit7,7,Phase 2,194,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,2000,Visit8,8,Phase 2,223,2,96,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,2400,Visit10,10,Phase 3,271,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,2600,Visit11,11,Phase 3,307,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,2800,Visit12,12,Phase 3,334,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,3000,Visit13,13,Phase 3,363,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,3200,Visit14,14,Phase 3,397,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,3600,Visit16,16,Phase 3,446,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,3800,Visit17,17,Phase 3,475,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,63,1 or 1A,25,2,,1,,,,,,4,2,3,,,2,2,2,3,3,2,3,109,120,3,15,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,5800,EndofPhase2,9,Phase 2,245,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH904FGL,2722,,,M,6000,EndofPhase3,18,Phase 3,512,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH949JKC,1350,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,97,2,,,,,,,,1,2,400,,,2,2,2,400,400,2,2,15,15,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH949JKC,1350,,,M,800,Visit2,2,Phase 2,63,2,91,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWH949JKC,1350,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,35,1 or 1A,97,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ007FDD,1422,,,F,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,2,,,,,,,,1,2,3,,,1,1,3,4,4,3,3,23,23,3,254,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ007FDD,1422,,,F,1000,Visit3,3,Phase 2,96,2,79,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ007FDD,1422,,,F,1200,Visit4,4,Phase 2,119,2,95,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ007FDD,1422,,,F,1800,Visit7,7,Phase 3,212,3,,,,,,6,100,,,4,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ007FDD,1422,,,F,2000,Visit8,8,Phase 3,225,3,,,,,,6,125,,,1,,,,125,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ007FDD,1422,,,F,2200,Visit9,9,Phase 3,267,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ007FDD,1422,,,F,2400,Visit10,10,Phase 3,288,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ007FDD,1422,,,F,2600,Visit11,11,Phase 3,316,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ007FDD,1422,,,F,2800,Visit12,12,Phase 3,357,3,,,,,,6,300,,,4,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ007FDD,1422,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ007FDD,1422,,,F,5800,EndofPhase2,5,Phase 2,148,2,72,4,,,,,,,,2,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,600,Visit1,1,Phase 1/1A,44,1 or 1A,100,1,,1,,,,,,1,1,40,,,2,,4,155,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,100,5,,1,,,,,,1,5,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,88,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,1600,Visit6,6,Phase 1/1A,184,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,2200,Visit9,9,Phase 1/1A,261,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,2400,Visit10,10,Phase 1/1A,289,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,2600,Visit11,11,Phase 1/1A,317,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,3000,Visit13,13,Phase 1/1A,359,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,3200,Visit14,14,Phase 1/1A,387,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,3400,Visit15,15,Phase 1/1A,415,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,3600,Visit16,16,Phase 1/1A,445,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,3800,Visit17,17,Phase 1/1A,471,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ096ZPM,2660,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,503,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ587VB6,1489,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,73,1 or 1A,100,4,,,,,,,,1,4,30,,,2,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ809GRR,1144,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,4,,,,,,,,1,4,32,,,2,,4,32,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ809GRR,1144,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,57,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ939AKX,2207,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,50,2,,1,,,,,,3,2,3,,,2,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ939AKX,2207,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,70,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWJ939AKX,2207,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,95,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,2,2,3,4,4,3,3,21,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,1000,Visit3,3,Phase 2,64,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,1200,Visit4,4,Phase 2,98,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,1400,Visit5,5,Phase 2,134,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,1600,Visit6,6,Phase 2,169,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,1800,Visit7,7,Phase 2,197,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,2000,Visit8,8,Phase 2,225,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,2200,Visit9,9,Phase 2,253,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,2400,Visit10,10,Phase 2,281,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,2600,Visit11,11,Phase 2,307,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,2800,Visit12,12,Phase 2,336,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,3000,Visit13,13,Phase 2,370,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,3200,Visit14,14,Phase 2,391,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,3400,Visit15,15,Phase 2,419,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,3600,Visit16,16,Phase 2,448,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,3800,Visit17,17,Phase 2,476,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,44,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK468BDC,1074,,,M,5800,EndofPhase2,18,Phase 2,504,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWK758BB0,2068,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,0,2,,,,,,,,4,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWL604YP7,2898,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,4,,1,,,,,,1,4,800,,,2,,4,800,800,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWL604YP7,2898,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWL604YP7,2898,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,23,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWL604YP7,2898,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,86,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWL604YP7,2898,,,F,1400,Visit5,5,Phase 1/1A,136,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWL604YP7,2898,,,F,1600,Visit6,6,Phase 1/1A,164,1 or 1A,57,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWL604YP7,2898,,,F,1800,Visit7,7,Phase 1/1A,199,1 or 1A,48,4,,1,,,,,,3,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWL604YP7,2898,,,F,2000,Visit8,8,Phase 1/1A,227,1 or 1A,70,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWL604YP7,2898,,,F,2200,Visit9,9,Phase 1/1A,258,1 or 1A,72,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWL604YP7,2898,,,F,2400,Visit10,10,Phase 1/1A,294,1 or 1A,52,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,98,3,,,,,,,,1,3,120,,,2,,3,101,120,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,2000,Visit8,8,Phase 1/1A,229,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,2200,Visit9,9,Phase 1/1A,259,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,2400,Visit10,10,Phase 1/1A,286,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,93,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,3200,Visit14,14,Phase 1/1A,397,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,96,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,3800,Visit17,17,Phase 1/1A,483,1 or 1A,99,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM052HDK,1892,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,504,1 or 1A,87,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM802BEV,1050,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,95,2,,,,,,,,1,2,15,,,2,,3,23,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM802BEV,1050,,,M,800,Visit2,2,Phase 1/1A,94,1 or 1A,6,4,,,,,,,,4,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM802BEV,1050,,,M,1000,Visit3,3,Phase 1/1A,121,1 or 1A,97,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM802BEV,1050,,,M,1200,Visit4,4,Phase 1/1A,149,1 or 1A,98,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM802BEV,1050,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,204,1 or 1A,75,3,,,,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM868JXL,2882,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,98,2,,1,,,,,,1,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM868JXL,2882,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,54,1 or 1A,,2,,1,,,,,,,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWM868JXL,2882,,,M,5400,EndofPhase1b,2,Phase 1B,96,1B,88,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,4,,1,,,,,,1,4,32,,,2,,4,32,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,96,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,1400,Visit5,5,Phase 1B,125,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,1600,Visit6,6,Phase 1B,160,1B,91,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,1800,Visit7,7,Phase 1B,194,1B,75,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,2000,Visit8,8,Phase 1B,223,1B,95,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,2200,Visit9,9,Phase 1B,251,1B,95,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,2400,Visit10,10,Phase 1B,279,1B,93,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,2600,Visit11,11,Phase 1B,307,1B,96,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,2800,Visit12,12,Phase 1B,335,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,3000,Visit13,13,Phase 1B,363,1B,77,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,3200,Visit14,14,Phase 1B,391,1B,,4,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,3400,Visit15,15,Phase 1B,419,1B,60,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,3600,Visit16,16,Phase 1B,447,1B,86,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,3800,Visit17,17,Phase 1B,475,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,99,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWN355NBL,2369,,,M,5400,EndofPhase1b,18,Phase 1B,496,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,600,Visit1,1,Phase 1/1A,36,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,2,18,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,1000,Visit3,3,Phase 1/1A,92,1 or 1A,73,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,1200,Visit4,4,Phase 1/1A,120,1 or 1A,95,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,1400,Visit5,5,Phase 1/1A,148,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,90,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,2600,Visit11,11,Phase 1/1A,316,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,2800,Visit12,12,Phase 1/1A,351,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,3000,Visit13,13,Phase 1/1A,386,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,3600,Visit16,16,Phase 1/1A,463,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,3800,Visit17,17,Phase 1/1A,484,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP163WP6,1547,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,520,1 or 1A,87,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,600,Visit1,1,Phase 1/1A,38,1 or 1A,96,1,,1,,,,,,1,1,40,,,2,2,2,93,120,2,2,400,400,2,10,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,78,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,1200,Visit4,4,Phase 2,144,2,91,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,1400,Visit5,5,Phase 2,172,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,1800,Visit7,7,Phase 3,228,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,2000,Visit8,8,Phase 3,256,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,2400,Visit10,10,Phase 3,283,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,2600,Visit11,11,Phase 3,311,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,2800,Visit12,12,Phase 3,340,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,3000,Visit13,13,Phase 3,369,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,3200,Visit14,14,Phase 3,397,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,3400,Visit15,15,Phase 3,425,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,3600,Visit16,16,Phase 3,451,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,3800,Visit17,17,Phase 3,481,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,95,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,5800,EndofPhase2,6,Phase 2,200,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWP198XXF,2772,,,F,6000,EndofPhase3,18,Phase 3,530,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,3,,,1,2,2,3,3,2,2,18,15,2,400,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,95,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,1000,Visit3,3,Phase 1/1A,84,1 or 1A,93,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,1600,Visit6,6,Phase 1/1A,167,1 or 1A,96,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,1800,Visit7,7,Phase 1/1A,192,1 or 1A,96,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,2400,Visit10,10,Phase 2,259,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,2600,Visit11,11,Phase 2,294,2,85,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,3000,Visit13,13,Phase 3,364,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,3200,Visit14,14,Phase 3,391,3,,,,,,2,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,5200,EndofPhase1_1a,9,Phase 1/1A,234,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,5800,EndofPhase2,12,Phase 2,329,2,100,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWR380PJN,1530,,,F,6000,EndofPhase3,18,Phase 3,507,3,,,,,,2,400,,,4,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,800,Visit2,2,Phase 1/1A,49,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,1200,Visit4,4,Phase 1/1A,107,1 or 1A,97,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,1400,Visit5,5,Phase 1/1A,134,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,1800,Visit7,7,Phase 1B,189,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,2000,Visit8,8,Phase 1B,224,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,2200,Visit9,9,Phase 1B,261,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,2400,Visit10,10,Phase 1B,295,1B,96,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,2600,Visit11,11,Phase 1B,315,1B,100,1,,0,1,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,2800,Visit12,12,Phase 1B,352,1B,94,2,,0,1,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,3000,Visit13,13,Phase 1B,390,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,3200,Visit14,14,Phase 1B,415,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,3400,Visit15,15,Phase 1B,443,1B,94,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,3600,Visit16,16,Phase 1B,478,1B,97,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,3800,Visit17,17,Phase 1B,506,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,162,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT182JWM,2194,,,M,5400,EndofPhase1b,18,Phase 1B,537,1B,96,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,800,Visit2,2,Phase 1B,57,1B,96,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,1000,Visit3,3,Phase 1B,81,1B,96,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,1200,Visit4,4,Phase 1B,113,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,1400,Visit5,5,Phase 1B,142,1B,90,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,1600,Visit6,6,Phase 1B,165,1B,89,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,1800,Visit7,7,Phase 1B,200,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,2000,Visit8,8,Phase 1B,220,1B,63,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,2200,Visit9,9,Phase 1B,249,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,2400,Visit10,10,Phase 1B,280,1B,98,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,2600,Visit11,11,Phase 1B,309,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,2800,Visit12,12,Phase 1B,337,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,3000,Visit13,13,Phase 1B,364,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,3200,Visit14,14,Phase 1B,393,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,3400,Visit15,15,Phase 1B,421,1B,98,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,3600,Visit16,16,Phase 1B,449,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,3800,Visit17,17,Phase 1B,477,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,24,1 or 1A,100,3,,,,,,,,1,3,24,,,2,,3,24,24,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT265WW6,1233,,,M,5400,EndofPhase1b,18,Phase 1B,506,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,,3,124,160,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,98,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,90,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,92,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,1400,Visit5,5,Phase 1/1A,152,1 or 1A,94,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,82,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,1800,Visit7,7,Phase 1/1A,194,1 or 1A,98,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,2000,Visit8,8,Phase 1/1A,226,1 or 1A,95,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,2200,Visit9,9,Phase 1/1A,257,1 or 1A,96,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,2400,Visit10,10,Phase 1/1A,278,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,2600,Visit11,11,Phase 1/1A,308,1 or 1A,93,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,3000,Visit13,13,Phase 1/1A,362,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,3200,Visit14,14,Phase 1/1A,392,1 or 1A,96,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,3600,Visit16,16,Phase 1/1A,450,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,3800,Visit17,17,Phase 1/1A,481,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT712VKA,2659,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT826NYV,2271,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,87,4,,1,,,,,,1,4,30,,,2,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT826NYV,2271,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,31,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT826NYV,2271,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,89,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT826NYV,2271,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,86,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT826NYV,2271,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,70,4,,1,,,,,,2,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT826NYV,2271,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWT826NYV,2271,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,229,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,1000,Visit3,3,Phase 1/1A,90,1 or 1A,89,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,90,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,1400,Visit5,5,Phase 1/1A,144,1 or 1A,93,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,1600,Visit6,6,Phase 1/1A,179,1 or 1A,97,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,1800,Visit7,7,Phase 1/1A,200,1 or 1A,96,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,2400,Visit10,10,Phase 2,287,2,,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,2600,Visit11,11,Phase 2,299,,,,,,,,,,,,,,,,1,2,4,5,6,4,4,800,800,4,149,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,2800,Visit12,12,Phase 3,333,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,3000,Visit13,13,Phase 3,362,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,3200,Visit14,14,Phase 3,390,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,3400,Visit15,15,Phase 3,419,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,3600,Visit16,16,Phase 3,446,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,3800,Visit17,17,Phase 3,474,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,5200,EndofPhase1_1a,8,Phase 1/1A,229,1 or 1A,,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,5800,EndofPhase2,11,Phase 2,299,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWU491FFH,1043,,,F,6000,EndofPhase3,18,Phase 3,512,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV068RYW,1828,,,M,600,Visit1,1,Phase 1/1A,37,1 or 1A,,,,,,,,,,1,,,,,2,,3,667,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV068RYW,1828,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,4,,1,,,,,,2,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV068RYW,1828,,,M,1000,Visit3,3,Phase 1/1A,93,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV068RYW,1828,,,M,1200,Visit4,4,Phase 1/1A,130,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV068RYW,1828,,,M,1400,Visit5,5,Phase 1/1A,161,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV068RYW,1828,,,M,1600,Visit6,6,Phase 1/1A,190,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV068RYW,1828,,,M,1800,Visit7,7,Phase 1/1A,225,1 or 1A,,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,87,3,,,,,,,,1,3,22.5,,,2,,3,23,23,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,93,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,90,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,69,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,93,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,93,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,99,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,87,3,,0,2,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,43,3,,0,2,,,,,3,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,75,3,,0,2,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,3,,0,2,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,3,,0,2,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,3,,0,2,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV686ED9,1548,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,497,1 or 1A,100,3,,0,2,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,800,Visit2,2,Phase 2,54,2,92,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,1000,Visit3,3,Phase 2,85,,,,,,,,,,,,,,,,2,2,3,23,23,3,3,100,100,3,4,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,1200,Visit4,4,Phase 3,110,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,1400,Visit5,5,Phase 3,138,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,1600,Visit6,6,Phase 3,171,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,1800,Visit7,7,Phase 3,199,3,,,,,,3,5,,,2,,,,5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,2000,Visit8,8,Phase 3,227,3,,,,,,3,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,2200,Visit9,9,Phase 3,255,3,,,,,,3,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,2400,Visit10,10,Phase 3,283,3,,,,,,3,5,,,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,2600,Visit11,11,Phase 3,311,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,2800,Visit12,12,Phase 3,340,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,3000,Visit13,13,Phase 3,368,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,3200,Visit14,14,Phase 3,396,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,3400,Visit15,15,Phase 3,430,3,,,,,,3,4,,,2,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,29,1 or 1A,94,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,5800,EndofPhase2,3,Phase 2,85,2,90,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWV744AC3,2867,,,F,6000,EndofPhase3,16,Phase 3,452,3,,,,,,3,1,3,3,2,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWW220XN4,2179,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,9,1 or 1A,100,2,,,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX000YP0,1897,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,36,1 or 1A,36,2,,,,,,,,3,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX303CE3,2137,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX379RGM,1645,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,66,1 or 1A,100,1,,,,,,,,1,1,1.5,,,1,,1,2,2,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,,,,,,,,,,1,,,,,2,2,4,30,30,4,4,800,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,,,,,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,1400,Visit5,5,Phase 1/1A,136,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,1800,Visit7,7,Phase 2,192,2,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,2000,Visit8,8,Phase 2,219,2,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,2200,Visit9,9,Phase 2,247,2,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,2800,Visit12,12,Phase 2,352,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,3000,Visit13,13,Phase 2,385,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,3200,Visit14,14,Phase 2,414,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,3400,Visit15,15,Phase 2,442,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,3600,Visit16,16,Phase 2,470,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,3800,Visit17,17,Phase 2,498,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX388WVU,2043,,,M,5800,EndofPhase2,18,Phase 2,531,2,42,4,,1,,,,,,3,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,95,4,,,,,,,,1,4,800,,,2,1,4,800,800,4,4,6,6,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,1000,Visit3,3,Phase 1/1A,82,1 or 1A,96,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,91,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,1800,Visit7,7,Phase 1/1A,202,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,2200,Visit9,9,Phase 2,253,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,2400,Visit10,10,Phase 2,280,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,2600,Visit11,11,Phase 2,308,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,3000,Visit13,13,Phase 2,366,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,3200,Visit14,14,Phase 2,400,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,3400,Visit15,15,Phase 2,434,2,100,4,,,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,3600,Visit16,16,Phase 2,463,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,3800,Visit17,17,Phase 2,495,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWX599CYL,1566,,,M,4000,Visit18,18,Phase 2,539,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY161EP2,2462,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,0,,,,,,1,4,30,,,2,,4,30,30,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY161EP2,2462,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,44,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY161EP2,2462,,,M,5800,EndofPhase2,3,Phase 2,57,1 or 1A,100,4,,0,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY835VCC,2402,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,10,1 or 1A,45,2,,1,,,,,,3,2,3,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,79,2,,,,,,,,2,2,15,,,1,,3,22,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,94,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,88,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,2200,Visit9,9,Phase 1/1A,259,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,2400,Visit10,10,Phase 1/1A,287,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,2600,Visit11,11,Phase 1/1A,313,1 or 1A,96,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,2800,Visit12,12,Phase 1/1A,343,1 or 1A,98,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,98,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,3200,Visit14,14,Phase 1/1A,390,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,3400,Visit15,15,Phase 1/1A,434,1 or 1A,96,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,3600,Visit16,16,Phase 1/1A,447,1 or 1A,100,3,,0,1,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVWY945VJF,2359,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,539,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,120,,,1,1,3,133,160,3,2,11,11,2,771,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,91,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,1000,Visit3,3,Phase 1/1A,101,1 or 1A,75,4,,1,,,,,,2,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,1200,Visit4,4,Phase 1/1A,130,1 or 1A,70,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,1400,Visit5,5,Phase 1/1A,158,1 or 1A,42,4,,0,1,,,,,3,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,2200,Visit9,9,Phase 2,280,2,53,2,,1,,,,,,2,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,2800,Visit12,12,Phase 3,381,3,,,,,,2,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,3000,Visit13,13,Phase 3,409,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,3200,Visit14,14,Phase 3,435,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,3400,Visit15,15,Phase 3,464,3,,,,,,2,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,3600,Visit16,16,Phase 3,487,3,,,,,,2,800,,,2,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,3800,Visit17,17,Phase 3,529,3,,,,,,2,800,,,2,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,217,1 or 1A,50,2,,0,1,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,5800,EndofPhase2,11,Phase 2,346,2,,1,,0,1,,,,,4,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA288NGN,2456,,,M,6000,EndofPhase3,18,Phase 3,578,3,,,,,,2,800,,,3,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,1,10,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,1000,Visit3,3,Phase 1/1A,96,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,1200,Visit4,4,Phase 1/1A,124,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,1400,Visit5,5,Phase 1/1A,155,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,90,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,85,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,1,,1,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,3400,Visit15,15,Phase 1/1A,426,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,3600,Visit16,16,Phase 1/1A,454,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA574EBZ,1255,,,M,4000,Visit18,18,Phase 1/1A,510,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,0,2,,,,,,,,4,2,16,,,2,2,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,1400,Visit5,5,Phase 3,85,3,,,,,,7,25,3,3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,1600,Visit6,6,Phase 3,127,3,,,,,,7,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,1800,Visit7,7,Phase 3,155,3,,,,,,7,50,3,3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,2000,Visit8,8,Phase 3,183,3,,,,,,7,50,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,2200,Visit9,9,Phase 3,214,3,,,,,,7,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,2400,Visit10,10,Phase 3,239,3,,,,,,7,50,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,2600,Visit11,11,Phase 3,267,3,,,,,,7,50,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,2800,Visit12,12,Phase 3,317,3,,,,,,7,50,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,3000,Visit13,13,Phase 3,360,3,,,,,,3,3,7,25,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,3200,Visit14,14,Phase 3,388,3,,,,,,3,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,3400,Visit15,15,Phase 3,421,3,,,,,,3,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,3600,Visit16,16,Phase 3,451,3,,,,,,3,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,3800,Visit17,17,Phase 3,484,3,,,,,,3,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,4000,Visit18,18,Phase 3,518,3,,,,,,3,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,38,1 or 1A,0,2,,,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,5400,EndofPhase1b,3,Phase 1B,51,1B,0,2,,,,,,,,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA578PJQ,1377,,,F,5800,EndofPhase2,4,Phase 2,71,2,,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA592ED6,1044,,,F,600,Visit1,1,Phase 1/1A,37,1 or 1A,96,3,,,,,,,,1,3,4.5,,,1,,3,5,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA592ED6,1044,,,F,800,Visit2,2,Phase 1/1A,84,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA592ED6,1044,,,F,1000,Visit3,3,Phase 1/1A,122,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA592ED6,1044,,,F,1200,Visit4,4,Phase 1/1A,147,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA592ED6,1044,,,F,1400,Visit5,5,Phase 1/1A,180,1 or 1A,,3,,,,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA592ED6,1044,,,F,1600,Visit6,6,Phase 1/1A,275,1 or 1A,,4,,1,,,,,,4,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA592ED6,1044,,,F,2200,Visit9,9,Phase 1/1A,330,1 or 1A,,4,,1,,,,,,4,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA592ED6,1044,,,F,2400,Visit10,10,Phase 1/1A,351,1 or 1A,,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA592ED6,1044,,,F,2800,Visit12,12,Phase 1/1A,404,1 or 1A,,4,,1,,,,,,3,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA592ED6,1044,,,F,3200,Visit14,14,Phase 1/1A,449,1 or 1A,,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA592ED6,1044,,,F,3400,Visit15,15,Phase 1/1A,477,1 or 1A,,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA592ED6,1044,,,F,3800,Visit17,17,Phase 1/1A,533,1 or 1A,,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXA592ED6,1044,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,561,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,80,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,93,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,90,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,98,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,88,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,98,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,2000,Visit8,8,Phase 1/1A,229,1 or 1A,95,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,92,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,2400,Visit10,10,Phase 1/1A,285,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,2600,Visit11,11,Phase 1/1A,313,1 or 1A,88,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,94,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,3000,Visit13,13,Phase 1/1A,369,1 or 1A,97,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,3200,Visit14,14,Phase 1/1A,407,1 or 1A,88,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,3400,Visit15,15,Phase 1/1A,435,1 or 1A,95,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,89,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,93,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB092YZA,1266,,,M,4000,Visit18,18,Phase 1/1A,512,1 or 1A,81,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB261TTZ,2761,,,M,5200,EndofPhase1_1a,0,Phase 1/1A,77,1 or 1A,70,2,,1,,,,,,2,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,2,3,23,30,3,4,813,800,4,160,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,1200,Visit4,4,Phase 2,115,2,98,5,,,,,,,,1,5,,1000,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,1400,Visit5,5,Phase 2,141,2,94,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,1600,Visit6,6,Phase 2,175,2,98,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,1800,Visit7,7,Phase 2,196,2,97,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,2000,Visit8,8,Phase 2,226,2,98,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,2200,Visit9,9,Phase 2,252,2,96,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,2400,Visit10,10,Phase 2,281,2,99,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,2600,Visit11,11,Phase 2,308,2,96,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,2800,Visit12,12,Phase 2,337,2,97,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,3000,Visit13,13,Phase 2,365,2,93,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,3200,Visit14,14,Phase 2,395,2,97,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,3400,Visit15,15,Phase 2,421,2,97,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,3600,Visit16,16,Phase 2,448,2,99,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,3800,Visit17,17,Phase 2,479,2,98,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,4200,Visit19,19,Phase 3,532,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,4400,Visit20,20,Phase 3,559,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,93,1 or 1A,98,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,5800,EndofPhase2,18,Phase 2,493,2,93,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB267UT7,1137,,,M,6000,EndofPhase3,21,Phase 3,568,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,1,3,3,5,6,3,2,278,300,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,1200,Visit4,4,Phase 2,114,2,59,,75,,,,,,,2,,,75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,1400,Visit5,5,Phase 2,142,2,,2,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,1600,Visit6,6,Phase 2,184,2,98,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,1800,Visit7,7,Phase 2,197,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,2000,Visit8,8,Phase 2,225,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,2200,Visit9,9,Phase 2,253,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,2400,Visit10,10,Phase 2,281,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,2600,Visit11,11,Phase 2,309,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,2800,Visit12,12,Phase 2,332,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,3000,Visit13,13,Phase 2,365,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,3200,Visit14,14,Phase 2,393,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB750UM2,2050,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,73,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB788BB9,2710,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,99,3,,1,,,,,,1,3,600,,,2,3,4,700,700,4,3,450,450,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB788BB9,2710,,,F,1000,Visit3,3,Phase 2,76,2,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB788BB9,2710,,,F,1200,Visit4,4,Phase 2,110,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB788BB9,2710,,,F,1400,Visit5,5,Phase 2,146,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB788BB9,2710,,,F,1600,Visit6,6,Phase 2,174,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB788BB9,2710,,,F,1800,Visit7,7,Phase 2,209,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB788BB9,2710,,,F,2000,Visit8,8,Phase 2,237,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB788BB9,2710,,,F,2200,Visit9,9,Phase 2,272,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB788BB9,2710,,,F,2400,Visit10,10,Phase 2,300,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB788BB9,2710,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,41,1 or 1A,98,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXB788BB9,2710,,,F,5800,EndofPhase2,11,Phase 2,309,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,600,Visit1,1,Phase 1/1A,40,1 or 1A,79,1,,1,,,,,,1,1,7.5,,,2,,4,28,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,800,Visit2,2,Phase 1/1A,80,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,1000,Visit3,3,Phase 1/1A,100,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,1200,Visit4,4,Phase 1/1A,127,1 or 1A,97,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,1400,Visit5,5,Phase 1/1A,162,1 or 1A,89,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,1600,Visit6,6,Phase 1/1A,197,1 or 1A,89,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,1800,Visit7,7,Phase 1/1A,229,1 or 1A,97,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,2000,Visit8,8,Phase 1/1A,257,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,2200,Visit9,9,Phase 1/1A,295,1 or 1A,95,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,2400,Visit10,10,Phase 1/1A,324,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,2600,Visit11,11,Phase 1/1A,355,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,2800,Visit12,12,Phase 1/1A,390,1 or 1A,89,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,3200,Visit14,14,Phase 1/1A,418,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,3800,Visit17,17,Phase 1/1A,485,1 or 1A,86,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC182HF0,2566,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,508,1 or 1A,81,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,2,2,89,80,2,3,650,600,3,5,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,800,Visit2,2,Phase 1/1A,72,1 or 1A,99,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,1000,Visit3,3,Phase 1/1A,80,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,1400,Visit5,5,Phase 1/1A,148,1 or 1A,67,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,95,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,1800,Visit7,7,Phase 1/1A,204,1 or 1A,51,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,2000,Visit8,8,Phase 1/1A,230,1 or 1A,67,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,2400,Visit10,10,Phase 2,282,2,93,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,2600,Visit11,11,Phase 2,310,2,93,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,2800,Visit12,12,Phase 2,344,2,91,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,3200,Visit14,14,Phase 3,393,3,,,,,,3,3,,,1,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,3400,Visit15,15,Phase 3,419,3,,,,,,3,4,,,1,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,3600,Visit16,16,Phase 3,447,3,,,,,,3,2,3,3,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,3800,Visit17,17,Phase 3,478,3,,,,,,3,5,3,2,1,,,,7,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,5200,EndofPhase1_1a,9,Phase 1/1A,247,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,5800,EndofPhase2,13,Phase 2,364,2,98,3,,1,,,,,,4,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXC730ZZK,2211,,,F,6000,EndofPhase3,18,Phase 3,507,3,,,,,,3,3,3,2,1,,,,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,600,Visit1,1,Phase 1/1A,15,1 or 1A,,,,1,,,,,,2,,,,,1,,3,4,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,800,Visit2,2,Phase 1/1A,43,1 or 1A,68,1,,1,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,1000,Visit3,3,Phase 1/1A,68,1 or 1A,86,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,1200,Visit4,4,Phase 1/1A,99,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,1400,Visit5,5,Phase 1/1A,127,1 or 1A,95,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,1600,Visit6,6,Phase 1/1A,163,1 or 1A,75,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,1800,Visit7,7,Phase 1/1A,191,1 or 1A,,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,2000,Visit8,8,Phase 1/1A,225,1 or 1A,,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,2200,Visit9,9,Phase 1/1A,255,1 or 1A,29,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,2400,Visit10,10,Phase 1/1A,291,1 or 1A,71,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,2600,Visit11,11,Phase 1/1A,320,1 or 1A,55,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,2800,Visit12,12,Phase 1/1A,358,1 or 1A,53,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,3000,Visit13,13,Phase 1/1A,390,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,3200,Visit14,14,Phase 1/1A,429,1 or 1A,75,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,3400,Visit15,15,Phase 1/1A,459,1 or 1A,99,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,3600,Visit16,16,Phase 1/1A,488,1 or 1A,37,4,,1,,,,,,3,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,3800,Visit17,17,Phase 1/1A,520,1 or 1A,83,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD210MY4,2340,,,F,4000,Visit18,18,Phase 1/1A,561,1 or 1A,100,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXD772LJ0,2597,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,2,,0,1,,,,,,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXE202FDR,1772,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,,,,,,,,,,,,,,,1,1,2,3,3,2,3,23,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXE202FDR,1772,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,50,1 or 1A,0,2,,,,,,,,4,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXE202FDR,1772,,,M,5800,EndofPhase2,3,Phase 2,64,2,94,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF265FDL,1536,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,2,3,5,5,3,3,533,600,3,25,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF265FDL,1536,,,M,1000,Visit3,3,Phase 2,64,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF265FDL,1536,,,M,1200,Visit4,4,Phase 2,99,2,96,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF265FDL,1536,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,37,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF265FDL,1536,,,M,5800,EndofPhase2,5,Phase 2,124,2,,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF265FDL,1536,,,M,6000,EndofPhase3,7,Phase 3,187,3,,,,,,1,25,,,1,,,,25,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF276WCM,2649,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,83,3,,,,,,,,1,3,4.5,,,2,2,4,5,5,4,4,140,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF276WCM,2649,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF276WCM,2649,,,M,1000,Visit3,3,Phase 1/1A,79,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF276WCM,2649,,,M,1400,Visit5,5,Phase 2,134,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF276WCM,2649,,,M,1600,Visit6,6,Phase 2,159,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF276WCM,2649,,,M,1800,Visit7,7,Phase 2,187,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF276WCM,2649,,,M,2000,Visit8,8,Phase 2,219,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF276WCM,2649,,,M,2200,Visit9,9,Phase 2,247,2,88,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF276WCM,2649,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,107,1 or 1A,86,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXF276WCM,2649,,,M,5800,EndofPhase2,9,Phase 2,270,2,93,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,,,,,,,,,1,,,,,2,,3,4,3,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,93,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,95,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,98,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,97,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,3400,Visit15,15,Phase 1/1A,426,1 or 1A,,4,,1,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,3800,Visit17,17,Phase 1/1A,472,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG204PYC,1664,,,M,4000,Visit18,18,Phase 1/1A,489,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG904XGE,2476,,,M,600,Visit1,1,Phase 1/1A,61,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,2,4,26,30,4,3,600,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG904XGE,2476,,,M,800,Visit2,2,Phase 1/1A,89,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG904XGE,2476,,,M,1000,Visit3,3,Phase 1/1A,119,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG904XGE,2476,,,M,1400,Visit5,5,Phase 2,159,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG904XGE,2476,,,M,1600,Visit6,6,Phase 2,189,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG904XGE,2476,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,133,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXG904XGE,2476,,,M,5800,EndofPhase2,7,Phase 2,229,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH101CXX,2249,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,,,,,,,,,,,,,,,1,2,4,6,6,4,4,26,26,4,147,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH101CXX,2249,,,M,800,Visit2,2,Phase 1/1A,74,1 or 1A,75,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH101CXX,2249,,,M,1000,Visit3,3,Phase 1/1A,95,1 or 1A,,4,,1,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH101CXX,2249,,,M,1400,Visit5,5,Phase 2,153,2,78,3,,1,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH101CXX,2249,,,M,1800,Visit7,7,Phase 3,214,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH101CXX,2249,,,M,2000,Visit8,8,Phase 3,245,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH101CXX,2249,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,124,1 or 1A,90,4,,0,1,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH101CXX,2249,,,M,5800,EndofPhase2,6,Phase 2,181,2,88,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH101CXX,2249,,,M,6000,EndofPhase3,9,Phase 3,273,3,,,,,,4,160,,,1,,,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,32,,,2,,3,26,24,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,1600,Visit6,6,Phase 1B,170,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,1800,Visit7,7,Phase 1B,197,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,2000,Visit8,8,Phase 1B,219,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,2200,Visit9,9,Phase 1B,246,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,2400,Visit10,10,Phase 1B,274,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,2600,Visit11,11,Phase 1B,303,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,2800,Visit12,12,Phase 1B,345,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,3000,Visit13,13,Phase 1B,372,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,3200,Visit14,14,Phase 1B,399,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,3400,Visit15,15,Phase 1B,420,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,3600,Visit16,16,Phase 1B,456,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,3800,Visit17,17,Phase 1B,477,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,130,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH192GCR,1299,,,M,5400,EndofPhase1b,18,Phase 1B,543,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH305UKL,2245,,,M,600,Visit1,1,Phase 1/1A,51,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,,3,500,500,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH305UKL,2245,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,99,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH328AN2,2574,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,3,,1,,,,,,1,3,120,,,2,2,4,147,160,4,4,6,6,4,500,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH328AN2,2574,,,M,800,Visit2,2,Phase 1/1A,52,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH328AN2,2574,,,M,1200,Visit4,4,Phase 2,107,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH328AN2,2574,,,M,1600,Visit6,6,Phase 3,165,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH328AN2,2574,,,M,1800,Visit7,7,Phase 3,204,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH328AN2,2574,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH328AN2,2574,,,M,2200,Visit9,9,Phase 3,254,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH328AN2,2574,,,M,2400,Visit10,10,Phase 3,289,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH328AN2,2574,,,M,2600,Visit11,11,Phase 3,310,3,,,,,,6,800,,,1,,,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH328AN2,2574,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,71,1 or 1A,77,4,,,,,,,,2,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH328AN2,2574,,,M,5800,EndofPhase2,5,Phase 2,123,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH328AN2,2574,,,M,6000,EndofPhase3,12,Phase 3,331,3,,,,,,6,800,,,1,,,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH667DBR,2466,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,,3,,1,,,,,,,3,600,,,2,,3,600,600,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH667DBR,2466,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,94,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH667DBR,2466,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,97,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH667DBR,2466,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH667DBR,2466,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,93,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH667DBR,2466,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH786JCF,2434,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH910TVL,2415,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,96,2,,0,1,,,,,1,2,400,,,1,2,2,400,400,2,2,80,80,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH910TVL,2415,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,94,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH910TVL,2415,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,,2,,1,,,,,,,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH910TVL,2415,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH910TVL,2415,,,M,3000,Visit13,13,Phase 2,366,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH910TVL,2415,,,M,3200,Visit14,14,Phase 2,394,2,98,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH910TVL,2415,,,M,3400,Visit15,15,Phase 2,418,2,90,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH910TVL,2415,,,M,3600,Visit16,16,Phase 2,457,2,96,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH910TVL,2415,,,M,3800,Visit17,17,Phase 2,478,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH910TVL,2415,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,355,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXH910TVL,2415,,,M,5800,EndofPhase2,18,Phase 2,505,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,94,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,95,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,98,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,96,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,93,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,93,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,86,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,2600,Visit11,11,Phase 1/1A,308,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,98,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,95,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,98,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ148ADL,1691,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,497,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,600,Visit1,1,Phase 1/1A,40,1 or 1A,98,1,,1,,,,,,1,1,200,,,2,1,3,560,600,3,1,8,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,97,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,99,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,1800,Visit7,7,Phase 3,205,3,,,,,,4,80,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,2000,Visit8,8,Phase 3,226,3,,,,,,4,80,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,2400,Visit10,10,Phase 3,282,3,,,,,,4,80,2,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,4,80,2,100,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,2800,Visit12,12,Phase 3,343,3,,,,,,2,100,4,80,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,3000,Visit13,13,Phase 3,373,3,,,,,,2,100,4,80,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,3200,Visit14,14,Phase 3,387,3,,,,,,4,120,2,100,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,3400,Visit15,15,Phase 3,422,3,,,,,,4,160,2,100,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,3600,Visit16,16,Phase 3,450,3,,,,,,4,80,2,100,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,3800,Visit17,17,Phase 3,478,3,,,,,,4,80,2,100,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,152,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,5800,EndofPhase2,6,Phase 2,169,2,100,1,,1,,,,,,1,1,,7.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ223PJ2,2287,,,M,6000,EndofPhase3,18,Phase 3,520,3,,,,,,4,80,2,100,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,600,Visit1,1,Phase 1/1A,37,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,1000,Visit3,3,Phase 1/1A,77,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,1200,Visit4,4,Phase 1/1A,106,1 or 1A,86,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,1400,Visit5,5,Phase 1/1A,136,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,1600,Visit6,6,Phase 1/1A,163,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,2400,Visit10,10,Phase 1/1A,277,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,2800,Visit12,12,Phase 1/1A,339,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXJ640TP1,1205,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,520,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK326HCD,2144,,,M,800,Visit2,2,Phase 2,60,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK326HCD,2144,,,M,1000,Visit3,3,Phase 2,94,2,78,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK326HCD,2144,,,M,1200,Visit4,4,Phase 2,127,2,27,3,,1,,,,,,3,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK326HCD,2144,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,32,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,1,2,1,2,2,1,2,450,400,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK326HCD,2144,,,M,5800,EndofPhase2,5,Phase 2,142,2,50,2,,1,,,,,,3,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK451YLG,2278,,,F,600,Visit1,1,Phase 1/1A,49,1 or 1A,49,1,,1,,,,,,3,1,8,,,1,,2,13,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK451YLG,2278,,,F,800,Visit2,2,Phase 1/1A,62,1 or 1A,12,2,,1,,,,,,4,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK451YLG,2278,,,F,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK451YLG,2278,,,F,1400,Visit5,5,Phase 1/1A,160,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK451YLG,2278,,,F,1800,Visit7,7,Phase 1B,201,1B,45,1,,1,,,,,,3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK451YLG,2278,,,F,2000,Visit8,8,Phase 1B,232,1B,83,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK451YLG,2278,,,F,2400,Visit10,10,Phase 1B,288,1B,63,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK451YLG,2278,,,F,2800,Visit12,12,Phase 1B,343,1B,96,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK451YLG,2278,,,F,3000,Visit13,13,Phase 1B,366,1B,75,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK451YLG,2278,,,F,3200,Visit14,14,Phase 1B,400,1B,,2,,1,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK451YLG,2278,,,F,3400,Visit15,15,Phase 1B,439,1B,35,2,,1,,,,,,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK451YLG,2278,,,F,3600,Visit16,16,Phase 1B,446,1B,29,2,,1,,,,,,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK451YLG,2278,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,195,1 or 1A,83,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXK715BHZ,2501,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,89,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,87,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,2200,Visit9,9,Phase 1/1A,255,1 or 1A,90,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,99,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,3000,Visit13,13,Phase 1/1A,374,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL106AEQ,2670,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,97,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,1200,Visit4,4,Phase 1/1A,120,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,1800,Visit7,7,Phase 1B,204,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,2000,Visit8,8,Phase 1B,225,1B,88,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,2200,Visit9,9,Phase 1B,253,1B,88,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,2400,Visit10,10,Phase 1B,281,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,2600,Visit11,11,Phase 1B,305,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,2800,Visit12,12,Phase 1B,348,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,3000,Visit13,13,Phase 1B,372,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,3200,Visit14,14,Phase 1B,393,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,3400,Visit15,15,Phase 1B,422,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,3600,Visit16,16,Phase 1B,449,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,3800,Visit17,17,Phase 1B,480,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,186,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL394HGK,1471,,,F,5400,EndofPhase1b,18,Phase 1B,508,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL556MPF,1704,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,80,,,2,2,3,120,120,3,3,20,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL556MPF,1704,,,M,1000,Visit3,3,Phase 2,86,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL556MPF,1704,,,M,1200,Visit4,4,Phase 2,114,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL556MPF,1704,,,M,1400,Visit5,5,Phase 2,142,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL556MPF,1704,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,63,1 or 1A,73,4,,,,,,,,2,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXL630DDW,2571,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXM711GLX,1035,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,400,,,2,2,3,620,600,3,2,80,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXM711GLX,1035,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXM711GLX,1035,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXM711GLX,1035,,,M,1200,Visit4,4,Phase 1/1A,117,1 or 1A,99,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXM711GLX,1035,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXM711GLX,1035,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,96,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXM711GLX,1035,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,99,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXM711GLX,1035,,,M,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXM711GLX,1035,,,M,2200,Visit9,9,Phase 1/1A,264,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXM711GLX,1035,,,M,5200,EndofPhase1_1a,10,Phase 1/1A,280,1 or 1A,76,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXM711GLX,1035,,,M,5800,EndofPhase2,13,Phase 2,372,2,0,2,,,,,,,,4,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,1,,,,,,,,1,1,8,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,1400,Visit5,5,Phase 1/1A,143,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,96,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,3400,Visit15,15,Phase 1/1A,422,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,100,1,,,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN758CUX,1627,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,511,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,3,,,,,,,,1,3,24,,,2,,3,24,24,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,80,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,2200,Visit9,9,Phase 1/1A,249,1 or 1A,98,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,97,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,3000,Visit13,13,Phase 1/1A,373,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,3200,Visit14,14,Phase 1/1A,401,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,3400,Visit15,15,Phase 1/1A,434,1 or 1A,97,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,3600,Visit16,16,Phase 1/1A,462,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,3800,Visit17,17,Phase 1/1A,497,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXN941TKH,1458,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,535,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,15,,,1,,1,10,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,95,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,87,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,91,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,91,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,96,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,93,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,88,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,93,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,2400,Visit10,10,Phase 1/1A,285,1 or 1A,97,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,2600,Visit11,11,Phase 1/1A,313,1 or 1A,86,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,2800,Visit12,12,Phase 1/1A,341,1 or 1A,89,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,3000,Visit13,13,Phase 1/1A,369,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,3400,Visit15,15,Phase 1/1A,415,1 or 1A,,1,,,,,,,,,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,3600,Visit16,16,Phase 1/1A,445,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,3800,Visit17,17,Phase 1/1A,465,1 or 1A,100,1,,0,1,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP042YFP,1610,,,M,5200,EndofPhase1_1a,17,Phase 1/1A,465,1 or 1A,,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,600,Visit1,1,Phase 1/1A,24,1 or 1A,93,2,,,,,,,,1,2,400,,,2,,3,511,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,800,Visit2,2,Phase 1/1A,51,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,1000,Visit3,3,Phase 1/1A,79,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,1200,Visit4,4,Phase 1/1A,107,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,1400,Visit5,5,Phase 1/1A,135,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,1600,Visit6,6,Phase 1/1A,163,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,1800,Visit7,7,Phase 1/1A,191,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,2000,Visit8,8,Phase 1/1A,219,1 or 1A,97,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,2200,Visit9,9,Phase 1/1A,247,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,2400,Visit10,10,Phase 1/1A,275,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,2600,Visit11,11,Phase 1/1A,302,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,2800,Visit12,12,Phase 1/1A,331,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,3000,Visit13,13,Phase 1/1A,358,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,3200,Visit14,14,Phase 1/1A,387,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,3400,Visit15,15,Phase 1/1A,417,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,3600,Visit16,16,Phase 1/1A,443,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,3800,Visit17,17,Phase 1/1A,471,1 or 1A,90,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP458GJD,1411,,,F,4000,Visit18,18,Phase 1/1A,506,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,97,2,,1,,,,,,1,2,16,,,1,,3,22,24,3,,,,,14,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,1200,Visit4,4,Phase 1/1A,116,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,1600,Visit6,6,Phase 3,172,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,1800,Visit7,7,Phase 3,199,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,2000,Visit8,8,Phase 3,227,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,2200,Visit9,9,Phase 3,256,3,,,,,,1,10,1,5,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,2400,Visit10,10,Phase 3,283,3,,,,,,1,10,1,5,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,2600,Visit11,11,Phase 3,308,3,,,,,,1,10,1,5,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,2800,Visit12,12,Phase 3,336,3,,,,,,1,10,1,5,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,3000,Visit13,13,Phase 3,364,3,,,,,,1,10,1,5,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,3200,Visit14,14,Phase 3,393,3,,,,,,1,10,1,5,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,3400,Visit15,15,Phase 3,420,3,,,,,,1,10,1,5,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,3600,Visit16,16,Phase 3,451,3,,,,,,1,5,1,10,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,5200,EndofPhase1_1a,5,Phase 1/1A,144,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXP616CEB,1751,,,F,6000,EndofPhase3,17,Phase 3,492,3,,,,,,1,5,1,10,,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR112YLZ,1572,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,44,1 or 1A,21,2,,,,,,,,4,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR353XA4,1406,,,F,600,Visit1,1,Phase 1/1A,38,1 or 1A,26,2,,,,,,,,4,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR353XA4,1406,,,F,800,Visit2,2,Phase 1/1A,66,1 or 1A,75,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR353XA4,1406,,,F,1000,Visit3,3,Phase 1/1A,87,1 or 1A,73,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR353XA4,1406,,,F,1200,Visit4,4,Phase 1/1A,108,1 or 1A,76,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR353XA4,1406,,,F,1400,Visit5,5,Phase 1/1A,142,1 or 1A,61,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR353XA4,1406,,,F,1600,Visit6,6,Phase 1/1A,179,1 or 1A,22,2,,,,,,,,4,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR353XA4,1406,,,F,5200,EndofPhase1_1a,6,Phase 1/1A,179,1 or 1A,22,2,,,,,,,,4,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,33,4,,1,,,,,,3,4,32,,,2,,4,29,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,24,4,,1,,,,,,4,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,1400,Visit5,5,Phase 1B,138,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,1600,Visit6,6,Phase 1B,169,1B,88,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,2000,Visit8,8,Phase 1B,222,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,2200,Visit9,9,Phase 1B,254,1B,,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,2400,Visit10,10,Phase 1B,290,1B,80,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,2600,Visit11,11,Phase 1B,310,1B,66,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,2800,Visit12,12,Phase 1B,339,1B,69,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,3000,Visit13,13,Phase 1B,366,1B,,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,3200,Visit14,14,Phase 1B,401,1B,,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,3400,Visit15,15,Phase 1B,422,1B,99,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,3600,Visit16,16,Phase 1B,449,1B,85,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,3800,Visit17,17,Phase 1B,477,1B,82,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,128,1 or 1A,95,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXR766RLV,2711,,,F,5400,EndofPhase1b,18,Phase 1B,520,1B,98,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT013LMB,2418,,,F,600,Visit1,1,Phase 1/1A,22,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT013LMB,2418,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,42,1 or 1A,97,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT174RYM,2639,,,M,600,Visit1,1,Phase 1/1A,21,1 or 1A,94,2,,1,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT174RYM,2639,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,88,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT174RYM,2639,,,M,1000,Visit3,3,Phase 1/1A,76,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT174RYM,2639,,,M,1200,Visit4,4,Phase 1/1A,96,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT174RYM,2639,,,M,1400,Visit5,5,Phase 1/1A,128,1 or 1A,0,2,,,,,,,,4,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT174RYM,2639,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,87,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT174RYM,2639,,,M,1800,Visit7,7,Phase 1/1A,218,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT174RYM,2639,,,M,2000,Visit8,8,Phase 1/1A,246,1 or 1A,91,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT174RYM,2639,,,M,2200,Visit9,9,Phase 1/1A,274,1 or 1A,91,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT174RYM,2639,,,M,2400,Visit10,10,Phase 1/1A,306,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT174RYM,2639,,,M,2600,Visit11,11,Phase 1/1A,330,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,3,5,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,74,3,,,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,1000,Visit3,3,Phase 1/1A,77,1 or 1A,75,3,,,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,1200,Visit4,4,Phase 1/1A,105,1 or 1A,88,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,1400,Visit5,5,Phase 1/1A,134,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,1600,Visit6,6,Phase 1/1A,166,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,1800,Visit7,7,Phase 1/1A,193,1 or 1A,81,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,2000,Visit8,8,Phase 1/1A,221,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,2400,Visit10,10,Phase 1/1A,277,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,2600,Visit11,11,Phase 1/1A,306,1 or 1A,98,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,2800,Visit12,12,Phase 1/1A,335,1 or 1A,97,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,3400,Visit15,15,Phase 1/1A,418,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT430HG3,1180,,,M,5200,EndofPhase1_1a,15,Phase 1/1A,434,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT740AX1,2814,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,19,1 or 1A,36,2,,0,1,,,,,3,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT836FR8,1909,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,8,,,1,2,2,12,12,2,4,30,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT836FR8,1909,,,M,1000,Visit3,3,Phase 1B,85,1B,96,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT836FR8,1909,,,M,1200,Visit4,4,Phase 1B,109,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT836FR8,1909,,,M,1400,Visit5,5,Phase 1B,136,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT836FR8,1909,,,M,1800,Visit7,7,Phase 2,179,2,100,4,,0,2,,,,,2,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT836FR8,1909,,,M,2000,Visit8,8,Phase 2,205,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT836FR8,1909,,,M,2200,Visit9,9,Phase 2,234,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT836FR8,1909,,,M,2400,Visit10,10,Phase 2,266,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT836FR8,1909,,,M,2600,Visit11,11,Phase 2,295,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT836FR8,1909,,,M,2800,Visit12,12,Phase 2,325,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT836FR8,1909,,,M,3200,Visit14,14,Phase 2,393,2,100,4,,0,2,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT836FR8,1909,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,44,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXT836FR8,1909,,,M,5400,EndofPhase1b,6,Phase 1B,148,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU187EDV,2680,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,81,3,,1,,,,,,1,3,120,,,2,,3,120,120,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,1600,Visit6,6,Phase 1/1A,178,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,1800,Visit7,7,Phase 1/1A,206,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,2200,Visit9,9,Phase 1/1A,262,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,2400,Visit10,10,Phase 1/1A,296,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,2600,Visit11,11,Phase 1/1A,324,1 or 1A,43,2,,1,,,,,,3,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,2800,Visit12,12,Phase 1/1A,352,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,3000,Visit13,13,Phase 1/1A,386,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,3200,Visit14,14,Phase 1/1A,415,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,3400,Visit15,15,Phase 1/1A,450,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,3600,Visit16,16,Phase 1/1A,483,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,3800,Visit17,17,Phase 1/1A,514,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU201XFE,1750,,,M,4000,Visit18,18,Phase 1/1A,547,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU370CAA,1674,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU934NRA,1920,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,96,2,,,,,,,,1,2,80,,,2,,3,130,160,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU934NRA,1920,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,93,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU934NRA,1920,,,F,1000,Visit3,3,Phase 1/1A,88,1 or 1A,81,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU934NRA,1920,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,130,1 or 1A,48,3,,,,,,,,3,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,,2,80,80,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,98,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,1600,Visit6,6,Phase 1/1A,168,1 or 1A,77,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,1800,Visit7,7,Phase 1/1A,196,1 or 1A,89,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,2000,Visit8,8,Phase 1/1A,224,1 or 1A,93,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,2200,Visit9,9,Phase 1/1A,252,1 or 1A,75,2,,1,,,,,,2,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,2400,Visit10,10,Phase 1/1A,280,1 or 1A,86,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,2600,Visit11,11,Phase 1/1A,308,1 or 1A,96,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,2800,Visit12,12,Phase 1/1A,336,1 or 1A,83,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,3400,Visit15,15,Phase 1/1A,427,1 or 1A,94,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,3600,Visit16,16,Phase 1/1A,455,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXU990CJK,2848,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,503,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV106FT9,2799,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,30,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,600,Visit1,1,Phase 1/1A,24,1 or 1A,96,2,,,,,,,,1,2,80,,,1,1,2,86,80,2,3,5,3,3,15,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,0,1,,,,,3,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,1400,Visit5,5,Phase 1/1A,135,1 or 1A,100,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,2,,0,1,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,2000,Visit8,8,Phase 2,226,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,2200,Visit9,9,Phase 2,259,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,2400,Visit10,10,Phase 2,290,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,2600,Visit11,11,Phase 2,314,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,2800,Visit12,12,Phase 2,343,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,3000,Visit13,13,Phase 2,366,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,3200,Visit14,14,Phase 2,402,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,3600,Visit16,16,Phase 3,455,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,3800,Visit17,17,Phase 3,476,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,5200,EndofPhase1_1a,7,Phase 1/1A,196,1 or 1A,100,3,,0,1,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,5800,EndofPhase2,15,Phase 2,429,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV605VZJ,2086,,,F,6000,EndofPhase3,18,Phase 3,497,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV817DG6,2008,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,6,,,1,2,4,6,6,4,4,160,160,4,38,40,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV817DG6,2008,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,97,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV817DG6,2008,,,M,1200,Visit4,4,Phase 2,112,2,99,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV817DG6,2008,,,M,1400,Visit5,5,Phase 2,141,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV817DG6,2008,,,M,1800,Visit7,7,Phase 3,197,3,,,,,,1,26,,,1,,,,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV817DG6,2008,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV817DG6,2008,,,M,2200,Visit9,9,Phase 3,253,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV817DG6,2008,,,M,2400,Visit10,10,Phase 3,287,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV817DG6,2008,,,M,2600,Visit11,11,Phase 3,308,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV817DG6,2008,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,85,1 or 1A,89,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV817DG6,2008,,,M,5800,EndofPhase2,6,Phase 2,156,2,100,,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV817DG6,2008,,,M,6000,EndofPhase3,12,Phase 3,338,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV903GLK,2675,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,93,1,,1,,,,,,1,1,8,,,2,,2,12,8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV903GLK,2675,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,70,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV903GLK,2675,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,86,2,,0,2,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV903GLK,2675,,,M,1400,Visit5,5,Phase 1B,113,1B,1,1,,1,,,,,,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV903GLK,2675,,,M,1600,Visit6,6,Phase 1B,141,1B,2,2,,1,,,,,,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV903GLK,2675,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,99,1 or 1A,81,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXV903GLK,2675,,,M,5400,EndofPhase1b,8,Phase 1B,188,1B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW062TX9,2590,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,,,,,,,,,,1,,,,,2,,4,30,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW062TX9,2590,,,M,1200,Visit4,4,Phase 1/1A,104,1 or 1A,50,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW062TX9,2590,,,M,1400,Visit5,5,Phase 1/1A,130,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW062TX9,2590,,,M,1600,Visit6,6,Phase 1/1A,158,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW062TX9,2590,,,M,1800,Visit7,7,Phase 1/1A,188,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW062TX9,2590,,,M,2000,Visit8,8,Phase 1/1A,218,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW062TX9,2590,,,M,2200,Visit9,9,Phase 1/1A,250,1 or 1A,0,4,,,,,,,,4,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW062TX9,2590,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,90,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW062TX9,2590,,,M,5200,EndofPhase1_1a,11,Phase 1/1A,315,1 or 1A,94,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW131AAK,2633,,,F,600,Visit1,1,Phase 1/1A,23,1 or 1A,,2,,1,,,,,,4,2,80,,,1,,4,147,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW131AAK,2633,,,F,800,Visit2,2,Phase 1/1A,51,1 or 1A,,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW131AAK,2633,,,F,1000,Visit3,3,Phase 1/1A,76,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW131AAK,2633,,,F,1200,Visit4,4,Phase 1/1A,112,1 or 1A,,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW131AAK,2633,,,F,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW131AAK,2633,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,94,4,,0,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW292EP7,1589,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXW476UYR,2002,,,M,600,Visit1,1,Phase 1/1A,21,1 or 1A,85,2,,,,,,,,1,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,1,2,400,400,2,3,5,5,3,138,140,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,1400,Visit5,5,Phase 2,147,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,1800,Visit7,7,Phase 3,203,3,,,,,,4,120,,,1,,,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,2000,Visit8,8,Phase 3,231,3,,,,,,4,140,,,1,,,,140,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,2200,Visit9,9,Phase 3,259,3,,,,,,4,140,,,1,,,,140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,2400,Visit10,10,Phase 3,287,3,,,,,,4,140,,,1,,,,140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,2600,Visit11,11,Phase 3,315,3,,,,,,4,140,,,1,,,,140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,2800,Visit12,12,Phase 3,343,3,,,,,,4,140,,,1,,,,140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,3000,Visit13,13,Phase 3,371,3,,,,,,4,140,,,1,,,,140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,3200,Visit14,14,Phase 3,399,3,,,,,,4,140,,,1,,,,140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,3400,Visit15,15,Phase 3,430,3,,,,,,4,140,,,1,,,,140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,3600,Visit16,16,Phase 3,461,3,,,,,,4,140,,,1,,,,140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,3800,Visit17,17,Phase 3,489,3,,,,,,4,140,,,1,,,,140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,126,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,5800,EndofPhase2,6,Phase 2,178,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX208GER,2604,,,M,6000,EndofPhase3,18,Phase 3,524,3,,,,,,4,140,,,1,,,,140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,1000,Visit3,3,Phase 3,57,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,1200,Visit4,4,Phase 3,85,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,1400,Visit5,5,Phase 3,120,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,1600,Visit6,6,Phase 3,141,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,1800,Visit7,7,Phase 3,176,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,2000,Visit8,8,Phase 3,204,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,2200,Visit9,9,Phase 3,232,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,2400,Visit10,10,Phase 3,260,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,2600,Visit11,11,Phase 3,296,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,2800,Visit12,12,Phase 3,323,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,3000,Visit13,13,Phase 3,351,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,3200,Visit14,14,Phase 3,379,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,3400,Visit15,15,Phase 3,414,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,3600,Visit16,16,Phase 3,451,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,3800,Visit17,17,Phase 3,479,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,4000,Visit18,18,Phase 3,519,3,,,,,,1,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,22,1 or 1A,100,2,,,,,,,,1,2,400,,,2,2,2,400,400,2,1,40,40,1,12,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX227MDF,1816,,,F,5800,EndofPhase2,2,Phase 2,36,2,48,1,,,,,,,,3,1,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,93,2,,,,,,,,1,2,80,,,2,1,3,114,120,3,3,514,400,3,42,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,94,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,1200,Visit4,4,Phase 1/1A,115,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,1400,Visit5,5,Phase 1/1A,147,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,1600,Visit6,6,Phase 1/1A,178,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,2000,Visit8,8,Phase 2,227,2,58,2,,1,,,,,,2,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,2200,Visit9,9,Phase 2,252,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,2400,Visit10,10,Phase 2,281,2,85,4,,0,1,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,2600,Visit11,11,Phase 2,308,2,85,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,2800,Visit12,12,Phase 2,339,2,84,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,3000,Visit13,13,Phase 2,365,2,88,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,3600,Visit16,16,Phase 3,466,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,3800,Visit17,17,Phase 3,480,3,,,,,,7,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,197,1 or 1A,49,3,,1,,,,,,3,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,5800,EndofPhase2,15,Phase 2,435,2,0,2,,,,,,,,4,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX278VNH,2089,,,M,6000,EndofPhase3,18,Phase 3,508,3,,,,,,7,25,,,1,,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX284NYD,1368,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX284NYD,1368,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX284NYD,1368,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,2,,,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,1,,,,,,1,4,800,,,2,1,4,800,800,4,3,4,4,3,20,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,1200,Visit4,4,Phase 2,107,2,100,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,1600,Visit6,6,Phase 3,162,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,1800,Visit7,7,Phase 3,191,3,,,,,,1,25,,,1,,,,25,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,2000,Visit8,8,Phase 3,219,3,,,,,,1,25,,,1,,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,2400,Visit10,10,Phase 3,289,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,2600,Visit11,11,Phase 3,323,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,2800,Visit12,12,Phase 3,352,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,3000,Visit13,13,Phase 3,379,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,3200,Visit14,14,Phase 3,403,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,3400,Visit15,15,Phase 3,421,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,3600,Visit16,16,Phase 3,449,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,3800,Visit17,17,Phase 3,477,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,72,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,5800,EndofPhase2,5,Phase 2,135,2,74,3,,,,,,,,2,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX511REB,1447,,,F,6000,EndofPhase3,18,Phase 3,505,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX793AFN,1062,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,76,2,,,,,,,,2,2,15,,,2,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX793AFN,1062,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,23,2,,,,,,,,4,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXX793AFN,1062,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,131,1 or 1A,,2,,,,,,,,4,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY139LUK,2880,,,M,1200,Visit4,4,Phase 3,102,3,,,,,,2,400,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY139LUK,2880,,,M,1400,Visit5,5,Phase 3,154,3,,,,,,2,400,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY139LUK,2880,,,M,1800,Visit7,7,Phase 3,215,3,,,,,,2,400,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY139LUK,2880,,,M,2000,Visit8,8,Phase 3,259,3,,,,,,3,2,2,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY139LUK,2880,,,M,2400,Visit10,10,Phase 3,313,3,,,,,,2,400,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY139LUK,2880,,,M,3000,Visit13,13,Phase 3,349,3,,,,,,2,400,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY139LUK,2880,,,M,3200,Visit14,14,Phase 3,398,3,,,,,,2,400,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY139LUK,2880,,,M,3400,Visit15,15,Phase 3,440,3,,,,,,3,3,2,500,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY139LUK,2880,,,M,3600,Visit16,16,Phase 3,466,3,,,,,,3,4,2,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY139LUK,2880,,,M,3800,Visit17,17,Phase 3,494,3,,,,,,3,4,2,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY139LUK,2880,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,28,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,1,2,1,2,2,1,1,40,40,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY139LUK,2880,,,M,5800,EndofPhase2,2,Phase 2,67,2,96,1,,1,,,,,,1,1,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY139LUK,2880,,,M,6000,EndofPhase3,18,Phase 3,530,3,,,,,,3,4,2,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY472UVR,2309,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,,3,533,400,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY472UVR,2309,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY472UVR,2309,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY641YZD,1250,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,9,1 or 1A,100,1,,,,,,,,1,1,8,,,2,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY641YZD,1250,,,M,5400,EndofPhase1b,2,Phase 1B,14,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY828FPT,1880,,,F,600,Visit1,1,Phase 1/1A,22,1 or 1A,100,2,,,,,,,,1,2,80,,,2,,3,107,80,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY828FPT,1880,,,F,800,Visit2,2,Phase 1/1A,50,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY828FPT,1880,,,F,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY828FPT,1880,,,F,1200,Visit4,4,Phase 1/1A,106,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY828FPT,1880,,,F,1400,Visit5,5,Phase 1/1A,134,1 or 1A,100,1,,1,,,,,,1,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY828FPT,1880,,,F,1600,Visit6,6,Phase 1/1A,162,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY828FPT,1880,,,F,1800,Visit7,7,Phase 1/1A,184,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY828FPT,1880,,,F,2000,Visit8,8,Phase 1/1A,211,1 or 1A,100,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY828FPT,1880,,,F,5200,EndofPhase1_1a,9,Phase 1/1A,245,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY858UYV,2753,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,64,3,,1,,,,,,2,3,120,,,2,2,3,120,120,3,4,7,6,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY858UYV,2753,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY858UYV,2753,,,M,1200,Visit4,4,Phase 2,113,2,86,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY858UYV,2753,,,M,1400,Visit5,5,Phase 2,143,2,76,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY858UYV,2753,,,M,1600,Visit6,6,Phase 2,168,2,100,6,,0,2,,,,,1,6,,9,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY858UYV,2753,,,M,1800,Visit7,7,Phase 2,192,2,76,5,,1,,,,,,1,5,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY858UYV,2753,,,M,2000,Visit8,8,Phase 2,210,2,72,4,,1,,,,,,2,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY858UYV,2753,,,M,2200,Visit9,9,Phase 2,254,2,,4,,0,2,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY858UYV,2753,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,86,1 or 1A,98,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXY858UYV,2753,,,M,5800,EndofPhase2,10,Phase 2,282,2,,4,,0,2,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ398RJA,1945,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,15,,,2,,3,25,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,96,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,1800,Visit7,7,Phase 1/1A,191,1 or 1A,74,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,92,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,2600,Visit11,11,Phase 1/1A,317,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,2800,Visit12,12,Phase 1/1A,345,1 or 1A,45,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,3000,Visit13,13,Phase 1/1A,370,1 or 1A,32,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,33,4,,1,,,,,,3,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ418ZBP,1143,,,M,5200,EndofPhase1_1a,15,Phase 1/1A,408,1 or 1A,,4,,1,,,,,,,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,96,2,,,,,,,,1,2,15,,,1,2,1,11,8,1,3,600,600,3,13,13,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,1000,Visit3,3,Phase 1/1A,82,1 or 1A,93,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,92,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,1600,Visit6,6,Phase 2,166,2,94,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,1800,Visit7,7,Phase 2,198,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,2000,Visit8,8,Phase 2,222,2,99,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,2200,Visit9,9,Phase 2,250,2,96,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,2400,Visit10,10,Phase 2,279,2,100,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,2800,Visit12,12,Phase 3,338,3,,,,,,7,13,,0,1,,,,12.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,3000,Visit13,13,Phase 3,363,3,,,,,,7,13,,,1,,,,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,3200,Visit14,14,Phase 3,399,3,,,,,,7,13,,,1,,,,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,3400,Visit15,15,Phase 3,420,3,,,,,,7,13,,,1,,,,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,3600,Visit16,16,Phase 3,448,3,,,,,,7,13,,0,1,,,,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,3800,Visit17,17,Phase 3,474,3,,,,,,7,13,,,1,,,,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,5200,EndofPhase1_1a,5,Phase 1/1A,133,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,5800,EndofPhase2,11,Phase 2,287,2,83,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ419RXZ,1594,,,F,6000,EndofPhase3,18,Phase 3,510,3,,,,,,7,13,,,1,,,,12.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ493DN1,2417,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,1,2,3,5,5,3,4,140,140,4,115,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ493DN1,2417,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ493DN1,2417,,,F,1200,Visit4,4,Phase 2,113,2,98,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ493DN1,2417,,,F,1600,Visit6,6,Phase 3,173,3,,,,,,6,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ493DN1,2417,,,F,1800,Visit7,7,Phase 3,197,3,,,,,,6,125,,,1,,,,125,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ493DN1,2417,,,F,2000,Visit8,8,Phase 3,225,3,,,,,,6,150,,,1,,,,150,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ493DN1,2417,,,F,2200,Visit9,9,Phase 3,253,3,,,,,,6,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ493DN1,2417,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,85,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ493DN1,2417,,,F,5800,EndofPhase2,5,Phase 2,141,2,92,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ493DN1,2417,,,F,6000,EndofPhase3,11,Phase 3,307,3,,,,,,6,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,3,,,1,,2,4,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,1000,Visit3,3,Phase 1/1A,106,1 or 1A,46,3,,1,,,,,,3,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,1200,Visit4,4,Phase 1/1A,134,1 or 1A,71,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,1400,Visit5,5,Phase 1/1A,176,1 or 1A,52,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,1600,Visit6,6,Phase 1/1A,211,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,1800,Visit7,7,Phase 1/1A,253,1 or 1A,78,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,2000,Visit8,8,Phase 1/1A,274,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,2200,Visit9,9,Phase 1/1A,305,1 or 1A,,3,,,,,,,,,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,2400,Visit10,10,Phase 1/1A,338,1 or 1A,73,3,,,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,2600,Visit11,11,Phase 1/1A,366,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,2800,Visit12,12,Phase 1/1A,394,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,3000,Visit13,13,Phase 1/1A,421,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,3200,Visit14,14,Phase 1/1A,449,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,3400,Visit15,15,Phase 1/1A,477,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,3600,Visit16,16,Phase 1/1A,513,1 or 1A,81,2,,,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,3800,Visit17,17,Phase 1/1A,540,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ560ELT,1151,,,M,4000,Visit18,18,Phase 1/1A,568,1 or 1A,56,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,600,Visit1,1,Phase 1/1A,22,1 or 1A,100,2,,1,,,,,,1,2,3,,,2,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,88,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,1200,Visit4,4,Phase 1/1A,120,1 or 1A,98,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,2000,Visit8,8,Phase 1/1A,218,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,2200,Visit9,9,Phase 1/1A,239,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,2400,Visit10,10,Phase 1/1A,274,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,99,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,3000,Visit13,13,Phase 1/1A,372,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVXZ661HM2,2587,,,F,5200,EndofPhase1_1a,16,Phase 1/1A,442,1 or 1A,97,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,1000,Visit3,3,Phase 3,85,3,,,,,,3,3,1,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,1200,Visit4,4,Phase 3,113,3,,,,,,3,3,1,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,1400,Visit5,5,Phase 3,144,3,,,,,,1,15,3,3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,1600,Visit6,6,Phase 3,176,3,,,,,,1,20,3,3,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,1800,Visit7,7,Phase 3,204,3,,,,,,3,2,1,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,2000,Visit8,8,Phase 3,232,3,,,,,,1,20,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,2200,Visit9,9,Phase 3,263,3,,,,,,3,2,1,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,2400,Visit10,10,Phase 3,291,3,,,,,,1,20,3,2,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,2600,Visit11,11,Phase 3,318,3,,,,,,3,2,1,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,2800,Visit12,12,Phase 3,353,3,,,,,,3,4,1,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,3000,Visit13,13,Phase 3,379,3,,,,,,1,20,3,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,3200,Visit14,14,Phase 3,407,3,,,,,,3,4,1,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,3400,Visit15,15,Phase 3,435,3,,,,,,1,25,3,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,3600,Visit16,16,Phase 3,463,3,,,,,,1,20,3,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,3800,Visit17,17,Phase 3,491,3,,,,,,1,25,3,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,22,1 or 1A,100,3,,,,,,,,1,3,600,,,2,2,3,600,600,3,3,120,120,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,5800,EndofPhase2,2,Phase 2,36,2,36,3,,,,,,,,3,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA067HP5,2049,,,M,6000,EndofPhase3,18,Phase 3,519,3,,,,,,1,25,3,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,3,,,,,,,,1,3,24,,,2,,4,29,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,92,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,90,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,97,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,1600,Visit6,6,Phase 1/1A,180,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,96,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,92,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,96,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,2600,Visit11,11,Phase 1/1A,311,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,2800,Visit12,12,Phase 1/1A,339,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,3000,Visit13,13,Phase 1/1A,367,1 or 1A,91,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,3200,Visit14,14,Phase 1/1A,401,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,3400,Visit15,15,Phase 1/1A,442,1 or 1A,36,4,,0,2,,,,,3,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,50,4,,1,,,,,,3,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA343DNP,1973,,,M,4000,Visit18,18,Phase 1/1A,509,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,97,1,,1,,,,,,1,1,1.5,,,1,2,2,4,3,2,3,550,600,3,12,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,1200,Visit4,4,Phase 1/1A,119,1 or 1A,98,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,1400,Visit5,5,Phase 1/1A,151,1 or 1A,89,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,1600,Visit6,6,Phase 1/1A,190,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,1800,Visit7,7,Phase 1/1A,235,1 or 1A,99,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,2000,Visit8,8,Phase 1/1A,253,1 or 1A,93,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,2600,Visit11,11,Phase 2,339,2,99,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,2800,Visit12,12,Phase 2,373,2,100,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,3000,Visit13,13,Phase 2,410,2,92,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,5200,EndofPhase1_1a,9,Phase 1/1A,276,1 or 1A,93,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,5800,EndofPhase2,14,Phase 2,424,2,61,1,,1,,,,,,2,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA403LF9,2647,,,F,6000,EndofPhase3,15,Phase 3,450,3,,,,,,8,12,,0,1,,,,12,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,120,,,2,2,4,156,160,4,4,30,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,800,Visit2,2,Phase 1/1A,61,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,1000,Visit3,3,Phase 1/1A,89,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,1400,Visit5,5,Phase 1/1A,146,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,1800,Visit7,7,Phase 1/1A,208,1 or 1A,91,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,2000,Visit8,8,Phase 1/1A,237,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,2200,Visit9,9,Phase 1/1A,267,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,2400,Visit10,10,Phase 1/1A,285,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,2600,Visit11,11,Phase 1/1A,314,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,2800,Visit12,12,Phase 1/1A,344,1 or 1A,,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,3000,Visit13,13,Phase 2,371,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,3200,Visit14,14,Phase 2,400,2,,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,3400,Visit15,15,Phase 2,429,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,3600,Visit16,16,Phase 2,457,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,3800,Visit17,17,Phase 2,489,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYA994XHT,2658,,,F,5800,EndofPhase2,18,Phase 2,517,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,98,2,,,,,,,,1,2,3,,,2,,3,5,6,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,61,3,,,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,1200,Visit4,4,Phase 1/1A,107,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,1400,Visit5,5,Phase 1/1A,135,1 or 1A,93,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,2000,Visit8,8,Phase 1/1A,240,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,2200,Visit9,9,Phase 1/1A,282,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,2400,Visit10,10,Phase 1/1A,310,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,2600,Visit11,11,Phase 1/1A,334,1 or 1A,,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,2800,Visit12,12,Phase 1/1A,387,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,3000,Visit13,13,Phase 1/1A,415,1 or 1A,,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,3200,Visit14,14,Phase 1/1A,442,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,3400,Visit15,15,Phase 1/1A,471,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,3600,Visit16,16,Phase 1/1A,499,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,3800,Visit17,17,Phase 1/1A,530,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB087YTU,1683,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,558,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB380LYZ,1962,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB394WDJ,1260,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYB693UTW,1110,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,17,1 or 1A,,,,,,,,,,4,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYD654DNE,2450,,,M,600,Visit1,1,Phase 1/1A,44,1 or 1A,19,2,,1,,,,,,4,2,80,,,2,,3,120,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYD654DNE,2450,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,84,1 or 1A,43,4,,1,,,,,,3,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYD724AHZ,1225,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,30,2,,,,,,,,1,2,400,,,2,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYD724AHZ,1225,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,50,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYD724AHZ,1225,,,M,1000,Visit3,3,Phase 1/1A,75,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYD724AHZ,1225,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,75,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,99,3,,,,,,,,1,3,22.5,,,2,2,3,23,23,3,2,3,3,2,30,30,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,1000,Visit3,3,Phase 2,87,2,100,3,,0,2,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,1200,Visit4,4,Phase 2,115,2,96,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,1400,Visit5,5,Phase 2,142,2,96,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,1600,Visit6,6,Phase 2,171,2,96,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,1800,Visit7,7,Phase 2,196,2,100,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,2000,Visit8,8,Phase 2,227,2,90,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,2200,Visit9,9,Phase 2,258,2,100,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,2400,Visit10,10,Phase 2,286,2,96,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,2600,Visit11,11,Phase 2,314,2,100,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,2800,Visit12,12,Phase 2,342,2,100,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,3000,Visit13,13,Phase 2,370,2,96,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,3200,Visit14,14,Phase 2,398,2,96,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,3600,Visit16,16,Phase 3,454,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,3800,Visit17,17,Phase 3,485,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,62,1 or 1A,98,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,5800,EndofPhase2,15,Phase 2,426,2,100,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE038KR1,1881,,,M,6000,EndofPhase3,18,Phase 3,513,3,,,,,,8,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE479NCG,1243,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,1,,,,,,,,1,1,1.5,,,1,,2,4,5,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE479NCG,1243,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE479NCG,1243,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,600,Visit1,1,Phase 1/1A,24,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,2,14,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,1200,Visit4,4,Phase 1/1A,122,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,1400,Visit5,5,Phase 1/1A,150,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,1600,Visit6,6,Phase 1/1A,182,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,1800,Visit7,7,Phase 1/1A,210,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,2200,Visit9,9,Phase 1/1A,271,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,2400,Visit10,10,Phase 1/1A,304,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,2600,Visit11,11,Phase 1/1A,332,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,2800,Visit12,12,Phase 1/1A,360,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,3400,Visit15,15,Phase 1/1A,423,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYE536UAJ,2756,,,M,5200,EndofPhase1_1a,17,Phase 1/1A,500,1 or 1A,0,0,,,,,,,,4,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,80,,,2,1,3,120,120,3,4,27,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,800,Visit2,2,Phase 1/1A,51,1 or 1A,100,3,,,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,1000,Visit3,3,Phase 2,90,2,96,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,1200,Visit4,4,Phase 2,128,2,96,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,1400,Visit5,5,Phase 2,163,2,100,3,,,,,,,,1,3,,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,1600,Visit6,6,Phase 2,191,2,100,4,,0,1,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,1800,Visit7,7,Phase 2,218,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,2000,Visit8,8,Phase 2,250,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,2200,Visit9,9,Phase 2,280,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,2400,Visit10,10,Phase 2,308,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,2600,Visit11,11,Phase 2,336,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,2800,Visit12,12,Phase 2,366,2,93,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,3200,Visit14,14,Phase 3,434,3,,,,,,1,20,8,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,3400,Visit15,15,Phase 3,460,3,,,,,,1,20,8,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,3600,Visit16,16,Phase 3,491,3,,,,,,8,30,1,25,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,3800,Visit17,17,Phase 3,519,3,,,,,,1,25,8,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,62,1 or 1A,100,4,,,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,5800,EndofPhase2,13,Phase 2,393,2,96,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYG383FDB,1943,,,F,6000,EndofPhase3,18,Phase 3,569,3,,,,,,1,25,8,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH349AMR,2453,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,1,,1,,,,,,1,1,1.5,,,2,,1,2,2,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH349AMR,2453,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH349AMR,2453,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH349AMR,2453,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH349AMR,2453,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,174,1 or 1A,47,1,,1,,,,,,3,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,92,2,,,,,,,,1,2,3,,,1,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,92,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,73,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,47,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,1800,Visit7,7,Phase 1/1A,190,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,83,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,90,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,2600,Visit11,11,Phase 1/1A,302,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,69,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,3400,Visit15,15,Phase 1/1A,433,1 or 1A,40,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,3600,Visit16,16,Phase 1/1A,461,1 or 1A,85,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,,3,,1,,,,,,4,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYH938UUA,1356,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,,3,,1,,,,,,,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ068NM9,2288,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,2,2,4,26,26,4,4,6,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ068NM9,2288,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,49,1 or 1A,95,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ068NM9,2288,,,M,5800,EndofPhase2,2,Phase 2,86,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,600,,,2,,2,433,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,1000,Visit3,3,Phase 1/1A,84,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,1200,Visit4,4,Phase 1/1A,112,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,98,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,1800,Visit7,7,Phase 1/1A,194,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,3400,Visit15,15,Phase 1/1A,426,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,3600,Visit16,16,Phase 1/1A,456,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ087RDW,2300,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,98,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,92,2,,,,,,,,1,2,400,,,2,1,2,450,400,2,2,16,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,99,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,91,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,1400,Visit5,5,Phase 2,147,2,,4,,,,,,,,,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,1800,Visit7,7,Phase 2,205,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,2000,Visit8,8,Phase 2,240,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,2200,Visit9,9,Phase 2,268,2,0,0,,,,,,,,4,0,,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,2400,Visit10,10,Phase 2,300,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,2600,Visit11,11,Phase 2,325,2,,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,2800,Visit12,12,Phase 2,386,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,3200,Visit14,14,Phase 2,421,2,97,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,3400,Visit15,15,Phase 2,447,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,3600,Visit16,16,Phase 2,477,2,93,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,3800,Visit17,17,Phase 2,526,2,98,2,,0,1,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,4000,Visit18,18,Phase 2,554,2,93,2,,0,1,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ090NRQ,1626,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,111,1 or 1A,91,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ108JZB,1651,,,M,600,Visit1,1,Phase 1/1A,25,1 or 1A,,2,,,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ108JZB,1651,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYJ108JZB,1651,,,M,1000,Visit3,3,Phase 1/1A,108,1 or 1A,90,2,,,,,,,,3,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYK381JU2,2395,,,M,600,Visit1,1,Phase 1/1A,61,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,3,20,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYK381JU2,2395,,,M,800,Visit2,2,Phase 1/1A,85,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYK381JU2,2395,,,M,1000,Visit3,3,Phase 1/1A,117,1 or 1A,,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYK381JU2,2395,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYK381JU2,2395,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,93,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYK381JU2,2395,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,73,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYK381JU2,2395,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,227,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYK747DF1,1300,,,M,1000,Visit3,3,Phase 3,79,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYK747DF1,1300,,,M,1200,Visit4,4,Phase 3,119,3,,,,,,1,20,,,2,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYK747DF1,1300,,,M,1400,Visit5,5,Phase 3,147,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYK747DF1,1300,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,14,1 or 1A,100,1,,,,,,,,1,1,1.5,,,1,2,1,2,2,1,2,15,15,2,20,20,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYK747DF1,1300,,,M,5800,EndofPhase2,2,Phase 2,46,2,100,2,,,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL125WYU,2484,,,M,600,Visit1,1,Phase 1/1A,50,1 or 1A,,,,,,,,,,3,,,,,1,1,2,16,16,2,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL125WYU,2484,,,M,1000,Visit3,3,Phase 1B,110,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL125WYU,2484,,,M,1200,Visit4,4,Phase 1B,138,1B,87,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL125WYU,2484,,,M,1400,Visit5,5,Phase 1B,166,1B,100,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL125WYU,2484,,,M,1800,Visit7,7,Phase 2,200,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL125WYU,2484,,,M,2000,Visit8,8,Phase 2,228,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL125WYU,2484,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,81,1 or 1A,,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL125WYU,2484,,,M,5400,EndofPhase1b,6,Phase 1B,186,1B,0,4,,,,,,,,3,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,4,,0,1,,,,,1,4,160,,,1,1,4,160,160,4,4,6,6,4,567,600,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,800,Visit2,2,Phase 1/1A,52,1 or 1A,92,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,1000,Visit3,3,Phase 1/1A,75,1 or 1A,78,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,1200,Visit4,4,Phase 1/1A,106,1 or 1A,100,4,,0,2,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,1400,Visit5,5,Phase 1/1A,127,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,1600,Visit6,6,Phase 1/1A,155,1 or 1A,100,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,2000,Visit8,8,Phase 2,222,2,99,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,2200,Visit9,9,Phase 2,257,2,99,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,2400,Visit10,10,Phase 2,297,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,2600,Visit11,11,Phase 2,326,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,2800,Visit12,12,Phase 2,354,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,3000,Visit13,13,Phase 2,387,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,3200,Visit14,14,Phase 2,419,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,3400,Visit15,15,Phase 2,445,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,3800,Visit17,17,Phase 3,514,3,,,,,,6,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,4000,Visit18,18,Phase 3,549,3,,,,,,6,500,,,1,,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,4200,Visit19,19,Phase 3,577,3,,,,,,6,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,4400,Visit20,20,Phase 3,605,3,,,,,,6,600,,,1,,,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,4600,Visit21,21,Phase 3,633,3,,,,,,6,700,,,1,,,,700,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,4800,Visit22,22,Phase 3,662,3,,,,,,6,700,,,1,,,,700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,5200,EndofPhase1_1a,7,Phase 1/1A,192,1 or 1A,93,4,,0,1,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL522DTK,2180,,,M,5800,EndofPhase2,16,Phase 2,481,2,100,4,,1,,,,,,1,4,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,1,,,,,,,,1,1,1.5,,,1,,1,2,2,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,1000,Visit3,3,Phase 1/1A,90,1 or 1A,89,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,1200,Visit4,4,Phase 1/1A,114,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,1800,Visit7,7,Phase 1/1A,202,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,2000,Visit8,8,Phase 1/1A,231,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,2200,Visit9,9,Phase 1/1A,258,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,91,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,2600,Visit11,11,Phase 1/1A,307,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,2800,Visit12,12,Phase 1/1A,336,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,3000,Visit13,13,Phase 1/1A,363,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,3400,Visit15,15,Phase 1/1A,427,1 or 1A,97,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,3600,Visit16,16,Phase 1/1A,450,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,3800,Visit17,17,Phase 1/1A,476,1 or 1A,92,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYL820KJT,1413,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,95,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,97,2,,,,,,,,1,2,16,,,2,,4,30,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,93,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,93,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,96,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,91,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,90,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,2200,Visit9,9,Phase 1B,252,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,2400,Visit10,10,Phase 1B,280,1B,71,3,,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,2600,Visit11,11,Phase 1B,307,1B,68,3,,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,2800,Visit12,12,Phase 1B,343,1B,63,3,,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,3000,Visit13,13,Phase 1B,365,1B,90,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,3200,Visit14,14,Phase 1B,392,1B,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,3400,Visit15,15,Phase 1B,421,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,3600,Visit16,16,Phase 1B,449,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,3800,Visit17,17,Phase 1B,470,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,218,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM059HFY,1006,,,M,5400,EndofPhase1b,18,Phase 1B,503,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,86,1,,,,,,,,1,1,7.5,,,1,,3,19,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,1600,Visit6,6,Phase 1/1A,176,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,1800,Visit7,7,Phase 1/1A,207,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,2200,Visit9,9,Phase 1/1A,260,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,92,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,2600,Visit11,11,Phase 1/1A,327,1 or 1A,99,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,2800,Visit12,12,Phase 1/1A,355,1 or 1A,95,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,3000,Visit13,13,Phase 1/1A,383,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,3200,Visit14,14,Phase 1/1A,409,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,3400,Visit15,15,Phase 1/1A,446,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,3600,Visit16,16,Phase 1/1A,481,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,3800,Visit17,17,Phase 1/1A,516,1 or 1A,94,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM362BU4,1686,,,M,4000,Visit18,18,Phase 1/1A,549,1 or 1A,98,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,4,,,,,,,,1,4,800,,,2,2,4,800,800,4,4,160,160,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,1000,Visit3,3,Phase 1/1A,89,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,1200,Visit4,4,Phase 1/1A,124,1 or 1A,90,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,1400,Visit5,5,Phase 1/1A,152,1 or 1A,83,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,93,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,99,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,2000,Visit8,8,Phase 1/1A,216,1 or 1A,89,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,2200,Visit9,9,Phase 1/1A,230,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,2400,Visit10,10,Phase 1/1A,265,1 or 1A,97,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,2600,Visit11,11,Phase 1/1A,300,1 or 1A,95,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,2800,Visit12,12,Phase 1/1A,324,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,3000,Visit13,13,Phase 2,358,2,96,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,3200,Visit14,14,Phase 2,386,2,98,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,3400,Visit15,15,Phase 2,414,2,100,4,,,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,3600,Visit16,16,Phase 2,442,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,3800,Visit17,17,Phase 2,470,2,98,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,324,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM492GB6,1551,,,M,5800,EndofPhase2,18,Phase 2,509,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM825RX9,2047,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM856XE8,1565,,,F,600,Visit1,1,Phase 1/1A,32,1 or 1A,0,2,,,,,,,,4,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM856XE8,1565,,,F,1000,Visit3,3,Phase 1B,76,1B,100,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM856XE8,1565,,,F,1200,Visit4,4,Phase 1B,111,1B,100,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM856XE8,1565,,,F,1400,Visit5,5,Phase 1B,134,1B,100,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM856XE8,1565,,,F,1600,Visit6,6,Phase 1B,169,1B,100,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM856XE8,1565,,,F,1800,Visit7,7,Phase 1B,195,1B,100,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM856XE8,1565,,,F,2000,Visit8,8,Phase 1B,224,1B,100,1,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM856XE8,1565,,,F,2200,Visit9,9,Phase 1B,258,1B,,1,,0,2,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM856XE8,1565,,,F,2400,Visit10,10,Phase 1B,280,1B,,4,,0,2,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM856XE8,1565,,,F,2600,Visit11,11,Phase 1B,309,1B,,2,,0,2,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM856XE8,1565,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,42,1 or 1A,16,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYM856XE8,1565,,,F,5400,EndofPhase1b,12,Phase 1B,355,1B,,0,,0,2,,,,,4,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,1,,,,,,1,2,15,,,2,,3,21,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,1000,Visit3,3,Phase 1/1A,88,1 or 1A,93,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,1200,Visit4,4,Phase 1/1A,113,1 or 1A,99,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,1600,Visit6,6,Phase 1/1A,168,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,1800,Visit7,7,Phase 1/1A,204,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,2200,Visit9,9,Phase 1/1A,253,1 or 1A,96,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,89,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,2600,Visit11,11,Phase 1/1A,309,1 or 1A,93,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,2800,Visit12,12,Phase 1/1A,347,1 or 1A,90,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,3200,Visit14,14,Phase 1/1A,393,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,3400,Visit15,15,Phase 1/1A,422,1 or 1A,92,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,3600,Visit16,16,Phase 1/1A,448,1 or 1A,92,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,3800,Visit17,17,Phase 1/1A,477,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN214KFZ,2762,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,505,1 or 1A,75,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,800,Visit2,2,Phase 1/1A,54,1 or 1A,88,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,1000,Visit3,3,Phase 1/1A,99,1 or 1A,93,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,1200,Visit4,4,Phase 1/1A,118,1 or 1A,97,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,1600,Visit6,6,Phase 1/1A,169,1 or 1A,98,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,1800,Visit7,7,Phase 1/1A,197,1 or 1A,93,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,2200,Visit9,9,Phase 1/1A,251,1 or 1A,94,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,2400,Visit10,10,Phase 1/1A,293,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,2600,Visit11,11,Phase 1/1A,308,1 or 1A,91,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,2800,Visit12,12,Phase 1/1A,343,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,3000,Visit13,13,Phase 1/1A,371,1 or 1A,96,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,3200,Visit14,14,Phase 1/1A,392,1 or 1A,91,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,3400,Visit15,15,Phase 1/1A,428,1 or 1A,96,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,3600,Visit16,16,Phase 1/1A,455,1 or 1A,91,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYN551CY5,1925,,,F,5200,EndofPhase1_1a,18,Phase 1/1A,503,1 or 1A,93,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,600,Visit1,1,Phase 1/1A,42,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,1,3,667,800,3,4,30,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,800,Visit2,2,Phase 1/1A,71,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,1000,Visit3,3,Phase 1/1A,102,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,1200,Visit4,4,Phase 1/1A,130,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,1400,Visit5,5,Phase 1/1A,160,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,1800,Visit7,7,Phase 2,228,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,2000,Visit8,8,Phase 2,256,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,2200,Visit9,9,Phase 2,284,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,2400,Visit10,10,Phase 2,314,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,2600,Visit11,11,Phase 2,342,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,2800,Visit12,12,Phase 2,365,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,3000,Visit13,13,Phase 2,392,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,3200,Visit14,14,Phase 2,424,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,3400,Visit15,15,Phase 2,452,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,3600,Visit16,16,Phase 2,484,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,3800,Visit17,17,Phase 2,515,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,195,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP256TU1,2749,,,M,5800,EndofPhase2,18,Phase 2,561,2,100,4,,1,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP894MM3,1092,,,F,800,Visit2,2,Phase 2,62,2,100,2,,0,1,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP894MM3,1092,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,34,1 or 1A,100,3,,,,,,,,1,3,22.5,,,1,1,3,23,23,3,2,400,400,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP894MM3,1092,,,F,5800,EndofPhase2,3,Phase 2,77,2,100,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,1,2,3,21,16,3,2,400,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,1200,Visit4,4,Phase 1B,108,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,1400,Visit5,5,Phase 1B,134,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,1600,Visit6,6,Phase 1B,172,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,1800,Visit7,7,Phase 1B,205,1B,100,2,,,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,2000,Visit8,8,Phase 1B,227,1B,100,2,,,,,,,,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,2200,Visit9,9,Phase 1B,255,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,2400,Visit10,10,Phase 1B,283,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,2600,Visit11,11,Phase 1B,311,1B,100,2,,,,,,,,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,2800,Visit12,12,Phase 1B,337,1B,,2,,,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,3000,Visit13,13,Phase 1B,365,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,3200,Visit14,14,Phase 1B,393,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,3600,Visit16,16,Phase 2,456,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,3800,Visit17,17,Phase 2,486,2,100,2,,1,,,,,,2,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,4000,Visit18,18,Phase 2,512,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,4200,Visit19,19,Phase 2,547,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,4400,Visit20,20,Phase 2,568,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,4600,Visit21,21,Phase 2,596,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,4800,Visit22,22,Phase 2,624,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,86,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,5400,EndofPhase1b,15,Phase 1B,435,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYP933BN2,1814,,,M,5800,EndofPhase2,23,Phase 2,659,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,85,2,,1,,,,,,1,2,16,,,2,3,2,16,16,2,,398,350,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,1000,Visit3,3,Phase 1B,91,1B,89,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,1200,Visit4,4,Phase 1B,108,1B,93,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,1600,Visit6,6,Phase 2,174,2,100,,175,,,,,,,1,,,175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,1800,Visit7,7,Phase 2,195,2,100,,350,,,,,,,1,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,2000,Visit8,8,Phase 2,223,2,100,,350,,,,,,,1,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,2200,Visit9,9,Phase 2,252,2,100,,350,,,,,,,1,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,2400,Visit10,10,Phase 2,280,2,100,,350,,,,,,,1,,,350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,2600,Visit11,11,Phase 2,308,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,2800,Visit12,12,Phase 2,338,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,3000,Visit13,13,Phase 2,364,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,3200,Visit14,14,Phase 2,395,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,3400,Visit15,15,Phase 2,427,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,3600,Visit16,16,Phase 2,450,2,100,,450,,,,,,,1,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,3800,Visit17,17,Phase 2,478,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,48,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,5400,EndofPhase1b,5,Phase 1B,134,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR189BCW,2684,,,M,5800,EndofPhase2,18,Phase 2,505,2,100,,500,,,,,,,1,,,500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,92,2,,1,,,,,,1,2,16,,,2,,2,16,16,2,,,,,400,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,1,,1,,,,,,1,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,1400,Visit5,5,Phase 1B,134,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,1600,Visit6,6,Phase 1B,169,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,1800,Visit7,7,Phase 1B,190,1B,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,2000,Visit8,8,Phase 1B,225,1B,100,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,2200,Visit9,9,Phase 1B,253,1B,70,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,2400,Visit10,10,Phase 1B,295,1B,6,3,,1,,,,,,4,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,2600,Visit11,11,Phase 1B,309,1B,93,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,2800,Visit12,12,Phase 1B,344,1B,76,3,,1,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,3600,Visit16,16,Phase 3,420,3,,,,,,6,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,103,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,5400,EndofPhase1b,14,Phase 1B,378,1B,70,3,,1,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,5800,EndofPhase2,15,Phase 2,386,1B,,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYR649KT1,1578,,,F,6000,EndofPhase3,17,Phase 3,450,3,,,,,,6,400,,,1,,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYT079EX0,2592,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,59,2,,0,1,,,,,4,2,80,,,1,2,2,80,80,2,2,15,15,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYT079EX0,2592,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,43,2,,1,,,,,,3,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYT079EX0,2592,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,6,2,,,,,,,,4,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYT079EX0,2592,,,M,1400,Visit5,5,Phase 2,131,2,100,2,,1,,,,,,2,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYT079EX0,2592,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,113,1 or 1A,,2,,1,,,,,,,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYT713VNN,1725,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,22,1 or 1A,50,2,,1,,,,,,3,2,3,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYT931KAZ,1434,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,4,29,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYT931KAZ,1434,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYT931KAZ,1434,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYT931KAZ,1434,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,98,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYT931KAZ,1434,,,M,5200,EndofPhase1_1a,5,Phase 1/1A,128,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,,3,,1,,,,,,1,3,600,,,2,1,3,625,600,3,3,5,5,3,450,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,1000,Visit3,3,Phase 1/1A,98,1 or 1A,,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,1200,Visit4,4,Phase 1/1A,128,1 or 1A,,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,1400,Visit5,5,Phase 1/1A,164,1 or 1A,,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,1600,Visit6,6,Phase 1/1A,189,1 or 1A,,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,1800,Visit7,7,Phase 1/1A,231,1 or 1A,,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,2200,Visit9,9,Phase 2,290,2,,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,2600,Visit11,11,Phase 3,338,3,,,,,,6,225,6,225,1,,,,450,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,2800,Visit12,12,Phase 3,373,3,,,,,,6,225,6,225,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,3000,Visit13,13,Phase 3,408,3,,,,,,6,225,6,225,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,3400,Visit15,15,Phase 3,462,3,,,,,,6,225,6,225,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,3800,Visit17,17,Phase 3,483,3,,,,,,6,225,6,225,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,268,1 or 1A,,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,5800,EndofPhase2,10,Phase 2,304,2,,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU332RLR,1831,,,M,6000,EndofPhase3,18,Phase 3,521,3,,,,,,6,225,6,225,1,,,,450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,600,Visit1,1,Phase 1/1A,31,1 or 1A,100,2,,,,,,,,1,2,400,,,1,1,4,720,800,4,3,123,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,1000,Visit3,3,Phase 1/1A,101,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,1200,Visit4,4,Phase 1/1A,127,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,1600,Visit6,6,Phase 2,185,2,100,2,,,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,1800,Visit7,7,Phase 2,213,2,100,2,,0,1,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,2000,Visit8,8,Phase 2,234,2,100,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,2200,Visit9,9,Phase 2,253,2,100,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,2400,Visit10,10,Phase 2,283,2,97,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,2600,Visit11,11,Phase 2,311,2,90,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,2800,Visit12,12,Phase 2,344,2,95,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,3000,Visit13,13,Phase 2,367,2,89,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,3200,Visit14,14,Phase 2,400,2,43,3,,0,1,,,,,3,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,3400,Visit15,15,Phase 2,428,2,100,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,3600,Visit16,16,Phase 2,465,2,97,3,,0,1,,,,,1,3,,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,3800,Visit17,17,Phase 2,486,2,100,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,4000,Visit18,18,Phase 2,512,2,96,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,5200,EndofPhase1_1a,5,Phase 1/1A,162,1 or 1A,100,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYU438EL6,1409,,,F,5800,EndofPhase2,18,Phase 2,512,2,96,4,,0,1,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV384BA9,2432,,,F,600,Visit1,1,Phase 1/1A,37,1 or 1A,99,3,,1,,,,,,1,3,120,,,2,,4,156,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV384BA9,2432,,,F,800,Visit2,2,Phase 1/1A,72,1 or 1A,96,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV384BA9,2432,,,F,1000,Visit3,3,Phase 1/1A,93,1 or 1A,94,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV384BA9,2432,,,F,1200,Visit4,4,Phase 1/1A,120,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV384BA9,2432,,,F,1400,Visit5,5,Phase 1/1A,155,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV384BA9,2432,,,F,1600,Visit6,6,Phase 1/1A,199,1 or 1A,93,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV384BA9,2432,,,F,1800,Visit7,7,Phase 1/1A,212,1 or 1A,96,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV384BA9,2432,,,F,2000,Visit8,8,Phase 1/1A,231,1 or 1A,,4,,1,,,,,,,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV384BA9,2432,,,F,4000,Visit18,18,Phase 1/1A,282,1 or 1A,98,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,,,,,,,1,1,1.5,,,2,,3,5,6,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,800,Visit2,2,Phase 1/1A,65,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,1000,Visit3,3,Phase 1/1A,100,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,1200,Visit4,4,Phase 1/1A,128,1 or 1A,94,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,1600,Visit6,6,Phase 1/1A,166,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,86,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,2200,Visit9,9,Phase 1/1A,247,1 or 1A,100,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,2400,Visit10,10,Phase 1/1A,275,1 or 1A,96,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,2600,Visit11,11,Phase 1/1A,303,1 or 1A,94,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,2800,Visit12,12,Phase 1/1A,331,1 or 1A,34,4,,1,,,,,,3,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,3000,Visit13,13,Phase 1/1A,359,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,3200,Visit14,14,Phase 1/1A,387,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,3400,Visit15,15,Phase 1/1A,409,1 or 1A,99,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,3600,Visit16,16,Phase 1/1A,436,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,3800,Visit17,17,Phase 1/1A,457,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYV558JKN,1617,,,M,4000,Visit18,18,Phase 1/1A,491,1 or 1A,100,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,1,,,,,,1,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,1800,Visit7,7,Phase 1/1A,194,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,97,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,2400,Visit10,10,Phase 1/1A,279,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,2800,Visit12,12,Phase 1/1A,312,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,3000,Visit13,13,Phase 1/1A,357,1 or 1A,98,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,3400,Visit15,15,Phase 1/1A,417,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,3600,Visit16,16,Phase 1/1A,445,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW349DX4,2510,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,497,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW648YM5,2386,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,84,2,,1,,,,,,1,2,16,,,2,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,94,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,1200,Visit4,4,Phase 1/1A,121,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,1400,Visit5,5,Phase 1/1A,149,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,2200,Visit9,9,Phase 1/1A,261,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,2400,Visit10,10,Phase 1/1A,289,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,2600,Visit11,11,Phase 1/1A,317,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,2800,Visit12,12,Phase 1/1A,345,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,3000,Visit13,13,Phase 1/1A,373,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,3200,Visit14,14,Phase 1/1A,402,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,3400,Visit15,15,Phase 1/1A,435,1 or 1A,97,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,3600,Visit16,16,Phase 1/1A,458,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,3800,Visit17,17,Phase 1/1A,486,1 or 1A,100,4,,0,1,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYW713NWQ,2468,,,M,4000,Visit18,18,Phase 1/1A,508,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,3,,,,,,,,1,3,4.5,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,93,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,90,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,95,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,1400,Visit5,5,Phase 1/1A,151,1 or 1A,91,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,86,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,89,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,89,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,75,2,,0,1,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,93,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,2600,Visit11,11,Phase 1/1A,312,1 or 1A,86,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,2800,Visit12,12,Phase 1/1A,347,1 or 1A,89,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,3000,Visit13,13,Phase 1/1A,384,1 or 1A,88,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,3200,Visit14,14,Phase 1/1A,403,1 or 1A,89,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,3400,Visit15,15,Phase 1/1A,438,1 or 1A,97,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,3600,Visit16,16,Phase 1/1A,466,1 or 1A,89,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,3800,Visit17,17,Phase 1/1A,504,1 or 1A,95,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX172DCJ,2058,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,522,1 or 1A,89,2,,0,1,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX695ZU9,2168,,,M,800,Visit2,2,Phase 2,64,2,84,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX695ZU9,2168,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,31,1 or 1A,93,4,,1,,,,,,1,4,800,,,2,2,4,800,800,4,4,160,160,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYX695ZU9,2168,,,M,5800,EndofPhase2,3,Phase 2,102,2,58,4,,1,,,,,,2,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,80,2,,,,,,,,1,2,15,,,2,2,2,17,15,2,4,140,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,74,2,,,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,1000,Visit3,3,Phase 1/1A,92,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,88,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,1600,Visit6,6,Phase 1/1A,173,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,93,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,2200,Visit9,9,Phase 1/1A,257,1 or 1A,100,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,90,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,2800,Visit12,12,Phase 1/1A,341,1 or 1A,68,2,,1,,,,,,2,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,3000,Visit13,13,Phase 1/1A,362,1 or 1A,82,2,,1,,,,,,1,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,3200,Visit14,14,Phase 1/1A,393,1 or 1A,62,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,3400,Visit15,15,Phase 1/1A,431,1 or 1A,76,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,3600,Visit16,16,Phase 1/1A,449,1 or 1A,18,3,,1,,,,,,4,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,4200,Visit19,19,Phase 2,544,2,87,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,4400,Visit20,20,Phase 2,560,2,100,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,4600,Visit21,21,Phase 2,596,2,99,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,4800,Visit22,22,Phase 2,617,2,,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,76,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ011TV0,1555,,,M,5800,EndofPhase2,23,Phase 2,644,2,99,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,73,2,,1,,,,,,2,2,400,,,2,2,2,400,400,2,2,80,80,2,80,80,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,1000,Visit3,3,Phase 2,88,2,98,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,1200,Visit4,4,Phase 2,127,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,1400,Visit5,5,Phase 2,145,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,1800,Visit7,7,Phase 3,198,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,2000,Visit8,8,Phase 3,233,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,2200,Visit9,9,Phase 3,254,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,2400,Visit10,10,Phase 3,282,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,2600,Visit11,11,Phase 3,310,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,2800,Visit12,12,Phase 3,338,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,3000,Visit13,13,Phase 3,367,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,3400,Visit15,15,Phase 3,435,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,3600,Visit16,16,Phase 3,450,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,3800,Visit17,17,Phase 3,478,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,54,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,5800,EndofPhase2,6,Phase 2,177,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ748FC0,2826,,,M,6000,EndofPhase3,18,Phase 3,515,3,,,,,,4,80,,,1,,,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVYZ979KAE,1004,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZA315XLU,1982,,,F,800,Visit2,2,Phase 2,59,2,100,5,,,,,,,,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZA315XLU,1982,,,F,1000,Visit3,3,Phase 2,83,2,99,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZA315XLU,1982,,,F,1200,Visit4,4,Phase 2,111,2,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZA315XLU,1982,,,F,1400,Visit5,5,Phase 2,132,2,100,3,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZA315XLU,1982,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,30,1 or 1A,87,2,,,,,,,,1,2,3,,,1,3,2,3,3,2,4,,,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZA367GRG,2128,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZA367GRG,2128,,,M,800,Visit2,2,Phase 1/1A,50,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZA367GRG,2128,,,M,1000,Visit3,3,Phase 1/1A,79,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZA367GRG,2128,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZA367GRG,2128,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,169,1 or 1A,50,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZA489JDG,2850,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,31,1 or 1A,100,2,,1,,,,,,1,2,15,,,1,,2,15,15,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZA947JV5,2280,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,53,3,,1,,,,,,2,3,22.5,,,1,,3,19,19,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZA947JV5,2280,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,58,1 or 1A,0,2,,,,,,,,4,2,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,800,Visit2,2,Phase 2,58,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,1200,Visit4,4,Phase 3,117,3,,,,,,,10,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,1400,Visit5,5,Phase 3,141,3,,,,,,,10,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,1600,Visit6,6,Phase 3,171,3,,,,,,,10,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,1800,Visit7,7,Phase 3,199,3,,,,,,,10,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,2000,Visit8,8,Phase 3,241,3,,,,,,,10,5,16,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,2200,Visit9,9,Phase 3,254,3,,,,,,,10,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,2400,Visit10,10,Phase 3,282,3,,,,,,,15,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,2600,Visit11,11,Phase 3,310,3,,,,,,,15,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,2800,Visit12,12,Phase 3,339,3,,,,,,,15,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,3000,Visit13,13,Phase 3,372,3,,,,,,,10,5,8,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,3200,Visit14,14,Phase 3,394,3,,,,,,,10,5,16,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,3400,Visit15,15,Phase 3,422,3,,,,,,,10,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,3600,Visit16,16,Phase 3,450,3,,,,,,,10,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,3800,Visit17,17,Phase 3,479,3,,,,,,,10,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,30,1 or 1A,98,3,,1,,,,,,1,3,600,,,2,2,3,600,600,3,3,19,19,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,5800,EndofPhase2,3,Phase 2,82,2,11,3,,1,,,,,,4,3,,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB079KUC,2757,,,F,6000,EndofPhase3,18,Phase 3,500,3,,,,,,,10,5,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,,,,,,,1,3,22.5,,,1,,4,30,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,1000,Visit3,3,Phase 1/1A,90,1 or 1A,86,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,1400,Visit5,5,Phase 1/1A,146,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,1800,Visit7,7,Phase 1/1A,203,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,2000,Visit8,8,Phase 1/1A,231,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,2200,Visit9,9,Phase 1/1A,259,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,2400,Visit10,10,Phase 1/1A,287,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,2600,Visit11,11,Phase 1/1A,315,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,2800,Visit12,12,Phase 1/1A,330,1 or 1A,93,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,3000,Visit13,13,Phase 1/1A,360,1 or 1A,97,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,3200,Visit14,14,Phase 1/1A,387,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,3400,Visit15,15,Phase 1/1A,416,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,3800,Visit17,17,Phase 1/1A,479,1 or 1A,100,4,,,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,4000,Visit18,18,Phase 1/1A,511,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,4200,Visit19,19,Phase 1/1A,533,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZB671CCF,1384,,,F,5200,EndofPhase1_1a,20,Phase 1/1A,573,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,16,,,1,2,2,19,16,2,4,160,160,4,29,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,91,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,1200,Visit4,4,Phase 1B,107,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,1400,Visit5,5,Phase 1B,128,1B,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,1600,Visit6,6,Phase 1B,148,1B,72,4,,1,,,,,,2,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,2200,Visit9,9,Phase 3,228,3,,,,,,1,20,,0,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,2400,Visit10,10,Phase 3,253,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,2600,Visit11,11,Phase 3,288,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,2800,Visit12,12,Phase 3,323,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,3000,Visit13,13,Phase 3,360,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,3200,Visit14,14,Phase 3,395,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,3400,Visit15,15,Phase 3,429,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,3600,Visit16,16,Phase 3,457,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,3800,Visit17,17,Phase 3,491,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,80,1 or 1A,88,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,5400,EndofPhase1b,7,Phase 1B,169,1B,80,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,5800,EndofPhase2,8,Phase 2,177,2,70,4,,1,,,,,,2,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC017DAL,2098,,,M,6000,EndofPhase3,18,Phase 3,533,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,600,Visit1,1,Phase 1/1A,46,1 or 1A,100,2,,,,,,,,1,2,3,,,2,,2,2,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,800,Visit2,2,Phase 1/1A,75,1 or 1A,87,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,1000,Visit3,3,Phase 1/1A,103,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,1200,Visit4,4,Phase 1/1A,131,1 or 1A,100,1,,,,,,,,4,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,1400,Visit5,5,Phase 1/1A,152,1 or 1A,52,1,,,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,1800,Visit7,7,Phase 1/1A,193,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,2000,Visit8,8,Phase 1/1A,231,1 or 1A,31,2,,,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,2200,Visit9,9,Phase 1/1A,266,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,2400,Visit10,10,Phase 1/1A,287,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,2800,Visit12,12,Phase 1/1A,334,1 or 1A,100,1,,,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,,2,,,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,3400,Visit15,15,Phase 1/1A,419,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,3600,Visit16,16,Phase 1/1A,454,1 or 1A,6,2,,1,,,,,,4,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,3800,Visit17,17,Phase 1/1A,475,1 or 1A,,2,,1,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,4000,Visit18,18,Phase 1/1A,502,1 or 1A,,2,,,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC126XG4,1539,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,502,1 or 1A,,2,,1,,,,,,,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,3,4,5,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,800,Visit2,2,Phase 1/1A,59,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,1600,Visit6,6,Phase 1/1A,175,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,1800,Visit7,7,Phase 1/1A,217,1 or 1A,98,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,2000,Visit8,8,Phase 1/1A,238,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,2200,Visit9,9,Phase 1/1A,266,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,2400,Visit10,10,Phase 1/1A,294,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,2600,Visit11,11,Phase 1/1A,315,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,3200,Visit14,14,Phase 1/1A,392,1 or 1A,99,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,3400,Visit15,15,Phase 1/1A,420,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,3600,Visit16,16,Phase 1/1A,448,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,3800,Visit17,17,Phase 1/1A,476,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC132JY9,1815,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,504,1 or 1A,100,4,,1,,,,,,,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC401KAW,2174,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,1,,,,,,1,2,80,,,2,,3,100,100,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC401KAW,2174,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,43,1 or 1A,54,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC637XPY,2046,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,37,2,,,,,,,,3,2,80,,,2,,3,120,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC637XPY,2046,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,94,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC637XPY,2046,,,F,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC637XPY,2046,,,F,1200,Visit4,4,Phase 1/1A,124,1 or 1A,70,3,,1,,,,,,2,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC637XPY,2046,,,F,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC637XPY,2046,,,F,1600,Visit6,6,Phase 1/1A,178,1 or 1A,,3,,,,,,,,,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC675ZWV,1768,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,,,,,,,1,2,3,,,1,2,3,4,3,3,3,600,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC675ZWV,1768,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,89,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC675ZWV,1768,,,F,1000,Visit3,3,Phase 1/1A,91,1 or 1A,93,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC675ZWV,1768,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,110,1 or 1A,,4,,1,,,,,,,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZC675ZWV,1768,,,F,5800,EndofPhase2,5,Phase 2,124,2,2,3,,1,,,,,,4,3,,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD259FL1,2863,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,97,2,,,,,,,,1,2,3,,,2,2,2,3,3,2,1,200,200,1,115,150,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,1200,Visit4,4,Phase 3,113,3,,,,,,6,25,,,1,,,,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,1400,Visit5,5,Phase 3,143,3,,,,,,6,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,1600,Visit6,6,Phase 3,172,3,,,,,,6,50,,,1,,,,50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,1800,Visit7,7,Phase 3,201,3,,,,,,6,75,,,1,,,,75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,2000,Visit8,8,Phase 3,227,3,,,,,,6,75,,,1,,,,75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,2200,Visit9,9,Phase 3,260,3,,,,,,6,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,2400,Visit10,10,Phase 3,276,3,,,,,,6,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,2600,Visit11,11,Phase 3,305,3,,,,,,6,150,,,1,,,,150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,2800,Visit12,12,Phase 3,345,3,,,,,,6,150,,,1,,,,150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,3000,Visit13,13,Phase 3,362,3,,,,,,6,150,,,1,,,,150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,3200,Visit14,14,Phase 3,390,3,,,,,,6,150,,,1,,,,150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,3400,Visit15,15,Phase 3,432,3,,,,,,6,150,,,1,,,,150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,3600,Visit16,16,Phase 3,458,3,,,,,,6,150,,,1,,,,150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,3800,Visit17,17,Phase 3,472,3,,,,,,6,150,,,1,,,,150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,4000,Visit18,18,Phase 3,521,3,,,,,,6,200,,,1,,,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,64,1 or 1A,81,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZD464XBQ,1352,,,M,5800,EndofPhase2,3,Phase 2,88,2,56,1,,,,,,,,2,1,,200,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZE002CN1,2104,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF004WP5,2273,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,86,2,,1,,,,,,1,2,3,,,2,3,4,6,6,4,,100,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF004WP5,2273,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF004WP5,2273,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,92,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF004WP5,2273,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,81,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF004WP5,2273,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,92,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF004WP5,2273,,,M,1600,Visit6,6,Phase 1/1A,182,1 or 1A,78,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF004WP5,2273,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,69,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF004WP5,2273,,,M,2000,Visit8,8,Phase 1/1A,223,1 or 1A,73,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF004WP5,2273,,,M,2200,Visit9,9,Phase 1/1A,250,1 or 1A,86,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF004WP5,2273,,,M,2400,Visit10,10,Phase 1/1A,280,1 or 1A,73,4,,1,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF004WP5,2273,,,M,2600,Visit11,11,Phase 1/1A,315,1 or 1A,67,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF004WP5,2273,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,323,1 or 1A,,4,,1,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF004WP5,2273,,,M,5800,EndofPhase2,13,Phase 2,344,2,97,,100,,,,,,,1,,,100,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,600,Visit1,1,Phase 1/1A,32,1 or 1A,90,2,,1,,,,,,1,2,400,,,1,1,2,433,400,2,2,3,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,800,Visit2,2,Phase 1/1A,60,1 or 1A,96,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,1000,Visit3,3,Phase 1/1A,89,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,96,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,1400,Visit5,5,Phase 1/1A,144,1 or 1A,87,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,1800,Visit7,7,Phase 1/1A,202,1 or 1A,89,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,2000,Visit8,8,Phase 1/1A,235,1 or 1A,,3,,0,1,,,,,,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,2200,Visit9,9,Phase 1/1A,263,1 or 1A,100,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,2400,Visit10,10,Phase 1/1A,293,1 or 1A,97,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,2600,Visit11,11,Phase 1/1A,321,1 or 1A,84,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,3000,Visit13,13,Phase 2,384,2,95,2,,0,1,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,5200,EndofPhase1_1a,12,Phase 1/1A,348,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF305EDY,2518,,,F,5800,EndofPhase2,14,Phase 2,407,2,22,2,,0,1,,,,,4,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF330CXA,2522,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,2,,0,1,,,,,1,2,400,,,1,2,3,600,600,3,2,80,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF330CXA,2522,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF330CXA,2522,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,85,1 or 1A,100,4,,0,1,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZF330CXA,2522,,,F,5800,EndofPhase2,4,Phase 2,113,2,68,2,,0,2,,,,,2,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG053MM6,1009,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,2,,,,,,,,1,2,3,,,1,2,2,3,3,2,4,800,800,4,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG053MM6,1009,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,83,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG053MM6,1009,,,M,1000,Visit3,3,Phase 1/1A,108,1 or 1A,70,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG053MM6,1009,,,M,1200,Visit4,4,Phase 1/1A,129,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG053MM6,1009,,,M,1400,Visit5,5,Phase 1/1A,151,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG053MM6,1009,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,57,2,,,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG053MM6,1009,,,M,1800,Visit7,7,Phase 1/1A,204,1 or 1A,100,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG053MM6,1009,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,219,2,27,4,,,,,,,,3,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,600,Visit1,1,Phase 1/1A,31,1 or 1A,75,2,,1,,,,,,2,2,80,,,2,1,2,80,80,2,2,3,3,2,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,800,Visit2,2,Phase 1/1A,52,1 or 1A,95,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,1000,Visit3,3,Phase 1/1A,87,1 or 1A,100,2,,,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,1600,Visit6,6,Phase 2,169,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,1800,Visit7,7,Phase 2,192,2,64,2,,1,,,,,,2,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,2000,Visit8,8,Phase 2,219,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,2200,Visit9,9,Phase 2,247,2,96,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,2400,Visit10,10,Phase 2,303,2,66,2,,1,,,,,,2,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,2600,Visit11,11,Phase 2,331,2,96,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,2800,Visit12,12,Phase 2,359,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,3000,Visit13,13,Phase 2,393,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,3200,Visit14,14,Phase 2,422,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,3400,Visit15,15,Phase 2,463,2,96,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,3600,Visit16,16,Phase 2,491,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,3800,Visit17,17,Phase 2,519,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,4000,Visit18,18,Phase 2,547,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,121,1 or 1A,,2,,1,,,,,,1,2,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZG288UA6,2003,,,M,5800,EndofPhase2,19,Phase 2,575,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH210YRA,1421,,,F,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,1,,2,2,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,89,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,56,2,,1,,,,,,2,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,50,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,97,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,2400,Visit10,10,Phase 1/1A,288,1 or 1A,97,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,2600,Visit11,11,Phase 1/1A,318,1 or 1A,,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,2800,Visit12,12,Phase 1/1A,347,1 or 1A,,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,3000,Visit13,13,Phase 1/1A,368,1 or 1A,,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,3200,Visit14,14,Phase 1/1A,401,1 or 1A,100,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,3400,Visit15,15,Phase 1/1A,427,1 or 1A,88,2,,1,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,3600,Visit16,16,Phase 1/1A,456,1 or 1A,66,1,,1,,,,,,2,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,3800,Visit17,17,Phase 1/1A,484,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH401DX1,2804,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,512,1 or 1A,100,1,,1,,,,,,1,1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH488YFD,1330,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,2,4,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH488YFD,1330,,,M,800,Visit2,2,Phase 1/1A,53,1 or 1A,91,2,,,,,,,,1,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH488YFD,1330,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,86,1 or 1A,96,3,,,,,,,,1,3,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH723BZD,2470,,,M,600,Visit1,1,Phase 1/1A,42,1 or 1A,38,1,,1,,,,,,3,1,200,,,2,,1,200,200,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,76,2,,0,1,,,,,1,2,400,,,1,,2,456,400,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,97,2,,0,1,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,1200,Visit4,4,Phase 1/1A,119,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,1400,Visit5,5,Phase 1/1A,145,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,1800,Visit7,7,Phase 1/1A,210,1 or 1A,99,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,2000,Visit8,8,Phase 1/1A,236,1 or 1A,100,3,,0,1,,,,,3,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,2400,Visit10,10,Phase 1/1A,277,1 or 1A,87,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,3000,Visit13,13,Phase 1/1A,365,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,3200,Visit14,14,Phase 1/1A,398,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,3400,Visit15,15,Phase 1/1A,435,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,94,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,3800,Visit17,17,Phase 1/1A,482,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZH818ULC,2455,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,509,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,600,Visit1,1,Phase 1/1A,44,1 or 1A,86,2,,1,,,,,,1,2,400,,,2,2,2,400,400,2,2,86,80,2,17,15,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,93,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,1400,Visit5,5,Phase 2,141,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,1600,Visit6,6,Phase 2,169,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,1800,Visit7,7,Phase 2,197,2,100,3,,1,,,,,,1,3,,120,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,2000,Visit8,8,Phase 2,226,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,2200,Visit9,9,Phase 2,252,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,2400,Visit10,10,Phase 2,288,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,2800,Visit12,12,Phase 3,337,3,,,,,,8,15,8,15,1,,,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,3000,Visit13,13,Phase 3,367,3,,,,,,8,15,,0,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,3200,Visit14,14,Phase 3,393,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,3400,Visit15,15,Phase 3,421,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,3600,Visit16,16,Phase 3,452,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,3800,Visit17,17,Phase 3,478,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,5200,EndofPhase1_1a,4,Phase 1/1A,113,1 or 1A,93,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,5800,EndofPhase2,11,Phase 2,303,2,100,2,,1,,,,,,1,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ340TPB,2185,,,F,6000,EndofPhase3,18,Phase 3,505,3,,,,,,8,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,100,3,,1,,,,,,1,3,600,,,2,3,3,644,600,3,4,317,300,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,800,Visit2,2,Phase 1/1A,63,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,1200,Visit4,4,Phase 1/1A,120,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,2000,Visit8,8,Phase 1/1A,226,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,2200,Visit9,9,Phase 2,254,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,2400,Visit10,10,Phase 2,289,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,2600,Visit11,11,Phase 2,324,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,2800,Visit12,12,Phase 2,345,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,3000,Visit13,13,Phase 2,371,2,100,,300,,,,,,,1,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,3200,Visit14,14,Phase 2,394,2,92,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,3400,Visit15,15,Phase 2,422,2,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,3600,Visit16,16,Phase 2,450,2,100,,400,,,,,,,1,,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,3800,Visit17,17,Phase 2,478,2,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,4000,Visit18,18,Phase 2,506,2,100,4,,1,,,,,,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ551UCZ,2508,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,245,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZJ890VAE,1818,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,69,1 or 1A,15,2,,0,1,,,,,4,2,400,,,1,,2,400,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,2,1,3,23,23,3,3,5,5,3,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,800,Visit2,2,Phase 1/1A,49,1 or 1A,98,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,1000,Visit3,3,Phase 1/1A,77,1 or 1A,92,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,1200,Visit4,4,Phase 1/1A,105,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,1600,Visit6,6,Phase 2,147,2,98,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,1800,Visit7,7,Phase 2,168,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,2000,Visit8,8,Phase 2,210,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,2200,Visit9,9,Phase 2,238,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,2400,Visit10,10,Phase 2,266,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,2600,Visit11,11,Phase 2,287,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,2800,Visit12,12,Phase 2,315,2,100,3,,,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,3000,Visit13,13,Phase 2,343,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,3200,Visit14,14,Phase 2,371,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,3400,Visit15,15,Phase 2,392,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,3600,Visit16,16,Phase 2,420,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,3800,Visit17,17,Phase 2,448,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,5200,EndofPhase1_1a,5,Phase 1/1A,111,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK240HUH,2764,,,F,5800,EndofPhase2,18,Phase 2,490,2,100,3,,1,,,,,,1,3,,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,600,Visit1,1,Phase 1/1A,29,1 or 1A,89,3,,,,,,,,1,3,22.5,,,2,,3,25,23,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,800,Visit2,2,Phase 1/1A,55,1 or 1A,80,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,1000,Visit3,3,Phase 1/1A,78,1 or 1A,81,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,1200,Visit4,4,Phase 1/1A,105,1 or 1A,100,3,,,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,1400,Visit5,5,Phase 1/1A,134,1 or 1A,62,3,,1,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,1600,Visit6,6,Phase 1/1A,184,1 or 1A,62,3,,,,,,,,2,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,2000,Visit8,8,Phase 1/1A,226,1 or 1A,95,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,2200,Visit9,9,Phase 1/1A,254,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,2400,Visit10,10,Phase 1/1A,281,1 or 1A,99,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,2600,Visit11,11,Phase 1/1A,318,1 or 1A,76,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,2800,Visit12,12,Phase 1/1A,351,1 or 1A,,4,,1,,,,,,,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,3000,Visit13,13,Phase 1/1A,379,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,3200,Visit14,14,Phase 1/1A,400,1 or 1A,,4,,1,,,,,,,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,3400,Visit15,15,Phase 1/1A,421,1 or 1A,,4,,1,,,,,,,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK633ZJJ,1760,,,F,3600,Visit16,16,Phase 1/1A,456,1 or 1A,,4,,1,,,,,,,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,4,,,,,,,,1,4,32,,,1,,4,32,32,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,800,Visit2,2,Phase 1/1A,62,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,1000,Visit3,3,Phase 1/1A,90,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,1200,Visit4,4,Phase 1/1A,118,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,1400,Visit5,5,Phase 1/1A,148,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,1600,Visit6,6,Phase 1/1A,174,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,2600,Visit11,11,Phase 1/1A,303,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,3200,Visit14,14,Phase 1/1A,394,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,4,,1,,,,,,3,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,3600,Visit16,16,Phase 1/1A,446,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,3800,Visit17,17,Phase 1/1A,471,1 or 1A,100,4,,,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,4000,Visit18,18,Phase 1/1A,495,1 or 1A,100,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,4200,Visit19,19,Phase 1/1A,523,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,4400,Visit20,20,Phase 1/1A,551,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK736AJ2,2097,,,M,4600,Visit21,21,Phase 1/1A,579,1 or 1A,100,4,,1,,,,,,2,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK741LAD,1206,,,M,600,Visit1,1,Phase 1/1A,37,1 or 1A,100,1,,,,,,,,1,1,7.5,,,1,,1,8,8,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK741LAD,1206,,,M,800,Visit2,2,Phase 1/1A,69,1 or 1A,100,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK741LAD,1206,,,M,1000,Visit3,3,Phase 1/1A,98,1 or 1A,64,1,,,,,,,,3,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK741LAD,1206,,,M,1200,Visit4,4,Phase 1/1A,125,1 or 1A,93,1,,,,,,,,1,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,97,3,,1,,,,,,1,3,120,,,2,1,3,130,120,3,2,300,300,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,96,3,,0,2,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,96,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,1400,Visit5,5,Phase 2,120,2,100,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,1800,Visit7,7,Phase 3,176,3,,,,,,,10,5,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,2000,Visit8,8,Phase 3,204,3,,,,,,,10,5,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,2200,Visit9,9,Phase 3,253,3,,,,,,,15,5,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,2400,Visit10,10,Phase 3,281,3,,,,,,,20,5,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,2600,Visit11,11,Phase 3,309,3,,,,,,,20,5,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,2800,Visit12,12,Phase 3,344,3,,,,,,,30,5,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,,30,5,4,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,,30,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,,30,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,,30,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,3800,Visit17,17,Phase 3,475,3,,,,,,,30,5,8,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,92,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,5800,EndofPhase2,6,Phase 2,148,2,100,1,,0,1,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZK857MGR,2801,,,M,6000,EndofPhase3,18,Phase 3,505,3,,,,,,,30,5,12,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZL037CT6,2890,,,F,800,Visit2,2,Phase 1/1A,64,1 or 1A,97,3,,1,,,,,,1,3,24,,,1,,3,24,24,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZL222KFD,2428,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,80,2,,1,,,,,,1,2,3,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZL222KFD,2428,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,39,1 or 1A,30,2,,1,,,,,,3,2,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,90,2,,1,,,,,,1,2,80,,,2,,3,133,120,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,800,Visit2,2,Phase 1/1A,68,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,88,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,88,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,1600,Visit6,6,Phase 1/1A,170,1 or 1A,91,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,1800,Visit7,7,Phase 1/1A,198,1 or 1A,100,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,97,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,76,4,,1,,,,,,1,4,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,2400,Visit10,10,Phase 1/1A,282,1 or 1A,89,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,2600,Visit11,11,Phase 1/1A,309,1 or 1A,91,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,2800,Visit12,12,Phase 1/1A,337,1 or 1A,95,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,3000,Visit13,13,Phase 1/1A,368,1 or 1A,97,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,3200,Visit14,14,Phase 1/1A,400,1 or 1A,89,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,3400,Visit15,15,Phase 1/1A,421,1 or 1A,100,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,3600,Visit16,16,Phase 1/1A,450,1 or 1A,,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,3800,Visit17,17,Phase 1/1A,477,1 or 1A,81,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZM258APH,2311,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,508,1 or 1A,86,3,,1,,,,,,1,3,120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZN083WAB,1295,,,M,600,Visit1,1,Phase 1/1A,24,1 or 1A,50,2,,,,,,,,3,2,400,,,2,,2,333,400,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZN083WAB,1295,,,M,800,Visit2,2,Phase 1/1A,52,1 or 1A,100,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZN083WAB,1295,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,80,1 or 1A,100,1,,,,,,,,1,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR336YKJ,2032,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,100,2,,1,,,,,,1,2,16,,,1,,2,16,16,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,95,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,96,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,93,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,1600,Visit6,6,Phase 1/1A,169,1 or 1A,89,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,79,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,2000,Visit8,8,Phase 1/1A,227,1 or 1A,97,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,2200,Visit9,9,Phase 1/1A,254,1 or 1A,72,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,85,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,83,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,2800,Visit12,12,Phase 1/1A,338,1 or 1A,61,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,3000,Visit13,13,Phase 1/1A,369,1 or 1A,70,2,,1,,,,,,2,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,3200,Visit14,14,Phase 1/1A,397,1 or 1A,80,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,3400,Visit15,15,Phase 1/1A,425,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,3600,Visit16,16,Phase 1/1A,453,1 or 1A,79,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,3800,Visit17,17,Phase 1/1A,479,1 or 1A,90,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR477LH7,2336,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,509,1 or 1A,100,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR518GZB,2176,,,M,600,Visit1,1,Phase 1/1A,35,1 or 1A,100,3,,0,1,,,,,1,3,4.5,,,1,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR518GZB,2176,,,M,800,Visit2,2,Phase 1/1A,71,1 or 1A,53,3,,1,,,,,,2,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,79,2,,1,,,,,,2,2,400,,,2,,3,614,800,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,100,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,1000,Visit3,3,Phase 1/1A,78,1 or 1A,95,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,1200,Visit4,4,Phase 1/1A,105,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,1400,Visit5,5,Phase 1/1A,133,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,1600,Visit6,6,Phase 1/1A,161,1 or 1A,44,2,,1,,,,,,3,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,1800,Visit7,7,Phase 1/1A,185,1 or 1A,92,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,2000,Visit8,8,Phase 1/1A,220,1 or 1A,91,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,2200,Visit9,9,Phase 1/1A,241,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,2400,Visit10,10,Phase 1/1A,269,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,2600,Visit11,11,Phase 1/1A,304,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,2800,Visit12,12,Phase 1/1A,325,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,3000,Visit13,13,Phase 1/1A,353,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,3200,Visit14,14,Phase 1/1A,388,1 or 1A,,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR791ULN,1781,,,M,5200,EndofPhase1_1a,15,Phase 1/1A,396,1 or 1A,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,93,2,,1,,,,,,1,2,16,,,1,,4,30,32,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,800,Visit2,2,Phase 1/1A,61,1 or 1A,96,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,1000,Visit3,3,Phase 1/1A,82,1 or 1A,98,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,1200,Visit4,4,Phase 1/1A,110,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,1600,Visit6,6,Phase 1/1A,177,1 or 1A,97,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,1800,Visit7,7,Phase 1/1A,205,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,2000,Visit8,8,Phase 1/1A,233,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,2200,Visit9,9,Phase 1/1A,257,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,2400,Visit10,10,Phase 1/1A,278,1 or 1A,95,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,2600,Visit11,11,Phase 1/1A,310,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,2800,Visit12,12,Phase 1/1A,341,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,3000,Visit13,13,Phase 1/1A,366,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,3200,Visit14,14,Phase 1/1A,397,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,3400,Visit15,15,Phase 1/1A,429,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,3600,Visit16,16,Phase 1/1A,454,1 or 1A,92,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,3800,Visit17,17,Phase 1/1A,478,1 or 1A,100,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZR817KBP,2251,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,509,1 or 1A,93,4,,1,,,,,,1,4,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,88,2,,,,,,,,1,2,400,,,2,1,2,475,400,2,2,3,3,2,16,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,1000,Visit3,3,Phase 1/1A,77,1 or 1A,86,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,1200,Visit4,4,Phase 1/1A,105,1 or 1A,96,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,60,1,,,,,,,,2,1,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,1600,Visit6,6,Phase 1/1A,182,1 or 1A,,3,,,,,,,,,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,1800,Visit7,7,Phase 1/1A,203,1 or 1A,65,2,,,,,,,,2,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,2400,Visit10,10,Phase 2,266,2,,2,,,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,2600,Visit11,11,Phase 2,301,2,,2,,,,,,,,4,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,3000,Visit13,13,Phase 3,364,3,,,,,,1,10,,,2,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,3200,Visit14,14,Phase 3,392,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,1,15,,,1,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,1,15,,,2,,,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,5200,EndofPhase1_1a,9,Phase 1/1A,237,1 or 1A,91,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,5800,EndofPhase2,12,Phase 2,329,2,,2,,,,,,,,4,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT470LM3,1625,,,M,6000,EndofPhase3,18,Phase 3,498,3,,,,,,1,20,,,1,,,,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT810LKK,1100,,,M,600,Visit1,1,Phase 1/1A,33,1 or 1A,100,2,,,,,,,,1,2,400,,,2,,3,500,500,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT810LKK,1100,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,72,1 or 1A,30,3,,,,,,,,3,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT841FC7,2452,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,2,,1,,,,,,1,2,400,,,1,,3,583,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT841FC7,2452,,,M,800,Visit2,2,Phase 1/1A,55,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT841FC7,2452,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT841FC7,2452,,,M,1200,Visit4,4,Phase 1/1A,111,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT841FC7,2452,,,M,1400,Visit5,5,Phase 1/1A,139,1 or 1A,100,3,,0,1,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT841FC7,2452,,,M,1600,Visit6,6,Phase 1/1A,167,1 or 1A,98,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT841FC7,2452,,,M,1800,Visit7,7,Phase 1/1A,195,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT841FC7,2452,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT841FC7,2452,,,M,2200,Visit9,9,Phase 1/1A,251,1 or 1A,96,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT841FC7,2452,,,M,2400,Visit10,10,Phase 1/1A,279,1 or 1A,98,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT841FC7,2452,,,M,2600,Visit11,11,Phase 1/1A,301,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZT841FC7,2452,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,323,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU124ADY,2295,,,M,5200,EndofPhase1_1a,1,Phase 1/1A,13,1 or 1A,100,2,,,,,,,,1,2,3,,,1,,2,3,3,2,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,600,Visit1,1,Phase 1/1A,28,1 or 1A,87,3,,1,,,,,,1,3,4.5,,,1,,3,5,5,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,800,Visit2,2,Phase 1/1A,56,1 or 1A,88,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,1000,Visit3,3,Phase 1/1A,81,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,1200,Visit4,4,Phase 1/1A,109,1 or 1A,89,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,1400,Visit5,5,Phase 1/1A,137,1 or 1A,99,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,1600,Visit6,6,Phase 1/1A,176,1 or 1A,97,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,1800,Visit7,7,Phase 1/1A,200,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,2000,Visit8,8,Phase 1/1A,221,1 or 1A,95,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,2200,Visit9,9,Phase 1/1A,249,1 or 1A,96,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,2400,Visit10,10,Phase 1/1A,280,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,2600,Visit11,11,Phase 1/1A,311,1 or 1A,97,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,2800,Visit12,12,Phase 1/1A,343,1 or 1A,97,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,3000,Visit13,13,Phase 1/1A,365,1 or 1A,95,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,3200,Visit14,14,Phase 1/1A,396,1 or 1A,90,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,3400,Visit15,15,Phase 1/1A,423,1 or 1A,86,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,3600,Visit16,16,Phase 1/1A,442,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,3800,Visit17,17,Phase 1/1A,469,1 or 1A,93,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU271LFJ,2790,,,F,5200,EndofPhase1_1a,17,Phase 1/1A,494,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU777BMH,1376,,,F,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,4,,,,,,,,1,4,6,,,2,,4,6,6,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU777BMH,1376,,,F,800,Visit2,2,Phase 1/1A,57,1 or 1A,,4,,,,,,,,,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU777BMH,1376,,,F,1000,Visit3,3,Phase 1/1A,93,1 or 1A,54,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU777BMH,1376,,,F,1200,Visit4,4,Phase 1/1A,117,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU777BMH,1376,,,F,1400,Visit5,5,Phase 1/1A,145,1 or 1A,,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU777BMH,1376,,,F,1600,Visit6,6,Phase 1/1A,182,1 or 1A,76,4,,,,,,,,2,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU777BMH,1376,,,F,1800,Visit7,7,Phase 1/1A,210,1 or 1A,100,4,,,,,,,,3,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU777BMH,1376,,,F,2000,Visit8,8,Phase 1/1A,238,1 or 1A,45,4,,1,,,,,,3,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU777BMH,1376,,,F,5200,EndofPhase1_1a,10,Phase 1/1A,307,1 or 1A,,,,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU996DWF,1614,,,M,600,Visit1,1,Phase 1/1A,26,1 or 1A,75,1,,,,,,,,1,1,7.5,,,1,2,2,11,11,2,1,2,2,1,33,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU996DWF,1614,,,M,1200,Visit4,4,Phase 3,91,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU996DWF,1614,,,M,1400,Visit5,5,Phase 3,110,3,,,,,,1,30,,,1,,,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU996DWF,1614,,,M,1600,Visit6,6,Phase 3,155,3,,,,,,1,40,,,1,,,,40,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU996DWF,1614,,,M,5200,EndofPhase1_1a,2,Phase 1/1A,41,1 or 1A,0,2,,,,,,,,1,2,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZU996DWF,1614,,,M,5800,EndofPhase2,3,Phase 2,49,2,2,1,,,,,,,,1,1,,1.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,600,Visit1,1,Phase 1/1A,36,1 or 1A,,2,,,,,,,,1,2,400,,,2,,4,720,800,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,800,Visit2,2,Phase 1/1A,64,1 or 1A,98,2,,,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,1000,Visit3,3,Phase 1/1A,121,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,1200,Visit4,4,Phase 1/1A,134,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,1400,Visit5,5,Phase 1/1A,162,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,1600,Visit6,6,Phase 1/1A,190,1 or 1A,93,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,1800,Visit7,7,Phase 1/1A,212,1 or 1A,,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,2000,Visit8,8,Phase 1/1A,246,1 or 1A,,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,2200,Visit9,9,Phase 1/1A,273,1 or 1A,95,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,2400,Visit10,10,Phase 1/1A,295,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,2600,Visit11,11,Phase 1/1A,323,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,3000,Visit13,13,Phase 1/1A,372,1 or 1A,99,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,3200,Visit14,14,Phase 1/1A,401,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,3400,Visit15,15,Phase 1/1A,447,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW128RLG,1474,,,M,3800,Visit17,17,Phase 1/1A,466,1 or 1A,,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,100,2,,,,,,,,1,2,16,,,2,,3,24,24,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,800,Visit2,2,Phase 1/1A,60,1 or 1A,85,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,1000,Visit3,3,Phase 1/1A,88,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,94,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,1400,Visit5,5,Phase 1/1A,140,1 or 1A,100,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,1600,Visit6,6,Phase 1/1A,168,1 or 1A,98,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,93,3,,,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,2200,Visit9,9,Phase 1/1A,258,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,88,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,2600,Visit11,11,Phase 1/1A,312,1 or 1A,94,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,2800,Visit12,12,Phase 1/1A,340,1 or 1A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,3000,Visit13,13,Phase 1/1A,368,1 or 1A,,,,,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,3200,Visit14,14,Phase 1/1A,396,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,3400,Visit15,15,Phase 1/1A,424,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,3600,Visit16,16,Phase 1/1A,452,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,3800,Visit17,17,Phase 1/1A,480,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW181KNK,1711,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,508,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,1,,1,,,,,,1,1,8,,,1,1,3,20,24,3,1,250,200,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,94,2,,1,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,1000,Visit3,3,Phase 1/1A,83,1 or 1A,96,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,1800,Visit7,7,Phase 1B,190,1B,100,2,,1,,,,,,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,2000,Visit8,8,Phase 1B,223,1B,,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,2200,Visit9,9,Phase 1B,258,1B,96,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,2400,Visit10,10,Phase 1B,288,1B,93,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,2600,Visit11,11,Phase 1B,308,1B,53,2,,1,,,,,,2,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,2800,Visit12,12,Phase 1B,338,1B,100,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,3000,Visit13,13,Phase 1B,366,1B,,1,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,3400,Visit15,15,Phase 2,415,2,100,1,,0,1,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,3600,Visit16,16,Phase 2,449,2,94,2,,1,,,,,,1,2,,400,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,3800,Visit17,17,Phase 2,475,2,100,1,,1,,,,,,1,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,5200,EndofPhase1_1a,6,Phase 1/1A,171,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,5400,EndofPhase1b,14,Phase 1B,379,1B,100,1,,1,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZW704PKP,2543,,,M,5800,EndofPhase2,18,Phase 2,492,2,70,1,,1,,,,,,3,1,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX006NX8,1655,,,M,600,Visit1,1,Phase 1/1A,32,1 or 1A,90,1,,,,,,,,1,1,8,,,2,,2,12,16,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX006NX8,1655,,,M,800,Visit2,2,Phase 1/1A,72,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX006NX8,1655,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX006NX8,1655,,,M,1200,Visit4,4,Phase 1/1A,113,1 or 1A,100,2,,,,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX006NX8,1655,,,M,1400,Visit5,5,Phase 1/1A,141,1 or 1A,100,0,,,,,,,,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX006NX8,1655,,,M,5200,EndofPhase1_1a,8,Phase 1/1A,233,1 or 1A,31,2,,,,,,,,4,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX111CN3,2314,,,F,600,Visit1,1,Phase 1/1A,37,1 or 1A,96,2,,1,,,,,,1,2,16,,,1,1,2,19,16,2,2,15,15,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX111CN3,2314,,,F,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,3,,1,,,,,,1,3,24,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX111CN3,2314,,,F,1400,Visit5,5,Phase 2,143,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX111CN3,2314,,,F,1600,Visit6,6,Phase 2,170,2,100,2,,1,,,,,,1,2,,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX111CN3,2314,,,F,5200,EndofPhase1_1a,3,Phase 1/1A,87,1 or 1A,100,2,,0,1,,,,,1,2,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX111CN3,2314,,,F,5400,EndofPhase1b,4,Phase 1B,113,1B,15,2,,1,,,,,,4,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,3,,1,,,,,,1,3,22.5,,,1,,4,29,30,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,1000,Visit3,3,Phase 1/1A,86,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,1200,Visit4,4,Phase 1/1A,114,1 or 1A,,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,1400,Visit5,5,Phase 1/1A,142,1 or 1A,80,3,,1,,,,,,1,3,22.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,1600,Visit6,6,Phase 1/1A,172,1 or 1A,85,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,1800,Visit7,7,Phase 1/1A,200,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,2000,Visit8,8,Phase 1/1A,228,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,2200,Visit9,9,Phase 1/1A,256,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,2400,Visit10,10,Phase 1/1A,284,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,2600,Visit11,11,Phase 1/1A,319,1 or 1A,86,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,2800,Visit12,12,Phase 1/1A,346,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,3000,Visit13,13,Phase 1/1A,376,1 or 1A,98,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,3200,Visit14,14,Phase 1/1A,404,1 or 1A,97,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,3400,Visit15,15,Phase 1/1A,432,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,3600,Visit16,16,Phase 1/1A,460,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,3800,Visit17,17,Phase 1/1A,488,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX445VNF,2160,,,M,5200,EndofPhase1_1a,18,Phase 1/1A,534,1 or 1A,100,4,,1,,,,,,1,4,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX552JRP,2494,,,M,600,Visit1,1,Phase 1/1A,30,1 or 1A,100,3,,0,,,,,,1,3,24,,,1,,3,24,24,3,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX552JRP,2494,,,M,800,Visit2,2,Phase 1/1A,72,1 or 1A,100,3,,0,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZX552JRP,2494,,,M,1000,Visit3,3,Phase 1/1A,110,1 or 1A,100,3,,0,,,,,,1,3,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,2,,1,,,,,,1,2,400,,,2,1,2,400,400,2,2,3,3,2,10,10,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,800,Visit2,2,Phase 1/1A,54,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,1200,Visit4,4,Phase 2,107,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,1400,Visit5,5,Phase 2,138,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,1600,Visit6,6,Phase 2,169,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,1800,Visit7,7,Phase 2,196,2,96,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,2000,Visit8,8,Phase 2,223,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,2200,Visit9,9,Phase 2,252,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,2400,Visit10,10,Phase 2,281,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,2600,Visit11,11,Phase 2,309,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,3200,Visit14,14,Phase 3,399,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,3400,Visit15,15,Phase 3,441,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,3800,Visit17,17,Phase 3,477,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,84,1 or 1A,100,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,5800,EndofPhase2,12,Phase 2,331,2,100,2,,1,,,,,,1,2,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY528EBG,2301,,,M,6000,EndofPhase3,18,Phase 3,503,3,,,,,,8,10,,,1,,,,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY642WFE,1930,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,86,2,,1,,,,,,1,2,15,,,2,2,2,15,15,2,2,80,80,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY642WFE,1930,,,M,800,Visit2,2,Phase 1/1A,57,1 or 1A,13,3,,,,,,,,4,3,22.5,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY642WFE,1930,,,M,1200,Visit4,4,Phase 2,141,2,47,2,,0,2,,,,,3,2,,80,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY642WFE,1930,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,112,1 or 1A,,1,,0,2,,,,,4,1,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY642WFE,1930,,,M,5800,EndofPhase2,5,Phase 2,176,2,43,2,,0,2,,,,,3,2,,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,600,Visit1,1,Phase 1/1A,29,1 or 1A,,,,,,,,,,,,,,,2,2,3,600,600,3,4,160,160,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,800,Visit2,2,Phase 1/1A,58,1 or 1A,,3,,1,,,,,,,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,1000,Visit3,3,Phase 1/1A,85,1 or 1A,84,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,1600,Visit6,6,Phase 1/1A,183,1 or 1A,,4,,1,,,,,,,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,1800,Visit7,7,Phase 1/1A,197,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,2000,Visit8,8,Phase 1/1A,225,1 or 1A,,2,,1,,,,,,1,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,2200,Visit9,9,Phase 1/1A,253,1 or 1A,,2,,1,,,,,,,2,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,,3,,1,,,,,,,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,2600,Visit11,11,Phase 1/1A,316,1 or 1A,42,3,,1,,,,,,3,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,2800,Visit12,12,Phase 1/1A,344,1 or 1A,,3,,1,,,,,,,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,3000,Visit13,13,Phase 1/1A,364,1 or 1A,,4,,1,,,,,,,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,3600,Visit16,16,Phase 2,448,2,98,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,3800,Visit17,17,Phase 2,477,2,,4,,1,,,,,,,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,5200,EndofPhase1_1a,15,Phase 1/1A,421,1 or 1A,,4,,1,,,,,,,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY693LFJ,2259,,,M,5800,EndofPhase2,18,Phase 2,506,2,94,4,,1,,,,,,1,4,,160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY740HGN,2378,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,800,Visit2,2,Phase 2,78,2,50,1,,1,,,,,,3,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,1000,Visit3,3,Phase 2,106,2,100,1,,1,,,,,,1,1,,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,1400,Visit5,5,Phase 3,168,3,,,,,,2,100,,,1,,,,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,1600,Visit6,6,Phase 3,195,3,,,,,,2,200,,,1,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,1800,Visit7,7,Phase 3,237,3,,,,,,2,200,,,2,,,,200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,2000,Visit8,8,Phase 3,251,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,2200,Visit9,9,Phase 3,279,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,2400,Visit10,10,Phase 3,307,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,2600,Visit11,11,Phase 3,335,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,2800,Visit12,12,Phase 3,362,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,3000,Visit13,13,Phase 3,400,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,3200,Visit14,14,Phase 3,439,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,3400,Visit15,15,Phase 3,470,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,3600,Visit16,16,Phase 3,502,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,3800,Visit17,17,Phase 3,538,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,5200,EndofPhase1_1a,1,Phase 1/1A,48,1 or 1A,84,2,,1,,,,,,1,2,15,,,1,1,2,15,15,2,1,2,2,1,271,300,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,5800,EndofPhase2,4,Phase 2,123,2,19,2,,1,,,,,,4,2,,3,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY888ZC7,2307,,,F,6000,EndofPhase3,18,Phase 3,573,3,,,,,,2,300,,,1,,,,300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY901AJ9,1779,,,M,600,Visit1,1,Phase 1/1A,28,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY901AJ9,1779,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,87,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY901AJ9,1779,,,M,1000,Visit3,3,Phase 1/1A,91,1 or 1A,99,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY901AJ9,1779,,,M,1200,Visit4,4,Phase 1/1A,116,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY901AJ9,1779,,,M,1400,Visit5,5,Phase 1/1A,144,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY901AJ9,1779,,,M,1600,Visit6,6,Phase 1/1A,165,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY901AJ9,1779,,,M,1800,Visit7,7,Phase 1/1A,196,1 or 1A,100,3,,,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY901AJ9,1779,,,M,2000,Visit8,8,Phase 1/1A,224,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY901AJ9,1779,,,M,2200,Visit9,9,Phase 1/1A,252,1 or 1A,,3,,1,,,,,,,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY901AJ9,1779,,,M,2400,Visit10,10,Phase 1/1A,281,1 or 1A,100,3,,1,,,,,,1,3,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY901AJ9,1779,,,M,2600,Visit11,11,Phase 1/1A,305,1 or 1A,,4,,1,,,,,,,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZY901AJ9,1779,,,M,5200,EndofPhase1_1a,12,Phase 1/1A,337,,,,,,,,,,,,,,,,2,,3,618,600,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ168GJJ,2816,,,F,600,Visit1,1,Phase 1/1A,34,1 or 1A,100,4,,1,,,,,,1,4,800,,,2,,4,800,800,4,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ168GJJ,2816,,,F,5200,EndofPhase1_1a,2,Phase 1/1A,43,1 or 1A,100,4,,1,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,600,Visit1,1,Phase 1/1A,38,1 or 1A,91,2,,,,,,,,1,2,3,,,1,2,3,5,6,3,4,709,800,4,250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,800,Visit2,2,Phase 1/1A,70,1 or 1A,100,3,,1,,,,,,1,3,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,1000,Visit3,3,Phase 1/1A,95,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,1400,Visit5,5,Phase 2,162,2,76,,50,,,,,,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,1600,Visit6,6,Phase 2,189,2,57,3,,0,2,,,,,2,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,1800,Visit7,7,Phase 2,220,2,90,3,,1,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,2000,Visit8,8,Phase 2,253,2,80,2,,,,,,,,1,2,,400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,2200,Visit9,9,Phase 2,280,2,83,3,,,,,,,,1,3,,600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,2400,Visit10,10,Phase 2,315,2,81,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,2600,Visit11,11,Phase 2,343,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,2800,Visit12,12,Phase 2,364,2,84,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,3000,Visit13,13,Phase 2,409,2,100,4,,,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,3200,Visit14,14,Phase 2,434,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,3400,Visit15,15,Phase 2,462,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,3800,Visit17,17,Phase 3,518,3,,,,,,6,150,,,1,,,,150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,5200,EndofPhase1_1a,4,Phase 1/1A,122,1 or 1A,100,4,,,,,,,,1,4,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,5800,EndofPhase2,16,Phase 2,487,2,100,4,,1,,,,,,1,4,,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ241YP6,1636,,,M,6000,EndofPhase3,18,Phase 3,546,3,,,,,,6,350,,,1,,,,350,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ243NW0,2745,,,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,600,Visit1,1,Phase 1/1A,27,1 or 1A,100,1,,,,,,,,1,1,200,,,2,2,3,600,800,3,3,23,30,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,800,Visit2,2,Phase 1/1A,56,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,1200,Visit4,4,Phase 2,117,2,99,1,,,,,,,,1,1,,7.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,1400,Visit5,5,Phase 2,144,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,1800,Visit7,7,Phase 3,200,3,,,,,,6,100,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,2000,Visit8,8,Phase 3,225,3,,,,,,6,500,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,2200,Visit9,9,Phase 3,258,3,,,,,,6,500,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,2400,Visit10,10,Phase 3,285,3,,,,,,6,600,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,2600,Visit11,11,Phase 3,313,3,,,,,,6,600,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,2800,Visit12,12,Phase 3,342,3,,,,,,6,600,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,3000,Visit13,13,Phase 3,365,3,,,,,,6,600,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,3200,Visit14,14,Phase 3,393,3,,,,,,6,600,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,3400,Visit15,15,Phase 3,421,3,,,,,,6,600,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,3600,Visit16,16,Phase 3,449,3,,,,,,6,600,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,3800,Visit17,17,Phase 3,484,3,,,,,,6,600,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,4000,Visit18,18,Phase 3,505,3,,,,,,6,600,4,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,5200,EndofPhase1_1a,3,Phase 1/1A,78,1 or 1A,100,4,,,,,,,,1,4,800,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
2081,8974,NDAR_INVZZ292CU2,1165,,,M,5800,EndofPhase2,6,Phase 2,161,2,100,4,,,,,,,,1,4,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia
